<SEC-DOCUMENT>0001493152-21-010965.txt : 20210511
<SEC-HEADER>0001493152-21-010965.hdr.sgml : 20210511
<ACCEPTANCE-DATETIME>20210511090032
ACCESSION NUMBER:		0001493152-21-010965
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		65
CONFORMED PERIOD OF REPORT:	20210331
FILED AS OF DATE:		20210511
DATE AS OF CHANGE:		20210511

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Surna Inc.
		CENTRAL INDEX KEY:			0001482541
		STANDARD INDUSTRIAL CLASSIFICATION:	AGRICULTURE SERVICES [0700]
		IRS NUMBER:				273911608
		STATE OF INCORPORATION:			NV
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-54286
		FILM NUMBER:		21909815

	BUSINESS ADDRESS:	
		STREET 1:		1780 55TH STREET, SUITE C
		CITY:			BOULDER
		STATE:			CO
		ZIP:			80301
		BUSINESS PHONE:		303-993-5271

	MAIL ADDRESS:	
		STREET 1:		1780 55TH STREET, SUITE C
		CITY:			BOULDER
		STATE:			CO
		ZIP:			80301
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>form10-q.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<!-- Field: Rule-Page --><DIV STYLE="width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 4pt solid; border-bottom: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 18pt"><B>UNITED
STATES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 18pt"><B>SECURITIES
AND EXCHANGE COMMISSION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 12pt"><B>Washington,
D.C. 20549</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 18pt"><B>FORM
10-Q</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>[X]
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>FOR
THE QUARTERLY PERIOD ENDED MARCH 31, 2021</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>OR</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>[&nbsp;&nbsp;]
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Commission
File Number: 000-54286</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 18pt"><B>SURNA
INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Exact
name of registrant as specified in its charter)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 49%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Nevada</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 49%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>27-3911608</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(State
    or other jurisdiction of</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">incorporation
    or organization)</FONT></P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(I.R.S.
    Employer</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Identification
    No.)</FONT></P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 49%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>1780
    55<SUP>th </SUP>Street, Boulder, Colorado</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 49%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>80301</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Address
    of principal executive offices)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Zip
    code)</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(303)
993-5271</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Registrant&rsquo;s
telephone number, including area code)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the issuer (1) has filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act during the
preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such
filing requirements for the last 90 days. <B>YES&nbsp;[X] NO&nbsp;[&nbsp;&nbsp;]</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule
405 of Regulation S-T (&sect; 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant
was required to submit such files). <B>YES&nbsp;[X] NO&nbsp;[&nbsp;&nbsp;]</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting
company, or an emerging growth company. See the definitions of &ldquo;large accelerated filer, &ldquo;accelerated filer,&rdquo; &ldquo;non-accelerated
filer,&rdquo; &ldquo;smaller reporting company,&rdquo; and &ldquo;emerging growth company&rdquo; in Rule 12b-2 of the Exchange Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 30%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Large
    Accelerated Filer</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 20%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>[&nbsp;&nbsp;]</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 30%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Accelerated
    Filer</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 20%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>[&nbsp;&nbsp;]</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Non-accelerated
    Filer</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>[X]</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Smaller
    Reporting Company</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>[X]</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Emerging
    Growth Company</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>[&nbsp;&nbsp;]</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.&nbsp;[&nbsp;&nbsp;]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). <B>YES&nbsp;[&nbsp;&nbsp;] NO&nbsp;[X]</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Securities
registered pursuant to Section 12(b) of the Exchange Act:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 38%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Title
    of each class</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 20%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Trading
    Symbol(s)</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 38%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Name
    of each exchange on which registered</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of May 11, 2021, the number of outstanding shares of common stock of the registrant was 237,526,638.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B></B></FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid; border-bottom: Black 4pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 1; Options: NewSection -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Surna
Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Quarterly
Report on Form 10-Q</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>For
the Quarterly Period Ended March 31, 2021</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Table
of Contents</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 0.5in; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Page</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#d_001">Cautionary Statement</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#d_002">PART I &mdash; FINANCIAL INFORMATION</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#d_003">Item 1. Financial Statements (Unaudited)</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 20pt; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#d_004">Condensed Consolidated Balance Sheets as of March 31, 2021 and December 31, 2020</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">2</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 20pt; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#d_005">Condensed Consolidated Statements of Operations for the Three Months Ended March 31, 2021 and 2020</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 20pt; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#d_006">Condensed Consolidated Statements of Changes in Shareholders&rsquo; Deficit for the Three Months Ended March 31, 2021 and 2020</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 20pt; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#d_007">Condensed Consolidated Statements of Cash Flows for the Three Months Ended March 31, 2021 and 2020</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 20pt; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#d_008">Notes to the Condensed Consolidated Financial Statements</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#c_001">Item 2. Management&rsquo;s Discussion and Analysis of Financial Condition and Results of Operations</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">20</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#c_002">Item 3. Quantitative and Qualitative Disclosures About Market Risk</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">31</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#c_003">Item 4. Controls and Procedures</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">31</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#c_004">PART II &mdash; OTHER INFORMATION</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#c_005">Item 1. Legal Proceedings</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">32</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#c_006">Item 1A. Risk Factors</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">32</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#c_007">Item 2. Unregistered Sales of Equity Securities and Use of Proceeds</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">32</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#c_008">Item 3. Defaults Upon Senior Securities</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">32</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#c_009">Item 4. Mine Safety Disclosures</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">32</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#c_010">Item 5. Other Information</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">32</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#c_011">Item 6. Exhibits</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">32</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#c_012">SIGNATURES</A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">33</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><A HREF="#c_013"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">EXHIBIT INDEX</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">34</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2; Options: NewSection -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->i<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>In
this Quarterly Report on Form 10-Q, unless otherwise indicated, the &ldquo;Company&rdquo;, &ldquo;we&rdquo;, &ldquo;us&rdquo; or &ldquo;our&rdquo;
refer to Surna Inc. and, where appropriate, its wholly owned subsidiary.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="d_001"></A>CAUTIONARY
STATEMENT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Quarterly Report on Form 10-Q, including &ldquo;Management&rsquo;s Discussion and Analysis of Financial Condition and Results of Operations&rdquo;
in Item 2, contains forward-looking statements that involve substantial risks and uncertainties. These forward-looking statements are
not historical fact, but are based on current management expectations that involve substantial risks, uncertainties, and other factors,
some of which are beyond our control and difficult to predict and could cause actual results to differ materially from those expressed
in, or implied by, these forward-looking statements. Forward-looking statements relate to future events or our future financial performance.
We generally identify forward-looking statements by terminology such as &ldquo;may,&rdquo; &ldquo;will,&rdquo; &ldquo;should,&rdquo;
&ldquo;expects,&rdquo; &ldquo;plans,&rdquo; &ldquo;anticipates,&rdquo; &ldquo;could,&rdquo; &ldquo;intends,&rdquo; &ldquo;target,&rdquo;
&ldquo;projects,&rdquo; &ldquo;contemplates,&rdquo; &ldquo;believes,&rdquo; &ldquo;estimates,&rdquo; &ldquo;predicts,&rdquo; &ldquo;potential,&rdquo;
or &ldquo;continue&rdquo; or the negative of these terms or other similar words. All statements, other than statements of historical
fact, are statements that could be deemed forward-looking statements including, but not limited to, any projections of revenue, gross
profit, earnings or loss, tax provisions, cash flows or other financial items; any statements of the plans, strategies or objectives
of management for future operations; any statements regarding current or future macroeconomic or industry-specific trends or events and
the impact of those trends and events on us or our financial performance; any statements regarding pending investigations, legal claims
or tax disputes; any statements of expectation or belief; and any statements of assumptions underlying any of the foregoing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
forward-looking statements are subject to known and unknown risks, uncertainties, assumptions and other factors that could cause our
actual results of operations, financial condition, liquidity, performance, prospects, opportunities, achievements or industry results,
as well as those of the markets we serve or intend to serve, to differ materially from those expressed in, or suggested by, these forward-looking
statements. These forward-looking statements are based on assumptions regarding our present and future business strategies and the environment
in which we operate. Important factors that could cause those differences include, but are not limited to:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    business prospects and the prospects of our existing and prospective customers;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    impact on our business and that of our customers of the current and future response by the government and businesses to the COVID-19
    pandemic, including what is necessary to protect our staff and the staff of our customers in the conduct of our respective businesses;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    overall impact of the COVID-19 pandemic on the business climate in our industry and the willingness of our customers to undertake
    projects in light of economic uncertainties;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    overall financial condition, including any adverse changes in our revenue and business disruption, due to the COVID-19 pandemic business
    and economic response and its consequences;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">variations
    in our sales from reporting period to reporting period;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    inherent uncertainty of product development;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">regulatory,
    legislative and judicial developments, especially those related to changes in, and the enforcement of, cannabis laws;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">increasing
    competitive pressures in the CEA (Controlled Environment Agriculture) industry;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    ability to effectively operate our business, including servicing our existing customers and obtaining new business;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    relationships with our customers and suppliers;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
continuation of normal payment terms and conditions with our customers and suppliers, including our ability to obtain advance payments
from our customers;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->ii<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">general
    economic conditions, our customers&rsquo; operations and access to capital, and market and business disruptions including severe
    weather conditions, natural disasters, health hazards, terrorist activities, financial crises, political crises or other major events,
    or the prospect of these events, adversely affecting demand for the products and services offered by us in the markets in which we
    operate;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">changes
    in our business strategy or development plans, including our expected level of capital expenses and working capital;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    ability to attract and retain qualified personnel;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    ability to raise equity and debt capital to fund our operations and growth strategy, including possible acquisitions; </FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    ability to identify, complete and integrate potential strategic acquisitions; </FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">future
    revenue being lower than expected; </FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    ability to convert our backlog into revenue in a timely manner, or at all; and</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    intention not to pay dividends.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Although
we believe that the assumptions on which these forward-looking statements are based are reasonable, any of those assumptions could prove
to be inaccurate, and as a result, the forward-looking statements based on those assumptions also could be inaccurate. In light of these
and other uncertainties, the inclusion of a projection or forward-looking statement in this Quarterly Report on Form 10-Q should not
be regarded as a representation by us that our plans and objectives will be achieved. These risks and uncertainties include those described
or identified in &ldquo;Item 1A &ndash; Risk Factors&rdquo; in our Annual Report on Form 10-K for the year ended December 31, 2020, as
updated from time to time in the Company&rsquo;s filings with the U.S. Securities and Exchange Commission (the &ldquo;SEC&rdquo;). You
should not place undue reliance on these forward-looking statements, which apply only as of the date of this Quarterly Report on Form
10-Q. Except as required by the federal securities laws, we undertake no obligation to revise or update any forward-looking statements,
whether as a result of new information, future events or otherwise, to reflect events or circumstances occurring after the date of this
Quarterly Report on Form 10-Q. The forward-looking statements and projections contained in this Quarterly Report on Form 10-Q are excluded
from the safe harbor protection provided by Section 27A of the Securities Act of 1933, as amended (the &ldquo;Securities Act&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->iii<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="d_002"></A>PART
I &mdash; FINANCIAL INFORMATION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="d_003"></A>ITEM
1. FINANCIAL STATEMENTS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Surna
Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="d_004"></A>Condensed
Consolidated Balance Sheets</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">March 31,</TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">December 31,</TD><TD STYLE="font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2020</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">(Unaudited)</TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold">ASSETS</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left">Current Assets</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; width: 60%; text-align: left">Cash, cash equivalents and restricted cash</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 16%; text-align: right">3,271,128</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 16%; text-align: right">2,284,881</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left">Accounts receivable (net of allowance for doubtful accounts of $165,098 and $165,098, respectively)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">26,732</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">33,480</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-align: left">Inventory, net</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">519,159</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">327,109</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Prepaid expenses and other</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">2,064,588</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">1,037,823</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Total Current Assets</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">5,881,607</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">3,683,293</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left">Noncurrent Assets</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-align: left">Property and equipment, net</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">141,825</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">147,732</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt">Goodwill</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">631,064</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">631,064</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-align: left">Intangible assets, net</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">7,082</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">7,227</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt">Deposits</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">8,061</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Operating lease right-of-use asset</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">294,900</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">343,950</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Total Noncurrent Assets</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">1,082,932</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">1,129,973</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 2.5pt">TOTAL ASSETS</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">6,964,539</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">4,813,266</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left">LIABILITIES AND SHAREHOLDERS&rsquo; DEFICIT</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left">CURRENT LIABILITIES</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-align: left">Accounts payable and accrued liabilities</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">1,790,315</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">1,784,961</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left">Deferred revenue</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">6,087,093</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,724,189</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-align: left">Accrued equity compensation</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">52,794</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">128,434</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left">Other liabilities</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">37,078</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Current portion of operating lease liability</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">263,662</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">266,105</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Total Current Liabilities</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">8,230,942</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">5,903,689</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left">NONCURRENT LIABILITIES</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-align: left">Note payable and accrued interest</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">514,918</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left">Other liabilities</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">37,078</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">74,156</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Operating lease liability, net of current portion</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">106,891</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">169,119</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Total Noncurrent Liabilities</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">658,887</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">243,275</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 1.5pt">TOTAL LIABILITIES</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">8,889,829</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">6,146,964</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Commitments and Contingencies (Note 7)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left">SHAREHOLDERS&rsquo; DEFICIT</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-align: left">Preferred stock, $0.00001 par value; 150,000,000 shares authorized; 42,030,331 shares issued and outstanding</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">420</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">420</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left">Common stock, $0.00001 par value; 350,000,000 shares authorized; 236,526,638 and 236,526,638 shares issued and outstanding, respectively</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,366</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,366</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-align: left">Common stock, $0.00001 par value; 1,000,000 shares to be issued</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">67,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left">Additional paid in capital</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">26,241,935</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">26,107,159</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Accumulated deficit</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(28,237,011</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(27,443,643</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Total Shareholders&rsquo; Deficit</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(1,925,290</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(1,333,698</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 2.5pt">TOTAL LIABILITIES AND SHAREHOLDERS&rsquo; DEFICIT</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">6,964,539</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">4,813,266</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying notes are an integral part of these condensed consolidated financial statements.</FONT></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 5; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Surna
Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="d_005"></A>Condensed
Consolidated Statements of Operations</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(Unaudited)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0; margin-bottom: 0">For the Three Months Ended</P>
                                                                                <P STYLE="margin-top: 0; margin-bottom: 0">March 31,</P></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2020</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 60%; text-align: left">Revenue, net</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 16%; text-align: right">2,366,529</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 16%; text-align: right">1,809,925</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 1.5pt">Cost of revenue</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">2,021,923</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">1,353,401</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Gross profit</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">344,606</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">456,524</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Operating expenses:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left">Advertising and marketing expenses</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">177,145</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">148,921</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-align: left">Product development costs</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">112,638</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">144,948</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Selling, general and administrative expenses</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">740,473</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">1,108,993</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Total operating expenses</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">1,030,256</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">1,402,862</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Operating loss</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(685,650</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(946,338</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Other income (expense):</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left">Other income (expense), net</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(107,000</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">14,320</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Interest expense</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(718</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(6,295</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Total other income (expense)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(107,718</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">8,025</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Loss before provision for income taxes</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(793,368</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(938,313</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Income taxes</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt">Net loss</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(793,368</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(938,313</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt">Loss per common share &ndash; basic and dilutive</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(0.00</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(0.00</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt">Weighted average number of common shares outstanding, basic and dilutive</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">236,526,638</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">231,062,462</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
accompanying notes are an integral part of these condensed consolidated financial statements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Surna
Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="d_006"></A>Condensed
Consolidated Statements of Changes in Shareholders&rsquo; Deficit</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>For
the Three Months Ended March 31, 2021 and 2020</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(Unaudited)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
<TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="6" STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-size: 8pt">Preferred
    Stock</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="14" STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-size: 8pt">Common
    Stock</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-size: 8pt">Number
    of Shares</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-size: 8pt">Amount</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-size: 8pt">Number
    of Shares</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-size: 8pt">Amount</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-size: 8pt">Number
    of Shares to be Issued</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-size: 8pt">Amount</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-size: 8pt">Additional
    Paid in Capital</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-size: 8pt">Accumulated
    Deficit</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-size: 8pt">Shareholders&rsquo;
    Equity</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 28%; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">Balance December 31, 2020</FONT></TD><TD STYLE="width: 2%; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="width: 4%; font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">42,030,331</FONT></TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="width: 2%; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">$</FONT></TD><TD STYLE="width: 4%; font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">420</FONT></TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="width: 2%; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="width: 4%; font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">236,526,638</FONT></TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="width: 2%; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">$</FONT></TD><TD STYLE="width: 4%; font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">2,366</FONT></TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="width: 2%; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="width: 4%; font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="width: 2%; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">$</FONT></TD><TD STYLE="width: 4%; font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="width: 2%; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">$</FONT></TD><TD STYLE="width: 4%; font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">26,107,159</FONT></TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="width: 2%; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">$</FONT></TD><TD STYLE="width: 4%; font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">(27,443,643</FONT></TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">)</FONT></TD><TD STYLE="width: 2%; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">$</FONT></TD><TD STYLE="width: 4%; font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">(1,333,698</FONT></TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">Common shares to be
    issued in settlement of legal dispute</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">1,000,000</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">67,000</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">67,000</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">Fair value of vested
    stock options granted to employees</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">128,434</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">128,434</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">Fair value of vested
    stock options granted to directors</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">6,342</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">6,342</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-size: 8pt">Net
    loss</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">(793,368</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">(793,368</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-size: 8pt">Balance March
    31, 2021</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">42,030,331</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">420</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">236,526,638</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">2,366</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">1,000,000</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">67,000</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">26,241,935</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">(28,237,011</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">(1,925,290</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">)</FONT></TD></TR>
</TABLE>

<P STYLE="font: 11pt/107% Calibri, Helvetica, Sans-Serif; margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 8pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="text-align: center; border-bottom: Black 1.5pt solid">Preferred Stock</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="10" STYLE="text-align: center; border-bottom: Black 1.5pt solid">Common Stock</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">Number of Shares</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">Amount</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">Number of Shares</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">Number of Shares to be Issued</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">Amount</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">Additional Paid in Capital</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">Accumulated Deficit</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">Shareholders&rsquo; Equity</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 28%">Balance December 31, 2019</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 5%; text-align: right">42,030,331</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 5%; text-align: right">420</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 5%; text-align: right">228,216,638</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 5%; text-align: right">1,560,000</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 5%; text-align: right">2,283</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 5%; text-align: right">25,326,593</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 5%; text-align: right">(25,684,927</TD><TD STYLE="width: 1%; text-align: left">)</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 5%; text-align: right">(355,631</TD><TD STYLE="width: 1%; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Common shares issued or to be issued on settlement of restricted stock units and award of stock bonuses</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">8,310,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(1,560,000</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">83</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(83</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Fair value of vested restricted stock units awarded to employees</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">18,872</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">18,872</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Fair value of vested stock options granted to employees and directors</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">639,020</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">639,020</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Net loss</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(938,313</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(938,313</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 2.5pt">Balance March 31, 2020</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">42,030,331</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">420</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">236,526,638</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">-</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">2,366</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">25,984,402</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(26,623,240</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(636,052</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying notes are an integral part of these condensed consolidated financial statements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Surna
Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="d_007"></A>Condensed
Consolidated Statements of Cash Flows</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(Unaudited)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">For the Three Months Ended <BR> March 31,</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2020</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Cash Flows From Operating Activities:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 60%; text-align: left">Net loss</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 16%; text-align: right">(793,368</TD><TD STYLE="width: 1%; text-align: left">)</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 16%; text-align: right">(938,313</TD><TD STYLE="width: 1%; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Adjustments to reconcile net loss to net cash provided by (used in) operating activities:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 10pt">Depreciation and intangible asset amortization expense</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">18,377</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">30,735</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 10pt">Share-based compensation</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">6,342</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">154,426</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 10pt">Other share-based expense</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">67,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 10pt">Provision for excess and obsolete inventory</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(4,371</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(11,657</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 10pt">Loss on disposal of assets</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,124</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 10pt">Amortization of ROU asset</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">49,051</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">46,666</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Changes in operating assets and liabilities:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 10pt">Accounts receivable</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">6,748</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">688</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt">Inventory</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(187,679</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(71,279</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 10pt">Prepaid expenses and other</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(1,026,765</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">74,924</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 10pt">Accounts payable and accrued liabilities</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5,354</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">289,289</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 10pt">Deferred revenue</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,362,905</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(291,104</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 10pt">Accrued interest</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">718</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 10pt">Lease deposit</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(8,061</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 10pt">Operating lease liability, net</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(64,672</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(52,849</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; padding-left: 10pt">Accrued equity compensation</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">52,794</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">36,463</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Net cash provided by operating activities</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">484,373</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(727,887</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Cash Flows From Investing Activities</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; padding-left: 10pt">Purchases of property and equipment</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(12,326</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Net cash used in investing activities</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(12,326</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Cash Flows From Financing Activities</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; padding-left: 10pt">Proceeds from issuance of note payable</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">514,200</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Net cash provided by financing activities</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">514,200</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Net change in cash, cash equivalents and restricted cash</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">986,247</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(727,887</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Cash, cash equivalents and restricted cash, beginning of period</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">2,284,881</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">922,177</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt">Cash, cash equivalents and restricted cash, end of period</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">3,271,128</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">194,290</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Supplemental cash flow information:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt; padding-left: 10pt">Interest paid</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">-</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">-</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt; padding-left: 10pt">Income taxes paid</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">-</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">-</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>


<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying notes are an integral part of these condensed consolidated financial statements.</FONT></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Surna
Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="d_008"></A>Notes
to Condensed Consolidated Financial Statements</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(Unaudited)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Note
1 &ndash; General</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Description
of Business</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Surna
Inc. (the &ldquo;Company&rdquo;) was incorporated in Nevada on October 15, 2009 and operates under a trade name of Surna Cultivation
Technologies. We design, engineer and sell environmental control and other technologies for the Controlled Environment Agriculture (CEA)
industry. The CEA industry is one of the fastest-growing sectors of the United States&rsquo; economy. From leafy greens (kale, Swiss
chard, mustard, cress), microgreens (leafy greens harvested at the first true leaf stage), ethnic vegetables and small fruits (such as
strawberries, blackberries and raspberries) to bell peppers, cucumbers, tomatoes, and cannabis, some producers grow crops indoors in
response to market dynamics or as part of their preferred farming practice. In service of the CEA industry, our principal technologies
include: (i) liquid-based process cooling systems and other climate control systems, (ii) air handling equipment and systems, (iii) a
full-service engineering package for designing and engineering commercial scale thermodynamic systems specific to cultivation facilities,
and (iv) automation and control devices, systems and technologies used for environmental, lighting and climate control. Our customers
include commercial, state- and provincial-regulated CEA growers in the U.S. and Canada as well as other international locations. Customers
are those growers building new facilities and those expanding or retrofitting existing facilities. Currently, our revenue stream is derived
primarily from supplying our products, services and technologies to commercial indoor facilities ranging from several thousand to more
than 100,000 square feet. Headquartered in Boulder, Colorado, we leverage our experience in this space to bring value-added climate control
solutions to our customers that help improve their overall crop quality and yield, optimize energy and water efficiency, and satisfy
the evolving state and local codes, permitting and regulatory requirements. Although our customers do, we neither produce nor sell cannabis
or its related products.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Impact
of the COVID-19 Pandemic on Our Business</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
impact of the government and the business economic response to the COVID-19 pandemic has affected demand across the majority of our markets
and disrupted work on projects. The COVID-19 pandemic is expected to have continued adverse effects on our sales, project implementation,
operating margins, and working capital. As of the date of this filing, uncertainty continues to exist concerning the magnitude and duration
of the economic impact of the COVID-19 pandemic.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
response to the COVID-19 pandemic and the government and business response, during 2020, the Company took measures to adjust its
operations. These actions included initial measures to cut costs and preserve cash, and encompassed downsizing workforce, compensation
reductions, and reduced hours worked that were later changed upwards and in some cases fully restored late in 2020, as the Company
gained new contracts, bank funding was available and the overall business climate improved. The Company continues to actively
monitor its operations and sales efforts in light of the continuing effects of the COVID-19 pandemic and will make adjustments
to its operations as necessary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Due
to the speed with which the COVID-19 pandemic developed and the resulting uncertainties, including the depth and duration of the disruptions
to customers and suppliers, its future effect on our business, on our results of operations, and on our financial condition, we cannot
predict the overall effect on our business over the longer term. Addressing this uncertainty, we have undertaken various plans to reduce
costs so as to mitigate the impact of the COVID-19 pandemic to the best of our ability, although they may not be sufficient in the long-run
for us to avoid reduced sales, increased losses and reduced operating cash flows.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Refer
to <I>Risk Factors</I>, included in Part II, Item 1A of this Quarterly Report on Form 10-Q below, for further discussion of the possible
impact of the COVID-19 pandemic on our business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Surna
Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Notes
to Condensed Consolidated Financial Statements</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(Unaudited)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Financial
Statement Presentation</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying unaudited condensed consolidated financial statements of the Company have been prepared in conformity with accounting principles
generally accepted in the United States of America (&ldquo;GAAP&rdquo;) for interim financial information and with the instructions to
Form 10-Q and Rule 10-01 of Regulation S-X. Pursuant to these rules and regulations, certain information and note disclosures, normally
included in financial statements prepared in accordance with GAAP, have been condensed or omitted. In the opinion of management, all
adjustments (consisting of normal recurring items) considered necessary for a fair presentation have been included. Operating results
for the three months ended March 31, 2021 are not necessarily indicative of the results that may be expected for the fiscal year ending
December 31, 2021. The balance sheet as of December 31, 2020 has been derived from the audited financial statements at that date but
does not include all the information and footnotes required by GAAP for complete financial statements. For further information, refer
to the consolidated financial statements and notes thereto contained in the Annual Report on Form 10-K for the year ended December 31,
2020. The notes to the unaudited condensed consolidated financial statements are presented on a going concern basis.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Basis
of Consolidation and Reclassifications</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
condensed consolidated financial statements include the accounts of the Company and its controlled and wholly owned subsidiary, Hydro
Innovations, LLC (&ldquo;Hydro&rdquo;). Intercompany transactions, profit, and balances are eliminated in consolidation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 30.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Going
Concern</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying condensed consolidated financial statements have been prepared assuming that the Company will continue as a going concern,
which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. The Company has experienced
recurring losses since its inception. Since inception, the Company has financed its activities principally through debt and equity financing,
customer deposits and revenues from completed contracts. Management expects to incur additional losses and cash outflows in the foreseeable
future in connection with its operating activities. Management believes that the economic dislocations in the overall economy, in the
near term, will impact our revenues, losses and cash flows. There can be no assurance that the Company will be able to raise debt or
equity financing in sufficient amounts, when and if needed, on acceptable terms or at all. If results of operations for 2021 do not meet
management&rsquo;s expectations, or additional capital is not available, management believes it has the ability to reduce certain expenditures.
The precise amount and timing of the funding needs cannot be determined accurately at this time, and will depend on a number of factors,
including the overall economy, market demand for the Company&rsquo;s products and services, the quality of product development efforts,
management of working capital, and continuation of normal payment terms and conditions for purchase of the Company&rsquo;s products.
The Company believes its cash balances and cash flow from operations will be insufficient to fund its operations for the next 12 months.
If the Company is unable to substantially increase revenues, reduce expenditures, or otherwise generate cash flows from operations, then
the Company will need to raise additional funding to continue as a going concern. The foregoing factors raise substantial doubt about
the Company&rsquo;s ability to continue as a going concern for a period of one year from the date the financial statements are issued.
These condensed consolidated financial statements do not include any adjustment that might result from the outcome of this uncertainty.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Use
of Estimates</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management
makes estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and
liabilities at the date of the financial statements and that affect the reported amounts of revenue and expenses during the reporting
period. The Company bases its estimates on historical experience and on various other assumptions that it believes to be reasonable under
the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that
are not readily apparent from other sources. Actual results could differ from those estimates. Key estimates include: allocation of transaction
prices to performance obligations under contracts with customers, standalone selling prices, timing of expected revenue recognition on
remaining performance obligations under contracts with customers, valuation of intangible assets, valuation of equity-based compensation,
valuation of deferred tax assets and liabilities, warranty accruals, accounts receivable and inventory allowances, and legal contingencies.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Cash,
Cash Equivalents and Restricted Cash</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
highly liquid investments with original maturities of three months or less at the date of purchase are considered to be cash equivalents.
The Company may, from time to time, have deposits in financial institutions that exceed the federally insured amount. The Company has
not experienced any losses to date on depository accounts.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Surna
Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Notes
to Condensed Consolidated Financial Statements</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(Unaudited)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the three months ended March 31, 2021, the Company transferred a balance of $180,000 into a new bank account which was to be used for
the sole purpose of paying certain warranty claims. The balance on this restricted bank account as of March 31, 2021 was $86,697.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Income
(Loss) Per Common Share</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic
income (loss) per common share is computed by dividing net income (loss) attributable to common stockholders by the weighted-average
number of common shares outstanding during the period without consideration of common stock equivalents. Diluted net income (loss) per
common share is computed by dividing net income (loss) by the weighted-average number of common shares outstanding and potentially dilutive
common stock equivalents, including stock options, warrants and restricted stock units and other equity-based awards, except in cases
where the effect of the common stock equivalents would be antidilutive. Potential common stock equivalents consist of common stock issuable
upon exercise of stock options and warrants and the vesting of restricted stock units using the treasury method.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the three months ended March 31, 2021 and 2020, there were warrants and options outstanding to purchase Company common stock and restricted
stock units that were convertible into shares of the Company&rsquo;s common stock. During the three-month periods ended March 31, 2021
and 2020, the Company incurred a net loss and consequently the common share equivalents of these potentially dilutive equity instruments
have not been included in the calculations of loss per share because such inclusion would have been anti-dilutive. As of March 31, 2021,
and 2020, there were respectively, 30,249,300 and 45,748,400, potentially dilutive equity instruments outstanding in respect of warrants
and options outstanding to purchase Company common stock and restricted stock units that were convertible into shares of the Company&rsquo;s
common stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Goodwill</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 30.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company recorded goodwill in connection with its acquisition of Hydro Innovations, LLC in July 2014. Goodwill is reviewed for impairment
annually or more frequently when events or changes in circumstances indicate that fair value of the reporting unit has been reduced to
less than its carrying value. The Company performs a quantitative impairment test annually on December 31 by comparing the fair value
of the reporting unit with its carrying amount, including goodwill. If the fair value of the reporting unit exceeds its carrying amount,
goodwill is considered not impaired. An impairment charge would be recognized for the amount by which the carrying amount exceeds the
reporting unit&rsquo;s fair value. The Company determined that it has one reporting unit.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the three months ended March 31, 2021, the Company concluded that the projected impact of the COVID-19 pandemic on its sales, contract
completion and revenues in the near term, together with the volatility in its share price during the quarter represented potential indicators
of impairment. Accordingly, the Company performed an interim impairment analysis at March 31, 2021, and concluded that no impairment
relating to goodwill existed at March 31, 2021.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 30.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Revenue
Recognition</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 1, 2018, the Company adopted Accounting Standards Update (&ldquo;ASU&rdquo;) 2014-09 (Topic 606), <I>Revenue from Contracts with
Customers</I> and all the related amendments (&ldquo;ASC 606&rdquo; or the &ldquo;revenue standard&rdquo;) to all contracts and elected
the modified retrospective method.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the revenue standard, a performance obligation is a promise in a contract with a customer to transfer a distinct good or service to the
customer. Most of the Company&rsquo;s contracts contain multiple performance obligations that include engineering and technical services
as well as the delivery of a diverse range of climate control system equipment and components, which can span multiple phases of a customer&rsquo;s
project life-cycle from facility design and construction to equipment delivery and system installation and start-up.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Surna
Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Notes
to Condensed Consolidated Financial Statements</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(Unaudited)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
contract&rsquo;s transaction price is allocated to each distinct performance obligation and recognized as revenue when, or as, the performance
obligation is satisfied. When there are multiple performance obligations within a contract, the Company allocates the transaction price
to each performance obligation based on standalone selling price. When estimating the selling price, the Company uses various observable
inputs. The best observable input is the Company&rsquo;s actual selling price for the same good or service, however, this input is generally
not available for the Company&rsquo;s contracts containing multiple performance obligations. For engineering services, the Company estimates
the standalone selling price by reference to certain physical characteristics of the project, such as facility size and mechanical systems
involved, which are indicative of the scope and complexity of the mechanical engineering services to be provided. For equipment sales,
the standalone selling price is determined by forecasting the expected costs of the equipment and then adding an appropriate margin,
based on a range of acceptable margins established by management. Depending on the nature of the performance obligations, the Company
may use a combination of different methods and observable inputs if certain performance obligations have highly variable or uncertain
standalone selling prices. Once the selling prices are determined, the Company applies the relative values to the total contract consideration
and estimates the amount of the transaction price to be recognized as each performance obligation is fulfilled.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company recognizes revenue for the sale of goods when control transfers to the customer, which primarily occurs at the time of shipment.
The Company&rsquo;s historical rates of return are insignificant as a percentage of sales and, as a result, the Company does not record
a reserve for returns at the time the Company recognizes revenue. The Company has elected to exclude from the measurement of the transaction
price all taxes (e.g., sales, use, value added, and certain excise taxes) that are assessed by a governmental authority in connection
with a specific revenue-producing transaction and collected by the Company from the customer. Accordingly, the Company recognizes revenue
net of sales taxes. The revenue and cost for freight and shipping is recorded when control over the sale of goods passes to the Company&rsquo;s
customers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company also has performance obligations to perform certain engineering services that are satisfied over a period of time. Revenue is
recognized from this type of performance obligation as services are rendered based on the percentage completion towards certain specified
milestones.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company offers assurance-type warranties for its products and products manufactured by others to meet specifications defined by the contracts
with customers and does not have any material separate performance obligations related to these warranties. The Company maintains a warranty
reserve based on historical warranty costs.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Applying
the practical expedient in ASC 606-10-32-18, which the Company has elected, the Company does not adjust the promised amount of consideration
for the effects of a significant financing component since the Company expects, at contract inception, that the period between when the
Company transfers a promised good or service to a customer and when the customer pays for that good or service will be one year or less.
Accordingly, the remaining performance obligations related to customer contracts does not consider the effects of the time value of money.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Applying
the practical expedient in ASC 340-40-25-4, the Company recognizes the incremental costs of obtaining contracts as an expense when incurred
since the amortization period of the assets that the Company otherwise would have recognized is one year or less. These costs include
certain sales commissions and incentives, which are included in selling, general and administrative expenses, and are payable only when
associated revenue has been collected and earned by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company does not have material amounts of contract assets since revenue is recognized as control of goods is transferred or as services
are performed. Contract liabilities consist of advance payments and deferred revenue.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the three months ended March 31, 2021, the Company recognized revenue of $1,880,364 related to the deferred revenue at January
1, 2021. For the three months ended March 31, 2020, the Company recognized revenue of $859,705 related to the deferred
revenue at January 1, 2020.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Remaining
performance obligations, or backlog, represents the aggregate amount of the transaction price allocated to the remaining obligations
that the Company has not performed under its customer contracts. The Company has elected not to use the optional exemption in ASC 606-10-50-14,
which exempts an entity from such disclosures if a performance obligation is part of a contract with an original expected duration of
one year or less. Accordingly, the information disclosed about remaining performance obligations includes all customer contracts, including
those with an expected duration of one year or less.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Surna
Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Notes
to Condensed Consolidated Financial Statements</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(Unaudited)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Industry
uncertainty, project financing concerns, and the licensing and qualification of our prospective customers, which are out of the Company&rsquo;s
control, make it difficult for the Company to predict when it will recognize revenue on its remaining performance obligations. There
are risks that the Company may not realize the full contract value on customer projects in a timely manner or at all, and completion
of a customer&rsquo;s cultivation facility project is dependent upon the customer&rsquo;s ability to secure funding and real estate,
obtain a license and then build their cultivation facility so they can take possession of the equipment. Accordingly, the time it takes
for customers to complete a project, which corresponds to when the Company is able to recognize revenue, is driven by numerous factors
including: (i) the large number of first-time participants interested in the indoor cannabis cultivation business; (ii) the complexities
and uncertainties involved in obtaining state and local licensure and permitting; (iii) local and state government delays in approving
licenses and permits due to lack of staff or the large number of pending applications, especially in states where there is no cap on
the number of cultivators; (iv) the customer&rsquo;s need to obtain cultivation facility financing; (v) the time needed, and coordination
required, for our customers to acquire real estate and properly design and build the facility (to the stage when climate control systems
can be installed); (vi) the large price tag and technical complexities of the climate control and air sanitation system; (vii) the availability
of power; and (viii) delays that are typical in completing any construction project.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of March 31, 2021, the Company&rsquo;s remaining performance obligations, or backlog, was $11,578,000, of which $2,006,000, or 17%, was
attributable to customer contracts for which the Company has only received an initial advance payment to cover the allocated value of
the Company&rsquo;s engineering services (&ldquo;engineering only paid contracts&rdquo;). There is the risk that the equipment portion
of these engineering only paid contracts will not be completed or will be delayed. These reasons include the customer being dissatisfied
with the quality or timeliness of the Company&rsquo;s engineering services, delay or abandonment of the project because of the customer&rsquo;s
inability to obtain project financing or licensing, or other reasons such as a challenging business climate including an overall post-Covid-19
economic downturn, or change in business direction. After the customer has made an advance payment for a portion of the equipment to
be delivered under the contract (&ldquo;partial equipment paid contracts&rdquo;), the Company is typically better able to estimate the
timing of revenue recognition since the risks and delays associated with licensing, permitting and project funding are typically mitigated
once the initial equipment payment is received. There is significant uncertainty regarding the timing of the Company&rsquo;s recognition
of revenue on its remaining performance obligations, and there is no certainty that these will result in actual revenues. The backlog
at March 31, 2021, includes booked sales orders of $449,000 from several customers that the Company does not expect to be realized until
2022, if at all. Given the present economic uncertainty arising from the impact of the novel coronavirus COVID-19, the Company believes
that several of its current contracts may be delayed or cancelled in the short term.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
remaining performance obligations expected to be recognized through 2022 are as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="border-collapse: collapse; width: 90%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2022</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Total</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 52%; text-align: left">Remaining performance obligations related to engineering only paid contracts</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 12%; text-align: right">1,563,000</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 12%; text-align: right">443,000</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 12%; text-align: right">2,006,000</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Remaining performance obligations related to partial equipment paid contracts</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">9,566,000</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">6,000</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">$</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">9,572,000</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt">Total remaining performance obligations</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">11,129,000</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">449,000</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">11,578,000</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth the Company&rsquo;s revenue by source:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="border-collapse: collapse; width: 75%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">For the Three Months <BR>
Ended March 31,</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2020</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 52%; text-align: left">Equipment and systems sales</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 20%; text-align: right">2,163,468</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 20%; text-align: right">1,606,946</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Engineering and other services</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">181,083</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">131,591</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Shipping and handling</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">21,978</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">71,388</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt">Total revenue</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">2,366,529</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">1,809,925</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>


<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Surna
Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Notes
to Condensed Consolidated Financial Statements</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(Unaudited)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Accounting
for Share-Based Compensation</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 30.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company recognizes the cost resulting from all share-based compensation arrangements, including stock options, restricted stock awards
and restricted stock units that the Company grants under its equity incentive plan in its condensed consolidated financial statements
based on their grant date fair value. The expense is recognized over the requisite service period or performance period of the award.
Awards with a graded vesting period based on service are expensed on a straight-line basis for the entire award. Awards with performance-based
vesting conditions, which require the achievement of a specific company financial performance goal at the end of the performance period
and required service period, are recognized over the performance period. Each reporting period, the Company reassesses the probability
of achieving the respective performance goal. If the goals are not expected to be met, no compensation cost is recognized and any previously
recognized amount recorded is reversed. If the award contains market-based vesting conditions, the compensation cost is based on the
grant date fair value and expected achievement of market condition and is not subsequently reversed if it is later determined that the
condition is not likely to be met or is expected to be lower than initially expected.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
grant date fair value of stock options is based on the Black-Scholes Option Pricing Model (the &ldquo;Black-Scholes Model&rdquo;). The
Black-Scholes Model requires judgmental assumptions including volatility and expected term, both based on historical experience. The
risk-free interest rate is based on U.S. Treasury interest rates whose term is consistent with the expected term of the option. The Company
determines the assumptions used in the valuation of option awards as of the date of grant. Differences in the expected stock price volatility,
expected term or risk-free interest rate may necessitate distinct valuation assumptions at those grant dates. As such, the Company may
use different assumptions for options granted throughout the year. During the three months ended March 31, 2021, the valuation assumptions
used to determine the fair value of each option award on the date of grant were: expected stock price volatility of 152.51%; expected
term in years 10 and risk-free interest rate of 1.2%.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
grant date fair value of restricted stock and restricted stock units is based on the closing price of the underlying stock on the date
of the grant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has elected to reduce share-based compensation expense for forfeitures as the forfeitures occur since the Company does not have
historical data or other factors to appropriately estimate the expected employee terminations and to evaluate whether particular groups
of employees have significantly different forfeiture expectations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 27.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following is a summary of share-based compensation expenses included in the condensed consolidated statements of operations for the three
months ended March 31, 2021 and 2020:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="border-collapse: collapse; width: 75%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">For the Three Months <BR>
Ended March 31,</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2020</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Share-based compensation expense included in:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 52%">Cost of revenue</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 20%; text-align: right">14,135</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 20%; text-align: right">8,558</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Advertising and marketing expenses</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">6,474</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,912</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Product development costs</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">6,694</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">6,545</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Selling, general and administrative expenses</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">31,833</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">172,874</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt">Total share-based compensation expense included in consolidated statement of operations</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">59,136</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">190,889</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Included
in the $59,136 expense for the three months ended March 31, 2021, is an accrual for $52,794 in respect of the 2021 Annual Employee Incentive
Compensation Plan. Included in the $190,889 expense for the three months ended March 31, 2020, is an accrual for $36,463 in respect of
the 2020 Annual Employee Incentive Compensation Plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Concentrations</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Three
customers accounted for 38%, 16%, and 11% of the Company&rsquo;s revenue for the three months March 31, 2021. For the three
months ended March 31, 2020, four customers accounted for 17%, 16%, 10% and 10% of the Company&rsquo;s revenue.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Two
customers accounted for 60%, and 31% of the Company&rsquo;s accounts receivable for the three months ended March 31, 2021.
For the three months ended March 31, 2020, three customers accounted for 59%, 18%, and 15% of the Company&rsquo;s accounts
receivable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Surna
Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Notes
to Condensed Consolidated Financial Statements</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(Unaudited)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Recently
Issued Accounting Pronouncements</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
August 2020, the FASB issued ASU No. 2020-06, <I>Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging&mdash;Contracts
in Entity&rsquo;s Own Equity (Subtopic 815-40)</I> which simplifies the accounting for convertible instruments. The guidance removes
certain accounting models which separate the embedded conversion features from the host contract for convertible instruments. Either
a modified retrospective method of transition or a fully retrospective method of transition is permissible for the adoption of this standard.
Update No. 2020-06 is effective for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years.
Early adoption is permitted no earlier than the fiscal year beginning after December 15, 2020. The Company does not expect this ASU to
have a material impact on its consolidated results of operations, cash flows and financial position.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
March 2020, the FAS issued ASU No. 2020-04 &ldquo;<I>Reference Reform (Topic 848) Facilitation of the Effects of Reference Rate Reform
on Financial Reporting&rdquo; (&ldquo;ASU 2020-04&rdquo;).</I> ASU 2020-04 provides optional guidance for a limited period of time to
ease the potential burden in accounting for (or recognizing the effects of) reference rate reform on financial reporting. The amendments
are effective for the Company as of March 12, 2020 through December 31, 2022. The Company does not expect this ASU to have a material
impact on its consolidated results of operations, cash flows and financial position.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
January 2020, the FASB issued ASU No. 2020-01, <I>Investments&mdash;Equity Securities (Topic 321), Investments&mdash;Equity Method and
Joint Ventures (Topic 323), and Derivatives and Hedging (Topic 815)&mdash;Clarifying the Interactions between Topic 321, Topic 323, and
Topic 815</I> (a consensus of the Emerging Issues Task Force). This update clarifies whether an entity should consider observable transactions
that require it to either apply or discontinue the equity method of accounting for the purposes of applying the measurement alternative
and how to account for certain forward contracts and purchased options to purchase securities. For public entities, this guidance is
effective for fiscal years beginning after December 15, 2020. The Company does not expect this ASU to have a material impact on its consolidated
results of operations, cash flows and financial position. The adoption of this ASU has not had a material impact on the Company&rsquo;s
consolidated results of operations, cash flows and financial position.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
December 2019, the FASB issued ASU 2019-12, <I>Income Taxes (Topic 740) &ndash; Simplifying the Accounting for Income Taxes, </I>which
simplifies the accounting for income taxes by removing certain exceptions to the general principles in Topic 740. The amendments also
improve consistent application of and simplify GAAP for other areas of Topic 740 by clarifying and amending existing guidance. ASU 2019-12
is effective for fiscal years beginning after December 15, 2020. Early adoption is permitted. The adoption of this ASU has not had a
material impact on the Company&rsquo;s consolidated results of operations, cash flows and financial position.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
accounting standards that have been issued or proposed by FASB that do not require adoption until a future date are not expected to have
a material impact on the financial statements upon adoption. The Company does not discuss recent pronouncements that are not anticipated
to have an impact on or are unrelated to its financial condition, results of operations, cash flows or disclosures.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Note
2 &ndash; Leases</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
February 2016 the FASB issued ASU 2016-02, <I>Leases (Topic 842)</I>(&ldquo;ASC 842&rdquo; or the &ldquo;new lease standard&rdquo;).
The Company adopted ASC 842 as of January 1, 2019, using the effective date method.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
new standard provides a number of optional practical expedients in transition. The Company has elected to apply the &ldquo;package of
practical expedients&rdquo; which allow the Company to not reassess: (i) whether existing or expired arrangements contain a lease, (ii)
the lease classification of existing or expired leases, or (iii) whether previous initial direct costs would qualify for capitalization
under the new lease standard. The Company has also elected to apply the short-term lease exemption for all leases with an original term
of less than 12 months, for purposes of applying the recognition and measurements requirements in the new lease standard.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
adoption, the Company recognized its lease for manufacturing and office space (the &ldquo;Facility Lease&rdquo;) on the balance sheet
as an operating lease right-of-use asset in the amount of $714,416 and as a lease liability of $822,374. The Facility Lease commenced
September 29, 2017 and continues through August 31, 2022. The Company has the option to renew the Facility Lease for an additional five
years. However, the renewal option to extend the Facility Lease is not included in the right-of-use asset or lease liability as the option
is not reasonably certain of exercise. The Company regularly evaluates the renewal option and when it is reasonably certain of exercise,
the Company will include the renewal period in its lease term.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Surna
Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Notes
to Condensed Consolidated Financial Statements</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(Unaudited)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Beginning
September 1, 2018, and each subsequent September 1 during the term, the monthly rent under the Facility Lease will increase by 3%. Total
rent under the current building lease is charged to expense over the term of the lease on a straight-line basis, resulting in the same
monthly rent expense throughout the lease. The difference between the rent expense amount and the actual rent paid is recorded to operating
lease liability on the Company&rsquo;s condensed consolidated balance sheets.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the Facility Lease, the landlord agreed to pay the Company or the Company&rsquo;s contractors for tenant improvements made by the Company
not to exceed $100,000, which were used for normal tenant improvements. The Company determined that these improvements were not specialized
and could be utilized by a subsequent tenant and, as such, the improvements were considered assets of the lessor. As of January 1, 2019,
the unamortized amount of tenant improvement allowance of $81,481 was treated as a reduction in measuring the right-of-use asset.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the Facility Lease, the Company pays the actual amounts for property taxes and insurance, excludes such payments from lease contract
consideration, and records such payments as incurred. The Company also pays the landlord for common area maintenance, which is considered
a nonlease component. For the Facility Lease, the Company has not elected the accounting policy to include both the lease and nonlease
components as a single component and account for it as the lease.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
determining the right-of-use asset and lease liability, the Company applied a discount rate to the minimum lease payments under the Facility
Lease. ASC 842 requires the Company to use the rate of interest that the Company would have to pay to borrow on a collateralized basis
over a similar term an amount equal to the lease payments in a similar economic environment. Since the discount rate is not implicit
in the lease agreement, we utilized an estimated incremental borrowing rate provided by the Company&rsquo;s depository bank.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
lease cost, cash flows and other information related to the Facility Lease were as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="border-collapse: collapse; width: 70%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">For the Three Months Ended March 31,</TD><TD STYLE="text-align: center; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; text-align: left">Operating lease cost</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 20%; text-align: right">54,222</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Operating cash outflow from operating lease</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">69,844</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="border-collapse: collapse; width: 70%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: center; padding-bottom: 1.5pt; width: 76%">&nbsp;</TD><TD STYLE="text-align: center; font-weight: bold; padding-bottom: 1.5pt; width: 2%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center; width: 1%">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center; width: 20%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>As of March 31, 2021</B></FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: center; width: 1%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Operating lease right-of-use assset</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">294,900</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Operating lease liability, current</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">263,662</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Operating lease liability, long-term</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">106,891</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Remaining lease term</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.4 years</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Discount rate</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5.00</TD><TD STYLE="text-align: left">%</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Surna
Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Notes
to Condensed Consolidated Financial Statements</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(Unaudited)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Future
annual minimum lease payments on the Facility Lease as of March 31, 2021 were as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="border-collapse: collapse; width: 70%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; border-bottom: Black 1.5pt solid">Years ended December 31,</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%">2021 (excluding the three months ended March 31, 2021)</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 20%; text-align: right">212,020</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="vertical-align: bottom; text-align: left; padding-bottom: 1.5pt">2022</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">170,891</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Total minimum lease payments</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">382,911</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt">Less imputed interest</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(12,358</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; padding-bottom: 2.5pt">Present value of minimum lease payments</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">370,553</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Note
3 &ndash; Inventory</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inventory
consisted of the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="border-collapse: collapse; width: 75%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="font-weight: bold; text-align: center">March 31,</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="font-weight: bold; text-align: center">December 31,</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 1pt">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 52%; text-align: left">Finished goods</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 20%; text-align: right">325,451</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 20%; text-align: right">201,778</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Work in progress</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">10,083</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,231</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Raw materials</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">272,299</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">214,145</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Allowance for excess &amp; obsolete inventory</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(88,674</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(93,045</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt">Inventory, net</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">519,159</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">327,109</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Overhead
expenses of $17,443 and $17,974 were included in the inventory balance as of March 31, 2021, and December 31, 2020, respectively.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Advance
payments on inventory purchases are recorded in prepaid expenses until title for such inventory passes to the Company. Prepaid expenses
included $1,960,000 and $916,000 in advance payments for inventory for the periods ended March 31, 2021, and December 31, 2020, respectively.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Note
4 &ndash; Property and Equipment</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property
and equipment consisted of the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="border-collapse: collapse; width: 75%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">March 31,</TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">December 31,</TD><TD STYLE="font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2020</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 52%; text-align: justify">Furniture and equipment</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 20%; text-align: right">410,748</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 20%; text-align: right">398,422</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Vehicles</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">15,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">15,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt">Leasehold improvements</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">215,193</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">215,193</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">640,941</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">628,615</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt">Accumulated depreciation</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(499,116</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(480,883</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-bottom: 2.5pt">Property and equipment, net</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">141,825</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">147,732</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Depreciation
expense was $18,233 for the three months ended March 31, 2021. For the three months ended March 31, 2021, $1,249 was allocated to cost
of sales and $312 was allocated to inventory with the remainder recorded as selling, general and administrative expense.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 17; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Surna
Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Notes
to Condensed Consolidated Financial Statements</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(Unaudited)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Note
5 &ndash; Accounts Payable and Accrued Liabilities </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounts
payable and accrued liabilities consisted of the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="border-collapse: collapse; width: 75%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">March 31,</TD><TD STYLE="text-align: center; font-weight: bold">&nbsp;</TD><TD STYLE="text-align: center; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; font-weight: bold">December 31,</TD><TD STYLE="text-align: center; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="text-align: center; font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 52%; text-align: left">Accounts payable</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 20%; text-align: right">860,087</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 20%; text-align: right">918,639</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Sales commissions payable</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">13,649</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">48,263</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Accrued payroll liabilities</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">275,024</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">288,071</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Product warranty accrual</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">264,956</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">173,365</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Other accrued expenses</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">376,599</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">356,623</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; padding-bottom: 2.5pt">Total</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">1,790,315</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">1,784,961</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Note
6 &ndash; Note Payable and Accrued Interest</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 10, 2021, the Company entered into a note payable with its current bank in the principal amount of $514,200, for working capital
purposes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
loan amount bears interest at 1% and is due on February 5, 2026. The loan may be repaid in advance without penalty. The loan is also
potentially forgivable in full provided proceeds are used for payment of payroll expenses, rent, utilities and mortgage interest and
certain other terms and conditions are met. The loan has typical default provisions, including for change of ownership, general lender
insecurity as to repayment, non-payment of amounts due, defaults on other debt instruments, insolvency, dissolution or termination of
the business as a going concern and bankruptcy.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the three ended March 31, 2021, interest of $718 was accrued in respect of this note payable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Note
7 &ndash; Commitments and Contingencies</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Litigation</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2019, there were 6,750,000 restricted stock units that had not been settled due to a dispute with a former employee over
the required withholding taxes to be paid to the Company for remittance to the appropriate tax authorities. The Company commenced an
arbitration action against the former employee regarding the dispute. The former employee also made claims in the arbitration action
against the Company for unpaid wages. As stated in a pleading in the arbitration, on March 9, 2020, the Company issued the former employee
6,750,000 shares of the Company&rsquo;s common stock in settlement of these restricted stock units after taking measures to mitigate
the Company&rsquo;s exposure to penalties and liability for the failure to properly withhold income taxes. The Arbitrator issued an interim
award of approximately $10,000 in the Company&rsquo;s favor and a finding against the former employee. Effective June 9, 2020, the Arbitrator
issued his final award in the Company&rsquo;s favor in the Colorado arbitration. The Arbitrator found against the former employee and
awarded the Company costs of $33,985, with interest at 8% per year. Effective July 22, 2020, the Colorado Court confirmed the Arbitration
award and entered a final judgement in favor of the Company and against the former employee. The Company pursued collection of this debt
and has now collected the debt owed. This former employee continued to pursue separate litigation against the Company for recovery of
alleged consulting fees owed to him for the 2015 calendar year prior to his appointment as an executive officer of the Company. Effective
March 30, 2021, this separate litigation has now been settled. While the Company disputed the merits of the claims, the Company has agreed
and will be obliged to pay $40,000 over eight months and to issue upon execution of the settlement agreement an aggregate of 1,000,000
shares of common stock of the Company. As further discussed in <I>Note 11 Subsequent Events</I> below, these shares were issued on April
8, 2021 as &ldquo;restricted securities,&rdquo; subject to a lock-up agreement of six months, without registration rights, and pursuant
to a private placement exemption. The settlement agreement also included mutual releases and no admission of liability. The cost to the
Company of this settlement, $107,000, has been recognized in full in other expenses during the three months ended March 31, 2021. As
of March 31, 2021, $40,000 in respect of the cash portion of the settlement has been included in accounts payables and accruals and $67,000
in respect of the stock issuance has included in common stock to be issued.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">From
time to time, in the normal course of its operations, the Company is subject to litigation matters and claims. Litigation can be expensive
and disruptive to normal business operations. Moreover, the results of complex legal proceedings are difficult to predict, and the Company&rsquo;s
view of these matters may change in the future as the litigation and events related thereto unfold. The Company expenses legal fees as
incurred. The Company records a liability for contingent losses when it is both probable that a liability has been incurred and the amount
of the loss is known. An unfavorable outcome to any legal matter, if material, could have an adverse effect on the Company&rsquo;s operations
or its financial position, liquidity or results of operations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 18; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Surna
Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Notes
to Condensed Consolidated Financial Statements</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(Unaudited)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Leases</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has a lease agreement for its manufacturing and office space. Refer to <I>Note 2 Leases</I> above.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Other
Commitments</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 30.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the ordinary course of business, the Company enters into commitments to purchase inventory and may also provide indemnifications of varying
scope and terms to customers, vendors, lessors, business partners, and other parties with respect to certain matters, including, but
not limited to, losses arising out of the Company&rsquo;s breach of such agreements, services to be provided by the Company, or from
intellectual property infringement claims made by third parties. In addition, the Company has entered into indemnification agreements
with its directors and certain of its officers and employees that will require the Company to, among other things, indemnify them against
certain liabilities that may arise by reason of their status or service as directors, officers, or employees. The Company maintains director
and officer insurance, which may cover certain liabilities arising from its obligation to indemnify its directors and certain of its
officers and employees, and former officers, directors, and employees of acquired companies, in certain circumstances.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Note
8 &ndash; Equity Incentive Plan </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>2017
Equity Incentive Plan</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the Company&rsquo;s 2017 Equity Incentive Plan, as may be modified and amended by the Company from time to time (the &ldquo;2017 Equity
Plan&rdquo;), the Board of Directors (the &ldquo;Board&rdquo;) (or the compensation committee of the Board, if one is established) may
award stock options, stock appreciation rights (&ldquo;SARs&rdquo;), restricted stock awards (&ldquo;RSAs&rdquo;), restricted stock unit
awards (&ldquo;RSUs&rdquo;), shares granted as a bonus or in lieu of another award, and other stock-based performance awards. The 2017
Equity Plan allocates 50,000,000 shares of the Company&rsquo;s common stock (&ldquo;Plan Shares&rdquo;) for issuance of equity awards
under the 2017 Equity Plan. If any shares subject to an award are forfeited, expire, or otherwise terminate without issuance of such
shares, the shares will, to the extent of such forfeiture, expiration, or termination, again be available for awards under the 2017 Equity
Plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white">During
the three months ended March 31, 2021, the Company issued no shares of its common stock under the 2017 Equity Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white">As
of March 31, 2021, awards related to 22,686,800 shares remain outstanding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white">There
was no unrecognized compensation expense for unvested non-qualified stock options and RSUs at March 31, 2021.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>2021
Equity Incentive Plan</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">On
March 22, 2021, the Board approved the 2021 Equity Incentive Plan (the &ldquo;2021 Plan&rdquo;), which permits the Board to grant awards
of up to 100,000,000 shares of common stock, subject to and effective upon stockholder approval. The 2021 Plan provides for the grant
of incentive stock options intended to qualify under Section 422 of the Internal Revenue Code of 1986, as amended (the &ldquo;Code&rdquo;),
non-qualified stock options, stock appreciation rights (&ldquo;SARs&rdquo;), restricted stock awards and restricted stock unit awards
and other equity linked awards.to our employees, consultants and directors. If an equity award (i) expires or otherwise terminates without
having been exercised in full or (ii) is settled in cash (<I>i.e.</I>, the holder of the award receives cash rather than stock), such
expiration, termination or settlement will not reduce (or otherwise offset) the number of shares of common stock that may be issued pursuant
to this Plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Approval
of the 2021 Plan will be considered by stockholders at the Annual General Meeting of Stockholders to be held on May 28, 2021. If the
2021 Plan is not approved, it may be continued as an equity plan by the Board, but it will not be able to provide for tax qualified incentive
options or satisfy exchange requirements. If not approved by the stockholders, the current intention of the Board is to continue the
2021 Plan and issue awards as appropriate thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 19; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Surna
Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Notes
to Condensed Consolidated Financial Statements</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(Unaudited)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Non-Qualified
Stock Options</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
summary of the non-qualified stock options granted to employees and consultants under the 2017 Equity Plan during the three months ended
March 31, 2021, are presented in the table below:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="border-collapse: collapse; width: 90%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Number of Options</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Weighted Average Exercise Price</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Weighted Average Remaining Contractual Term</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Aggregate Intrinsic Value</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 40%">Outstanding, December 31, 2020</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 11%; text-align: right">14,251,000</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 11%; text-align: right">0.083</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 11%; text-align: right">8.3</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 11%; text-align: right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;-</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt">Granted</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,035,800</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">0.130</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">10.0</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt">Exercised</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt">Forfeited</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; padding-bottom: 1.5pt">Expired</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 2.5pt">Outstanding, March 31, 2021</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">15,286,800</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 2.5pt; text-align: left">$</TD><TD STYLE="padding-bottom: 2.5pt; text-align: right">0.084</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt; text-align: right">8.2</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 2.5pt; text-align: left">$</TD><TD STYLE="padding-bottom: 2.5pt; text-align: right">-</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 2.5pt">Exercisable, March 31, 2021</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">15,286,800</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 2.5pt; text-align: left">$</TD><TD STYLE="padding-bottom: 2.5pt; text-align: right">0.084</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt; text-align: right">8.2</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 2.5pt; text-align: left">$</TD><TD STYLE="padding-bottom: 2.5pt; text-align: right">-</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
summary of non-vested non-qualified stock options activity for employees and consultants under the 2017 Equity Plan for the three months
ended March 31, 2021, are presented in the table below:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="border-collapse: collapse; width: 90%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Number of Options</TD><TD STYLE="text-align: center; font-weight: bold">&nbsp;</TD><TD STYLE="text-align: center; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Weighted Average Grant-Date Fair Value</TD><TD STYLE="text-align: center; font-weight: bold">&nbsp;</TD><TD STYLE="text-align: center; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Aggregate Intrinsic Value</TD><TD STYLE="text-align: center; font-weight: bold">&nbsp;</TD><TD STYLE="text-align: center; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Grant-Date Fair Value</TD><TD STYLE="text-align: center; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>Nonvested, December 31, 2020</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; width: 40%">Granted</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 11%; text-align: right">1,035,800</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 11%; text-align: right">0.124</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 11%; text-align: right">-</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 11%; text-align: right">128,543</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt">Vested</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(1,035,800</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">0.124</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">128,543</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt">Forfeited</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; padding-bottom: 1.5pt">Expired</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">$</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 2.5pt">Nonvested, March 31, 2021</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">-</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 2.5pt; text-align: left">$</TD><TD STYLE="padding-bottom: 2.5pt; text-align: right">-</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 2.5pt; text-align: left">$</TD><TD STYLE="padding-bottom: 2.5pt; text-align: right">-</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">-</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the three months ended March 31, 2021 and March 31, 2020, the Company recorded $0 and $106,288 as compensation expense
related to vested options issued to employees and consultants, net of forfeitures, respectively.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
summary of the non-qualified stock options granted to directors under the 2017 Equity Plan during the three months ended March 31, 2021,
are presented in the table below:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="border-collapse: collapse; width: 90%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid; font-weight: bold">Number of Options</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid; font-weight: bold">Weighted Average Exercise Price</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid; font-weight: bold">Weighted Average Remaining Contractual Term</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid; font-weight: bold">Aggregate Intrinsic Value ($000)</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 40%">Outstanding, December 31, 2020</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 11%; text-align: right">7,400,000</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 11%; text-align: right">0.067</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 11%; text-align: right">7.5</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 11%; text-align: right">2,780</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt">Granted</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt">Exercised</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt">Forfeited/Cancelled</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 1.5pt; padding-left: 10pt">Expired</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 2.5pt">Outstanding, March 31, 2021</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">7,400,000</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 2.5pt; text-align: left">$</TD><TD STYLE="padding-bottom: 2.5pt; text-align: right">0.067</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt; text-align: right">7.2</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 2.5pt; text-align: left">$</TD><TD STYLE="padding-bottom: 2.5pt; text-align: right">2,780</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 2.5pt">Exerciseable, March 31, 2021</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">6,400,000</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 2.5pt; text-align: left">$</TD><TD STYLE="padding-bottom: 2.5pt; text-align: right">0.073</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt; text-align: right">7.7</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 2.5pt; text-align: left">$</TD><TD STYLE="padding-bottom: 2.5pt; text-align: right">-</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>




<!-- Field: Page; Sequence: 20; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Surna
Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Notes
to Condensed Consolidated Financial Statements</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(Unaudited)</B></FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
summary of non-vested non-qualified stock options activity for directors under the 2017 Equity Plan for the three months ended March
31, 2021, are presented in the table below:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="border-collapse: collapse; width: 90%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 1.5pt; text-align: center">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Number of Options</TD><TD STYLE="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Weighted Average Grant-Date Fair Value</TD><TD STYLE="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Aggregate Intrinsic Value</TD><TD STYLE="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Grant-Date Fair Value</TD><TD STYLE="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 40%">Nonvested, December 31, 2020</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 11%; text-align: right">1,000,000</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 11%; text-align: right">0.029</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 11%; text-align: right">29,000</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 11%; text-align: right">38,200</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt">Granted</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt">Vested</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt">Forfeited</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 1.5pt; padding-left: 10pt">Expired</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 2.5pt">Nonvested, March 31, 2021</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">1,000,000</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt; text-align: right">0.029</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">29,000</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">38,200</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the three months ended March 31, 2021 and 2020, the Company incurred $6,342 and $29,266, respectively, as compensation expense related
to 500,000 and 500,000 vested options, respectively, issued to directors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective
June 24, 2020<I>, </I>the Company issued 2 million non-qualified stock options under the 2017 Equity Plan to newly appointed directors.
The options vested 50% upon grant and 50% on April 1, 2021, if the Director remained on the Board up to that time. The options have a
term of 5 years and have an exercise price equal to the closing price of the Company&rsquo;s common stock on The OTC Markets on the day
immediately preceding the grant date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
further discussed in <I>Note 11 Subsequent Events</I> below, 1,000,000 stock options issued to directors effective June 24, 2020 vested on April 1, 2021.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Restricted
Stock Units</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 40.5pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
summary of the RSUs awarded to employees, directors and consultants under the 2017 Equity Plan during the three months ended March 31,
2021, are presented in the table below:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="border-collapse: collapse; width: 90%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 1.5pt; text-align: center">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Number of Units</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><P STYLE="margin-top: 0; margin-bottom: 0">Weighted Average Grant-Date</P>
                                                                                <P STYLE="margin-top: 0; margin-bottom: 0">Fair Value</P></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><P STYLE="margin-top: 0; margin-bottom: 0">Aggregate Intrinsic</P>
                                                                                <P STYLE="margin-top: 0; margin-bottom: 0">Value</P></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 58%">Outstanding, December 31, 2020</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; text-align: right">&nbsp;&nbsp;&nbsp;&nbsp;-</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; text-align: right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 10%; text-align: right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;-</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt">Granted</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"></TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-align: left">Vested and settled with share issuance</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 1.5pt; padding-left: 10pt">Forfeited/canceled</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right"></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 2.5pt">Outstanding, March 31, 2021</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">-</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 2.5pt; text-align: left">$</TD><TD STYLE="padding-bottom: 2.5pt; text-align: right">-</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the three months ended March 31, 2021 and 2020, the Company recorded $0 and $18,872, respectively, as compensation expense related to
vested RSUs issued to employees, directors and consultants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective
April 30, 2020, 800,000 RSUs vested. However, the holder elected to cancel the RSUs.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 21; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Surna
Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Notes
to Condensed Consolidated Financial Statements</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(Unaudited)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Note
9 &ndash; Warrants</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table summarizes information with respect to outstanding warrants to purchase common stock during the three months ended March
31, 2021:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="border-collapse: collapse; width: 90%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; font-weight: bold"></TD><TD STYLE="text-align: center; font-weight: bold">&nbsp;</TD><TD STYLE="text-align: center; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; font-weight: bold">Weighted</TD><TD STYLE="text-align: center; font-weight: bold">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; font-weight: bold">Weighted</TD><TD STYLE="text-align: center; font-weight: bold">&nbsp;</TD><TD STYLE="text-align: center; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; font-weight: bold">Average</TD><TD STYLE="text-align: center; font-weight: bold">&nbsp;</TD><TD STYLE="text-align: center; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; font-weight: bold"></TD><TD STYLE="text-align: center; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; font-weight: bold">Number</TD><TD STYLE="text-align: center; font-weight: bold">&nbsp;</TD><TD STYLE="text-align: center; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; font-weight: bold"><P STYLE="margin-top: 0; margin-bottom: 0">Average</P>
                                                                  <P STYLE="margin-top: 0; margin-bottom: 0">Exercise</P></TD><TD STYLE="text-align: center; font-weight: bold">&nbsp;</TD><TD STYLE="text-align: center; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; font-weight: bold">Remaining Life</TD><TD STYLE="text-align: center; font-weight: bold">&nbsp;</TD><TD STYLE="text-align: center; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; font-weight: bold"><P STYLE="margin-top: 0; margin-bottom: 0">Aggregate</P>
                                                                  <P STYLE="margin-top: 0; margin-bottom: 0">Intrincic</P></TD><TD STYLE="text-align: center; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 1.5pt; text-align: center">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Outstanding</TD><TD STYLE="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Price</TD><TD STYLE="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">In Months</TD><TD STYLE="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: center; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Value</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 40%">Outstanding at December 31, 2020</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 11%; text-align: right">7,562,500</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 11%; text-align: right">0.25</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 11%; text-align: right">&nbsp;&nbsp;&nbsp;&nbsp;6</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 11%; text-align: right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;0</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>Issued</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>Exercised</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 1.5pt">Expired</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">0</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">$</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">0.00</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">$</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">0</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 2.5pt">Outstanding at March 31, 2021</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">7,562,500</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">0.25</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">6</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">0</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table summarizes information about warrants outstanding at March 31, 2021:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="border-collapse: collapse; width: 70%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">Weighted Average <BR>
Life of</TD><TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">Warrants</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">Outstanding Warrants</TD><TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1.5pt solid">Exercise price</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center">Outstanding</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center">In Months</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 36%">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 28%; text-align: right">&nbsp;</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 28%; text-align: right">&nbsp;</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: right">0.25</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">7,562,500</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Note
10 &ndash; Income Taxes </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of March 31, 2021, the Company has U.S. federal and state net operating losses (&ldquo;NOLs&rdquo;) of approximately $20,115,000, of
which $11,196,261 will expire, if not utilized, in the years 2034 through 2037, however, NOLs generated subsequent to December 31, 2017
do not expire but may only be used against taxable income to 80%. In response to the novel coronavirus COVID-19, the Coronavirus Aid,
Relief, and Economic Security Act temporarily repealed the 80% limitation for NOLs arising in 2018, 2019 and 2020. Pursuant to Section
382 of the Internal Revenue Code of 1986, as amended, use of the Company&rsquo;s NOLs carryforwards may be limited in the event of cumulative
changes in ownership of more than 50% within a three-year period.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company must assess the likelihood that its net deferred tax assets will be recovered from future taxable income, and to the extent the
Company believes that recovery is not likely, the Company establishes a valuation allowance. Management&rsquo;s judgment is required
in determining the Company&rsquo;s provision for income taxes, deferred tax assets and liabilities, and any valuation allowance recorded
against the net deferred tax assets. The Company recorded a full valuation allowance as of March 31, 2021 and December 31, 2020. Based
on the available evidence, the Company believes it is more likely than not that it will not be able to utilize its net deferred tax assets
in the foreseeable future. The Company intends to maintain valuation allowances until sufficient evidence exists to support the reversal
of such valuation allowances. The Company makes estimates and judgments about its future taxable income that are based on assumptions
that are consistent with the Company&rsquo;s plans. Should the actual amounts differ from the Company&rsquo;s estimates, the carrying
value of the Company&rsquo;s deferred tax assets could be materially impacted.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Note
11 &ndash; Subsequent Events </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
accordance with ASC 855, <I>Subsequent Events</I>, the Company has evaluated all subsequent events through the date the financial statements
were available to be issued. No material subsequent events occurred after March 31, 2021, other than as set out below:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
further discussed in <I>Note 8 Equity Incentive Plan </I>below, 1,000,000 stock options issued to directors effective June 24, 2020 vested
on April 1, 2021.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
further discussed in <I>Note 7 Commitments and Contingencies</I> above, on April 8, 2021, the Company issued 1,000,000 shares of its
common stock in settlement of litigation brought by a former employee.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
April 30, 2021, the Company entered into an agreement to sublease approximately 6,900 square feet of its office and manufacturing space.
The sublease commenced on April 30, 2021 and will continue on a month-to-month basis until either party gives 30-days&rsquo; notice.
Rent will initially be charged at $5,989 per month, increasing to $11,978 per month effective July 1, 2021. The Sublessor will also be
responsible for its prorated share of utilities and other related costs.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 22; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="c_001"></A>ITEM
2. MANAGEMENT&rsquo;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>The
following discussion should be read in conjunction with our unaudited condensed consolidated financial statements and related notes included
elsewhere in this Quarterly Report, which include additional information about our accounting policies, practices, and the transactions
underlying our financial results, as well as with our audited consolidated financial statements included in our Annual Report on Form
10-K for the year ended December 31, 2020, as filed with the SEC. In addition to historical information, the following discussion and
other parts of this Quarterly Report contain forward-looking information that involves risks and uncertainties. Our actual results could
differ materially from those anticipated by such forward-looking information due to the factors discussed under &ldquo;Cautionary Statements&rdquo;
appearing elsewhere herein and the risks and uncertainties described or identified in &ldquo;Item 1A &ndash; Risk Factors&rdquo; in our
Annual Report on Form 10-K for the year ended December 31, 2020, as updated from time to time in the Company&rsquo;s filings with the
SEC, and Part II, Item 1A of this Quarterly Report entitled &ldquo;Risk Factors.&rdquo;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Non-GAAP
Financial Measures</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>To
supplement our financial results on U.S. generally accepted accounting principles (&ldquo;GAAP&rdquo;) basis, we use non-GAAP measures
including net bookings, backlog, as well as adjusted net income (loss) which reflects adjustments for certain non-cash expenses such
as stock-based compensation, certain debt-related items and depreciation expense. We believe these non-GAAP measures are helpful in understanding
our past performance and are intended to aid in evaluating our potential future results. The presentation of these non-GAAP measures
should be considered in addition to our GAAP results and are not intended to be considered in isolation or as a substitute for financial
information prepared or presented in accordance with GAAP. We believe these non-GAAP financial measures reflect an additional way to
view aspects of our operations that, when viewed with our GAAP results, provide a more complete understanding of factors and trends affecting
our business. For purposes of this Quarterly Report, (i) &ldquo;adjusted net income (loss)&rdquo; and &ldquo;adjusted operating income
(loss)&rdquo; mean GAAP net income (loss) and operating income (loss), respectively, after adjustment for non-cash equity compensation
expense, debt-related items and depreciation expense, and (ii) &ldquo;net bookings&rdquo; means new sales contracts executed during the
quarter for which we received an initial deposit, net of any adjustments including cancellations and change orders during the quarter.
</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Our
backlog, remaining performance obligations and net bookings may not be indicative of future operating results, and our customers may
attempt to renegotiate or terminate their contracts for a number of reasons, including delays in or inability to obtain project financing
or licensing or abandonment of the project entirely. Accordingly, there can be no assurance that contracts included in the backlog or
remaining performance obligations will actually generate revenues or when the actual revenues will be generated. </I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Overview</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
design, engineer and sell environmental control and other technologies for the Controlled Environment Agriculture (CEA) industry. The
CEA industry is one of the fastest-growing sectors of the United States&rsquo; economy. From leafy greens (kale, Swiss chard, mustard,
cress), microgreens (leafy greens harvested at the first true leaf stage), ethnic vegetables and small fruits (such as strawberries,
blackberries and raspberries) to bell peppers, cucumbers, tomatoes, and cannabis, some producers grow crops indoors in response to market
dynamics or as part of their preferred farming practice. In service of the CEA, our principal technologies include: (i) liquid-based
process cooling systems and other climate control systems, (ii) air handling equipment and systems, (iii) a full-service engineering
package for designing and engineering commercial scale thermodynamic systems specific to cultivation facilities, and (iv) automation
and control devices, systems and technologies used for environmental, lighting and climate control. Our customers include commercial,
state- and provincial-regulated CEA growers in the U.S. and Canada as well as other international locations. Customers are those growers
building new facilities and those expanding or retrofitting existing facilities. Currently, our revenue stream is derived primarily from
supplying our products, services and technologies to commercial indoor facilities ranging from several thousand to more than 100,000
square feet.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Headquartered
in Boulder, Colorado, we leverage our experience in this space to bring value-added climate control solutions to our customers that help
improve their overall crop quality and yield, optimize energy and water efficiency, and satisfy the evolving state and local codes, permitting
and regulatory requirements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 23; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
CEA facility operators are facing multiple headwinds of high energy costs, issues about water usage and waste materials, and, in the
case of cannabis growing, increasingly rigorous quality standards and declining cannabis prices. To be competitive, among other things,
our customers must develop innovative ways to meet the demands of their business and reduce energy costs, 90% of which is typically related
to their HVACD (50%) and lighting systems (40%). HVACD systems have historically been our focus, but in May of 2021, we announced an
initiative to expand our offerings to include most of the technical infrastructure of CEA facilities. We often have the advantage of
early engagement with our customers at the pre-build and construction phases and the corresponding opportunity to build longer-term relationships
with our existing customers and their facilities. Going forward, our plan is to leverage our existing customer relationships and attempt
to sell them additional products and services, thereby becoming &ldquo;stickier&rdquo; to our customers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have three core assets that we believe are important to our going-forward business strategy. First, we have multi-year relationships
with customers and others in the CEA industry, notably in the cannabis segment. Second, we have specialized engineering know-how and
experience gathered from designing environmental control systems for CEA cultivation facilities since 2016. Third, we have a line of
proprietary environmental control products, which we are in the process of expanding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are an integrated provider of MEP (mechanical, electrical, plumbing) engineering design, proprietary environmental control equipment,
and controls and automation offerings serving the CEA industry. Historically, nearly all of our customers have been in the cannabis cultivation
business. We believe our employees have more experience than most other MEP firms serving this industry. Our customers engage us for
their environmental and climate control systems because they want experts to design their facilities, and they come to us because of
our reputation. We leverage our reputation and know-how against the many local contractors and MEP engineers who collectively constitute
our largest competitors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
number of recent events have had an adverse impact on our operations and financial condition, including constraints on capital availability
for our customers and prospects who have commenced, or are contemplating, new and expanded CEA cultivation facilities and the outbreak
of COVID-19, a novel strain of coronavirus, which has spread across the globe including the U.S. The response to this coronavirus by
federal, state and local governments in the U.S. has resulted in significant market and business disruptions across many industries and
affecting businesses of all sizes. This pandemic has also caused significant stock market volatility and further tightened capital access
for most businesses.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares
of our common stock are traded on the OTC Markets under the ticker symbol &ldquo;SRNA.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Impact
of the COVID-19 Pandemic on Our Business</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
impact of the government and the business economic response to the COVID-19 pandemic has affected demand across the majority of our markets
and disrupted work on projects. The COVID-19 pandemic is expected to have continued adverse effects on our sales, project implementation,
operating margins, and working capital. As of the date of this filing, uncertainty continues to exist concerning the magnitude and duration
of the economic impact of the COVID-19 pandemic.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
response to the COVID-19 pandemic and the government and business response, during 2020, the Company took measures to adjust its
operations. These actions included initial measures to cut costs and preserve cash, and encompassed downsizing workforce, compensation
reductions, and reduced hours worked that were later changed upwards and in some cases fully restored late in 2020, as the Company
gained new contracts, bank funding was available, and the overall business climate improved. The Company continues to actively
monitor its operations and sales efforts in light of the continuing effects of the COVID-19 pandemic and will make adjustments
to its operations as necessary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Due
to the speed with which the COVID-19 pandemic developed and the resulting uncertainties, including the depth and duration of the disruptions
to customers and suppliers, its future effect on our business, on our results of operations, and on our financial condition, we cannot
predict the overall effect on our business over the longer term. Addressing this uncertainty, we have undertaken various plans to reduce
costs so as to mitigate the impact of the COVID-19 pandemic to the best of our ability, although they may not be sufficient in the long-run
for us to avoid reduced sales, increased losses and reduced operating cash flows.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Refer
to <I>Risk Factors</I>, included in Part II, Item 1A of this Annual Report on Form 10-Q below, for further discussion of the possible
impact of the COVID-19 pandemic on our business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 24; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Our
Corporate Strategy </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
three key pillars of our corporate strategy for growing the Company and increasing shareholder value are:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1
&ndash; Pursue aggressive organic growth; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2
&ndash; Seek strategic relationships, mergers, and acquisitions to add to our existing business; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3
&ndash; Pursue an uplisting to a national exchange and seek additional growth capital.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Pursue
aggressive organic growth</I>. We serve a market for the construction and expansion of controlled environment agriculture (CEA)
facilities and businesses that is projected to grow at a 20%+ compound annual growth rate for the foreseeable future. Our
primary vertical market of cannabis cultivation facilities has been joined by the similarly rapidly growing urban vertical farming
market to create two market opportunity segments that we are positioned to serve.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Seek
strategic relationships, mergers, and acquisitions to add to our existing business. </I>We enjoy wide brand recognition in the
cannabis cultivation industry because of our longevity in the market segment (15 years) and the number of cultivation projects
(800+, including over 200 engineering projects for licensed, commercial facilities) we have served. Our core expertise is
engineering the environmental controls of these facilities, which is a sophisticated engineering challenge due to the high humidity
(latent heat) and heat load (sensible heat) within these facilities. Not only are the loads high, but the environmental conditions
within these facilities must be held within limits that the facility&rsquo;s managers request. Engineering to meet these limits
requires us to consider all of the primary components within the facility: lighting, irrigation, HVACD, fertigation, sensors,
controls, CO<SUB>2 </SUB>dosing, monitoring and alarms, facility physical limits such as power availability, and energy consumption.
We believe that the expertise gained in working with many of the primary components provides us with a uniquely well-informed
view of the efficacy of the many primary components on offer in the marketplace. We further believe that this knowledge will help
us make wise choices of which products to pursue for strategic relationships, and which providers to potentially merge with or
acquire. For smaller component providers we believe that our publicly traded platform and our existing sales and marketing reach
will make us an attractive partner.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Pursue
an uplisting to a national exchange and a growth-supporting capital raise.</I> In 2019 our revenue grew 60% year-over-year, and we had
our first-ever cash flow positive year. Despite the challenges brought on by the COVID-19 pandemic in the first half of 2020, we believe
that our revenue growth in 2019 and then in the Q3 2020 &ndash; Q1 2021 period validates our market opportunity and our business model.
We also recognize that the costs of being a small public company are substantial and require cash that could otherwise be used to sustain
and grow the business. There is only one solution to this issue: rapid revenue and margin growth. We believe that we have growth opportunities,
but we are capital constrained and must seek outside financing to pursue the growth we believe we can achieve. A capital raise is potentially
dilutive to our existing shareholders and options holders, which include our directors, officers, executives, and all of our employees.
As such, our insiders&rsquo; interests are aligned with those of our external shareholders and we do not take the prospect of dilution
lightly; we do so with the firm conviction that with additional capital we can create increased shareholder value. The Company has not
raised capital in nearly three years. In that time our management has operated the business with financial discipline, which included
reducing headcount and deferring compensation as needed. Despite this financial discipline we achieved record revenue growth. With more
capital, we are confident that we can achieve much more. Uplisting to a national exchange will enhance our stock as a currency for both
potential investors and for potential acquisition targets, as well as enhancing our credibility in the eyes of potential customers. Uplisting
will likely require a reverse split of our stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Our
Updated Organic Growth Strategy</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
growth strategy over the last few years had three primary components: increase number of customers by expanding our product line, increase
order size per customer by offering more products our customers need, and increase the number of sales opportunities by engaging in strategic
relationships with other leading technology providers who could bring us customers. While we will continue to conduct these activities,
we have recently updated and expanded our growth strategy in response to market opportunities and will execute it over the coming months.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Since
the Company was founded in 2006 as Hydro Innovations, the story of Surna has been one of growth and change, from a garage
start-up in Texas in 2006 to a publicly traded corporation serving one of the fastest growing industries in the world. Our
markets and customers have likewise changed as controlled environment agriculture has grown to include many plants and types
of facilities. As our customers grow and their needs expand, we intend to grow with them.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 25; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&rsquo;s primary expertise has been the engineering and supply of environmental control technologies to meet the sophisticated
demands of indoor CEA facilities. Most, but not all, of our customers have historically been in the legal cannabis industry and we believe
that we are the oldest and most experienced company providing such services and products to the industry. Mechanical engineering is the
core of our expertise and we maintain our own staff of licensed professional engineers, so we are able to stamp drawings anywhere in
the US and Canada.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
recent years we expanded our product line and as of this writing we now are selling the following products and services:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><IMG SRC="image_001.jpg" ALT="" STYLE="height: 312px; width: 660px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Changes
in our business and markets</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">According
to leading cannabis market research firms like Headset and New Frontier Data, the North American cannabis industry is expected to experience
compound annual growth on the order of 20%-25% over the foreseeable future. More US states are legalizing either medical or recreational
use of cannabis products, and sometimes both. Although the market is well aware of how the cannabis sector is growing, it seems to be
less aware of the non-cannabis CEA market, particularly the vertical farming segment which is growing nearly as fast as the cannabis
market. Since the technical infrastructure and requirements for growing any plant in a controlled environment are similar, we believe
that we can bring our engineering expertise to this other high growth market.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
light of these market changes we have updated our organic growth strategy which can be summarized as: <I>New Markets, New Products and
Services, New Trade Name</I>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>New
                                            Markets</I> - we will increase the addressable markets we serve &ndash; from primarily cannabis
                                            to the broader CEA market, including greenhouse and vertical farming facilities. We have
                                            already worked on several such non cannabis projects.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>New
                                            Products and Services</I> - we will expand our product and service range &ndash; expanding
                                            from exclusively environmental control to include most of the CEA technical infrastructure
                                            (see table below) and from facility selection to full lifecycle support after construction.
                                            In addition, we will increase our product and service range in each product category. We
                                            already provide some of these products and services, as noted below. As we do with environmental
                                            control, we will act as technology-agnostic engineers and assess each customer application,
                                            offering alternative designs and a select range of curated technologies.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>New
                                            Trade Name </I>&ndash; as we announced on May 4, 2021, we have enhanced our branding to Surna
                                            Cultivation Technologies to capture the changes in our capabilities and markets and to make
                                            it easier for prospects to find us.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 26; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CEA
Facility Technical Infrastructure</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><IMG SRC="image_002.jpg" ALT="" STYLE="height: 480px; width: 660px">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
primary objective in expanding our service and product offerings is to improve our customers&rsquo; operations and sustainability, increase
customer acquisition, and increase our revenue and revenue recurrence.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Customer
Operations</I> &ndash; first and foremost we seek to help our customers build the most effective and efficient facility possible. We
believe that we are uniquely positioned to engineer all of the complex components of a CEA facility into a holistic whole because of
our dedicated engineering staff and our experience in over 800 projects including over 200 commercial facilities. Our 15 years&rsquo;
in the business has provided us a wide network of technology vendors from which we curate a selection of the best products. In addition,
we are the leading experts in applying the most challenging component of the technical infrastructure, the environmental controls, and
we have the knowledge required to engineer the interactions among the required components. A professional engineer (PE) license is not
required for the design of any other component in the facility and this engineering knowledge is one of our greatest strengths.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Sustainability
</I>&ndash; indoor cultivation facilities, like data centers, are energy intensive. Several US states have implemented building code
changes that place limits on the energy consumption allowed within cultivation facilities, and we anticipate that more states will do
the same. Among our objectives is to provide our customers with the most energy-efficient alternatives for their infrastructure. Energy
and resource efficiency is a high priority to us as engineers, and our most senior engineering staff hold the LEED (Leadership in Energy
and Environmental Design) credential. Our CEO previously helped build a cleantech company, has been involved in the cleantech industry
for over five years, and published a book on selling energy efficient technologies. We believe that we are in a position to lead the
industry in sustainability initiatives which our customers will highly value.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Customer
Acquisition</I> &ndash; By offering Facility Selection &amp; Design services we seek to build relationships with prospects at the earliest
opportunity in the lifecycle of the cultivation business. By expanding our offerings to include nearly every piece of the technical infrastructure
required in a facility we hope to engage at the earliest possible moment with the customer and earn the opportunity to provide all the
products and services required for the facility. Our post-start-up, lifecycle services will help us maintain a relationship with the
customer as long as the facility is in operation. Our observation is that our customers want to grow plants, not maintain the technical
infrastructure of complex systems, and we believe that they will accept our offer to do so, as some already have.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Revenue
and Revenue Recurrence</I> &ndash; By offering most of the primary technical infrastructure components for a cultivation facility our
revenue can be expanded. For example, if we are able to provide all of the primary components, our revenue on a project could be up to
200% higher than if we provided the environmental controls systems alone. In the past we did not have products or services to offer our
customers after a facility was constructed. We have recently begun to offer maintenance services, and we believe that by expanding this
service offering that we will be able to gain long-term recurring revenue on a subscription basis.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 27; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Our
Commercial-Scale Projects </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the first quarter of 2021, we entered into sales contracts for five new build projects and one retrofit project, each with a contract
value over $100,000, which we refer to as commercial-scale projects. These new contracts totaled $5,008,000, which consisted of $4,844,000
for the new build projects (97%) and $164,000 for the retrofit project (3%).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Our
Bookings, Backlog and Revenue</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the three months ended March 31, 2021, we executed new sales contracts with a total contract value of $5,499,000. During this same period,
we had negative change orders of $2,000. After adjustments for these change orders, our net bookings in the three months ended March
31, 2021 were $5,497,000, representing an increase of $1,860,000 (or 51%) from net bookings of $3,637,000 in the fourth quarter of 2020.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
first quarter 2021 bookings represent a 51% increase over the fourth quarter of 2020 and a 388% increase over the first quarter of 2020.
However, there is no assurance that all bookings will be converted to revenue due to adjustments to the intended projects, delays and
cancellations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
backlog at March 31, 2021 was $11,578,000, an increase of $3,130,000, or 37%, from December 31, 2020. The increase in backlog is the
result of our higher net bookings and lower revenue in the first quarter. Revenue was lower primarily due to delays in production and
delivery by some of our suppliers. Our backlog at March 31, 2021 includes booked sales orders of $449,000 (4% of the total backlog) from
several customers that we do not expect to be realized until 2022, if at all. We believe the sales orders in this portion of our backlog
may be abandoned by our customer or ultimately cancelled.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth: (i) our beginning backlog (the remaining contract value of outstanding sales contracts for which we have
received an initial deposit as of the previous period), (ii) our net bookings for the period (new sales contracts executed during the
period for which we received an initial deposit, net of any adjustments including cancelations and change orders during the period),
(iii) our recognized revenue for the period, and (iv) our ending backlog for the period (the sum of the beginning backlog and net bookings,
less recognized revenue).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="border-collapse: collapse; width: 90%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="18" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">For the quarter ended</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">March 31, 2020</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">June 30, 2020</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">September 30, 2020</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">December 31, 2020</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">March 31, 2021</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 35%; text-align: left">Backlog, beginning balance</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 10%; text-align: right">9,558,000</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 10%; text-align: right">8,875,000</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 10%; text-align: right">5,592,000</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 10%; text-align: right">8,198,000</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 10%; text-align: right">8,448,000</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Net bookings, current period</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">1,127,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">(1,601,000</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">4,241,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">3,637,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">5,497,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Recognized revenue, current period</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">$</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">1,810,000</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">$</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">1,682,000</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">$</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">1,635,000</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">$</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">3,387,000</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">$</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">2,367,000</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 2.5pt">Backlog, ending balance</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">8,875,000</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">5,592,000</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">8,198,000</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">8,448,000</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">11,578,000</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
completion of a customer&rsquo;s <I>new</I> build facility project is dependent upon the customer&rsquo;s ability to secure funding and
real estate, obtain a license and then build their cultivation facility so they can take possession of the equipment. Accordingly, the
time it takes for these customers to complete a new build project, which corresponds to when we are able to recognize revenue, is driven
by numerous factors including: (i) the large number of first-time participants interested in the indoor cannabis cultivation business;
(ii) the complexities and uncertainties involved in obtaining state and local licensure and permitting; (iii) local and state government
delays in approving licenses and permits due to lack of staff or the large number of pending applications, especially in states where
there is no cap on the number of cultivators; (iv) the customer&rsquo;s need to obtain cultivation facility financing; (v) the time needed,
and coordination required, for our customers to acquire real estate and properly design and build the facility (to the stage when climate
control systems can be installed); (vi) the large price tag and technical complexities of the climate control and air sanitation system;
(vii) the availability of power; and (viii) delays that are typical in completing any construction project.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 28; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
has historically been the case for the Company at each quarter-end, there remains significant uncertainty regarding the timing of revenue
recognition of our backlog as of March 31, 2021. As of March 31, 2021, 17% of our backlog was attributable to customer contracts for
which we have only received an initial advance payment to cover our engineering services (&ldquo;engineering only paid contracts&rdquo;).
There are always risks that the equipment portion of our engineering only paid contracts will not be completed or will be delayed, which
could occur if the customer is dissatisfied with the quality or timeliness of our engineering services, there is a delay or abandonment
of the project due to the customer&rsquo;s inability to obtain project financing or licensing, or the customer determines not to proceed
with the project due to economic factors, such as declining cannabis wholesale prices in the state.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
contrast, after the customer has made an advance payment for a portion of the equipment to be delivered under the contract (&ldquo;partial
equipment paid contracts&rdquo;), we typically are better able to estimate the timing of revenue recognition since the risks and delays
associated with licensing, permitting and project funding are typically mitigated once the initial equipment payment is received. As
of March 31, 2021, 83% of our backlog was attributable to partial equipment paid contracts.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have provided an estimate in our condensed consolidated financial statements for when we expect to recognize revenue on our remaining
performance obligations (i.e., our Q1 2021 backlog), using separate time bands, with respect to engineering only paid contracts and partial
equipment paid contracts. We estimate that we will recognize approximately 96% of our Q1 2021 backlog during the remainder of 2021, or
$11.1 million. However, there continues to be significant uncertainty regarding the timing of our recognition of revenue on our Q1 2021
backlog. Refer to the <I>Revenue Recognition</I> section of note 1 in our condensed consolidated financial statements, included as part
of this Quarterly Report for additional information on our estimate of future revenue recognition on our remaining performance obligations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
backlog, remaining performance obligations and net bookings may not be indicative of future operating results, and our customers may
attempt to renegotiate or terminate their contracts for a number of reasons, including delays in or inability to obtain project financing
or licensing or abandonment of the project entirely. Accordingly, there can be no assurance that contracts included in backlog or remaining
performance obligations will actually generate revenues or when the actual revenues will be generated. Net bookings and backlog are considered
non-GAAP financial measures, and therefore, they should be considered in addition to, rather than as a substitute for, our GAAP measures
for recognized revenue, deferred revenue and remaining performance obligations. Further, we can provide no assurance as to the profitability
of our contracts reflected in remaining performance obligations, backlog and net bookings.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Results
of Operations</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Comparison
of Three Months Ended March 31, 2021 and 2020</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Revenues
and Cost of Goods Sold</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenue
for the three months ended March 31, 2021 was $2,367,000, compared to $1,810,000 for the three months ended March 31, 2020, representing
an increase of $557,000, or 31%. The increase was primarily due to equipment revenue which included several of our new product offerings.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cost
of revenue increased by $669,000, or 49%, from $1,353,000 for the three months ended March 31, 2020 to $2,022,000 for the three months
ended March 31, 2021.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
gross profit for the three months ended March 31, 2021 was $345,000 compared to $457,000 for the three months ended March 31,
2020, a decrease of 25%. Gross profit margin decreased by ten percentage points from 25% for the three months ended March 31,
2020 to 15% for the three months ended March 31, 2021 primarily due to a decrease in the selling price of our equipment
resulting in a decreased equipment margin, offset by a slight decrease in other variable costs as described below.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
fixed costs (which include engineering, service, manufacturing and project management salaries and benefits and manufacturing
overhead) totaled $337,000, or 14% of total revenue, for the three months ended March 31, 2021 as compared to $300,000, or 17%
of total revenue, for the three months ended March 31, 2020. The increase of $37,000 was primarily due to an increase
in salaries and benefits (including stock-based compensation) of $45,000, offset by a decrease in fixed overhead of $8,000.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 29; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
variable costs (which include the cost of equipment, outside engineering costs, shipping and handling, travel and warranty costs)
totaled $1,685,000, or 71% of total revenue, in the three months ended March 31, 2021 as compared to $1,054,000, or 58% of total
revenue, in the three months ended March 31, 2020. The increase in variable costs was primarily due to: (i) higher equipment costs
of $670,000 resulting from an increase of 17 percentage points for equipment costs as a percentage of total revenue, (ii) an increase
in warranty expense of $79,000, offset by (iii) a decrease in outside engineering costs of $37,000, (iv) a decrease in other overhead
of $30,000, (v) a decrease in excess and obsolete inventory expense of $20,000, (vi) a decrease of $17,000 in shipping
and handling costs, and (vii) a decrease in travel of $14,000.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
continue to focus on gross margin improvement through a combination of, among other things, more disciplined pricing, better absorption
of our fixed costs as we convert our increased bookings into revenue, and the implementation over time of lower-cost supplier alternatives.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Operating
Expenses</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Operating
expenses decreased to $1,030,000 for the three months ended March 31, 2021 from $1,403,000 for the three months ended March 31, 2020,
a decrease of $373,000, or 27%. The operating expense decrease consisted of: (i) a decrease in selling, general and administrative expenses
(&ldquo;SG&amp;A expenses&rdquo;) of $369,000, (ii) a decrease in product development expenses of $32,000, offset by (iii) an increase
in advertising and marketing expenses of $28,000.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
decrease in SG&amp;A expenses for the three months ended March 31, 2021 compared to the three months ended March 31, 2020, was
due primarily to: (i) a decrease of $141,000 in stock-related compensation expense to employees, consultants and directors, (ii)
a decrease in accounting, consulting and other professional fees of $92,000 (iii) a decrease of $42,000 in salaries and benefits,
(iv) a decrease of $27,000 in travel expenses, (v) a decrease in fees paid to directors of $23,000, (vi) a decrease in investor
relations costs of $13,000, (vii) a decrease in depreciation expense of $12,000, (viii) decreased commissions and other sales
related expenses of $10,000, and (iv) a decrease in facility, office and other expenses of $9,000.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
increase in marketing expenses was primarily due to (i) an increase in advertising and promotion of $16,000, (ii) an increase
in salaries, benefits and stock compensation of $14,000, (iii) an increase in expenses for web development of $9,000, offset by
(iv) a decrease in expenses related to trade shows, outside services and other marketing expenses of $11,000.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
decrease in product development costs was due to (i) a decrease in salaries and benefits (including stock compensation) of $47,000,
(ii) a decrease of $2,000 in travel, (iii) a decrease in material costs of $2,000, offset by (iv) an increase of $18,000
in expenses for consulting. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Operating
Income (Loss) </I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
had operating loss of $686,000 for the three months ended March 31, 2021, as compared to an operating loss of $946,000 for the
three months ended March 31, 2020, a decrease of $260,000, or 28%. The operating loss for the three months ended March
31, 2021 included $59,000 of non-cash, stock-based compensation and $17,000 of depreciation and amortization expense, compared
to $191,000 of non-cash, stock-based compensation and $29,000 of depreciation and amortization expense for the three months ended
March 31, 2020. Excluding these non-cash items, our operating loss decreased by $117,000, or 16%.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Other
Income (Expense)</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
had other expense (net) of $108,000 for the three months ended March 31, 2021 compared to other income (net) of $8,000 for the
three months ended March 31, 2020. Other expense for the three months ended March 31, 2021 consisted of expenses related
to the settlement of litigation with a former employee.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Net
Income (Loss)</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Overall,
we had net loss of $793,000 for the three months ended March 31, 2021 as compared to a net loss of $938,000 for the three months ended
March 31, 2020, a decrease of $145,000, or 15%. The net loss for the three months ended March 31, 2021 included $59,000 of non-cash,
stock-based compensation, $67,000 of other stock-based expense (related to settlement of litigation with a former employee), and $17,000
of depreciation and amortization expense, compared to $191,000 of non-cash, stock-based compensation and $29,000 of depreciation and
amortization expense for the three months ended March 31, 2020. Excluding these non-cash items, our net loss decreased by $68,000, or
9%.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 30; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Financial
Condition, Liquidity and Capital Resources</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Cash,
Cash Equivalents and Restricted Cash</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of March 31, 2021, we had cash, cash equivalents and restricted cash of $3,271,000, compared to cash and cash equivalents of $2,285,000
as of December 31, 2020, an increase of 43%. The $986,000 increase in cash and cash equivalents during the three months ended
March 31, 2021, was primarily the result of cash provided by our operating activities of $484,000 and proceeds from a note
payable of $514,000. Our cash is held in bank depository accounts in certain financial institutions. During the three months ended
March 31, 2021, we held deposits in financial institutions that exceeded the federally insured amount. During the three months
ended March 31, 2021, the Company transferred a balance of $180,000 into a new bank account which was to be used for the sole
purpose of paying certain warranty claims. The balance on this restricted bank account as of March 31, 2021 was $86,697</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of March 31, 2021, we had accounts receivable (net of allowance for doubtful accounts) of $27,000, inventory (net of excess and obsolete
allowance) of $519,000, and prepaid expenses of $2,065,000 (including $1,960,000 in advance payments on inventory purchases). While we
typically require advance payment before we commence engineering services or ship equipment to our customers, we have made exceptions
requiring us to record accounts receivable, which carry a risk of non-collectability especially since most of our customers are funded
on an as-needed basis to complete facility construction. We expect our exposure to accounts receivable risk to increase as we pursue
larger projects.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of March 31, 2021, we had total accounts payable and accrued expenses of $1,790,000, deferred revenue of $6,087,000, accrued equity
compensation of $53,000, other current liabilities of $37,000 and the current portion of operating lease liability of $264,000.
As of March 31, 2021, we had a working capital deficit of $2,349,000, compared to a working capital deficit of $2,220,000 as of
December 31, 2020. The increase in our working capital deficit was primarily related to (i) an increase in our deferred revenue
(which represents cash received from customers in advance of the performance of services or the delivery of equipment) of $2,363,000,
(ii) an increase in other current liabilities of $37,000, offset by, (iii) an increase in cash of $986,000, (iv)
an increase in prepaid expenses and other of $1,027,000, (v) and increase in inventory of $192,000 and (vi)
a decrease in accrued equity compensation of $76,000.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have never declared or paid any cash dividends on our common stock. We currently intend to retain all available funds and any future
earnings for use in the operation and expansion of our business and do not anticipate paying any cash dividends in the foreseeable future.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Summary
of Cash Flows </I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following summarizes our approximate cash flows for the three months ended March 31, 2021 and 2020:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="border-collapse: collapse; width: 75%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">For the Three Months <BR> Ended March 31,</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2020</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 52%; text-align: left">&nbsp;Net cash provided by operating activities</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 20%; text-align: right">484,000</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 20%; text-align: right">(728,000</TD><TD STYLE="width: 1%; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">&nbsp;Net cash used in investing activities</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(12,000</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">&nbsp;Net cash provided by financing activities</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">514,000</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt">&nbsp;Net increase in cash</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">986,000</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(728,000</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Operating
Activities </I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
incurred a net loss for the three months ended March 31, 2021 of $793,000 and have an accumulated deficit of $28,237,000 as of March
31, 2021.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash
provided by operations for the three months ended March 31, 2021 was $484,000 compared to cash used in operations of $728,000 for the
three months ended March 31, 2020, an increase in cash provided by operating activities of $1,212,000.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 31; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
increase in cash provided by operating activities during the three months ended March 31, 2021 was primarily attributable to: (i) a decrease
of $1,155,000 in cash used to fund working capital, (ii) a decrease of $88,000 in non-cash operating charges, and (iii) a decrease in
net loss of $145,000.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
significant changes in working capital related to: (i) a $2,363,000 increase in deferred revenue, (ii) an increase of $1,027,000
in prepaid expenses and other, and (iii) an increase in inventory of $192,000.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
significant change in non-cash operating charges was due to an increase for other share-based expense of $67,000 related to a legal settlement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Investing
Activities</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
$12,000 cash used in investing activities during the three months ended March 31, 2021 was related to the purchase of property and equipment.
The Company undertook no investing activities during the three months ended March 31, 2020.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Financing
Activities</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
February 2021, the Company entered into a note payable with its current bank in the principal amount of $514,200, for working capital
purposes. The Company undertook no financing activities during the three months ended March 31, 2020.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Going
Concern</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
condensed consolidated financial statements for the quarter ended March 31, 2021, have been presented on a going concern basis, which
contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. Our independent registered
public accounting firm included in its audit opinion on our consolidated financial statements for the year ended December 31, 2020, a
statement that there is substantial doubt as to our ability to continue as a going concern, and our consolidated financial statements
for the year ended December 31, 2020 were prepared assuming that we would continue as a going concern. We have determined that our ability
to continue as a going concern is dependent on raising additional capital to fund our operations and ultimately on generating future
profitable operations. There can be no assurance that we will be able to raise sufficient additional capital or eventually have positive
cash flow from operations to address all of our cash flow needs. If we are not able to generate positive cash flow from operations or
find alternative sources of cash, our business and shareholders will be materially and adversely affected. The foregoing factors raise
substantial doubt about our ability to continue as a going concern for a period of one year from the date our condensed consolidated
financial statements for the quarter ended March 31, 2021, are issued. Our condensed consolidated financial statements do not include
any adjustment that might result from the outcome of this uncertainty.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is subject to a number of risks similar to those of other similar stage and situated companies, including general economic conditions,
its customers&rsquo; operations and prospects for and ability to obtain project financing, and market and business disruptions, that
include the outbreak of COVID-19, dependence on key individuals, successful development, marketing and branding of products; uncertainty
of product development and generation of revenues; dependence on outside sources of financing; risks associated with research, development;
dependence on third-party suppliers and collaborators; protection of intellectual property; and competition with larger, better-capitalized
companies. Ultimately, the attainment of profitable operations is dependent on future events, including obtaining adequate financing
to fulfill its development activities and generating a level of revenues adequate to support the Company&rsquo;s cost structure.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company also will be affected by constraints on the availability of capital to its customers and prospects who have commenced, or are
contemplating, new or expanded cultivation facilities and the overall impact of the Covid-19 pandemic. The extent to which COVID-19 will
impact the Company&rsquo;s business and financial results will depend on future developments, which are uncertain and cannot be predicted.
The duration and likelihood of operational success going forward resulting from the fiscal year 2020 measures of adjusting the workforce
reductions and cost-cutting measures are uncertain. If these actions do not meet management&rsquo;s expectations, or additional capital
is not available, there is substantial doubt about the Company&rsquo;s ability to continue as a going concern. Other factors that will
impact the Company&rsquo;s ability to continue operations include the market demand for the Company&rsquo;s products and services, the
ability to service its customers and prospects, potential contract cancellations, project scope reductions and project delays, the Company&rsquo;s
ability to fulfill its backlog, the management of working capital, and the continuation of normal payment terms and conditions for purchase
of the Company&rsquo;s products. The Company believes its cash balances and cash flow from operations will be insufficient to fund its
operations for the next twelve months. If the Company is unable to increase revenues, or otherwise generate cash flows from operations,
there is substantial doubt about the Company&rsquo;s ability to continue as a going concern for a period of one year from the date the
financial statements are issued. These consolidated financial statements do not include any adjustment that might result from the outcome
of this uncertainty.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 32; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Capital
Raising</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
believe our cash balances and cash flow from operations will be insufficient to fund our operations for the next 12 months. If we are
unable to increase revenues or otherwise generate cash flows from operations, we will need to raise additional funding to continue as
a going concern. We will need to obtain financing in order to continue our operations and achieve our growth strategies. There can be
no assurance that we will be able to raise the necessary financing, when and if needed, on acceptable terms or at all. If our operating
results do not meet management&rsquo;s expectations, or additional capital is not available, management believes it can downsize or reorient
operations to reduce certain expenditures. The precise amount and timing of our financing needs cannot be determined accurately at this
time, and will depend on a number of factors, including the market demand for our products and services, management of working capital,
and continuation of normal payment terms and conditions for purchase of our products and services.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
can be no assurance that the Company will be able to raise debt or equity financing in sufficient amounts, when and if needed, on acceptable
terms or at all. The Company&rsquo;s ability to raise equity capital is also limited by the Company&rsquo;s stock price, and any such
issuance could be highly dilutive to existing shareholders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Inflation</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the opinion of management, inflation has not and will not have a material effect on our operations in the immediate future. Management
will continue to monitor inflation and evaluate the possible future effects of inflation on our business and operations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Contractual
Payment Obligations</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of March 31, 2021, our contractual payment obligations consisted of a building lease. On January 2, 2018, the leased space was expanded
to 18,600 square feet and the monthly rental rate increased to $18,979 and beginning September 1, 2018, the monthly rent will increase
by 3% each year through the end of the lease. Refer to <I>Note 2</I> &ndash; <I>Leases</I> of the notes to the condensed consolidated
financial statements, included as part of this Quarterly Report for a discussion of building lease.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
2020, the Company entered into an agreement with its landlord to apply its rent deposit of $52,600 to rent payments due during the period.
The deposit required on the lease was reduced to approximately $32,000 and is payable in 12 monthly installments from January through
December of 2021. Further, the landlord also agreed to defer payment of fifty percent of the three months of lease payments (base rent
only) for the period July to September 2020. The deferred lease payments amount to approximately $30,000 and are payable in 12 monthly
installments from January to December 2021.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Commitments
and Contingencies</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Refer
to <I>Note 7 &ndash; Commitments and Contingencies</I> of the notes to the condensed consolidated financial statements, included as part
of this Quarterly Report for a discussion of commitments and contingencies.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Off-Balance
Sheet Arrangements</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are required to disclose any off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on
our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures,
or capital resources that are material to investors. As of March 31, 2021, we had no off-balance sheet arrangements. During the three
months ended March 31, 2021, we did not engage in any off-balance sheet financing activities other than those included in the &ldquo;Contractual
Payment Obligations&rdquo; discussed above and those reflected in Note 7 of our condensed consolidated financial statements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 33; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Recent
Developments</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Refer
to <I>Note 11 - Subsequent Events</I> of the notes to condensed consolidated financial statements, included as part of this Quarterly
Report for certain significant events occurring since March 31, 2021.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Critical
Accounting Estimates</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
discussion and analysis of our financial condition and results of operations is based upon our condensed consolidated financial statements,
which have been prepared in conformity with accounting principles generally accepted in the United States of America. Certain accounting
policies are particularly important to the understanding of our financial position and results of operations and require the application
of significant judgment by our management or can be materially affected by changes from period to period in economic factors or conditions
that are outside of our control. As a result, they are subject to an inherent degree of uncertainty. In applying these policies, management
uses their judgment to determine the appropriate assumptions to be used in the determination of certain estimates. Those estimates are
based on our historical operations, our future business plans and projected financial results, the terms of existing contracts, observance
of trends in the industry, information provided by our customers, and information available from other outside sources, as appropriate.
Actual results could materially differ from those estimates. Key estimates include: allocation of transaction prices to performance obligations
under contracts with customers, standalone selling prices, timing of expected revenue recognition on remaining performance obligations
under contracts with customers, valuation of intangible assets, valuation of equity-based compensation, valuation of deferred tax assets
and liabilities, warranty accruals, accounts receivable and inventory allowances, and legal contingencies.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="c_002"></A>ITEM
3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are a smaller reporting company, as defined by Rule 12b-2 of the Exchange Act, therefore are not required to provide the information
under this item.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="c_003"></A>ITEM
4. CONTROLS AND PROCEDURES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Evaluation
of Disclosure Controls and Procedures</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
management, with the participation of our Chief Executive Officer and our Principal Financial and Accounting Officer, which positions
are currently held by the same person, has evaluated the effectiveness of our disclosure controls and procedures (as defined in Rules
13a-15(e) and 15d-15(e) under the Exchange Act), as of the end of the period covered by this Quarterly Report on Form 10-Q. Based on
this evaluation, our Chief Executive Officer and Principal Financial and Accounting Officer concluded that as a result of material weakness
in our internal control over financial reporting as described in Item 9A of our Annual Report on Form 10-K for the year ended December
31, 2020 filed with the SEC, our disclosure controls and procedures were not effective as of March 31, 2021.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
did not maintain effective controls over certain aspects of the financial reporting process because: (i) we lack a sufficient complement
of personnel with a level of accounting expertise and an adequate supervisory review structure that is commensurate with our financial
reporting requirements, (ii) there is inadequate segregation of duties due to the limitation on the number of our accounting personnel,
and (iii) we have insufficient controls and processes in place to adequately verify the accuracy and completeness of spreadsheets that
we use for a variety of purposes including revenue, taxes, stock-based compensation and other areas, and place significant reliance on,
for our financial reporting.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
intend to take appropriate and reasonable steps to make the necessary improvements to remediate these deficiencies. We are committed
to continuing to improve our financial organization including, without limitation, expanding our accounting staff and improving our systems
and controls to reduce our reliance on the manual nature of our existing systems. However, due to our size and our financial resources,
remediating the several identified weaknesses has not been possible and may not be economically feasible now or in the future.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Changes
in Internal Control over Financial Reporting</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
were no changes identified in connection with our internal control over financial reporting during the three months ended March 31, 2021,
that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 34; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="c_004"></A>PART
II &mdash; OTHER INFORMATION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="c_005"></A>Item
1. Legal Proceedings</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2019, there were 6,750,000 restricted stock units that had not been settled due to a dispute with a former employee over
the required withholding taxes to be paid to the Company for remittance to the appropriate tax authorities. The Company commenced an
arbitration action against the former employee regarding the dispute. The former employee also made claims in the arbitration action
against the Company for unpaid wages. As stated in a pleading in the arbitration, on March 9, 2020, the Company issued the former employee
6,750,000 shares of the Company&rsquo;s common stock in settlement of these restricted stock units after taking measures to mitigate
the Company&rsquo;s exposure to penalties and liability for the failure to properly withhold income taxes. The Arbitrator issued an interim
award of approximately $10,000 in the Company&rsquo;s favor and a finding against the former employee. Effective June 9, 2020, the Arbitrator
issued his final award in the Company&rsquo;s favor in the Colorado arbitration. The Arbitrator found against the former employee and
awarded the Company costs of $33,985, with interest at 8% per year. Effective July 22, 2020, the Colorado Court confirmed the Arbitration
award and entered a final judgement in favor of the Company and against the former employee. The Company pursued collection of this debt
and has now collected the debt owed. This former employee continued to pursue separate litigation against the Company for recovery of
alleged consulting fees owed to him for the 2015 calendar year prior to his appointment as an executive officer of the Company. Effective
March 30, 2021, this separate litigation has now been settled. While the Company disputed the merits of the claims, the Company has agreed
and will be obliged to pay $40,000 over eight months and to issue upon execution of the settlement agreement an aggregate of 1,000,000
shares of common stock of the Company, These shares were issued on April 8, 2020 as &ldquo;restricted securities,&rdquo; subject to a
lock-up agreement of six months, without registration rights, and pursuant to a private placement exemption. The settlement agreement
also included mutual releases and no admission of liability.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
than as set forth in the preceding paragraph, we are not currently a party to any material legal proceedings, nor are we aware of any
pending or threatened litigation that would have a material adverse effect on our business, operating results, cash flows, or financial
condition should such litigation be resolved unfavorably. We have and will continue to have commercial disputes arising in the ordinary
course of our business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="c_006"></A>Item
1A. Risk Factors</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition to the information set forth in this Form 10-Q, you should also carefully review and consider the risk factors contained in
our other reports and periodic filings with the SEC, including, without limitation, the risk factors and uncertainties contained under
the caption &ldquo;Item 1A&mdash;Risk Factors&rdquo; in our Annual Report on Form 10-K for the year ended December 31, 2020 that could
materially and adversely affect our business, financial condition, and results of operations. The risk factors discussed in that Form
10-K do not identify all risks that we face because our business operations could also be affected by additional factors that are not
known to us or that we currently consider to be immaterial to our operations. There have been no material changes in the significant
factors that may affect our business and operations as described in &ldquo;Item 1A&mdash;Risk Factors&rdquo; of the Annual Report on
10-K for the year ended December 31, 2020 other than as set out below:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="c_007"></A>Item
2. Unregistered Sales of Equity Securities and Use of Proceeds</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">None.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="c_008"></A>Item
3. Defaults upon Senior Securities</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">None.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="c_009"></A>Item
4. Mine Safety Disclosures</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
applicable</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="c_010"></A>Item
5. Other Information</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">None.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="c_011"></A>Item
6. Exhibits</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
documents listed in the Exhibit Index of this Form 10-Q are incorporated by reference or are filed with this Form 10-Q, in each case
as indicated therein (numbered in accordance with Item 601 of Regulation S-K).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 35; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="c_012"></A>SIGNATURES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed
on its behalf by the undersigned, thereunto duly authorized.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SURNA
    INC.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(the
    &ldquo;Registrant&rdquo;)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 3%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 47%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dated:
    May 11, 2021</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Anthony K. McDonald</I></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Anthony
    K. McDonald</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer and President</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Principal
    Executive Officer)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dated:
    May 11, 2021</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Anthony K. McDonald</I></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Anthony
    K. McDonald </FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Principal
    Financial and Accounting Officer</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 36; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="c_013"></A>EXHIBIT
INDEX</B></FONT></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exhibit</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: black 1.5pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Description
    of Exhibit</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">31.1
    *</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="ex31-1.htm">Certification of Principal Executive Officer, pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</A></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">31.2
    *</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="ex31-2.htm">Certification of Principal Financial and Accounting Officer, pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</A></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">32.1**</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="ex32-1.htm">Certification of Principal Executive Officer, pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</A></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">32.2**</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="ex32-2.htm">Certification of Principal Financial and Accounting, pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</A></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;101.INS*</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">XBRL
    Instance Document</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.SCH*</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">XBRL
    Taxonomy Schema</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.CAL*</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">XBRL
    Taxonomy Calculation Linkbase</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.DEF*</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">XBRL
    Taxonomy Definition Linkbase</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.LAB*</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">XBRL
    Taxonomy Label Linkbase</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.PRE*</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">XBRL
    Taxonomy Presentation Linkbase</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 24px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Filed
    herewith.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">**</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Furnished
    herewith.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 37; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>2
<FILENAME>ex31-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><B>Exhibit 31.1 </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><B>CERTIFICATION PURSUANT TO RULE 13a-14(a) and 15d-14(a)
</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><B>UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">I, Anthony K. McDonald, the Chief Executive Officer
of Surna Inc. certify that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt">1. I have reviewed this quarterly
report on Form 10-Q of Surna Inc. for the quarterly period ended March 31, 2021;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt">2. Based on my knowledge, this
report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made,
in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt">3. Based on my knowledge, the
financial statements, and other financial information included in this report, fairly present in all material respects the financial condition,
results of operations and cash flows of the registrant as of, and for, the periods presented in this report;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt">4. The registrant&rsquo;s other
certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act
Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f))
for the registrant and have:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 24.45pt; text-align: justify; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 48.95pt">(a) designed such disclosure
controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material
information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities,
particularly during the period in which this report is being prepared;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 24.45pt; text-align: justify; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 48.95pt">(b) designed such internal control
over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable
assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance
with generally accepted accounting principles;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 24.45pt; text-align: justify; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 48.95pt">(c) evaluated the effectiveness
of the registrant&rsquo;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the
disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 24.45pt; text-align: justify; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 48.95pt">(d) disclosed in this report
any change in the registrant&rsquo;s internal control over financial reporting that occurred during the registrant&rsquo;s most recent
fiscal quarter (the registrant&rsquo;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably
likely to materially affect, the registrant&rsquo;s internal control over financial reporting; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt">5. The registrant&rsquo;s other
certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&rsquo;s
auditors and the audit committee of the registrant&rsquo;s board of directors (or persons performing the equivalent functions):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 24.45pt; text-align: justify; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 48.95pt">(a) all significant deficiencies
and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely
affect the registrant&rsquo;s ability to record, process, summarize and report financial information; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 24.45pt; text-align: justify; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 48.95pt">(b) any fraud, whether or not
material, that involves management or other employees who have a significant role in the registrant&rsquo;s internal control over financial
reporting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Dated May 11, 2021.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 3%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid; width: 47%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/ Anthony K. McDonald</I></FONT></TD>
    <TD STYLE="width: 50%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Anthony K. McDonald</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Chief Executive Officer</B></P></TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: left">&nbsp;</P>

<!-- Field: Page; Sequence: 1; Options: NewSection Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>3
<FILENAME>ex31-2.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><B>Exhibit 31.2 </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><B>CERTIFICATION PURSUANT TO RULE 13a-14(a) and 15d-14(a)
</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><B>UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">I, Anthony K. McDonald, the Principal Financial and
Accounting Officer of Surna Inc. certify that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt">1. I have reviewed this quarterly
report on Form 10-Q of Surna Inc. for the quarterly period ended March 31, 2021;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt">2. Based on my knowledge, this
report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made,
in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt">3. Based on my knowledge, the
financial statements, and other financial information included in this report, fairly present in all material respects the financial condition,
results of operations and cash flows of the registrant as of, and for, the periods presented in this report;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt">4. The registrant&rsquo;s other
certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act
Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f))
for the registrant and have:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 24.45pt; text-align: justify; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 48.95pt">(a) designed such disclosure
controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material
information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities,
particularly during the period in which this report is being prepared;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 24.45pt; text-align: justify; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 48.95pt">(b) designed such internal control
over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable
assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance
with generally accepted accounting principles;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 24.45pt; text-align: justify; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 48.95pt">(c) evaluated the effectiveness
of the registrant&rsquo;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the
disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 24.45pt; text-align: justify; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 48.95pt">(d) disclosed in this report
any change in the registrant&rsquo;s internal control over financial reporting that occurred during the registrant&rsquo;s most recent
fiscal quarter (the registrant&rsquo;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably
likely to materially affect, the registrant&rsquo;s internal control over financial reporting; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt">5. The registrant&rsquo;s other
certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&rsquo;s
auditors and the audit committee of the registrant&rsquo;s board of directors (or persons performing the equivalent functions):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 24.45pt; text-align: justify; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 48.95pt">(a) all significant deficiencies
and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely
affect the registrant&rsquo;s ability to record, process, summarize and report financial information; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 24.45pt; text-align: justify; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 48.95pt">(b) any fraud, whether or not
material, that involves management or other employees who have a significant role in the registrant&rsquo;s internal control over financial
reporting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Dated May 11, 2021.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 3%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid; width: 47%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/ Anthony K. McDonald</I></FONT></TD>
    <TD STYLE="width: 50%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Anthony K. McDonald</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Principal Financial and Accounting Officer</B></P></TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: left">&nbsp;</P>

<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: left"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>4
<FILENAME>ex32-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><B>Exhibit 32.1 </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><B>CERTIFICATION PURSUANT TO SECTION 1350, CHAPTER
63 OF TITLE 18, UNITED STATES CODE, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">In connection with the Quarterly
Report on Form 10-Q for the quarter ended March 31, 2021 (the &ldquo;Report&rdquo;) of Surna Inc. (the &ldquo;Registrant&rdquo;), as filed
with the Securities and Exchange Commission on the date hereof, I, Anthony K. McDonald, the Chief Executive Officer of the Registrant,
hereby certify, to the best of my knowledge, that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 24.45pt; text-align: justify; text-indent: 24.5pt">1. The Report fully
complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 24.45pt; text-align: justify; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 24.45pt; text-align: justify; text-indent: 24.5pt">2. The information
contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Registrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; width: 50%">&nbsp;</TD>
    <TD STYLE="text-align: left; width: 5%">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: black 1.5pt solid; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/ Anthony K. McDonald</I></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Anthony K. McDonald,</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Executive Officer</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">May 11, 2021</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">This certification accompanies this Quarterly Report
on Form 10-Q pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and shall not be deemed filed by the Company for purposes of Section
18 of the Securities Exchange Act of 1934, as amended (the &ldquo;Exchange Act&rdquo;). Such certification will not be deemed to be incorporated
by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, except to the extent that the Company
specifically incorporates it by reference.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<!-- Field: Page; Sequence: 1; Options: NewSection Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>5
<FILENAME>ex32-2.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><B>Exhibit 32.2 </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><B>CERTIFICATION PURSUANT TO SECTION 1350, CHAPTER
63 OF TITLE 18, UNITED STATES CODE, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">In connection with the Quarterly
Report on Form 10-Q for the quarter ended March 31, 2021 (the &ldquo;Report&rdquo;) of Surna Inc. (the &ldquo;Registrant&rdquo;), as filed
with the Securities and Exchange Commission on the date hereof, I, Anthony K. McDonald, the Principal Financial and Accounting Officer
of the Registrant, hereby certify, to the best of my knowledge, that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 24.45pt; text-align: justify; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 24.45pt; text-align: justify; text-indent: 24.5pt">1. The Report fully
complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 24.45pt; text-align: justify; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 24.45pt; text-align: justify; text-indent: 24.5pt">2. The information
contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Registrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; width: 50%">&nbsp;</TD>
    <TD STYLE="text-align: left; width: 5%">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: black 1.5pt solid; width: 45%"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><I>/s/ Anthony K. McDonald</I></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Name:</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Anthony K. McDonald, </FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Principal Financial and Accounting Officer</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Date:</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">May 11, 2021</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">This certification accompanies this Quarterly Report
on Form 10-Q pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and shall not be deemed filed by the Company for purposes of Section
18 of the Securities Exchange Act of 1934, as amended (the &ldquo;Exchange Act&rdquo;). Such certification will not be deemed to be incorporated
by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, except to the extent that the Company
specifically incorporates it by reference.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<!-- Field: Page; Sequence: 1; Options: NewSection Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page --><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>image_001.jpg
<TEXT>
begin 644 image_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" +>!A(# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#W^BBDS0 M
M%)FC- "T4F:,T +129HS0 M%)FC- "T4F:,T +129HS0 M%)FC- "T4F:,T
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M<W&GWMM=PABOF6\JR+D=L@D9YJUF@!:*3-&: %HI,T9H 6BDS1F@!:*3-&:
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "G=J;3NU !1110 4WO3J;WH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M* /.K;X:RS_"F#PGJ5S"MY"[RQSP%F1'+LRGD D8;!X[FN7_ .$2^*O]C?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !3NU-IW:@ HHHH *;WIU-[T %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M )Z/_P!]&KE0S19^9>O<5WX7$V]R9RUZ3?O1(?.E_P">C_\ ?1H\Z7_GH_\
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M_?1H\Z7_ )Z/_P!]&F45=B;L?YTO_/1_^^C1YTO_ #T?_OHTRBBP78_SI?\
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M4OK9D23,<$C=&3=@8_!5I--Q2-(M*<Y]KV.Q50JA5   P .U+116ARA1110
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MBIG.,(\TBHQ<G9$\+EDY[=_6I*  !@=**\&I)2DVE8]2*:BDPHHHJ!A1110
M4444 %%%% !1110!C:B-#T![CQ!=10P3;-KS@?/)G'R^Y^4?E7*^$[&\U'5]
M7\8W4!MENXBEK$>I3 ^8_@J_7GVK-\9V?BC5/%:S0Z.UUI]DP^SQ2#,;G'+,
M-PSD_H![YZ/PQJOBZ^U-H-=TF&ULO*8ATC(^;(P/O'MFM[6C>YK:T3*^%4:/
MX,U,,H(:Y=6SW'EKQ^IIGPNL;74O!U[:WMND]N;TDI(,C.Q*SGT#QCX8EU'2
M]"MQ<:=>L2D@*DH#QW(PV."3QQ700Z+JWA3X=M8Z5"9]6F;,C1?P,W4C/HH
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MI!_W[%'V"S_Y](/^_8H]NNP?4)?S'"4H!8X R:[K[!9_\^D'_?L4HL;0=+6
M?]LQ0Z^FB!8"761QT<8C'JW<U)77?8[7_GVA_P"^!1]CM?\ GVA_[X%>=.C.
M;YI,ZXT.561R-%==]CM?^?:'_O@4?9+;_GWB_P"^!4_5GW*]D^YR-%==]DMO
M^?>+_O@4?9+;_GWB_P"^!1]6?</9/N<C177?9+;_ )]XO^^!1]DMO^?>+_O@
M4?5GW#V3[G(T5UWV2V_Y]XO^^!1]DMO^?>+_ +X%'U9]P]D^YR-%==]DMO\
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M;?\ /O%_WP*/LEM_S[Q?]\"CZL^X>R?<Y&BNN^R6W_/O%_WP*/LEM_S[Q?\
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MY)_WR*/)B_YY)_WR*/;^0?V>_P"8\_KOK'_D'VW_ %R7^0IWDQ?\\D_[Y%2
M   <"LZE3F.C#X;V+;O>XM%%%9G4%-[TZF]Z "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "N>\7:K]ATPVT;8GN<K]%[G^GXUONZQQM([
M!44$LQZ "O*]9U)M5U.6Y.0F=L:GLHZ?X_C7'C:WLZ=ENSGQ-3DA9;LW/!6J
M^3<OITK?)+\T>>S=Q^(_E7=5XW'(\,J21L5="&5AU!%>K:1J*:IIL5TN Q&'
M4?PL.HK/ 5N:/LWT,\)4NN1]"]1117H'8%%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% $5S<1VEK)<3-MCC4LQ
MKS./6[A=>_M0YW%\LN?X>FW\JWO&NJY*:9$W3#S8/Y#^OY5QM=^&I+EN^I\U
MFN,;K*$'\/Y_\ ]AAFCN((YHFW1R*&4^H-25R'@K5=\;Z;*WS)EXL]QW']?Q
M-=?7'4@X2<3W<+75>DJB_IA1114'0%%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%9VN:FNE:7+<<>8?EC![L>G^/
MX5,I*,7)]!2:BKLY'QEJOVJ^6QB;,5N<OCN__P!;I^=='X6U7^TM+5)&S/;X
M1\GDCL?\^E>;,S.Y=V+,QR23DDUI:#JATK5(YR3Y+?)*/]D]_P .M>/2Q35?
MGEL_Z_ \VG7?M>9[,]3HI 0P!!!!Y!%+7M'IA1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5B^)]5_LS2F$;8
MN)\I'CJ/4_A_,BMHD 9)P*\O\0:H=5U6252?)3Y(A[#O^-;X>GSSUV1Y^98K
MV%&R^)Z+]6:'@[5?LE^;*5L0W!^7/9^WY]/RKT"O&U8JP9200<@CM7J6A:F-
M5TN.<D>:OR2C_:'^/7\:UQ5.SYT<>3XKFBZ$NFJ]#2HHHKC/<"BBB@ HHHH
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MC<HZ/<*"K X((SUS6U7RIXM_Y'/7?^PA<?\ HQJZ,/155M-F-:JZ:31]&_\
M"9^&/^@_IO\ X$I_C1_PF?AC_H/Z;_X$I_C7RU175]1CW.?ZW+L?4O\ PF?A
MC_H/Z;_X$I_C1_PF?AC_ *#^F_\ @2G^-?+5%'U&/</K<NQ]=6=[:ZA:I=6=
MQ'<6[YVRQ,&5L'!P1[@U/7'_  M_Y)SI7_;7_P!&O77M]T_2O/G'EDUV.R+O
M%,I?VUI?_00MO^_HH_MK2_\ H(6W_?T5Y717B?VG/^5?B<GUJ78]4_MK2_\
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MMW2?^@C:_P#?T4?V[I/_ $$;7_OZ*\CHH^J1[A_;M7^1?B>N?V[I/_01M?\
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M>+_^1?D_WU_G7G5>B^+_ /D7Y/\ ?7^=>=5X69?QOD<&)^,****X#G"BBB@
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M%[(][(OCGZ+\RY1117$?2!7RIXM_Y'/7?^PA<?\ HQJ^JZ^5/%O_ ".>N_\
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MUS#-M^]Y;AL?7%<$\DB>"YE5V2.342DK*,X3K_,"MNQL= T_7[3[!=.L\D;
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M7[34=&349)$MDSLD$K@!&],G\/SJ_'>VDUPUO'=0O,GWHUD!9?J.M><HK?\
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M\OII-<[O[UM-/=UUZG43:A96\HBGNX(I#T1Y I_(FI);B&%HUEFCC:0[4#L
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M2W+$-NR7W#!W>O'TK8HI>SAV*>+KM-.;UW_(RX=!LX--NK!#+Y-RS.Y+#.2
M#CCVI\FBVLL%A"QDVV+(T6&YRO3/'/2M&JRW]L]^]BLF;E$\QDVGA?7/3O1R
MP70%7KR;:DWU_"U_NT.=_L"'5->UG[=;2")FB,,N"O\ #SM/?WK=71[!=+.F
MBW7[*1@ID\\YSGKG/>KU%*-.**JXRK4MK9*UE?LK7,O2O#VGZ/(\EK&WF.,%
MW;) ]!45UX7TF[OFO);<F1N6 ;"L?4CUK1O+^VT^.-[J3RUD<1J=I.6/0<?2
MK%/DA;EL+ZQB$_:\SN]+]RMI]C%IMC%:0%C''D+N.3R<_P!:A_L>U-U?3G>6
MO4$<H)XP!CC\*OT57*K6L9*M44G)/5[_ )_F92Z!9K8V=F#+Y5I,)H_F&=P)
M//'N:KZCX3T[5+Z2\N&G$LF,[' '  ]/:MVBI=.#TL:1Q=>+YE-WU_'5F1I7
MARQT=IFMFF)E7:V]@>/RJ[IVGPZ78QVEN7,29QO.3R<_UJU134(QV1-2O5J7
MYY-W_0****HQ"BBB@ HHHH ])\$_\B\O_75OZ5T=<YX)_P"1>7_KJW]*Z.O+
MJ_&S[C _[M3]$%<)XW_Y"T'_ %P'_H1KNZX3QO\ \A:#_K@/_0C7FYA_ ?JB
M\1_#.8HHHKP3SPHHHH ",C!Z5STW@G0YKOSS;,H)R8T<A#^';\,5T-%7"I.'
MPNQ492CLS/OM&L[[2O[-=#';#;A8OEQCIBG76DV]Y>V5W*7\RS),>T\<XZ_E
M5ZBA5)KK_3W#F?<PKGPEI5S<O,4EC\P[I8XI2J2'W'^&*N2Z)9RS6$@5H_L.
M?)1#A1G'7\JT:*;K5':\GH'/+N9?_"/V']NC6 CBZQV;Y<XQG'KCBJLO@_1I
MM1-Z]N=Q;<T8;Y"WKC^G2MZ@G S0JU1;2?8%.2ZA6%=>$-&N]0-Y+;'>QW.B
ML0KGU(_PK4L;^VU*U6ZM)?,A8D!MI'3KP>:LTHSG3;LVF"<HO30S=4T'3]8A
M2.[@SY8Q&R':4^G^%-M?#^GV6ESZ?;QLD4Z%)6SEFR,9S6I5;[?:_P!H_P!G
M^;_I7E^;Y>T_=SC.<8ZTU4J./*F[+4%*5K)E.?P_9W&B1Z2YE^S1XP0PW<=.
M<4NK>'[#6C";Q'+0GY2C8)'<'VK4HH5:HG=/^GN'/+>Y2M=+M[34+N]C+^;=
M;?,R>/E&!BJ6I>%-)U6Z%S<0,)207:-MN_Z_YS6U5:QU"UU* SVDOF1ABA.T
MCD=>HHC4J)\Z;]1J4E[R96NM"L;JQMK+8T4%M(LD:QG&",X_G4.H>&=.U&Z-
MRZRQ3M@.\,A4N/0]JV**%6J+9B4Y+9E>RL;;3K1+6TB$<*=%'/Z]ZL445FVV
M[LEN^K"BBB@ K?\ !W_(?7_KFU8%;_@[_D/K_P!<VK?#?QH^II2^-'H=%%%?
M2GIE'6O^0%J'_7M)_P"@FO(:]>UK_D!:A_U[2?\ H)KR&N["?"SYK/?XD/1_
MF4]1TR#5(HH[@N%BE$J[#CD9_P :%TV!-6?4@7\]XO*(S\NW(/3\*N45T\JO
M>QXRK5%'D3TU_'?\C,70; 07<#QM+%=2F:17/\1],=*98>';#3[D7""669<A
M&FD+; >PK6HJ>2/8MXJLTUS/7<S'T#3WU<ZFT;&<J5(W?*<C;G'TXJF/!VCK
M%.BPR+YN/FWY* $'"YZ=/K6_10Z<'T*CBZ\=%-_?V*BZ="-3_M#<YG,'D')X
MVYST]<T:;IT&E62VEN7,:DD;SD\G-6Z*I12=S*5:I)<K>FGX;?<9NI:'9:HZ
MRS+(DR#:LL3E6 ]*9:^&]*LYX)H+4++"25?<23GUR>:O3WMI:LJW%S#"S?=$
MD@4GZ9J7>GE^9N79C.[/&/7-3RP;O;4T5?$1@H\SM\R&_LHM1LI;28L(Y!AM
MIP>N:K2Z+:RQ:?&QDVV)5HL-_=QC/'/2KEO=6]TA>WGBF4<$QN&'Z5"-4T\@
M$7UM@@D'SEY ZGKVH:B]6*$J\?=C?3UZJW;L,.DVK:C/?,&:2:'R74GY2OT_
M"L]?!^D)#-&D4BF4CY]^60 @X4GIT^M;+75NEM]I>>)8" ?-+@+@]#GI5:.X
MF?5WA\^T:W$(98U;,P.1R1_=I.,.J-*=;$)-QDU;].FW05=,@75'U'+^>\/D
MGGC;D'IZ\5"FA6B:(=)!E^S'/.X;OO;NN/6KGVRU^T_9OM,/G_\ /+>-WY=:
M=/<P6L>^XGCA3IND<*/UI\L"/:U]%=]+?+;IT*-]H-CJ-C!:7",4@ $;!L,,
M#'7WQ4>H>&M,U)81-$P:% BLC8.T= ?6M3S8_*\WS%\O&=^>,?6H[>\M;L$V
MUS#,%ZF-PV/RH<(/=#C7Q$5>,GI?Y7W*D^A6,^FQ:>$:*WB8.JQG'(]SGUJ>
MXTV"YO[6\D+^;;;O+P>/F&#FK=%/DCV(]O5_F?7\=_O,23PGI$EU/<&!M\RL
M"-W"ELY8#UY_"K+:):O'IZ,TI%B083N';&,\<]*TJ*7LXKH4\57=KS>G^5OR
M*?\ 9L']K#4LOYXB\G&?EVYST]:H2>$]'EO_ +6UM\Q.XQ[OD)]2/Z=*VZ*;
MA%[H4<36C\,FM+?(S-5T#3]8VFZB/F*,+(APP'I5RSLK?3[5+:UB$<2] /\
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MN*?-IGB+2-0O6T8036UY(9/WA&8F/4X)']>W%)-X9O+?0-.LX0)YTO5N)R&
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M;?5__0C6U6+X4_Y%RV^K_P#H1K:KZ;#_ ,&/HCU*?P(*\X\<_P#(?7_K@O\
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MI_WS1_PD%E_TT_[YH^JX3O\ B'L:)S/_  @]]_S\V_YM_A1_P@]]_P _-O\
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MYH_X2"R_Z:?]\T?5<)W_ !#V-$YG_A![[_GYM_S;_"C_ (0>^_Y^;?\ -O\
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MGAMT3>7D&/E]:GZS4+_L?"=G][.4_P"$"O\ _GZMO_'O\*/^$"O_ /GZMO\
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M/^FO_?/_ ->FZ]5.S%_9&$[/[V<M_P (%?\ _/U;?^/?X4?\(%?_ //U;?\
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M.N;9" TL3(">@)!%</\ \(%?_P#/U;?^/?X5WTCB.-G()"@D@=:H_P!KP?\
M/&X_[]UI"I."]TX\3@Z&(:=5;>9Q_P#P@5__ ,_5M_X]_A1_P@5__P _5M_X
M]_A78?VQ!_SRG_[]U&=?L@<'S ?3;6GMZIS?V3@^S^]G)_\ "!7_ /S]6W_C
MW^%'_"!7_P#S]6W_ (]_A76C7;0G $O_ 'Q1_;MF.HE_[YH]O5#^R<'V?WLY
M+_A K_\ Y^K;_P >_P */^$"O_\ GZMO_'O\*ZW^WK/_ *:?]\T?V]9_]-/^
M^:/;U0_LG!]G][.2_P"$"O\ _GZMO_'O\*/^$"O_ /GZMO\ Q[_"NM_MVS_Z
M:?\ ?-']NV?_ $T_[YH]O5#^R<'V?WLY+_A K_\ Y^K;_P >_P */^$"O_\
MGZMO_'O\*Z[^W+3TD_[YH_MRT_Z:?]\T>WJA_9.#[/[V<C_P@5__ ,_5M_X]
M_A1_P@5__P _5M_X]_A77_VW:'M)_P!\T?VU:^DG_?-'MZH?V3@^S^]G(?\
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M.2?4UT1P-1K5I%>S99HJ 3X^\/RJ59$;HP^E<]2C.G\2)<6AU%%%9""BBB@
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M5?#1C8ZY>6#,AW1$-M?HZ-C&#[%NE>GFO&&">'OBQ]H5MD1O%1CSC#@!L_\
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M'0#"C.6$]I[UR9T]=RQG%)N7>J9&]R J]R3Z5;E_?0M'(5 D7F-X^2#V(/\
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M'<L21G.,=!D!:Z^>ZMX+.2[DE401H79^HP!DUX?#X@O[)VCOK-G' )@."/\
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M4 %<SXC_ ./Z+_KG_4UTU<SXC_X_HO\ KG_4USXK^&9U?A,>BBBO+.<****
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M0%? FB C:WV1,CT..:Z&L/P=;36?A'3;6X??-#%L=B,9()&<5N4@"N9\1_\
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M5.-WO_O"N]T'QY#=!;#5XE5W^4-C*/\ G_6N>=%QUCL:QJ)Z,S6-1,U=5?\
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M(Q6;::DLK#:3'.ISM/K[5J/!?^%]0:>Q#>5D^=;$_*^#V]ZM7&E:;XQM6O\
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MB/\ X_HO^N?]3735S/B/_C^B_P"N?]37/BOX9G5^$QZ***\LYPHHHH ****
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M !6IH'_(3'^X:RZU- _Y"8_W#6M'^)$</B1U5%%%>N=9C>+O^1,US_L'S_\
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MTNASVWEM<WFEPINP66^CFQ]5B+-^E "ZW\OB34!_=O) .>/OFNV^%3%9=>W
M@[X<_P#D2N:\0VNFQ^(M1DEURWW&\E)ABAD9U^<Y'SA5)'^]CWKJ/AU)I\,F
MNRV<UY<QDP%MUKM8$EP,*C.2.>M-;B>QZ.C#I[5YIJ=_"VLZB@B6> R&.7<=
MGEMP@YQW.>/;(QG)]'MG>Y03F"XA7<R 3IL8XXSCKCTS_+%<M#H=QJ.MWUKJ
M"N\I8/#(Q^18]YSCWQM'MG%%1[6)I+5MG.:#?6TR6_E>:8(;=D),>X1'=E@Q
M SU(&2.X[<UO/#;1GS&9&0X(*MN4@C(QP.Q!QVS5BW\ :CIOGOI]];1/.0TI
M$3 DC.#QGU-2S:9XBN-&DL@89KANLHB:(X.<D[@H)Y/IUK#G=S5TXE'0@+K3
M)965P9'9I9"0PA'14(&2,  8('2F:!H9U6:3;<P".$B0LV>O7&"/8@Y'YUI1
M^#I+.TM;1276,DN[1%F"G))!R><]ASSTKF]7MXM-F;S+^^+QY11.&CPG8 ;O
MTQ6\+S7(M63*48M3:M;J>M6D<94&5K5Y6'S');)QVS5I(XV482V([<#'\J\E
MM-6T>Y*+#JEQ;$*,AI,#\R,5U%I%I4O,6N7F<!OW;JW7OT-<TZ<Z;M*/]?<=
M49PGK&7]?>=O&)ER$AC0 \8(P:XKXJ:+<ZIX-OY;.'-W'$"R*>60,&;'J0 :
MZ"QACC*[=4FG7_; R/R%:NY0#SG^M$9-"E%'Q5LVQ[CU/ IM?2^K_"7PQJMX
M]RMN\#.266)BJY)SD#M69+\"O#LF/+O+^,]]KJ?Y@UM[:)C[%]SY[H)KW*]^
M 5LP_P! UB:/VGC#?RQ6</@#J!8#^VX.O/[@\?K3]K$/92/':Z7P)I2ZOXMM
M(I ##$?.D![A2,#\R*]%3X 2YQ)K@QZK#_\ 7KK/"WPHLO#,DLGVZ>>60 %L
M!<8["IE55M"HT[/4[RQ \I1[5>)P.:J11) H S@4LUR$'48K'FLC1QN]!+B?
M8M>5?$6P3Q/<6VFO<M"L2F8E5SD] /US7:>(=9BTO2;F]D8%8E^13_&_\*\>
MIKSVVN);JXMKB9BTLMMO8GN20:JFF_>%-J/NEK2+(Z=I\5IYS3>6,>8_WFJ6
MP/\ H$/';^M2Q$8J&P_X\(OI_6M&[LR6PE\<QQ\'_6H?U%>PZ3_R!K'_ *]X
M_P#T$5X[?-B.,_\ 35/YU[%I/_(&L?\ KWC_ /013B)ERBBBJ)"OE3Q;_P C
MGKO_ &$+C_T8U?5=?*GBW_D<]=_["%Q_Z,:N[ _$SDQ?PHQZ***]$X@HHHH
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M>U>MU#:VL-E:Q6UO&L<,2A$1>@ J:O*JU'4E<Y)2YG<****S$%%%% !1110
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M_P!&-7U77RIXM_Y'/7?^PA<?^C&KNP/Q,Y,7\*,>BBBO1.(**** /I'X6_\
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M('M_(YA&DM^'R1ZUEZOX=L]70O$$BF/7CY7^H[?6N[P/048'H*?*+VWD?/\
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M)"?=143QCG!QDC:C@U2FIQD?&;3NL+Q@XW<$XYQZ5<L9X[>6-\':O;O7U_\
M9H/^>,?_ 'P*/LT'_/&/_OD5P<IZ?MO(^88+F.=-R-D?J*L*[(P9"5<<A@<$
M5]+BWA'2*/\ [Y%+Y,7_ #R3_OD4<H_;>1XAH_CJ]L0(K]3=PC^/.' ^O?\
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MJ'Q(T:***S.HKWO_ !['ZBLNM2]_X]C]1677/5^(B6X4445F2%%%% !1110
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M=E,,;;'.(UQE=O*GGGOS2Y0L>F4445(@HHHH **** -6R_X]5_'^=3U!9?\
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M]Y&;^V81S7(A90@5L8!.XDX'.P^]1Z#-/:ZE!#_:#SJ_B*YBEE#;?. MFP&
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MQCNTDO"KF&1Y&1BH  "@ ';T&*;J,^H>#WG6UUJ\U,7%A<716^=93"Z!<.N
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M*XU*YCTZ*VQF1C(?+$6 >=^2"!@8STIV06.Z&J6;:LVEK-NO4B$S1A&.U"<
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MNW%FP2<X],<^M-U:UU*#4;7P_'J6OW$<D,EY+/:W$*7$C[P-H9RH5%_NK_>
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M1110 5M0_P"HC_W1_*L6MJ'_ %$?^Z/Y4I&M'=CZ***@W"OE3Q;_ ,CGKO\
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MK+NM;BL[F^@EB?=:V@NQCDRI\P(4>H*X_P"!#UH0&C##';P1P1+MCC4(@SG
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MEM"\/P65G;3YBG\Q6.(V4AF'7<_3[WXFKNH>&='U;2H--O[%)[6!56)6)!0
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MUN(H99)4DL2<D0D.9')_WG=^G;%,UGPO>336,=A#IMS86UL+=+34BYCC*]'
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MDR0)&*2 [>/5P!G' J/3O#FJ6\VE+<269AT^_N)U:-FW/%(LF,@C&[,G(SC
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M)G  '<\ <FN6TS2]9UC3KJQ\^R71Y=4N'D8AO/4+<LQ11]TY*]2>,GBO0:0
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MNFU+S&\R-V4,"IS@*N0 .F!1;N*QW%%<-=3:W#XLU-]%%A/(NG6KRR7;,%8
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M8[]<5VU-=$D #HK '(R,X--.P(\@@\I])\.1WPLVTMH;HQ_VI*\4)F\XXWD
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M *B/_='\J4C2CNQ]%%%0;A7RIXM_Y'/7?^PA<?\ HQJ^JZ^5/%O_ ".>N_\
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M%4,2?0!2#GZ^AIVDZ_I6NI*^EW\-T(FVOY9Y7TR.N/?OB@5F:5%%% !1110
M4444 %%%% !1110 5:L/]>W^[_455JU8?Z]O]W^HH>Q4/B1HT445F=17O?\
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MI>H1#6K@ZEJ 5;G4'C7?L QM11@(,$XQTR:L0>*+.VT,ZEK-U;VB?:IX 3D
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MV1!*(\K&3C+9!.>!SBK>G:WJDEY8V-W-$TT6J36-S)%&%6=5MVD5L'.T_=R
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M'^N7_=_K6C6=J'^N7_=_K657X0EL5****YR HHJG)J4,6L6^F,LGGSPR3*P
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M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !6U#_J(_\
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M6BBBK.<**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH *M6'^O;_=_J*JU:L/]>W^[_44/8J'Q(T:***S.HKWO_'L?J*R
MZU+W_CV/U%9=<]7XB);A11169(445G:YK%OH.CW&HW ++$I*QK]Z1NRCZ_IR
M3P* -&BH+*Y^V6%O=;-GG1+)MSG&0#C/XTB7UG),L*74#2MNVHL@+':<-@>Q
M!!]#0!8HK/@U2-FN1=&"V$4[Q(3<*V\*H8G_ &3C)*GD 9JVMU;O:BY6>(VY
M7?YH<%-OKGIBBP$M%1P3PW,*S02I+$XRKQL&4_0BFR7=M#<1V\MQ$DTO^KC9
MP&?Z#J: )J*A-W;*DSM<1!(3ME8N,1G .&].".OK0]W;1W26KW$2W#C<D1<!
MV'J!U- $U%9UEK=C?ZAJ%G#,AEL7"2C>I_A!)&#T&<'/<$58CU&REM3=1WEN
M]L#@S+*I3.<=<XZT6 LT56.HV*QM(;VW"+)Y3,95P'_NDYZ^U6: "BJ\-_:7
M+RI;W4$TD7$B1R!BI]#CI5>SU:"6PM)KN2VMIIXT<P_:%?!;H PX;G(!'7'%
M%@-"BLO4=:33=5TVSE1?+O/-+3-)M$0C3=D\<_F,5>^UVWV3[7]HB^S;=_G;
MQLV^N>F*+ 34576_LW@CG6[@:&4[8Y!("KGG@'OT/Y4Z&\MKBV^TP7$,L&"?
M-1PR\=>1Q0!-17.ZCXKALEOG@A2ZBMK6&Y61)AMD$DCI@$ ]-F<\YS6X]W;1
M7$=O)<1)/)DQQLX#/CT'4T68$U%0&]M1<"W-S")BVT1F0;B<9QCKG!!^AJ>@
M [UN5A]ZW*VH]2HA1116Q9BM]X_6DI6^\?K25H<84444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 :5C_P >_P")
MJS5:Q_X]_P 35FH>YU0^%!6=J'^N7_=_K6C6=J'^N7_=_K657X0EL5****YR
M K%O];EL;R^MC;!WCM%N+4!L&=B2NSV.[8/^!BMJLW4]&BU.\L+AW*FTE\P@
M#/F#A@OM\ZQM_P  ]Z:MU P-<\1P7>AW#I9BYLCIT=W*&D9#\[@(N5Y!P')^
M@]:S-8O=8%WKXE2.6WM]1L/(CCF8OGS(2J@$ #(///4^G-=!)X1B;1=7T^.Z
M*'49FD\PQY\I200@&>0.<<]Z6\\,376IWMP-1"6]U-;3M 8,E7A9#G=NZ$)C
M&.,Y]JI-(>A8T;5[^ZU.^TW5+."VN;9(YE,$QD5T?<!R5!R"A!XJAJ-C_P )
M)XHN=,O)YUTRRM8G>VAE:/SWD+\L5()4!.GJ:VH=+\KQ!=:KYV?/MXH/*V_=
MV,YSG/.=_3':JFK:#/=ZC%J>FZBVGWZ1^2[^4)4ECSD*R$C.#R""",GUI75P
M.+&IZ'-X0\46WA[69[JTCL2\=M*LN;;A@=KN,E3QQVP?6M2YEF;P3_8)D?[2
M+AM-9P>?+0%\Y]X5'/JU:,GA&YO+35?[0UAKF^U"T^R><+=42*,9( 0'GEB>
M6J])X;5]?GU/[4P66U, @V?*)" #+G/)VJJ_0>]5=!<XB6VT>]N_#Z:Y;7ES
M -!A9%MTF8A\CD^5STSUXKK/!4,L-KJ"QQ7D.F?:<6$5[O\ ,6,(H/#_ #!=
MP; -7-,\/_V=>65Q]J\S[-IJ6&WR\;MI!W]>.G3]:VZF4N@-G.#Q1Y:VR3P*
M+AK][.>-6_U2AMH?GL=T1^D@J ZREYK]@[6:E1<7D-M-YC @1+M<E1P<L&'.
M> #WJ]>^&8+RZU*<RE/MMMY6 O,;D &0'N2$BX_Z9CUI/^$>2'^R&CG.-,AD
M0 IDREDVDDYX.>3UR31[H:&?IGBK4YUTFZU#2HK;3]355BE2?<Z.4W#<N/NM
M@XP2>F<9Q573/'_VV]L3+%8)97\HB@6.]62YC+?<,D8'&[C@$[<\T_PUX;OW
MTO09-2U.66UM+>.6*Q>W",DGEXP[=2%W$ 8';.<5;TOPG=Z;/:Q#6=^G6C9A
MMQ:JLA4?=5I0<L!QV&<<TWRAH:>N:K<:>+2WL;5+F^O)O*A2238BX4LS,<$X
M 4] 2>*YFRUS4;/4=9#Z:'U6ZOX;:*U$W[O=]G4EM^/N;5+=,]L9KI];TB75
M([:2UO&LKVUE\V"<1AP#@J0RG&002.HK('@ZZ*W$[ZW(=2DNDNXKL0 >6ZQ^
M61MS@J5R,>A[]:2M8%8DB\3WT$TEMJ6GQ0SVUS!%<&*8NACF)5)$) /WP 00
M,#-3'Q1O%W'!;@W$=\EI!&S?ZT,VTO\ 0;93](S3K7PU+]FU3^T=1:\O-1C$
M<DZQ",1JH(4(N3C!8G.3R:?:>&(+6^TVZ\YG-E;>405_UK@$"0GU >7C_IH?
M2CW0T,N+Q9J[9NVTB :6FH&Q>47!\S_7>4'"XQC. ><]>W-=C6$OAO;HCZ=]
MK^]??;/,\OI_I'G;<9_X#G/OCM6[2=N@F%%%%( HHHH *LV/_'R/H:K59L?^
M/D?0U4/B0+<TZ***ZC49-_J)/]T_RK'K8F_U$G^Z?Y5CU<3"MN@HHHIF0444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 5M0_P"HC_W1_*L6MJ'_ %$?^Z/Y4I&M'=CZ***@W"OE3Q;_ ,CGKO\ V$+C
M_P!&-7U77RIXM_Y'/7?^PA<?^C&KNP/Q,Y,7\*,>BBBO1.(**** /I'X6_\
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ME0,NX/%@X/UKJ:*7,*YY'!#"=4%I<3V\?B#^TC-A-)D>[_UQ(83&0+Y97';
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M_=%7'<BK\)5HHHJSG"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M44R81>W ) Z@&O2J*?.%SRFZDT>:V\2S:% (K&2QM&79$8XW/G29**0,#MP
M,@U%K<4 UC6K?4I8(]4N+EFL\Z3)/<N@5?+,$@D51@8&.,$'->LJZ.S*K*2A
MPP!^Z<9P?P(_.G4<X7.3T6PMIO&_B&\G@CENH)+<1RN@)CS N=O]W/?'6NLH
MHJ&[B#O6Y6'WK<K:CU*B%%%%;%F*WWC]:2E;[Q^M)6AQA1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!I6/_'O
M^)JS5:Q_X]_Q-6:A[G5#X4%9VH?ZY?\ =_K6C6=J'^N7_=_K657X0EL5****
MYR JK>ZE8::BO?WMM:HYPK3RJ@8^@R:M5Q^O&VL?%\6H:II\MU8-8&")DMC.
M(Y=Y)!4 XW# SCM32N".CNM8TRQ6)KS4;2W689B,TZH'_P!W)YZ]J+S6-,T_
M;]MU&TMMR[AYTZID=,\GI7#6S6>F7CW.M>&YTM[G3XDL[=+9KH0JN[=!P/E8
MY!P0!SC/%6/#NAR+J6BQ:K8B1K?167$R!Q&QD7"Y/&0IQ^=/E0['97&KZ9:6
ML5S<ZC:0V\N/+EDG54?/H2<&JLGB+3X]<M-+-S;^9=6[W"-YR\@%0 !WW L1
M[*:X22P2#P]H,DIO;&:W^T1I.NG?:XHU,GW'CP6&0!@@>O-:FFM(MWX>N=0T
MI;2673KF!4AM"J1OOC* @ ^7E03@],D4^5!8["WUC2[MPEMJ5G,Q*J!'.K$E
ME+*.#W4$CU )J62_LX8YY);N!([<[9F:0 1' .&.>."#SZBN'LX%T?P=X2O/
ML$H6VEBENQ# 6D4&&12S*!DX9QGOS4%P6O5O=2DTN\EL5UV*YE@> [WA%LBA
M_+ZD!MK8QGCD9!%+E"QU6H^+=(L(+"<7UI-#>7 @21;A-H'\39SR!QGZCUJZ
M-6MH(+J>^O+&"&&<Q>9]H&U>F Y. K<]/I7&WSV5Q!!J%OH4EOIT6L12F3[,
M^Z9?+(>7RMN57.T=.<9J)H/LNKMJ&H:?/<:=#J]V9%6!I-A=(PDNP E@,,,@
M'&:?*@L=V=6TU;..\.H6HM9#A)S,NQNIX;.#T/Y&I+._L]1@\^QNX+J')7S(
M) ZY],BN"ATV*_$,BZ5)#IESX@6XAMYH-OR" @N4_A4NI/('7IS72Z!:"TUS
MQ$D=N(8&NHF0*FU3F!,D=NN<^])I(+'04445(@HHHH **** "BBB@ HHHH *
M*** "K-C_P ?(^AJM5FQ_P"/D?0U4/B0+<TZ***ZC49-_J)/]T_RK'K8F_U$
MG^Z?Y5CU<3"MN@HHHIF04444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 5M0_ZB/_ '1_*L6MJ'_41_[H_E2D:T=V/HHH
MJ#<*^5/%O_(YZ[_V$+C_ -&-7U77RIXM_P"1SUW_ +"%Q_Z,:N[ _$SDQ?PH
MQZ***]$X@HHHH ^D?A;_ ,DYTK_MK_Z->NP/2N/^%O\ R3G2O^VO_HUZ[ ]*
M\2K_ !)>IZM/X$8=%%%>>2%%%% &-XHU&^TK0WNM/@\V82(K'RFE\M"P#/L4
M@M@9. :QK/Q3<RZ$NI+?:=>PP7Z17$EO&\9\EB%R4;E'!8$CD8'OQTFJZ8FK
M6?V=[BXMR'61)K9]CHRG((."/;!!'-8=]H@TG0=5CMK:^UB\U0&.5I'3>Q*%
M5W'Y0$'L,C-4K6&BMJGB;5(;2ZO+18ULTU'[()_LKS^5$J'?(54@M^\!7VQ5
M0ZE>ZU)X3NH-3TZ4G4)E>2WB=D?$4F#M8@J=F05.<%@<D#!WX/#"IX>TW3OM
MUW;S6>'^TVT@5VDP=Q.0002Q)!!I(O"-G#!;+'>7HGAO&O3<[U,DDC*5;=E<
M8*G& !TIWB&A@0>-K^XNX[I'MFM'O/(^Q+:RF41;]GF>9]W=GYMN,8[YJ:X\
M1^(HQ?WL*:>UI::H+%8'1@\H+J@;>#A<%QV.<'VK:B\)V\-V'BU'4DM!<&X%
MBLP$.\G=_=W;=W.W=C/:IV\-V;V=S:F2?9<7HOF.X9#AU? X^[E1[X[T7B&A
M!H6HZG)J^J:5JK6LLMHL,J36\;(&60-P5).""A[\@BM^J4&F0V^KWFI(TAFN
MXXHW4D;0$W8QQG^(YY]*NU#$%%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110!JV7_'JOX_SJ>H++_CU7\?YU/75'X4:+8*SK[_ (^!_NBM&LZ^_P"/
M@?[HJX[D5?A*M%%%6<X4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 5:L/]>W^[_455JU8?Z]O]W^HH>Q4/B1HT445F
M=17O?^/8_45EUJ7O_'L?J*RZYZOQ$2W"BBBLR0K#NY/M/C'3K)_]7;VTMYCU
M?*QJ?P#/^)'I6Y65>VDJ:]I^IPH7"H]K.!U$;X8-^#(H^C$]J: R-)U;7]2B
MAUG_ $!=(DDD)MMC"985W -OS@MD9VXQCO4%GX@UU8='U:^6Q.FZI-'&((48
M2P"7_5$L6PW4!N!C/%:$7@RPANXI!=7K6D-P;F*P:13 DAR<@;<X!)(&< ]J
M+/P;96=S:O\ ;;^:VLY#):V<TH:&%N0,#;DX!.,DXJKQ'H8X\1>)6M["\1=-
M,5Y?R6$<+(^X8,@60MN[%.5QR!U&>)I/$&OP0M:#[!-J":NMAYGELD;(T/F!
MB,D@C(R,]L>];J^'+-+2QMQ)/LLKMKR,[ADN2YP>.G[P^G;FLOQ!X:^U20?9
MC<YN=6CN[AXW"M#B$IN4XXQM4]^?;BBZ#0S]4U#47AN-*U4V\ES::AI\B3VZ
M%%DCDG7&5).&!1L\^E,D\:ZC]KFN8VM6M8KPP"Q6VE:9XU?8S^8/EW9!8+C&
M.,YKH(O"=FD$R2W5Y<3S7,-S+<S.ID=HF#(I(4 *-O0 =3ZTG_")6XNY)(]2
MU**UDN/M#V4<X$)?.X_P[@">2 V,DT7B%T5I]>U.#Q7_ ,(\(X&FN&6XMY^@
M2V_CW+G)<%2!C@[@>Q%:/B/4[K3;.V2Q2)KR\NDM83-G8A;)+,!R0 IXJ.7P
MM937<MZ\]S]L>Z2Y6XW+OCVC 1?EQLP6&"#G<W<YJ[J^D6^M60MIWEC*2++'
M+"VUXW4Y#*?6E=:!H<KK@\0)-HD=P^GRW@U7%M,BLJ,I@D^9TR2".> W.!R*
MG;6-05'M-2BL;BYM=9MK;S%A.QE?8RN%).UP']3@BM.V\)6=O<Q73W5Y<7:7
M0NFGF=2TC",Q@-A0-H5C@ "K$WAVTGN9IVDG#37D-XP## >(*% XZ?(,_CR*
M=T%SE;:ZCL=5M;N7/EP7.L2OCKA9,G^53:/XQU">\L7O'M9;>[5VDA@MI5>U
MPA=<NWRN.-IZ<D8XKHXO#=E%=13[I7,<ES)L<@JWGMN<$8Z>GZYJ'3?"L&FS
MP,NI:E/;VRLL%K/,#%&",8P%!; ) W$XHO$+HYX7FMZE=>$]2OVLOL=Y>">*
M*%&#P[H)"BDDD-E3R<#!'?/'5ZGJ,NG:AIQ;9]BG=X9F(YC;865L]A\C+]6%
M9]IX+L[.[LI4U#4GBL93):VTDP,460R[0-N2,-QDDC P>N=?5]*MM;TR;3[P
M/Y$N-VQMIX((P?J!2;5P,/3O$EYJ/]GPB&.*[DGE:YC8?ZN!5W@]>N)(!_P(
M^E9]EXFU:;5=/@:\T^XBOI'A/V>TFV0-L9U(E)VR#Y>>A/;CIU T2R_M&[O2
MA,EU ('4GY0HR#CT)& ?]U?2LRT\&V]M=Z?</JFIW']GD?9HYI4*(-I7& HS
MP>IYXZ]<EXAH<SI>O:AI'AG1[3[5;">]GN7%S);.ZQ1H_P V45B68LW'('//
M3G4B\3:S<Z7:"%;3[9)JGV SM"ZQ.AC9Q(J'##C'&>JD9YS6FO@ZTCLX((K^
M_B>VG>:VG21!)#O^\BG;@H?1@?Y5;@\.6\4-HCW=Y<26]V;SSIY0SR2;67YN
M, 8;HH'0>^6W$+HKLTMCXLTU)) \E]921W!5=JL\14JP&3C[[]SU'/%=!64;
M26Y\3I>2)M@L[=HX2?XWD(+GZ (H_P"!-Z5JU+$%%%%( [UN5A]ZW*VH]2HA
M1116Q9BM]X_6DI6^\?K25H<84444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 :5C_P >_P")JS5:Q_X]_P 35FH>
MYU0^%!6=J'^N7_=_K6C6=J'^N7_=_K657X0EL5****YR HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ JS8_P#'R/H:
MK59L?^/D?0U4/B0+<TZ***ZC49-_J)/]T_RK'K8F_P!1)_NG^58]7$PK;H**
M**9D%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %;4/^HC_ -T?RK%K:A_U$?\ NC^5*1K1W8^BBBH-PKY4\6_\CGKO
M_80N/_1C5]5U\J>+?^1SUW_L(7'_ *,:N[ _$SDQ?PHQZ***]$X@HHHH ^D?
MA;_R3G2O^VO_ *->NP/2N/\ A;_R3G2O^VO_ *->NP/2O$J_Q)>IZM/X$8=%
M%%>>2%%%% !14%Y>6VGVDMW=S)#;Q#<\CG  K/TCQ/HVNRR1:=>B66,;FC9&
MC;'3.& )'N*+,#7HHHH **@N+R"T>W2>38UQ+Y,0P3N?:6QQTX4]?2DLKZWU
M&T6ZM)/,A9F4-M(Y5BIX//4&@"Q14-M=07ENMQ;2K+"^=KJ<@X../RJ:@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** -6R_X]5_'^=3U!9?\>J_
MC_.IZZH_"C1;!6=??\? _P!T5HUG7W_'P/\ =%7'<BK\)5HHHJSG"BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "K5A
M_KV_W?ZBJM6K#_7M_N_U%#V*A\2-&BBBLSJ*][_Q['ZBLNM2]_X]C]1677/5
M^(B6X4445F2%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 '>MRL/O6Y6U'J5$****V+,5OO'ZTE*WWC]:2M#C"BBB@
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M<X4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M*ZC49-_J)/\ =/\ *L>MB;_42?[I_E6/5Q,*VZ"BBBF9!1110 4444 %%%%
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MUZ[ ]*X_X6_\DYTK_MK_ .C7KL#TKQ*O\27J>K3^!&'1117GDA1110 4444
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M0:==-?Z9H7B#1-6-J+EWCU"'[,6\LI), X4-R '&3_OT<O0+'ILC,D3LB%V
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M]#3A\2!;FG11174:C)O]1)_NG^58];$W^HD_W3_*L>KB85MT%%%%,R"BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MBBMBS%;[Q^M)2M]X_6DK0XPHHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M_P#?'Y5HT4>SB'*C._LY_P"^/RH_LY_[X_*M&BCV<0Y49W]G/_?'Y4?V<_\
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A.9A[.)G?V>_]\?E5^-=D:KZ "G44-W*C%1V"BBBD4?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>image_002.jpg
<TEXT>
begin 644 image_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 1>!@ # 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#W^BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** .._X6GX,_P"@S_Y*S?\ Q%'_  M/P9_T&?\
MR5F_^(KYMHKU/J5/NSS_ *U/LCZ2_P"%I^#/^@S_ .2LW_Q%'_"T_!G_ $&?
M_)6;_P"(KYMHH^I4^[#ZU/LCZ2_X6GX,_P"@S_Y*S?\ Q%'_  M/P9_T&?\
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MW_Q%'_"T_!G_ $&?_)6;_P"(KYMHH^I4^[#ZU/LCZ2_X6GX,_P"@S_Y*S?\
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M_)6;_P"(KYMHH^I4^[#ZU/LCZ2_X6GX,_P"@S_Y*S?\ Q%'_  M/P9_T&?\
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MW_Q%'_"T_!G_ $&?_)6;_P"(KYMHH^I4^[#ZU/LCZ2_X6GX,_P"@S_Y*S?\
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M_)6;_P"(KYMHH^I4^[#ZU/LCZ2_X6GX,_P"@S_Y*S?\ Q%'_  M/P9_T&?\
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MO_B*/^%I^#/^@S_Y*S?_ !%?-M%;?4J?=F7UJ?9'TE_PM/P9_P!!G_R5F_\
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M2I]V'UJ?9'UCHFOZ9XCLGO-)N?M$"2&)G\MDPP )&& /0BL#_A:?@S_H,_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M[\ */8#@?@*Q5!\Z?1._7\C5UERM=;&=11174<P4444 >]?!+_D3+S_L(/\
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M &RC_A1/_4Q_^2/_ -LKV&BCZU5[A]7I]CQ[_A1/_4Q_^2/_ -LH_P"%$_\
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M &RC_A1/_4Q_^2/_ -LKV&BCZU5[A]7I]CQ[_A1/_4Q_^2/_ -LH_P"%$_\
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M &RC_A1/_4Q_^2/_ -LKV&BCZU5[A]7I]CQ[_A1/_4Q_^2/_ -LH_P"%$_\
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M &RC_A1/_4Q_^2/_ -LKV&BCZU5[A]7I]CQ[_A1/_4Q_^2/_ -LH_P"%$_\
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MX43_ -3'_P"2/_VRO8:*/K57N'U>GV/'O^%$_P#4Q_\ DC_]LH_X43_U,?\
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MX43_ -3'_P"2/_VRC_A1/_4Q_P#DC_\ ;*]AHH^M5>X?5Z?8\>_X43_U,?\
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M/_VRC_A1/_4Q_P#DC_\ ;*]AHH^M5>X?5Z?8RJ***\XH**** "BBB@ HHHH
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MNXK: '&^5L#/H/4T 6Z*YO2O'_A;6KM;2QUB)YV("I(CQECZ#>!D_2NDIVL
M445076=/?7'T5;C.H)!]H:'8W$>0,[L8ZD<9S2 OT444 %%%5Y;ZU@N[>TEG
MC6XN-WE1%OF?:,G ] * +%%4H=6L9]6N=+BGW7MLBR2Q;&&U6Z'.,'\#5V@
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M5/LAGD4= R@[E'_ @16/\,64Z3K29!8:Q<@C/(^[7(R1203W7PY3<$N-821
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M\3/$5C>:YJ^DW%P8KBV6QN_)%PFW!['<0>/SK;TG0-$T[QO;K_PDFLZEK-O
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M'5M3UFWM3'*EY/YPCC+ X+;, YYV[L\DXKN:EB84444@"BBB@ HHHH ****
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M;/\ U)_WJI5<MD-[(****@04444 %%%% !1110 4444 %%%% !1110 4444
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M444 %%%% !1110 445D>)O$-MX7T234[J.25%945(\99F.!UZ#/>@#7HHHH
M***CN'DBMI9(H_-D5"R1YQN(' SVS0!)16%X/\2Q^+?#=OJZ6YMC(SJ\)??L
M96(QG ST!Z=ZRM&\?PZOXYU#PVM@8TM3(L=WYNX3/&5#KMV\$;O4]/>@#LJ*
MY_Q!XF_L35]#TV.T%S/JMR80/-V>6@ +/T.< CCCZUT% !115;4;O^S],N[W
M9YGV>%Y=F<;MJDXSVZ4 6:*R_#FL?V_X=L=6\CR/M40D\K?NVY[9P,_E6I0
M45R7BGQ??:%KFE:1IFA_VK>:BLK1I]K6#&P9/+*1TR>HZ55_X2?QU_T3O_RM
MP?X4 =O17.VWBEI_'4OAA['RVCT\7IG\W/)95V;<?[77/;I714 %%%% !111
M0 45Y]9>/?$NKM>/I'@C[9;6US);&;^U8X\LAY^5E![C\ZTM(\;7$^O1:'KV
MASZ+J-PA>W5IUFCF Y(#KQG':F!U]%%%( HHHH **** "BBB@ HHHH ***Q?
M$OBBP\+V4<]X)99IF\NWM8$WRSOZ** -JBN%?QOXCLXVO-2\"7T&FKEFFAO(
MYI57^\8A@CCD\\5UVE:I9:UID&HZ?.L]K.NY''\B.Q'0B@"Y116/XC\0V_AN
MQM[FXBDE^T7,=K&J8^^YXR>PX- &Q15&^NK^"]L8K33?M5O,Y6YF\]4^SKCA
MMIY?)XP*O4 %%%17+RQ6LLD$/G3*A9(MP7>P'"Y/3)XS0!+1573I[JYTZ":^
ML_L5TZ9DM_-$GEGTW#@_45:H **** "BN?TKQ.=?\-7.KZ1823LCRI!;R2+&
MTS(< ;CPN3ZULV4L\]C;RW5M]FN'B5I8-X?RG(R5W#@X.1D=<4 3T444 %%%
M% !1110 4]NE,I[=*8#****0!1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% #UZ4RGKTIE, HHHI %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 9U%%%8&84444 %%%% !1110 4C,J*68A5 R23@ 4M>:
M?&'Q.VEZ''H]M(5N;_/FD'E81U'_  (\?0&FE=V YOQM\7+NXN9=/\.2>1:H
M2K7@'SR?[O\ ='OU^E>77%S/=SM/<S233.<M)(Q9C]2:BHK9)(9!.6R!_#7O
M&E^(O[2_9VN-\A,]F%L'SWPZ;0/^ ,OY&O#64,I!K9T'6I;31-5T0Y\J[>*;
MKT*$_P ]P_[Y%;45>I%>9,W:+/0/%>NBT^ N@Z;&Q$FHS.K#'6..5BW_ (]L
MKR" MR/X:U]>U26_M],T[>QBL874*3P&>1F)'X%?RK.50J@"E6_B2]0@[Q19
MLK^\TVY6XL;J:VF7H\+E3^8KV3P#\5GU"YBTGQ"Z+.^%ANP-H=NRN.@)[$<5
MXG163291]BT5Q7PQ\4OXE\,*ERY>^LB(9F)R7'\+GZCCZJ:[6L6K""BBBD 4
M444 %%%<#X@^)HTS7Y=$TC0[O6+V 9F6 D;>,G&%8G&1GC%-)L$KG?45S_A'
MQ=9^+]-DNK:*2"6%_+F@E^\C?7N*Z"AJP!17 ^*/B/<Z!XH70K/P]-J=PT0D
M40S$,V020%",> ":I0?%LVVH0VWB+PU?Z-',<++*6(^I!13CZ9I\K'9GI=%(
MK*Z*Z,&5AD$'((I:D04444 <QXL\"Z5XRDLWU&6[C-KN"?9W5=P;&<Y4_P!W
MMCJ:VM(TFRT/2X-.T^$16T(PJYR3W))[DGFLJ_\ $.HVGBVRT>'0+JXL[A T
MFHIN\N(G=P<*1V'\0ZUT5-WL 4444@"BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH ?%_KD_WA6BWW:SHO]<G^\*T6^[6M/9E1&4445104444 <#\
M7)?(\+6$WEO)Y>J6[;(QEFP2< =S4_\ PLC_ *DOQC_X*_\ [*F?%7_D7M,_
M["]M_P"A&NZI@<QXM35KJRM/L6L6^BV!;??W<S[)4CQD*F05!ZY)(QCOS7GE
MUKEOX:\3Z(F@>.=0UM+J\2"[M+NZ%TNPD L& P.O;O\ 0UO_ !,2"/Q%X<O-
M<MYI_#$#2_:U12Z)(5PC.HZC_P"OZX/,>+=:T?49/#I\-:28=$MM4ADFOHK/
MR(2Y;A5RH)_BR<8''K0!UM[<:IXR\>ZEH%KK%YI>DZ3%']H>Q8)--*_( ?J
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MI.EK\<M4N),^7%X>WMCT$B$U7\/:9KGCW3/^$BO_ !+JNF)<NYL;33I1$D2
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M%\G2I;0E9H[> !;F,]58 @ ]><']!5?Q#X7U>[M]$U*SO(KC7M);=YDZA$N
MP =2%'RYQQ_]?-5#IGB/Q=KFE3Z]I,&DZ=ILWVCR!=+.\\H'RG*\!0?Z]<\*
MXB+P7H^F1>.O%C1Z=:(;2YA%N5@4>2"ASLX^7/M5OX3_ /(D+_U]S_\ H=/T
M[3M=T7Q]JT\>F1W6E:M)'(UTMPJM;[4(.4/+<GM]?:J&BV'C#PE]KT?3M(L]
M0L9+AY;6]DNQ&L(8YPZ8W'\/SH>H'.R_\DX^(/\ V&I?_1D==M9^&M!TKP=Y
MSA;!VT_;=:E$ LY5E!=B^"221GO[5S=MX.\01?#SQ3I,]N)M0O;]I82)$'GK
MN0[_ +V%SM)P3FNRU_0)]<\"3:*L@AN)+9$!)X#KM."1VRN#[4VQL\]G/ARZ
M\+36FA^ [ZZA2U;9J4]JD.<+Q)YIY/KVZ=,5->S27'PE\'R2N6?^T+9<DY.
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MMC_NO^0JC11RH/:2+WVV/^Z_Y"C[;'_=?\A5&BCE0>TD7OML?]U_R%'VV/\
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M0JC13Y43[21>^VQ_W7_(4?;8_P"Z_P"0JC11RH/:2+WVV/\ NO\ D*/ML?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MRRB(L5;J 6) _(BN@HHKFD[MLU2L%%%%2 4444 %%%% !1110 4444 %%%%
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M '.>,_%$OA73;.Y@T[^T)KN\2TCA\\1?,P8@[B".JX_'K61/XR\66$+W6H^
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MB!J6JWS:]J6E:5:73VEG#I\OE,Y3J[GG(.>G^%+X"NM;3QOXIT[6]3EO#9)
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M>*_[1^S_ &S^T!YWV?/E[L'.W=SCZT[P4R>'-9\2>')F\NVM)?MUL3T$#C)
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M1I<MO:PPR3VR/,\<84R-CJQ'4_6BX-)(ZFBBBF0%%%% !1110 4444 %%%%
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MW9I+X4%%%%,S"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M4HK.T#5!K6@V6H@!3/$&8#H&Z,/S!K1KSVK.S-0HHHI %%%% !1110 4444
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MT^XN#);:CJ%JI.?+60,H^F1G\R:74OAO8RZ08-.NKF&^492XEF9MY]&'3'T
M_&C^U8WORC^HJUN83X9S,/"4=A,H2>UD<%,@G:S%@>/J1^%=E6?HMB;#2K>.
M2WB@N3&IG$0&"^,$\5H4G-5'SKJ8N/(^7L%%%%(04444 %%%% !15;4+^VTN
MPGOKR7RK:!2\C[2VT>N ":Y;_A:O@K_H-?\ DK-_\11<:3>QV5%<]HOCGPYX
MAO\ [#I>H_:+G87V>1(G ZG+*!WKH: ::W"BBB@045D:OXGT?0KNTM=2O/(F
MNSM@7RG;><@=5! Y(ZUKT#L%%%% @HK)U?Q-I&@W-G;ZE=^1+>,5@7RW;>00
M/X0<<L.OK6M0.P4444""BBLG3/$VD:SJ-YI]A=^==63%;A/+==A!(/) !Y!Z
M9H'8UJ***!!1110 4444 %%%% !1110 4444 %%%% #XO]<G^\*TG^X:S8O]
M<G^\*TG^X:F6YM3V9#1112&%%%% %74M-M-7TV?3[Z%9K6==DB'N/\>^:X^/
MP/XBLH19:9XZOK?35^589;2.:15]!*2"..!QQ7=44!<Q?#/ABP\+::UI9>9(
M\CF2>XF;=),YZLQK(O/ LL.IW&H^&=<N="N+EM]Q&D2S02-_>\MN W7FNQHH
M"YR>D^"?(UB+6=<U>YUK4X%(@>9%CBASU*1KP#[T>*+)[:PU;6+G6;Z(QQ9L
MH[65XA"P7 &U3B5F?^\#U Q765R=_IOB.Y\3?;6MM,N].MMK6-M+>R1;'QS(
MX$+;FZXYPH]^: .DL6N'T^V>[4)<M$IE4= ^!D?GFN3U?P7J]UXMF\0:/XF_
MLJ>:V6V=?L"3Y4'/5FQUQVKL83*T,9F1$E*@NJ,64-CD D#(]\#Z"GT <.?
M6HZK+$/%/BFYUBTB<.+1+9+:)R.F\+G<,UO>)?#%CXGT@6%T7A,;"2WFA.UX
M''1E-;5% 7.%;P#J>IO!#XD\5W.K:; ZN+,6J0"0CH)&4DN.G6M'Q#X.?5-6
M@UK2M5FTC5X8O)^TQ1+(KQYSM=#PW^>N!74T4!<Y+1_!4MIJ<^KZOK,^K:M+
M;FV6XDB6)(HR<X6->!^?KZFL/7-%M?!_PB31KZVDUFSA?;/)&/)9%>1F\P#Y
ML%2P^M>DTC*KJ58!E(P01D$4!<\,\3+:W7A4VC>/7\1%PJ:;IL"()"Y("^9M
M)9L _P 6.1^%>DQ^#W?6O#&K27GEOHUHT#0>7N\PM'L/S9XQGT.:V[30='T^
MZ:ZLM)L+:X;.98;9$<YZ\@9K0H&V8>N>'?[:U71+W[5Y/]F7)GV>7N\W(QC.
M1CZ\UN444".,OO UW'K%YJ?AOQ#/HLU\VZZC%NL\<C?W@K$;6/K5-/A59I/!
MJ(UG4O[<2Y$\FI[QOD'0IMZ!<<#KCW'%=_10%V%<CK'@AKG6I-:T/6+C1-3F
M4+-)#&LD<V#P7C/!..*ZZB@#C]/\$7+:O;:KXCU^YUJZM&W6R-"L$,3?WMB\
M%O?-/UWP7<7WB!=?T77)M'U,P^1+(L"S)*G;*,0,].?8<5UM% 7..T/P&='\
M7/XADUBXO;B6T-O/]H0;I'+ [\@X   4*!P!UKC/ OAS5-0AU^_T;Q'<:1<'
M5[B"4"!9XY$ 4CY6QA@6/S9Z5[)5>TL+.P21+.T@MEED,L@AC"!W/5CCJ3@<
M^U [G#ZYX9M/#/PQ\10P2S7%Q<0237-U.V9)I#U)_P *S_#_ ('U.^\'Z5!%
MXMOK?1;NRBDGL5A1G^= 7593RJDGI@]Z]+N+:"[MY+>YACF@D&UXY%#*P]"#
MP:=##%;01P01)%#&H1(T4*JJ!@  = !VH"YS6M>"[;4O#^EZ-9S"QMM/N8IX
MP(]^1'GY>HZYZUE?%'4M,F\+W6BBXCFUB=XEM;.&0>?YI<%6V]0.^?\ &N]J
MHVEZ>VHC46L+4WP7:+DPKY@'INQG% KE?P[I":#X=L-*C((MH5C)'\38^8_B
M<FM.BB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MN@]]H&!G@4F5%)J[/5?$7CS3M#\)6^NQ*;E;P+]DC^[O)&>?0 =?RKEQX_\
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M&L7ET([ JC"8(S AL;3@ GG([4#-*BBB@04444 %%%% !1110 4444 %%%%
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M^'?$EG91W4EN;BWN+%F,3J#@C#<Y_P *S=*B:#XQR0ORT?A]%/U$B"KVI?\
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MY,THEEA\YD!);W*\'DD=AS77_#O5/"^LV>H:?IVA)ITP4"\M)5WAU.1@D_>
M)(P0.O2BX.*2NC-\"?$4:OXGU6WU;41_I,T<>F0K"P7:"^<8'&1MR6/\JZJ7
MXC>$X5NC)JZ+]EE$4H,,F0YR, ;<M]T],UQ/PETVPE\1>*))+*V=[6ZC^SLT
M2DP_-+]PX^7H.GH*H_#C0M.UCQSXDEU&RANUMY'").@= 6D;G!XSQ2393C&[
M/49_&&@VUWIMK+?[9M2"-:*(G/FASA3D+@9)[XJ76?$^CZ!<6D&IWGD279*P
M+Y3MO((!^Z#C[PZUYS\0E2+XI^#54*B+)   ,  3BE^,1'_"0>%1GD2N<?\
M XZ=R5%.QZ=JNLZ=H=F;O4[R*V@!QN<]3Z =2?850T7QGX>\13F#2]3BGF )
M\LJR,0.I 8 G\*X#QI&FM?&/0='U ;[!8E;RF/RL3N8_GM _"NV_X0#PXFO6
MVLV]@MK<V^"B6Q\J/()Y*KC)Y_'O1=BLDM3CM6^)D5M\3;6T;4Q%H-IYB76V
M%LF4*ZX;C<<-CIQW]Z[U_%NAQZQ::2U[B^O(UD@B\I_G5@2#G&!T/4UYQJ6E
M:=)\?+&TDT^U:VF@:26%H5*2,8I"69<8)R <GO4GB)4B^.V@(BJB+!&JJ!@
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M5E>BK'V;_;_2C[-_M_I1=!RLKT58^S?[?Z4?9O\ ;_2BZ#E97HHHIDA1110
M4444 %%%% ".RHC.Y 51DD]A7RMIVJ,WC.UU64DLU^L[YZG+Y/\ ,U],^()#
M#X;U25>J6DK#G'1#7R<"58$'!'(J)FM,^K**I6VIVTUK#*\\4;NBLR,X!4D=
M",U+]NM/^?J#_OX*1J6*MIJ5TB*BN,*,#Y169]NM/^?J#_OX*/MUI_S]0?\
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M*\K[7;1S^7NW;-ZAL9P,XSUQ5V@ HHHH **** "BBB@ HHHH **** "BBB@
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M"3P=/JFF>,=;\,7NIW&I6UM%%<6T]TVZ4!NJLW?_ .M[UW;,J*68A5 R23@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M'I0%F='15'2-1M]5TR&ZMKN"Y4J [PN&&[ R..,^U7J "BBB@04444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !5Z]_P!2/]ZJ-7KW_4C_ 'J3W1I'X64:***9F%%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 7K+_4G_ 'JHU>LO]2?]ZJ-);LTE
M\*"BBBF9A1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M^%]]POVB.YEN .B @84'N>OH:!7T,6WT2QUCXQ:\VH6\=U#!:P,L,RAD+%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M:\O%GU#2O"M[?Z# Q#Z@DRJS!20S)$>7 ]CZ],4)\2O/\#W/BFWTAI;>WO#
M\8GY\O('F9V?[0^7'XT!9G>T5C:_XBM]#\+7.N[1/%'$)(T#;?-+8"@'!QDD
M=JTK.66>R@FGA\B:2-6>+=NV,1DKG SCIG% $]%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !4LGW1]:BJ63[H^M(:V9%1113$
M%%%% !1110 4444 %%%<U=_$#PK8WILY]8A$RG:0BNZ@^A900/SXIJ+ELA-I
M;G2T5';W$-W;I<6TR30R#<DD;!E8>H(J2D 4444#"BBB@ HHHH **** )8_N
MGZU%4L?W3]:BI#>R"BBBF(**** "BBB@ HHHH **CN+B&TMWN+F9(88QN>21
M@JJ/4DUSUI\0/"M]>BS@UB$S,=H#JZ*3Z!F !_/FFHR>J0FTMSI:***0PHHH
MH **** "BBB@ HHHH H44459@%%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 ^+_7)_O"M)_N&LV+
M_7)_O"M)_N&IEN;4]F0T444AA1110!SWBGQ)%X>?3%N[-9;&_N1:33.^%AW#
M@L,$$'GJ165J_P *_".I!IDL/[/G RL]FYBV'DY"_=_3M75ZGI=EK.GRV&HV
MR7%K*,/&_0_U!]Q7(CX7:9Y7V8ZWXA;3\;?L!U ^05_N[<9Q^- T<)J.H:IJ
M7PCL)+C4#(MGKBPM?LN_?"I8+(0?O ,5Z]<<UV.I^%O%%UHUTFI?$:'^SI86
M6=I-)@5/+(Y);<,#!ZYKL_["TO\ L/\ L46,0TWR_*^S@?+M_P >^>N>>M<M
M'\+-&"QV\VI:W<Z=&04TZ>^+6XP<@;< X_&D%S$^Q1V/C_X=6:7B7T4%A.D=
MRH&V51"=K#!/&,=S6WXY _X2OP2>_P#:3?\ H-;]UX8L;KQ%I6MEIHY],CDC
M@BC*B/:ZE3D8SP#Q@BI=5\/VFL:AI=Y<23+)ILYGA$; !FQC#9!R/IBF%SC+
MS0?[2\7ZQ?\ @[Q/)INLQ&--1MG@+1,V/E)##'0'D!AUZ9JE>^)-:O/#OC+P
M[XAM[4:CI^GLYGM"?+D5ER.#R#R/3Z"NNUSP+INM:H-42[U'3=0*A'NM.N/)
M>10, -P0?Y\"BT\!:/9:'J6F1M=,=30I=WDLN^>7(QDL1C/)[8YZ4@N<5K2A
MO#7PL5AD&[L 1_P!*Z/XK 'PM:9[:E;8_P"^JU[GP9IUU9>'[5YKH1Z')#);
M%67+F( +O^7GH,XQ^%7?$'A^T\2:?'9WDDR1QSI.#"P!W*<@<@\4PN<KH3>5
M\9?%$=RP\V:TMWM@3UC"@-C_ (%3=4EMG^-^@QQE3<)ITWFXZ@'=M!_7\ZS?
M'DUFGB^)O$<5WIVG1P V.N::'6:)\_,CLN[@\X^7//N34/@S2['4/'L.LZ&E
M_/IEI:R+-JE]N,E[._&<L 6POL,>G/*'YGJTKF.)W5"[*I(4=6]J\D\/>%(/
MB'X2NM?U*]E?7+R23R)O,.+$HYVJJCH. 3WP?QKUZN-O?AMI%S?7%S:7VK:6
M+EM]Q!I]V8HICW++@_ICK3$F<_X&\8^(->\6IHU]-!$-+M9([Y0R,;F96VAE
M.,\<9P<=?45ZBRAE*GH1@URUK\.O#5C<Z9<V=BUM/IQ)BDBD*L^?[YZL,\\_
M3H2*ZJ@3. ^%,B6.B7OAN9@M]I-Y+')&?O%"V5?Z')YKH/%?BF'PO9VTA@-U
M=75PD$%JC[7D)."1P>@_H,C-1Z]X)TG7[U+]WN[+447:M[8S&&7'H2.#^(J'
M1_ .DZ3JBZI+/?ZIJ*#$=UJ5P9G0?[/  ^N,T#TW,;0&$/QF\4I=$+//:V[V
MX)^]&$ ;;^./RI?%Q2;XH>"H;<9NXVN))"O58MHZ^QPWZUT7B+P?IGB26WN+
MEKFVOK;_ %%[9R^5-&/0-Z<^E,\/^"]+\/7<U[%)=WNH3+LDO;Z8RS,N<XSP
M .G0=AF@+F)\/ /[?\:MCDZPXS^=5=' 'C[XB@?\\;<_^06KL-&\.VFAW>J7
M-M).[ZE<FZF$K A6/9< 8'US26/ANRL-=U?5HWF>?51&)TD(* (NT;1C/(/.
M2: N>;?\VT_]L/\ VYKH?'\,K?!FXCME/RVMN2%_N!D)_0?E5R#X9Z3;Z+J.
MCQ:AJPTZ] 7[,UR&2##[_P!V"IQD]<YS76I9PK8+9,HD@$7E%9 #N7&,'UR*
M07*5A=V!\+V]V)(_[/%FKEL@J(PG/X8KQRV21/@]X;+HR(^O(T2MV0N^/ZUW
MQ^%6AY:!;[6$TQG+G3$O6%L2?]G&?UK=U?PIINL:58Z:XDMK6RGCFA2V*K@I
MG:O(/'-,+HW*Y+XG?\DWUO\ ZXK_ .AK76UG:[HUOXAT2ZTJ[>5(+E0KM$0&
M R#P2".WI0)'#_$-)7^#D/E[MBQVK2[5W80%>2.XSBK,GAWQ9=:4\DGQ&B:P
ME@)9SH\ 0QE>3G=P,5VHTVU.DC3)8Q-:^2(&249WIC&#^%<@/A5HP7[/_:>N
M?V9G/]F_;V^SX]-N,X[]:0[G--I\6B^)OAO;_P!HQZAI\*W$45X@ CD8CY<8
M)'=1U[5WWB75='TV^T6+4M.^VW5U=B*R"PI(T4G'SC<1M XR1R*LZMX6T?6M
M&CTF[LU^R0[3"L9V&$KP"A'3 XK.T7P%IFCZHFIR7FI:G?1*4AGU*Y\YH5(P
M0O  _P#KFF%S*^'B*/$'C9\#<=8<$^PSC^9JGI''Q$^(0'3[- <?]LC79Z-X
M=M-#N]4N;:2=WU*Y-U,)6!"L>RX P/KFHK?PM8VVM:SJJ2W!GU9$2=69=JA5
MVC:,9''J30%S$^$2@?##2"!@DS$^_P"^>O/9!Y?PYL)G'^AP>*2]SZ"/<PR?
M;I^8KV7P[H-KX9T&VT>RDFDM[?=L:8@N=S%CD@ =6/:JNG>$-*L-!NM%9)+J
MQNI7EE2X(.2YR1P!QGIW'K2"^HWQM<6L?@/6Y;ED:!K&0#)X8E2%Q]21BO/M
M%CFB\4?#!)PPD&F3\-U \EL?IBNI@^%FB(\*7%[J][8P$&'3[J\+V\>#QA,#
MCV)Q6_>>&K*]\2:7KKR3K<Z:DB0QH0(R'4J=PQGH>,$4PN<O\.&$>O>,[:<@
M7HU>21E)^8QDG8?IUQ]:R?%BR7?Q(U9-+!-S%X8G2=D[.=VT'WY7'X>E=CKO
M@;3-<U-=3%Q?Z=J078;O3KCR9'7T)P<_E4NC^%;/PMIU[_8T;2ZA.A9KB[D,
MCSR ';O;CC/88')I!<K?#RXM7^'.C21.@B2U D.1A67(;/X@USWPVL+/6_AW
MJ]B%'V.[O+J->.B-C!_#BN3M+GPFD<J:VVN:5J<K$WGAZS\U+>Y?)Z)@\-QQ
MN'2NY\&"+P/\/&O=>4Z=$]P]Q)&8V8P"1P$4A02/X>W&:!LY?2+R?Q!9^%?!
MUSDS6%[+_:*^B6Q^13['*C\*]FKS[P#81ZCXCU_QDEJ\%OJ4@CLA(FTO$ -T
MF#V8@'\*]!IB84444""BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MBJ6]_P"^WYT;W_OM^='*'.7:*I;W_OM^=&]_[[?G1RASEVBJ6]_[[?G1O?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MT?LL/]S]31]EA_N?J:.9![-F=16C]EA_N?J:/LL/]S]31S(/9LSJ*T?LL/\
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MT?LL/]S]31]EA_N?J:.9![-F=16C]EA_N?J:/LL/]S]31S(/9LSJ*T?LL/\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %7;S_4C_ 'JI5=O/]2/]ZKCLQK9E*BBBH$%%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 7;/_4G_>JE5VS_ -2?]ZJ5
M7+9#>R"BBBH$%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M4%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 /B_UR?[PJ[<_P#'NWX?SJE%_KD_WA5VY_X]V_#^
M=:1^%C6QGT445F(**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MXB>*:-MKHXP5/H12/+)*%$DCN%&%#,3@>U>J_&:")4TF98D$KM(K.%&Y@ N
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MHJ?9G]5H^S/ZK5NBCD0<J*GV9_5:/LS^JU;HHY$'*C.HHHK(@**** "BBB@
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M"_Z\(?\ T 5,MA/8W****@04444 %%%% !1110 ^+_7)_O"M%ONUG1?ZY/\
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MRT_4VBM@?X%\U?E_ _S-=OK>BZ=;?!N[LHK2%8(M+,JKL'^L$>[?_O9&<]:
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M;?X8:PD,21JL,2*$4#"B1<#Z#- &[X7UZP\1:%!>Z?=&YC $;R%&4[P!N'S
M'OUK(\?:Y?Z;!I6G:9<QVEUJUXMJ+N0 B!3U(!X+= *Z;3/^039_]<$_]!%8
M?BZV\-ZW]C\-:\Q\Z_9FM%"L&W(,DJX&%(![]<XYS0!CWW@G6M.L9[_1_&.O
MS:G$AD6.\G$T$K#DKY>WC)&!CIGO73:-K,ESX5MM6U> Z;)Y&^Y2X!C\HCAL
M[L$#C//:N,D\$>,O#\;2^&?&%Q<QQC*V6I+Y@;'\(8YQGV Y[C.1C>*/%-QX
MM\$^%I8].\UM0U-8KFP\T1B9D)_=[FX"LP!Y]J .^TOXA>%-9U(:?8:U#+=%
MMJHR.F\^BE@ WX$U;UCQ?H.@736VJ:BEM,+?[3M9&/[O=MR" 03GC'7VKA/$
M\7BWQ)X?;2_^%=1VK)AK6=-6@)MG!!#( !CIC@BIY[-KWXP>&&U2%3=0Z+YT
MB-A@LH+ ].#@D_E0!V.C>,] U^ZCM=,U#SYI(#<HIA=-T8?86!91_$",=>*O
M7NMZ=I^I6.G75R$N[]F6VB",Q<J,GH#@ =SBN/\ '2C0O$WAGQ1&NR*&Y-E=
M[0 /+ESR?H<GZFG:63X@^+NJZAR;70[9;*$]C,_+D>X&5/X4 ;WA>YTU[75'
ML=8O=0CCOY1/)>NQ\B0!=T:E@,(O&.HY/-5H/B/X0NM4&FPZ[;-<E@J\,$8G
MH ^-IZ]C7F-S>SV7PH\;F!BK3>(9H6(_NL8]P_$<?C7IVI>%/#]UX$71KT1V
MNEQ0JWG*50Q;0#O#," ?4GU.: -C6==TOP]8F\U:]BM8,X#.>6/7"@<D^P%5
MM!\7:#XG$G]CZE%=-&,N@#(ZCIG:P!Q[XKSK4;R\F^)MDNEZ6OB>/3M'1K4/
M>Q1CYB 9]Q&UF/ X^M:$MMXLU;QOH>LOX,&DO;2E+JZ34H93) PP58#!..HZ
MT =5J_Q!\*Z%J!L=1UB&*Z!PT:H\A0_[6T';U[XK=LKZUU*SBO+*XCN+:4;D
MEC;*L/K7F=M;>)_ 6J:R8_#HU[2M1O'N6GMW'G@-U5EP2V!VQC.>>:ZCX?7_
M (=O-!E7PY;2V<$<[>=:3;M\,AY(().![#C]: .LHHHI %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %/;I3*>W2F RBBBD 4444 %
M%%% !1110 45B^+M9D\/^%=0U.)0TL,8\L'IN8A03]"0:^9+S4[Z_OC>W=W-
M-<D[O-=R6!]CV_"NFAAG53=[&%6LJ;M8^M:*\]^$OB6]UW1+JUU"5YYK%U"S
M.<LR,#@$]R-IY^E>A5C4@X2<7T-824HJ2"BBBH*"BBB@ HHHH **** 'KTIE
M/7I3*8!1112 **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M9,LUK=X!=)@2=Y^I)S]:Z_S$_OK^='F)_?7\Z+A<X-]%^(>IQ+I^HZ[I=G9
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M)_O"KMS_ ,>[?A_.J47^N3_>%7;G_CW;\/YUI'X6-;&?11168@HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ J[>?ZD?[U4
MJNWG^I'^]5QV8ULRE1114""BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MO[_Z"CE8>T1HT5G?:IO[_P"@H^U3?W_T%'*P]HC1HK.^U3?W_P!!1]JF_O\
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M_O\ Z"C[5-_?_04<K#VB-&BL[[5-_?\ T%'VJ;^_^@HY6'M$:-%9WVJ;^_\
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M4W]_]!1]JF_O_H*.5A[1&C16=]JF_O\ Z"C[5-_?_04<K#VB-&BL[[5-_?\
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M:);>62*3*C?&Q4]^XKI^KQ]G?J1S/VG*?0U%<%X+\>G5]2ET;4MJWB,P@E'
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MQ8?H?TKFQ$5R)]2U?F?8ZRBBBN,L**** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** 'Q?ZY/]
MX5>NO^/9_P /YU1B_P!<G^\*O77_ ![/^'\ZE[HUA\+,ZBBBJ,@HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M=V&EZ?;RF-1,H9FX!&<HW..> !SWKUIE5U*L 5(P0>XKQC4?AKXH\+ZE-?\
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M !1110 4444 %%%% %"BBBK, HHHH **** "BBN1\<>/+/P?:JFP7.HS*3%
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MMB'X:^#H-0^W1Z#;B;.X LQ0'V0G;^E;<&BZ9:ZK/JD%E#'?7"!)9U7#,HZ
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MK1]I_P!C]:KT460<S+'VG_8_6K-R_EQ@XSSBLZKU[_J1_O4FM47%NS(?M/\
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M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *O7O\
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MG_CM'V'_ *:?^.U;HHYF')$J?8?^FG_CM'V'_II_X[5NBCF8<D2I]A_Z:?\
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M=H^P_P#33_QVK=%',PY(E3[#_P!-/_':/L/_ $T_\=JW11S,.2)4^P_]-/\
MQVC[#_TT_P#':MT4<S#DB5/L/_33_P =H^P_]-/_ !VK=%',PY(E3[#_ --/
M_':/L/\ TT_\=JW11S,.2)4^P_\ 33_QVC[#_P!-/_':MT4<S#DB5/L/_33_
M ,=H^P_]-/\ QVK=%',PY(E3[#_TT_\ ':/L/_33_P =JW11S,.2)4^P_P#3
M3_QVC[#_ --/_':MT4<S#DB5/L/_ $T_\=H^P_\ 33_QVK=%',PY(E3[#_TT
M_P#':/L/_33_ ,=JW11S,.2)4^P_]-/_ !VC[#_TT_\ ':MT4<S#DB5/L/\
MTT_\=H^P_P#33_QVK=%',PY(E3[#_P!-/_':/L/_ $T_\=JW11S,.2)4^P_]
M-/\ QVC[#_TT_P#':MT4<S#DB5/L/_33_P =H^P_]-/_ !VK=%',PY(E3[#_
M --/_':/L/\ TT_\=JW11S,.2)4^P_\ 33_QVC[#_P!-/_':MT4<S#DB5/L/
M_33_ ,=H^P_]-/\ QVK=%',PY(E3[#_TT_\ ':/L/_33_P =JW11S,.2)4^P
M_P#33_QVC[#_ --/_':MT4<S#DB5/L/_ $T_\=H^P_\ 33_QVK=%',PY(E3[
M#_TT_P#':/L/_33_ ,=JW11S,.2)4^P_]-/_ !VC[#_TT_\ ':MT4<S#DB5/
ML/\ TT_\=H^P_P#33_QVK=%',PY(E3[#_P!-/_':/L/_ $T_\=JW11S,.2)4
M^P_]-/\ QVC[#_TT_P#':MT4<S#DB5/L/_33_P =H^P_]-/_ !VK=%',PY(E
M3[#_ --/_':/L/\ TT_\=JW11S,.2)4^P_\ 33_QVC[#_P!-/_':MT4<S#DB
M5/L/_33_ ,=H^P_]-/\ QVK=%',PY(E3[#_TT_\ ':/L/_33_P =JW11S,.2
M)4^P_P#33_QVC[#_ --/_':MT4<S#DB5/L/_ $T_\=H^P_\ 33_QVK=%',PY
M(E3[#_TT_P#':/L/_33_ ,=JW11S,.2)4^P_]-/_ !VIYHO.0+NQ@YZ5)11=
MC44BI]A_Z:?^.T?8?^FG_CM6Z*.9BY(E3[#_ --/_':/L/\ TT_\=JW11S,.
M2)4^P_\ 33_QVC[#_P!-/_':MT4<S#DB5/L/_33_ ,=H^P_]-/\ QVK=%',P
MY(E3[#_TT_\ ':/L/_33_P =JW11S,.2)4^P_P#33_QVC[#_ --/_':MT4<S
M#DB5/L/_ $T_\=H^P_\ 33_QVK=%',PY(E3[#_TT_P#':/L/_33_ ,=JW11S
M,.2)4^P_]-/_ !VC[#_TT_\ ':MT4<S#DB5/L/\ TT_\=H^P_P#33_QVK=%'
M,PY(D<,7DH5W9R<]*@^P_P#33_QVK=%%V-Q3*GV'_II_X[1]A_Z:?^.U;HHY
MF+DB5/L/_33_ ,=H^P_]-/\ QVK=%',PY(E3[#_TT_\ ':/L/_33_P =JW11
MS,.2)4^P_P#33_QVC[#_ --/_':MT4<S#DB5/L/_ $T_\=H^P_\ 33_QVK=%
M',PY(E3[#_TT_P#':/L/_33_ ,=JW11S,.2)4^P_]-/_ !VC[#_TT_\ ':MT
M4<S#DB5/L/\ TT_\=H^P_P#33_QVK=%',PY(E3[#_P!-/_':/L/_ $T_\=JW
M11S,.2)4^P_]-/\ QVC[#_TT_P#':MT4<S#DB95%%%<H@HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** 'Q?ZY/]X5=N?^/=OP_G5*+_7)_O"KMS_Q[M^'\ZTC\+&MC/HHHK,04444
M %%9NO:[9^'=*DU"]+F-2%5(UW/(QZ*H[DUSDGC+Q#:Q->7G@>]CTY 6:6.[
MC>4+ZF+K^M-)L+':T54TS4K76--M]0L91+;3IO1\8R/IV/:K=( HHHH **RD
MUZWD\4R: L<GVB*U^U.YQM +!0!ZGFM6@ HHJ"\N/LEC<7.W?Y,32;<XS@9Q
MF@">BL7P]XACUOPK;:[-$MG%+&TCJTFX1A6()+8'IGI6(GC?5=44S^'/"=UJ
M5D"0+F:Y2U63'= V2PZ\T[,+':T5@:!XLM-<GN+-[>XL-1MN9[.Z7:ZC^\.S
M+[C_  K$G\9:K-=/)9VD<5@JQ2+++#Y@,<K%8V8^:K+N*G[J/P03Z4<K"QW5
M%4=*U$:E:-(8C#-'(T,T).?+=3@C/<="#W!%<YXX\=MX-FL(TTHWQNEE<XG\
MO8$ )_A.>"3VZ46=[!8[&BHK:XCN[6&YA;=%,BR(?4$9%<AIWQ 74O'4OAR+
M3<0H\L:WOGY#-&,L-NWUXZT686.THHHI %%%4M3N;ZU@C>PT_P"W2-*J/'YR
MQ;$/5\GKCT[T 7:*RKS7K>S\0Z;HK1R-<7RR.K#&U51<G/OVK5H **** "BJ
M.F75_=)<F_TW["T<[1Q+YZR^;&,8DX^[GGY3R,5>H **** "BBL/Q+XEC\/Q
M6L<=I)>W][)Y5I:1L%,K=\D_=4<9/;-"5P-RBN<\.^*I-7U"[TK4=+ETO5;5
M1(]L\HD#(>C*XX(Z9^M='3:L 45A>+/$@\,:0EVMJ;NXFG2W@M@^PRNQZ9P>
MP)Z=JM^']9A\0Z!9:K NQ+F,,4W;MC=&7/?!!'X46TN!I45AV7B+[9XNU30?
MLNS[#%%)Y_F9W[QG&W'&/J:W*+ %%%%( HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ J[>?ZD?[U4JNWG^I'^]
M5QV8ULRE1114""BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M +MG_J3_ +U4JNV?^I/^]5*KELAO9!1114""BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHJ.>>*U@DGGD6.
M*-2SNYP% [DT")*Q]9\4Z+H"G^T+Z..3&1$OS.?^ CG\Z\X\3_$R^U.Z.F>&
M5D1';8)U4F64_P"P.P_7Z4F@_":\O6%WX@NF@#G<88SND;_>8\#]?PKMCA8P
M7-7=O+J9.HV[05R_J/QEMT9ETW2I)!VDN) G_CHS_.L9_BWXCF#>186*KZB)
MV(_\>Q^E>F:;X+\.Z4H%MI5NSC_EI,OF-^;9Q^%;JJJ*%4!5'  & */;8>/P
MT[^K#DJ/>1XNGQ<\0P[?M&GV+#U,;J3_ ./8_2MK3OC):.574M+EB]9('#C\
MCC'YFO371)$*.JLIZJPR#6#J?@GPYJJ-]HTN"-R/]9 /*8>^5QG\<T>VP\M)
M4[>C#DJ+:1;T;Q+H^OINTZ^CF8#+1_==?JIY_'I6K7CNN_"O4=+?[=X?NY+C
MRSN6,G9,G^Z1P?T-3^%?B?<V<ZZ;XE5R%.S[25P\9]''?Z]?K2EA5*/-1=UV
MZ@JC3M-6/6Z*9%+'/"DL3K)&ZAE=3D,#T(-/KC-@HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M,?6H=+N[K6$\8:L]Q,UB3):6<1<^6%C0AG5>GS-W]JK?$M[G0KC3?%-@C-/
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M'.B>+A(NG2R)<1C<]O.NUPN<9X)!'T)ZBNDI-6 ****0!1110 4444 %%%%
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MZ#4+"836LZ[XY I7</H0"/QH M45R>J>(- U;1X[D:[>VEK'J*6_GV8DC+S
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M %%%% !1110 4444 %%%% #UZ4RGKTIE, HHHI %%%% !1110 4444 %%%%
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MWVK0M"8Q;SA]H)(.[F1N1@CIWI?"7@7_ (1>;6Y/[1^T_P!ILK8\C9Y6-_\
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M')<G=D G=SCO7HFO^&KS7?%F@WDDL TK3':X>(D^9)-_ <8Q@8!SGN:ZGK3
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M\W_0DN/-RK8^\?EQ@].N?:JWV'4[_P =0>&O'^N7%U;DB>QCBA2*WO",\/M
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M,I[=*8#****0!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M,*BC_.3[U9K*O7=5Z:);(J$.5>84445SF@4444 %%%% !1110 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MBBB@ HHHH NV?^I/^]5*KMG_ *D_[U4JN6R&]D%%%%0(**** "BBB@ HHHH
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M! (]#5*-DT4D9=%:7E1_\\U_*CRH_P#GFOY5/LV3RF;16EY4?_/-?RH\J/\
MYYK^5'LV'*9M%:7E1_\ /-?RH\J/_GFOY4>S8<IFT5I>5'_SS7\J/*C_ .>:
M_E1[-ARF;16EY4?_ #S7\J/*C_YYK^5'LV'*9M%:7E1_\\U_*CRH_P#GFOY4
M>S8<IFT5I>5'_P \U_*CRH_^>:_E1[-ARF;16EY4?_/-?RH\J/\ YYK^5'LV
M'*9M%:7E1_\ /-?RH\J/_GFOY4>S8<IFT5I>5'_SS7\J/*C_ .>:_E1[-ARF
M;16EY4?_ #S7\J/*C_YYK^5'LV'*9M%:7E1_\\U_*CRH_P#GFOY4>S8<IFT5
MI>5'_P \U_*CRH_^>:_E1[-ARF;16EY4?_/-?RH\J/\ YYK^5'LV'*9M%:7E
M1_\ /-?RH\J/_GFOY4>S8<IFT5I>5'_SS7\J/*C_ .>:_E1[-ARF;16EY4?_
M #S7\J/*C_YYK^5'LV'*9M%:7E1_\\U_*CRH_P#GFOY4>S8<IFT5I>5'_P \
MU_*CRH_^>:_E1[-ARF;16EY4?_/-?RH\J/\ YYK^5'LV'*9M%:7E1_\ /-?R
MH\J/_GFOY4>S8<IFT5I>5'_SS7\J/*C_ .>:_E1[-ARF;16EY4?_ #S7\J/*
MC_YYK^5'LV'*9M%:7E1_\\U_*CRH_P#GFOY4>S8<IFT5I>5'_P \U_*CRH_^
M>:_E1[-ARF;16EY4?_/-?RH\J/\ YYK^5'LV'*9M%:7E1_\ /-?RH\J/_GFO
MY4>S8<IFT5I>5'_SS7\J/*C_ .>:_E1[-ARF;16EY4?_ #S7\J/*C_YYK^5'
MLV'*9M%:7E1_\\U_*CRH_P#GFOY4>S8<IFT5I>5'_P \U_*CRH_^>:_E1[-A
MRF;16EY4?_/-?RH\J/\ YYK^5'LV'*9M%:7E1_\ /-?RH\J/_GFOY4>S8<IF
MT5I>5'_SS7\J/*C_ .>:_E1[-ARF;16EY4?_ #S7\J/*C_YYK^5'LV'*9M%:
M7E1_\\U_*CRH_P#GFOY4>S8<IFT5I>5'_P \U_*CRH_^>:_E1[-ARF;16EY4
M?_/-?RH\J/\ YYK^5'LV'*9M%:7E1_\ /-?RH\J/_GFOY4>S8<IFT5I>5'_S
MS7\J/*C_ .>:_E1[-ARF;16EY4?_ #S7\J/*C_YYK^5'LV'*9M%:7E1_\\U_
M*CRH_P#GFOY4>S8<IFT5I>5'_P \U_*CRH_^>:_E1[-ARF;16EY4?_/-?RH\
MJ/\ YYK^5'LV'*9M%:7E1_\ /-?RH\J/_GFOY4>S8<IFT5I>5'_SS7\J/*C_
M .>:_E1[-ARF;5V\_P!2/]ZI?*C_ .>:_E3BH888 CW%4H630TC+HK2\J/\
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MV%-\J/\ YYK^54X720VC-HK2\J/_ )YK^5'E1_\ /-?RJ?9L7*9M%:7E1_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
B*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.INS
<SEQUENCE>8
<FILENAME>srna-20210331.xml
<DESCRIPTION>XBRL INSTANCE FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.8a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Source; Value: SRNA %2D 20210331 10Q Q1 DFN.xfr; Date: 2021%2D05%2D10T22:03:41Z -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x800A0000 -->
<xbrli:xbrl xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2021" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:us-roles="http://fasb.org/us-roles/2021-01-31" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:us-types="http://fasb.org/us-types/2021-01-31" xmlns:country="http://xbrl.sec.gov/country/2021" xmlns:currency="http://xbrl.sec.gov/currency/2021" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:SRNA="http://surna.com/20210331">
    <link:schemaRef xlink:href="srna-20210331.xsd" xlink:type="simple" />
    <xbrli:context id="AsOf2019-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-01to2021-03-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-03-31_us-gaap_FurnitureAndFixturesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-03-31_us-gaap_VehiclesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:VehiclesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-03-31_us-gaap_LeaseholdImprovementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-01to2021-03-31_us-gaap_CostOfSalesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-01to2021-03-31_us-gaap_AdvertisingMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:AdvertisingMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-01to2021-03-31_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SoftwareAndSoftwareDevelopmentCostsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-01to2021-03-31_us-gaap_SellingGeneralAndAdministrativeExpensesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-03-31_custom_EngineeringAndOtherServicesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">SRNA:EngineeringAndOtherServicesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-03-31_us-gaap_ShippingAndHandlingMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ShippingAndHandlingMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-01-02_us-gaap_AccountingStandardsUpdate201602Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201602Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-01-02</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-12-31_us-gaap_RestrictedStockUnitsRSUMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-01to2021-03-31_us-gaap_CustomerConcentrationRiskMember_us-gaap_AccountsReceivableMember_custom_CustomerOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">SRNA:CustomerOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-01to2021-03-31_us-gaap_CustomerConcentrationRiskMember_us-gaap_AccountsReceivableMember_custom_CustomerTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">SRNA:CustomerTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-03-31_us-gaap_CustomerConcentrationRiskMember_us-gaap_AccountsReceivableMember_custom_CustomerThreeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">SRNA:CustomerThreeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-01to2021-03-31_us-gaap_PropertyPlantAndEquipmentMember_custom_InventoryMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:PropertyPlantAndEquipmentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">SRNA:InventoryMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-03-31_custom_TwoThousandAndTwentyTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">SRNA:TwoThousandAndTwentyTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-01to2021-03-31_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_CustomerOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">SRNA:CustomerOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-01to2021-03-31_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_CustomerTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">SRNA:CustomerTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-01to2021-03-31_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_CustomerThreeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">SRNA:CustomerThreeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-03-31_custom_TwoThousandAndTwentyOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">SRNA:TwoThousandAndTwentyOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-01to2021-03-31_us-gaap_EquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:EquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-01to2021-03-31_custom_EngineeringAndOtherServicesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">SRNA:EngineeringAndOtherServicesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-01to2021-03-31_us-gaap_ShippingAndHandlingMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ShippingAndHandlingMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-03-31_us-gaap_CostOfSalesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-03-31_us-gaap_AdvertisingMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:AdvertisingMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-03-31_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SoftwareAndSoftwareDevelopmentCostsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-03-31_us-gaap_SellingGeneralAndAdministrativeExpensesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-01to2021-03-31_us-gaap_PropertyPlantAndEquipmentMember_us-gaap_CostOfSalesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:PropertyPlantAndEquipmentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_FurnitureAndFixturesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_VehiclesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:VehiclesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_LeaseholdImprovementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-01to2021-03-31_custom_TwoThousandSeventeenEquityPlanMember_srt_DirectorMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandSeventeenEquityPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-03-08to2020-03-09_us-gaap_RestrictedStockUnitsRSUMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-03-08</xbrli:startDate>
        <xbrli:endDate>2020-03-09</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-03-29to2021-04-01_us-gaap_SubsequentEventMember_custom_TwoThousandAndSeventeenEquityPlanMember_custom_NonQualifiedStockOptionsMember_custom_DirectorsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">SRNA:NonQualifiedStockOptionsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SRNA:DirectorsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-03-29</xbrli:startDate>
        <xbrli:endDate>2021-04-01</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-04-29to2020-04-30_us-gaap_SubsequentEventMember_us-gaap_RestrictedStockUnitsRSUMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-04-29</xbrli:startDate>
        <xbrli:endDate>2020-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-01to2021-03-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_NonQualifiedStockOptionsMember_custom_EmployeesAndConsultantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">SRNA:NonQualifiedStockOptionsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">SRNA:EmployeesAndConsultantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember_custom_NonQualifiedStockOptionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">SRNA:EmployeesAndConsultantsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">SRNA:NonQualifiedStockOptionsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-01to2021-03-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SRNA:DirectorsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">SRNA:NonQualifiedStockOptionsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SRNA:DirectorsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">SRNA:NonQualifiedStockOptionsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-01to2021-03-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">SRNA:EmployeesAndConsultantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">SRNA:EmployeesAndConsultantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-01to2021-03-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SRNA:DirectorsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SRNA:DirectorsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-01to2021-03-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesDirectorsandConsultantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SRNA:EmployeesDirectorsandConsultantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesDirectorsandConsultantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SRNA:EmployeesDirectorsandConsultantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-01to2021-03-31_custom_TwoThousandSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandSeventeenEquityPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SRNA:EmployeesAndConsultantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-06-07to2020-06-09_us-gaap_SubsequentEventMember_custom_FormerEmployeeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SRNA:FormerEmployeeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-06-07</xbrli:startDate>
        <xbrli:endDate>2020-06-09</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-05-11">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-05-11</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-01to2021-03-31_custom_WarrantsRangeOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">SRNA:WarrantsRangeOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-03-31_custom_WarrantsRangeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">SRNA:WarrantsRangeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-01-02_us-gaap_AccountingStandardsUpdate201602Member_srt_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201602Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-01-02</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-03-31_us-gaap_CustomerContractsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerContractsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_PreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_PreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-03-31_us-gaap_EquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:EquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-03-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-03-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-03-31_us-gaap_PreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-01to2021-03-31_us-gaap_PreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-03-31_us-gaap_PreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-03-31_us-gaap_PreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-03-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-01to2021-03-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-03-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-03-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-03-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-01to2021-03-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-03-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-03-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-03-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-01to2021-03-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-03-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-03-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-03-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-01to2021-03-31_custom_TwoThousandTwentyOneAnnualEmployeeIncentiveCompensationPlanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandTwentyOneAnnualEmployeeIncentiveCompensationPlanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-03-31_custom_TwoThousandTwentyOneAnnualEmployeeIncentiveCompensationPlanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandTwentyOneAnnualEmployeeIncentiveCompensationPlanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-03-31_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_CustomerFourMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">SRNA:CustomerFourMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-03-31_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_CustomerOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">SRNA:CustomerOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-03-31_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_CustomerTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">SRNA:CustomerTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-03-31_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_CustomerThreeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">SRNA:CustomerThreeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-03-31_us-gaap_CustomerConcentrationRiskMember_us-gaap_AccountsReceivableMember_custom_CustomerOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">SRNA:CustomerOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-03-31_us-gaap_CustomerConcentrationRiskMember_us-gaap_AccountsReceivableMember_custom_CustomerTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">SRNA:CustomerTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-03-29to2021-03-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-03-29</xbrli:startDate>
        <xbrli:endDate>2021-03-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-03-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember_custom_NonQualifiedStockOptionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">SRNA:EmployeesAndConsultantsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">SRNA:NonQualifiedStockOptionsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-03-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">SRNA:EmployeesAndConsultantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-03-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SRNA:DirectorsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">SRNA:NonQualifiedStockOptionsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-03-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SRNA:DirectorsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-03-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesDirectorsandConsultantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SRNA:EmployeesDirectorsandConsultantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-03-31_custom_FacilityLeaseMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">SRNA:FacilityLeaseMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-02-10">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-02-10</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-03-31_custom_TwoThousandAndSeventeenEquityIncentivePlanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityIncentivePlanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-03-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_NonQualifiedStockOptionsMember_custom_EmployeesAndConsultantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">SRNA:NonQualifiedStockOptionsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">SRNA:EmployeesAndConsultantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-01to2021-03-31_custom_TwoThousandAndSeventeenEquityPlanMember_srt_DirectorMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-03-31_custom_TwoThousandAndSeventeenEquityPlanMember_srt_DirectorMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-01to2021-03-31_us-gaap_RestrictedStockUnitsRSUMember_custom_EmployeesDirectorsandConsultantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SRNA:EmployeesDirectorsandConsultantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-01to2020-03-31_us-gaap_RestrictedStockUnitsRSUMember_custom_EmployeesDirectorsandConsultantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SRNA:EmployeesDirectorsandConsultantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-03-31_custom_IncentiveStockBonusAwardsMember_custom_EmployeesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">SRNA:IncentiveStockBonusAwardsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">SRNA:EmployeesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-04-30_us-gaap_SubsequentEventMember_custom_OfficeandManufacturingMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">SRNA:OfficeandManufacturingMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-04-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-04-28to2021-04-30_us-gaap_SubsequentEventMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-04-28</xbrli:startDate>
        <xbrli:endDate>2021-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-02-09to2021-02-10">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-02-09</xbrli:startDate>
        <xbrli:endDate>2021-02-10</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-03-22_custom_TwoThousandAndTwentyOneEquityIncentivePlanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndTwentyOneEquityIncentivePlanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-03-22</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-06-23to2020-06-24_custom_TwoThousandAndSeventeenEquityPlanMember_custom_NonQualifiedStockOptionsMember_custom_DirectorsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SRNA:TwoThousandAndSeventeenEquityPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">SRNA:NonQualifiedStockOptionsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SRNA:DirectorsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-06-23</xbrli:startDate>
        <xbrli:endDate>2020-06-24</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-04-07to2021-04-08_us-gaap_SubsequentEventMember_custom_FormerEmployeeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">SRNA:FormerEmployeeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-04-07</xbrli:startDate>
        <xbrli:endDate>2021-04-08</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-06-29to2021-07-01_srt_ScenarioForecastMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001482541</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-06-29</xbrli:startDate>
        <xbrli:endDate>2021-07-01</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="usd">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="usdPershares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
    <xbrli:unit id="shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Percentage">
      <xbrli:measure>xbrli:pure</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Sqft">
      <xbrli:measure>utr:sqft</xbrli:measure>
    </xbrli:unit>
    <us-gaap:StockholdersEquity contextRef="AsOf2019-12-31" unitRef="usd" decimals="0">-355631</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2020-12-31" unitRef="usd" decimals="0">-1333698</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2019-12-31_us-gaap_PreferredStockMember" unitRef="usd" decimals="0">420</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2019-12-31_us-gaap_CommonStockMember" unitRef="usd" decimals="0">2283</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2019-12-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="usd" decimals="0">25326593</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2019-12-31_us-gaap_RetainedEarningsMember" unitRef="usd" decimals="0">-25684927</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2020-12-31_us-gaap_PreferredStockMember" unitRef="usd" decimals="0">420</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2020-12-31_us-gaap_CommonStockMember" unitRef="usd" decimals="0">2366</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2020-12-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="usd" decimals="0">26107159</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2020-12-31_us-gaap_RetainedEarningsMember" unitRef="usd" decimals="0">-27443643</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2021-03-31" unitRef="usd" decimals="0">-1925290</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2020-03-31_us-gaap_PreferredStockMember" unitRef="usd" decimals="0">420</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2021-03-31_us-gaap_PreferredStockMember" unitRef="usd" decimals="0">420</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2020-03-31_us-gaap_CommonStockMember" unitRef="usd" decimals="0">2366</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2021-03-31_us-gaap_CommonStockMember" unitRef="usd" decimals="0">2366</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2020-03-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="usd" decimals="0">25984402</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2021-03-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="usd" decimals="0">26241935</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2020-03-31_us-gaap_RetainedEarningsMember" unitRef="usd" decimals="0">-26623240</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2021-03-31_us-gaap_RetainedEarningsMember" unitRef="usd" decimals="0">-28237011</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2020-03-31" unitRef="usd" decimals="0">-636052</us-gaap:StockholdersEquity>
    <us-gaap:PreferredStockParOrStatedValuePerShare contextRef="AsOf2020-12-31" unitRef="usdPershares" decimals="INF">0.00001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare contextRef="AsOf2021-03-31" unitRef="usdPershares" decimals="INF">0.00001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesIssued contextRef="AsOf2020-12-31" unitRef="shares" decimals="INF">42030331</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued contextRef="AsOf2021-03-31" unitRef="shares" decimals="INF">42030331</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding contextRef="AsOf2020-12-31" unitRef="shares" decimals="INF">42030331</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding contextRef="AsOf2021-03-31" unitRef="shares" decimals="INF">42030331</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued contextRef="AsOf2020-12-31" unitRef="shares" decimals="INF">236526638</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued contextRef="AsOf2021-03-31" unitRef="shares" decimals="INF">236526638</us-gaap:CommonStockSharesIssued>
    <us-gaap:NetIncomeLoss contextRef="From2021-01-01to2021-03-31" unitRef="usd" decimals="0">-793368</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="From2020-01-01to2020-03-31" unitRef="usd" decimals="0">-938313</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="From2020-01-01to2020-03-31_us-gaap_PreferredStockMember" unitRef="usd" xsi:nil="true" />
    <us-gaap:NetIncomeLoss contextRef="From2020-01-01to2020-03-31_us-gaap_CommonStockMember" unitRef="usd" xsi:nil="true" />
    <us-gaap:NetIncomeLoss contextRef="From2020-01-01to2020-03-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="usd" xsi:nil="true" />
    <us-gaap:NetIncomeLoss contextRef="From2020-01-01to2020-03-31_us-gaap_RetainedEarningsMember" unitRef="usd" decimals="0">-938313</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="From2021-01-01to2021-03-31_us-gaap_RetainedEarningsMember" unitRef="usd" decimals="0">-793368</us-gaap:NetIncomeLoss>
    <dei:DocumentPeriodEndDate contextRef="From2021-01-01to2021-03-31">2021-03-31</dei:DocumentPeriodEndDate>
    <dei:AmendmentFlag contextRef="From2021-01-01to2021-03-31">false</dei:AmendmentFlag>
    <dei:CurrentFiscalYearEndDate contextRef="From2021-01-01to2021-03-31">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:EntityFilerCategory contextRef="From2021-01-01to2021-03-31">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:DocumentFiscalPeriodFocus contextRef="From2021-01-01to2021-03-31">Q1</dei:DocumentFiscalPeriodFocus>
    <dei:EntityCentralIndexKey contextRef="From2021-01-01to2021-03-31">0001482541</dei:EntityCentralIndexKey>
    <us-gaap:ShareBasedCompensation contextRef="From2021-01-01to2021-03-31" unitRef="usd" decimals="0">6342</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="From2021-01-01to2021-03-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_NonQualifiedStockOptionsMember_custom_EmployeesAndConsultantsMember" unitRef="usd" decimals="0">0</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="From2020-01-01to2020-03-31" unitRef="usd" decimals="0">154426</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="From2020-01-01to2020-03-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_NonQualifiedStockOptionsMember_custom_EmployeesAndConsultantsMember" unitRef="usd" decimals="0">106288</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="From2021-01-01to2021-03-31_custom_TwoThousandAndSeventeenEquityPlanMember_srt_DirectorMember" unitRef="usd" decimals="0">6342</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="From2020-01-01to2020-03-31_custom_TwoThousandAndSeventeenEquityPlanMember_srt_DirectorMember" unitRef="usd" decimals="0">29266</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="From2021-01-01to2021-03-31_us-gaap_RestrictedStockUnitsRSUMember_custom_EmployeesDirectorsandConsultantsMember" unitRef="usd" decimals="0">0</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="From2020-01-01to2020-03-31_us-gaap_RestrictedStockUnitsRSUMember_custom_EmployeesDirectorsandConsultantsMember" unitRef="usd" decimals="0">18872</us-gaap:ShareBasedCompensation>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent contextRef="AsOf2020-12-31" unitRef="usd" decimals="0">165098</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent contextRef="AsOf2021-03-31" unitRef="usd" decimals="0">165098</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:PreferredStockSharesAuthorized contextRef="AsOf2020-12-31" unitRef="shares" decimals="INF">150000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized contextRef="AsOf2021-03-31" unitRef="shares" decimals="INF">150000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:CommonStockParOrStatedValuePerShare contextRef="AsOf2020-12-31" unitRef="usdPershares" decimals="INF">0.00001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare contextRef="AsOf2021-03-31" unitRef="usdPershares" decimals="INF">0.00001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized contextRef="AsOf2020-12-31" unitRef="shares" decimals="INF">350000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized contextRef="AsOf2021-03-31" unitRef="shares" decimals="INF">350000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesOutstanding contextRef="AsOf2020-12-31" unitRef="shares" decimals="INF">236526638</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding contextRef="AsOf2021-03-31" unitRef="shares" decimals="INF">236526638</us-gaap:CommonStockSharesOutstanding>
    <dei:DocumentFiscalYearFocus contextRef="From2021-01-01to2021-03-31">2021</dei:DocumentFiscalYearFocus>
    <dei:EntitySmallBusiness contextRef="From2021-01-01to2021-03-31">true</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany contextRef="From2021-01-01to2021-03-31">false</dei:EntityEmergingGrowthCompany>
    <us-gaap:AssetsCurrent contextRef="AsOf2020-12-31" unitRef="usd" decimals="0">3683293</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="AsOf2021-03-31" unitRef="usd" decimals="0">5881607</us-gaap:AssetsCurrent>
    <us-gaap:InventoryNet contextRef="AsOf2020-12-31" unitRef="usd" decimals="0">327109</us-gaap:InventoryNet>
    <us-gaap:InventoryNet contextRef="AsOf2021-03-31" unitRef="usd" decimals="0">519159</us-gaap:InventoryNet>
    <us-gaap:AccountsReceivableNetCurrent contextRef="AsOf2020-12-31" unitRef="usd" decimals="0">33480</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent contextRef="AsOf2021-03-31" unitRef="usd" decimals="0">26732</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AssetsNoncurrent contextRef="AsOf2020-12-31" unitRef="usd" decimals="0">1129973</us-gaap:AssetsNoncurrent>
    <us-gaap:AssetsNoncurrent contextRef="AsOf2021-03-31" unitRef="usd" decimals="0">1082932</us-gaap:AssetsNoncurrent>
    <us-gaap:DepositsAssetsNoncurrent contextRef="AsOf2020-12-31" unitRef="usd" xsi:nil="true" />
    <us-gaap:DepositsAssetsNoncurrent contextRef="AsOf2021-03-31" unitRef="usd" decimals="0">8061</us-gaap:DepositsAssetsNoncurrent>
    <us-gaap:Goodwill contextRef="AsOf2020-12-31" unitRef="usd" decimals="0">631064</us-gaap:Goodwill>
    <us-gaap:Goodwill contextRef="AsOf2021-03-31" unitRef="usd" decimals="0">631064</us-gaap:Goodwill>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="AsOf2020-12-31" unitRef="usd" decimals="0">147732</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="AsOf2021-03-31" unitRef="usd" decimals="0">141825</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:Assets contextRef="AsOf2020-12-31" unitRef="usd" decimals="0">4813266</us-gaap:Assets>
    <us-gaap:Assets contextRef="AsOf2021-03-31" unitRef="usd" decimals="0">6964539</us-gaap:Assets>
    <us-gaap:LiabilitiesCurrent contextRef="AsOf2020-12-31" unitRef="usd" decimals="0">5903689</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="AsOf2021-03-31" unitRef="usd" decimals="0">8230942</us-gaap:LiabilitiesCurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent contextRef="AsOf2020-12-31" unitRef="usd" decimals="0">1784961</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent contextRef="AsOf2021-03-31" unitRef="usd" decimals="0">1790315</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:LiabilitiesNoncurrent contextRef="AsOf2020-12-31" unitRef="usd" decimals="0">243275</us-gaap:LiabilitiesNoncurrent>
    <us-gaap:LiabilitiesNoncurrent contextRef="AsOf2021-03-31" unitRef="usd" decimals="0">658887</us-gaap:LiabilitiesNoncurrent>
    <us-gaap:Liabilities contextRef="AsOf2020-12-31" unitRef="usd" decimals="0">6146964</us-gaap:Liabilities>
    <us-gaap:Liabilities contextRef="AsOf2021-03-31" unitRef="usd" decimals="0">8889829</us-gaap:Liabilities>
    <us-gaap:AdditionalPaidInCapital contextRef="AsOf2020-12-31" unitRef="usd" decimals="0">26107159</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital contextRef="AsOf2021-03-31" unitRef="usd" decimals="0">26241935</us-gaap:AdditionalPaidInCapital>
    <us-gaap:CommonStockValue contextRef="AsOf2020-12-31" unitRef="usd" decimals="0">2366</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue contextRef="AsOf2021-03-31" unitRef="usd" decimals="0">2366</us-gaap:CommonStockValue>
    <us-gaap:PreferredStockValue contextRef="AsOf2020-12-31" unitRef="usd" decimals="0">420</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue contextRef="AsOf2021-03-31" unitRef="usd" decimals="0">420</us-gaap:PreferredStockValue>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="AsOf2020-12-31" unitRef="usd" decimals="0">4813266</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="AsOf2021-03-31" unitRef="usd" decimals="0">6964539</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:ContractWithCustomerLiabilityCurrent contextRef="AsOf2020-12-31" unitRef="usd" decimals="0">3724189</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent contextRef="AsOf2021-03-31" unitRef="usd" decimals="0">6087093</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="AsOf2019-01-02_us-gaap_AccountingStandardsUpdate201602Member" unitRef="usd" decimals="0">714416</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="AsOf2020-12-31" unitRef="usd" decimals="0">343950</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="AsOf2021-03-31" unitRef="usd" decimals="0">294900</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="AsOf2020-12-31" unitRef="usd" decimals="0">266105</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="AsOf2021-03-31" unitRef="usd" decimals="0">263662</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="AsOf2020-12-31" unitRef="usd" decimals="0">169119</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="AsOf2021-03-31" unitRef="usd" decimals="0">106891</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:CommitmentsAndContingencies contextRef="AsOf2020-12-31" unitRef="usd" xsi:nil="true" />
    <us-gaap:CommitmentsAndContingencies contextRef="AsOf2021-03-31" unitRef="usd" xsi:nil="true" />
    <dei:EntityCommonStockSharesOutstanding contextRef="AsOf2021-05-11" unitRef="shares" decimals="INF">237526638</dei:EntityCommonStockSharesOutstanding>
    <dei:EntityCurrentReportingStatus contextRef="From2021-01-01to2021-03-31">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent contextRef="From2021-01-01to2021-03-31">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityShellCompany contextRef="From2021-01-01to2021-03-31">false</dei:EntityShellCompany>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="AsOf2020-12-31" unitRef="usd" decimals="0">7227</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="AsOf2021-03-31" unitRef="usd" decimals="0">7082</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:DeferredCompensationLiabilityCurrent contextRef="AsOf2020-12-31" unitRef="usd" decimals="0">128434</us-gaap:DeferredCompensationLiabilityCurrent>
    <us-gaap:DeferredCompensationLiabilityCurrent contextRef="AsOf2021-03-31" unitRef="usd" decimals="0">52794</us-gaap:DeferredCompensationLiabilityCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="AsOf2020-12-31" unitRef="usd" decimals="0">1037823</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="AsOf2021-03-31" unitRef="usd" decimals="0">2064588</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:SellingGeneralAndAdministrativeExpense contextRef="From2021-01-01to2021-03-31" unitRef="usd" decimals="0">740473</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense contextRef="From2021-01-01to2021-03-31_us-gaap_PropertyPlantAndEquipmentMember_custom_InventoryMember" unitRef="usd" decimals="0">312</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense contextRef="From2021-01-01to2021-03-31_us-gaap_PropertyPlantAndEquipmentMember_us-gaap_CostOfSalesMember" unitRef="usd" decimals="0">1249</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense contextRef="From2020-01-01to2020-03-31" unitRef="usd" decimals="0">1108993</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="AsOf2020-12-31" unitRef="usd" decimals="0">-27443643</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="AsOf2021-03-31" unitRef="usd" decimals="0">-28237011</us-gaap:RetainedEarningsAccumulatedDeficit>
    <SRNA:NumberOfUnitsVestedButNotSettled contextRef="From2019-01-01to2019-12-31_us-gaap_RestrictedStockUnitsRSUMember" unitRef="shares" decimals="INF">6750000</SRNA:NumberOfUnitsVestedButNotSettled>
    <SRNA:NumberOfUnitsVestedAndSettled contextRef="From2020-03-08to2020-03-09_us-gaap_RestrictedStockUnitsRSUMember" unitRef="shares" decimals="INF">6750000</SRNA:NumberOfUnitsVestedAndSettled>
    <us-gaap:LossContingencyDamagesAwardedValue contextRef="From2020-03-08to2020-03-09_us-gaap_RestrictedStockUnitsRSUMember" unitRef="usd" decimals="0">10000</us-gaap:LossContingencyDamagesAwardedValue>
    <us-gaap:LossContingencyDamagesAwardedValue contextRef="From2020-06-07to2020-06-09_us-gaap_SubsequentEventMember_custom_FormerEmployeeMember" unitRef="usd" decimals="0">33985</us-gaap:LossContingencyDamagesAwardedValue>
    <SRNA:RestrictedStockUnitsSharesIssuedInterestPercentage contextRef="From2020-06-07to2020-06-09_us-gaap_SubsequentEventMember_custom_FormerEmployeeMember" unitRef="Percentage" decimals="INF">0.08</SRNA:RestrictedStockUnitsSharesIssuedInterestPercentage>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod contextRef="From2021-01-01to2021-03-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_NonQualifiedStockOptionsMember_custom_EmployeesAndConsultantsMember" unitRef="shares" xsi:nil="true" />
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod contextRef="From2021-01-01to2021-03-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember" unitRef="shares" xsi:nil="true" />
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="From2021-01-01to2021-03-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_NonQualifiedStockOptionsMember_custom_EmployeesAndConsultantsMember" unitRef="shares" decimals="INF">1035800</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="From2021-01-01to2021-03-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember" unitRef="shares" xsi:nil="true" />
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="From2021-01-01to2021-03-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember" unitRef="shares" decimals="INF">1035800</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="From2021-01-01to2021-03-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember" unitRef="shares" xsi:nil="true" />
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="From2021-01-01to2021-03-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_NonQualifiedStockOptionsMember_custom_EmployeesAndConsultantsMember">P8Y3M19D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="From2021-01-01to2021-03-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember">P7Y6M0D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="From2020-06-23to2020-06-24_custom_TwoThousandAndSeventeenEquityPlanMember_custom_NonQualifiedStockOptionsMember_custom_DirectorsMember">P5Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares contextRef="From2021-03-29to2021-04-01_us-gaap_SubsequentEventMember_custom_TwoThousandAndSeventeenEquityPlanMember_custom_NonQualifiedStockOptionsMember_custom_DirectorsMember" unitRef="shares" decimals="INF">1000000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares contextRef="From2020-04-29to2020-04-30_us-gaap_SubsequentEventMember_us-gaap_RestrictedStockUnitsRSUMember" unitRef="shares" decimals="INF">800000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares contextRef="From2021-01-01to2021-03-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember" unitRef="shares" decimals="INF">1035800</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares contextRef="From2021-01-01to2021-03-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember" unitRef="shares" xsi:nil="true" />
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares contextRef="From2021-01-01to2021-03-31_custom_TwoThousandAndSeventeenEquityPlanMember_srt_DirectorMember" unitRef="shares" decimals="INF">500000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares contextRef="From2020-01-01to2020-03-31_custom_TwoThousandAndSeventeenEquityPlanMember_srt_DirectorMember" unitRef="shares" decimals="INF">500000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="AsOf2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember_custom_NonQualifiedStockOptionsMember" unitRef="shares" decimals="INF">14251000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="AsOf2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember" unitRef="shares" decimals="INF">7400000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="AsOf2021-03-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember_custom_NonQualifiedStockOptionsMember" unitRef="shares" decimals="INF">15286800</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="AsOf2021-03-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember" unitRef="shares" decimals="INF">7400000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="From2021-01-01to2021-03-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_NonQualifiedStockOptionsMember_custom_EmployeesAndConsultantsMember" unitRef="shares" xsi:nil="true" />
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="From2021-01-01to2021-03-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember" unitRef="shares" xsi:nil="true" />
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod contextRef="From2021-01-01to2021-03-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_NonQualifiedStockOptionsMember_custom_EmployeesAndConsultantsMember" unitRef="shares" xsi:nil="true" />
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod contextRef="From2021-01-01to2021-03-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember" unitRef="shares" xsi:nil="true" />
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber contextRef="AsOf2021-03-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember_custom_NonQualifiedStockOptionsMember" unitRef="shares" decimals="INF">15286800</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber contextRef="AsOf2021-03-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember" unitRef="shares" decimals="INF">6400000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice contextRef="AsOf2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember_custom_NonQualifiedStockOptionsMember" unitRef="usdPershares" decimals="INF">0.083</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice contextRef="AsOf2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember" unitRef="usdPershares" decimals="INF">0.067</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice contextRef="AsOf2021-03-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember_custom_NonQualifiedStockOptionsMember" unitRef="usdPershares" decimals="INF">0.084</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice contextRef="AsOf2021-03-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember" unitRef="usdPershares" decimals="INF">0.067</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice contextRef="From2021-01-01to2021-03-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_NonQualifiedStockOptionsMember_custom_EmployeesAndConsultantsMember" unitRef="usdPershares" decimals="INF">0.130</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice contextRef="From2021-01-01to2021-03-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember" unitRef="usdPershares" xsi:nil="true" />
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice contextRef="From2021-01-01to2021-03-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_NonQualifiedStockOptionsMember_custom_EmployeesAndConsultantsMember" unitRef="usdPershares" xsi:nil="true" />
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice contextRef="From2021-01-01to2021-03-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember" unitRef="usdPershares" xsi:nil="true" />
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice contextRef="From2021-01-01to2021-03-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_NonQualifiedStockOptionsMember_custom_EmployeesAndConsultantsMember" unitRef="usdPershares" xsi:nil="true" />
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice contextRef="From2021-01-01to2021-03-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember" unitRef="usdPershares" xsi:nil="true" />
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice contextRef="From2021-01-01to2021-03-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_NonQualifiedStockOptionsMember_custom_EmployeesAndConsultantsMember" unitRef="usdPershares" xsi:nil="true" />
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice contextRef="From2021-01-01to2021-03-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember" unitRef="usdPershares" xsi:nil="true" />
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice contextRef="AsOf2021-03-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember_custom_NonQualifiedStockOptionsMember" unitRef="usdPershares" decimals="INF">0.084</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice contextRef="AsOf2021-03-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember" unitRef="usdPershares" decimals="INF">0.073</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm contextRef="From2021-01-01to2021-03-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_NonQualifiedStockOptionsMember_custom_EmployeesAndConsultantsMember">P8Y2M12D</SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm>
    <SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm contextRef="From2021-01-01to2021-03-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember">P7Y2M12D</SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue contextRef="AsOf2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember_custom_NonQualifiedStockOptionsMember" unitRef="usd" xsi:nil="true" />
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue contextRef="AsOf2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember" unitRef="usd" decimals="0">2780</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue contextRef="AsOf2021-03-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember_custom_NonQualifiedStockOptionsMember" unitRef="usd" xsi:nil="true" />
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue contextRef="AsOf2021-03-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember" unitRef="usd" decimals="0">2780</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 contextRef="AsOf2021-03-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember_custom_NonQualifiedStockOptionsMember" unitRef="usd" xsi:nil="true" />
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 contextRef="AsOf2021-03-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember" unitRef="usd" xsi:nil="true" />
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod contextRef="From2021-01-01to2021-03-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesDirectorsandConsultantsMember" unitRef="shares" xsi:nil="true" />
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 contextRef="AsOf2020-12-31" unitRef="usdPershares" decimals="INF">0.25</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 contextRef="AsOf2021-03-31_custom_WarrantsRangeMember" unitRef="usdPershares" decimals="INF">0.25</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 contextRef="AsOf2021-03-31" unitRef="usdPershares" decimals="INF">0.25</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightOutstanding contextRef="AsOf2020-12-31" unitRef="shares" decimals="INF">7562500</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding contextRef="AsOf2021-03-31_custom_WarrantsRangeMember" unitRef="shares" decimals="INF">7562500</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding contextRef="AsOf2021-03-31" unitRef="shares" decimals="INF">7562500</us-gaap:ClassOfWarrantOrRightOutstanding>
    <SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm contextRef="From2021-01-01to2021-03-31">P6M</SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm>
    <SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm contextRef="From2021-01-01to2021-03-31_custom_WarrantsRangeOneMember">P6M</SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm>
    <us-gaap:IncomeTaxesPaidNet contextRef="From2021-01-01to2021-03-31" unitRef="usd" xsi:nil="true" />
    <us-gaap:IncomeTaxesPaidNet contextRef="From2020-01-01to2020-03-31" unitRef="usd" xsi:nil="true" />
    <us-gaap:InterestPaidNet contextRef="From2021-01-01to2021-03-31" unitRef="usd" xsi:nil="true" />
    <us-gaap:InterestPaidNet contextRef="From2020-01-01to2020-03-31" unitRef="usd" xsi:nil="true" />
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations contextRef="AsOf2019-12-31" unitRef="usd" decimals="0">922177</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations contextRef="AsOf2020-12-31" unitRef="usd" decimals="0">2284881</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations contextRef="AsOf2021-03-31" unitRef="usd" decimals="0">3271128</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations contextRef="AsOf2020-03-31" unitRef="usd" decimals="0">194290</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect contextRef="From2021-01-01to2021-03-31" unitRef="usd" decimals="0">986247</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect contextRef="From2020-01-01to2020-03-31" unitRef="usd" decimals="0">-727887</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="From2021-01-01to2021-03-31" unitRef="usd" decimals="0">514200</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="From2020-01-01to2020-03-31" unitRef="usd" xsi:nil="true" />
    <us-gaap:ProceedsFromNotesPayable contextRef="From2021-01-01to2021-03-31" unitRef="usd" decimals="0">514200</us-gaap:ProceedsFromNotesPayable>
    <us-gaap:ProceedsFromNotesPayable contextRef="From2020-01-01to2020-03-31" unitRef="usd" xsi:nil="true" />
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="From2021-01-01to2021-03-31" unitRef="usd" decimals="0">-12326</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="From2020-01-01to2020-03-31" unitRef="usd" xsi:nil="true" />
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="From2021-01-01to2021-03-31" unitRef="usd" decimals="0">12326</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="From2020-01-01to2020-03-31" unitRef="usd" xsi:nil="true" />
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="From2021-01-01to2021-03-31" unitRef="usd" decimals="0">484373</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="From2020-01-01to2020-03-31" unitRef="usd" decimals="0">-727887</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:IncreaseDecreaseInDeferredCompensation contextRef="From2021-01-01to2021-03-31" unitRef="usd" decimals="0">52794</us-gaap:IncreaseDecreaseInDeferredCompensation>
    <us-gaap:IncreaseDecreaseInDeferredCompensation contextRef="From2020-01-01to2020-03-31" unitRef="usd" decimals="0">36463</us-gaap:IncreaseDecreaseInDeferredCompensation>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability contextRef="From2021-01-01to2021-03-31" unitRef="usd" decimals="0">2362905</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability contextRef="From2020-01-01to2020-03-31" unitRef="usd" decimals="0">-291104</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities contextRef="From2021-01-01to2021-03-31" unitRef="usd" decimals="0">5354</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities contextRef="From2020-01-01to2020-03-31" unitRef="usd" decimals="0">289289</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInPrepaidExpensesOther contextRef="From2021-01-01to2021-03-31" unitRef="usd" decimals="0">1026765</us-gaap:IncreaseDecreaseInPrepaidExpensesOther>
    <us-gaap:IncreaseDecreaseInPrepaidExpensesOther contextRef="From2020-01-01to2020-03-31" unitRef="usd" decimals="0">-74924</us-gaap:IncreaseDecreaseInPrepaidExpensesOther>
    <us-gaap:IncreaseDecreaseInInventories contextRef="From2021-01-01to2021-03-31" unitRef="usd" decimals="0">187679</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories contextRef="From2020-01-01to2020-03-31" unitRef="usd" decimals="0">71279</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInAccountsAndNotesReceivable contextRef="From2021-01-01to2021-03-31" unitRef="usd" decimals="0">-6748</us-gaap:IncreaseDecreaseInAccountsAndNotesReceivable>
    <us-gaap:IncreaseDecreaseInAccountsAndNotesReceivable contextRef="From2020-01-01to2020-03-31" unitRef="usd" decimals="0">-688</us-gaap:IncreaseDecreaseInAccountsAndNotesReceivable>
    <us-gaap:GainLossOnDispositionOfAssets contextRef="From2021-01-01to2021-03-31" unitRef="usd" xsi:nil="true" />
    <us-gaap:GainLossOnDispositionOfAssets contextRef="From2020-01-01to2020-03-31" unitRef="usd" decimals="0">-4124</us-gaap:GainLossOnDispositionOfAssets>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="From2021-01-01to2021-03-31" unitRef="usd" decimals="0">18377</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="From2020-01-01to2020-03-31" unitRef="usd" decimals="0">30735</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense contextRef="From2021-01-01to2021-03-31" unitRef="usd" decimals="0">49051</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense contextRef="From2020-01-01to2020-03-31" unitRef="usd" decimals="0">46666</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:IncreaseDecreaseInInterestPayableNet contextRef="From2021-01-01to2021-03-31" unitRef="usd" decimals="0">718</us-gaap:IncreaseDecreaseInInterestPayableNet>
    <us-gaap:IncreaseDecreaseInInterestPayableNet contextRef="From2020-01-01to2020-03-31" unitRef="usd" xsi:nil="true" />
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized contextRef="From2020-01-01to2020-03-31" unitRef="usd" decimals="0">859705</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:RevenueRemainingPerformanceObligation contextRef="AsOf2021-03-31_custom_TwoThousandAndTwentyTwoMember" unitRef="usd" decimals="0">449000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligation contextRef="AsOf2021-03-31_custom_TwoThousandAndTwentyOneMember" unitRef="usd" decimals="0">11129000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligation contextRef="AsOf2021-03-31_us-gaap_CustomerContractsMember" unitRef="usd" decimals="0">2006000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligation contextRef="AsOf2021-03-31" unitRef="usd" decimals="0">11578000</us-gaap:RevenueRemainingPerformanceObligation>
    <SRNA:RemainingPerformanceObligationsRelatedToEngineeringOnlyPaidContracts contextRef="AsOf2021-03-31_custom_TwoThousandAndTwentyTwoMember" unitRef="usd" decimals="0">443000</SRNA:RemainingPerformanceObligationsRelatedToEngineeringOnlyPaidContracts>
    <SRNA:RemainingPerformanceObligationsRelatedToEngineeringOnlyPaidContracts contextRef="AsOf2021-03-31_custom_TwoThousandAndTwentyOneMember" unitRef="usd" decimals="0">1563000</SRNA:RemainingPerformanceObligationsRelatedToEngineeringOnlyPaidContracts>
    <SRNA:RemainingPerformanceObligationsRelatedToEngineeringOnlyPaidContracts contextRef="AsOf2021-03-31" unitRef="usd" decimals="0">2006000</SRNA:RemainingPerformanceObligationsRelatedToEngineeringOnlyPaidContracts>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="From2021-01-01to2021-03-31_us-gaap_CustomerConcentrationRiskMember_us-gaap_AccountsReceivableMember_custom_CustomerOneMember" unitRef="Percentage" decimals="INF">0.60</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="From2021-01-01to2021-03-31_us-gaap_CustomerConcentrationRiskMember_us-gaap_AccountsReceivableMember_custom_CustomerTwoMember" unitRef="Percentage" decimals="INF">0.31</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="From2020-01-01to2020-03-31_us-gaap_CustomerConcentrationRiskMember_us-gaap_AccountsReceivableMember_custom_CustomerThreeMember" unitRef="Percentage" decimals="INF">0.15</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="From2021-01-01to2021-03-31_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_CustomerOneMember" unitRef="Percentage" decimals="INF">0.38</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="From2021-01-01to2021-03-31_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_CustomerTwoMember" unitRef="Percentage" decimals="INF">0.16</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="From2021-01-01to2021-03-31_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_CustomerThreeMember" unitRef="Percentage" decimals="INF">0.11</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="From2020-01-01to2020-03-31_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_CustomerFourMember" unitRef="Percentage" decimals="INF">0.10</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="From2020-01-01to2020-03-31_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_CustomerOneMember" unitRef="Percentage" decimals="INF">0.17</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="From2020-01-01to2020-03-31_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_CustomerTwoMember" unitRef="Percentage" decimals="INF">0.16</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="From2020-01-01to2020-03-31_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember_custom_CustomerThreeMember" unitRef="Percentage" decimals="INF">0.10</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="From2020-01-01to2020-03-31_us-gaap_CustomerConcentrationRiskMember_us-gaap_AccountsReceivableMember_custom_CustomerOneMember" unitRef="Percentage" decimals="INF">0.59</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="From2020-01-01to2020-03-31_us-gaap_CustomerConcentrationRiskMember_us-gaap_AccountsReceivableMember_custom_CustomerTwoMember" unitRef="Percentage" decimals="INF">0.18</us-gaap:ConcentrationRiskPercentage1>
    <SRNA:RemainingPerformanceObligationsRelatedToPartialEquipmentPaidContracts contextRef="AsOf2021-03-31_custom_TwoThousandAndTwentyTwoMember" unitRef="usd" decimals="0">6000</SRNA:RemainingPerformanceObligationsRelatedToPartialEquipmentPaidContracts>
    <SRNA:RemainingPerformanceObligationsRelatedToPartialEquipmentPaidContracts contextRef="AsOf2021-03-31_custom_TwoThousandAndTwentyOneMember" unitRef="usd" decimals="0">9566000</SRNA:RemainingPerformanceObligationsRelatedToPartialEquipmentPaidContracts>
    <SRNA:RemainingPerformanceObligationsRelatedToPartialEquipmentPaidContracts contextRef="AsOf2021-03-31" unitRef="usd" decimals="0">9572000</SRNA:RemainingPerformanceObligationsRelatedToPartialEquipmentPaidContracts>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="From2021-01-01to2021-03-31" unitRef="usd" decimals="0">59136</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="From2021-01-01to2021-03-31_us-gaap_CostOfSalesMember" unitRef="usd" decimals="0">14135</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="From2021-01-01to2021-03-31_us-gaap_AdvertisingMember" unitRef="usd" decimals="0">6474</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="From2021-01-01to2021-03-31_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" unitRef="usd" decimals="0">6694</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="From2021-01-01to2021-03-31_us-gaap_SellingGeneralAndAdministrativeExpensesMember" unitRef="usd" decimals="0">31833</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="From2020-01-01to2020-03-31_us-gaap_CostOfSalesMember" unitRef="usd" decimals="0">8558</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="From2020-01-01to2020-03-31_us-gaap_AdvertisingMember" unitRef="usd" decimals="0">2912</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="From2020-01-01to2020-03-31_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" unitRef="usd" decimals="0">6545</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="From2020-01-01to2020-03-31_us-gaap_SellingGeneralAndAdministrativeExpensesMember" unitRef="usd" decimals="0">172874</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="From2020-01-01to2020-03-31" unitRef="usd" decimals="0">190889</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="From2021-01-01to2021-03-31_custom_TwoThousandTwentyOneAnnualEmployeeIncentiveCompensationPlanMember" unitRef="usd" decimals="0">52794</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="From2020-01-01to2020-03-31_custom_TwoThousandTwentyOneAnnualEmployeeIncentiveCompensationPlanMember" unitRef="usd" decimals="0">36463</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:Depreciation contextRef="From2021-01-01to2021-03-31" unitRef="usd" decimals="0">18233</us-gaap:Depreciation>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="AsOf2021-03-31_us-gaap_FurnitureAndFixturesMember" unitRef="usd" decimals="0">410748</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="AsOf2021-03-31_us-gaap_VehiclesMember" unitRef="usd" decimals="0">15000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="AsOf2021-03-31_us-gaap_LeaseholdImprovementsMember" unitRef="usd" decimals="0">215193</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="AsOf2020-12-31" unitRef="usd" decimals="0">628615</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="AsOf2020-12-31_us-gaap_FurnitureAndFixturesMember" unitRef="usd" decimals="0">398422</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="AsOf2020-12-31_us-gaap_VehiclesMember" unitRef="usd" decimals="0">15000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="AsOf2020-12-31_us-gaap_LeaseholdImprovementsMember" unitRef="usd" decimals="0">215193</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="AsOf2021-03-31" unitRef="usd" decimals="0">640941</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="AsOf2020-12-31" unitRef="usd" decimals="0">480883</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="AsOf2021-03-31" unitRef="usd" decimals="0">499116</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="From2021-01-01to2021-03-31">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermGranted contextRef="From2021-01-01to2021-03-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_NonQualifiedStockOptionsMember_custom_EmployeesAndConsultantsMember">P10Y</SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermGranted>
    <SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermGranted contextRef="From2021-01-01to2021-03-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember" xsi:nil="true" />
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares contextRef="AsOf2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember" unitRef="shares" xsi:nil="true" />
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares contextRef="AsOf2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember" unitRef="shares" decimals="INF">1000000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares contextRef="AsOf2021-03-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember" unitRef="shares" xsi:nil="true" />
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares contextRef="AsOf2021-03-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember" unitRef="shares" decimals="INF">1000000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares contextRef="From2021-01-01to2021-03-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember" unitRef="shares" xsi:nil="true" />
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares contextRef="From2021-01-01to2021-03-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember" unitRef="shares" xsi:nil="true" />
    <SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsNumberOfOptionsExpired contextRef="From2021-01-01to2021-03-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember" unitRef="shares" xsi:nil="true" />
    <SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsNumberOfOptionsExpired contextRef="From2021-01-01to2021-03-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember" unitRef="shares" xsi:nil="true" />
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue contextRef="AsOf2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember" unitRef="usdPershares" xsi:nil="true" />
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue contextRef="AsOf2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember" unitRef="usdPershares" decimals="INF">0.029</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue contextRef="AsOf2021-03-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember" unitRef="usdPershares" xsi:nil="true" />
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue contextRef="AsOf2021-03-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember" unitRef="usdPershares" decimals="INF">0.029</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue contextRef="From2021-01-01to2021-03-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember" unitRef="usdPershares" decimals="INF">0.124</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue contextRef="From2021-01-01to2021-03-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember" unitRef="usdPershares" xsi:nil="true" />
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue contextRef="From2021-01-01to2021-03-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember" unitRef="usdPershares" decimals="INF">0.124</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue contextRef="From2021-01-01to2021-03-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember" unitRef="usdPershares" xsi:nil="true" />
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue contextRef="From2021-01-01to2021-03-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember" unitRef="usdPershares" xsi:nil="true" />
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue contextRef="From2021-01-01to2021-03-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember" unitRef="usdPershares" xsi:nil="true" />
    <SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsExpired contextRef="From2021-01-01to2021-03-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember" unitRef="usdPershares" xsi:nil="true" />
    <SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsExpired contextRef="From2021-01-01to2021-03-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember" unitRef="usdPershares" xsi:nil="true" />
    <SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1 contextRef="AsOf2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember" unitRef="usd" xsi:nil="true" />
    <SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1 contextRef="AsOf2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember" unitRef="usd" decimals="0">29000</SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1>
    <SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1 contextRef="AsOf2021-03-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember" unitRef="usd" xsi:nil="true" />
    <SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1 contextRef="AsOf2021-03-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember" unitRef="usd" decimals="0">29000</SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1>
    <SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested contextRef="AsOf2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember" unitRef="usd" xsi:nil="true" />
    <SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested contextRef="AsOf2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember" unitRef="usd" decimals="0">38200</SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested>
    <SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested contextRef="AsOf2021-03-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember" unitRef="usd" xsi:nil="true" />
    <SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested contextRef="AsOf2021-03-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember" unitRef="usd" decimals="0">38200</SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested>
    <SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValuesGranted contextRef="From2021-01-01to2021-03-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember" unitRef="usd" decimals="0">128543</SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValuesGranted>
    <SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValuesGranted contextRef="From2021-01-01to2021-03-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember" unitRef="usd" xsi:nil="true" />
    <SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValueVested contextRef="From2021-01-01to2021-03-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember" unitRef="usd" decimals="0">128543</SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValueVested>
    <SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValueVested contextRef="From2021-01-01to2021-03-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember" unitRef="usd" xsi:nil="true" />
    <SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantDateFairValueForfeited contextRef="From2021-01-01to2021-03-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember" unitRef="usd" xsi:nil="true" />
    <SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantDateFairValueForfeited contextRef="From2021-01-01to2021-03-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember" unitRef="usd" xsi:nil="true" />
    <SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfSharesGrantDateFairValueExpired contextRef="From2021-01-01to2021-03-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember" unitRef="usd" xsi:nil="true" />
    <SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfSharesGrantDateFairValueExpired contextRef="From2021-01-01to2021-03-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember" unitRef="usd" xsi:nil="true" />
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber contextRef="AsOf2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesDirectorsandConsultantsMember" unitRef="shares" xsi:nil="true" />
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber contextRef="AsOf2021-03-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesDirectorsandConsultantsMember" unitRef="shares" xsi:nil="true" />
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod contextRef="From2021-01-01to2021-03-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesDirectorsandConsultantsMember" unitRef="shares" xsi:nil="true" />
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod contextRef="From2021-01-01to2021-03-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesDirectorsandConsultantsMember" unitRef="shares" xsi:nil="true" />
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue contextRef="AsOf2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesDirectorsandConsultantsMember" unitRef="usdPershares" xsi:nil="true" />
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue contextRef="AsOf2021-03-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesDirectorsandConsultantsMember" unitRef="usdPershares" xsi:nil="true" />
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue contextRef="From2021-01-01to2021-03-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesDirectorsandConsultantsMember" unitRef="usdPershares" xsi:nil="true" />
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue contextRef="From2021-01-01to2021-03-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesDirectorsandConsultantsMember" unitRef="usdPershares" xsi:nil="true" />
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue contextRef="From2021-01-01to2021-03-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesDirectorsandConsultantsMember" unitRef="usdPershares" xsi:nil="true" />
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding contextRef="AsOf2020-12-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesDirectorsandConsultantsMember" unitRef="usd" xsi:nil="true" />
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding contextRef="AsOf2021-03-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_EmployeesDirectorsandConsultantsMember" unitRef="usd" xsi:nil="true" />
    <us-gaap:InventoryWriteDown contextRef="From2021-01-01to2021-03-31" unitRef="usd" decimals="0">-4371</us-gaap:InventoryWriteDown>
    <us-gaap:InventoryWriteDown contextRef="From2020-01-01to2020-03-31" unitRef="usd" decimals="0">-11657</us-gaap:InventoryWriteDown>
    <us-gaap:OtherLiabilitiesCurrent contextRef="AsOf2020-12-31" unitRef="usd" xsi:nil="true" />
    <us-gaap:OtherLiabilitiesCurrent contextRef="AsOf2021-03-31" unitRef="usd" decimals="0">37078</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesNoncurrent contextRef="AsOf2020-12-31" unitRef="usd" decimals="0">74156</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent contextRef="AsOf2021-03-31" unitRef="usd" decimals="0">37078</us-gaap:OtherLiabilitiesNoncurrent>
    <SRNA:CommonSharesToBeIssued contextRef="AsOf2021-03-31" unitRef="usd" decimals="0">1000000</SRNA:CommonSharesToBeIssued>
    <SRNA:CommonStockSharesToBeIssuedValue contextRef="AsOf2020-12-31" unitRef="usd" xsi:nil="true" />
    <SRNA:CommonStockSharesToBeIssuedValue contextRef="AsOf2021-03-31" unitRef="usd" decimals="0">67000</SRNA:CommonStockSharesToBeIssuedValue>
    <SRNA:OtherSharebasedExpense contextRef="From2021-01-01to2021-03-31" unitRef="usd" decimals="0">67000</SRNA:OtherSharebasedExpense>
    <SRNA:OtherSharebasedExpense contextRef="From2020-01-01to2020-03-31" unitRef="usd" xsi:nil="true" />
    <SRNA:CashBalanceTransferredToBankAccount contextRef="AsOf2021-03-31" unitRef="usd" decimals="0">180000</SRNA:CashBalanceTransferredToBankAccount>
    <us-gaap:RestrictedCash contextRef="AsOf2021-03-31" unitRef="usd" decimals="0">86697</us-gaap:RestrictedCash>
    <us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities contextRef="From2021-01-01to2021-03-31" unitRef="shares" decimals="INF">30249300</us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities>
    <us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities contextRef="From2020-01-01to2020-03-31" unitRef="shares" decimals="INF">45748400</us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities>
    <us-gaap:GoodwillImpairmentLoss contextRef="From2021-01-01to2021-03-31" unitRef="usd" xsi:nil="true" />
    <us-gaap:RevenueRemainingPerformanceObligationPercentage contextRef="AsOf2021-03-31" unitRef="Percentage" decimals="INF">0.17</us-gaap:RevenueRemainingPerformanceObligationPercentage>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate contextRef="From2021-01-01to2021-03-31" unitRef="Percentage" decimals="INF">1.5251</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate contextRef="From2021-01-01to2021-03-31" unitRef="Percentage" decimals="INF">0.012</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:LossContingencyDamagesPaidValue contextRef="From2021-03-29to2021-03-30" unitRef="usd" decimals="0">40000</us-gaap:LossContingencyDamagesPaidValue>
    <SRNA:AggregateSharesIssuedUponExecutionOfSettlement contextRef="From2021-03-29to2021-03-30" unitRef="shares" decimals="INF">1000000</SRNA:AggregateSharesIssuedUponExecutionOfSettlement>
    <SRNA:AggregateSharesIssuedUponExecutionOfSettlement contextRef="From2021-04-07to2021-04-08_us-gaap_SubsequentEventMember_custom_FormerEmployeeMember" unitRef="shares" decimals="INF">1000000</SRNA:AggregateSharesIssuedUponExecutionOfSettlement>
    <us-gaap:OtherNonoperatingExpense contextRef="From2021-01-01to2021-03-31" unitRef="usd" decimals="0">107000</us-gaap:OtherNonoperatingExpense>
    <SRNA:StockIssuanceAmount contextRef="AsOf2021-03-31" unitRef="usd" decimals="0">67000</SRNA:StockIssuanceAmount>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock contextRef="From2021-01-01to2021-03-31_custom_TwoThousandSeventeenEquityPlanMember_srt_DirectorMember">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;A summary of the non-qualified&#13;stock options granted to directors under the 2017 Equity Plan during the three months ended March 31, 2021, are presented in the table&#13;below:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;  &lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Number of Options&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Weighted Average Exercise Price&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Weighted Average Remaining Contractual Term&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Aggregate Intrinsic Value ($000)&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="width: 44%"&gt;&lt;font style="font-size: 10pt"&gt;Outstanding, December 31, 2020&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 11%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;7,400,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 11%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0.067&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 11%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;7.5&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 11%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;2,780&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-left: 10pt"&gt;&lt;font style="font-size: 10pt"&gt;Granted&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-left: 10pt"&gt;&lt;font style="font-size: 10pt"&gt;Exercised&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-left: 10pt"&gt;&lt;font style="font-size: 10pt"&gt;Forfeited/Cancelled&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; padding-left: 10pt"&gt;&lt;font style="font-size: 10pt"&gt;Expired&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;font style="font-size: 10pt"&gt;Outstanding, March 31, 2021&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;7,400,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0.067&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;7.2&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;2,780&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;font style="font-size: 10pt"&gt;Exerciseable, March 31, 2021&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;6,400,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0.073&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;7.7&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;/table&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock contextRef="From2021-01-01to2021-03-31_custom_TwoThousandSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;A summary&#13;of the non-qualified stock options granted to employees and consultants under the 2017 Equity Plan during the three months ended March&#13;31, 2021, are presented in the table below:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;  &lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Number of Options&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Weighted Average Exercise Price&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Weighted Average Remaining Contractual Term&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Aggregate Intrinsic Value&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="width: 44%"&gt;&lt;font style="font-size: 10pt"&gt;Outstanding, December 31, 2020&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 11%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;14,251,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 11%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0.083&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 11%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;8.3&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 11%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-left: 10pt"&gt;&lt;font style="font-size: 10pt"&gt;Granted&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1,035,800&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0.130&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;10.0&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-left: 10pt"&gt;&lt;font style="font-size: 10pt"&gt;Exercised&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-left: 10pt"&gt;&lt;font style="font-size: 10pt"&gt;Forfeited&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; padding-left: 10pt"&gt;&lt;font style="font-size: 10pt"&gt;Expired&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;font style="font-size: 10pt"&gt;Outstanding, March 31, 2021&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;15,286,800&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0.084&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;8.2&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;font style="font-size: 10pt"&gt;Exercisable, March 31, 2021&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;15,286,800&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0.084&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;8.2&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;/table&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ScheduleOfNonvestedShareActivityTableTextBlock contextRef="From2021-01-01to2021-03-31_custom_TwoThousandSeventeenEquityPlanMember_srt_DirectorMember">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;A summary of non-vested non-qualified&#13;stock options activity for directors under the 2017 Equity Plan for the three months ended March 31, 2021, are presented in the table&#13;below:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;  &lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Number of Options&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Weighted Average Grant-Date Fair Value&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Aggregate Intrinsic Value&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Grant-Date Fair Value&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="width: 44%"&gt;&lt;font style="font-size: 10pt"&gt;Nonvested, December 31, 2020&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 11%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1,000,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 11%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0.029&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 11%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;29,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 11%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;38,200&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-left: 10pt"&gt;&lt;font style="font-size: 10pt"&gt;Granted&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-left: 10pt"&gt;&lt;font style="font-size: 10pt"&gt;Vested&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-left: 10pt"&gt;&lt;font style="font-size: 10pt"&gt;Forfeited&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; padding-left: 10pt"&gt;&lt;font style="font-size: 10pt"&gt;Expired&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;font style="font-size: 10pt"&gt;Nonvested, March 31, 2021&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1,000,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0.029&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;29,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;38,200&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;/table&gt;</us-gaap:ScheduleOfNonvestedShareActivityTableTextBlock>
    <us-gaap:ScheduleOfNonvestedShareActivityTableTextBlock contextRef="From2021-01-01to2021-03-31_custom_TwoThousandSeventeenEquityPlanMember_custom_EmployeesAndConsultantsMember">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;A summary of non-vested non-qualified&#13;stock options activity for employees and consultants under the 2017 Equity Plan for the three months ended March 31, 2021, are presented&#13;in the table below:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;  &lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Number of Options&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Weighted Average Grant-Date Fair Value&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Aggregate Intrinsic Value&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Grant-Date Fair Value&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Nonvested, December 31, 2020&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="width: 44%; padding-left: 10pt"&gt;&lt;font style="font-size: 10pt"&gt;Granted&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 11%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1,035,800&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 11%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0.124&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 11%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 11%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;128,543&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-left: 10pt"&gt;&lt;font style="font-size: 10pt"&gt;Vested&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(1,035,800&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0.124&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;128,543&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-left: 10pt"&gt;&lt;font style="font-size: 10pt"&gt;Forfeited&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; padding-left: 10pt"&gt;&lt;font style="font-size: 10pt"&gt;Expired&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;font style="font-size: 10pt"&gt;Nonvested, March 31, 2021&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;/table&gt;</us-gaap:ScheduleOfNonvestedShareActivityTableTextBlock>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1 contextRef="From2021-01-01to2021-03-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_NonQualifiedStockOptionsMember_custom_EmployeesAndConsultantsMember">P8Y2M12D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1 contextRef="From2021-01-01to2021-03-31_custom_TwoThousandAndSeventeenEquityPlanMember_custom_DirectorsMember_custom_NonQualifiedStockOptionsMember">P7Y8M12D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted contextRef="From2021-01-01to2021-03-31" unitRef="shares" decimals="INF">236526638</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted contextRef="From2020-01-01to2020-03-31" unitRef="shares" decimals="INF">231062462</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted contextRef="From2021-01-01to2021-03-31" unitRef="usdPershares" decimals="INF">-0.00</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted contextRef="From2020-01-01to2020-03-31" unitRef="usdPershares" decimals="INF">-0.00</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="From2021-01-01to2021-03-31" unitRef="usd" xsi:nil="true" />
    <us-gaap:IncomeTaxExpenseBenefit contextRef="From2020-01-01to2020-03-31" unitRef="usd" xsi:nil="true" />
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="From2021-01-01to2021-03-31" unitRef="usd" decimals="0">-793368</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="From2020-01-01to2020-03-31" unitRef="usd" decimals="0">-938313</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:NonoperatingIncomeExpense contextRef="From2021-01-01to2021-03-31" unitRef="usd" decimals="0">-107718</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense contextRef="From2020-01-01to2020-03-31" unitRef="usd" decimals="0">8025</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:InterestExpense contextRef="From2021-01-01to2021-03-31" unitRef="usd" decimals="0">718</us-gaap:InterestExpense>
    <us-gaap:InterestExpense contextRef="From2020-01-01to2020-03-31" unitRef="usd" decimals="0">6295</us-gaap:InterestExpense>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="From2021-01-01to2021-03-31" unitRef="usd" decimals="0">-107000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="From2020-01-01to2020-03-31" unitRef="usd" decimals="0">14320</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OperatingIncomeLoss contextRef="From2021-01-01to2021-03-31" unitRef="usd" decimals="0">-685650</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="From2020-01-01to2020-03-31" unitRef="usd" decimals="0">-946338</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingExpenses contextRef="From2021-01-01to2021-03-31" unitRef="usd" decimals="0">1030256</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses contextRef="From2020-01-01to2020-03-31" unitRef="usd" decimals="0">1402862</us-gaap:OperatingExpenses>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="From2021-01-01to2021-03-31" unitRef="usd" decimals="0">112638</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="From2020-01-01to2020-03-31" unitRef="usd" decimals="0">144948</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:MarketingAndAdvertisingExpense contextRef="From2021-01-01to2021-03-31" unitRef="usd" decimals="0">177145</us-gaap:MarketingAndAdvertisingExpense>
    <us-gaap:MarketingAndAdvertisingExpense contextRef="From2020-01-01to2020-03-31" unitRef="usd" decimals="0">148921</us-gaap:MarketingAndAdvertisingExpense>
    <us-gaap:GrossProfit contextRef="From2021-01-01to2021-03-31" unitRef="usd" decimals="0">344606</us-gaap:GrossProfit>
    <us-gaap:GrossProfit contextRef="From2020-01-01to2020-03-31" unitRef="usd" decimals="0">456524</us-gaap:GrossProfit>
    <us-gaap:CostOfRevenue contextRef="From2021-01-01to2021-03-31" unitRef="usd" decimals="0">2021923</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue contextRef="From2020-01-01to2020-03-31" unitRef="usd" decimals="0">1353401</us-gaap:CostOfRevenue>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="From2021-01-01to2021-03-31" unitRef="usd" decimals="0">2366529</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="From2020-01-01to2020-03-31_custom_EngineeringAndOtherServicesMember" unitRef="usd" decimals="0">131591</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="From2020-01-01to2020-03-31_us-gaap_ShippingAndHandlingMember" unitRef="usd" decimals="0">71388</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="From2021-01-01to2021-03-31_us-gaap_EquipmentMember" unitRef="usd" decimals="0">2163468</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="From2021-01-01to2021-03-31_custom_EngineeringAndOtherServicesMember" unitRef="usd" decimals="0">181083</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="From2021-01-01to2021-03-31_us-gaap_ShippingAndHandlingMember" unitRef="usd" decimals="0">21978</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="From2020-01-01to2020-03-31_us-gaap_EquipmentMember" unitRef="usd" decimals="0">1606946</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="From2020-01-01to2020-03-31" unitRef="usd" decimals="0">1809925</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:LesseeOperatingLeaseDescription contextRef="From2021-01-01to2021-03-31">The Facility Lease commenced September 29, 2017 and continues through August 31, 2022.</us-gaap:LesseeOperatingLeaseDescription>
    <us-gaap:LesseeOperatingLeaseRenewalTerm contextRef="AsOf2021-03-31_custom_FacilityLeaseMember">P5Y</us-gaap:LesseeOperatingLeaseRenewalTerm>
    <us-gaap:OperatingLeaseLiability contextRef="AsOf2019-01-02_us-gaap_AccountingStandardsUpdate201602Member" unitRef="usd" decimals="0">822374</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseLiability contextRef="AsOf2021-03-31" unitRef="usd" decimals="0">370553</us-gaap:OperatingLeaseLiability>
    <SRNA:MonthlyRentDescription contextRef="From2021-01-01to2021-03-31">Beginning September 1, 2018, and each subsequent September 1 during the term, the monthly rent under the Facility Lease will increase by 3%.</SRNA:MonthlyRentDescription>
    <us-gaap:TenantImprovements contextRef="AsOf2019-01-02_us-gaap_AccountingStandardsUpdate201602Member_srt_MinimumMember" unitRef="usd" decimals="0">100000</us-gaap:TenantImprovements>
    <SRNA:UnamortizedAmountOfTenantImprovementAllowance contextRef="AsOf2019-01-02_us-gaap_AccountingStandardsUpdate201602Member" unitRef="usd" decimals="0">81481</SRNA:UnamortizedAmountOfTenantImprovementAllowance>
    <us-gaap:OperatingLeaseCost contextRef="From2021-01-01to2021-03-31" unitRef="usd" decimals="0">54222</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeasePayments contextRef="From2021-01-01to2021-03-31" unitRef="usd" decimals="0">69844</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1 contextRef="AsOf2021-03-31">P1Y4M24D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent contextRef="AsOf2021-03-31" unitRef="Percentage" decimals="INF">0.05</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear contextRef="AsOf2021-03-31" unitRef="usd" decimals="0">212020</us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths contextRef="AsOf2021-03-31" unitRef="usd" decimals="0">170891</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue contextRef="AsOf2021-03-31" unitRef="usd" decimals="0">382911</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount contextRef="AsOf2021-03-31" unitRef="usd" decimals="0">12358</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:CostOfGoodsAndServicesSoldOverhead contextRef="From2021-01-01to2021-03-31" unitRef="usd" decimals="0">17443</us-gaap:CostOfGoodsAndServicesSoldOverhead>
    <us-gaap:CostOfGoodsAndServicesSoldOverhead contextRef="From2020-01-01to2020-12-31" unitRef="usd" decimals="0">17974</us-gaap:CostOfGoodsAndServicesSoldOverhead>
    <SRNA:PrepaidInventoryExpenses contextRef="AsOf2020-12-31" unitRef="usd" decimals="0">916000</SRNA:PrepaidInventoryExpenses>
    <SRNA:PrepaidInventoryExpenses contextRef="AsOf2021-03-31" unitRef="usd" decimals="0">1960000</SRNA:PrepaidInventoryExpenses>
    <us-gaap:InventoryFinishedGoods contextRef="AsOf2020-12-31" unitRef="usd" decimals="0">201778</us-gaap:InventoryFinishedGoods>
    <us-gaap:InventoryFinishedGoods contextRef="AsOf2021-03-31" unitRef="usd" decimals="0">325451</us-gaap:InventoryFinishedGoods>
    <us-gaap:InventoryWorkInProcess contextRef="AsOf2020-12-31" unitRef="usd" decimals="0">4231</us-gaap:InventoryWorkInProcess>
    <us-gaap:InventoryWorkInProcess contextRef="AsOf2021-03-31" unitRef="usd" decimals="0">10083</us-gaap:InventoryWorkInProcess>
    <us-gaap:InventoryRawMaterials contextRef="AsOf2020-12-31" unitRef="usd" decimals="0">214145</us-gaap:InventoryRawMaterials>
    <us-gaap:InventoryRawMaterials contextRef="AsOf2021-03-31" unitRef="usd" decimals="0">272299</us-gaap:InventoryRawMaterials>
    <us-gaap:InventoryValuationReserves contextRef="AsOf2020-12-31" unitRef="usd" decimals="0">93045</us-gaap:InventoryValuationReserves>
    <us-gaap:InventoryValuationReserves contextRef="AsOf2021-03-31" unitRef="usd" decimals="0">88674</us-gaap:InventoryValuationReserves>
    <us-gaap:AccountsPayableCurrent contextRef="AsOf2020-12-31" unitRef="usd" decimals="0">918639</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent contextRef="AsOf2021-03-31" unitRef="usd" decimals="0">860087</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccruedSalesCommissionCurrent contextRef="AsOf2020-12-31" unitRef="usd" decimals="0">48263</us-gaap:AccruedSalesCommissionCurrent>
    <us-gaap:AccruedSalesCommissionCurrent contextRef="AsOf2021-03-31" unitRef="usd" decimals="0">13649</us-gaap:AccruedSalesCommissionCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent contextRef="AsOf2020-12-31" unitRef="usd" decimals="0">288071</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent contextRef="AsOf2021-03-31" unitRef="usd" decimals="0">275024</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:ProductWarrantyAccrualClassifiedCurrent contextRef="AsOf2020-12-31" unitRef="usd" decimals="0">173365</us-gaap:ProductWarrantyAccrualClassifiedCurrent>
    <us-gaap:ProductWarrantyAccrualClassifiedCurrent contextRef="AsOf2021-03-31" unitRef="usd" decimals="0">264956</us-gaap:ProductWarrantyAccrualClassifiedCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent contextRef="AsOf2020-12-31" unitRef="usd" decimals="0">356623</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent contextRef="AsOf2021-03-31" unitRef="usd" decimals="0">376599</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:DebtInstrumentIncreaseAccruedInterest contextRef="From2021-01-01to2021-03-31" unitRef="usd" decimals="0">718</us-gaap:DebtInstrumentIncreaseAccruedInterest>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance contextRef="AsOf2021-03-31_custom_TwoThousandAndSeventeenEquityIncentivePlanMember" unitRef="shares" decimals="INF">50000000</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant contextRef="AsOf2021-03-31_custom_IncentiveStockBonusAwardsMember_custom_EmployeesMember" unitRef="shares" decimals="INF">22686800</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant contextRef="AsOf2021-03-22_custom_TwoThousandAndTwentyOneEquityIncentivePlanMember" unitRef="shares" decimals="INF">100000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage contextRef="From2021-03-29to2021-04-01_us-gaap_SubsequentEventMember_custom_TwoThousandAndSeventeenEquityPlanMember_custom_NonQualifiedStockOptionsMember_custom_DirectorsMember" unitRef="Percentage" decimals="INF">0.50</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage contextRef="From2020-06-23to2020-06-24_custom_TwoThousandAndSeventeenEquityPlanMember_custom_NonQualifiedStockOptionsMember_custom_DirectorsMember" unitRef="Percentage" decimals="INF">0.50</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <us-gaap:OperatingLossCarryforwards contextRef="AsOf2021-03-31" unitRef="usd" decimals="0">20115000</us-gaap:OperatingLossCarryforwards>
    <SRNA:NetOperatingLossCarryForwardExpectedToExpireAmount contextRef="AsOf2021-03-31" unitRef="usd" decimals="0">11196261</SRNA:NetOperatingLossCarryForwardExpectedToExpireAmount>
    <SRNA:NetOperatingLossExpirationTerm contextRef="From2021-01-01to2021-03-31">2034 through 2037</SRNA:NetOperatingLossExpirationTerm>
    <SRNA:NolsUsageAgainstTaxableIncomePercentage contextRef="AsOf2021-03-31" unitRef="Percentage" decimals="INF">0.80</SRNA:NolsUsageAgainstTaxableIncomePercentage>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired contextRef="AsOf2021-03-31" unitRef="Percentage" decimals="INF">0.50</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <SRNA:NolsCarryforwardsTerm contextRef="From2021-01-01to2021-03-31">P3Y</SRNA:NolsCarryforwardsTerm>
    <us-gaap:AreaOfLand contextRef="AsOf2021-04-30_us-gaap_SubsequentEventMember_custom_OfficeandManufacturingMember" unitRef="Sqft" decimals="INF">6900</us-gaap:AreaOfLand>
    <us-gaap:OperatingLeasesRentExpenseSubleaseRentals1 contextRef="From2021-04-28to2021-04-30_us-gaap_SubsequentEventMember" unitRef="usd" decimals="0">5989</us-gaap:OperatingLeasesRentExpenseSubleaseRentals1>
    <us-gaap:OperatingLeasesRentExpenseSubleaseRentals1 contextRef="From2021-06-29to2021-07-01_srt_ScenarioForecastMember" unitRef="usd" decimals="0">11978</us-gaap:OperatingLeasesRentExpenseSubleaseRentals1>
    <SRNA:ClassOfWarrantOrRightIssued contextRef="From2021-01-01to2021-03-31" unitRef="shares" xsi:nil="true" />
    <SRNA:ClassOfWarrantOrRightExercised contextRef="From2021-01-01to2021-03-31" unitRef="shares" xsi:nil="true" />
    <SRNA:ClassOfWarrantOrRightExpired contextRef="From2021-01-01to2021-03-31" unitRef="shares" decimals="INF">0</SRNA:ClassOfWarrantOrRightExpired>
    <SRNA:ClassOfWarrantOrRightWeightedAverageExercisePriceIssued contextRef="From2021-01-01to2021-03-31" unitRef="usdPershares" xsi:nil="true" />
    <SRNA:ClassOfWarrantOrRightWeightedAverageExercisePriceExercised contextRef="From2021-01-01to2021-03-31" unitRef="usdPershares" xsi:nil="true" />
    <SRNA:ClassOfWarrantOrRightWeightedAverageExercisePriceExpired contextRef="From2021-01-01to2021-03-31" unitRef="usdPershares" decimals="INF">0.00</SRNA:ClassOfWarrantOrRightWeightedAverageExercisePriceExpired>
    <SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerms contextRef="From2021-01-01to2021-03-31">P6M</SRNA:SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerms>
    <SRNA:ClassOfWarrantOrRightOutstandingAggregateIntrinsicValue contextRef="AsOf2020-12-31" unitRef="usd" decimals="0">0</SRNA:ClassOfWarrantOrRightOutstandingAggregateIntrinsicValue>
    <SRNA:ClassOfWarrantOrRightOutstandingAggregateIntrinsicValue contextRef="AsOf2021-03-31" unitRef="usd" decimals="0">0</SRNA:ClassOfWarrantOrRightOutstandingAggregateIntrinsicValue>
    <SRNA:ClassOfWarrantOrRightIssuedAggregateIntrinsicValue contextRef="From2021-01-01to2021-03-31" unitRef="usd" xsi:nil="true" />
    <SRNA:ClassOfWarrantOrRightExercisedAggregateIntrinsicValue contextRef="From2021-01-01to2021-03-31" unitRef="usd" xsi:nil="true" />
    <SRNA:ClassOfWarrantOrRightExpiredAggregateIntrinsicValue contextRef="From2021-01-01to2021-03-31" unitRef="usd" decimals="0">0</SRNA:ClassOfWarrantOrRightExpiredAggregateIntrinsicValue>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="AsOf2020-12-31" unitRef="usd" decimals="0">2284881</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="AsOf2021-03-31" unitRef="usd" decimals="0">3271128</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <SRNA:CommonStockSharesToBeIssuedParOrStatedValuePerShare contextRef="AsOf2021-03-31" unitRef="usdPershares" decimals="INF">0.00001</SRNA:CommonStockSharesToBeIssuedParOrStatedValuePerShare>
    <dei:EntityRegistrantName contextRef="From2021-01-01to2021-03-31">Surna Inc.</dei:EntityRegistrantName>
    <us-gaap:SharesOutstanding contextRef="AsOf2019-12-31_us-gaap_PreferredStockMember" unitRef="shares" decimals="INF">42030331</us-gaap:SharesOutstanding>
    <us-gaap:SharesOutstanding contextRef="AsOf2019-12-31_us-gaap_CommonStockMember" unitRef="shares" decimals="INF">228216638</us-gaap:SharesOutstanding>
    <us-gaap:SharesOutstanding contextRef="AsOf2020-12-31_us-gaap_PreferredStockMember" unitRef="shares" decimals="INF">42030331</us-gaap:SharesOutstanding>
    <us-gaap:SharesOutstanding contextRef="AsOf2020-12-31_us-gaap_CommonStockMember" unitRef="shares" decimals="INF">236526638</us-gaap:SharesOutstanding>
    <us-gaap:SharesOutstanding contextRef="AsOf2020-03-31_us-gaap_PreferredStockMember" unitRef="shares" decimals="INF">42030331</us-gaap:SharesOutstanding>
    <us-gaap:SharesOutstanding contextRef="AsOf2021-03-31_us-gaap_PreferredStockMember" unitRef="shares" decimals="INF">42030331</us-gaap:SharesOutstanding>
    <us-gaap:SharesOutstanding contextRef="AsOf2020-03-31_us-gaap_CommonStockMember" unitRef="shares" decimals="INF">236526638</us-gaap:SharesOutstanding>
    <us-gaap:SharesOutstanding contextRef="AsOf2021-03-31_us-gaap_CommonStockMember" unitRef="shares" decimals="INF">236526638</us-gaap:SharesOutstanding>
    <SRNA:CommonStockSharesToBeIssuedBalance contextRef="AsOf2019-12-31" unitRef="shares" xsi:nil="true" />
    <SRNA:CommonStockSharesToBeIssuedBalance contextRef="AsOf2020-12-31" unitRef="shares" xsi:nil="true" />
    <SRNA:CommonStockSharesToBeIssuedBalance contextRef="AsOf2019-12-31_us-gaap_PreferredStockMember" unitRef="shares" xsi:nil="true" />
    <SRNA:CommonStockSharesToBeIssuedBalance contextRef="AsOf2019-12-31_us-gaap_CommonStockMember" unitRef="shares" decimals="INF">1560000</SRNA:CommonStockSharesToBeIssuedBalance>
    <SRNA:CommonStockSharesToBeIssuedBalance contextRef="AsOf2019-12-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="shares" xsi:nil="true" />
    <SRNA:CommonStockSharesToBeIssuedBalance contextRef="AsOf2019-12-31_us-gaap_RetainedEarningsMember" unitRef="shares" xsi:nil="true" />
    <SRNA:CommonStockSharesToBeIssuedBalance contextRef="AsOf2020-12-31_us-gaap_CommonStockMember" unitRef="shares" xsi:nil="true" />
    <SRNA:CommonStockSharesToBeIssuedBalance contextRef="AsOf2020-03-31_us-gaap_PreferredStockMember" unitRef="shares" xsi:nil="true" />
    <SRNA:CommonStockSharesToBeIssuedBalance contextRef="AsOf2021-03-31_us-gaap_PreferredStockMember" unitRef="shares" xsi:nil="true" />
    <SRNA:CommonStockSharesToBeIssuedBalance contextRef="AsOf2020-03-31_us-gaap_CommonStockMember" unitRef="shares" xsi:nil="true" />
    <SRNA:CommonStockSharesToBeIssuedBalance contextRef="AsOf2021-03-31_us-gaap_CommonStockMember" unitRef="shares" decimals="INF">1000000</SRNA:CommonStockSharesToBeIssuedBalance>
    <SRNA:CommonStockSharesToBeIssuedBalance contextRef="AsOf2020-03-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="shares" xsi:nil="true" />
    <SRNA:CommonStockSharesToBeIssuedBalance contextRef="AsOf2020-03-31_us-gaap_RetainedEarningsMember" unitRef="shares" xsi:nil="true" />
    <SRNA:CommonStockSharesToBeIssuedBalance contextRef="AsOf2020-03-31" unitRef="shares" xsi:nil="true" />
    <SRNA:CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonuses contextRef="From2020-01-01to2020-03-31" unitRef="usd" xsi:nil="true" />
    <SRNA:CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonuses contextRef="From2020-01-01to2020-03-31_us-gaap_PreferredStockMember" unitRef="usd" xsi:nil="true" />
    <SRNA:CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonuses contextRef="From2020-01-01to2020-03-31_us-gaap_CommonStockMember" unitRef="usd" decimals="0">83</SRNA:CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonuses>
    <SRNA:CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonuses contextRef="From2020-01-01to2020-03-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="usd" decimals="0">-83</SRNA:CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonuses>
    <SRNA:CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonuses contextRef="From2020-01-01to2020-03-31_us-gaap_RetainedEarningsMember" unitRef="usd" xsi:nil="true" />
    <SRNA:CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesShares contextRef="From2020-01-01to2020-03-31_us-gaap_PreferredStockMember" unitRef="shares" xsi:nil="true" />
    <SRNA:CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesShares contextRef="From2020-01-01to2020-03-31_us-gaap_CommonStockMember" unitRef="shares" decimals="INF">8310000</SRNA:CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesShares>
    <SRNA:CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesSharesToBeIssued contextRef="From2020-01-01to2020-03-31_us-gaap_PreferredStockMember" unitRef="shares" xsi:nil="true" />
    <SRNA:CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesSharesToBeIssued contextRef="From2020-01-01to2020-03-31_us-gaap_CommonStockMember" unitRef="shares" decimals="INF">-1560000</SRNA:CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesSharesToBeIssued>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition contextRef="From2020-01-01to2020-03-31" unitRef="usd" decimals="0">18872</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition contextRef="From2020-01-01to2020-03-31_us-gaap_PreferredStockMember" unitRef="usd" xsi:nil="true" />
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition contextRef="From2020-01-01to2020-03-31_us-gaap_CommonStockMember" unitRef="usd" xsi:nil="true" />
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition contextRef="From2020-01-01to2020-03-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="usd" decimals="0">18872</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition contextRef="From2020-01-01to2020-03-31_us-gaap_RetainedEarningsMember" unitRef="usd" xsi:nil="true" />
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition contextRef="From2020-01-01to2020-03-31" unitRef="usd" decimals="0">639020</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition contextRef="From2020-01-01to2020-03-31_us-gaap_PreferredStockMember" unitRef="usd" xsi:nil="true" />
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition contextRef="From2020-01-01to2020-03-31_us-gaap_CommonStockMember" unitRef="usd" xsi:nil="true" />
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition contextRef="From2020-01-01to2020-03-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="usd" decimals="0">639020</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition contextRef="From2020-01-01to2020-03-31_us-gaap_RetainedEarningsMember" unitRef="usd" xsi:nil="true" />
    <SRNA:CommonSharesToBeIssuedInSettlementOfLegalDispute contextRef="From2021-01-01to2021-03-31" unitRef="usd" decimals="0">67000</SRNA:CommonSharesToBeIssuedInSettlementOfLegalDispute>
    <SRNA:CommonSharesToBeIssuedInSettlementOfLegalDispute contextRef="From2020-01-01to2020-03-31" unitRef="usd" xsi:nil="true" />
    <SRNA:CommonSharesToBeIssuedInSettlementOfLegalDispute contextRef="From2020-01-01to2020-03-31_us-gaap_PreferredStockMember" unitRef="usd" xsi:nil="true" />
    <SRNA:CommonSharesToBeIssuedInSettlementOfLegalDispute contextRef="From2020-01-01to2020-03-31_us-gaap_CommonStockMember" unitRef="usd" xsi:nil="true" />
    <SRNA:CommonSharesToBeIssuedInSettlementOfLegalDispute contextRef="From2021-01-01to2021-03-31_us-gaap_CommonStockMember" unitRef="usd" decimals="0">67000</SRNA:CommonSharesToBeIssuedInSettlementOfLegalDispute>
    <SRNA:CommonSharesToBeIssuedInSettlementOfLegalDispute contextRef="From2020-01-01to2020-03-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="usd" xsi:nil="true" />
    <SRNA:CommonSharesToBeIssuedInSettlementOfLegalDispute contextRef="From2021-01-01to2021-03-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="usd" xsi:nil="true" />
    <SRNA:CommonSharesToBeIssuedInSettlementOfLegalDispute contextRef="From2020-01-01to2020-03-31_us-gaap_RetainedEarningsMember" unitRef="usd" xsi:nil="true" />
    <SRNA:CommonSharesToBeIssuedInSettlementOfLegalDispute contextRef="From2021-01-01to2021-03-31_us-gaap_RetainedEarningsMember" unitRef="usd" xsi:nil="true" />
    <SRNA:FairValueOfVestedStockOptionsGrantedToEmployees contextRef="From2021-01-01to2021-03-31" unitRef="usd" decimals="0">128434</SRNA:FairValueOfVestedStockOptionsGrantedToEmployees>
    <SRNA:FairValueOfVestedStockOptionsGrantedToEmployees contextRef="From2020-01-01to2020-03-31_us-gaap_PreferredStockMember" unitRef="usd" xsi:nil="true" />
    <SRNA:FairValueOfVestedStockOptionsGrantedToEmployees contextRef="From2021-01-01to2021-03-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="usd" decimals="0">128434</SRNA:FairValueOfVestedStockOptionsGrantedToEmployees>
    <SRNA:FairValueOfVestedStockOptionsGrantedToDirectors contextRef="From2021-01-01to2021-03-31" unitRef="usd" decimals="0">6342</SRNA:FairValueOfVestedStockOptionsGrantedToDirectors>
    <SRNA:FairValueOfVestedStockOptionsGrantedToDirectors contextRef="From2020-01-01to2020-03-31_us-gaap_PreferredStockMember" unitRef="usd" xsi:nil="true" />
    <SRNA:FairValueOfVestedStockOptionsGrantedToDirectors contextRef="From2021-01-01to2021-03-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="usd" decimals="0">6342</SRNA:FairValueOfVestedStockOptionsGrantedToDirectors>
    <SRNA:CommonSharesToBeIssuedInSettlementOfLegalDisputeSharesToBeIssued contextRef="From2021-01-01to2021-03-31_us-gaap_PreferredStockMember" unitRef="shares" xsi:nil="true" />
    <SRNA:CommonSharesToBeIssuedInSettlementOfLegalDisputeSharesToBeIssued contextRef="From2021-01-01to2021-03-31_us-gaap_CommonStockMember" unitRef="shares" decimals="INF">1000000</SRNA:CommonSharesToBeIssuedInSettlementOfLegalDisputeSharesToBeIssued>
    <dei:DocumentType contextRef="From2021-01-01to2021-03-31">10-Q</dei:DocumentType>
    <SRNA:CommonStockValueToBeIssuedBalance contextRef="AsOf2020-12-31_us-gaap_CommonStockMember" unitRef="usd" xsi:nil="true" />
    <SRNA:CommonStockValueToBeIssuedBalance contextRef="AsOf2021-03-31_us-gaap_CommonStockMember" unitRef="usd" decimals="0">67000</SRNA:CommonStockValueToBeIssuedBalance>
    <us-gaap:LongTermNotesPayable contextRef="AsOf2020-12-31" unitRef="usd" xsi:nil="true" />
    <us-gaap:LongTermNotesPayable contextRef="AsOf2021-03-31" unitRef="usd" decimals="0">514918</us-gaap:LongTermNotesPayable>
    <us-gaap:IncreaseDecreaseInOperatingLeaseLiability contextRef="From2021-01-01to2021-03-31" unitRef="usd" decimals="0">-64672</us-gaap:IncreaseDecreaseInOperatingLeaseLiability>
    <us-gaap:IncreaseDecreaseInOperatingLeaseLiability contextRef="From2020-01-01to2020-03-31" unitRef="usd" decimals="0">-52849</us-gaap:IncreaseDecreaseInOperatingLeaseLiability>
    <SRNA:IncreaseDecreaseInLeaseDeposit contextRef="From2021-01-01to2021-03-31" unitRef="usd" decimals="0">-8061</SRNA:IncreaseDecreaseInLeaseDeposit>
    <SRNA:IncreaseDecreaseInLeaseDeposit contextRef="From2020-01-01to2020-03-31" unitRef="usd" xsi:nil="true" />
    <us-gaap:DebtInstrumentMaturityDate contextRef="From2021-02-09to2021-02-10">2026-02-05</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:DebtInstrumentFaceAmount contextRef="AsOf2021-02-10" unitRef="usd" decimals="0">514200</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="AsOf2021-02-10" unitRef="Percentage" decimals="INF">0.01</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent contextRef="AsOf2021-03-31" unitRef="usd" decimals="0">40000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod contextRef="From2020-06-23to2020-06-24_custom_TwoThousandAndSeventeenEquityPlanMember_custom_NonQualifiedStockOptionsMember_custom_DirectorsMember" unitRef="shares" decimals="INF">2000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod>
    <us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock contextRef="From2021-01-01to2021-03-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;b&gt;Note 1 &amp;#8211; General&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;b&gt;&lt;i&gt;Description of Business&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;Surna Inc. (the &amp;#8220;Company&amp;#8221;)&#13;was incorporated in Nevada on October 15, 2009 and operates under a trade name of Surna Cultivation Technologies. We design, engineer&#13;and sell environmental control and other technologies for the Controlled Environment Agriculture (CEA) industry. The CEA industry is one&#13;of the fastest-growing sectors of the United States&amp;#8217; economy. From leafy greens (kale, Swiss chard, mustard, cress), microgreens&#13;(leafy greens harvested at the first true leaf stage), ethnic vegetables and small fruits (such as strawberries, blackberries and raspberries)&#13;to bell peppers, cucumbers, tomatoes, and cannabis, some producers grow crops indoors in response to market dynamics or as part of their&#13;preferred farming practice. In service of the CEA industry, our principal technologies include: (i) liquid-based process cooling systems&#13;and other climate control systems, (ii) air handling equipment and systems, (iii) a full-service engineering package for designing and&#13;engineering commercial scale thermodynamic systems specific to cultivation facilities, and (iv) automation and control devices, systems&#13;and technologies used for environmental, lighting and climate control. Our customers include commercial, state- and provincial-regulated&#13;CEA growers in the U.S. and Canada as well as other international locations. Customers are those growers building new facilities and those&#13;expanding or retrofitting existing facilities. Currently, our revenue stream is derived primarily from supplying our products, services&#13;and technologies to commercial indoor facilities ranging from several thousand to more than 100,000 square feet. Headquartered in Boulder,&#13;Colorado, we leverage our experience in this space to bring value-added climate control solutions to our customers that help improve their&#13;overall crop quality and yield, optimize energy and water efficiency, and satisfy the evolving state and local codes, permitting and regulatory&#13;requirements. Although our customers do, we neither produce nor sell cannabis or its related products.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;b&gt;&lt;i&gt;Impact of the COVID-19 Pandemic&#13;on Our Business&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;The impact&#13;of the government and the business economic response to the COVID-19 pandemic has affected demand across the majority of our markets and&#13;disrupted work on projects. The COVID-19 pandemic is expected to have continued adverse effects on our sales, project implementation,&#13;operating margins, and working capital. As of the date of this filing, uncertainty continues to exist concerning the magnitude and duration&#13;of the economic impact of the COVID-19 pandemic.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;In response&#13;to the COVID-19 pandemic and the government and business response, during 2020, the Company took measures to adjust its operations. These&#13;actions included initial measures to cut costs and preserve cash, and encompassed downsizing workforce, compensation reductions, and reduced&#13;hours worked that were later changed upwards and in some cases fully restored late in 2020, as the Company gained new contracts, bank&#13;funding was available and the overall business climate improved. The Company continues to actively monitor its operations and sales efforts&#13;in light of the continuing effects of the COVID-19 pandemic and will make adjustments to its operations as necessary.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;Due to&#13;the speed with which the COVID-19 pandemic developed and the resulting uncertainties, including the depth and duration of the disruptions&#13;to customers and suppliers, its future effect on our business, on our results of operations, and on our financial condition, we cannot&#13;predict the overall effect on our business over the longer term. Addressing this uncertainty, we have undertaken various plans to reduce&#13;costs so as to mitigate the impact of the COVID-19 pandemic to the best of our ability, although they may not be sufficient in the long-run&#13;for us to avoid reduced sales, increased losses and reduced operating cash flows.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;Refer&#13;to &lt;i&gt;Risk Factors&lt;/i&gt;, included in Part II, Item 1A of this Quarterly Report on Form 10-Q below, for further discussion of the possible&#13;impact of the COVID-19 pandemic on our business.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;b&gt;&lt;i&gt;Financial Statement Presentation&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;The accompanying unaudited condensed&#13;consolidated financial statements of the Company have been prepared in conformity with accounting principles generally accepted in the&#13;United States of America (&amp;#8220;GAAP&amp;#8221;) for interim financial information and with the instructions to Form 10-Q and Rule 10-01&#13;of Regulation S-X. Pursuant to these rules and regulations, certain information and note disclosures, normally included in financial statements&#13;prepared in accordance with GAAP, have been condensed or omitted. In the opinion of management, all adjustments (consisting of normal&#13;recurring items) considered necessary for a fair presentation have been included. Operating results for the three months ended March 31,&#13;2021 are not necessarily indicative of the results that may be expected for the fiscal year ending December 31, 2021. The balance sheet&#13;as of December 31, 2020 has been derived from the audited financial statements at that date but does not include all the information and&#13;footnotes required by GAAP for complete financial statements. For further information, refer to the consolidated financial statements&#13;and notes thereto contained in the Annual Report on Form 10-K for the year ended December 31, 2020. The notes to the unaudited condensed&#13;consolidated financial statements are presented on a going concern basis.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;b&gt;&lt;i&gt;Basis of Consolidation and&#13;Reclassifications&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;The condensed consolidated financial&#13;statements include the accounts of the Company and its controlled and wholly owned subsidiary, Hydro Innovations, LLC (&amp;#8220;Hydro&amp;#8221;).&#13;Intercompany transactions, profit, and balances are eliminated in consolidation.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 30.25pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;b&gt;&lt;i&gt;Going Concern&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;The accompanying&#13;condensed consolidated financial statements have been prepared assuming that the Company will continue as a going concern, which contemplates&#13;the realization of assets and the satisfaction of liabilities in the normal course of business. The Company has experienced recurring&#13;losses since its inception. Since inception, the Company has financed its activities principally through debt and equity financing, customer&#13;deposits and revenues from completed contracts. Management expects to incur additional losses and cash outflows in the foreseeable future&#13;in connection with its operating activities. Management believes that the economic dislocations in the overall economy, in the near term,&#13;will impact our revenues, losses and cash flows. There can be no assurance that the Company will be able to raise debt or equity financing&#13;in sufficient amounts, when and if needed, on acceptable terms or at all. If results of operations for 2021 do not meet management&amp;#8217;s&#13;expectations, or additional capital is not available, management believes it has the ability to reduce certain expenditures. The precise&#13;amount and timing of the funding needs cannot be determined accurately at this time, and will depend on a number of factors, including&#13;the overall economy, market demand for the Company&amp;#8217;s products and services, the quality of product development efforts, management&#13;of working capital, and continuation of normal payment terms and conditions for purchase of the Company&amp;#8217;s products. The Company&#13;believes its cash balances and cash flow from operations will be insufficient to fund its operations for the next 12 months. If the Company&#13;is unable to substantially increase revenues, reduce expenditures, or otherwise generate cash flows from operations, then the Company&#13;will need to raise additional funding to continue as a going concern. The foregoing factors raise substantial doubt about the Company&amp;#8217;s&#13;ability to continue as a going concern for a period of one year from the date the financial statements are issued. These condensed consolidated&#13;financial statements do not include any adjustment that might result from the outcome of this uncertainty.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;b&gt;&lt;i&gt;Use of Estimates&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;Management makes estimates and&#13;assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the&#13;date of the financial statements and that affect the reported amounts of revenue and expenses during the reporting period. The Company&#13;bases its estimates on historical experience and on various other assumptions that it believes to be reasonable under the circumstances,&#13;the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent&#13;from other sources. Actual results could differ from those estimates. Key estimates include: allocation of transaction prices to performance&#13;obligations under contracts with customers, standalone selling prices, timing of expected revenue recognition on remaining performance&#13;obligations under contracts with customers, valuation of intangible assets, valuation of equity-based compensation, valuation of deferred&#13;tax assets and liabilities, warranty accruals, accounts receivable and inventory allowances, and legal contingencies.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;b&gt;&lt;i&gt;Cash, Cash Equivalents and&#13;Restricted Cash&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;All highly liquid investments&#13;with original maturities of three months or less at the date of purchase are considered to be cash equivalents. The Company may, from&#13;time to time, have deposits in financial institutions that exceed the federally insured amount. The Company has not experienced any losses&#13;to date on depository accounts.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;During the three months ended&#13;March 31, 2021, the Company transferred a balance of $180,000 into a new bank account which was to be used for the sole purpose of paying&#13;certain warranty claims. The balance on this restricted bank account as of March 31, 2021 was $86,697.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;b&gt;&lt;i&gt;Income (Loss) Per Common&#13;Share&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;Basic income (loss) per common&#13;share is computed by dividing net income (loss) attributable to common stockholders by the weighted-average number of common shares outstanding&#13;during the period without consideration of common stock equivalents. Diluted net income (loss) per common share is computed by dividing&#13;net income (loss) by the weighted-average number of common shares outstanding and potentially dilutive common stock equivalents, including&#13;stock options, warrants and restricted stock units and other equity-based awards, except in cases where the effect of the common stock&#13;equivalents would be antidilutive. Potential common stock equivalents consist of common stock issuable upon exercise of stock options&#13;and warrants and the vesting of restricted stock units using the treasury method.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;During&#13;the three months ended March 31, 2021 and 2020, there were warrants and options outstanding to purchase Company common stock and restricted&#13;stock units that were convertible into shares of the Company&amp;#8217;s common stock. During the three-month periods ended March 31, 2021&#13;and 2020, the Company incurred a net loss and consequently the common share equivalents of these potentially dilutive equity instruments&#13;have not been included in the calculations of loss per share because such inclusion would have been anti-dilutive. As of March 31, 2021,&#13;and 2020, there were respectively, 30,249,300 and 45,748,400, potentially dilutive equity instruments outstanding in respect of warrants&#13;and options outstanding to purchase Company common stock and restricted stock units that were convertible into shares of the Company&amp;#8217;s&#13;common stock.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;b&gt;&lt;i&gt;Goodwill&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 30.25pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;The Company recorded goodwill&#13;in connection with its acquisition of Hydro Innovations, LLC in July 2014. Goodwill is reviewed for impairment annually or more frequently&#13;when events or changes in circumstances indicate that fair value of the reporting unit has been reduced to less than its carrying value.&#13;The Company performs a quantitative impairment test annually on December 31 by comparing the fair value of the reporting unit with its&#13;carrying amount, including goodwill. If the fair value of the reporting unit exceeds its carrying amount, goodwill is considered not impaired.&#13;An impairment charge would be recognized for the amount by which the carrying amount exceeds the reporting unit&amp;#8217;s fair value. The&#13;Company determined that it has one reporting unit.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;During the three months ended&#13;March 31, 2021, the Company concluded that the projected impact of the COVID-19 pandemic on its sales, contract completion and revenues&#13;in the near term, together with the volatility in its share price during the quarter represented potential indicators of impairment. Accordingly,&#13;the Company performed an interim impairment analysis at March 31, 2021, and concluded that no impairment relating to goodwill existed&#13;at March 31, 2021.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 30.25pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;b&gt;&lt;i&gt;Revenue Recognition&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;On January 1, 2018, the Company&#13;adopted Accounting Standards Update (&amp;#8220;ASU&amp;#8221;) 2014-09 (Topic 606), &lt;i&gt;Revenue from Contracts with Customers&lt;/i&gt; and all the&#13;related amendments (&amp;#8220;ASC 606&amp;#8221; or the &amp;#8220;revenue standard&amp;#8221;) to all contracts and elected the modified retrospective&#13;method.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;Under the revenue standard, a&#13;performance obligation is a promise in a contract with a customer to transfer a distinct good or service to the customer. Most of the&#13;Company&amp;#8217;s contracts contain multiple performance obligations that include engineering and technical services as well as the delivery&#13;of a diverse range of climate control system equipment and components, which can span multiple phases of a customer&amp;#8217;s project life-cycle&#13;from facility design and construction to equipment delivery and system installation and start-up.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;A contract&amp;#8217;s transaction&#13;price is allocated to each distinct performance obligation and recognized as revenue when, or as, the performance obligation is satisfied.&#13;When there are multiple performance obligations within a contract, the Company allocates the transaction price to each performance obligation&#13;based on standalone selling price. When estimating the selling price, the Company uses various observable inputs. The best observable&#13;input is the Company&amp;#8217;s actual selling price for the same good or service, however, this input is generally not available for the&#13;Company&amp;#8217;s contracts containing multiple performance obligations. For engineering services, the Company estimates the standalone&#13;selling price by reference to certain physical characteristics of the project, such as facility size and mechanical systems involved,&#13;which are indicative of the scope and complexity of the mechanical engineering services to be provided. For equipment sales, the standalone&#13;selling price is determined by forecasting the expected costs of the equipment and then adding an appropriate margin, based on a range&#13;of acceptable margins established by management. Depending on the nature of the performance obligations, the Company may use a combination&#13;of different methods and observable inputs if certain performance obligations have highly variable or uncertain standalone selling prices.&#13;Once the selling prices are determined, the Company applies the relative values to the total contract consideration and estimates the&#13;amount of the transaction price to be recognized as each performance obligation is fulfilled.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;The Company recognizes revenue&#13;for the sale of goods when control transfers to the customer, which primarily occurs at the time of shipment. The Company&amp;#8217;s historical&#13;rates of return are insignificant as a percentage of sales and, as a result, the Company does not record a reserve for returns at the&#13;time the Company recognizes revenue. The Company has elected to exclude from the measurement of the transaction price all taxes (e.g.,&#13;sales, use, value added, and certain excise taxes) that are assessed by a governmental authority in connection with a specific revenue-producing&#13;transaction and collected by the Company from the customer. Accordingly, the Company recognizes revenue net of sales taxes. The revenue&#13;and cost for freight and shipping is recorded when control over the sale of goods passes to the Company&amp;#8217;s customers.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;The Company also has performance&#13;obligations to perform certain engineering services that are satisfied over a period of time. Revenue is recognized from this type of&#13;performance obligation as services are rendered based on the percentage completion towards certain specified milestones.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;The Company offers assurance-type&#13;warranties for its products and products manufactured by others to meet specifications defined by the contracts with customers and does&#13;not have any material separate performance obligations related to these warranties. The Company maintains a warranty reserve based on&#13;historical warranty costs.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;Applying the practical expedient&#13;in ASC 606-10-32-18, which the Company has elected, the Company does not adjust the promised amount of consideration for the effects of&#13;a significant financing component since the Company expects, at contract inception, that the period between when the Company transfers&#13;a promised good or service to a customer and when the customer pays for that good or service will be one year or less. Accordingly, the&#13;remaining performance obligations related to customer contracts does not consider the effects of the time value of money.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;Applying the practical expedient&#13;in ASC 340-40-25-4, the Company recognizes the incremental costs of obtaining contracts as an expense when incurred since the amortization&#13;period of the assets that the Company otherwise would have recognized is one year or less. These costs include certain sales commissions&#13;and incentives, which are included in selling, general and administrative expenses, and are payable only when associated revenue has been&#13;collected and earned by the Company.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;The Company does not have material&#13;amounts of contract assets since revenue is recognized as control of goods is transferred or as services are performed. Contract liabilities&#13;consist of advance payments and deferred revenue.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;For the three months ended March&#13;31, 2021, the Company recognized revenue of $1,880,364 related to the deferred revenue at January 1, 2021. For the three months ended&#13;March 31, 2020, the Company recognized revenue of $859,705 related to the deferred revenue at January 1, 2020.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;Remaining performance obligations,&#13;or backlog, represents the aggregate amount of the transaction price allocated to the remaining obligations that the Company has not performed&#13;under its customer contracts. The Company has elected not to use the optional exemption in ASC 606-10-50-14, which exempts an entity from&#13;such disclosures if a performance obligation is part of a contract with an original expected duration of one year or less. Accordingly,&#13;the information disclosed about remaining performance obligations includes all customer contracts, including those with an expected duration&#13;of one year or less.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;Industry uncertainty, project&#13;financing concerns, and the licensing and qualification of our prospective customers, which are out of the Company&amp;#8217;s control, make&#13;it difficult for the Company to predict when it will recognize revenue on its remaining performance obligations. There are risks that&#13;the Company may not realize the full contract value on customer projects in a timely manner or at all, and completion of a customer&amp;#8217;s&#13;cultivation facility project is dependent upon the customer&amp;#8217;s ability to secure funding and real estate, obtain a license and then&#13;build their cultivation facility so they can take possession of the equipment. Accordingly, the time it takes for customers to complete&#13;a project, which corresponds to when the Company is able to recognize revenue, is driven by numerous factors including: (i) the large&#13;number of first-time participants interested in the indoor cannabis cultivation business; (ii) the complexities and uncertainties involved&#13;in obtaining state and local licensure and permitting; (iii) local and state government delays in approving licenses and permits due to&#13;lack of staff or the large number of pending applications, especially in states where there is no cap on the number of cultivators; (iv)&#13;the customer&amp;#8217;s need to obtain cultivation facility financing; (v) the time needed, and coordination required, for our customers&#13;to acquire real estate and properly design and build the facility (to the stage when climate control systems can be installed); (vi) the&#13;large price tag and technical complexities of the climate control and air sanitation system; (vii) the availability of power; and (viii)&#13;delays that are typical in completing any construction project.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;As of March 31, 2021, the Company&amp;#8217;s&#13;remaining performance obligations, or backlog, was $11,578,000, of which $2,006,000, or 17%, was attributable to customer contracts for&#13;which the Company has only received an initial advance payment to cover the allocated value of the Company&amp;#8217;s engineering services&#13;(&amp;#8220;engineering only paid contracts&amp;#8221;). There is the risk that the equipment portion of these engineering only paid contracts&#13;will not be completed or will be delayed. These reasons include the customer being dissatisfied with the quality or timeliness of the&#13;Company&amp;#8217;s engineering services, delay or abandonment of the project because of the customer&amp;#8217;s inability to obtain project&#13;financing or licensing, or other reasons such as a challenging business climate including an overall post-Covid-19 economic downturn,&#13;or change in business direction. After the customer has made an advance payment for a portion of the equipment to be delivered under the&#13;contract (&amp;#8220;partial equipment paid contracts&amp;#8221;), the Company is typically better able to estimate the timing of revenue recognition&#13;since the risks and delays associated with licensing, permitting and project funding are typically mitigated once the initial equipment&#13;payment is received. There is significant uncertainty regarding the timing of the Company&amp;#8217;s recognition of revenue on its remaining&#13;performance obligations, and there is no certainty that these will result in actual revenues. The backlog at March 31, 2021, includes&#13;booked sales orders of $449,000 from several customers that the Company does not expect to be realized until 2022, if at all. Given the&#13;present economic uncertainty arising from the impact of the novel coronavirus COVID-19, the Company believes that several of its current&#13;contracts may be delayed or cancelled in the short term.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;The remaining performance obligations&#13;expected to be recognized through 2022 are as follows:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;  &lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;2021&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;2022&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="width: 55%"&gt;&lt;font style="font-size: 10pt"&gt;Remaining performance obligations related to engineering only paid contracts&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 12%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1,563,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 12%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;443,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 12%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;2,006,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;Remaining performance obligations related to partial equipment paid contracts&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;9,566,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;6,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;9,572,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;font style="font-size: 10pt"&gt;Total remaining performance obligations&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;11,129,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;449,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;11,578,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;The following table sets forth&#13;the Company&amp;#8217;s revenue by source:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;  &lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;For the Three Months &lt;br /&gt;&#13;Ended March 31,&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;2021&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;2020&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="width: 54%"&gt;&lt;font style="font-size: 10pt"&gt;Equipment and systems sales&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 20%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;2,163,468&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 20%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1,606,946&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Engineering and other services&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;181,083&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;131,591&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;Shipping and handling&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;21,978&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;71,388&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;font style="font-size: 10pt"&gt;Total revenue&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;2,366,529&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1,809,925&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;b&gt;&lt;i&gt;Accounting for Share-Based&#13;Compensation&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 30.25pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;The Company recognizes the cost&#13;resulting from all share-based compensation arrangements, including stock options, restricted stock awards and restricted stock units&#13;that the Company grants under its equity incentive plan in its condensed consolidated financial statements based on their grant date fair&#13;value. The expense is recognized over the requisite service period or performance period of the award. Awards with a graded vesting period&#13;based on service are expensed on a straight-line basis for the entire award. Awards with performance-based vesting conditions, which require&#13;the achievement of a specific company financial performance goal at the end of the performance period and required service period, are&#13;recognized over the performance period. Each reporting period, the Company reassesses the probability of achieving the respective performance&#13;goal. If the goals are not expected to be met, no compensation cost is recognized and any previously recognized amount recorded is reversed.&#13;If the award contains market-based vesting conditions, the compensation cost is based on the grant date fair value and expected achievement&#13;of market condition and is not subsequently reversed if it is later determined that the condition is not likely to be met or is expected&#13;to be lower than initially expected.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;The grant&#13;date fair value of stock options is based on the Black-Scholes Option Pricing Model (the &amp;#8220;Black-Scholes Model&amp;#8221;). The Black-Scholes&#13;Model requires judgmental assumptions including volatility and expected term, both based on historical experience. The risk-free interest&#13;rate is based on U.S. Treasury interest rates whose term is consistent with the expected term of the option. The Company determines the&#13;assumptions used in the valuation of option awards as of the date of grant. Differences in the expected stock price volatility, expected&#13;term or risk-free interest rate may necessitate distinct valuation assumptions at those grant dates. As such, the Company may use different&#13;assumptions for options granted throughout the year. During the three months ended March 31, 2021, the valuation assumptions used to determine&#13;the fair value of each option award on the date of grant were: expected stock price volatility of 152.51%; expected term in years 10 and&#13;risk-free interest rate of 1.2%.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;The grant date fair value of restricted&#13;stock and restricted stock units is based on the closing price of the underlying stock on the date of the grant.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;The Company has elected to reduce&#13;share-based compensation expense for forfeitures as the forfeitures occur since the Company does not have historical data or other factors&#13;to appropriately estimate the expected employee terminations and to evaluate whether particular groups of employees have significantly&#13;different forfeiture expectations.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.8pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"&gt;The following is a summary of share-based compensation&#13;expenses included in the condensed consolidated statements of operations for the three months ended March 31, 2021 and 2020:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;  &lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;For the Three Months &lt;br /&gt;&#13;Ended March 31,&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;2021&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;2020&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Share-based compensation expense included in:&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="width: 54%"&gt;&lt;font style="font-size: 10pt"&gt;Cost of revenue&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 20%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;14,135&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 20%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;8,558&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Advertising and marketing expenses&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;6,474&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;2,912&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Product development costs&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;6,694&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;6,545&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;Selling, general and administrative expenses&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;31,833&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;172,874&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;font style="font-size: 10pt"&gt;Total share-based compensation expense included in consolidated statement of operations&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;59,136&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;190,889&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;Included in the $59,136 expense&#13;for the three months ended March 31, 2021, is an accrual for $52,794 in respect of the 2021 Annual Employee Incentive Compensation Plan.&#13;Included in the $190,889 expense for the three months ended March 31, 2020, is an accrual for $36,463 in respect of the 2020 Annual Employee&#13;Incentive Compensation Plan.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"&gt;&lt;b&gt;&lt;i&gt;Concentrations&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;Three customers accounted for&#13;38%, 16%, and 11% of the Company&amp;#8217;s revenue for the three months March 31, 2021. For the three months ended March 31, 2020, four&#13;customers accounted for 17%, 16%, 10% and 10% of the Company&amp;#8217;s revenue.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;Two customers accounted for 60%,&#13;and 31% of the Company&amp;#8217;s accounts receivable for the three months ended March 31, 2021. For the three months ended March 31, 2020,&#13;three customers accounted for 59%, 18%, and 15% of the Company&amp;#8217;s accounts receivable.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;b&gt;&lt;i&gt;Recently Issued Accounting&#13;Pronouncements&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;In August 2020, the FASB issued&#13;ASU No. 2020-06, &lt;i&gt;Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging&amp;#8212;Contracts in Entity&amp;#8217;s&#13;Own Equity (Subtopic 815-40)&lt;/i&gt; which simplifies the accounting for convertible instruments. The guidance removes certain accounting&#13;models which separate the embedded conversion features from the host contract for convertible instruments. Either a modified retrospective&#13;method of transition or a fully retrospective method of transition is permissible for the adoption of this standard. Update No. 2020-06&#13;is effective for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. Early adoption is&#13;permitted no earlier than the fiscal year beginning after December 15, 2020. The Company does not expect this ASU to have a material impact&#13;on its consolidated results of operations, cash flows and financial position.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;In March 2020, the FAS issued&#13;ASU No. 2020-04 &amp;#8220;&lt;i&gt;Reference Reform (Topic 848) Facilitation of the Effects of Reference Rate Reform on Financial Reporting&amp;#8221;&#13;(&amp;#8220;ASU 2020-04&amp;#8221;).&lt;/i&gt; ASU 2020-04 provides optional guidance for a limited period of time to ease the potential burden in accounting&#13;for (or recognizing the effects of) reference rate reform on financial reporting. The amendments are effective for the Company as of March&#13;12, 2020 through December 31, 2022. The Company does not expect this ASU to have a material impact on its consolidated results of operations,&#13;cash flows and financial position.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;In January 2020, the FASB issued&#13;ASU No. 2020-01, &lt;i&gt;Investments&amp;#8212;Equity Securities (Topic 321), Investments&amp;#8212;Equity Method and Joint Ventures (Topic 323), and&#13;Derivatives and Hedging (Topic 815)&amp;#8212;Clarifying the Interactions between Topic 321, Topic 323, and Topic 815&lt;/i&gt; (a consensus of&#13;the Emerging Issues Task Force). This update clarifies whether an entity should consider observable transactions that require it to either&#13;apply or discontinue the equity method of accounting for the purposes of applying the measurement alternative and how to account for certain&#13;forward contracts and purchased options to purchase securities. For public entities, this guidance is effective for fiscal years beginning&#13;after December 15, 2020. The Company does not expect this ASU to have a material impact on its consolidated results of operations, cash&#13;flows and financial position. The adoption of this ASU has not had a material impact on the Company&amp;#8217;s consolidated results of operations,&#13;cash flows and financial position.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;In December 2019, the FASB issued&#13;ASU 2019-12, &lt;i&gt;Income Taxes (Topic 740) &amp;#8211; Simplifying the Accounting for Income Taxes, &lt;/i&gt;which simplifies the accounting for&#13;income taxes by removing certain exceptions to the general principles in Topic 740. The amendments also improve consistent application&#13;of and simplify GAAP for other areas of Topic 740 by clarifying and amending existing guidance. ASU 2019-12 is effective for fiscal years&#13;beginning after December 15, 2020. Early adoption is permitted. The adoption of this ASU has not had a material impact on the Company&amp;#8217;s&#13;consolidated results of operations, cash flows and financial position.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;Other accounting standards that&#13;have been issued or proposed by FASB that do not require adoption until a future date are not expected to have a material impact on the&#13;financial statements upon adoption. The Company does not discuss recent pronouncements that are not anticipated to have an impact on&#13;or are unrelated to its financial condition, results of operations, cash flows or disclosures.&lt;/p&gt;</us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock>
    <us-gaap:LesseeOperatingLeasesTextBlock contextRef="From2021-01-01to2021-03-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;Note 2 &amp;#8211; Leases&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;In February 2016 the FASB issued&#13;ASU 2016-02, &lt;i&gt;Leases (Topic 842)&lt;/i&gt;(&amp;#8220;ASC 842&amp;#8221; or the &amp;#8220;new lease standard&amp;#8221;). The Company adopted ASC 842 as&#13;of January 1, 2019, using the effective date method.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;The new standard provides a number&#13;of optional practical expedients in transition. The Company has elected to apply the &amp;#8220;package of practical expedients&amp;#8221; which&#13;allow the Company to not reassess: (i) whether existing or expired arrangements contain a lease, (ii) the lease classification of existing&#13;or expired leases, or (iii) whether previous initial direct costs would qualify for capitalization under the new lease standard. The Company&#13;has also elected to apply the short-term lease exemption for all leases with an original term of less than 12 months, for purposes of&#13;applying the recognition and measurements requirements in the new lease standard.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;Upon adoption, the Company recognized&#13;its lease for manufacturing and office space (the &amp;#8220;Facility Lease&amp;#8221;) on the balance sheet as an operating lease right-of-use&#13;asset in the amount of $714,416 and as a lease liability of $822,374. The Facility Lease commenced September 29, 2017 and continues through&#13;August 31, 2022. The Company has the option to renew the Facility Lease for an additional five years. However, the renewal option to extend&#13;the Facility Lease is not included in the right-of-use asset or lease liability as the option is not reasonably certain of exercise. The&#13;Company regularly evaluates the renewal option and when it is reasonably certain of exercise, the Company will include the renewal period&#13;in its lease term.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;Beginning September 1, 2018, and&#13;each subsequent September 1 during the term, the monthly rent under the Facility Lease will increase by 3%. Total rent under the current&#13;building lease is charged to expense over the term of the lease on a straight-line basis, resulting in the same monthly rent expense throughout&#13;the lease. The difference between the rent expense amount and the actual rent paid is recorded to operating lease liability on the Company&amp;#8217;s&#13;condensed consolidated balance sheets.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;Under the Facility Lease, the&#13;landlord agreed to pay the Company or the Company&amp;#8217;s contractors for tenant improvements made by the Company not to exceed $100,000,&#13;which were used for normal tenant improvements. The Company determined that these improvements were not specialized and could be utilized&#13;by a subsequent tenant and, as such, the improvements were considered assets of the lessor. As of January 1, 2019, the unamortized amount&#13;of tenant improvement allowance of $81,481 was treated as a reduction in measuring the right-of-use asset.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;Under the Facility Lease, the&#13;Company pays the actual amounts for property taxes and insurance, excludes such payments from lease contract consideration, and records&#13;such payments as incurred. The Company also pays the landlord for common area maintenance, which is considered a nonlease component. For&#13;the Facility Lease, the Company has not elected the accounting policy to include both the lease and nonlease components as a single component&#13;and account for it as the lease.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;In determining the right-of-use&#13;asset and lease liability, the Company applied a discount rate to the minimum lease payments under the Facility Lease. ASC 842 requires&#13;the Company to use the rate of interest that the Company would have to pay to borrow on a collateralized basis over a similar term an&#13;amount equal to the lease payments in a similar economic environment. Since the discount rate is not implicit in the lease agreement,&#13;we utilized an estimated incremental borrowing rate provided by the Company&amp;#8217;s depository bank.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;The lease cost, cash flows and&#13;other information related to the Facility Lease were as follows:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;  &lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;For the Three Months Ended March 31,&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;2021&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="width: 77%"&gt;&lt;font style="font-size: 10pt"&gt;Operating lease cost&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 20%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;54,222&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Operating cash outflow from operating lease&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;69,844&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="width: 77%; padding-bottom: 1.5pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; width: 1%; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; width: 20%; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;As of March 31, 2021&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Operating lease right-of-use assset&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;294,900&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Operating lease liability, current&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;263,662&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Operating lease liability, long-term&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;106,891&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Remaining lease term&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1.4 years&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Discount rate&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;5.00&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&amp;#160;&amp;#160;&lt;/p&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;Future annual minimum lease payments&#13;on the Facility Lease as of March 31, 2021 were as follows:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;  &lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Years ended December 31,&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="width: 77%"&gt;&lt;font style="font-size: 10pt"&gt;2021 (excluding the three months ended March 31, 2021)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 20%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;212,020&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;2022&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;170,891&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Total minimum lease payments&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;382,911&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Less imputed interest&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(12,358&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-bottom: 2.5pt; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Present value of minimum lease payments&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;370,553&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;/table&gt;</us-gaap:LesseeOperatingLeasesTextBlock>
    <us-gaap:InventoryDisclosureTextBlock contextRef="From2021-01-01to2021-03-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;Note 3 &amp;#8211; Inventory&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;Inventory consisted of the following:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;  &lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;March 31,&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;December 31,&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;2021&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;2020&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="width: 54%"&gt;&lt;font style="font-size: 10pt"&gt;Finished goods&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 20%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;325,451&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 20%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;201,778&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Work in progress&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;10,083&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;4,231&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Raw materials&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;272,299&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;214,145&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;Allowance for excess &amp;#38; obsolete inventory&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(88,674&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(93,045&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;font style="font-size: 10pt"&gt;Inventory, net&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;519,159&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;327,109&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;Overhead expenses of $17,443 and&#13;$17,974 were included in the inventory balance as of March 31, 2021, and December 31, 2020, respectively.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;Advance payments on inventory&#13;purchases are recorded in prepaid expenses until title for such inventory passes to the Company. Prepaid expenses included $1,960,000&#13;and $916,000 in advance payments for inventory for the periods ended March 31, 2021, and December 31, 2020, respectively.&lt;/p&gt;</us-gaap:InventoryDisclosureTextBlock>
    <us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock contextRef="From2021-01-01to2021-03-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;Note 4 &amp;#8211; Property and Equipment&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;Property and equipment consisted&#13;of the following:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;  &lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;March 31,&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;December 31,&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;2021&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;2020&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="width: 54%; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Furniture and equipment&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 20%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;410,748&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 20%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;398,422&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Vehicles&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;15,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;15,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Leasehold improvements&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;215,193&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;215,193&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;640,941&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;628,615&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Accumulated depreciation&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(499,116&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(480,883&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-bottom: 2.5pt; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Property and equipment, net&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;141,825&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;147,732&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;Depreciation expense was $18,233&#13;for the three months ended March 31, 2021. For the three months ended March 31, 2021, $1,249 was allocated to cost of sales and $312&#13;was allocated to inventory with the remainder recorded as selling, general and administrative expense.&lt;/p&gt;</us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock contextRef="From2021-01-01to2021-03-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;Note 5 &amp;#8211; Accounts Payable and Accrued Liabilities&#13;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;Accounts payable and accrued liabilities&#13;consisted of the following:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;  &lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;March 31,&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;December 31,&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;2021&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;2020&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="width: 54%"&gt;&lt;font style="font-size: 10pt"&gt;Accounts payable&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 20%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;860,087&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 20%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;918,639&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Sales commissions payable&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;13,649&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;48,263&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Accrued payroll liabilities&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;275,024&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;288,071&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Product warranty accrual&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;264,956&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;173,365&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;Other accrued expenses&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;376,599&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;356,623&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-bottom: 2.5pt; padding-left: 10pt"&gt;&lt;font style="font-size: 10pt"&gt;Total&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1,790,315&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1,784,961&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;/table&gt;</us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock>
    <us-gaap:DebtDisclosureTextBlock contextRef="From2021-01-01to2021-03-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;b&gt;Note 6 &amp;#8211; Note Payable and Accrued Interest&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;On February 10, 2021, the Company&#13;entered into a note payable with its current bank in the principal amount of $514,200, for working capital purposes.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;The loan amount bears interest&#13;at 1% and is due on February 5, 2026. The loan may be repaid in advance without penalty. The loan is also potentially forgivable in full&#13;provided proceeds are used for payment of payroll expenses, rent, utilities and mortgage interest and certain other terms and conditions&#13;are met. The loan has typical default provisions, including for change of ownership, general lender insecurity as to repayment, non-payment&#13;of amounts due, defaults on other debt instruments, insolvency, dissolution or termination of the business as a going concern and bankruptcy.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&amp;#160;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;During the three ended March&#13;31, 2021, interest of $718 was accrued in respect of this note payable.&lt;/p&gt;</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="From2021-01-01to2021-03-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;Note 7 &amp;#8211; Commitments and Contingencies&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;b&gt;&lt;i&gt;Litigation&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;As of December 31, 2019, there&#13;were 6,750,000 restricted stock units that had not been settled due to a dispute with a former employee over the required withholding&#13;taxes to be paid to the Company for remittance to the appropriate tax authorities. The Company commenced an arbitration action against&#13;the former employee regarding the dispute. The former employee also made claims in the arbitration action against the Company for unpaid&#13;wages. As stated in a pleading in the arbitration, on March 9, 2020, the Company issued the former employee 6,750,000 shares of the Company&amp;#8217;s&#13;common stock in settlement of these restricted stock units after taking measures to mitigate the Company&amp;#8217;s exposure to penalties&#13;and liability for the failure to properly withhold income taxes. The Arbitrator issued an interim award of approximately $10,000 in the&#13;Company&amp;#8217;s favor and a finding against the former employee. Effective June 9, 2020, the Arbitrator issued his final award in the&#13;Company&amp;#8217;s favor in the Colorado arbitration. The Arbitrator found against the former employee and awarded the Company costs of $33,985,&#13;with interest at 8% per year. Effective July 22, 2020, the Colorado Court confirmed the Arbitration award and entered a final judgement&#13;in favor of the Company and against the former employee. The Company pursued collection of this debt and has now collected the debt owed.&#13;This former employee continued to pursue separate litigation against the Company for recovery of alleged consulting fees owed to him for&#13;the 2015 calendar year prior to his appointment as an executive officer of the Company. Effective March 30, 2021, this separate litigation&#13;has now been settled. While the Company disputed the merits of the claims, the Company has agreed and will be obliged to pay $40,000 over&#13;eight months and to issue upon execution of the settlement agreement an aggregate of 1,000,000 shares of common stock of the Company.&#13;As further discussed in &lt;i&gt;Note 11 Subsequent Events&lt;/i&gt; below, these shares were issued on April 8, 2021 as &amp;#8220;restricted securities,&amp;#8221;&#13;subject to a lock-up agreement of six months, without registration rights, and pursuant to a private placement exemption. The settlement&#13;agreement also included mutual releases and no admission of liability. The cost to the Company of this settlement, $107,000, has been&#13;recognized in full in other expenses during the three months ended March 31, 2021. As of March 31, 2021, $40,000 in respect of the cash&#13;portion of the settlement has been included in accounts payables and accruals and $67,000 in respect of the stock issuance has included&#13;in common stock to be issued.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;From time to time, in the normal&#13;course of its operations, the Company is subject to litigation matters and claims. Litigation can be expensive and disruptive to normal&#13;business operations. Moreover, the results of complex legal proceedings are difficult to predict, and the Company&amp;#8217;s view of these&#13;matters may change in the future as the litigation and events related thereto unfold. The Company expenses legal fees as incurred. The&#13;Company records a liability for contingent losses when it is both probable that a liability has been incurred and the amount of the loss&#13;is known. An unfavorable outcome to any legal matter, if material, could have an adverse effect on the Company&amp;#8217;s operations or its&#13;financial position, liquidity or results of operations.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;b&gt;&lt;i&gt;Leases&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;The Company has a lease agreement&#13;for its manufacturing and office space. Refer to &lt;i&gt;Note 2 Leases&lt;/i&gt; above.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;b&gt;&lt;i&gt;Other Commitments&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 30.25pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;In the ordinary course of business,&#13;the Company enters into commitments to purchase inventory and may also provide indemnifications of varying scope and terms to customers,&#13;vendors, lessors, business partners, and other parties with respect to certain matters, including, but not limited to, losses arising&#13;out of the Company&amp;#8217;s breach of such agreements, services to be provided by the Company, or from intellectual property infringement&#13;claims made by third parties. In addition, the Company has entered into indemnification agreements with its directors and certain of&#13;its officers and employees that will require the Company to, among other things, indemnify them against certain liabilities that may&#13;arise by reason of their status or service as directors, officers, or employees. The Company maintains director and officer insurance,&#13;which may cover certain liabilities arising from its obligation to indemnify its directors and certain of its officers and employees,&#13;and former officers, directors, and employees of acquired companies, in certain circumstances.&amp;#160;&lt;/p&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock contextRef="From2021-01-01to2021-03-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;Note 8 &amp;#8211; Equity Incentive Plan &lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&amp;#160;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;2017 Equity Incentive Plan&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;Under&#13;the Company&amp;#8217;s 2017 Equity Incentive Plan, as may be modified and amended by the Company from time to time (the &amp;#8220;2017 Equity&#13;Plan&amp;#8221;), the Board of Directors (the &amp;#8220;Board&amp;#8221;) (or the compensation committee of the Board, if one is established) may&#13;award stock options, stock appreciation rights (&amp;#8220;SARs&amp;#8221;), restricted stock awards (&amp;#8220;RSAs&amp;#8221;), restricted stock unit&#13;awards (&amp;#8220;RSUs&amp;#8221;), shares granted as a bonus or in lieu of another award, and other stock-based performance awards. The 2017&#13;Equity Plan allocates 50,000,000 shares of the Company&amp;#8217;s common stock (&amp;#8220;Plan Shares&amp;#8221;) for issuance of equity awards&#13;under the 2017 Equity Plan. If any shares subject to an award are forfeited, expire, or otherwise terminate without issuance of such shares,&#13;the shares will, to the extent of such forfeiture, expiration, or termination, again be available for awards under the 2017 Equity Plan.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;During&#13;the three months ended March 31, 2021, the Company issued no shares of its common stock under the 2017 Equity Plan.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;As of&#13;March 31, 2021, awards related to 22,686,800 shares remain outstanding.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;There&#13;was no unrecognized compensation expense for unvested non-qualified stock options and RSUs at March 31, 2021.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;2021 Equity Incentive Plan&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&amp;#160;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="background-color: white"&gt;On&#13;March 22, 2021, the Board approved the 2021 Equity Incentive Plan (the &amp;#8220;2021 Plan&amp;#8221;), which permits the Board to grant awards&#13;of up to 100,000,000 shares of common stock, subject to and effective upon stockholder approval. The 2021 Plan provides for the grant&#13;of incentive stock options intended to qualify under Section 422 of the Internal Revenue Code of 1986, as amended (the &amp;#8220;Code&amp;#8221;),&#13;non-qualified stock options, stock appreciation rights (&amp;#8220;SARs&amp;#8221;), restricted stock awards and restricted stock unit awards&#13;and other equity linked awards.to our employees, consultants and directors. If an equity award (i) expires or otherwise terminates without&#13;having been exercised in full or (ii) is settled in cash (&lt;i&gt;i.e.&lt;/i&gt;, the holder of the award receives cash rather than stock), such&#13;expiration, termination or settlement will not reduce (or otherwise offset) the number of shares of common stock that may be issued pursuant&#13;to this Plan.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="background-color: white"&gt;Approval&#13;of the 2021 Plan will be considered by stockholders at the Annual General Meeting of Stockholders to be held on May 28, 2021. If the 2021&#13;Plan is not approved, it may be continued as an equity plan by the Board, but it will not be able to provide for tax qualified incentive&#13;options or satisfy exchange requirements. If not approved by the stockholders, the current intention of the Board is to continue the 2021&#13;Plan and issue awards as appropriate thereunder.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;u&gt;Non-Qualified Stock Options&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;A summary&#13;of the non-qualified stock options granted to employees and consultants under the 2017 Equity Plan during the three months ended March&#13;31, 2021, are presented in the table below:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;  &lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Number of Options&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Weighted Average Exercise Price&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Weighted Average Remaining Contractual Term&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Aggregate Intrinsic Value&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="width: 44%"&gt;&lt;font style="font-size: 10pt"&gt;Outstanding, December 31, 2020&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 11%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;14,251,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 11%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0.083&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 11%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;8.3&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 11%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-left: 10pt"&gt;&lt;font style="font-size: 10pt"&gt;Granted&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1,035,800&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0.130&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;10.0&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-left: 10pt"&gt;&lt;font style="font-size: 10pt"&gt;Exercised&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-left: 10pt"&gt;&lt;font style="font-size: 10pt"&gt;Forfeited&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; padding-left: 10pt"&gt;&lt;font style="font-size: 10pt"&gt;Expired&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;font style="font-size: 10pt"&gt;Outstanding, March 31, 2021&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;15,286,800&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0.084&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;8.2&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;font style="font-size: 10pt"&gt;Exercisable, March 31, 2021&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;15,286,800&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0.084&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;8.2&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;A summary of non-vested non-qualified&#13;stock options activity for employees and consultants under the 2017 Equity Plan for the three months ended March 31, 2021, are presented&#13;in the table below:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;  &lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Number of Options&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Weighted Average Grant-Date Fair Value&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Aggregate Intrinsic Value&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Grant-Date Fair Value&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Nonvested, December 31, 2020&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="width: 44%; padding-left: 10pt"&gt;&lt;font style="font-size: 10pt"&gt;Granted&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 11%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1,035,800&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 11%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0.124&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 11%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 11%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;128,543&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-left: 10pt"&gt;&lt;font style="font-size: 10pt"&gt;Vested&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(1,035,800&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0.124&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;128,543&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-left: 10pt"&gt;&lt;font style="font-size: 10pt"&gt;Forfeited&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; padding-left: 10pt"&gt;&lt;font style="font-size: 10pt"&gt;Expired&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;font style="font-size: 10pt"&gt;Nonvested, March 31, 2021&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;For the three months ended March&#13;31, 2021 and March 31, 2020, the Company recorded $0 and $106,288 as compensation expense related to vested options issued to employees&#13;and consultants, net of forfeitures, respectively.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;A summary of the non-qualified&#13;stock options granted to directors under the 2017 Equity Plan during the three months ended March 31, 2021, are presented in the table&#13;below:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;  &lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Number of Options&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Weighted Average Exercise Price&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Weighted Average Remaining Contractual Term&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Aggregate Intrinsic Value ($000)&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="width: 44%"&gt;&lt;font style="font-size: 10pt"&gt;Outstanding, December 31, 2020&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 11%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;7,400,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 11%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0.067&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 11%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;7.5&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 11%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;2,780&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-left: 10pt"&gt;&lt;font style="font-size: 10pt"&gt;Granted&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-left: 10pt"&gt;&lt;font style="font-size: 10pt"&gt;Exercised&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-left: 10pt"&gt;&lt;font style="font-size: 10pt"&gt;Forfeited/Cancelled&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; padding-left: 10pt"&gt;&lt;font style="font-size: 10pt"&gt;Expired&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;font style="font-size: 10pt"&gt;Outstanding, March 31, 2021&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;7,400,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0.067&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;7.2&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;2,780&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;font style="font-size: 10pt"&gt;Exerciseable, March 31, 2021&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;6,400,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0.073&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;7.7&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;A summary of non-vested non-qualified&#13;stock options activity for directors under the 2017 Equity Plan for the three months ended March 31, 2021, are presented in the table&#13;below:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;  &lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Number of Options&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Weighted Average Grant-Date Fair Value&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Aggregate Intrinsic Value&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Grant-Date Fair Value&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="width: 44%"&gt;&lt;font style="font-size: 10pt"&gt;Nonvested, December 31, 2020&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 11%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1,000,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 11%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0.029&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 11%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;29,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 11%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;38,200&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-left: 10pt"&gt;&lt;font style="font-size: 10pt"&gt;Granted&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-left: 10pt"&gt;&lt;font style="font-size: 10pt"&gt;Vested&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-left: 10pt"&gt;&lt;font style="font-size: 10pt"&gt;Forfeited&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; padding-left: 10pt"&gt;&lt;font style="font-size: 10pt"&gt;Expired&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;font style="font-size: 10pt"&gt;Nonvested, March 31, 2021&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1,000,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0.029&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;29,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;38,200&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;During the three months ended&#13;March 31, 2021 and 2020, the Company incurred $6,342 and $29,266, respectively, as compensation expense related to 500,000 and 500,000&#13;vested options, respectively, issued to directors.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;Effective June 24, 2020&lt;i&gt;, &lt;/i&gt;the&#13;Company issued 2 million non-qualified stock options under the 2017 Equity Plan to newly appointed directors. The options vested 50% upon&#13;grant and 50% on April 1, 2021, if the Director remained on the Board up to that time. The options have a term of 5 years and have an&#13;exercise price equal to the closing price of the Company&amp;#8217;s common stock on The OTC Markets on the day immediately preceding the&#13;grant date.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;As further discussed in &lt;i&gt;Note&#13;11 Subsequent Events&lt;/i&gt; below, 1,000,000 stock options issued to directors effective June 24, 2020 vested on April 1, 2021.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;u&gt;Restricted Stock Units&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 40.5pt; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;A summary of the RSUs awarded&#13;to employees, directors and consultants under the 2017 Equity Plan during the three months ended March 31, 2021, are presented in the&#13;table below:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;  &lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Number of Units&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid"&gt;&#13;    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;Weighted Average Grant-Date&lt;/b&gt;&lt;/p&gt;&#13;    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;Fair Value&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid"&gt;&#13;    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;Aggregate Intrinsic&lt;/b&gt;&lt;/p&gt;&#13;    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;Value&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="width: 61%"&gt;&lt;font style="font-size: 10pt"&gt;Outstanding, December 31, 2020&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 10%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 10%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 10%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-left: 10pt"&gt;&lt;font style="font-size: 10pt"&gt;Granted&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-left: 10pt"&gt;&lt;font style="font-size: 10pt"&gt;Vested and settled with share issuance&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; padding-left: 10pt"&gt;&lt;font style="font-size: 10pt"&gt;Forfeited/canceled&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;font style="font-size: 10pt"&gt;Outstanding, March 31, 2021&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;For the three months ended March&#13;31, 2021 and 2020, the Company recorded $0 and $18,872, respectively, as compensation expense related to vested RSUs issued to employees,&#13;directors and consultants.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;Effective April 30, 2020, 800,000&#13;RSUs vested. However, the holder elected to cancel the RSUs.&lt;/p&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <SRNA:WarrantsDisclosureTextBlock contextRef="From2021-01-01to2021-03-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;b&gt;Note 9 &amp;#8211; Warrants&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;The following table summarizes&#13;information with respect to outstanding warrants to purchase common stock during the three months ended March 31, 2021:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;  &lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Weighted&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Weighted&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Average&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Number&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2"&gt;&#13;    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;Average&lt;/b&gt;&lt;/p&gt;&#13;    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;Exercise&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Remaining Life&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2"&gt;&#13;    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;Aggregate&lt;/b&gt;&lt;/p&gt;&#13;    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;Intrincic&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Outstanding&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Price&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;In Months&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Value&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="width: 44%"&gt;&lt;font style="font-size: 10pt"&gt;Outstanding at December 31, 2020&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 11%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;7,562,500&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 11%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0.25&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 11%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;6&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 11%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;0&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Issued&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Exercised&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;Expired&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0.00&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;font style="font-size: 10pt"&gt;Outstanding at March 31, 2021&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;7,562,500&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0.25&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;6&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&amp;#160;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The following table summarizes information about warrants&#13;outstanding at March 31, 2021:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;  &lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;Weighted Average &lt;br /&gt;&#13;Life of&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;Warrants&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;Outstanding Warrants&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&lt;font style="font-size: 10pt"&gt;Exercise price&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;Outstanding&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;In Months&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="width: 38%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 28%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 28%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0.25&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;7,562,500&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;3&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;/table&gt;</SRNA:WarrantsDisclosureTextBlock>
    <us-gaap:IncomeTaxDisclosureTextBlock contextRef="From2021-01-01to2021-03-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;Note 10 &amp;#8211; Income Taxes &lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;As of March 31, 2021, the Company&#13;has U.S. federal and state net operating losses (&amp;#8220;NOLs&amp;#8221;) of approximately $20,115,000, of which $11,196,261 will expire, if&#13;not utilized, in the years 2034 through 2037, however, NOLs generated subsequent to December 31, 2017 do not expire but may only be used&#13;against taxable income to 80%. In response to the novel coronavirus COVID-19, the Coronavirus Aid, Relief, and Economic Security Act temporarily&#13;repealed the 80% limitation for NOLs arising in 2018, 2019 and 2020. Pursuant to Section 382 of the Internal Revenue Code of 1986, as&#13;amended, use of the Company&amp;#8217;s NOLs carryforwards may be limited in the event of cumulative changes in ownership of more than 50%&#13;within a three-year period.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;The Company must assess the likelihood&#13;that its net deferred tax assets will be recovered from future taxable income, and to the extent the Company believes that recovery is&#13;not likely, the Company establishes a valuation allowance. Management&amp;#8217;s judgment is required in determining the Company&amp;#8217;s&#13;provision for income taxes, deferred tax assets and liabilities, and any valuation allowance recorded against the net deferred tax assets.&#13;The Company recorded a full valuation allowance as of March 31, 2021 and December 31, 2020. Based on the available evidence, the Company&#13;believes it is more likely than not that it will not be able to utilize its net deferred tax assets in the foreseeable future. The Company&#13;intends to maintain valuation allowances until sufficient evidence exists to support the reversal of such valuation allowances. The Company&#13;makes estimates and judgments about its future taxable income that are based on assumptions that are consistent with the Company&amp;#8217;s&#13;plans. Should the actual amounts differ from the Company&amp;#8217;s estimates, the carrying value of the Company&amp;#8217;s deferred tax assets&#13;could be materially impacted.&lt;/p&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:SubsequentEventsTextBlock contextRef="From2021-01-01to2021-03-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;Note 11 &amp;#8211; Subsequent Events &lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&amp;#160;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;In accordance with ASC 855, &lt;i&gt;Subsequent&#13;Events&lt;/i&gt;, the Company has evaluated all subsequent events through the date the financial statements were available to be issued. No&#13;material subsequent events occurred after March 31, 2021, other than as set out below:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;As further discussed in &lt;i&gt;Note&#13;8 Equity Incentive Plan &lt;/i&gt;below, 1,000,000 stock options issued to directors effective June 24, 2020 vested on April 1, 2021.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;As further discussed in &lt;i&gt;Note&#13;7 Commitments and Contingencies&lt;/i&gt; above, on April 8, 2021, the Company issued 1,000,000 shares of its common stock in settlement of&#13;litigation brought by a former employee.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;On April 30, 2021, the Company&#13;entered into an agreement to sublease approximately 6,900 square feet of its office and manufacturing space. The sublease commenced on&#13;April 30, 2021 and will continue on a month-to-month basis until either party gives 30-days&amp;#8217; notice. Rent will initially be charged&#13;at $5,989 per month, increasing to $11,978 per month effective July 1, 2021. The Sublessor will also be responsible for its prorated&#13;share of utilities and other related costs.&lt;/p&gt;</us-gaap:SubsequentEventsTextBlock>
    <SRNA:DescriptionOfBusinessPolicyTextBlock contextRef="From2021-01-01to2021-03-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;b&gt;&lt;i&gt;Description of Business&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;Surna Inc. (the &amp;#8220;Company&amp;#8221;)&#13;was incorporated in Nevada on October 15, 2009 and operates under a trade name of Surna Cultivation Technologies. We design, engineer&#13;and sell environmental control and other technologies for the Controlled Environment Agriculture (CEA) industry. The CEA industry is one&#13;of the fastest-growing sectors of the United States&amp;#8217; economy. From leafy greens (kale, Swiss chard, mustard, cress), microgreens&#13;(leafy greens harvested at the first true leaf stage), ethnic vegetables and small fruits (such as strawberries, blackberries and raspberries)&#13;to bell peppers, cucumbers, tomatoes, and cannabis, some producers grow crops indoors in response to market dynamics or as part of their&#13;preferred farming practice. In service of the CEA industry, our principal technologies include: (i) liquid-based process cooling systems&#13;and other climate control systems, (ii) air handling equipment and systems, (iii) a full-service engineering package for designing and&#13;engineering commercial scale thermodynamic systems specific to cultivation facilities, and (iv) automation and control devices, systems&#13;and technologies used for environmental, lighting and climate control. Our customers include commercial, state- and provincial-regulated&#13;CEA growers in the U.S. and Canada as well as other international locations. Customers are those growers building new facilities and those&#13;expanding or retrofitting existing facilities. Currently, our revenue stream is derived primarily from supplying our products, services&#13;and technologies to commercial indoor facilities ranging from several thousand to more than 100,000 square feet. Headquartered in Boulder,&#13;Colorado, we leverage our experience in this space to bring value-added climate control solutions to our customers that help improve their&#13;overall crop quality and yield, optimize energy and water efficiency, and satisfy the evolving state and local codes, permitting and regulatory&#13;requirements. Although our customers do, we neither produce nor sell cannabis or its related products.&lt;/p&gt;</SRNA:DescriptionOfBusinessPolicyTextBlock>
    <SRNA:ImpactOfCovid19PandemicOnOurBusinessPolicyTextBlock contextRef="From2021-01-01to2021-03-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;b&gt;&lt;i&gt;Impact of the COVID-19 Pandemic&#13;on Our Business&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;The impact&#13;of the government and the business economic response to the COVID-19 pandemic has affected demand across the majority of our markets and&#13;disrupted work on projects. The COVID-19 pandemic is expected to have continued adverse effects on our sales, project implementation,&#13;operating margins, and working capital. As of the date of this filing, uncertainty continues to exist concerning the magnitude and duration&#13;of the economic impact of the COVID-19 pandemic.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;In response&#13;to the COVID-19 pandemic and the government and business response, during 2020, the Company took measures to adjust its operations. These&#13;actions included initial measures to cut costs and preserve cash, and encompassed downsizing workforce, compensation reductions, and reduced&#13;hours worked that were later changed upwards and in some cases fully restored late in 2020, as the Company gained new contracts, bank&#13;funding was available and the overall business climate improved. The Company continues to actively monitor its operations and sales efforts&#13;in light of the continuing effects of the COVID-19 pandemic and will make adjustments to its operations as necessary.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;Due to&#13;the speed with which the COVID-19 pandemic developed and the resulting uncertainties, including the depth and duration of the disruptions&#13;to customers and suppliers, its future effect on our business, on our results of operations, and on our financial condition, we cannot&#13;predict the overall effect on our business over the longer term. Addressing this uncertainty, we have undertaken various plans to reduce&#13;costs so as to mitigate the impact of the COVID-19 pandemic to the best of our ability, although they may not be sufficient in the long-run&#13;for us to avoid reduced sales, increased losses and reduced operating cash flows.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;Refer&#13;to &lt;i&gt;Risk Factors&lt;/i&gt;, included in Part II, Item 1A of this Quarterly Report on Form 10-Q below, for further discussion of the possible&#13;impact of the COVID-19 pandemic on our business.&lt;/p&gt;</SRNA:ImpactOfCovid19PandemicOnOurBusinessPolicyTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock contextRef="From2021-01-01to2021-03-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;b&gt;&lt;i&gt;Financial Statement Presentation&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;The accompanying unaudited condensed&#13;consolidated financial statements of the Company have been prepared in conformity with accounting principles generally accepted in the&#13;United States of America (&amp;#8220;GAAP&amp;#8221;) for interim financial information and with the instructions to Form 10-Q and Rule 10-01&#13;of Regulation S-X. Pursuant to these rules and regulations, certain information and note disclosures, normally included in financial&#13;statements prepared in accordance with GAAP, have been condensed or omitted. In the opinion of management, all adjustments (consisting&#13;of normal recurring items) considered necessary for a fair presentation have been included. Operating results for the three months ended&#13;March 31, 2021 are not necessarily indicative of the results that may be expected for the fiscal year ending December 31, 2021. The balance&#13;sheet as of December 31, 2020 has been derived from the audited financial statements at that date but does not include all the information&#13;and footnotes required by GAAP for complete financial statements. For further information, refer to the consolidated financial statements&#13;and notes thereto contained in the Annual Report on Form 10-K for the year ended December 31, 2020. The notes to the unaudited condensed&#13;consolidated financial statements are presented on a going concern basis.&lt;/p&gt;</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <SRNA:GoingConcernPolicyTextBlock contextRef="From2021-01-01to2021-03-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;b&gt;&lt;i&gt;Going Concern&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;The&#13;accompanying condensed consolidated financial statements have been prepared assuming that the Company will continue as a going concern,&#13;which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. The Company has experienced&#13;recurring losses since its inception. Since inception, the Company has financed its activities principally through debt and equity financing,&#13;customer deposits and revenues from completed contracts. Management expects to incur additional losses and cash outflows in the foreseeable&#13;future in connection with its operating activities. Management believes that the economic dislocations in the overall economy, in the&#13;near term, will impact our revenues, losses and cash flows. There can be no assurance that the Company will be able to raise debt or&#13;equity financing in sufficient amounts, when and if needed, on acceptable terms or at all. If results of operations for 2021 do not meet&#13;management&amp;#8217;s expectations, or additional capital is not available, management believes it has the ability to reduce certain expenditures.&#13;The precise amount and timing of the funding needs cannot be determined accurately at this time, and will depend on a number of factors,&#13;including the overall economy, market demand for the Company&amp;#8217;s products and services, the quality of product development efforts,&#13;management of working capital, and continuation of normal payment terms and conditions for purchase of the Company&amp;#8217;s products.&#13;The Company believes its cash balances and cash flow from operations will be insufficient to fund its operations for the next 12 months.&#13;If the Company is unable to substantially increase revenues, reduce expenditures, or otherwise generate cash flows from operations, then&#13;the Company will need to raise additional funding to continue as a going concern. The foregoing factors raise substantial doubt about&#13;the Company&amp;#8217;s ability to continue as a going concern for a period of one year from the date the financial statements are issued.&#13;These condensed consolidated financial statements do not include any adjustment that might result from the outcome of this uncertainty.&lt;/p&gt;</SRNA:GoingConcernPolicyTextBlock>
    <us-gaap:UseOfEstimates contextRef="From2021-01-01to2021-03-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;b&gt;&lt;i&gt;Use of Estimates&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;Management makes estimates and&#13;assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the&#13;date of the financial statements and that affect the reported amounts of revenue and expenses during the reporting period. The Company&#13;bases its estimates on historical experience and on various other assumptions that it believes to be reasonable under the circumstances,&#13;the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent&#13;from other sources. Actual results could differ from those estimates. Key estimates include: allocation of transaction prices to performance&#13;obligations under contracts with customers, standalone selling prices, timing of expected revenue recognition on remaining performance&#13;obligations under contracts with customers, valuation of intangible assets, valuation of equity-based compensation, valuation of deferred&#13;tax assets and liabilities, warranty accruals, accounts receivable and inventory allowances, and legal contingencies.&lt;/p&gt;</us-gaap:UseOfEstimates>
    <us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy contextRef="From2021-01-01to2021-03-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;b&gt;&lt;i&gt;Cash, Cash Equivalents and&#13;Restricted Cash&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;All highly liquid investments&#13;with original maturities of three months or less at the date of purchase are considered to be cash equivalents. The Company may, from&#13;time to time, have deposits in financial institutions that exceed the federally insured amount. The Company has not experienced any losses&#13;to date on depository accounts.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;During the three months ended&#13;March 31, 2021, the Company transferred a balance of $180,000 into a new bank account which was to be used for the sole purpose of paying&#13;certain warranty claims. The balance on this restricted bank account as of March 31, 2021 was $86,697.&amp;#160;&lt;/p&gt;</us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy>
    <us-gaap:EarningsPerSharePolicyTextBlock contextRef="From2021-01-01to2021-03-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;b&gt;&lt;i&gt;Income (Loss) Per Common&#13;Share&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;Basic income (loss) per common&#13;share is computed by dividing net income (loss) attributable to common stockholders by the weighted-average number of common shares outstanding&#13;during the period without consideration of common stock equivalents. Diluted net income (loss) per common share is computed by dividing&#13;net income (loss) by the weighted-average number of common shares outstanding and potentially dilutive common stock equivalents, including&#13;stock options, warrants and restricted stock units and other equity-based awards, except in cases where the effect of the common stock&#13;equivalents would be antidilutive. Potential common stock equivalents consist of common stock issuable upon exercise of stock options&#13;and warrants and the vesting of restricted stock units using the treasury method.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;During&#13;the three months ended March 31, 2021 and 2020, there were warrants and options outstanding to purchase Company common stock and restricted&#13;stock units that were convertible into shares of the Company&amp;#8217;s common stock. During the three-month periods ended March 31, 2021&#13;and 2020, the Company incurred a net loss and consequently the common share equivalents of these potentially dilutive equity instruments&#13;have not been included in the calculations of loss per share because such inclusion would have been anti-dilutive. As of March 31, 2021,&#13;and 2020, there were respectively, 30,249,300 and 45,748,400, potentially dilutive equity instruments outstanding in respect of warrants&#13;and options outstanding to purchase Company common stock and restricted stock units that were convertible into shares of the Company&amp;#8217;s&#13;common stock.&lt;/p&gt;</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock contextRef="From2021-01-01to2021-03-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;b&gt;&lt;i&gt;Goodwill&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 30.25pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;The Company recorded goodwill&#13;in connection with its acquisition of Hydro Innovations, LLC in July 2014. Goodwill is reviewed for impairment annually or more frequently&#13;when events or changes in circumstances indicate that fair value of the reporting unit has been reduced to less than its carrying value.&#13;The Company performs a quantitative impairment test annually on December 31 by comparing the fair value of the reporting unit with its&#13;carrying amount, including goodwill. If the fair value of the reporting unit exceeds its carrying amount, goodwill is considered not impaired.&#13;An impairment charge would be recognized for the amount by which the carrying amount exceeds the reporting unit&amp;#8217;s fair value. The&#13;Company determined that it has one reporting unit.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;During the three months ended&#13;March 31, 2021, the Company concluded that the projected impact of the COVID-19 pandemic on its sales, contract completion and revenues&#13;in the near term, together with the volatility in its share price during the quarter represented potential indicators of impairment.&#13;Accordingly, the Company performed an interim impairment analysis at March 31, 2021, and concluded that no impairment relating to goodwill&#13;existed at March 31, 2021.&lt;/p&gt;</us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock>
    <us-gaap:RevenueFromContractWithCustomerPolicyTextBlock contextRef="From2021-01-01to2021-03-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;b&gt;&lt;i&gt;Revenue Recognition&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;On January 1, 2018, the Company&#13;adopted Accounting Standards Update (&amp;#8220;ASU&amp;#8221;) 2014-09 (Topic 606), &lt;i&gt;Revenue from Contracts with Customers&lt;/i&gt; and all the&#13;related amendments (&amp;#8220;ASC 606&amp;#8221; or the &amp;#8220;revenue standard&amp;#8221;) to all contracts and elected the modified retrospective&#13;method.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;Under the revenue standard, a&#13;performance obligation is a promise in a contract with a customer to transfer a distinct good or service to the customer. Most of the&#13;Company&amp;#8217;s contracts contain multiple performance obligations that include engineering and technical services as well as the delivery&#13;of a diverse range of climate control system equipment and components, which can span multiple phases of a customer&amp;#8217;s project life-cycle&#13;from facility design and construction to equipment delivery and system installation and start-up.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;A contract&amp;#8217;s transaction&#13;price is allocated to each distinct performance obligation and recognized as revenue when, or as, the performance obligation is satisfied.&#13;When there are multiple performance obligations within a contract, the Company allocates the transaction price to each performance obligation&#13;based on standalone selling price. When estimating the selling price, the Company uses various observable inputs. The best observable&#13;input is the Company&amp;#8217;s actual selling price for the same good or service, however, this input is generally not available for the&#13;Company&amp;#8217;s contracts containing multiple performance obligations. For engineering services, the Company estimates the standalone&#13;selling price by reference to certain physical characteristics of the project, such as facility size and mechanical systems involved,&#13;which are indicative of the scope and complexity of the mechanical engineering services to be provided. For equipment sales, the standalone&#13;selling price is determined by forecasting the expected costs of the equipment and then adding an appropriate margin, based on a range&#13;of acceptable margins established by management. Depending on the nature of the performance obligations, the Company may use a combination&#13;of different methods and observable inputs if certain performance obligations have highly variable or uncertain standalone selling prices.&#13;Once the selling prices are determined, the Company applies the relative values to the total contract consideration and estimates the&#13;amount of the transaction price to be recognized as each performance obligation is fulfilled.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;The Company recognizes revenue&#13;for the sale of goods when control transfers to the customer, which primarily occurs at the time of shipment. The Company&amp;#8217;s historical&#13;rates of return are insignificant as a percentage of sales and, as a result, the Company does not record a reserve for returns at the&#13;time the Company recognizes revenue. The Company has elected to exclude from the measurement of the transaction price all taxes (e.g.,&#13;sales, use, value added, and certain excise taxes) that are assessed by a governmental authority in connection with a specific revenue-producing&#13;transaction and collected by the Company from the customer. Accordingly, the Company recognizes revenue net of sales taxes. The revenue&#13;and cost for freight and shipping is recorded when control over the sale of goods passes to the Company&amp;#8217;s customers.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;The Company also has performance&#13;obligations to perform certain engineering services that are satisfied over a period of time. Revenue is recognized from this type of&#13;performance obligation as services are rendered based on the percentage completion towards certain specified milestones.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;The Company offers assurance-type&#13;warranties for its products and products manufactured by others to meet specifications defined by the contracts with customers and does&#13;not have any material separate performance obligations related to these warranties. The Company maintains a warranty reserve based on&#13;historical warranty costs.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;Applying the practical expedient&#13;in ASC 606-10-32-18, which the Company has elected, the Company does not adjust the promised amount of consideration for the effects of&#13;a significant financing component since the Company expects, at contract inception, that the period between when the Company transfers&#13;a promised good or service to a customer and when the customer pays for that good or service will be one year or less. Accordingly, the&#13;remaining performance obligations related to customer contracts does not consider the effects of the time value of money.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;Applying the practical expedient&#13;in ASC 340-40-25-4, the Company recognizes the incremental costs of obtaining contracts as an expense when incurred since the amortization&#13;period of the assets that the Company otherwise would have recognized is one year or less. These costs include certain sales commissions&#13;and incentives, which are included in selling, general and administrative expenses, and are payable only when associated revenue has been&#13;collected and earned by the Company.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;The Company does not have material&#13;amounts of contract assets since revenue is recognized as control of goods is transferred or as services are performed. Contract liabilities&#13;consist of advance payments and deferred revenue.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;For the three months ended March&#13;31, 2021, the Company recognized revenue of $1,880,364 related to the deferred revenue at January 1, 2021. For the three months ended&#13;March 31, 2020, the Company recognized revenue of $859,705 related to the deferred revenue at January 1, 2020.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;Remaining performance obligations,&#13;or backlog, represents the aggregate amount of the transaction price allocated to the remaining obligations that the Company has not performed&#13;under its customer contracts. The Company has elected not to use the optional exemption in ASC 606-10-50-14, which exempts an entity from&#13;such disclosures if a performance obligation is part of a contract with an original expected duration of one year or less. Accordingly,&#13;the information disclosed about remaining performance obligations includes all customer contracts, including those with an expected duration&#13;of one year or less.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;Industry uncertainty, project&#13;financing concerns, and the licensing and qualification of our prospective customers, which are out of the Company&amp;#8217;s control, make&#13;it difficult for the Company to predict when it will recognize revenue on its remaining performance obligations. There are risks that&#13;the Company may not realize the full contract value on customer projects in a timely manner or at all, and completion of a customer&amp;#8217;s&#13;cultivation facility project is dependent upon the customer&amp;#8217;s ability to secure funding and real estate, obtain a license and then&#13;build their cultivation facility so they can take possession of the equipment. Accordingly, the time it takes for customers to complete&#13;a project, which corresponds to when the Company is able to recognize revenue, is driven by numerous factors including: (i) the large&#13;number of first-time participants interested in the indoor cannabis cultivation business; (ii) the complexities and uncertainties involved&#13;in obtaining state and local licensure and permitting; (iii) local and state government delays in approving licenses and permits due to&#13;lack of staff or the large number of pending applications, especially in states where there is no cap on the number of cultivators; (iv)&#13;the customer&amp;#8217;s need to obtain cultivation facility financing; (v) the time needed, and coordination required, for our customers&#13;to acquire real estate and properly design and build the facility (to the stage when climate control systems can be installed); (vi) the&#13;large price tag and technical complexities of the climate control and air sanitation system; (vii) the availability of power; and (viii)&#13;delays that are typical in completing any construction project.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;As of March 31, 2021, the Company&amp;#8217;s&#13;remaining performance obligations, or backlog, was $11,578,000, of which $2,006,000, or 17%, was attributable to customer contracts for&#13;which the Company has only received an initial advance payment to cover the allocated value of the Company&amp;#8217;s engineering services&#13;(&amp;#8220;engineering only paid contracts&amp;#8221;). There is the risk that the equipment portion of these engineering only paid contracts&#13;will not be completed or will be delayed. These reasons include the customer being dissatisfied with the quality or timeliness of the&#13;Company&amp;#8217;s engineering services, delay or abandonment of the project because of the customer&amp;#8217;s inability to obtain project&#13;financing or licensing, or other reasons such as a challenging business climate including an overall post-Covid-19 economic downturn,&#13;or change in business direction. After the customer has made an advance payment for a portion of the equipment to be delivered under the&#13;contract (&amp;#8220;partial equipment paid contracts&amp;#8221;), the Company is typically better able to estimate the timing of revenue recognition&#13;since the risks and delays associated with licensing, permitting and project funding are typically mitigated once the initial equipment&#13;payment is received. There is significant uncertainty regarding the timing of the Company&amp;#8217;s recognition of revenue on its remaining&#13;performance obligations, and there is no certainty that these will result in actual revenues. The backlog at March 31, 2021, includes&#13;booked sales orders of $449,000 from several customers that the Company does not expect to be realized until 2022, if at all. Given the&#13;present economic uncertainty arising from the impact of the novel coronavirus COVID-19, the Company believes that several of its current&#13;contracts may be delayed or cancelled in the short term.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;The remaining performance obligations&#13;expected to be recognized through 2022 are as follows:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;  &lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;2021&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;2022&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="width: 55%"&gt;&lt;font style="font-size: 10pt"&gt;Remaining performance obligations related to engineering only paid contracts&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 12%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1,563,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 12%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;443,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 12%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;2,006,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;Remaining performance obligations related to partial equipment paid contracts&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;9,566,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;6,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;9,572,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;font style="font-size: 10pt"&gt;Total remaining performance obligations&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;11,129,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;449,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;11,578,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;The following table sets forth&#13;the Company&amp;#8217;s revenue by source:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;  &lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;For the Three Months &lt;br /&gt;&#13;Ended March 31,&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;2021&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;2020&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="width: 54%"&gt;&lt;font style="font-size: 10pt"&gt;Equipment and systems sales&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 20%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;2,163,468&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 20%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1,606,946&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Engineering and other services&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;181,083&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;131,591&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;Shipping and handling&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;21,978&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;71,388&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;font style="font-size: 10pt"&gt;Total revenue&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;2,366,529&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1,809,925&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;/table&gt;</us-gaap:RevenueFromContractWithCustomerPolicyTextBlock>
    <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy contextRef="From2021-01-01to2021-03-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;b&gt;&lt;i&gt;Accounting for Share-Based&#13;Compensation&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 30.25pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;The Company recognizes the cost&#13;resulting from all share-based compensation arrangements, including stock options, restricted stock awards and restricted stock units&#13;that the Company grants under its equity incentive plan in its condensed consolidated financial statements based on their grant date fair&#13;value. The expense is recognized over the requisite service period or performance period of the award. Awards with a graded vesting period&#13;based on service are expensed on a straight-line basis for the entire award. Awards with performance-based vesting conditions, which require&#13;the achievement of a specific company financial performance goal at the end of the performance period and required service period, are&#13;recognized over the performance period. Each reporting period, the Company reassesses the probability of achieving the respective performance&#13;goal. If the goals are not expected to be met, no compensation cost is recognized and any previously recognized amount recorded is reversed.&#13;If the award contains market-based vesting conditions, the compensation cost is based on the grant date fair value and expected achievement&#13;of market condition and is not subsequently reversed if it is later determined that the condition is not likely to be met or is expected&#13;to be lower than initially expected.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;The grant&#13;date fair value of stock options is based on the Black-Scholes Option Pricing Model (the &amp;#8220;Black-Scholes Model&amp;#8221;). The Black-Scholes&#13;Model requires judgmental assumptions including volatility and expected term, both based on historical experience. The risk-free interest&#13;rate is based on U.S. Treasury interest rates whose term is consistent with the expected term of the option. The Company determines the&#13;assumptions used in the valuation of option awards as of the date of grant. Differences in the expected stock price volatility, expected&#13;term or risk-free interest rate may necessitate distinct valuation assumptions at those grant dates. As such, the Company may use different&#13;assumptions for options granted throughout the year. During the three months ended March 31, 2021, the valuation assumptions used to determine&#13;the fair value of each option award on the date of grant were: expected stock price volatility of 152.51%; expected term in years 10 and&#13;risk-free interest rate of 1.2%.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;The grant date fair value of restricted&#13;stock and restricted stock units is based on the closing price of the underlying stock on the date of the grant.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;The Company has elected to reduce&#13;share-based compensation expense for forfeitures as the forfeitures occur since the Company does not have historical data or other factors&#13;to appropriately estimate the expected employee terminations and to evaluate whether particular groups of employees have significantly&#13;different forfeiture expectations.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.8pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"&gt;The following is a summary of share-based compensation&#13;expenses included in the condensed consolidated statements of operations for the three months ended March 31, 2021 and 2020:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;  &lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;For the Three Months &lt;br /&gt;&#13;Ended March 31,&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;2021&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;2020&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Share-based compensation expense included in:&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="width: 54%"&gt;&lt;font style="font-size: 10pt"&gt;Cost of revenue&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 20%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;14,135&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 20%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;8,558&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Advertising and marketing expenses&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;6,474&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;2,912&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Product development costs&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;6,694&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;6,545&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;Selling, general and administrative expenses&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;31,833&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;172,874&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;font style="font-size: 10pt"&gt;Total share-based compensation expense included in consolidated statement of operations&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;59,136&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;190,889&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;Included in the $59,136 expense&#13;for the three months ended March 31, 2021, is an accrual for $52,794 in respect of the 2021 Annual Employee Incentive Compensation Plan.&#13;Included in the $190,889 expense for the three months ended March 31, 2020, is an accrual for $36,463 in respect of the 2020 Annual Employee&#13;Incentive Compensation Plan.&lt;/p&gt;</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
    <us-gaap:ConcentrationRiskCreditRisk contextRef="From2021-01-01to2021-03-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"&gt;&lt;b&gt;&lt;i&gt;Concentrations&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;Three customers accounted for&#13;38%, 16%, and 11% of the Company&amp;#8217;s revenue for the three months March 31, 2021. For the three months ended March 31, 2020, four&#13;customers accounted for 17%, 16%, 10% and 10% of the Company&amp;#8217;s revenue.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;Two customers accounted for 60%,&#13;and 31% of the Company&amp;#8217;s accounts receivable for the three months ended March 31, 2021. For the three months ended March 31, 2020,&#13;three customers accounted for 59%, 18%, and 15% of the Company&amp;#8217;s accounts receivable.&lt;/p&gt;</us-gaap:ConcentrationRiskCreditRisk>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="From2021-01-01to2021-03-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;b&gt;&lt;i&gt;Recently Issued Accounting&#13;Pronouncements&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;In August 2020, the FASB issued&#13;ASU No. 2020-06, &lt;i&gt;Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging&amp;#8212;Contracts in Entity&amp;#8217;s&#13;Own Equity (Subtopic 815-40)&lt;/i&gt; which simplifies the accounting for convertible instruments. The guidance removes certain accounting&#13;models which separate the embedded conversion features from the host contract for convertible instruments. Either a modified retrospective&#13;method of transition or a fully retrospective method of transition is permissible for the adoption of this standard. Update No. 2020-06&#13;is effective for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. Early adoption is&#13;permitted no earlier than the fiscal year beginning after December 15, 2020. The Company does not expect this ASU to have a material impact&#13;on its consolidated results of operations, cash flows and financial position.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;In March 2020, the FAS issued&#13;ASU No. 2020-04 &amp;#8220;&lt;i&gt;Reference Reform (Topic 848) Facilitation of the Effects of Reference Rate Reform on Financial Reporting&amp;#8221;&#13;(&amp;#8220;ASU 2020-04&amp;#8221;).&lt;/i&gt; ASU 2020-04 provides optional guidance for a limited period of time to ease the potential burden in accounting&#13;for (or recognizing the effects of) reference rate reform on financial reporting. The amendments are effective for the Company as of March&#13;12, 2020 through December 31, 2022. The Company does not expect this ASU to have a material impact on its consolidated results of operations,&#13;cash flows and financial position.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;In January 2020, the FASB issued&#13;ASU No. 2020-01, &lt;i&gt;Investments&amp;#8212;Equity Securities (Topic 321), Investments&amp;#8212;Equity Method and Joint Ventures (Topic 323), and&#13;Derivatives and Hedging (Topic 815)&amp;#8212;Clarifying the Interactions between Topic 321, Topic 323, and Topic 815&lt;/i&gt; (a consensus of&#13;the Emerging Issues Task Force). This update clarifies whether an entity should consider observable transactions that require it to either&#13;apply or discontinue the equity method of accounting for the purposes of applying the measurement alternative and how to account for certain&#13;forward contracts and purchased options to purchase securities. For public entities, this guidance is effective for fiscal years beginning&#13;after December 15, 2020. The Company does not expect this ASU to have a material impact on its consolidated results of operations, cash&#13;flows and financial position. The adoption of this ASU has not had a material impact on the Company&amp;#8217;s consolidated results of operations,&#13;cash flows and financial position.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;In December 2019, the FASB issued&#13;ASU 2019-12, &lt;i&gt;Income Taxes (Topic 740) &amp;#8211; Simplifying the Accounting for Income Taxes, &lt;/i&gt;which simplifies the accounting for&#13;income taxes by removing certain exceptions to the general principles in Topic 740. The amendments also improve consistent application&#13;of and simplify GAAP for other areas of Topic 740 by clarifying and amending existing guidance. ASU 2019-12 is effective for fiscal years&#13;beginning after December 15, 2020. Early adoption is permitted. The adoption of this ASU has not had a material impact on the Company&amp;#8217;s&#13;consolidated results of operations, cash flows and financial position.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;Other accounting standards that&#13;have been issued or proposed by FASB that do not require adoption until a future date are not expected to have a material impact on the&#13;financial statements upon adoption. The Company does not discuss recent pronouncements that are not anticipated to have an impact on&#13;or are unrelated to its financial condition, results of operations, cash flows or disclosures.&lt;/p&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:ConsolidationPolicyTextBlock contextRef="From2021-01-01to2021-03-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;b&gt;&lt;i&gt;Basis of Consolidation and&#13;Reclassifications&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;The condensed consolidated financial&#13;statements include the accounts of the Company and its controlled and wholly owned subsidiary, Hydro Innovations, LLC (&amp;#8220;Hydro&amp;#8221;).&#13;Intercompany transactions, profit, and balances are eliminated in consolidation.&lt;/p&gt;</us-gaap:ConsolidationPolicyTextBlock>
    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock contextRef="From2021-01-01to2021-03-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;The remaining performance obligations&#13;expected to be recognized through 2022 are as follows:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;  &lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;2021&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;2022&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="width: 55%"&gt;&lt;font style="font-size: 10pt"&gt;Remaining performance obligations related to engineering only paid contracts&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 12%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1,563,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 12%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;443,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 12%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;2,006,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;Remaining performance obligations related to partial equipment paid contracts&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;9,566,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;6,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;9,572,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;font style="font-size: 10pt"&gt;Total remaining performance obligations&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;11,129,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;449,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;11,578,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;/table&gt;</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock>
    <us-gaap:DisaggregationOfRevenueTableTextBlock contextRef="From2021-01-01to2021-03-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;The following table sets forth&#13;the Company&amp;#8217;s revenue by source:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;  &lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;For the Three Months &lt;br /&gt;&#13;Ended March 31,&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;2021&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;2020&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="width: 54%"&gt;&lt;font style="font-size: 10pt"&gt;Equipment and systems sales&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 20%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;2,163,468&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 20%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1,606,946&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Engineering and other services&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;181,083&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;131,591&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;Shipping and handling&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;21,978&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;71,388&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;font style="font-size: 10pt"&gt;Total revenue&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;2,366,529&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1,809,925&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;/table&gt;</us-gaap:DisaggregationOfRevenueTableTextBlock>
    <us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock contextRef="From2021-01-01to2021-03-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"&gt;The following is a summary of share-based compensation&#13;expenses included in the condensed consolidated statements of operations for the three months ended March 31, 2021 and 2020:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;  &lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;For the Three Months &lt;br /&gt;&#13;Ended March 31,&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;2021&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;2020&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Share-based compensation expense included in:&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="width: 54%"&gt;&lt;font style="font-size: 10pt"&gt;Cost of revenue&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 20%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;14,135&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 20%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;8,558&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Advertising and marketing expenses&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;6,474&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;2,912&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Product development costs&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;6,694&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;6,545&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;Selling, general and administrative expenses&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;31,833&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;172,874&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;font style="font-size: 10pt"&gt;Total share-based compensation expense included in consolidated statement of operations&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;59,136&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;190,889&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;/table&gt;</us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock>
    <us-gaap:LeaseCostTableTextBlock contextRef="From2021-01-01to2021-03-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;The lease cost, cash flows and&#13;other information related to the Facility Lease were as follows:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;  &lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;For the Three Months Ended March 31,&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;2021&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="width: 77%"&gt;&lt;font style="font-size: 10pt"&gt;Operating lease cost&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 20%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;54,222&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Operating cash outflow from operating lease&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;69,844&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="width: 77%; padding-bottom: 1.5pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; width: 1%; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; width: 20%; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;As of March 31, 2021&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; padding-bottom: 1.5pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Operating lease right-of-use assset&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;294,900&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Operating lease liability, current&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;263,662&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Operating lease liability, long-term&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;106,891&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Remaining lease term&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1.4 years&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Discount rate&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;5.00&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;/table&gt;</us-gaap:LeaseCostTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock contextRef="From2021-01-01to2021-03-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;Future annual minimum lease payments&#13;on the Facility Lease as of March 31, 2021 were as follows:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;  &lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Years ended December 31,&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="width: 77%"&gt;&lt;font style="font-size: 10pt"&gt;2021 (excluding the three months ended March 31, 2021)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 20%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;212,020&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;2022&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;170,891&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Total minimum lease payments&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;382,911&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Less imputed interest&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(12,358&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-bottom: 2.5pt; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Present value of minimum lease payments&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;370,553&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;/table&gt;</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:ScheduleOfInventoryCurrentTableTextBlock contextRef="From2021-01-01to2021-03-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;Inventory consisted of the following:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;  &lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;March 31,&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;December 31,&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;2021&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="3" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;2020&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="width: 54%"&gt;&lt;font style="font-size: 10pt"&gt;Finished goods&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 20%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;325,451&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 20%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;201,778&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Work in progress&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;10,083&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;4,231&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Raw materials&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;272,299&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;214,145&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;Allowance for excess &amp;#38; obsolete inventory&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(88,674&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(93,045&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;font style="font-size: 10pt"&gt;Inventory, net&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;519,159&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;327,109&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;/table&gt;</us-gaap:ScheduleOfInventoryCurrentTableTextBlock>
    <us-gaap:PropertyPlantAndEquipmentTextBlock contextRef="From2021-01-01to2021-03-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;Property and equipment consisted&#13;of the following:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;  &lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;March 31,&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;December 31,&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;2021&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;2020&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="width: 54%; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Furniture and equipment&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 20%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;410,748&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 20%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;398,422&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Vehicles&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;15,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;15,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Leasehold improvements&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;215,193&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;215,193&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;640,941&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;628,615&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Accumulated depreciation&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(499,116&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(480,883&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-bottom: 2.5pt; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Property and equipment, net&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;141,825&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;147,732&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;/table&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock contextRef="From2021-01-01to2021-03-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;Accounts payable and accrued liabilities&#13;consisted of the following:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;  &lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;March 31,&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;December 31,&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;2021&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;2020&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="width: 54%"&gt;&lt;font style="font-size: 10pt"&gt;Accounts payable&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 20%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;860,087&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 20%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;918,639&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Sales commissions payable&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;13,649&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;48,263&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Accrued payroll liabilities&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;275,024&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;288,071&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Product warranty accrual&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;264,956&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;173,365&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;Other accrued expenses&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;376,599&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;356,623&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-bottom: 2.5pt; padding-left: 10pt"&gt;&lt;font style="font-size: 10pt"&gt;Total&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1,790,315&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1,784,961&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;/table&gt;</us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock>
    <us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock contextRef="From2021-01-01to2021-03-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;u&gt;Restricted Stock Units&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 40.5pt; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;A summary of the RSUs awarded&#13;to employees, directors and consultants under the 2017 Equity Plan during the three months ended March 31, 2021, are presented in the&#13;table below:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;  &lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Number of Units&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid"&gt;&#13;    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;Weighted Average Grant-Date&lt;/b&gt;&lt;/p&gt;&#13;    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;Fair Value&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid"&gt;&#13;    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;Aggregate Intrinsic&lt;/b&gt;&lt;/p&gt;&#13;    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;Value&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="width: 61%"&gt;&lt;font style="font-size: 10pt"&gt;Outstanding, December 31, 2020&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 10%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 10%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 10%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-left: 10pt"&gt;&lt;font style="font-size: 10pt"&gt;Granted&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-left: 10pt"&gt;&lt;font style="font-size: 10pt"&gt;Vested and settled with share issuance&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; padding-left: 10pt"&gt;&lt;font style="font-size: 10pt"&gt;Forfeited/canceled&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;font style="font-size: 10pt"&gt;Outstanding, March 31, 2021&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;/table&gt;</us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock>
    <SRNA:ScheduleOfOutstandingWarrantsToPurchaseCommonStockTableTextBlock contextRef="From2021-01-01to2021-03-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;The following table summarizes&#13;information with respect to outstanding warrants to purchase common stock during the three months ended March 31, 2021:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;  &lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Weighted&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Weighted&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Average&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Number&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2"&gt;&#13;    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;Average&lt;/b&gt;&lt;/p&gt;&#13;    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;Exercise&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Remaining Life&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2"&gt;&#13;    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;Aggregate&lt;/b&gt;&lt;/p&gt;&#13;    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;Intrincic&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Outstanding&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Price&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;In Months&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Value&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="width: 44%"&gt;&lt;font style="font-size: 10pt"&gt;Outstanding at December 31, 2020&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 11%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;7,562,500&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 11%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0.25&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 11%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;6&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 11%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;0&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Issued&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Exercised&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;Expired&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0.00&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;font style="font-size: 10pt"&gt;Outstanding at March 31, 2021&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;7,562,500&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0.25&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;6&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;/table&gt;</SRNA:ScheduleOfOutstandingWarrantsToPurchaseCommonStockTableTextBlock>
    <us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock contextRef="From2021-01-01to2021-03-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The following table summarizes information about warrants&#13;outstanding at March 31, 2021:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;  &lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;Weighted Average &lt;br /&gt;&#13;Life of&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;Warrants&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;Outstanding Warrants&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&lt;font style="font-size: 10pt"&gt;Exercise price&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;Outstanding&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;In Months&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="width: 38%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 28%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 28%; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0.25&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;7,562,500&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;3&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;  &lt;/table&gt;</us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock>
</xbrli:xbrl>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>9
<FILENAME>srna-20210331.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.8a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Source; Value: SRNA %2D 20210331 10Q Q1 DFN.xfr; Date: 2021%2D05%2D10T22:03:41Z -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x800A0000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: 96Mps7xRiXgen8uDanwsWaCMibP9z5Z8KekhvWBwbcnary8tY0HO+i8S3vY24SYH -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2021" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:us-roles="http://fasb.org/us-roles/2021-01-31" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:srt-types="http://fasb.org/srt-types/2021-01-31" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:us-types="http://fasb.org/us-types/2021-01-31" xmlns:SRNA="http://surna.com/20210331" elementFormDefault="qualified" targetNamespace="http://surna.com/20210331">
    <annotation>
      <appinfo>
	<link:roleType roleURI="http://surna.com/role/DocumentAndEntityInformation" id="DocumentAndEntityInformation">
	  <link:definition>00000001 - Document - Document and Entity Information</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/BalanceSheets" id="BalanceSheets">
	  <link:definition>00000002 - Statement - Condensed Consolidated Balance Sheets</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/BalanceSheetsParenthetical" id="BalanceSheetsParenthetical">
	  <link:definition>00000003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/StatementsOfOperations" id="StatementsOfOperations">
	  <link:definition>00000004 - Statement - Condensed Consolidated Statements of Operations (Unaudited)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/StatementsOfChangesInShareholdersDeficit" id="StatementsOfChangesInShareholdersDeficit">
	  <link:definition>00000005 - Statement - Condensed Consolidated Statements of Changes in Shareholders' Deficit (Unaudited)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/StatementsOfCashFlows" id="StatementsOfCashFlows">
	  <link:definition>00000006 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/General" id="General">
	  <link:definition>00000007 - Disclosure - General</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/Leases" id="Leases">
	  <link:definition>00000008 - Disclosure - Leases</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/Inventory" id="Inventory">
	  <link:definition>00000009 - Disclosure - Inventory</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/PropertyAndEquipment" id="PropertyAndEquipment">
	  <link:definition>00000010 - Disclosure - Property and Equipment</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/AccountsPayableAndAccruedLiabilities" id="AccountsPayableAndAccruedLiabilities">
	  <link:definition>00000011 - Disclosure - Accounts Payable and Accrued Liabilities</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/NotePayableAndAccruedInterest" id="NotePayableAndAccruedInterest">
	  <link:definition>00000012 - Disclosure - Note Payable and Accrued Interest</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/CommitmentsAndContingencies" id="CommitmentsAndContingencies">
	  <link:definition>00000013 - Disclosure - Commitments and Contingencies</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/EquityIncentivePlan" id="EquityIncentivePlan">
	  <link:definition>00000014 - Disclosure - Equity Incentive Plan</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/Warrants" id="Warrants">
	  <link:definition>00000015 - Disclosure - Warrants</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/IncomeTaxes" id="IncomeTaxes">
	  <link:definition>00000016 - Disclosure - Income Taxes</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/SubsequentEvents" id="SubsequentEvents">
	  <link:definition>00000017 - Disclosure - Subsequent Events</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/GeneralPolicies" id="GeneralPolicies">
	  <link:definition>00000018 - Disclosure - General (Policies)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/GeneralTables" id="GeneralTables">
	  <link:definition>00000019 - Disclosure - General (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/LeasesTables" id="LeasesTables">
	  <link:definition>00000020 - Disclosure - Leases (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/InventoryTables" id="InventoryTables">
	  <link:definition>00000021 - Disclosure - Inventory (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/PropertyAndEquipmentTables" id="PropertyAndEquipmentTables">
	  <link:definition>00000022 - Disclosure - Property and Equipment (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/AccountsPayableAndAccruedLiabilitiesTables" id="AccountsPayableAndAccruedLiabilitiesTables">
	  <link:definition>00000023 - Disclosure - Accounts Payable and Accrued Liabilities (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/EquityIncentivePlanTables" id="EquityIncentivePlanTables">
	  <link:definition>00000024 - Disclosure - Equity Incentive Plan (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/WarrantsTables" id="WarrantsTables">
	  <link:definition>00000025 - Disclosure - Warrants (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/GeneralDetailsNarrative" id="GeneralDetailsNarrative">
	  <link:definition>00000026 - Disclosure - General (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/General-ScheduleOfRemainingPerformanceObligationsExpectedToBeRecognizedDetails" id="General-ScheduleOfRemainingPerformanceObligationsExpectedToBeRecognizedDetails">
	  <link:definition>00000027 - Disclosure - General - Schedule of Remaining Performance Obligations Expected to be Recognized (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/General-ScheduleOfRevenueBySourceDetails" id="General-ScheduleOfRevenueBySourceDetails">
	  <link:definition>00000028 - Disclosure - General - Schedule of Revenue by Source (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/General-ScheduleOfShare-basedCompensationCostsDetails" id="General-ScheduleOfShare-basedCompensationCostsDetails">
	  <link:definition>00000029 - Disclosure - General - Schedule of Share-based Compensation Costs (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/LeasesDetailsNarrative" id="LeasesDetailsNarrative">
	  <link:definition>00000030 - Disclosure - Leases (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/Leases-ScheduleOfLeaseCostDetails" id="Leases-ScheduleOfLeaseCostDetails">
	  <link:definition>00000031 - Disclosure - Leases - Schedule of Lease Cost (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/Leases-ScheduleOfFutureAnnualMinimumLeasePaymentsDetails" id="Leases-ScheduleOfFutureAnnualMinimumLeasePaymentsDetails">
	  <link:definition>00000032 - Disclosure - Leases - Schedule of Future Annual Minimum Lease Payments (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/InventoryDetailsNarrative" id="InventoryDetailsNarrative">
	  <link:definition>00000033 - Disclosure - Inventory (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/Inventory-ScheduleOfInventoryDetails" id="Inventory-ScheduleOfInventoryDetails">
	  <link:definition>00000034 - Disclosure - Inventory - Schedule of Inventory (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/PropertyAndEquipmentDetailsNarrative" id="PropertyAndEquipmentDetailsNarrative">
	  <link:definition>00000035 - Disclosure - Property and Equipment (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/PropertyAndEquipment-ScheduleOfPropertyAndEquipmentDetails" id="PropertyAndEquipment-ScheduleOfPropertyAndEquipmentDetails">
	  <link:definition>00000036 - Disclosure - Property and Equipment - Schedule of Property and Equipment (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/AccountsPayableAndAccruedLiabilities-ScheduleOfAccountsPayableAndAccruedLiabilitiesDetails" id="AccountsPayableAndAccruedLiabilities-ScheduleOfAccountsPayableAndAccruedLiabilitiesDetails">
	  <link:definition>00000037 - Disclosure - Accounts Payable and Accrued Liabilities - Schedule of Accounts Payable and Accrued Liabilities (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/NotePayableAndAccruedInterestDetailsNarrative" id="NotePayableAndAccruedInterestDetailsNarrative">
	  <link:definition>00000038 - Disclosure - Note Payable and Accrued Interest (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/CommitmentsAndContingenciesDetailsNarrative" id="CommitmentsAndContingenciesDetailsNarrative">
	  <link:definition>00000039 - Disclosure - Commitments and Contingencies (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/EquityIncentivePlanDetailsNarrative" id="EquityIncentivePlanDetailsNarrative">
	  <link:definition>00000040 - Disclosure - Equity Incentive Plan (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/EquityIncentivePlan-ScheduleOfStockOptionActivityDetails" id="EquityIncentivePlan-ScheduleOfStockOptionActivityDetails">
	  <link:definition>00000041 - Disclosure - Equity Incentive Plan - Schedule of Stock Option Activity (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/EquityIncentivePlan-SummaryOfNon-vestedNon-qualifiedStockOptionActivityDetails" id="EquityIncentivePlan-SummaryOfNon-vestedNon-qualifiedStockOptionActivityDetails">
	  <link:definition>00000042 - Disclosure - Equity Incentive Plan - Summary of Non-vested Non-qualified Stock Option Activity (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/EquityIncentivePlan-ScheduleOfRestrictedStockUnitsActivityDetails" id="EquityIncentivePlan-ScheduleOfRestrictedStockUnitsActivityDetails">
	  <link:definition>00000043 - Disclosure - Equity Incentive Plan - Schedule of Restricted Stock Units Activity (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/Warrants-ScheduleOfOutstandingWarrantsToPurchaseCommonStockDetails" id="Warrants-ScheduleOfOutstandingWarrantsToPurchaseCommonStockDetails">
	  <link:definition>00000044 - Disclosure - Warrants - Schedule of Outstanding Warrants to Purchase Common Stock (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/Warrants-ScheduleOfWarrantsOutstandingDetails" id="Warrants-ScheduleOfWarrantsOutstandingDetails">
	  <link:definition>00000045 - Disclosure - Warrants - Schedule of Warrants Outstanding (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/IncomeTaxesDetailsNarrative" id="IncomeTaxesDetailsNarrative">
	  <link:definition>00000046 - Disclosure - Income Taxes (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://surna.com/role/SubsequentEventsDetailsNarrative" id="SubsequentEventsDetailsNarrative">
	  <link:definition>00000047 - Disclosure - Subsequent Events (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:linkbaseRef xlink:type="simple" xlink:href="srna-20210331_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="srna-20210331_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="srna-20210331_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Calculation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="srna-20210331_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Definition Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2021" schemaLocation="https://xbrl.sec.gov/dei/2021/dei-2021.xsd" />
    <import namespace="http://fasb.org/us-gaap/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd" />
    <import namespace="http://fasb.org/us-types/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2021" schemaLocation="https://xbrl.sec.gov/country/2021/country-2021.xsd" />
    <import namespace="http://xbrl.sec.gov/currency/2021" schemaLocation="https://xbrl.sec.gov/currency/2021/currency-2021.xsd" />
    <import namespace="http://fasb.org/srt/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd" />
    <import namespace="http://fasb.org/srt-types/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd" />
    <element id="SRNA_NumberOfUnitsVestedButNotSettled" name="NumberOfUnitsVestedButNotSettled" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_NumberOfUnitsVestedAndSettled" name="NumberOfUnitsVestedAndSettled" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_RestrictedStockUnitsSharesIssuedInterestPercentage" name="RestrictedStockUnitsSharesIssuedInterestPercentage" nillable="true" xbrli:periodType="duration" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm" name="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm" name="SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_RemainingPerformanceObligationsRelatedToEngineeringOnlyPaidContracts" name="RemainingPerformanceObligationsRelatedToEngineeringOnlyPaidContracts" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_RemainingPerformanceObligationsRelatedToPartialEquipmentPaidContracts" name="RemainingPerformanceObligationsRelatedToPartialEquipmentPaidContracts" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermGranted" name="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermGranted" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsNumberOfOptionsExpired" name="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsNumberOfOptionsExpired" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsExpired" name="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsExpired" nillable="true" xbrli:periodType="duration" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1" name="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested" name="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValuesGranted" name="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValuesGranted" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValueVested" name="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValueVested" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantDateFairValueForfeited" name="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantDateFairValueForfeited" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfSharesGrantDateFairValueExpired" name="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfSharesGrantDateFairValueExpired" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_CommonSharesToBeIssued" name="CommonSharesToBeIssued" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_CommonStockSharesToBeIssuedValue" name="CommonStockSharesToBeIssuedValue" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_OtherSharebasedExpense" name="OtherSharebasedExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_CashBalanceTransferredToBankAccount" name="CashBalanceTransferredToBankAccount" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_AggregateSharesIssuedUponExecutionOfSettlement" name="AggregateSharesIssuedUponExecutionOfSettlement" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_StockIssuanceAmount" name="StockIssuanceAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_MonthlyRentDescription" name="MonthlyRentDescription" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_UnamortizedAmountOfTenantImprovementAllowance" name="UnamortizedAmountOfTenantImprovementAllowance" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_PrepaidInventoryExpenses" name="PrepaidInventoryExpenses" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_NetOperatingLossCarryForwardExpectedToExpireAmount" name="NetOperatingLossCarryForwardExpectedToExpireAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_NetOperatingLossExpirationTerm" name="NetOperatingLossExpirationTerm" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_NolsUsageAgainstTaxableIncomePercentage" name="NolsUsageAgainstTaxableIncomePercentage" nillable="true" xbrli:periodType="instant" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_NolsCarryforwardsTerm" name="NolsCarryforwardsTerm" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_ClassOfWarrantOrRightIssued" name="ClassOfWarrantOrRightIssued" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_ClassOfWarrantOrRightExercised" name="ClassOfWarrantOrRightExercised" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_ClassOfWarrantOrRightExpired" name="ClassOfWarrantOrRightExpired" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_ClassOfWarrantOrRightWeightedAverageExercisePriceIssued" name="ClassOfWarrantOrRightWeightedAverageExercisePriceIssued" nillable="true" xbrli:periodType="duration" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_ClassOfWarrantOrRightWeightedAverageExercisePriceExercised" name="ClassOfWarrantOrRightWeightedAverageExercisePriceExercised" nillable="true" xbrli:periodType="duration" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_ClassOfWarrantOrRightWeightedAverageExercisePriceExpired" name="ClassOfWarrantOrRightWeightedAverageExercisePriceExpired" nillable="true" xbrli:periodType="duration" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerms" name="SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerms" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_ClassOfWarrantOrRightOutstandingAggregateIntrinsicValue" name="ClassOfWarrantOrRightOutstandingAggregateIntrinsicValue" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_ClassOfWarrantOrRightIssuedAggregateIntrinsicValue" name="ClassOfWarrantOrRightIssuedAggregateIntrinsicValue" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_ClassOfWarrantOrRightExercisedAggregateIntrinsicValue" name="ClassOfWarrantOrRightExercisedAggregateIntrinsicValue" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_ClassOfWarrantOrRightExpiredAggregateIntrinsicValue" name="ClassOfWarrantOrRightExpiredAggregateIntrinsicValue" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_CommonStockSharesToBeIssuedParOrStatedValuePerShare" name="CommonStockSharesToBeIssuedParOrStatedValuePerShare" nillable="true" xbrli:periodType="instant" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_CommonStockSharesToBeIssuedBalance" name="CommonStockSharesToBeIssuedBalance" nillable="true" xbrli:periodType="instant" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonuses" name="CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonuses" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesShares" name="CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesShares" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesSharesToBeIssued" name="CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesSharesToBeIssued" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_CommonSharesToBeIssuedInSettlementOfLegalDispute" name="CommonSharesToBeIssuedInSettlementOfLegalDispute" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_FairValueOfVestedStockOptionsGrantedToEmployees" name="FairValueOfVestedStockOptionsGrantedToEmployees" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_FairValueOfVestedStockOptionsGrantedToDirectors" name="FairValueOfVestedStockOptionsGrantedToDirectors" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_CommonSharesToBeIssuedInSettlementOfLegalDisputeSharesToBeIssued" name="CommonSharesToBeIssuedInSettlementOfLegalDisputeSharesToBeIssued" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_CommonStockValueToBeIssuedBalance" name="CommonStockValueToBeIssuedBalance" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_IncreaseDecreaseInLeaseDeposit" name="IncreaseDecreaseInLeaseDeposit" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_WarrantsDisclosureTextBlock" name="WarrantsDisclosureTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_DescriptionOfBusinessPolicyTextBlock" name="DescriptionOfBusinessPolicyTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_ImpactOfCovid19PandemicOnOurBusinessPolicyTextBlock" name="ImpactOfCovid19PandemicOnOurBusinessPolicyTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_GoingConcernPolicyTextBlock" name="GoingConcernPolicyTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_ScheduleOfOutstandingWarrantsToPurchaseCommonStockTableTextBlock" name="ScheduleOfOutstandingWarrantsToPurchaseCommonStockTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_EngineeringAndOtherServicesMember" name="EngineeringAndOtherServicesMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_CustomerOneMember" name="CustomerOneMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_CustomerTwoMember" name="CustomerTwoMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_CustomerThreeMember" name="CustomerThreeMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_InventoryMember" name="InventoryMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_TwoThousandAndTwentyTwoMember" name="TwoThousandAndTwentyTwoMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_TwoThousandAndTwentyOneMember" name="TwoThousandAndTwentyOneMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_TwoThousandSeventeenEquityPlanMember" name="TwoThousandSeventeenEquityPlanMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_TwoNewIndependentDirectorsMember" name="TwoNewIndependentDirectorsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_TwoThousandAndSeventeenEquityPlanMember" name="TwoThousandAndSeventeenEquityPlanMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_NonQualifiedStockOptionsMember" name="NonQualifiedStockOptionsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_DirectorsMember" name="DirectorsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_EmployeesAndConsultantsMember" name="EmployeesAndConsultantsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_EmployeesDirectorsandConsultantsMember" name="EmployeesDirectorsandConsultantsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_FormerEmployeeMember" name="FormerEmployeeMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_WarrantsRangeOneMember" name="WarrantsRangeOneMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_WarrantsRangeMember" name="WarrantsRangeMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_TwoThousandTwentyOneAnnualEmployeeIncentiveCompensationPlanMember" name="TwoThousandTwentyOneAnnualEmployeeIncentiveCompensationPlanMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_CustomerFourMember" name="CustomerFourMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_FacilityLeaseMember" name="FacilityLeaseMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_TwoThousandAndSeventeenEquityIncentivePlanMember" name="TwoThousandAndSeventeenEquityIncentivePlanMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_UnvestedOptionsMember" name="UnvestedOptionsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_TwoThousandAndNineteenSpecialEquityPlanMember" name="TwoThousandAndNineteenSpecialEquityPlanMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_IncentiveStockBonusAwardsMember" name="IncentiveStockBonusAwardsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_EmployeesMember" name="EmployeesMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_OfficeandManufacturingMember" name="OfficeandManufacturingMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_TwoThousandAndTwentyOneEquityIncentivePlanMember" name="TwoThousandAndTwentyOneEquityIncentivePlanMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SRNA_WarrantsAbstract" name="WarrantsAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>10
<FILENAME>srna-20210331_cal.xml
<DESCRIPTION>XBRL CALCULATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.8a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Source; Value: SRNA %2D 20210331 10Q Q1 DFN.xfr; Date: 2021%2D05%2D10T22:03:41Z -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x800A0000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://surna.com/role/DocumentAndEntityInformation" xlink:href="srna-20210331.xsd#DocumentAndEntityInformation" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/BalanceSheets" xlink:href="srna-20210331.xsd#BalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/BalanceSheetsParenthetical" xlink:href="srna-20210331.xsd#BalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/StatementsOfOperations" xlink:href="srna-20210331.xsd#StatementsOfOperations" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/StatementsOfChangesInShareholdersDeficit" xlink:href="srna-20210331.xsd#StatementsOfChangesInShareholdersDeficit" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/StatementsOfCashFlows" xlink:href="srna-20210331.xsd#StatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/General" xlink:href="srna-20210331.xsd#General" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/Leases" xlink:href="srna-20210331.xsd#Leases" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/Inventory" xlink:href="srna-20210331.xsd#Inventory" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/PropertyAndEquipment" xlink:href="srna-20210331.xsd#PropertyAndEquipment" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/AccountsPayableAndAccruedLiabilities" xlink:href="srna-20210331.xsd#AccountsPayableAndAccruedLiabilities" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/NotePayableAndAccruedInterest" xlink:href="srna-20210331.xsd#NotePayableAndAccruedInterest" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/CommitmentsAndContingencies" xlink:href="srna-20210331.xsd#CommitmentsAndContingencies" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/EquityIncentivePlan" xlink:href="srna-20210331.xsd#EquityIncentivePlan" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/Warrants" xlink:href="srna-20210331.xsd#Warrants" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/IncomeTaxes" xlink:href="srna-20210331.xsd#IncomeTaxes" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/SubsequentEvents" xlink:href="srna-20210331.xsd#SubsequentEvents" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/GeneralPolicies" xlink:href="srna-20210331.xsd#GeneralPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/GeneralTables" xlink:href="srna-20210331.xsd#GeneralTables" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/LeasesTables" xlink:href="srna-20210331.xsd#LeasesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/InventoryTables" xlink:href="srna-20210331.xsd#InventoryTables" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/PropertyAndEquipmentTables" xlink:href="srna-20210331.xsd#PropertyAndEquipmentTables" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/AccountsPayableAndAccruedLiabilitiesTables" xlink:href="srna-20210331.xsd#AccountsPayableAndAccruedLiabilitiesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/EquityIncentivePlanTables" xlink:href="srna-20210331.xsd#EquityIncentivePlanTables" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/WarrantsTables" xlink:href="srna-20210331.xsd#WarrantsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/GeneralDetailsNarrative" xlink:href="srna-20210331.xsd#GeneralDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/General-ScheduleOfRemainingPerformanceObligationsExpectedToBeRecognizedDetails" xlink:href="srna-20210331.xsd#General-ScheduleOfRemainingPerformanceObligationsExpectedToBeRecognizedDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/General-ScheduleOfRevenueBySourceDetails" xlink:href="srna-20210331.xsd#General-ScheduleOfRevenueBySourceDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/General-ScheduleOfShare-basedCompensationCostsDetails" xlink:href="srna-20210331.xsd#General-ScheduleOfShare-basedCompensationCostsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/LeasesDetailsNarrative" xlink:href="srna-20210331.xsd#LeasesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/Leases-ScheduleOfLeaseCostDetails" xlink:href="srna-20210331.xsd#Leases-ScheduleOfLeaseCostDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/Leases-ScheduleOfFutureAnnualMinimumLeasePaymentsDetails" xlink:href="srna-20210331.xsd#Leases-ScheduleOfFutureAnnualMinimumLeasePaymentsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/InventoryDetailsNarrative" xlink:href="srna-20210331.xsd#InventoryDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/Inventory-ScheduleOfInventoryDetails" xlink:href="srna-20210331.xsd#Inventory-ScheduleOfInventoryDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/PropertyAndEquipmentDetailsNarrative" xlink:href="srna-20210331.xsd#PropertyAndEquipmentDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/PropertyAndEquipment-ScheduleOfPropertyAndEquipmentDetails" xlink:href="srna-20210331.xsd#PropertyAndEquipment-ScheduleOfPropertyAndEquipmentDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/AccountsPayableAndAccruedLiabilities-ScheduleOfAccountsPayableAndAccruedLiabilitiesDetails" xlink:href="srna-20210331.xsd#AccountsPayableAndAccruedLiabilities-ScheduleOfAccountsPayableAndAccruedLiabilitiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/NotePayableAndAccruedInterestDetailsNarrative" xlink:href="srna-20210331.xsd#NotePayableAndAccruedInterestDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:href="srna-20210331.xsd#CommitmentsAndContingenciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/EquityIncentivePlanDetailsNarrative" xlink:href="srna-20210331.xsd#EquityIncentivePlanDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/EquityIncentivePlan-ScheduleOfStockOptionActivityDetails" xlink:href="srna-20210331.xsd#EquityIncentivePlan-ScheduleOfStockOptionActivityDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/EquityIncentivePlan-SummaryOfNon-vestedNon-qualifiedStockOptionActivityDetails" xlink:href="srna-20210331.xsd#EquityIncentivePlan-SummaryOfNon-vestedNon-qualifiedStockOptionActivityDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/EquityIncentivePlan-ScheduleOfRestrictedStockUnitsActivityDetails" xlink:href="srna-20210331.xsd#EquityIncentivePlan-ScheduleOfRestrictedStockUnitsActivityDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/Warrants-ScheduleOfOutstandingWarrantsToPurchaseCommonStockDetails" xlink:href="srna-20210331.xsd#Warrants-ScheduleOfOutstandingWarrantsToPurchaseCommonStockDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/Warrants-ScheduleOfWarrantsOutstandingDetails" xlink:href="srna-20210331.xsd#Warrants-ScheduleOfWarrantsOutstandingDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/IncomeTaxesDetailsNarrative" xlink:href="srna-20210331.xsd#IncomeTaxesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/SubsequentEventsDetailsNarrative" xlink:href="srna-20210331.xsd#SubsequentEventsDetailsNarrative" xlink:type="simple" />
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/DocumentAndEntityInformation" xlink:title="00000001 - Document - Document and Entity Information" />
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/BalanceSheets" xlink:title="00000002 - Statement - Condensed Consolidated Balance Sheets">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaapAccountsReceivableNetCurrent" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapAccountsReceivableNetCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaapInventoryNet" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapInventoryNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsNoncurrent" xlink:label="loc_us-gaapAssetsNoncurrent" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsNoncurrent" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaapGoodwill" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsNoncurrent" xlink:to="loc_us-gaapGoodwill" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepositsAssetsNoncurrent" xlink:label="loc_us-gaapDepositsAssetsNoncurrent" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsNoncurrent" xlink:to="loc_us-gaapDepositsAssetsNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaapOperatingLeaseRightOfUseAsset" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsNoncurrent" xlink:to="loc_us-gaapOperatingLeaseRightOfUseAsset" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="loc_us-gaapIntangibleAssetsNetExcludingGoodwill" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsNoncurrent" xlink:to="loc_us-gaapIntangibleAssetsNetExcludingGoodwill" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapAssetsCurrent" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapAssetsNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent" xlink:label="loc_us-gaapContractWithCustomerLiabilityCurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapContractWithCustomerLiabilityCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityCurrent" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapOperatingLeaseLiabilityCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredCompensationLiabilityCurrent" xlink:label="loc_us-gaapDeferredCompensationLiabilityCurrent" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapDeferredCompensationLiabilityCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="loc_us-gaapOtherLiabilitiesCurrent" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapOtherLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesNoncurrent" xlink:label="loc_us-gaapLiabilitiesNoncurrent" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityNoncurrent" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesNoncurrent" xlink:to="loc_us-gaapOperatingLeaseLiabilityNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="loc_us-gaapOtherLiabilitiesNoncurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesNoncurrent" xlink:to="loc_us-gaapOtherLiabilitiesNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermNotesPayable" xlink:label="loc_us-gaapLongTermNotesPayable" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesNoncurrent" xlink:to="loc_us-gaapLongTermNotesPayable" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapLiabilitiesNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapCommonStockValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaapAdditionalPaidInCapital" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapAdditionalPaidInCapital" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaapPreferredStockValue" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapPreferredStockValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_CommonStockSharesToBeIssuedValue" xlink:label="loc_SRNACommonStockSharesToBeIssuedValue" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_SRNACommonStockSharesToBeIssuedValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapLiabilities" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/BalanceSheetsParenthetical" xlink:title="00000003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/StatementsOfOperations" xlink:title="00000004 - Statement - Condensed Consolidated Statements of Operations (Unaudited)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit" xlink:label="loc_us-gaapGrossProfit" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfRevenue" xlink:label="loc_us-gaapCostOfRevenue" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapGrossProfit" xlink:to="loc_us-gaapCostOfRevenue" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapGrossProfit" xlink:to="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaapOperatingExpenses" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketingAndAdvertisingExpense" xlink:label="loc_us-gaapMarketingAndAdvertisingExpense" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapMarketingAndAdvertisingExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaapResearchAndDevelopmentExpense" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapResearchAndDevelopmentExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="loc_us-gaapSellingGeneralAndAdministrativeExpense" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapSellingGeneralAndAdministrativeExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaapOperatingIncomeLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingIncomeLoss" xlink:to="loc_us-gaapGrossProfit" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingIncomeLoss" xlink:to="loc_us-gaapOperatingExpenses" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="loc_us-gaapNonoperatingIncomeExpense" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="loc_us-gaapOtherNonoperatingIncomeExpense" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapOtherNonoperatingIncomeExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense" xlink:label="loc_us-gaapInterestExpense" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapInterestExpense" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="loc_us-gaapOperatingIncomeLoss" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="loc_us-gaapNonoperatingIncomeExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit" xlink:type="arc" weight="-1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/StatementsOfChangesInShareholdersDeficit" xlink:title="00000005 - Statement - Condensed Consolidated Statements of Changes in Shareholders&apos; Deficit (Unaudited)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/StatementsOfCashFlows" xlink:title="00000006 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="loc_us-gaapDepreciationDepletionAndAmortization" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapDepreciationDepletionAndAmortization" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaapShareBasedCompensation" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapShareBasedCompensation" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsAndNotesReceivable" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsAndNotesReceivable" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsAndNotesReceivable" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="loc_us-gaapIncreaseDecreaseInInventories" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInInventories" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidExpensesOther" xlink:label="loc_us-gaapIncreaseDecreaseInPrepaidExpensesOther" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInPrepaidExpensesOther" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsPayableAndAccruedLiabilities" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:label="loc_us-gaapIncreaseDecreaseInContractWithCustomerLiability" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInContractWithCustomerLiability" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnDispositionOfAssets" xlink:label="loc_us-gaapGainLossOnDispositionOfAssets" />
      <link:calculationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapGainLossOnDispositionOfAssets" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredCompensation" xlink:label="loc_us-gaapIncreaseDecreaseInDeferredCompensation" />
      <link:calculationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInDeferredCompensation" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:label="loc_us-gaapOperatingLeaseRightOfUseAssetAmortizationExpense" />
      <link:calculationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapOperatingLeaseRightOfUseAssetAmortizationExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInterestPayableNet" xlink:label="loc_us-gaapIncreaseDecreaseInInterestPayableNet" />
      <link:calculationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInInterestPayableNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryWriteDown" xlink:label="loc_us-gaapInventoryWriteDown" />
      <link:calculationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapInventoryWriteDown" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_OtherSharebasedExpense" xlink:label="loc_SRNAOtherSharebasedExpense" />
      <link:calculationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_SRNAOtherSharebasedExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:label="loc_us-gaapIncreaseDecreaseInOperatingLeaseLiability" />
      <link:calculationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInOperatingLeaseLiability" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_IncreaseDecreaseInLeaseDeposit" xlink:label="loc_SRNAIncreaseDecreaseInLeaseDeposit" />
      <link:calculationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_SRNAIncreaseDecreaseInLeaseDeposit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromNotesPayable" xlink:label="loc_us-gaapProceedsFromNotesPayable" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromNotesPayable" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:type="arc" weight="1" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/General" xlink:title="00000007 - Disclosure - General" />
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/Leases" xlink:title="00000008 - Disclosure - Leases" />
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/Inventory" xlink:title="00000009 - Disclosure - Inventory" />
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/PropertyAndEquipment" xlink:title="00000010 - Disclosure - Property and Equipment" />
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/AccountsPayableAndAccruedLiabilities" xlink:title="00000011 - Disclosure - Accounts Payable and Accrued Liabilities" />
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/NotePayableAndAccruedInterest" xlink:title="00000012 - Disclosure - Note Payable and Accrued Interest" />
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/CommitmentsAndContingencies" xlink:title="00000013 - Disclosure - Commitments and Contingencies" />
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/EquityIncentivePlan" xlink:title="00000014 - Disclosure - Equity Incentive Plan" />
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/Warrants" xlink:title="00000015 - Disclosure - Warrants" />
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/IncomeTaxes" xlink:title="00000016 - Disclosure - Income Taxes" />
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/SubsequentEvents" xlink:title="00000017 - Disclosure - Subsequent Events" />
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/GeneralPolicies" xlink:title="00000018 - Disclosure - General (Policies)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/GeneralTables" xlink:title="00000019 - Disclosure - General (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/LeasesTables" xlink:title="00000020 - Disclosure - Leases (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/InventoryTables" xlink:title="00000021 - Disclosure - Inventory (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/PropertyAndEquipmentTables" xlink:title="00000022 - Disclosure - Property and Equipment (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/AccountsPayableAndAccruedLiabilitiesTables" xlink:title="00000023 - Disclosure - Accounts Payable and Accrued Liabilities (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/EquityIncentivePlanTables" xlink:title="00000024 - Disclosure - Equity Incentive Plan (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/WarrantsTables" xlink:title="00000025 - Disclosure - Warrants (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/GeneralDetailsNarrative" xlink:title="00000026 - Disclosure - General (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/General-ScheduleOfRemainingPerformanceObligationsExpectedToBeRecognizedDetails" xlink:title="00000027 - Disclosure - General - Schedule of Remaining Performance Obligations Expected to be Recognized (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligation" xlink:label="loc_us-gaapRevenueRemainingPerformanceObligation" />
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_RemainingPerformanceObligationsRelatedToEngineeringOnlyPaidContracts" xlink:label="loc_SRNARemainingPerformanceObligationsRelatedToEngineeringOnlyPaidContracts" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapRevenueRemainingPerformanceObligation" xlink:to="loc_SRNARemainingPerformanceObligationsRelatedToEngineeringOnlyPaidContracts" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_RemainingPerformanceObligationsRelatedToPartialEquipmentPaidContracts" xlink:label="loc_SRNARemainingPerformanceObligationsRelatedToPartialEquipmentPaidContracts" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapRevenueRemainingPerformanceObligation" xlink:to="loc_SRNARemainingPerformanceObligationsRelatedToPartialEquipmentPaidContracts" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/General-ScheduleOfRevenueBySourceDetails" xlink:title="00000028 - Disclosure - General - Schedule of Revenue by Source (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/General-ScheduleOfShare-basedCompensationCostsDetails" xlink:title="00000029 - Disclosure - General - Schedule of Share-based Compensation Costs (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/LeasesDetailsNarrative" xlink:title="00000030 - Disclosure - Leases (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/Leases-ScheduleOfLeaseCostDetails" xlink:title="00000031 - Disclosure - Leases - Schedule of Lease Cost (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/Leases-ScheduleOfFutureAnnualMinimumLeasePaymentsDetails" xlink:title="00000032 - Disclosure - Leases - Schedule of Future Annual Minimum Lease Payments (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDue" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/InventoryDetailsNarrative" xlink:title="00000033 - Disclosure - Inventory (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/Inventory-ScheduleOfInventoryDetails" xlink:title="00000034 - Disclosure - Inventory - Schedule of Inventory (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaapInventoryNet" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryFinishedGoods" xlink:label="loc_us-gaapInventoryFinishedGoods" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapInventoryNet" xlink:to="loc_us-gaapInventoryFinishedGoods" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryWorkInProcess" xlink:label="loc_us-gaapInventoryWorkInProcess" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapInventoryNet" xlink:to="loc_us-gaapInventoryWorkInProcess" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryRawMaterials" xlink:label="loc_us-gaapInventoryRawMaterials" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapInventoryNet" xlink:to="loc_us-gaapInventoryRawMaterials" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryValuationReserves" xlink:label="loc_us-gaapInventoryValuationReserves" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapInventoryNet" xlink:to="loc_us-gaapInventoryValuationReserves" xlink:type="arc" weight="-1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/PropertyAndEquipmentDetailsNarrative" xlink:title="00000035 - Disclosure - Property and Equipment (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/PropertyAndEquipment-ScheduleOfPropertyAndEquipmentDetails" xlink:title="00000036 - Disclosure - Property and Equipment - Schedule of Property and Equipment (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="loc_us-gaapPropertyPlantAndEquipmentGross" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:to="loc_us-gaapPropertyPlantAndEquipmentGross" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:to="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" weight="-1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/AccountsPayableAndAccruedLiabilities-ScheduleOfAccountsPayableAndAccruedLiabilitiesDetails" xlink:title="00000037 - Disclosure - Accounts Payable and Accrued Liabilities - Schedule of Accounts Payable and Accrued Liabilities (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaapAccountsPayableCurrent" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent" xlink:to="loc_us-gaapAccountsPayableCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="loc_us-gaapEmployeeRelatedLiabilitiesCurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent" xlink:to="loc_us-gaapEmployeeRelatedLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductWarrantyAccrualClassifiedCurrent" xlink:label="loc_us-gaapProductWarrantyAccrualClassifiedCurrent" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent" xlink:to="loc_us-gaapProductWarrantyAccrualClassifiedCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="loc_us-gaapOtherAccruedLiabilitiesCurrent" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent" xlink:to="loc_us-gaapOtherAccruedLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedSalesCommissionCurrent" xlink:label="loc_us-gaapAccruedSalesCommissionCurrent" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent" xlink:to="loc_us-gaapAccruedSalesCommissionCurrent" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/NotePayableAndAccruedInterestDetailsNarrative" xlink:title="00000038 - Disclosure - Note Payable and Accrued Interest (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:title="00000039 - Disclosure - Commitments and Contingencies (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/EquityIncentivePlanDetailsNarrative" xlink:title="00000040 - Disclosure - Equity Incentive Plan (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/EquityIncentivePlan-ScheduleOfStockOptionActivityDetails" xlink:title="00000041 - Disclosure - Equity Incentive Plan - Schedule of Stock Option Activity (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/EquityIncentivePlan-SummaryOfNon-vestedNon-qualifiedStockOptionActivityDetails" xlink:title="00000042 - Disclosure - Equity Incentive Plan - Summary of Non-vested Non-qualified Stock Option Activity (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/EquityIncentivePlan-ScheduleOfRestrictedStockUnitsActivityDetails" xlink:title="00000043 - Disclosure - Equity Incentive Plan - Schedule of Restricted Stock Units Activity (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/Warrants-ScheduleOfOutstandingWarrantsToPurchaseCommonStockDetails" xlink:title="00000044 - Disclosure - Warrants - Schedule of Outstanding Warrants to Purchase Common Stock (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/Warrants-ScheduleOfWarrantsOutstandingDetails" xlink:title="00000045 - Disclosure - Warrants - Schedule of Warrants Outstanding (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/IncomeTaxesDetailsNarrative" xlink:title="00000046 - Disclosure - Income Taxes (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://surna.com/role/SubsequentEventsDetailsNarrative" xlink:title="00000047 - Disclosure - Subsequent Events (Details Narrative)" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>11
<FILENAME>srna-20210331_def.xml
<DESCRIPTION>XBRL DEFINITION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.8a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Source; Value: SRNA %2D 20210331 10Q Q1 DFN.xfr; Date: 2021%2D05%2D10T22:03:41Z -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x800A0000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://surna.com/role/DocumentAndEntityInformation" xlink:href="srna-20210331.xsd#DocumentAndEntityInformation" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/BalanceSheets" xlink:href="srna-20210331.xsd#BalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/BalanceSheetsParenthetical" xlink:href="srna-20210331.xsd#BalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/StatementsOfOperations" xlink:href="srna-20210331.xsd#StatementsOfOperations" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/StatementsOfChangesInShareholdersDeficit" xlink:href="srna-20210331.xsd#StatementsOfChangesInShareholdersDeficit" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/StatementsOfCashFlows" xlink:href="srna-20210331.xsd#StatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/General" xlink:href="srna-20210331.xsd#General" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/Leases" xlink:href="srna-20210331.xsd#Leases" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/Inventory" xlink:href="srna-20210331.xsd#Inventory" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/PropertyAndEquipment" xlink:href="srna-20210331.xsd#PropertyAndEquipment" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/AccountsPayableAndAccruedLiabilities" xlink:href="srna-20210331.xsd#AccountsPayableAndAccruedLiabilities" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/NotePayableAndAccruedInterest" xlink:href="srna-20210331.xsd#NotePayableAndAccruedInterest" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/CommitmentsAndContingencies" xlink:href="srna-20210331.xsd#CommitmentsAndContingencies" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/EquityIncentivePlan" xlink:href="srna-20210331.xsd#EquityIncentivePlan" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/Warrants" xlink:href="srna-20210331.xsd#Warrants" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/IncomeTaxes" xlink:href="srna-20210331.xsd#IncomeTaxes" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/SubsequentEvents" xlink:href="srna-20210331.xsd#SubsequentEvents" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/GeneralPolicies" xlink:href="srna-20210331.xsd#GeneralPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/GeneralTables" xlink:href="srna-20210331.xsd#GeneralTables" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/LeasesTables" xlink:href="srna-20210331.xsd#LeasesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/InventoryTables" xlink:href="srna-20210331.xsd#InventoryTables" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/PropertyAndEquipmentTables" xlink:href="srna-20210331.xsd#PropertyAndEquipmentTables" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/AccountsPayableAndAccruedLiabilitiesTables" xlink:href="srna-20210331.xsd#AccountsPayableAndAccruedLiabilitiesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/EquityIncentivePlanTables" xlink:href="srna-20210331.xsd#EquityIncentivePlanTables" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/WarrantsTables" xlink:href="srna-20210331.xsd#WarrantsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/GeneralDetailsNarrative" xlink:href="srna-20210331.xsd#GeneralDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/General-ScheduleOfRemainingPerformanceObligationsExpectedToBeRecognizedDetails" xlink:href="srna-20210331.xsd#General-ScheduleOfRemainingPerformanceObligationsExpectedToBeRecognizedDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/General-ScheduleOfRevenueBySourceDetails" xlink:href="srna-20210331.xsd#General-ScheduleOfRevenueBySourceDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/General-ScheduleOfShare-basedCompensationCostsDetails" xlink:href="srna-20210331.xsd#General-ScheduleOfShare-basedCompensationCostsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/LeasesDetailsNarrative" xlink:href="srna-20210331.xsd#LeasesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/Leases-ScheduleOfLeaseCostDetails" xlink:href="srna-20210331.xsd#Leases-ScheduleOfLeaseCostDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/Leases-ScheduleOfFutureAnnualMinimumLeasePaymentsDetails" xlink:href="srna-20210331.xsd#Leases-ScheduleOfFutureAnnualMinimumLeasePaymentsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/InventoryDetailsNarrative" xlink:href="srna-20210331.xsd#InventoryDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/Inventory-ScheduleOfInventoryDetails" xlink:href="srna-20210331.xsd#Inventory-ScheduleOfInventoryDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/PropertyAndEquipmentDetailsNarrative" xlink:href="srna-20210331.xsd#PropertyAndEquipmentDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/PropertyAndEquipment-ScheduleOfPropertyAndEquipmentDetails" xlink:href="srna-20210331.xsd#PropertyAndEquipment-ScheduleOfPropertyAndEquipmentDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/AccountsPayableAndAccruedLiabilities-ScheduleOfAccountsPayableAndAccruedLiabilitiesDetails" xlink:href="srna-20210331.xsd#AccountsPayableAndAccruedLiabilities-ScheduleOfAccountsPayableAndAccruedLiabilitiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/NotePayableAndAccruedInterestDetailsNarrative" xlink:href="srna-20210331.xsd#NotePayableAndAccruedInterestDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:href="srna-20210331.xsd#CommitmentsAndContingenciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/EquityIncentivePlanDetailsNarrative" xlink:href="srna-20210331.xsd#EquityIncentivePlanDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/EquityIncentivePlan-ScheduleOfStockOptionActivityDetails" xlink:href="srna-20210331.xsd#EquityIncentivePlan-ScheduleOfStockOptionActivityDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/EquityIncentivePlan-SummaryOfNon-vestedNon-qualifiedStockOptionActivityDetails" xlink:href="srna-20210331.xsd#EquityIncentivePlan-SummaryOfNon-vestedNon-qualifiedStockOptionActivityDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/EquityIncentivePlan-ScheduleOfRestrictedStockUnitsActivityDetails" xlink:href="srna-20210331.xsd#EquityIncentivePlan-ScheduleOfRestrictedStockUnitsActivityDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/Warrants-ScheduleOfOutstandingWarrantsToPurchaseCommonStockDetails" xlink:href="srna-20210331.xsd#Warrants-ScheduleOfOutstandingWarrantsToPurchaseCommonStockDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/Warrants-ScheduleOfWarrantsOutstandingDetails" xlink:href="srna-20210331.xsd#Warrants-ScheduleOfWarrantsOutstandingDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/IncomeTaxesDetailsNarrative" xlink:href="srna-20210331.xsd#IncomeTaxesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/SubsequentEventsDetailsNarrative" xlink:href="srna-20210331.xsd#SubsequentEventsDetailsNarrative" xlink:type="simple" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll" arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" />
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/DocumentAndEntityInformation" xlink:title="00000001 - Document - Document and Entity Information" />
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/BalanceSheets" xlink:title="00000002 - Statement - Condensed Consolidated Balance Sheets" />
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/BalanceSheetsParenthetical" xlink:title="00000003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/StatementsOfOperations" xlink:title="00000004 - Statement - Condensed Consolidated Statements of Operations (Unaudited)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/StatementsOfChangesInShareholdersDeficit" xlink:title="00000005 - Statement - Condensed Consolidated Statements of Changes in Shareholders&apos; Deficit (Unaudited)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockMember" xlink:label="loc_us-gaapPreferredStockMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapPreferredStockMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapCommonStockMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaapAdditionalPaidInCapitalMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapAdditionalPaidInCapitalMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaapRetainedEarningsMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapRetainedEarningsMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquity_60" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaapSharesOutstanding_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesOutstanding_60" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_CommonStockSharesToBeIssuedBalance" xlink:label="loc_SRNACommonStockSharesToBeIssuedBalance_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SRNACommonStockSharesToBeIssuedBalance_60" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_CommonStockValueToBeIssuedBalance" xlink:label="loc_SRNACommonStockValueToBeIssuedBalance_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SRNACommonStockValueToBeIssuedBalance_60" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonuses" xlink:label="loc_SRNACommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonuses_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SRNACommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonuses_60" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesShares" xlink:label="loc_SRNACommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesShares_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SRNACommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesShares_60" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesSharesToBeIssued" xlink:label="loc_SRNACommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesSharesToBeIssued_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SRNACommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesSharesToBeIssued_60" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition" xlink:label="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition_60" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" xlink:label="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_60" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_CommonSharesToBeIssuedInSettlementOfLegalDispute" xlink:label="loc_SRNACommonSharesToBeIssuedInSettlementOfLegalDispute_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SRNACommonSharesToBeIssuedInSettlementOfLegalDispute_60" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_CommonSharesToBeIssuedInSettlementOfLegalDisputeSharesToBeIssued" xlink:label="loc_SRNACommonSharesToBeIssuedInSettlementOfLegalDisputeSharesToBeIssued_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SRNACommonSharesToBeIssuedInSettlementOfLegalDisputeSharesToBeIssued_60" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_FairValueOfVestedStockOptionsGrantedToEmployees" xlink:label="loc_SRNAFairValueOfVestedStockOptionsGrantedToEmployees_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SRNAFairValueOfVestedStockOptionsGrantedToEmployees_60" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_FairValueOfVestedStockOptionsGrantedToDirectors" xlink:label="loc_SRNAFairValueOfVestedStockOptionsGrantedToDirectors_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SRNAFairValueOfVestedStockOptionsGrantedToDirectors_60" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLoss_60" xlink:type="arc" order="15" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/StatementsOfCashFlows" xlink:title="00000006 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/General" xlink:title="00000007 - Disclosure - General" />
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/Leases" xlink:title="00000008 - Disclosure - Leases" />
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/Inventory" xlink:title="00000009 - Disclosure - Inventory" />
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/PropertyAndEquipment" xlink:title="00000010 - Disclosure - Property and Equipment" />
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/AccountsPayableAndAccruedLiabilities" xlink:title="00000011 - Disclosure - Accounts Payable and Accrued Liabilities" />
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/NotePayableAndAccruedInterest" xlink:title="00000012 - Disclosure - Note Payable and Accrued Interest" />
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/CommitmentsAndContingencies" xlink:title="00000013 - Disclosure - Commitments and Contingencies" />
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/EquityIncentivePlan" xlink:title="00000014 - Disclosure - Equity Incentive Plan" />
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/Warrants" xlink:title="00000015 - Disclosure - Warrants" />
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/IncomeTaxes" xlink:title="00000016 - Disclosure - Income Taxes" />
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/SubsequentEvents" xlink:title="00000017 - Disclosure - Subsequent Events" />
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/GeneralPolicies" xlink:title="00000018 - Disclosure - General (Policies)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/GeneralTables" xlink:title="00000019 - Disclosure - General (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/LeasesTables" xlink:title="00000020 - Disclosure - Leases (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/InventoryTables" xlink:title="00000021 - Disclosure - Inventory (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/PropertyAndEquipmentTables" xlink:title="00000022 - Disclosure - Property and Equipment (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/AccountsPayableAndAccruedLiabilitiesTables" xlink:title="00000023 - Disclosure - Accounts Payable and Accrued Liabilities (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/EquityIncentivePlanTables" xlink:title="00000024 - Disclosure - Equity Incentive Plan (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaapPlanNameAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapPlanNameAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_TwoThousandSeventeenEquityPlanMember" xlink:label="loc_SRNATwoThousandSeventeenEquityPlanMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_SRNATwoThousandSeventeenEquityPlanMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtTitleOfIndividualAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_EmployeesAndConsultantsMember" xlink:label="loc_SRNAEmployeesAndConsultantsMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_SRNAEmployeesAndConsultantsMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_DirectorMember" xlink:label="loc_srtDirectorMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_srtDirectorMember_10" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_40" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock" xlink:label="loc_us-gaapScheduleOfNonvestedShareActivityTableTextBlock_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapScheduleOfNonvestedShareActivityTableTextBlock_40" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_40" xlink:type="arc" order="2" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/WarrantsTables" xlink:title="00000025 - Disclosure - Warrants (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/GeneralDetailsNarrative" xlink:title="00000026 - Disclosure - General (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerContractsMember" xlink:label="loc_us-gaapCustomerContractsMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapCustomerContractsMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardDateAxis" xlink:label="loc_us-gaapAwardDateAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapAwardDateAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardDateDomain" xlink:label="loc_us-gaapAwardDateDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAwardDateAxis" xlink:to="loc_us-gaapAwardDateDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardDateDomain" xlink:label="loc_us-gaapAwardDateDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAwardDateAxis" xlink:to="loc_us-gaapAwardDateDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_TwoThousandAndTwentyTwoMember" xlink:label="loc_SRNATwoThousandAndTwentyTwoMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAwardDateDomain" xlink:to="loc_SRNATwoThousandAndTwentyTwoMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaapPlanNameAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapPlanNameAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_TwoThousandTwentyOneAnnualEmployeeIncentiveCompensationPlanMember" xlink:label="loc_SRNATwoThousandTwentyOneAnnualEmployeeIncentiveCompensationPlanMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_SRNATwoThousandTwentyOneAnnualEmployeeIncentiveCompensationPlanMember_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="loc_us-gaapConcentrationRiskByTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapConcentrationRiskByTypeAxis" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="loc_us-gaapConcentrationRiskTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapConcentrationRiskByTypeAxis" xlink:to="loc_us-gaapConcentrationRiskTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="loc_us-gaapConcentrationRiskTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapConcentrationRiskByTypeAxis" xlink:to="loc_us-gaapConcentrationRiskTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerConcentrationRiskMember" xlink:label="loc_us-gaapCustomerConcentrationRiskMember_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConcentrationRiskTypeDomain" xlink:to="loc_us-gaapCustomerConcentrationRiskMember_70" xlink:type="arc" order="71" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="loc_us-gaapConcentrationRiskByBenchmarkAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapConcentrationRiskByBenchmarkAxis" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaapConcentrationRiskBenchmarkDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapConcentrationRiskByBenchmarkAxis" xlink:to="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaapConcentrationRiskBenchmarkDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapConcentrationRiskByBenchmarkAxis" xlink:to="loc_us-gaapConcentrationRiskBenchmarkDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesRevenueNetMember" xlink:label="loc_us-gaapSalesRevenueNetMember_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:to="loc_us-gaapSalesRevenueNetMember_70" xlink:type="arc" order="72" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableMember" xlink:label="loc_us-gaapAccountsReceivableMember_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:to="loc_us-gaapAccountsReceivableMember_140" xlink:type="arc" order="142" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MajorCustomersAxis" xlink:label="loc_srtMajorCustomersAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtMajorCustomersAxis" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_NameOfMajorCustomerDomain" xlink:label="loc_srtNameOfMajorCustomerDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtMajorCustomersAxis" xlink:to="loc_srtNameOfMajorCustomerDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_NameOfMajorCustomerDomain" xlink:label="loc_srtNameOfMajorCustomerDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtMajorCustomersAxis" xlink:to="loc_srtNameOfMajorCustomerDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_CustomerOneMember" xlink:label="loc_SRNACustomerOneMember_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_SRNACustomerOneMember_70" xlink:type="arc" order="73" />
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_CustomerTwoMember" xlink:label="loc_SRNACustomerTwoMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_SRNACustomerTwoMember_80" xlink:type="arc" order="83" />
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_CustomerThreeMember" xlink:label="loc_SRNACustomerThreeMember_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_SRNACustomerThreeMember_90" xlink:type="arc" order="93" />
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_CustomerFourMember" xlink:label="loc_SRNACustomerFourMember_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_SRNACustomerFourMember_130" xlink:type="arc" order="133" />
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_CashBalanceTransferredToBankAccount" xlink:label="loc_SRNACashBalanceTransferredToBankAccount_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SRNACashBalanceTransferredToBankAccount_200" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCash" xlink:label="loc_us-gaapRestrictedCash_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRestrictedCash_200" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities" xlink:label="loc_us-gaapIncrementalCommonSharesAttributableToConversionOfDebtSecurities_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncrementalCommonSharesAttributableToConversionOfDebtSecurities_200" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillImpairmentLoss" xlink:label="loc_us-gaapGoodwillImpairmentLoss_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapGoodwillImpairmentLoss_200" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:label="loc_us-gaapContractWithCustomerLiabilityRevenueRecognized_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapContractWithCustomerLiabilityRevenueRecognized_200" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligation" xlink:label="loc_us-gaapRevenueRemainingPerformanceObligation_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRevenueRemainingPerformanceObligation_200" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationPercentage" xlink:label="loc_us-gaapRevenueRemainingPerformanceObligationPercentage_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRevenueRemainingPerformanceObligationPercentage_200" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_200" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_200" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_200" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="loc_us-gaapAllocatedShareBasedCompensationExpense_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAllocatedShareBasedCompensationExpense_200" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="loc_us-gaapConcentrationRiskPercentage1_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapConcentrationRiskPercentage1_200" xlink:type="arc" order="11" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/General-ScheduleOfRemainingPerformanceObligationsExpectedToBeRecognizedDetails" xlink:title="00000027 - Disclosure - General - Schedule of Remaining Performance Obligations Expected to be Recognized (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems" xlink:label="loc_us-gaapRevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable" xlink:label="loc_us-gaapRevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems" xlink:to="loc_us-gaapRevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardDateAxis" xlink:label="loc_us-gaapAwardDateAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapRevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable" xlink:to="loc_us-gaapAwardDateAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardDateDomain" xlink:label="loc_us-gaapAwardDateDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAwardDateAxis" xlink:to="loc_us-gaapAwardDateDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardDateDomain" xlink:label="loc_us-gaapAwardDateDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAwardDateAxis" xlink:to="loc_us-gaapAwardDateDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_TwoThousandAndTwentyOneMember" xlink:label="loc_SRNATwoThousandAndTwentyOneMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAwardDateDomain" xlink:to="loc_SRNATwoThousandAndTwentyOneMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_TwoThousandAndTwentyTwoMember" xlink:label="loc_SRNATwoThousandAndTwentyTwoMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAwardDateDomain" xlink:to="loc_SRNATwoThousandAndTwentyTwoMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_RemainingPerformanceObligationsRelatedToEngineeringOnlyPaidContracts" xlink:label="loc_SRNARemainingPerformanceObligationsRelatedToEngineeringOnlyPaidContracts_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems" xlink:to="loc_SRNARemainingPerformanceObligationsRelatedToEngineeringOnlyPaidContracts_40" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_RemainingPerformanceObligationsRelatedToPartialEquipmentPaidContracts" xlink:label="loc_SRNARemainingPerformanceObligationsRelatedToPartialEquipmentPaidContracts_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems" xlink:to="loc_SRNARemainingPerformanceObligationsRelatedToPartialEquipmentPaidContracts_40" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligation" xlink:label="loc_us-gaapRevenueRemainingPerformanceObligation_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems" xlink:to="loc_us-gaapRevenueRemainingPerformanceObligation_40" xlink:type="arc" order="2" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/General-ScheduleOfRevenueBySourceDetails" xlink:title="00000028 - Disclosure - General - Schedule of Revenue by Source (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems" xlink:label="loc_us-gaapDisaggregationOfRevenueLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTable" xlink:label="loc_us-gaapDisaggregationOfRevenueTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDisaggregationOfRevenueLineItems" xlink:to="loc_us-gaapDisaggregationOfRevenueTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis" xlink:label="loc_srtProductOrServiceAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapDisaggregationOfRevenueTable" xlink:to="loc_srtProductOrServiceAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srtProductsAndServicesDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtProductOrServiceAxis" xlink:to="loc_srtProductsAndServicesDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srtProductsAndServicesDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtProductOrServiceAxis" xlink:to="loc_srtProductsAndServicesDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquipmentMember" xlink:label="loc_us-gaapEquipmentMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_us-gaapEquipmentMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_EngineeringAndOtherServicesMember" xlink:label="loc_SRNAEngineeringAndOtherServicesMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_SRNAEngineeringAndOtherServicesMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShippingAndHandlingMember" xlink:label="loc_us-gaapShippingAndHandlingMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_us-gaapShippingAndHandlingMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDisaggregationOfRevenueLineItems" xlink:to="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax_90" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/General-ScheduleOfShare-basedCompensationCostsDetails" xlink:title="00000029 - Disclosure - General - Schedule of Share-based Compensation Costs (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaapIncomeStatementLocationAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapIncomeStatementLocationAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaapIncomeStatementLocationDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapIncomeStatementLocationAxis" xlink:to="loc_us-gaapIncomeStatementLocationDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaapIncomeStatementLocationDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapIncomeStatementLocationAxis" xlink:to="loc_us-gaapIncomeStatementLocationDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfSalesMember" xlink:label="loc_us-gaapCostOfSalesMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncomeStatementLocationDomain" xlink:to="loc_us-gaapCostOfSalesMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdvertisingMember" xlink:label="loc_us-gaapAdvertisingMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncomeStatementLocationDomain" xlink:to="loc_us-gaapAdvertisingMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" xlink:label="loc_us-gaapSoftwareAndSoftwareDevelopmentCostsMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncomeStatementLocationDomain" xlink:to="loc_us-gaapSoftwareAndSoftwareDevelopmentCostsMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:label="loc_us-gaapSellingGeneralAndAdministrativeExpensesMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncomeStatementLocationDomain" xlink:to="loc_us-gaapSellingGeneralAndAdministrativeExpensesMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="loc_us-gaapAllocatedShareBasedCompensationExpense_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAllocatedShareBasedCompensationExpense_110" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/LeasesDetailsNarrative" xlink:title="00000030 - Disclosure - Leases (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems" xlink:label="loc_us-gaapLesseeLeaseDescriptionLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable" xlink:label="loc_us-gaapLesseeLeaseDescriptionTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapLesseeLeaseDescriptionLineItems" xlink:to="loc_us-gaapLesseeLeaseDescriptionTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapLesseeLeaseDescriptionTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_FacilityLeaseMember" xlink:label="loc_SRNAFacilityLeaseMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_SRNAFacilityLeaseMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:label="loc_us-gaapAdjustmentsForNewAccountingPronouncementsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapLesseeLeaseDescriptionTable" xlink:to="loc_us-gaapAdjustmentsForNewAccountingPronouncementsAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfAdoptionMember" xlink:label="loc_us-gaapTypeOfAdoptionMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAdjustmentsForNewAccountingPronouncementsAxis" xlink:to="loc_us-gaapTypeOfAdoptionMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfAdoptionMember" xlink:label="loc_us-gaapTypeOfAdoptionMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAdjustmentsForNewAccountingPronouncementsAxis" xlink:to="loc_us-gaapTypeOfAdoptionMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingStandardsUpdate201602Member" xlink:label="loc_us-gaapAccountingStandardsUpdate201602Member_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTypeOfAdoptionMember" xlink:to="loc_us-gaapAccountingStandardsUpdate201602Member_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapLesseeLeaseDescriptionTable" xlink:to="loc_srtRangeAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember_30" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaapOperatingLeaseRightOfUseAsset_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLesseeLeaseDescriptionLineItems" xlink:to="loc_us-gaapOperatingLeaseRightOfUseAsset_50" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability" xlink:label="loc_us-gaapOperatingLeaseLiability_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLesseeLeaseDescriptionLineItems" xlink:to="loc_us-gaapOperatingLeaseLiability_50" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseDescription" xlink:label="loc_us-gaapLesseeOperatingLeaseDescription_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLesseeLeaseDescriptionLineItems" xlink:to="loc_us-gaapLesseeOperatingLeaseDescription_50" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:label="loc_us-gaapLesseeOperatingLeaseRenewalTerm_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLesseeLeaseDescriptionLineItems" xlink:to="loc_us-gaapLesseeOperatingLeaseRenewalTerm_50" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_MonthlyRentDescription" xlink:label="loc_SRNAMonthlyRentDescription_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLesseeLeaseDescriptionLineItems" xlink:to="loc_SRNAMonthlyRentDescription_50" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TenantImprovements" xlink:label="loc_us-gaapTenantImprovements_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLesseeLeaseDescriptionLineItems" xlink:to="loc_us-gaapTenantImprovements_50" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_UnamortizedAmountOfTenantImprovementAllowance" xlink:label="loc_SRNAUnamortizedAmountOfTenantImprovementAllowance_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLesseeLeaseDescriptionLineItems" xlink:to="loc_SRNAUnamortizedAmountOfTenantImprovementAllowance_50" xlink:type="arc" order="6" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/Leases-ScheduleOfLeaseCostDetails" xlink:title="00000031 - Disclosure - Leases - Schedule of Lease Cost (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/Leases-ScheduleOfFutureAnnualMinimumLeasePaymentsDetails" xlink:title="00000032 - Disclosure - Leases - Schedule of Future Annual Minimum Lease Payments (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/InventoryDetailsNarrative" xlink:title="00000033 - Disclosure - Inventory (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/Inventory-ScheduleOfInventoryDetails" xlink:title="00000034 - Disclosure - Inventory - Schedule of Inventory (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/PropertyAndEquipmentDetailsNarrative" xlink:title="00000035 - Disclosure - Property and Equipment (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentMember" xlink:label="loc_us-gaapPropertyPlantAndEquipmentMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapPropertyPlantAndEquipmentMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaapIncomeStatementLocationAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapIncomeStatementLocationAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaapIncomeStatementLocationDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapIncomeStatementLocationAxis" xlink:to="loc_us-gaapIncomeStatementLocationDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaapIncomeStatementLocationDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapIncomeStatementLocationAxis" xlink:to="loc_us-gaapIncomeStatementLocationDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfSalesMember" xlink:label="loc_us-gaapCostOfSalesMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncomeStatementLocationDomain" xlink:to="loc_us-gaapCostOfSalesMember_10" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_InventoryMember" xlink:label="loc_SRNAInventoryMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncomeStatementLocationDomain" xlink:to="loc_SRNAInventoryMember_20" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Depreciation" xlink:label="loc_us-gaapDepreciation_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDepreciation_40" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="loc_us-gaapSellingGeneralAndAdministrativeExpense_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSellingGeneralAndAdministrativeExpense_40" xlink:type="arc" order="1" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/PropertyAndEquipment-ScheduleOfPropertyAndEquipmentDetails" xlink:title="00000036 - Disclosure - Property and Equipment - Schedule of Property and Equipment (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaapPropertyPlantAndEquipmentLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="loc_us-gaapFurnitureAndFixturesMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapFurnitureAndFixturesMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VehiclesMember" xlink:label="loc_us-gaapVehiclesMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapVehiclesMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="loc_us-gaapLeaseholdImprovementsMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapLeaseholdImprovementsMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="loc_us-gaapPropertyPlantAndEquipmentGross_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentGross_90" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_90" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet_90" xlink:type="arc" order="2" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/AccountsPayableAndAccruedLiabilities-ScheduleOfAccountsPayableAndAccruedLiabilitiesDetails" xlink:title="00000037 - Disclosure - Accounts Payable and Accrued Liabilities - Schedule of Accounts Payable and Accrued Liabilities (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/NotePayableAndAccruedInterestDetailsNarrative" xlink:title="00000038 - Disclosure - Note Payable and Accrued Interest (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:title="00000039 - Disclosure - Commitments and Contingencies (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapAwardTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="loc_us-gaapRestrictedStockUnitsRSUMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapRestrictedStockUnitsRSUMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtTitleOfIndividualAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_FormerEmployeeMember" xlink:label="loc_SRNAFormerEmployeeMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_SRNAFormerEmployeeMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_NumberOfUnitsVestedButNotSettled" xlink:label="loc_SRNANumberOfUnitsVestedButNotSettled_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SRNANumberOfUnitsVestedButNotSettled_70" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_NumberOfUnitsVestedAndSettled" xlink:label="loc_SRNANumberOfUnitsVestedAndSettled_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SRNANumberOfUnitsVestedAndSettled_70" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyDamagesAwardedValue" xlink:label="loc_us-gaapLossContingencyDamagesAwardedValue_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLossContingencyDamagesAwardedValue_70" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_RestrictedStockUnitsSharesIssuedInterestPercentage" xlink:label="loc_SRNARestrictedStockUnitsSharesIssuedInterestPercentage_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SRNARestrictedStockUnitsSharesIssuedInterestPercentage_70" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyDamagesPaidValue" xlink:label="loc_us-gaapLossContingencyDamagesPaidValue_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLossContingencyDamagesPaidValue_70" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_AggregateSharesIssuedUponExecutionOfSettlement" xlink:label="loc_SRNAAggregateSharesIssuedUponExecutionOfSettlement_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SRNAAggregateSharesIssuedUponExecutionOfSettlement_70" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingExpense" xlink:label="loc_us-gaapOtherNonoperatingExpense_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOtherNonoperatingExpense_70" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" xlink:label="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_70" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_StockIssuanceAmount" xlink:label="loc_SRNAStockIssuanceAmount_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SRNAStockIssuanceAmount_70" xlink:type="arc" order="8" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/EquityIncentivePlanDetailsNarrative" xlink:title="00000040 - Disclosure - Equity Incentive Plan (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaapPlanNameAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapPlanNameAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_TwoThousandAndSeventeenEquityIncentivePlanMember" xlink:label="loc_SRNATwoThousandAndSeventeenEquityIncentivePlanMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_SRNATwoThousandAndSeventeenEquityIncentivePlanMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_TwoThousandAndTwentyOneEquityIncentivePlanMember" xlink:label="loc_SRNATwoThousandAndTwentyOneEquityIncentivePlanMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_SRNATwoThousandAndTwentyOneEquityIncentivePlanMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_TwoThousandAndSeventeenEquityPlanMember" xlink:label="loc_SRNATwoThousandAndSeventeenEquityPlanMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_SRNATwoThousandAndSeventeenEquityPlanMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapAwardTypeAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_IncentiveStockBonusAwardsMember" xlink:label="loc_SRNAIncentiveStockBonusAwardsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_SRNAIncentiveStockBonusAwardsMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_NonQualifiedStockOptionsMember" xlink:label="loc_SRNANonQualifiedStockOptionsMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_SRNANonQualifiedStockOptionsMember_30" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="loc_us-gaapRestrictedStockUnitsRSUMember_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapRestrictedStockUnitsRSUMember_90" xlink:type="arc" order="91" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_EmployeesMember" xlink:label="loc_SRNAEmployeesMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_SRNAEmployeesMember_10" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_EmployeesAndConsultantsMember" xlink:label="loc_SRNAEmployeesAndConsultantsMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_SRNAEmployeesAndConsultantsMember_30" xlink:type="arc" order="33" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_srtTitleOfIndividualAxis" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_DirectorMember" xlink:label="loc_srtDirectorMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_srtDirectorMember_50" xlink:type="arc" order="52" />
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_DirectorsMember" xlink:label="loc_SRNADirectorsMember_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_SRNADirectorsMember_70" xlink:type="arc" order="73" />
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_EmployeesDirectorsandConsultantsMember" xlink:label="loc_SRNAEmployeesDirectorsandConsultantsMember_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_SRNAEmployeesDirectorsandConsultantsMember_90" xlink:type="arc" order="92" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaapSubsequentEventTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapSubsequentEventTypeAxis" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaapSubsequentEventMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventTypeDomain" xlink:to="loc_us-gaapSubsequentEventMember_80" xlink:type="arc" order="81" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:label="loc_us-gaapCommonStockCapitalSharesReservedForFutureIssuance_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapCommonStockCapitalSharesReservedForFutureIssuance_130" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_130" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaapShareBasedCompensation_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensation_130" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_130" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_130" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_130" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_130" xlink:type="arc" order="6" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/EquityIncentivePlan-ScheduleOfStockOptionActivityDetails" xlink:title="00000041 - Disclosure - Equity Incentive Plan - Schedule of Stock Option Activity (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaapPlanNameAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapPlanNameAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_TwoThousandAndSeventeenEquityPlanMember" xlink:label="loc_SRNATwoThousandAndSeventeenEquityPlanMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_SRNATwoThousandAndSeventeenEquityPlanMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_EmployeesAndConsultantsMember" xlink:label="loc_SRNAEmployeesAndConsultantsMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_SRNAEmployeesAndConsultantsMember_0" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapAwardTypeAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_NonQualifiedStockOptionsMember" xlink:label="loc_SRNANonQualifiedStockOptionsMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_SRNANonQualifiedStockOptionsMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_srtTitleOfIndividualAxis" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_DirectorsMember" xlink:label="loc_SRNADirectorsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_SRNADirectorsMember_10" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_30" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_30" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised_30" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_30" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_30" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_30" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_30" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_30" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_30" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_30" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_30" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_30" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_30" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermGranted" xlink:label="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermGranted_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermGranted_30" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm" xlink:label="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm_30" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_30" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_30" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_30" xlink:type="arc" order="23" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/EquityIncentivePlan-SummaryOfNon-vestedNon-qualifiedStockOptionActivityDetails" xlink:title="00000042 - Disclosure - Equity Incentive Plan - Summary of Non-vested Non-qualified Stock Option Activity (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaapPlanNameAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapPlanNameAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_TwoThousandAndSeventeenEquityPlanMember" xlink:label="loc_SRNATwoThousandAndSeventeenEquityPlanMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_SRNATwoThousandAndSeventeenEquityPlanMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_EmployeesAndConsultantsMember" xlink:label="loc_SRNAEmployeesAndConsultantsMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_SRNAEmployeesAndConsultantsMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_srtTitleOfIndividualAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_DirectorsMember" xlink:label="loc_SRNADirectorsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_SRNADirectorsMember_10" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_30" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_30" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_30" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_30" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsNumberOfOptionsExpired" xlink:label="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsNumberOfOptionsExpired_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsNumberOfOptionsExpired_30" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_30" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_30" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_30" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue_30" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsExpired" xlink:label="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsExpired_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsExpired_30" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1" xlink:label="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1_30" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested" xlink:label="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested_30" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValuesGranted" xlink:label="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValuesGranted_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValuesGranted_30" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValueVested" xlink:label="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValueVested_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValueVested_30" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantDateFairValueForfeited" xlink:label="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantDateFairValueForfeited_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantDateFairValueForfeited_30" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfSharesGrantDateFairValueExpired" xlink:label="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfSharesGrantDateFairValueExpired_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfSharesGrantDateFairValueExpired_30" xlink:type="arc" order="21" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/EquityIncentivePlan-ScheduleOfRestrictedStockUnitsActivityDetails" xlink:title="00000043 - Disclosure - Equity Incentive Plan - Schedule of Restricted Stock Units Activity (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaapPlanNameAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapPlanNameAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_TwoThousandAndSeventeenEquityPlanMember" xlink:label="loc_SRNATwoThousandAndSeventeenEquityPlanMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_SRNATwoThousandAndSeventeenEquityPlanMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_srtTitleOfIndividualAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_EmployeesDirectorsandConsultantsMember" xlink:label="loc_SRNAEmployeesDirectorsandConsultantsMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_SRNAEmployeesDirectorsandConsultantsMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_20" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_20" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_20" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_20" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_20" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_20" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_20" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_20" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_20" xlink:type="arc" order="12" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/Warrants-ScheduleOfOutstandingWarrantsToPurchaseCommonStockDetails" xlink:title="00000044 - Disclosure - Warrants - Schedule of Outstanding Warrants to Purchase Common Stock (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/Warrants-ScheduleOfWarrantsOutstandingDetails" xlink:title="00000045 - Disclosure - Warrants - Schedule of Warrants Outstanding (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:to="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:to="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_WarrantsRangeMember" xlink:label="loc_SRNAWarrantsRangeMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_SRNAWarrantsRangeMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_WarrantsRangeOneMember" xlink:label="loc_SRNAWarrantsRangeOneMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_SRNAWarrantsRangeOneMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_30" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="loc_us-gaapClassOfWarrantOrRightOutstanding_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightOutstanding_30" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm" xlink:label="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm_30" xlink:type="arc" order="2" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/IncomeTaxesDetailsNarrative" xlink:title="00000046 - Disclosure - Income Taxes (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://surna.com/role/SubsequentEventsDetailsNarrative" xlink:title="00000047 - Disclosure - Subsequent Events (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaapSubsequentEventTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapSubsequentEventTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaapSubsequentEventMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventTypeDomain" xlink:to="loc_us-gaapSubsequentEventMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaapPlanNameAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapPlanNameAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_TwoThousandAndSeventeenEquityPlanMember" xlink:label="loc_SRNATwoThousandAndSeventeenEquityPlanMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_SRNATwoThousandAndSeventeenEquityPlanMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapAwardTypeAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_NonQualifiedStockOptionsMember" xlink:label="loc_SRNANonQualifiedStockOptionsMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_SRNANonQualifiedStockOptionsMember_0" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtTitleOfIndividualAxis" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_DirectorsMember" xlink:label="loc_SRNADirectorsMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_SRNADirectorsMember_0" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_FormerEmployeeMember" xlink:label="loc_SRNAFormerEmployeeMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_SRNAFormerEmployeeMember_10" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_OfficeandManufacturingMember" xlink:label="loc_SRNAOfficeandManufacturingMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_SRNAOfficeandManufacturingMember_20" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis" xlink:label="loc_srtStatementScenarioAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtStatementScenarioAxis" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srtScenarioUnspecifiedDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtStatementScenarioAxis" xlink:to="loc_srtScenarioUnspecifiedDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srtScenarioUnspecifiedDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtStatementScenarioAxis" xlink:to="loc_srtScenarioUnspecifiedDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioForecastMember" xlink:label="loc_srtScenarioForecastMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtScenarioUnspecifiedDomain" xlink:to="loc_srtScenarioForecastMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_60" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_AggregateSharesIssuedUponExecutionOfSettlement" xlink:label="loc_SRNAAggregateSharesIssuedUponExecutionOfSettlement_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SRNAAggregateSharesIssuedUponExecutionOfSettlement_60" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_60" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AreaOfLand" xlink:label="loc_us-gaapAreaOfLand_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAreaOfLand_60" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasesRentExpenseSubleaseRentals1" xlink:label="loc_us-gaapOperatingLeasesRentExpenseSubleaseRentals1_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOperatingLeasesRentExpenseSubleaseRentals1_60" xlink:type="arc" order="4" />
    </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>12
<FILENAME>srna-20210331_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.8a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Source; Value: SRNA %2D 20210331 10Q Q1 DFN.xfr; Date: 2021%2D05%2D10T22:03:41Z -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x800A0000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl" xml:lang="en-US">Property, Plant and Equipment, Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="us-gaap_FurnitureAndFixturesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FurnitureAndFixturesMember" xlink:to="us-gaap_FurnitureAndFixturesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FurnitureAndFixturesMember_lbl" xml:lang="en-US">Furniture and Equipment [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VehiclesMember" xlink:label="us-gaap_VehiclesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_VehiclesMember" xlink:to="us-gaap_VehiclesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_VehiclesMember_lbl" xml:lang="en-US">Vehicles [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="us-gaap_LeaseholdImprovementsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseholdImprovementsMember" xlink:to="us-gaap_LeaseholdImprovementsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LeaseholdImprovementsMember_lbl" xml:lang="en-US">Leasehold Improvements [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeStatementLocationAxis_lbl" xml:lang="en-US">Income Statement Location [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfSalesMember" xlink:label="us-gaap_CostOfSalesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostOfSalesMember" xlink:to="us-gaap_CostOfSalesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CostOfSalesMember_lbl" xml:lang="en-US">Cost of Sales [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdvertisingMember" xlink:label="us-gaap_AdvertisingMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdvertisingMember" xlink:to="us-gaap_AdvertisingMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdvertisingMember_lbl" xml:lang="en-US">Advertising and Marketing Expenses [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" xlink:label="us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" xlink:to="us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_lbl" xml:lang="en-US">Product Development Costs [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpensesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:to="us-gaap_SellingGeneralAndAdministrativeExpensesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpensesMember_lbl" xml:lang="en-US">Selling, General and Administrative Expenses [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis" xlink:label="srt_ProductOrServiceAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ProductOrServiceAxis" xlink:to="srt_ProductOrServiceAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ProductOrServiceAxis_lbl" xml:lang="en-US">Product and Service [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_EngineeringAndOtherServicesMember" xlink:label="SRNA_EngineeringAndOtherServicesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_EngineeringAndOtherServicesMember" xlink:to="SRNA_EngineeringAndOtherServicesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_EngineeringAndOtherServicesMember_lbl" xml:lang="en-US">Engineering and Other Services [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShippingAndHandlingMember" xlink:label="us-gaap_ShippingAndHandlingMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShippingAndHandlingMember" xlink:to="us-gaap_ShippingAndHandlingMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShippingAndHandlingMember_lbl" xml:lang="en-US">Shipping and Handling [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:label="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:to="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_lbl" xml:lang="en-US">Adjustments for New Accounting Pronouncements [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingStandardsUpdate201602Member" xlink:label="us-gaap_AccountingStandardsUpdate201602Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountingStandardsUpdate201602Member" xlink:to="us-gaap_AccountingStandardsUpdate201602Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountingStandardsUpdate201602Member_lbl" xml:lang="en-US">ASU 2016-02 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_AwardTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AwardTypeAxis_lbl" xml:lang="en-US">Award Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="us-gaap_RestrictedStockUnitsRSUMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedStockUnitsRSUMember" xlink:to="us-gaap_RestrictedStockUnitsRSUMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RestrictedStockUnitsRSUMember_lbl" xml:lang="en-US">Restricted Stock Units (RSUs) [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="us-gaap_ConcentrationRiskByTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskByTypeAxis" xlink:to="us-gaap_ConcentrationRiskByTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskByTypeAxis_lbl" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerConcentrationRiskMember" xlink:label="us-gaap_CustomerConcentrationRiskMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CustomerConcentrationRiskMember" xlink:to="us-gaap_CustomerConcentrationRiskMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CustomerConcentrationRiskMember_lbl" xml:lang="en-US">Customer Concentration Risk [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="us-gaap_ConcentrationRiskByBenchmarkAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="us-gaap_ConcentrationRiskByBenchmarkAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskByBenchmarkAxis_lbl" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableMember" xlink:label="us-gaap_AccountsReceivableMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsReceivableMember" xlink:to="us-gaap_AccountsReceivableMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsReceivableMember_lbl" xml:lang="en-US">Accounts Receivable [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MajorCustomersAxis" xlink:label="srt_MajorCustomersAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MajorCustomersAxis" xlink:to="srt_MajorCustomersAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_MajorCustomersAxis_lbl" xml:lang="en-US">Customer [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_CustomerOneMember" xlink:label="SRNA_CustomerOneMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_CustomerOneMember" xlink:to="SRNA_CustomerOneMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_CustomerOneMember_lbl" xml:lang="en-US">Customer One [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_CustomerTwoMember" xlink:label="SRNA_CustomerTwoMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_CustomerTwoMember" xlink:to="SRNA_CustomerTwoMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_CustomerTwoMember_lbl" xml:lang="en-US">Customer Two [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_CustomerThreeMember" xlink:label="SRNA_CustomerThreeMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_CustomerThreeMember" xlink:to="SRNA_CustomerThreeMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_CustomerThreeMember_lbl" xml:lang="en-US">Customer Three [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentMember" xlink:label="us-gaap_PropertyPlantAndEquipmentMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentMember" xlink:to="us-gaap_PropertyPlantAndEquipmentMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentMember_lbl" xml:lang="en-US">Property and Equipment [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_InventoryMember" xlink:label="SRNA_InventoryMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_InventoryMember" xlink:to="SRNA_InventoryMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_InventoryMember_lbl" xml:lang="en-US">Inventory [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardDateAxis" xlink:label="us-gaap_AwardDateAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AwardDateAxis" xlink:to="us-gaap_AwardDateAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AwardDateAxis_lbl" xml:lang="en-US">Award Date [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_TwoThousandAndTwentyTwoMember" xlink:label="SRNA_TwoThousandAndTwentyTwoMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_TwoThousandAndTwentyTwoMember" xlink:to="SRNA_TwoThousandAndTwentyTwoMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_TwoThousandAndTwentyTwoMember_lbl" xml:lang="en-US">2022 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesRevenueNetMember" xlink:label="us-gaap_SalesRevenueNetMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SalesRevenueNetMember" xlink:to="us-gaap_SalesRevenueNetMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SalesRevenueNetMember_lbl" xml:lang="en-US">Sales Revenue, Net [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_TwoThousandAndTwentyOneMember" xlink:label="SRNA_TwoThousandAndTwentyOneMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_TwoThousandAndTwentyOneMember" xlink:to="SRNA_TwoThousandAndTwentyOneMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_TwoThousandAndTwentyOneMember_lbl" xml:lang="en-US">2021 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquipmentMember" xlink:label="us-gaap_EquipmentMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquipmentMember" xlink:to="us-gaap_EquipmentMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquipmentMember_lbl" xml:lang="en-US">Equipment and Systems Sales [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="us-gaap_PlanNameAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PlanNameAxis_lbl" xml:lang="en-US">Plan Name [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_TwoThousandSeventeenEquityPlanMember" xlink:label="SRNA_TwoThousandSeventeenEquityPlanMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_TwoThousandSeventeenEquityPlanMember" xlink:to="SRNA_TwoThousandSeventeenEquityPlanMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_TwoThousandSeventeenEquityPlanMember_lbl" xml:lang="en-US">2017 Equity Plan [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="srt_TitleOfIndividualAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_TitleOfIndividualAxis_lbl" xml:lang="en-US">Title of Individual [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_DirectorMember" xlink:label="srt_DirectorMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_DirectorMember" xlink:to="srt_DirectorMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_DirectorMember_lbl" xml:lang="en-US">Directors [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventTypeAxis_lbl" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="us-gaap_SubsequentEventMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventMember" xlink:to="us-gaap_SubsequentEventMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventMember_lbl" xml:lang="en-US">Subsequent Event [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_TwoThousandAndSeventeenEquityPlanMember" xlink:label="SRNA_TwoThousandAndSeventeenEquityPlanMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_TwoThousandAndSeventeenEquityPlanMember" xlink:to="SRNA_TwoThousandAndSeventeenEquityPlanMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_TwoThousandAndSeventeenEquityPlanMember_lbl" xml:lang="en-US">2017 Equity Incentive Plan [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_NonQualifiedStockOptionsMember" xlink:label="SRNA_NonQualifiedStockOptionsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_NonQualifiedStockOptionsMember" xlink:to="SRNA_NonQualifiedStockOptionsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_NonQualifiedStockOptionsMember_lbl" xml:lang="en-US">Non-Qualified Stock Options [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_DirectorsMember" xlink:label="SRNA_DirectorsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_DirectorsMember" xlink:to="SRNA_DirectorsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="SRNA_DirectorsMember_lbl" xml:lang="en-US">Directors [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl" xml:lang="en-US">Related Party [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_EmployeesAndConsultantsMember" xlink:label="SRNA_EmployeesAndConsultantsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_EmployeesAndConsultantsMember" xlink:to="SRNA_EmployeesAndConsultantsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_EmployeesAndConsultantsMember_lbl" xml:lang="en-US">Employees and Consultants [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_EmployeesDirectorsandConsultantsMember" xlink:label="SRNA_EmployeesDirectorsandConsultantsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_EmployeesDirectorsandConsultantsMember" xlink:to="SRNA_EmployeesDirectorsandConsultantsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_EmployeesDirectorsandConsultantsMember_lbl" xml:lang="en-US">Employees, Directors and Consultants [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_FormerEmployeeMember" xlink:label="SRNA_FormerEmployeeMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_FormerEmployeeMember" xlink:to="SRNA_FormerEmployeeMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_FormerEmployeeMember_lbl" xml:lang="en-US">Former Employee [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_lbl" xml:lang="en-US">Exercise Price Range [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_WarrantsRangeOneMember" xlink:label="SRNA_WarrantsRangeOneMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_WarrantsRangeOneMember" xlink:to="SRNA_WarrantsRangeOneMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_WarrantsRangeOneMember_lbl" xml:lang="en-US">Warrants Range One [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_WarrantsRangeMember" xlink:label="SRNA_WarrantsRangeMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_WarrantsRangeMember" xlink:to="SRNA_WarrantsRangeMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_WarrantsRangeMember_lbl" xml:lang="en-US">Warrants Range [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RangeAxis" xlink:to="srt_RangeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_RangeAxis_lbl" xml:lang="en-US">Range [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MinimumMember" xlink:to="srt_MinimumMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_MinimumMember_lbl" xml:lang="en-US">Minimum [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_lbl" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerContractsMember" xlink:label="us-gaap_CustomerContractsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CustomerContractsMember" xlink:to="us-gaap_CustomerContractsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CustomerContractsMember_lbl" xml:lang="en-US">Customer Contracts [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_StatementEquityComponentsAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementEquityComponentsAxis_lbl" xml:lang="en-US">Equity Components [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockMember" xlink:label="us-gaap_PreferredStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockMember" xlink:to="us-gaap_PreferredStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockMember_lbl" xml:lang="en-US">Preferred Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockMember_lbl" xml:lang="en-US">Common Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalMember" xlink:to="us-gaap_AdditionalPaidInCapitalMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapitalMember_lbl" xml:lang="en-US">Additional Paid in Capital [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="us-gaap_RetainedEarningsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsMember" xlink:to="us-gaap_RetainedEarningsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsMember_lbl" xml:lang="en-US">Accumulated Deficit [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_TwoThousandTwentyOneAnnualEmployeeIncentiveCompensationPlanMember" xlink:label="SRNA_TwoThousandTwentyOneAnnualEmployeeIncentiveCompensationPlanMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_TwoThousandTwentyOneAnnualEmployeeIncentiveCompensationPlanMember" xlink:to="SRNA_TwoThousandTwentyOneAnnualEmployeeIncentiveCompensationPlanMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_TwoThousandTwentyOneAnnualEmployeeIncentiveCompensationPlanMember_lbl" xml:lang="en-US">2021 Incentive Awards [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_CustomerFourMember" xlink:label="SRNA_CustomerFourMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_CustomerFourMember" xlink:to="SRNA_CustomerFourMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_CustomerFourMember_lbl" xml:lang="en-US">Customer Four [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_TypeOfArrangementAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TypeOfArrangementAxis_lbl" xml:lang="en-US">Type of Arrangement and Non-arrangement Transactions [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_FacilityLeaseMember" xlink:label="SRNA_FacilityLeaseMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_FacilityLeaseMember" xlink:to="SRNA_FacilityLeaseMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_FacilityLeaseMember_lbl" xml:lang="en-US">Facility Lease [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_TwoThousandAndSeventeenEquityIncentivePlanMember" xlink:label="SRNA_TwoThousandAndSeventeenEquityIncentivePlanMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_TwoThousandAndSeventeenEquityIncentivePlanMember" xlink:to="SRNA_TwoThousandAndSeventeenEquityIncentivePlanMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="SRNA_TwoThousandAndSeventeenEquityIncentivePlanMember_lbl" xml:lang="en-US">2017 Equity Incentive Plan [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_IncentiveStockBonusAwardsMember" xlink:label="SRNA_IncentiveStockBonusAwardsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_IncentiveStockBonusAwardsMember" xlink:to="SRNA_IncentiveStockBonusAwardsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_IncentiveStockBonusAwardsMember_lbl" xml:lang="en-US">Incentive Stock Bonus Awards [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_EmployeesMember" xlink:label="SRNA_EmployeesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_EmployeesMember" xlink:to="SRNA_EmployeesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_EmployeesMember_lbl" xml:lang="en-US">Employees [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_OfficeandManufacturingMember" xlink:label="SRNA_OfficeandManufacturingMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_OfficeandManufacturingMember" xlink:to="SRNA_OfficeandManufacturingMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_OfficeandManufacturingMember_lbl" xml:lang="en-US">Office and Manufacturing [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_TwoThousandAndTwentyOneEquityIncentivePlanMember" xlink:label="SRNA_TwoThousandAndTwentyOneEquityIncentivePlanMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_TwoThousandAndTwentyOneEquityIncentivePlanMember" xlink:to="SRNA_TwoThousandAndTwentyOneEquityIncentivePlanMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_TwoThousandAndTwentyOneEquityIncentivePlanMember_lbl" xml:lang="en-US">2021 Equity Incentive Plan [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis" xlink:label="srt_StatementScenarioAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_StatementScenarioAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_StatementScenarioAxis_lbl" xml:lang="en-US">Scenario [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioForecastMember" xlink:label="srt_ScenarioForecastMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ScenarioForecastMember" xlink:to="srt_ScenarioForecastMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ScenarioForecastMember_lbl" xml:lang="en-US">Forecast [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementOfFinancialPositionAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfFinancialPositionAbstract_lbl" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="us-gaap_AssetsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsAbstract_lbl" xml:lang="en-US">ASSETS</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="us-gaap_AssetsCurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrentAbstract_lbl" xml:lang="en-US">Current Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xml:lang="en-US">Cash, cash equivalents and restricted cash</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="us-gaap_AccountsReceivableNetCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsReceivableNetCurrent" xlink:to="us-gaap_AccountsReceivableNetCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsReceivableNetCurrent_lbl" xml:lang="en-US">Accounts receivable (net of allowance for doubtful accounts of $165,098 and $165,098, respectively)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet" xlink:label="us-gaap_InventoryNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryNet" xlink:to="us-gaap_InventoryNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryNet_lbl" xml:lang="en-US">Inventory, net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xml:lang="en-US">Prepaid expenses and other</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_AssetsCurrent_lbl" xml:lang="en-US">Total Current Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsNoncurrentAbstract" xlink:label="us-gaap_AssetsNoncurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsNoncurrentAbstract" xlink:to="us-gaap_AssetsNoncurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsNoncurrentAbstract_lbl" xml:lang="en-US">Noncurrent Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xml:lang="en-US">Property and equipment, net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill" xlink:label="us-gaap_Goodwill" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Goodwill" xlink:to="us-gaap_Goodwill_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Goodwill_lbl" xml:lang="en-US">Goodwill</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="us-gaap_IntangibleAssetsNetExcludingGoodwill_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill_lbl" xml:lang="en-US">Intangible assets, net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepositsAssetsNoncurrent" xlink:label="us-gaap_DepositsAssetsNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepositsAssetsNoncurrent" xlink:to="us-gaap_DepositsAssetsNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DepositsAssetsNoncurrent_lbl" xml:lang="en-US">Deposits</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset_lbl" xml:lang="en-US">Operating lease right-of-use asset</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsNoncurrent" xlink:label="us-gaap_AssetsNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsNoncurrent" xlink:to="us-gaap_AssetsNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_AssetsNoncurrent_lbl" xml:lang="en-US">Total Noncurrent Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Assets_lbl" xml:lang="en-US">TOTAL ASSETS</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xml:lang="en-US">LIABILITIES AND SHAREHOLDERS' DEFICIT</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="us-gaap_LiabilitiesCurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl" xml:lang="en-US">CURRENT LIABILITIES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_lbl" xml:lang="en-US">Accounts payable and accrued liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent" xlink:label="us-gaap_ContractWithCustomerLiabilityCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ContractWithCustomerLiabilityCurrent" xlink:to="us-gaap_ContractWithCustomerLiabilityCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ContractWithCustomerLiabilityCurrent_lbl" xml:lang="en-US">Deferred revenue</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredCompensationLiabilityCurrent" xlink:label="us-gaap_DeferredCompensationLiabilityCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredCompensationLiabilityCurrent" xlink:to="us-gaap_DeferredCompensationLiabilityCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredCompensationLiabilityCurrent_lbl" xml:lang="en-US">Accrued equity compensation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="us-gaap_OtherLiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLiabilitiesCurrent" xlink:to="us-gaap_OtherLiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherLiabilitiesCurrent_lbl" xml:lang="en-US">Other liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent_lbl" xml:lang="en-US">Current portion of operating lease liability</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesCurrent_lbl" xml:lang="en-US">Total Current Liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesNoncurrentAbstract" xlink:label="us-gaap_LiabilitiesNoncurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesNoncurrentAbstract" xlink:to="us-gaap_LiabilitiesNoncurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesNoncurrentAbstract_lbl" xml:lang="en-US">NONCURRENT LIABILITIES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermNotesPayable" xlink:label="us-gaap_LongTermNotesPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermNotesPayable" xlink:to="us-gaap_LongTermNotesPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermNotesPayable_lbl" xml:lang="en-US">Note payable and accrued interest</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="us-gaap_OtherLiabilitiesNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLiabilitiesNoncurrent" xlink:to="us-gaap_OtherLiabilitiesNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OtherLiabilitiesNoncurrent_lbl" xml:lang="en-US">Other liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl" xml:lang="en-US">Operating lease liability, net of current portion</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesNoncurrent" xlink:label="us-gaap_LiabilitiesNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesNoncurrent" xlink:to="us-gaap_LiabilitiesNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesNoncurrent_lbl" xml:lang="en-US">Total Noncurrent Liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Liabilities_lbl" xml:lang="en-US">TOTAL LIABILITIES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="us-gaap_CommitmentsAndContingencies" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingencies" xlink:to="us-gaap_CommitmentsAndContingencies_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingencies_lbl" xml:lang="en-US">Commitments and Contingencies (Note 7)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="us-gaap_StockholdersEquityAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityAbstract_lbl" xml:lang="en-US">SHAREHOLDERS' DEFICIT</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="us-gaap_PreferredStockValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockValue" xlink:to="us-gaap_PreferredStockValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockValue_lbl" xml:lang="en-US">Preferred stock, $0.00001 par value; 150,000,000 shares authorized; 42,030,331 shares issued and outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockValue" xlink:to="us-gaap_CommonStockValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockValue_lbl" xml:lang="en-US">Common stock, $0.00001 par value; 350,000,000 shares authorized; 236,526,638 and 236,526,638 shares issued and outstanding, respectively</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_CommonStockSharesToBeIssuedValue" xlink:label="SRNA_CommonStockSharesToBeIssuedValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_CommonStockSharesToBeIssuedValue" xlink:to="SRNA_CommonStockSharesToBeIssuedValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_CommonStockSharesToBeIssuedValue_lbl" xml:lang="en-US">Common stock, $0.00001 par value; 1,000,000 shares to be issued</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="us-gaap_AdditionalPaidInCapital" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapital" xlink:to="us-gaap_AdditionalPaidInCapital_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapital_lbl" xml:lang="en-US">Additional paid in capital</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xml:lang="en-US">Accumulated deficit</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_StockholdersEquity_lbl" xml:lang="en-US">Total Shareholders' Deficit</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xml:lang="en-US">TOTAL LIABILITIES AND SHAREHOLDERS' DEFICIT</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:to="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_lbl" xml:lang="en-US">Allowance for doubtful accounts, net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xml:lang="en-US">Preferred stock, par value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="us-gaap_PreferredStockSharesAuthorized" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesAuthorized" xlink:to="us-gaap_PreferredStockSharesAuthorized_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesAuthorized_lbl" xml:lang="en-US">Preferred stock, shares authorized</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="us-gaap_PreferredStockSharesIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesIssued" xlink:to="us-gaap_PreferredStockSharesIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesIssued_lbl" xml:lang="en-US">Preferred stock, shares issued</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="us-gaap_PreferredStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesOutstanding" xlink:to="us-gaap_PreferredStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl" xml:lang="en-US">Preferred stock, shares outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xml:lang="en-US">Common stock, par value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl" xml:lang="en-US">Common stock, shares authorized</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesIssued" xlink:to="us-gaap_CommonStockSharesIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xml:lang="en-US">Common stock, shares issued</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xml:lang="en-US">Common stock, shares outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_CommonStockSharesToBeIssuedParOrStatedValuePerShare" xlink:label="SRNA_CommonStockSharesToBeIssuedParOrStatedValuePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_CommonStockSharesToBeIssuedParOrStatedValuePerShare" xlink:to="SRNA_CommonStockSharesToBeIssuedParOrStatedValuePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_CommonStockSharesToBeIssuedParOrStatedValuePerShare_lbl" xml:lang="en-US">Common stock, shares to be issued, par value</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_CommonSharesToBeIssued" xlink:label="SRNA_CommonSharesToBeIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_CommonSharesToBeIssued" xlink:to="SRNA_CommonSharesToBeIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_CommonSharesToBeIssued_lbl" xml:lang="en-US">Common stock, shares to be issued</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="us-gaap_IncomeStatementAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_IncomeStatementAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeStatementAbstract_lbl" xml:lang="en-US">Income Statement [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_lbl" xml:lang="en-US">Revenue, net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfRevenue" xlink:label="us-gaap_CostOfRevenue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostOfRevenue" xlink:to="us-gaap_CostOfRevenue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CostOfRevenue_lbl" xml:lang="en-US">Cost of revenue</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit" xlink:label="us-gaap_GrossProfit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GrossProfit" xlink:to="us-gaap_GrossProfit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_GrossProfit_lbl" xml:lang="en-US">Gross profit</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="us-gaap_OperatingExpensesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_OperatingExpensesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingExpensesAbstract_lbl" xml:lang="en-US">Operating expenses:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketingAndAdvertisingExpense" xlink:label="us-gaap_MarketingAndAdvertisingExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MarketingAndAdvertisingExpense" xlink:to="us-gaap_MarketingAndAdvertisingExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MarketingAndAdvertisingExpense_lbl" xml:lang="en-US">Advertising and marketing expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="us-gaap_ResearchAndDevelopmentExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpense" xlink:to="us-gaap_ResearchAndDevelopmentExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ResearchAndDevelopmentExpense_lbl" xml:lang="en-US">Product development costs</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="us-gaap_SellingGeneralAndAdministrativeExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpense_lbl" xml:lang="en-US">Selling, general and administrative expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="us-gaap_OperatingExpenses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_OperatingExpenses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OperatingExpenses_lbl" xml:lang="en-US">Total operating expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OperatingIncomeLoss_lbl" xml:lang="en-US">Operating loss</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpenseAbstract" xlink:label="us-gaap_NonoperatingIncomeExpenseAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_NonoperatingIncomeExpenseAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NonoperatingIncomeExpenseAbstract_lbl" xml:lang="en-US">Other income (expense):</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="us-gaap_OtherNonoperatingIncomeExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherNonoperatingIncomeExpense" xlink:to="us-gaap_OtherNonoperatingIncomeExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherNonoperatingIncomeExpense_lbl" xml:lang="en-US">Other income (expense), net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense" xlink:label="us-gaap_InterestExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpense" xlink:to="us-gaap_InterestExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_InterestExpense_lbl" xml:lang="en-US">Interest expense</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="us-gaap_NonoperatingIncomeExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_NonoperatingIncomeExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NonoperatingIncomeExpense_lbl" xml:lang="en-US">Total other income (expense)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" xml:lang="en-US">Loss before provision for income taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl" xml:lang="en-US">Income taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetIncomeLoss_lbl" xml:lang="en-US">Net loss</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasicAndDiluted" xlink:to="us-gaap_EarningsPerShareBasicAndDiluted_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted_lbl" xml:lang="en-US">Loss per common share - basic and dilutive</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:to="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_lbl" xml:lang="en-US">Weighted average number of common shares outstanding, basic and dilutive</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementTable_lbl" xml:lang="en-US">Statement [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementLineItems_lbl" xml:lang="en-US">Statement [Line Items]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_StockholdersEquity_2_lbl" xml:lang="en-US">Balance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="us-gaap_SharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_SharesOutstanding_lbl" xml:lang="en-US">Balance, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_CommonStockSharesToBeIssuedBalance" xlink:label="SRNA_CommonStockSharesToBeIssuedBalance" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_CommonStockSharesToBeIssuedBalance" xlink:to="SRNA_CommonStockSharesToBeIssuedBalance_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="SRNA_CommonStockSharesToBeIssuedBalance_lbl" xml:lang="en-US">Balance, shares to be issued</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_CommonStockValueToBeIssuedBalance" xlink:label="SRNA_CommonStockValueToBeIssuedBalance" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_CommonStockValueToBeIssuedBalance" xlink:to="SRNA_CommonStockValueToBeIssuedBalance_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="SRNA_CommonStockValueToBeIssuedBalance_lbl" xml:lang="en-US">Balance, shares to be issued, value</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonuses" xlink:label="SRNA_CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonuses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonuses" xlink:to="SRNA_CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonuses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonuses_lbl" xml:lang="en-US">Common shares issued or to be issued on settlement of restricted stock units and award of stock bonuses</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesShares" xlink:label="SRNA_CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesShares" xlink:to="SRNA_CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesShares_lbl" xml:lang="en-US">Common shares issued or to be issued on settlement of restricted stock units and award of stock bonuses, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesSharesToBeIssued" xlink:label="SRNA_CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesSharesToBeIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesSharesToBeIssued" xlink:to="SRNA_CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesSharesToBeIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesSharesToBeIssued_lbl" xml:lang="en-US">Common shares issued or to be issued on settlement of restricted stock units and award of stock bonuses, shares to be issued</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition_lbl" xml:lang="en-US">Fair value of vested restricted stock units awarded to employees</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_lbl" xml:lang="en-US">Fair value of vested stock options granted to employees and directors</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_CommonSharesToBeIssuedInSettlementOfLegalDispute" xlink:label="SRNA_CommonSharesToBeIssuedInSettlementOfLegalDispute" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_CommonSharesToBeIssuedInSettlementOfLegalDispute" xlink:to="SRNA_CommonSharesToBeIssuedInSettlementOfLegalDispute_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_CommonSharesToBeIssuedInSettlementOfLegalDispute_lbl" xml:lang="en-US">Common shares to be issued in settlement of legal dispute</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_CommonSharesToBeIssuedInSettlementOfLegalDisputeSharesToBeIssued" xlink:label="SRNA_CommonSharesToBeIssuedInSettlementOfLegalDisputeSharesToBeIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_CommonSharesToBeIssuedInSettlementOfLegalDisputeSharesToBeIssued" xlink:to="SRNA_CommonSharesToBeIssuedInSettlementOfLegalDisputeSharesToBeIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_CommonSharesToBeIssuedInSettlementOfLegalDisputeSharesToBeIssued_lbl" xml:lang="en-US">Common shares to be issued in settlement of legal dispute, shares to be issued</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_FairValueOfVestedStockOptionsGrantedToEmployees" xlink:label="SRNA_FairValueOfVestedStockOptionsGrantedToEmployees" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_FairValueOfVestedStockOptionsGrantedToEmployees" xlink:to="SRNA_FairValueOfVestedStockOptionsGrantedToEmployees_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_FairValueOfVestedStockOptionsGrantedToEmployees_lbl" xml:lang="en-US">Fair value of vested stock options granted to employees</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_FairValueOfVestedStockOptionsGrantedToDirectors" xlink:label="SRNA_FairValueOfVestedStockOptionsGrantedToDirectors" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_FairValueOfVestedStockOptionsGrantedToDirectors" xlink:to="SRNA_FairValueOfVestedStockOptionsGrantedToDirectors_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_FairValueOfVestedStockOptionsGrantedToDirectors_lbl" xml:lang="en-US">Fair value of vested stock options granted to directors</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLoss_2_lbl" xml:lang="en-US">Net loss</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_StockholdersEquity_3_lbl" xml:lang="en-US">Balance</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_SharesOutstanding_2_lbl" xml:lang="en-US">Balance, shares</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_CommonStockSharesToBeIssuedBalance" xlink:to="SRNA_CommonStockSharesToBeIssuedBalance_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="SRNA_CommonStockSharesToBeIssuedBalance_2_lbl" xml:lang="en-US">Balance, shares to be issued</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_CommonStockValueToBeIssuedBalance" xlink:to="SRNA_CommonStockValueToBeIssuedBalance_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="SRNA_CommonStockValueToBeIssuedBalance_2_lbl" xml:lang="en-US">Balance, shares to be issued, value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="us-gaap_StatementOfCashFlowsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_StatementOfCashFlowsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfCashFlowsAbstract_lbl" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">Cash Flows From Operating Activities:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">Adjustments to reconcile net loss to net cash provided by (used in) operating activities:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="us-gaap_DepreciationDepletionAndAmortization" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepreciationDepletionAndAmortization" xlink:to="us-gaap_DepreciationDepletionAndAmortization_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DepreciationDepletionAndAmortization_lbl" xml:lang="en-US">Depreciation and intangible asset amortization expense</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="us-gaap_ShareBasedCompensation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensation" xlink:to="us-gaap_ShareBasedCompensation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensation_lbl" xml:lang="en-US">Share-based compensation</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_OtherSharebasedExpense" xlink:label="SRNA_OtherSharebasedExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_OtherSharebasedExpense" xlink:to="SRNA_OtherSharebasedExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_OtherSharebasedExpense_lbl" xml:lang="en-US">Other share-based expense</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryWriteDown" xlink:label="us-gaap_InventoryWriteDown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryWriteDown" xlink:to="us-gaap_InventoryWriteDown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryWriteDown_lbl" xml:lang="en-US">Provision for excess and obsolete inventory</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnDispositionOfAssets" xlink:label="us-gaap_GainLossOnDispositionOfAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainLossOnDispositionOfAssets" xlink:to="us-gaap_GainLossOnDispositionOfAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_GainLossOnDispositionOfAssets_lbl" xml:lang="en-US">Loss on disposal of assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:label="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:to="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_lbl" xml:lang="en-US">Amortization of ROU Asset</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xml:lang="en-US">Changes in operating assets and liabilities:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsAndNotesReceivable" xlink:label="us-gaap_IncreaseDecreaseInAccountsAndNotesReceivable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsAndNotesReceivable" xlink:to="us-gaap_IncreaseDecreaseInAccountsAndNotesReceivable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInAccountsAndNotesReceivable_lbl" xml:lang="en-US">Accounts receivable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="us-gaap_IncreaseDecreaseInInventories" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInInventories" xlink:to="us-gaap_IncreaseDecreaseInInventories_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInInventories_lbl" xml:lang="en-US">Inventory</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidExpensesOther" xlink:label="us-gaap_IncreaseDecreaseInPrepaidExpensesOther" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidExpensesOther" xlink:to="us-gaap_IncreaseDecreaseInPrepaidExpensesOther_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInPrepaidExpensesOther_lbl" xml:lang="en-US">Prepaid expenses and other</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl" xml:lang="en-US">Accounts payable and accrued liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:label="us-gaap_IncreaseDecreaseInContractWithCustomerLiability" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:to="us-gaap_IncreaseDecreaseInContractWithCustomerLiability_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncreaseDecreaseInContractWithCustomerLiability_lbl" xml:lang="en-US">Deferred revenue</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInterestPayableNet" xlink:label="us-gaap_IncreaseDecreaseInInterestPayableNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInInterestPayableNet" xlink:to="us-gaap_IncreaseDecreaseInInterestPayableNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInInterestPayableNet_lbl" xml:lang="en-US">Accrued interest</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_IncreaseDecreaseInLeaseDeposit" xlink:label="SRNA_IncreaseDecreaseInLeaseDeposit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_IncreaseDecreaseInLeaseDeposit" xlink:to="SRNA_IncreaseDecreaseInLeaseDeposit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_IncreaseDecreaseInLeaseDeposit_lbl" xml:lang="en-US">Lease deposit</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:label="us-gaap_IncreaseDecreaseInOperatingLeaseLiability" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:to="us-gaap_IncreaseDecreaseInOperatingLeaseLiability_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOperatingLeaseLiability_lbl" xml:lang="en-US">Operating lease liability, net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredCompensation" xlink:label="us-gaap_IncreaseDecreaseInDeferredCompensation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInDeferredCompensation" xlink:to="us-gaap_IncreaseDecreaseInDeferredCompensation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncreaseDecreaseInDeferredCompensation_lbl" xml:lang="en-US">Accrued equity compensation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xml:lang="en-US">Net cash provided by operating activities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xml:lang="en-US">Cash Flows From Investing Activities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xml:lang="en-US">Purchases of property and equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xml:lang="en-US">Net cash used in investing activities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xml:lang="en-US">Cash Flows From Financing Activities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromNotesPayable" xlink:label="us-gaap_ProceedsFromNotesPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromNotesPayable" xlink:to="us-gaap_ProceedsFromNotesPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromNotesPayable_lbl" xml:lang="en-US">Proceeds from issuance of note payable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xml:lang="en-US">Net cash provided by financing activities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl" xml:lang="en-US">Net change in cash, cash equivalents and restricted cash</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_lbl" xml:lang="en-US">Cash, cash equivalents and restricted cash, beginning of period</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_2_lbl" xml:lang="en-US">Cash, cash equivalents and restricted cash, end of period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="us-gaap_SupplementalCashFlowInformationAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract_lbl" xml:lang="en-US">Supplemental cash flow information:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPaidNet" xlink:label="us-gaap_InterestPaidNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestPaidNet" xlink:to="us-gaap_InterestPaidNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestPaidNet_lbl" xml:lang="en-US">Interest paid</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxesPaidNet" xlink:label="us-gaap_IncomeTaxesPaidNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxesPaidNet" xlink:to="us-gaap_IncomeTaxesPaidNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxesPaidNet_lbl" xml:lang="en-US">Income taxes paid</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" xlink:label="us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" xlink:to="us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock_lbl" xml:lang="en-US">General</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract" xlink:label="us-gaap_LeasesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_LeasesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LeasesAbstract_lbl" xml:lang="en-US">Leases [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeasesTextBlock" xlink:label="us-gaap_LesseeOperatingLeasesTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeasesTextBlock" xlink:to="us-gaap_LesseeOperatingLeasesTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeasesTextBlock_lbl" xml:lang="en-US">Leases</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="us-gaap_InventoryDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryDisclosureAbstract" xlink:to="us-gaap_InventoryDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryDisclosureAbstract_lbl" xml:lang="en-US">Inventory Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryDisclosureTextBlock" xlink:label="us-gaap_InventoryDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryDisclosureTextBlock" xlink:to="us-gaap_InventoryDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryDisclosureTextBlock_lbl" xml:lang="en-US">Inventory</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract_lbl" xml:lang="en-US">Property, Plant and Equipment [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_lbl" xml:lang="en-US">Property and Equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="us-gaap_PayablesAndAccrualsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PayablesAndAccrualsAbstract" xlink:to="us-gaap_PayablesAndAccrualsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PayablesAndAccrualsAbstract_lbl" xml:lang="en-US">Payables and Accruals [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_lbl" xml:lang="en-US">Accounts Payable and Accrued Liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="us-gaap_DebtDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_DebtDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtDisclosureAbstract_lbl" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureTextBlock" xlink:label="us-gaap_DebtDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtDisclosureTextBlock" xlink:to="us-gaap_DebtDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtDisclosureTextBlock_lbl" xml:lang="en-US">Note Payable and Accrued Interest</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xml:lang="en-US">Commitments and Contingencies</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_lbl" xml:lang="en-US">Share-based Payment Arrangement [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl" xml:lang="en-US">Equity Incentive Plan</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_WarrantsAbstract" xlink:label="SRNA_WarrantsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_WarrantsAbstract" xlink:to="SRNA_WarrantsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_WarrantsAbstract_lbl" xml:lang="en-US">Warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_WarrantsDisclosureTextBlock" xlink:label="SRNA_WarrantsDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_WarrantsDisclosureTextBlock" xlink:to="SRNA_WarrantsDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="SRNA_WarrantsDisclosureTextBlock_lbl" xml:lang="en-US">Warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxDisclosureAbstract_lbl" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xml:lang="en-US">Income Taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="us-gaap_SubsequentEventsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventsAbstract_lbl" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="us-gaap_SubsequentEventsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsTextBlock" xlink:to="us-gaap_SubsequentEventsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventsTextBlock_lbl" xml:lang="en-US">Subsequent Events</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_AccountingPoliciesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountingPoliciesAbstract_lbl" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_DescriptionOfBusinessPolicyTextBlock" xlink:label="SRNA_DescriptionOfBusinessPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_DescriptionOfBusinessPolicyTextBlock" xlink:to="SRNA_DescriptionOfBusinessPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_DescriptionOfBusinessPolicyTextBlock_lbl" xml:lang="en-US">Description of Business</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_ImpactOfCovid19PandemicOnOurBusinessPolicyTextBlock" xlink:label="SRNA_ImpactOfCovid19PandemicOnOurBusinessPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_ImpactOfCovid19PandemicOnOurBusinessPolicyTextBlock" xlink:to="SRNA_ImpactOfCovid19PandemicOnOurBusinessPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_ImpactOfCovid19PandemicOnOurBusinessPolicyTextBlock_lbl" xml:lang="en-US">Impact of the COVID-19 Pandemic on Our Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl" xml:lang="en-US">Financial Statement Presentation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock" xlink:label="us-gaap_ConsolidationPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConsolidationPolicyTextBlock" xlink:to="us-gaap_ConsolidationPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConsolidationPolicyTextBlock_lbl" xml:lang="en-US">Basis of Consolidation and Reclassifications</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_GoingConcernPolicyTextBlock" xlink:label="SRNA_GoingConcernPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_GoingConcernPolicyTextBlock" xlink:to="SRNA_GoingConcernPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_GoingConcernPolicyTextBlock_lbl" xml:lang="en-US">Going Concern</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UseOfEstimates" xlink:label="us-gaap_UseOfEstimates" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UseOfEstimates" xlink:to="us-gaap_UseOfEstimates_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UseOfEstimates_lbl" xml:lang="en-US">Use of Estimates</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:label="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:to="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_lbl" xml:lang="en-US">Cash, Cash Equivalents and Restricted Cash</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xml:lang="en-US">Income (Loss) Per Common Share</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:label="us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:to="us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_lbl" xml:lang="en-US">Goodwill</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:label="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:to="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_lbl" xml:lang="en-US">Revenue Recognition</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:to="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl" xml:lang="en-US">Accounting for Share-Based Compensation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:label="us-gaap_ConcentrationRiskCreditRisk" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskCreditRisk" xlink:to="us-gaap_ConcentrationRiskCreditRisk_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskCreditRisk_lbl" xml:lang="en-US">Concentrations</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xml:lang="en-US">Recently Issued Accounting Pronouncements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock" xlink:label="us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock" xlink:to="us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock_lbl" xml:lang="en-US">Schedule of Remaining Performance Obligations Expected to be Recognized</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:label="us-gaap_DisaggregationOfRevenueTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:to="us-gaap_DisaggregationOfRevenueTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisaggregationOfRevenueTableTextBlock_lbl" xml:lang="en-US">Schedule of Revenue by Source</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock_lbl" xml:lang="en-US">Schedule of Share-based Compensation Costs</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseCostTableTextBlock" xlink:label="us-gaap_LeaseCostTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseCostTableTextBlock" xlink:to="us-gaap_LeaseCostTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LeaseCostTableTextBlock_lbl" xml:lang="en-US">Schedule of Lease Cost</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_lbl" xml:lang="en-US">Schedule of Future Annual Minimum Lease Payments</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:label="us-gaap_ScheduleOfInventoryCurrentTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:to="us-gaap_ScheduleOfInventoryCurrentTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfInventoryCurrentTableTextBlock_lbl" xml:lang="en-US">Schedule of Inventory</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl" xml:lang="en-US">Schedule of Property and Equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:label="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_lbl" xml:lang="en-US">Schedule of Accounts Payable and Accrued Liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl" xml:lang="en-US">Schedule of Stock Option Activity</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock" xlink:label="us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock" xlink:to="us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock_lbl" xml:lang="en-US">Summary of Non-vested Non-qualified Stock Option Activity</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_lbl" xml:lang="en-US">Schedule of Restricted Stock Units Activity</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_ScheduleOfOutstandingWarrantsToPurchaseCommonStockTableTextBlock" xlink:label="SRNA_ScheduleOfOutstandingWarrantsToPurchaseCommonStockTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_ScheduleOfOutstandingWarrantsToPurchaseCommonStockTableTextBlock" xlink:to="SRNA_ScheduleOfOutstandingWarrantsToPurchaseCommonStockTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_ScheduleOfOutstandingWarrantsToPurchaseCommonStockTableTextBlock_lbl" xml:lang="en-US">Schedule of Outstanding Warrants to Purchase Common Stock</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:label="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:to="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_lbl" xml:lang="en-US">Schedule of Warrants Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_CashBalanceTransferredToBankAccount" xlink:label="SRNA_CashBalanceTransferredToBankAccount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_CashBalanceTransferredToBankAccount" xlink:to="SRNA_CashBalanceTransferredToBankAccount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_CashBalanceTransferredToBankAccount_lbl" xml:lang="en-US">Cash balance transferred to bank account</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCash" xlink:label="us-gaap_RestrictedCash" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedCash" xlink:to="us-gaap_RestrictedCash_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RestrictedCash_lbl" xml:lang="en-US">Restricted cash</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities" xlink:label="us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities" xlink:to="us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities_lbl" xml:lang="en-US">Potentially dilutive equity instruments that are convertible into common stock</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillImpairmentLoss" xlink:label="us-gaap_GoodwillImpairmentLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillImpairmentLoss" xlink:to="us-gaap_GoodwillImpairmentLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GoodwillImpairmentLoss_lbl" xml:lang="en-US">Impairment of goodwill</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:label="us-gaap_ContractWithCustomerLiabilityRevenueRecognized" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:to="us-gaap_ContractWithCustomerLiabilityRevenueRecognized_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ContractWithCustomerLiabilityRevenueRecognized_lbl" xml:lang="en-US">Revenue recognized</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligation" xlink:label="us-gaap_RevenueRemainingPerformanceObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueRemainingPerformanceObligation" xlink:to="us-gaap_RevenueRemainingPerformanceObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenueRemainingPerformanceObligation_lbl" xml:lang="en-US">Remaining performance obligations</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationPercentage" xlink:label="us-gaap_RevenueRemainingPerformanceObligationPercentage" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueRemainingPerformanceObligationPercentage" xlink:to="us-gaap_RevenueRemainingPerformanceObligationPercentage_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenueRemainingPerformanceObligationPercentage_lbl" xml:lang="en-US">Remaining performance obligations, percentage</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl" xml:lang="en-US">Expected stock price volatility</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl" xml:lang="en-US">Expected term</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl" xml:lang="en-US">Risk-free interest rate</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense_lbl" xml:lang="en-US">Share based compensation expense</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="us-gaap_ConcentrationRiskPercentage1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskPercentage1" xlink:to="us-gaap_ConcentrationRiskPercentage1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskPercentage1_lbl" xml:lang="en-US">Concentration risk percentage</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable" xlink:label="us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable" xlink:to="us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_lbl" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems" xlink:label="us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems" xlink:to="us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_lbl" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_RemainingPerformanceObligationsRelatedToEngineeringOnlyPaidContracts" xlink:label="SRNA_RemainingPerformanceObligationsRelatedToEngineeringOnlyPaidContracts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_RemainingPerformanceObligationsRelatedToEngineeringOnlyPaidContracts" xlink:to="SRNA_RemainingPerformanceObligationsRelatedToEngineeringOnlyPaidContracts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_RemainingPerformanceObligationsRelatedToEngineeringOnlyPaidContracts_lbl" xml:lang="en-US">Remaining performance obligations related to engineering only paid contracts</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_RemainingPerformanceObligationsRelatedToPartialEquipmentPaidContracts" xlink:label="SRNA_RemainingPerformanceObligationsRelatedToPartialEquipmentPaidContracts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_RemainingPerformanceObligationsRelatedToPartialEquipmentPaidContracts" xlink:to="SRNA_RemainingPerformanceObligationsRelatedToPartialEquipmentPaidContracts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_RemainingPerformanceObligationsRelatedToPartialEquipmentPaidContracts_lbl" xml:lang="en-US">Remaining performance obligations related to partial equipment paid contracts</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueRemainingPerformanceObligation" xlink:to="us-gaap_RevenueRemainingPerformanceObligation_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_RevenueRemainingPerformanceObligation_2_lbl" xml:lang="en-US">Total remaining performance obligations</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTable" xlink:label="us-gaap_DisaggregationOfRevenueTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisaggregationOfRevenueTable" xlink:to="us-gaap_DisaggregationOfRevenueTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisaggregationOfRevenueTable_lbl" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems" xlink:label="us-gaap_DisaggregationOfRevenueLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisaggregationOfRevenueLineItems" xlink:to="us-gaap_DisaggregationOfRevenueLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisaggregationOfRevenueLineItems_lbl" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_2_lbl" xml:lang="en-US">Total revenue</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense_2_lbl" xml:lang="en-US">Total share-based compensation expense included in consolidated statement of operations</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable" xlink:label="us-gaap_LesseeLeaseDescriptionTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeLeaseDescriptionTable" xlink:to="us-gaap_LesseeLeaseDescriptionTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeLeaseDescriptionTable_lbl" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems" xlink:label="us-gaap_LesseeLeaseDescriptionLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_LesseeLeaseDescriptionLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeLeaseDescriptionLineItems_lbl" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_TypeOfArrangementAxis_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_TypeOfArrangementAxis_2_lbl" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Axis]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:to="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_2_lbl" xml:lang="en-US">Accounting Standards Update [Axis]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RangeAxis" xlink:to="srt_RangeAxis_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="srt_RangeAxis_2_lbl" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability" xlink:label="us-gaap_OperatingLeaseLiability" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiability" xlink:to="us-gaap_OperatingLeaseLiability_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseLiability_lbl" xml:lang="en-US">Lease liability</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseDescription" xlink:label="us-gaap_LesseeOperatingLeaseDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseDescription" xlink:to="us-gaap_LesseeOperatingLeaseDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseDescription_lbl" xml:lang="en-US">Operating lease term description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:label="us-gaap_LesseeOperatingLeaseRenewalTerm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:to="us-gaap_LesseeOperatingLeaseRenewalTerm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseRenewalTerm_lbl" xml:lang="en-US">Operating lease renewal term</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_MonthlyRentDescription" xlink:label="SRNA_MonthlyRentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_MonthlyRentDescription" xlink:to="SRNA_MonthlyRentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_MonthlyRentDescription_lbl" xml:lang="en-US">Monthly rent description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TenantImprovements" xlink:label="us-gaap_TenantImprovements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TenantImprovements" xlink:to="us-gaap_TenantImprovements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TenantImprovements_lbl" xml:lang="en-US">Tenant improvements</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_UnamortizedAmountOfTenantImprovementAllowance" xlink:label="SRNA_UnamortizedAmountOfTenantImprovementAllowance" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_UnamortizedAmountOfTenantImprovementAllowance" xlink:to="SRNA_UnamortizedAmountOfTenantImprovementAllowance_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_UnamortizedAmountOfTenantImprovementAllowance_lbl" xml:lang="en-US">Unamortized amount of tenant improvement allowance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseCost" xlink:label="us-gaap_OperatingLeaseCost" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseCost" xlink:to="us-gaap_OperatingLeaseCost_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseCost_lbl" xml:lang="en-US">Operating lease cost</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasePayments" xlink:label="us-gaap_OperatingLeasePayments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasePayments" xlink:to="us-gaap_OperatingLeasePayments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeasePayments_lbl" xml:lang="en-US">Operating cash outflow from operating lease</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent_2_lbl" xml:lang="en-US">Operating lease liability, current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent_2_lbl" xml:lang="en-US">Operating lease liability, long-term</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:label="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_lbl" xml:lang="en-US">Remaining lease term</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:label="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_lbl" xml:lang="en-US">Discount rate</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_lbl" xml:lang="en-US">2021 (excluding the three months ended March 31, 2021)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl" xml:lang="en-US">2022</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl" xml:lang="en-US">Total minimum lease payments</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl" xml:lang="en-US">Less imputed interest</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiability" xlink:to="us-gaap_OperatingLeaseLiability_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OperatingLeaseLiability_2_lbl" xml:lang="en-US">Present value of minimum lease payments</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSoldOverhead" xlink:label="us-gaap_CostOfGoodsAndServicesSoldOverhead" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostOfGoodsAndServicesSoldOverhead" xlink:to="us-gaap_CostOfGoodsAndServicesSoldOverhead_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CostOfGoodsAndServicesSoldOverhead_lbl" xml:lang="en-US">Overhead expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_PrepaidInventoryExpenses" xlink:label="SRNA_PrepaidInventoryExpenses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_PrepaidInventoryExpenses" xlink:to="SRNA_PrepaidInventoryExpenses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_PrepaidInventoryExpenses_lbl" xml:lang="en-US">Prepaid inventory expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryFinishedGoods" xlink:label="us-gaap_InventoryFinishedGoods" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryFinishedGoods" xlink:to="us-gaap_InventoryFinishedGoods_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryFinishedGoods_lbl" xml:lang="en-US">Finished goods</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryWorkInProcess" xlink:label="us-gaap_InventoryWorkInProcess" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryWorkInProcess" xlink:to="us-gaap_InventoryWorkInProcess_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryWorkInProcess_lbl" xml:lang="en-US">Work in progress</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryRawMaterials" xlink:label="us-gaap_InventoryRawMaterials" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryRawMaterials" xlink:to="us-gaap_InventoryRawMaterials_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryRawMaterials_lbl" xml:lang="en-US">Raw materials</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryValuationReserves" xlink:label="us-gaap_InventoryValuationReserves" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryValuationReserves" xlink:to="us-gaap_InventoryValuationReserves_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_InventoryValuationReserves_lbl" xml:lang="en-US">Allowance for excess &amp; obsolete inventory</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryNet" xlink:to="us-gaap_InventoryNet_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_InventoryNet_2_lbl" xml:lang="en-US">Inventory, net</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis_2_lbl" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Depreciation" xlink:label="us-gaap_Depreciation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Depreciation" xlink:to="us-gaap_Depreciation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Depreciation_lbl" xml:lang="en-US">Depreciation expense</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_lbl" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems_lbl" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="us-gaap_PropertyPlantAndEquipmentGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentGross" xlink:to="us-gaap_PropertyPlantAndEquipmentGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentGross_lbl" xml:lang="en-US">Property and equipment, gross</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xml:lang="en-US">Accumulated depreciation</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_2_lbl" xml:lang="en-US">Property and equipment, net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="us-gaap_AccountsPayableCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableCurrent" xlink:to="us-gaap_AccountsPayableCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableCurrent_lbl" xml:lang="en-US">Accounts payable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedSalesCommissionCurrent" xlink:label="us-gaap_AccruedSalesCommissionCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedSalesCommissionCurrent" xlink:to="us-gaap_AccruedSalesCommissionCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccruedSalesCommissionCurrent_lbl" xml:lang="en-US">Sales commissions payable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl" xml:lang="en-US">Accrued payroll liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductWarrantyAccrualClassifiedCurrent" xlink:label="us-gaap_ProductWarrantyAccrualClassifiedCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProductWarrantyAccrualClassifiedCurrent" xlink:to="us-gaap_ProductWarrantyAccrualClassifiedCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProductWarrantyAccrualClassifiedCurrent_lbl" xml:lang="en-US">Product warranty accrual</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAccruedLiabilitiesCurrent" xlink:to="us-gaap_OtherAccruedLiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent_lbl" xml:lang="en-US">Other accrued expenses</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_2_lbl" xml:lang="en-US">Total</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="us-gaap_DebtInstrumentFaceAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentFaceAmount" xlink:to="us-gaap_DebtInstrumentFaceAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentFaceAmount_lbl" xml:lang="en-US">Loan principal amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="us-gaap_DebtInstrumentInterestRateStatedPercentage_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage_lbl" xml:lang="en-US">Loan interest rate</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="us-gaap_DebtInstrumentMaturityDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentMaturityDate" xlink:to="us-gaap_DebtInstrumentMaturityDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentMaturityDate_lbl" xml:lang="en-US">Loan due date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentIncreaseAccruedInterest" xlink:label="us-gaap_DebtInstrumentIncreaseAccruedInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentIncreaseAccruedInterest" xlink:to="us-gaap_DebtInstrumentIncreaseAccruedInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DebtInstrumentIncreaseAccruedInterest_lbl" xml:lang="en-US">Accrued interest</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_NumberOfUnitsVestedButNotSettled" xlink:label="SRNA_NumberOfUnitsVestedButNotSettled" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_NumberOfUnitsVestedButNotSettled" xlink:to="SRNA_NumberOfUnitsVestedButNotSettled_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_NumberOfUnitsVestedButNotSettled_lbl" xml:lang="en-US">Number of units, vested but not settled</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_NumberOfUnitsVestedAndSettled" xlink:label="SRNA_NumberOfUnitsVestedAndSettled" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_NumberOfUnitsVestedAndSettled" xlink:to="SRNA_NumberOfUnitsVestedAndSettled_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_NumberOfUnitsVestedAndSettled_lbl" xml:lang="en-US">Number of units, vested and settled</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyDamagesAwardedValue" xlink:label="us-gaap_LossContingencyDamagesAwardedValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LossContingencyDamagesAwardedValue" xlink:to="us-gaap_LossContingencyDamagesAwardedValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LossContingencyDamagesAwardedValue_lbl" xml:lang="en-US">Interim awarded value</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_RestrictedStockUnitsSharesIssuedInterestPercentage" xlink:label="SRNA_RestrictedStockUnitsSharesIssuedInterestPercentage" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_RestrictedStockUnitsSharesIssuedInterestPercentage" xlink:to="SRNA_RestrictedStockUnitsSharesIssuedInterestPercentage_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_RestrictedStockUnitsSharesIssuedInterestPercentage_lbl" xml:lang="en-US">Restricted stock units shares issued interest percentage</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyDamagesPaidValue" xlink:label="us-gaap_LossContingencyDamagesPaidValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LossContingencyDamagesPaidValue" xlink:to="us-gaap_LossContingencyDamagesPaidValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LossContingencyDamagesPaidValue_lbl" xml:lang="en-US">Obligate to pay for dispute</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_AggregateSharesIssuedUponExecutionOfSettlement" xlink:label="SRNA_AggregateSharesIssuedUponExecutionOfSettlement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_AggregateSharesIssuedUponExecutionOfSettlement" xlink:to="SRNA_AggregateSharesIssuedUponExecutionOfSettlement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_AggregateSharesIssuedUponExecutionOfSettlement_lbl" xml:lang="en-US">Aggregate common shares issued upon execution of settlement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingExpense" xlink:label="us-gaap_OtherNonoperatingExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherNonoperatingExpense" xlink:to="us-gaap_OtherNonoperatingExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherNonoperatingExpense_lbl" xml:lang="en-US">Other expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_lbl" xml:lang="en-US">Accounts payables and accruals</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_StockIssuanceAmount" xlink:label="SRNA_StockIssuanceAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_StockIssuanceAmount" xlink:to="SRNA_StockIssuanceAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_StockIssuanceAmount_lbl" xml:lang="en-US">Stock issuance amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:to="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_lbl" xml:lang="en-US">Number of common stock shares issuance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl" xml:lang="en-US">Number of share awards granted</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensation" xlink:to="us-gaap_ShareBasedCompensation_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensation_2_lbl" xml:lang="en-US">Share based compensation expense</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_lbl" xml:lang="en-US">Number of options vested</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_lbl" xml:lang="en-US">Number of options granted during the period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_lbl" xml:lang="en-US">Non-qualified stock options vested percentage</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl" xml:lang="en-US">Non-qualified stock options term</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xml:lang="en-US">Number of Options, Outstanding Beginning</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xml:lang="en-US">Number of Options, Granted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xml:lang="en-US">Number of Options, Exercised</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl" xml:lang="en-US">Number of Options, Forfeited/Cancelled</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_lbl" xml:lang="en-US">Number of Options, Expired</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2_lbl" xml:lang="en-US">Number of Options, Outstanding Ending</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl" xml:lang="en-US">Number of Options, Exercisable Ending</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xml:lang="en-US">Weighted Average Exercise Price, Outstanding Beginning</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">Weighted Average Exercise Price, Granted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">Weighted Average Exercise Price, Exercised</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">Weighted Average Exercise Price, Forfeited/Cancelled</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">Weighted Average Exercise Price, Expired</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2_lbl" xml:lang="en-US">Weighted Average Exercise Price, Outstanding Ending</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_lbl" xml:lang="en-US">Weighted Average Exercise Price, Exercisable Ending</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_2_lbl" xml:lang="en-US">Weighted Average Remaining Contractual Term, Outstanding Beginning</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermGranted" xlink:label="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermGranted" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermGranted" xlink:to="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermGranted_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermGranted_lbl" xml:lang="en-US">Weighted Average Remaining Contractual Term, Granted</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm" xlink:label="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm" xlink:to="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm_lbl" xml:lang="en-US">Weighted Average Remaining Contractual Term, Outstanding Ending</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_lbl" xml:lang="en-US">Weighted Average Remaining Contractual Term, Exercisable Ending</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl" xml:lang="en-US">Aggregate Intrinsic Value, Outstanding Beginning</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_2_lbl" xml:lang="en-US">Aggregate Intrinsic Value, Outstanding Ending</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_lbl" xml:lang="en-US">Aggregate Intrinsic Value, Exercisable Ending</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_lbl" xml:lang="en-US">Number of Options Nonvested, Beginning</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_2_lbl" xml:lang="en-US">Number of Options Nonvested, Granted</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_2_lbl" xml:lang="en-US">Number of Options Nonvested, Vested</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_lbl" xml:lang="en-US">Number of Options Nonvested, Forfeited</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsNumberOfOptionsExpired" xlink:label="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsNumberOfOptionsExpired" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsNumberOfOptionsExpired" xlink:to="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsNumberOfOptionsExpired_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsNumberOfOptionsExpired_lbl" xml:lang="en-US">Number of Options Nonvested, Expired</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_2_lbl" xml:lang="en-US">Number of Options Nonvested, Ending</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_lbl" xml:lang="en-US">Weighted Average Grant-Date Fair Value, Beginning</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xml:lang="en-US">Weighted Average Grant-Date Fair Value, Granted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_lbl" xml:lang="en-US">Weighted Average Grant-Date Fair Value, Vested</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue_lbl" xml:lang="en-US">Weighted Average Grant-Date Fair Value, Forfeited</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsExpired" xlink:label="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsExpired" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsExpired" xlink:to="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsExpired_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsExpired_lbl" xml:lang="en-US">Weighted Average Grant-Date Fair Value, Expired</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_2_lbl" xml:lang="en-US">Weighted Average Grant-Date Fair Value, Ending</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1" xlink:label="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1" xlink:to="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1_lbl" xml:lang="en-US">Aggregated Intrinsic Value, Nonvested Beginning</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1" xlink:to="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1_2_lbl" xml:lang="en-US">Aggregated Intrinsic Value, Nonvested Ending</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested" xlink:label="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested" xlink:to="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested_lbl" xml:lang="en-US">Grant Date Fair Value Nonvested, Beginning</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValuesGranted" xlink:label="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValuesGranted" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValuesGranted" xlink:to="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValuesGranted_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValuesGranted_lbl" xml:lang="en-US">Grant Date Fair Value Nonvested, Granted</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValueVested" xlink:label="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValueVested" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValueVested" xlink:to="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValueVested_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValueVested_lbl" xml:lang="en-US">Grant Date Fair Value Nonvested, Vested</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantDateFairValueForfeited" xlink:label="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantDateFairValueForfeited" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantDateFairValueForfeited" xlink:to="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantDateFairValueForfeited_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantDateFairValueForfeited_lbl" xml:lang="en-US">Grant Date Fair Value Nonvested, Forfeited</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfSharesGrantDateFairValueExpired" xlink:label="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfSharesGrantDateFairValueExpired" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfSharesGrantDateFairValueExpired" xlink:to="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfSharesGrantDateFairValueExpired_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfSharesGrantDateFairValueExpired_lbl" xml:lang="en-US">Grant Date Fair Value Nonvested, Expired</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested" xlink:to="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested_2_lbl" xml:lang="en-US">Grant Date Fair Value Nonvested, Ending</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl" xml:lang="en-US">Number of Units, beginning</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_lbl" xml:lang="en-US">Number of Units, Granted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_lbl" xml:lang="en-US">Number of Units, Vested and settled with share issuance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_lbl" xml:lang="en-US">Number of Units, Forfeited/canceled</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_2_lbl" xml:lang="en-US">Number of Units, ending</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_lbl" xml:lang="en-US">Weighted Average Grant Date Fair Value, beginning</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xml:lang="en-US">Weighted Average Grant Date Fair Value, Granted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_lbl" xml:lang="en-US">Weighted Average Grant Date Fair Value, Vested and settled with share issuance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_lbl" xml:lang="en-US">Weighted Average Grant Date Fair Value, Forfeited/canceled</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_2_lbl" xml:lang="en-US">Weighted Average Grant Date Fair Value, ending</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_lbl" xml:lang="en-US">Aggregated Intrinsic Value, Outstanding beginning</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_2_lbl" xml:lang="en-US">Aggregated Intrinsic Value, Outstanding ending</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xlink:label="us-gaap_WarrantsAndRightsNoteDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xlink:to="us-gaap_WarrantsAndRightsNoteDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WarrantsAndRightsNoteDisclosureAbstract_lbl" xml:lang="en-US">Warrants and Rights Note Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightOutstanding" xlink:to="us-gaap_ClassOfWarrantOrRightOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding_lbl" xml:lang="en-US">Warrants Outstanding, Beginning Balance</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_ClassOfWarrantOrRightIssued" xlink:label="SRNA_ClassOfWarrantOrRightIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_ClassOfWarrantOrRightIssued" xlink:to="SRNA_ClassOfWarrantOrRightIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_ClassOfWarrantOrRightIssued_lbl" xml:lang="en-US">Warrants, Issued</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_ClassOfWarrantOrRightExercised" xlink:label="SRNA_ClassOfWarrantOrRightExercised" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_ClassOfWarrantOrRightExercised" xlink:to="SRNA_ClassOfWarrantOrRightExercised_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_ClassOfWarrantOrRightExercised_lbl" xml:lang="en-US">Warrants, Exercised</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_ClassOfWarrantOrRightExpired" xlink:label="SRNA_ClassOfWarrantOrRightExpired" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_ClassOfWarrantOrRightExpired" xlink:to="SRNA_ClassOfWarrantOrRightExpired_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="SRNA_ClassOfWarrantOrRightExpired_lbl" xml:lang="en-US">Warrants, Expired</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightOutstanding" xlink:to="us-gaap_ClassOfWarrantOrRightOutstanding_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding_2_lbl" xml:lang="en-US">Warrants Outstanding, Ending Balance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl" xml:lang="en-US">Weighted Average Exercise Price, Beginning Balance</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_ClassOfWarrantOrRightWeightedAverageExercisePriceIssued" xlink:label="SRNA_ClassOfWarrantOrRightWeightedAverageExercisePriceIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_ClassOfWarrantOrRightWeightedAverageExercisePriceIssued" xlink:to="SRNA_ClassOfWarrantOrRightWeightedAverageExercisePriceIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_ClassOfWarrantOrRightWeightedAverageExercisePriceIssued_lbl" xml:lang="en-US">Weighted Average Exercise Price, Issued</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_ClassOfWarrantOrRightWeightedAverageExercisePriceExercised" xlink:label="SRNA_ClassOfWarrantOrRightWeightedAverageExercisePriceExercised" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_ClassOfWarrantOrRightWeightedAverageExercisePriceExercised" xlink:to="SRNA_ClassOfWarrantOrRightWeightedAverageExercisePriceExercised_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="SRNA_ClassOfWarrantOrRightWeightedAverageExercisePriceExercised_lbl" xml:lang="en-US">Weighted Average Exercise Price, Exercised</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_ClassOfWarrantOrRightWeightedAverageExercisePriceExpired" xlink:label="SRNA_ClassOfWarrantOrRightWeightedAverageExercisePriceExpired" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_ClassOfWarrantOrRightWeightedAverageExercisePriceExpired" xlink:to="SRNA_ClassOfWarrantOrRightWeightedAverageExercisePriceExpired_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="SRNA_ClassOfWarrantOrRightWeightedAverageExercisePriceExpired_lbl" xml:lang="en-US">Weighted Average Exercise Price, Expired</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_2_lbl" xml:lang="en-US">Weighted Average Exercise Price, Ending Balance</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerms" xlink:label="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerms" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerms" xlink:to="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerms_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerms_lbl" xml:lang="en-US">Weighted Average Life of Outstanding Warrants in Months, Beginning Balance</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm" xlink:label="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm" xlink:to="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm_lbl" xml:lang="en-US">Weighted Average Life of Outstanding Warrants in Months, Ending Balance</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_ClassOfWarrantOrRightOutstandingAggregateIntrinsicValue" xlink:label="SRNA_ClassOfWarrantOrRightOutstandingAggregateIntrinsicValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_ClassOfWarrantOrRightOutstandingAggregateIntrinsicValue" xlink:to="SRNA_ClassOfWarrantOrRightOutstandingAggregateIntrinsicValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="SRNA_ClassOfWarrantOrRightOutstandingAggregateIntrinsicValue_lbl" xml:lang="en-US">Aggregate Intrinsic Value, Beginning Balance</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_ClassOfWarrantOrRightIssuedAggregateIntrinsicValue" xlink:label="SRNA_ClassOfWarrantOrRightIssuedAggregateIntrinsicValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_ClassOfWarrantOrRightIssuedAggregateIntrinsicValue" xlink:to="SRNA_ClassOfWarrantOrRightIssuedAggregateIntrinsicValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_ClassOfWarrantOrRightIssuedAggregateIntrinsicValue_lbl" xml:lang="en-US">Aggregate Intrinsic Value, Issued</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_ClassOfWarrantOrRightExercisedAggregateIntrinsicValue" xlink:label="SRNA_ClassOfWarrantOrRightExercisedAggregateIntrinsicValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_ClassOfWarrantOrRightExercisedAggregateIntrinsicValue" xlink:to="SRNA_ClassOfWarrantOrRightExercisedAggregateIntrinsicValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_ClassOfWarrantOrRightExercisedAggregateIntrinsicValue_lbl" xml:lang="en-US">Aggregate Intrinsic Value, Exercised</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_ClassOfWarrantOrRightExpiredAggregateIntrinsicValue" xlink:label="SRNA_ClassOfWarrantOrRightExpiredAggregateIntrinsicValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_ClassOfWarrantOrRightExpiredAggregateIntrinsicValue" xlink:to="SRNA_ClassOfWarrantOrRightExpiredAggregateIntrinsicValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_ClassOfWarrantOrRightExpiredAggregateIntrinsicValue_lbl" xml:lang="en-US">Aggregate Intrinsic Value, Expired</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_ClassOfWarrantOrRightOutstandingAggregateIntrinsicValue" xlink:to="SRNA_ClassOfWarrantOrRightOutstandingAggregateIntrinsicValue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="SRNA_ClassOfWarrantOrRightOutstandingAggregateIntrinsicValue_2_lbl" xml:lang="en-US">Aggregate Intrinsic Value, Ending Balance</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_3_lbl" xml:lang="en-US">Exercise price</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightOutstanding" xlink:to="us-gaap_ClassOfWarrantOrRightOutstanding_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding_3_lbl" xml:lang="en-US">Warrants Outstanding</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm" xlink:to="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm_2_lbl" xml:lang="en-US">Weighted Average Life of Outstanding Warrants in Months</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="us-gaap_OperatingLossCarryforwards" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLossCarryforwards" xlink:to="us-gaap_OperatingLossCarryforwards_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLossCarryforwards_lbl" xml:lang="en-US">Net operating loss carry forward amount</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_NetOperatingLossCarryForwardExpectedToExpireAmount" xlink:label="SRNA_NetOperatingLossCarryForwardExpectedToExpireAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_NetOperatingLossCarryForwardExpectedToExpireAmount" xlink:to="SRNA_NetOperatingLossCarryForwardExpectedToExpireAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_NetOperatingLossCarryForwardExpectedToExpireAmount_lbl" xml:lang="en-US">Net operating loss carry forward expected to expire amount</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_NetOperatingLossExpirationTerm" xlink:label="SRNA_NetOperatingLossExpirationTerm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_NetOperatingLossExpirationTerm" xlink:to="SRNA_NetOperatingLossExpirationTerm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_NetOperatingLossExpirationTerm_lbl" xml:lang="en-US">Net operating loss expiration term</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_NolsUsageAgainstTaxableIncomePercentage" xlink:label="SRNA_NolsUsageAgainstTaxableIncomePercentage" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_NolsUsageAgainstTaxableIncomePercentage" xlink:to="SRNA_NolsUsageAgainstTaxableIncomePercentage_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_NolsUsageAgainstTaxableIncomePercentage_lbl" xml:lang="en-US">NOLs usage against taxable income, percentage</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:label="us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:to="us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_lbl" xml:lang="en-US">Percentage of ownership change</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_NolsCarryforwardsTerm" xlink:label="SRNA_NolsCarryforwardsTerm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_NolsCarryforwardsTerm" xlink:to="SRNA_NolsCarryforwardsTerm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_NolsCarryforwardsTerm_lbl" xml:lang="en-US">NOLs carryforwards term</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AreaOfLand" xlink:label="us-gaap_AreaOfLand" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AreaOfLand" xlink:to="us-gaap_AreaOfLand_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AreaOfLand_lbl" xml:lang="en-US">Area of land</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasesRentExpenseSubleaseRentals1" xlink:label="us-gaap_OperatingLeasesRentExpenseSubleaseRentals1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesRentExpenseSubleaseRentals1" xlink:to="us-gaap_OperatingLeasesRentExpenseSubleaseRentals1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeasesRentExpenseSubleaseRentals1_lbl" xml:lang="en-US">Sublease rent charged</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_AggregateSharesIssuedUponExecutionOfSettlement" xlink:to="SRNA_AggregateSharesIssuedUponExecutionOfSettlement_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_AggregateSharesIssuedUponExecutionOfSettlement_doc" xml:lang="en-US">Aggregate common shares issued upon execution of settlement.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_ClassOfWarrantOrRightExercised" xlink:to="SRNA_ClassOfWarrantOrRightExercised_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_ClassOfWarrantOrRightExercised_doc" xml:lang="en-US">Warrants exercised during the period.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_ClassOfWarrantOrRightExercisedAggregateIntrinsicValue" xlink:to="SRNA_ClassOfWarrantOrRightExercisedAggregateIntrinsicValue_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_ClassOfWarrantOrRightExercisedAggregateIntrinsicValue_doc" xml:lang="en-US">Aggregate intrinsic value of warrants exercised.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_ClassOfWarrantOrRightExpired" xlink:to="SRNA_ClassOfWarrantOrRightExpired_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_ClassOfWarrantOrRightExpired_doc" xml:lang="en-US">Warrants expired during the period.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_ClassOfWarrantOrRightExpiredAggregateIntrinsicValue" xlink:to="SRNA_ClassOfWarrantOrRightExpiredAggregateIntrinsicValue_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_ClassOfWarrantOrRightExpiredAggregateIntrinsicValue_doc" xml:lang="en-US">Aggregate intrinsic value of warrants expired.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_ClassOfWarrantOrRightIssued" xlink:to="SRNA_ClassOfWarrantOrRightIssued_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_ClassOfWarrantOrRightIssued_doc" xml:lang="en-US">Warrants issued during the period.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_ClassOfWarrantOrRightIssuedAggregateIntrinsicValue" xlink:to="SRNA_ClassOfWarrantOrRightIssuedAggregateIntrinsicValue_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_ClassOfWarrantOrRightIssuedAggregateIntrinsicValue_doc" xml:lang="en-US">Aggregate intrinsic value of warrants issued.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_ClassOfWarrantOrRightOutstandingAggregateIntrinsicValue" xlink:to="SRNA_ClassOfWarrantOrRightOutstandingAggregateIntrinsicValue_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_ClassOfWarrantOrRightOutstandingAggregateIntrinsicValue_doc" xml:lang="en-US">Aggregate intrinsic value of outstanding warrants.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_ClassOfWarrantOrRightWeightedAverageExercisePriceExercised" xlink:to="SRNA_ClassOfWarrantOrRightWeightedAverageExercisePriceExercised_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_ClassOfWarrantOrRightWeightedAverageExercisePriceExercised_doc" xml:lang="en-US">Weighted average exercise price of warrants exercised.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_ClassOfWarrantOrRightWeightedAverageExercisePriceExpired" xlink:to="SRNA_ClassOfWarrantOrRightWeightedAverageExercisePriceExpired_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_ClassOfWarrantOrRightWeightedAverageExercisePriceExpired_doc" xml:lang="en-US">Weighted average exercise price of warrants expired.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_ClassOfWarrantOrRightWeightedAverageExercisePriceIssued" xlink:to="SRNA_ClassOfWarrantOrRightWeightedAverageExercisePriceIssued_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_ClassOfWarrantOrRightWeightedAverageExercisePriceIssued_doc" xml:lang="en-US">Weighted average exercise price of warrants issued.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonuses" xlink:to="SRNA_CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonuses_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonuses_doc" xml:lang="en-US">Common shares issued or to be issued on settlement of restricted stock units and award of stock bonuses.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesShares" xlink:to="SRNA_CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesShares_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesShares_doc" xml:lang="en-US">Common shares issued or to be issued on settlement of restricted stock units and award of stock bonuses, shares.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesSharesToBeIssued" xlink:to="SRNA_CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesSharesToBeIssued_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesSharesToBeIssued_doc" xml:lang="en-US">Common shares issued or to be issued on settlement of restricted stock units and award of stock bonuses, shares to be issued.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_CustomerOneMember" xlink:to="SRNA_CustomerOneMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_CustomerOneMember_doc" xml:lang="en-US">Customer One [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_CustomerThreeMember" xlink:to="SRNA_CustomerThreeMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_CustomerThreeMember_doc" xml:lang="en-US">Customer Three [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_CustomerTwoMember" xlink:to="SRNA_CustomerTwoMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_CustomerTwoMember_doc" xml:lang="en-US">Customer Two [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_DirectorsMember" xlink:to="SRNA_DirectorsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_DirectorsMember_doc" xml:lang="en-US">Directors [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_EmployeesAndConsultantsMember" xlink:to="SRNA_EmployeesAndConsultantsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_EmployeesAndConsultantsMember_doc" xml:lang="en-US">Employees and Consultants [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_EmployeesDirectorsandConsultantsMember" xlink:to="SRNA_EmployeesDirectorsandConsultantsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_EmployeesDirectorsandConsultantsMember_doc" xml:lang="en-US">Employees, Directors and Consultants [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_EmployeesMember" xlink:to="SRNA_EmployeesMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_EmployeesMember_doc" xml:lang="en-US">Employees [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_EngineeringAndOtherServicesMember" xlink:to="SRNA_EngineeringAndOtherServicesMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_EngineeringAndOtherServicesMember_doc" xml:lang="en-US">Engineering and Other Services [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_FacilityLeaseMember" xlink:to="SRNA_FacilityLeaseMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_FacilityLeaseMember_doc" xml:lang="en-US">Facility Lease [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_FormerEmployeeMember" xlink:to="SRNA_FormerEmployeeMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_FormerEmployeeMember_doc" xml:lang="en-US">Former Employee [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_IncentiveStockBonusAwardsMember" xlink:to="SRNA_IncentiveStockBonusAwardsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_IncentiveStockBonusAwardsMember_doc" xml:lang="en-US">Incentive Stock Bonus Awards [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_NonQualifiedStockOptionsMember" xlink:to="SRNA_NonQualifiedStockOptionsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_NonQualifiedStockOptionsMember_doc" xml:lang="en-US">Non-qualified Stock Options [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_NumberOfUnitsVestedAndSettled" xlink:to="SRNA_NumberOfUnitsVestedAndSettled_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_NumberOfUnitsVestedAndSettled_doc" xml:lang="en-US">Number of units, vested and settled.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_NumberOfUnitsVestedButNotSettled" xlink:to="SRNA_NumberOfUnitsVestedButNotSettled_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_NumberOfUnitsVestedButNotSettled_doc" xml:lang="en-US">Number of Units, Vested but not settled .</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_RemainingPerformanceObligationsRelatedToEngineeringOnlyPaidContracts" xlink:to="SRNA_RemainingPerformanceObligationsRelatedToEngineeringOnlyPaidContracts_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_RemainingPerformanceObligationsRelatedToEngineeringOnlyPaidContracts_doc" xml:lang="en-US">Remaining performance obligations related to engineering only paid contracts.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_RemainingPerformanceObligationsRelatedToPartialEquipmentPaidContracts" xlink:to="SRNA_RemainingPerformanceObligationsRelatedToPartialEquipmentPaidContracts_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_RemainingPerformanceObligationsRelatedToPartialEquipmentPaidContracts_doc" xml:lang="en-US">Remaining performance obligations related to partial equipment paid contracts.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_RestrictedStockUnitsSharesIssuedInterestPercentage" xlink:to="SRNA_RestrictedStockUnitsSharesIssuedInterestPercentage_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_RestrictedStockUnitsSharesIssuedInterestPercentage_doc" xml:lang="en-US">Restricted stock units shares issued interest percentage.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_ScheduleOfOutstandingWarrantsToPurchaseCommonStockTableTextBlock" xlink:to="SRNA_ScheduleOfOutstandingWarrantsToPurchaseCommonStockTableTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_ScheduleOfOutstandingWarrantsToPurchaseCommonStockTableTextBlock_doc" xml:lang="en-US">Schedule of Outstanding Warrants to Purchase Common Stock [Table TextBlock]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm" xlink:to="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm_doc" xml:lang="en-US">Weighted average life of outstanding warrants in months, ending balance.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerms" xlink:to="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerms_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerms_doc" xml:lang="en-US">Weighted average life of outstanding warrants in months, beginning balance.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantDateFairValueForfeited" xlink:to="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantDateFairValueForfeited_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantDateFairValueForfeited_doc" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Forfeited.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1" xlink:to="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1_doc" xml:lang="en-US">Fair value of options nonvested. Excludes equity instruments other than options, for example, but not limited to, share units, stock appreciation rights, restricted stock.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested" xlink:to="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested_doc" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValueVested" xlink:to="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValueVested_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValueVested_doc" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Vested.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValuesGranted" xlink:to="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValuesGranted_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValuesGranted_doc" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested Granted.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsExpired" xlink:to="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsExpired_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsExpired_doc" xml:lang="en-US">Weighted Average Grant Date Fair Value, Expired.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfSharesGrantDateFairValueExpired" xlink:to="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfSharesGrantDateFairValueExpired_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfSharesGrantDateFairValueExpired_doc" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested Grant Date Fair Value, Expired</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsNumberOfOptionsExpired" xlink:to="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsNumberOfOptionsExpired_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsNumberOfOptionsExpired_doc" xml:lang="en-US">Number of Options, Expired.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm" xlink:to="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm_doc" xml:lang="en-US">Weighted Average Remaining Contractual Term, Ending.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermGranted" xlink:to="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermGranted_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermGranted_doc" xml:lang="en-US">Weighted average remaining contractual term, granted.</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_TwoNewIndependentDirectorsMember" xlink:label="SRNA_TwoNewIndependentDirectorsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_TwoNewIndependentDirectorsMember" xlink:to="SRNA_TwoNewIndependentDirectorsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_TwoNewIndependentDirectorsMember_doc" xml:lang="en-US">Two New Independent Directors [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_TwoThousandAndNineteenSpecialEquityPlanMember" xlink:label="SRNA_TwoThousandAndNineteenSpecialEquityPlanMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_TwoThousandAndNineteenSpecialEquityPlanMember" xlink:to="SRNA_TwoThousandAndNineteenSpecialEquityPlanMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_TwoThousandAndNineteenSpecialEquityPlanMember_doc" xml:lang="en-US">2019 special equity plan.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_TwoThousandAndSeventeenEquityIncentivePlanMember" xlink:to="SRNA_TwoThousandAndSeventeenEquityIncentivePlanMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_TwoThousandAndSeventeenEquityIncentivePlanMember_doc" xml:lang="en-US">2017 Equity Incentive Plan [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_TwoThousandAndSeventeenEquityPlanMember" xlink:to="SRNA_TwoThousandAndSeventeenEquityPlanMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_TwoThousandAndSeventeenEquityPlanMember_doc" xml:lang="en-US">2017 Equity Incentive Plan [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_TwoThousandAndTwentyOneMember" xlink:to="SRNA_TwoThousandAndTwentyOneMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_TwoThousandAndTwentyOneMember_doc" xml:lang="en-US">2021 [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_TwoThousandAndTwentyTwoMember" xlink:to="SRNA_TwoThousandAndTwentyTwoMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_TwoThousandAndTwentyTwoMember_doc" xml:lang="en-US">2022 [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_TwoThousandSeventeenEquityPlanMember" xlink:to="SRNA_TwoThousandSeventeenEquityPlanMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_TwoThousandSeventeenEquityPlanMember_doc" xml:lang="en-US">2017 Equity Plan [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_UnvestedOptionsMember" xlink:label="SRNA_UnvestedOptionsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_UnvestedOptionsMember" xlink:to="SRNA_UnvestedOptionsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_UnvestedOptionsMember_doc" xml:lang="en-US">Unvested Options [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_WarrantsDisclosureTextBlock" xlink:to="SRNA_WarrantsDisclosureTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_WarrantsDisclosureTextBlock_doc" xml:lang="en-US">Warrants [Text block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_WarrantsRangeMember" xlink:to="SRNA_WarrantsRangeMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_WarrantsRangeMember_doc" xml:lang="en-US">Warrants Range [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_WarrantsRangeOneMember" xlink:to="SRNA_WarrantsRangeOneMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_WarrantsRangeOneMember_doc" xml:lang="en-US">Warrants Range One [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_CommonSharesToBeIssued" xlink:to="SRNA_CommonSharesToBeIssued_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_CommonSharesToBeIssued_doc" xml:lang="en-US">Common stock, shares to be issued.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_CommonSharesToBeIssuedInSettlementOfLegalDispute" xlink:to="SRNA_CommonSharesToBeIssuedInSettlementOfLegalDispute_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_CommonSharesToBeIssuedInSettlementOfLegalDispute_doc" xml:lang="en-US">Common shares to be issued in settlement of legal dispute.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_FairValueOfVestedStockOptionsGrantedToEmployees" xlink:to="SRNA_FairValueOfVestedStockOptionsGrantedToEmployees_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_FairValueOfVestedStockOptionsGrantedToEmployees_doc" xml:lang="en-US">Fair value of vested stock options granted to employees.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_FairValueOfVestedStockOptionsGrantedToDirectors" xlink:to="SRNA_FairValueOfVestedStockOptionsGrantedToDirectors_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_FairValueOfVestedStockOptionsGrantedToDirectors_doc" xml:lang="en-US">Fair value of vested stock options granted to directors.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_CommonSharesToBeIssuedInSettlementOfLegalDisputeSharesToBeIssued" xlink:to="SRNA_CommonSharesToBeIssuedInSettlementOfLegalDisputeSharesToBeIssued_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_CommonSharesToBeIssuedInSettlementOfLegalDisputeSharesToBeIssued_doc" xml:lang="en-US">Common shares to be issued in settlement of legal dispute, shares to be issued.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_CommonStockSharesToBeIssuedValue" xlink:to="SRNA_CommonStockSharesToBeIssuedValue_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_CommonStockSharesToBeIssuedValue_doc" xml:lang="en-US">Common stock, $0.00001 par value; 1,000,000 shares to be issued.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_CommonStockSharesToBeIssuedBalance" xlink:to="SRNA_CommonStockSharesToBeIssuedBalance_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_CommonStockSharesToBeIssuedBalance_doc" xml:lang="en-US">Balance, shares to be issued.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_OtherSharebasedExpense" xlink:to="SRNA_OtherSharebasedExpense_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_OtherSharebasedExpense_doc" xml:lang="en-US">Other share-based expense.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_CashBalanceTransferredToBankAccount" xlink:to="SRNA_CashBalanceTransferredToBankAccount_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_CashBalanceTransferredToBankAccount_doc" xml:lang="en-US">Cash balance transferred to bank account.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_TwoThousandTwentyOneAnnualEmployeeIncentiveCompensationPlanMember" xlink:to="SRNA_TwoThousandTwentyOneAnnualEmployeeIncentiveCompensationPlanMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_TwoThousandTwentyOneAnnualEmployeeIncentiveCompensationPlanMember_doc" xml:lang="en-US">2021 Incentive Awards [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_CustomerFourMember" xlink:to="SRNA_CustomerFourMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_CustomerFourMember_doc" xml:lang="en-US">Customer Four [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_InventoryMember" xlink:to="SRNA_InventoryMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_InventoryMember_doc" xml:lang="en-US">Inventory [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_StockIssuanceAmount" xlink:to="SRNA_StockIssuanceAmount_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_StockIssuanceAmount_doc" xml:lang="en-US">Stock issuance amount.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_DescriptionOfBusinessPolicyTextBlock" xlink:to="SRNA_DescriptionOfBusinessPolicyTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_DescriptionOfBusinessPolicyTextBlock_doc" xml:lang="en-US">Description of Business.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_ImpactOfCovid19PandemicOnOurBusinessPolicyTextBlock" xlink:to="SRNA_ImpactOfCovid19PandemicOnOurBusinessPolicyTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_ImpactOfCovid19PandemicOnOurBusinessPolicyTextBlock_doc" xml:lang="en-US">Impact of the COVID-19 Pandemic on Our Business.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_GoingConcernPolicyTextBlock" xlink:to="SRNA_GoingConcernPolicyTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_GoingConcernPolicyTextBlock_doc" xml:lang="en-US">Going Concern.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_MonthlyRentDescription" xlink:to="SRNA_MonthlyRentDescription_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_MonthlyRentDescription_doc" xml:lang="en-US">Monthly rent description.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_UnamortizedAmountOfTenantImprovementAllowance" xlink:to="SRNA_UnamortizedAmountOfTenantImprovementAllowance_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_UnamortizedAmountOfTenantImprovementAllowance_doc" xml:lang="en-US">Unamortized amount of tenant improvement allowance.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_PrepaidInventoryExpenses" xlink:to="SRNA_PrepaidInventoryExpenses_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_PrepaidInventoryExpenses_doc" xml:lang="en-US">Prepaid inventory expenses.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_NetOperatingLossCarryForwardExpectedToExpireAmount" xlink:to="SRNA_NetOperatingLossCarryForwardExpectedToExpireAmount_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_NetOperatingLossCarryForwardExpectedToExpireAmount_doc" xml:lang="en-US">Net operating loss carry forward expected to expire amount.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_NetOperatingLossExpirationTerm" xlink:to="SRNA_NetOperatingLossExpirationTerm_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_NetOperatingLossExpirationTerm_doc" xml:lang="en-US">Net operating loss expiration term.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_NolsUsageAgainstTaxableIncomePercentage" xlink:to="SRNA_NolsUsageAgainstTaxableIncomePercentage_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_NolsUsageAgainstTaxableIncomePercentage_doc" xml:lang="en-US">NOLs usage against taxable income percentage.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_NolsCarryforwardsTerm" xlink:to="SRNA_NolsCarryforwardsTerm_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_NolsCarryforwardsTerm_doc" xml:lang="en-US">NOLs carryforwards term.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_OfficeandManufacturingMember" xlink:to="SRNA_OfficeandManufacturingMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_OfficeandManufacturingMember_doc" xml:lang="en-US">Office and Manufacturing [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_CommonStockSharesToBeIssuedParOrStatedValuePerShare" xlink:to="SRNA_CommonStockSharesToBeIssuedParOrStatedValuePerShare_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_CommonStockSharesToBeIssuedParOrStatedValuePerShare_doc" xml:lang="en-US">Common stock, shares to be issued, par value.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_CommonStockValueToBeIssuedBalance" xlink:to="SRNA_CommonStockValueToBeIssuedBalance_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_CommonStockValueToBeIssuedBalance_doc" xml:lang="en-US">Balance, shares to be issued, value.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_IncreaseDecreaseInLeaseDeposit" xlink:to="SRNA_IncreaseDecreaseInLeaseDeposit_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_IncreaseDecreaseInLeaseDeposit_doc" xml:lang="en-US">Lease deposit.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_TwoThousandAndTwentyOneEquityIncentivePlanMember" xlink:to="SRNA_TwoThousandAndTwentyOneEquityIncentivePlanMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SRNA_TwoThousandAndTwentyOneEquityIncentivePlanMember_doc" xml:lang="en-US">2021 Equity Incentive Plan [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_DirectorsMember" xlink:to="SRNA_DirectorsMember_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_DirectorsMember_3_lbl" xml:lang="en-US">DirectorsMember</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_TwoThousandAndSeventeenEquityIncentivePlanMember" xlink:to="SRNA_TwoThousandAndSeventeenEquityIncentivePlanMember_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_TwoThousandAndSeventeenEquityIncentivePlanMember_3_lbl" xml:lang="en-US">TwoThousandAndSeventeenEquityIncentivePlanMember</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrent_2_lbl" xml:lang="en-US">Assets, Current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsNoncurrent" xlink:to="us-gaap_AssetsNoncurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsNoncurrent_2_lbl" xml:lang="en-US">Assets, Noncurrent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Assets_2_lbl" xml:lang="en-US">Assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrent_2_lbl" xml:lang="en-US">Liabilities, Current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLiabilitiesNoncurrent" xlink:to="us-gaap_OtherLiabilitiesNoncurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherLiabilitiesNoncurrent_2_lbl" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesNoncurrent" xlink:to="us-gaap_LiabilitiesNoncurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesNoncurrent_2_lbl" xml:lang="en-US">Liabilities, Noncurrent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Liabilities_2_lbl" xml:lang="en-US">Liabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_4_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquity_4_lbl" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_2_lbl" xml:lang="en-US">Liabilities and Equity</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GrossProfit" xlink:to="us-gaap_GrossProfit_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GrossProfit_2_lbl" xml:lang="en-US">Gross Profit</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_OperatingExpenses_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingExpenses_2_lbl" xml:lang="en-US">Operating Expenses</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingIncomeLoss_2_lbl" xml:lang="en-US">Operating Income (Loss)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpense" xlink:to="us-gaap_InterestExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestExpense_2_lbl" xml:lang="en-US">Interest Expense</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_NonoperatingIncomeExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NonoperatingIncomeExpense_2_lbl" xml:lang="en-US">Nonoperating Income (Expense)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_lbl" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharesOutstanding_3_lbl" xml:lang="en-US">Shares, Outstanding</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_CommonStockSharesToBeIssuedBalance" xlink:to="SRNA_CommonStockSharesToBeIssuedBalance_4_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_CommonStockSharesToBeIssuedBalance_4_lbl" xml:lang="en-US">CommonStockSharesToBeIssuedBalance</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_CommonStockValueToBeIssuedBalance" xlink:to="SRNA_CommonStockValueToBeIssuedBalance_4_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_CommonStockValueToBeIssuedBalance_4_lbl" xml:lang="en-US">CommonStockValueToBeIssuedBalance</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainLossOnDispositionOfAssets" xlink:to="us-gaap_GainLossOnDispositionOfAssets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GainLossOnDispositionOfAssets_2_lbl" xml:lang="en-US">Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsAndNotesReceivable" xlink:to="us-gaap_IncreaseDecreaseInAccountsAndNotesReceivable_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccountsAndNotesReceivable_2_lbl" xml:lang="en-US">Increase (Decrease) in Accounts and Notes Receivable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInInventories" xlink:to="us-gaap_IncreaseDecreaseInInventories_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInInventories_2_lbl" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidExpensesOther" xlink:to="us-gaap_IncreaseDecreaseInPrepaidExpensesOther_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInPrepaidExpensesOther_2_lbl" xml:lang="en-US">Increase (Decrease) in Prepaid Expenses, Other</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_2_lbl" xml:lang="en-US">Increase (Decrease) in Accounts Payable and Accrued Liabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:to="us-gaap_IncreaseDecreaseInContractWithCustomerLiability_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInContractWithCustomerLiability_2_lbl" xml:lang="en-US">Increase (Decrease) in Contract with Customer, Liability</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInDeferredCompensation" xlink:to="us-gaap_IncreaseDecreaseInDeferredCompensation_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInDeferredCompensation_2_lbl" xml:lang="en-US">Increase (Decrease) in Deferred Compensation</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_2_lbl" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_3_lbl" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_WarrantsDisclosureTextBlock" xlink:to="SRNA_WarrantsDisclosureTextBlock_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_WarrantsDisclosureTextBlock_3_lbl" xml:lang="en-US">WarrantsDisclosureTextBlock</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:to="us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_2_lbl" xml:lang="en-US">Goodwill and Intangible Assets, Policy [Policy Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_2_lbl" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_2_lbl" xml:lang="en-US">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryValuationReserves" xlink:to="us-gaap_InventoryValuationReserves_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryValuationReserves_2_lbl" xml:lang="en-US">Inventory Valuation Reserves</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_2_lbl" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentIncreaseAccruedInterest" xlink:to="us-gaap_DebtInstrumentIncreaseAccruedInterest_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentIncreaseAccruedInterest_2_lbl" xml:lang="en-US">Debt Instrument, Increase, Accrued Interest</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_3_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_2_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_2_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_2_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_2_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_3_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_2_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_3_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_2_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_3_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_2_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested Options Forfeited, Number of Shares</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_3_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Option, Nonvested, Weighted Average Exercise Price</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1" xlink:to="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1_4_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1_4_lbl" xml:lang="en-US">SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested" xlink:to="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested_4_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested_4_lbl" xml:lang="en-US">SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_3_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_2_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_2_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_3_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_3_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Outstanding</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_ClassOfWarrantOrRightExpired" xlink:to="SRNA_ClassOfWarrantOrRightExpired_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_ClassOfWarrantOrRightExpired_3_lbl" xml:lang="en-US">ClassOfWarrantOrRightExpired</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_ClassOfWarrantOrRightWeightedAverageExercisePriceExercised" xlink:to="SRNA_ClassOfWarrantOrRightWeightedAverageExercisePriceExercised_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_ClassOfWarrantOrRightWeightedAverageExercisePriceExercised_3_lbl" xml:lang="en-US">United States - 2032</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_ClassOfWarrantOrRightWeightedAverageExercisePriceExpired" xlink:to="SRNA_ClassOfWarrantOrRightWeightedAverageExercisePriceExpired_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_ClassOfWarrantOrRightWeightedAverageExercisePriceExpired_3_lbl" xml:lang="en-US">ClassOfWarrantOrRightWeightedAverageExercisePriceExpired</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SRNA_ClassOfWarrantOrRightOutstandingAggregateIntrinsicValue" xlink:to="SRNA_ClassOfWarrantOrRightOutstandingAggregateIntrinsicValue_4_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SRNA_ClassOfWarrantOrRightOutstandingAggregateIntrinsicValue_4_lbl" xml:lang="en-US">ClassOfWarrantOrRightOutstandingAggregateIntrinsicValue</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>13
<FILENAME>srna-20210331_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.8a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Source; Value: SRNA %2D 20210331 10Q Q1 DFN.xfr; Date: 2021%2D05%2D10T22:03:41Z -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x800A0000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://surna.com/role/DocumentAndEntityInformation" xlink:href="srna-20210331.xsd#DocumentAndEntityInformation" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/BalanceSheets" xlink:href="srna-20210331.xsd#BalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/BalanceSheetsParenthetical" xlink:href="srna-20210331.xsd#BalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/StatementsOfOperations" xlink:href="srna-20210331.xsd#StatementsOfOperations" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/StatementsOfChangesInShareholdersDeficit" xlink:href="srna-20210331.xsd#StatementsOfChangesInShareholdersDeficit" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/StatementsOfCashFlows" xlink:href="srna-20210331.xsd#StatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/General" xlink:href="srna-20210331.xsd#General" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/Leases" xlink:href="srna-20210331.xsd#Leases" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/Inventory" xlink:href="srna-20210331.xsd#Inventory" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/PropertyAndEquipment" xlink:href="srna-20210331.xsd#PropertyAndEquipment" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/AccountsPayableAndAccruedLiabilities" xlink:href="srna-20210331.xsd#AccountsPayableAndAccruedLiabilities" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/NotePayableAndAccruedInterest" xlink:href="srna-20210331.xsd#NotePayableAndAccruedInterest" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/CommitmentsAndContingencies" xlink:href="srna-20210331.xsd#CommitmentsAndContingencies" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/EquityIncentivePlan" xlink:href="srna-20210331.xsd#EquityIncentivePlan" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/Warrants" xlink:href="srna-20210331.xsd#Warrants" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/IncomeTaxes" xlink:href="srna-20210331.xsd#IncomeTaxes" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/SubsequentEvents" xlink:href="srna-20210331.xsd#SubsequentEvents" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/GeneralPolicies" xlink:href="srna-20210331.xsd#GeneralPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/GeneralTables" xlink:href="srna-20210331.xsd#GeneralTables" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/LeasesTables" xlink:href="srna-20210331.xsd#LeasesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/InventoryTables" xlink:href="srna-20210331.xsd#InventoryTables" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/PropertyAndEquipmentTables" xlink:href="srna-20210331.xsd#PropertyAndEquipmentTables" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/AccountsPayableAndAccruedLiabilitiesTables" xlink:href="srna-20210331.xsd#AccountsPayableAndAccruedLiabilitiesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/EquityIncentivePlanTables" xlink:href="srna-20210331.xsd#EquityIncentivePlanTables" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/WarrantsTables" xlink:href="srna-20210331.xsd#WarrantsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/GeneralDetailsNarrative" xlink:href="srna-20210331.xsd#GeneralDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/General-ScheduleOfRemainingPerformanceObligationsExpectedToBeRecognizedDetails" xlink:href="srna-20210331.xsd#General-ScheduleOfRemainingPerformanceObligationsExpectedToBeRecognizedDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/General-ScheduleOfRevenueBySourceDetails" xlink:href="srna-20210331.xsd#General-ScheduleOfRevenueBySourceDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/General-ScheduleOfShare-basedCompensationCostsDetails" xlink:href="srna-20210331.xsd#General-ScheduleOfShare-basedCompensationCostsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/LeasesDetailsNarrative" xlink:href="srna-20210331.xsd#LeasesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/Leases-ScheduleOfLeaseCostDetails" xlink:href="srna-20210331.xsd#Leases-ScheduleOfLeaseCostDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/Leases-ScheduleOfFutureAnnualMinimumLeasePaymentsDetails" xlink:href="srna-20210331.xsd#Leases-ScheduleOfFutureAnnualMinimumLeasePaymentsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/InventoryDetailsNarrative" xlink:href="srna-20210331.xsd#InventoryDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/Inventory-ScheduleOfInventoryDetails" xlink:href="srna-20210331.xsd#Inventory-ScheduleOfInventoryDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/PropertyAndEquipmentDetailsNarrative" xlink:href="srna-20210331.xsd#PropertyAndEquipmentDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/PropertyAndEquipment-ScheduleOfPropertyAndEquipmentDetails" xlink:href="srna-20210331.xsd#PropertyAndEquipment-ScheduleOfPropertyAndEquipmentDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/AccountsPayableAndAccruedLiabilities-ScheduleOfAccountsPayableAndAccruedLiabilitiesDetails" xlink:href="srna-20210331.xsd#AccountsPayableAndAccruedLiabilities-ScheduleOfAccountsPayableAndAccruedLiabilitiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/NotePayableAndAccruedInterestDetailsNarrative" xlink:href="srna-20210331.xsd#NotePayableAndAccruedInterestDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:href="srna-20210331.xsd#CommitmentsAndContingenciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/EquityIncentivePlanDetailsNarrative" xlink:href="srna-20210331.xsd#EquityIncentivePlanDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/EquityIncentivePlan-ScheduleOfStockOptionActivityDetails" xlink:href="srna-20210331.xsd#EquityIncentivePlan-ScheduleOfStockOptionActivityDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/EquityIncentivePlan-SummaryOfNon-vestedNon-qualifiedStockOptionActivityDetails" xlink:href="srna-20210331.xsd#EquityIncentivePlan-SummaryOfNon-vestedNon-qualifiedStockOptionActivityDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/EquityIncentivePlan-ScheduleOfRestrictedStockUnitsActivityDetails" xlink:href="srna-20210331.xsd#EquityIncentivePlan-ScheduleOfRestrictedStockUnitsActivityDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/Warrants-ScheduleOfOutstandingWarrantsToPurchaseCommonStockDetails" xlink:href="srna-20210331.xsd#Warrants-ScheduleOfOutstandingWarrantsToPurchaseCommonStockDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/Warrants-ScheduleOfWarrantsOutstandingDetails" xlink:href="srna-20210331.xsd#Warrants-ScheduleOfWarrantsOutstandingDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/IncomeTaxesDetailsNarrative" xlink:href="srna-20210331.xsd#IncomeTaxesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://surna.com/role/SubsequentEventsDetailsNarrative" xlink:href="srna-20210331.xsd#SubsequentEventsDetailsNarrative" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/DocumentAndEntityInformation" xlink:title="00000001 - Document - Document and Entity Information">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/BalanceSheets" xlink:title="00000002 - Statement - Condensed Consolidated Balance Sheets">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaapStatementOfFinancialPositionAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="loc_us-gaapAssetsAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapAssetsAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="loc_us-gaapAssetsCurrentAbstract" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapAssetsCurrentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaapAccountsReceivableNetCurrent" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapAccountsReceivableNetCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaapInventoryNet" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapInventoryNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapAssetsCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsNoncurrentAbstract" xlink:label="loc_us-gaapAssetsNoncurrentAbstract" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapAssetsNoncurrentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsNoncurrentAbstract" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaapGoodwill" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsNoncurrentAbstract" xlink:to="loc_us-gaapGoodwill" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="loc_us-gaapIntangibleAssetsNetExcludingGoodwill" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsNoncurrentAbstract" xlink:to="loc_us-gaapIntangibleAssetsNetExcludingGoodwill" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepositsAssetsNoncurrent" xlink:label="loc_us-gaapDepositsAssetsNoncurrent" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsNoncurrentAbstract" xlink:to="loc_us-gaapDepositsAssetsNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaapOperatingLeaseRightOfUseAsset" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsNoncurrentAbstract" xlink:to="loc_us-gaapOperatingLeaseRightOfUseAsset" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsNoncurrent" xlink:label="loc_us-gaapAssetsNoncurrent" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsNoncurrentAbstract" xlink:to="loc_us-gaapAssetsNoncurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="loc_us-gaapLiabilitiesCurrentAbstract" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapLiabilitiesCurrentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent" xlink:label="loc_us-gaapContractWithCustomerLiabilityCurrent" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapContractWithCustomerLiabilityCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredCompensationLiabilityCurrent" xlink:label="loc_us-gaapDeferredCompensationLiabilityCurrent" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapDeferredCompensationLiabilityCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="loc_us-gaapOtherLiabilitiesCurrent" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapOtherLiabilitiesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityCurrent" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapOperatingLeaseLiabilityCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapLiabilitiesCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesNoncurrentAbstract" xlink:label="loc_us-gaapLiabilitiesNoncurrentAbstract" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapLiabilitiesNoncurrentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermNotesPayable" xlink:label="loc_us-gaapLongTermNotesPayable" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract" xlink:to="loc_us-gaapLongTermNotesPayable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="loc_us-gaapOtherLiabilitiesNoncurrent" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract" xlink:to="loc_us-gaapOtherLiabilitiesNoncurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityNoncurrent" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract" xlink:to="loc_us-gaapOperatingLeaseLiabilityNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesNoncurrent" xlink:label="loc_us-gaapLiabilitiesNoncurrent" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract" xlink:to="loc_us-gaapLiabilitiesNoncurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="loc_us-gaapCommitmentsAndContingencies" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapCommitmentsAndContingencies" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="loc_us-gaapStockholdersEquityAbstract" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapStockholdersEquityAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaapPreferredStockValue" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapPreferredStockValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapCommonStockValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_CommonStockSharesToBeIssuedValue" xlink:label="loc_SRNACommonStockSharesToBeIssuedValue" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_SRNACommonStockSharesToBeIssuedValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaapAdditionalPaidInCapital" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapAdditionalPaidInCapital" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/BalanceSheetsParenthetical" xlink:title="00000003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaapStatementOfFinancialPositionAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:label="loc_us-gaapAllowanceForDoubtfulAccountsReceivableCurrent" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapAllowanceForDoubtfulAccountsReceivableCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaapPreferredStockParOrStatedValuePerShare" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapPreferredStockParOrStatedValuePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaapPreferredStockSharesAuthorized" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapPreferredStockSharesAuthorized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="loc_us-gaapPreferredStockSharesIssued" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapPreferredStockSharesIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="loc_us-gaapPreferredStockSharesOutstanding" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapPreferredStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaapCommonStockSharesAuthorized" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapCommonStockSharesAuthorized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaapCommonStockSharesIssued" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapCommonStockSharesIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_CommonStockSharesToBeIssuedParOrStatedValuePerShare" xlink:label="loc_SRNACommonStockSharesToBeIssuedParOrStatedValuePerShare" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_SRNACommonStockSharesToBeIssuedParOrStatedValuePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_CommonSharesToBeIssued" xlink:label="loc_SRNACommonSharesToBeIssued" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_SRNACommonSharesToBeIssued" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/StatementsOfOperations" xlink:title="00000004 - Statement - Condensed Consolidated Statements of Operations (Unaudited)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="loc_us-gaapIncomeStatementAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfRevenue" xlink:label="loc_us-gaapCostOfRevenue" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapCostOfRevenue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit" xlink:label="loc_us-gaapGrossProfit" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapGrossProfit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="loc_us-gaapOperatingExpensesAbstract" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapOperatingExpensesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketingAndAdvertisingExpense" xlink:label="loc_us-gaapMarketingAndAdvertisingExpense" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_us-gaapMarketingAndAdvertisingExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaapResearchAndDevelopmentExpense" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_us-gaapResearchAndDevelopmentExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="loc_us-gaapSellingGeneralAndAdministrativeExpense" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_us-gaapSellingGeneralAndAdministrativeExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaapOperatingExpenses" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_us-gaapOperatingExpenses" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaapOperatingIncomeLoss" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_us-gaapOperatingIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpenseAbstract" xlink:label="loc_us-gaapNonoperatingIncomeExpenseAbstract" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="loc_us-gaapOtherNonoperatingIncomeExpense" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapOtherNonoperatingIncomeExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense" xlink:label="loc_us-gaapInterestExpense" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapInterestExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="loc_us-gaapNonoperatingIncomeExpense" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNonoperatingIncomeExpenseAbstract" xlink:to="loc_us-gaapNonoperatingIncomeExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:label="loc_us-gaapEarningsPerShareBasicAndDiluted" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapEarningsPerShareBasicAndDiluted" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:label="loc_us-gaapWeightedAverageNumberOfShareOutstandingBasicAndDiluted" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapWeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/StatementsOfChangesInShareholdersDeficit" xlink:title="00000005 - Statement - Condensed Consolidated Statements of Changes in Shareholders&apos; Deficit (Unaudited)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="loc_us-gaapStatementOfStockholdersEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfStockholdersEquityAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="50" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockMember" xlink:label="loc_us-gaapPreferredStockMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapPreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaapAdditionalPaidInCapitalMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapAdditionalPaidInCapitalMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaapRetainedEarningsMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapRetainedEarningsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaapSharesOutstanding" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesOutstanding" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_CommonStockSharesToBeIssuedBalance" xlink:label="loc_SRNACommonStockSharesToBeIssuedBalance" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SRNACommonStockSharesToBeIssuedBalance" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_CommonStockValueToBeIssuedBalance" xlink:label="loc_SRNACommonStockValueToBeIssuedBalance" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SRNACommonStockValueToBeIssuedBalance" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonuses" xlink:label="loc_SRNACommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonuses" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SRNACommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonuses" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesShares" xlink:label="loc_SRNACommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesShares" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SRNACommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesSharesToBeIssued" xlink:label="loc_SRNACommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesSharesToBeIssued" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SRNACommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesSharesToBeIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition" xlink:label="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" xlink:label="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_CommonSharesToBeIssuedInSettlementOfLegalDispute" xlink:label="loc_SRNACommonSharesToBeIssuedInSettlementOfLegalDispute" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SRNACommonSharesToBeIssuedInSettlementOfLegalDispute" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_CommonSharesToBeIssuedInSettlementOfLegalDisputeSharesToBeIssued" xlink:label="loc_SRNACommonSharesToBeIssuedInSettlementOfLegalDisputeSharesToBeIssued" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SRNACommonSharesToBeIssuedInSettlementOfLegalDisputeSharesToBeIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_FairValueOfVestedStockOptionsGrantedToEmployees" xlink:label="loc_SRNAFairValueOfVestedStockOptionsGrantedToEmployees" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SRNAFairValueOfVestedStockOptionsGrantedToEmployees" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_FairValueOfVestedStockOptionsGrantedToDirectors" xlink:label="loc_SRNAFairValueOfVestedStockOptionsGrantedToDirectors" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SRNAFairValueOfVestedStockOptionsGrantedToDirectors" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity_2" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquity_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaapSharesOutstanding_2" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesOutstanding_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_CommonStockSharesToBeIssuedBalance" xlink:label="loc_SRNACommonStockSharesToBeIssuedBalance_2" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SRNACommonStockSharesToBeIssuedBalance_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_CommonStockValueToBeIssuedBalance" xlink:label="loc_SRNACommonStockValueToBeIssuedBalance_2" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SRNACommonStockValueToBeIssuedBalance_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/StatementsOfCashFlows" xlink:title="00000006 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="loc_us-gaapStatementOfCashFlowsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="loc_us-gaapDepreciationDepletionAndAmortization" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapDepreciationDepletionAndAmortization" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaapShareBasedCompensation" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapShareBasedCompensation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_OtherSharebasedExpense" xlink:label="loc_SRNAOtherSharebasedExpense" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_SRNAOtherSharebasedExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryWriteDown" xlink:label="loc_us-gaapInventoryWriteDown" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapInventoryWriteDown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnDispositionOfAssets" xlink:label="loc_us-gaapGainLossOnDispositionOfAssets" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapGainLossOnDispositionOfAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:label="loc_us-gaapOperatingLeaseRightOfUseAssetAmortizationExpense" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapOperatingLeaseRightOfUseAssetAmortizationExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsAndNotesReceivable" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsAndNotesReceivable" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsAndNotesReceivable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="loc_us-gaapIncreaseDecreaseInInventories" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInInventories" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidExpensesOther" xlink:label="loc_us-gaapIncreaseDecreaseInPrepaidExpensesOther" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInPrepaidExpensesOther" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsPayableAndAccruedLiabilities" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:label="loc_us-gaapIncreaseDecreaseInContractWithCustomerLiability" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInContractWithCustomerLiability" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInterestPayableNet" xlink:label="loc_us-gaapIncreaseDecreaseInInterestPayableNet" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInInterestPayableNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_IncreaseDecreaseInLeaseDeposit" xlink:label="loc_SRNAIncreaseDecreaseInLeaseDeposit" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_SRNAIncreaseDecreaseInLeaseDeposit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:label="loc_us-gaapIncreaseDecreaseInOperatingLeaseLiability" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInOperatingLeaseLiability" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredCompensation" xlink:label="loc_us-gaapIncreaseDecreaseInDeferredCompensation" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInDeferredCompensation" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromNotesPayable" xlink:label="loc_us-gaapProceedsFromNotesPayable" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapProceedsFromNotesPayable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_2" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="loc_us-gaapSupplementalCashFlowInformationAbstract" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapSupplementalCashFlowInformationAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPaidNet" xlink:label="loc_us-gaapInterestPaidNet" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSupplementalCashFlowInformationAbstract" xlink:to="loc_us-gaapInterestPaidNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxesPaidNet" xlink:label="loc_us-gaapIncomeTaxesPaidNet" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSupplementalCashFlowInformationAbstract" xlink:to="loc_us-gaapIncomeTaxesPaidNet" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/General" xlink:title="00000007 - Disclosure - General">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" xlink:label="loc_us-gaapOrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="loc_us-gaapOrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/Leases" xlink:title="00000008 - Disclosure - Leases">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract" xlink:label="loc_us-gaapLeasesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeasesTextBlock" xlink:label="loc_us-gaapLesseeOperatingLeasesTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLeasesAbstract" xlink:to="loc_us-gaapLesseeOperatingLeasesTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/Inventory" xlink:title="00000009 - Disclosure - Inventory">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="loc_us-gaapInventoryDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryDisclosureTextBlock" xlink:label="loc_us-gaapInventoryDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_us-gaapInventoryDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/PropertyAndEquipment" xlink:title="00000010 - Disclosure - Property and Equipment">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaapPropertyPlantAndEquipmentAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:label="loc_us-gaapPropertyPlantAndEquipmentDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentAbstract" xlink:to="loc_us-gaapPropertyPlantAndEquipmentDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/AccountsPayableAndAccruedLiabilities" xlink:title="00000011 - Disclosure - Accounts Payable and Accrued Liabilities">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="loc_us-gaapPayablesAndAccrualsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:label="loc_us-gaapAccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapAccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/NotePayableAndAccruedInterest" xlink:title="00000012 - Disclosure - Note Payable and Accrued Interest">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureTextBlock" xlink:label="loc_us-gaapDebtDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapDebtDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/CommitmentsAndContingencies" xlink:title="00000013 - Disclosure - Commitments and Contingencies">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapCommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/EquityIncentivePlan" xlink:title="00000014 - Disclosure - Equity Incentive Plan">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:label="loc_us-gaapDisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapDisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/Warrants" xlink:title="00000015 - Disclosure - Warrants">
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_WarrantsAbstract" xlink:label="loc_SRNAWarrantsAbstract" />
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_WarrantsDisclosureTextBlock" xlink:label="loc_SRNAWarrantsDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_SRNAWarrantsAbstract" xlink:to="loc_SRNAWarrantsDisclosureTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/IncomeTaxes" xlink:title="00000016 - Disclosure - Income Taxes">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="loc_us-gaapIncomeTaxDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapIncomeTaxDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/SubsequentEvents" xlink:title="00000017 - Disclosure - Subsequent Events">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="loc_us-gaapSubsequentEventsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="loc_us-gaapSubsequentEventsTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventsAbstract" xlink:to="loc_us-gaapSubsequentEventsTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/GeneralPolicies" xlink:title="00000018 - Disclosure - General (Policies)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_DescriptionOfBusinessPolicyTextBlock" xlink:label="loc_SRNADescriptionOfBusinessPolicyTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_SRNADescriptionOfBusinessPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_ImpactOfCovid19PandemicOnOurBusinessPolicyTextBlock" xlink:label="loc_SRNAImpactOfCovid19PandemicOnOurBusinessPolicyTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_SRNAImpactOfCovid19PandemicOnOurBusinessPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="loc_us-gaapBasisOfAccountingPolicyPolicyTextBlock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapBasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock" xlink:label="loc_us-gaapConsolidationPolicyTextBlock" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapConsolidationPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_GoingConcernPolicyTextBlock" xlink:label="loc_SRNAGoingConcernPolicyTextBlock" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_SRNAGoingConcernPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UseOfEstimates" xlink:label="loc_us-gaapUseOfEstimates" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapUseOfEstimates" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:label="loc_us-gaapCashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapCashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="loc_us-gaapEarningsPerSharePolicyTextBlock" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapEarningsPerSharePolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsPolicyTextBlock" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapGoodwillAndIntangibleAssetsPolicyTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:label="loc_us-gaapRevenueFromContractWithCustomerPolicyTextBlock" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapRevenueFromContractWithCustomerPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:label="loc_us-gaapShareBasedCompensationOptionAndIncentivePlansPolicy" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:label="loc_us-gaapConcentrationRiskCreditRisk" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapConcentrationRiskCreditRisk" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="loc_us-gaapNewAccountingPronouncementsPolicyPolicyTextBlock" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapNewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/GeneralTables" xlink:title="00000019 - Disclosure - General (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock" xlink:label="loc_us-gaapRevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapRevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:label="loc_us-gaapDisaggregationOfRevenueTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapDisaggregationOfRevenueTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationActivityTableTextBlock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationActivityTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/LeasesTables" xlink:title="00000020 - Disclosure - Leases (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract" xlink:label="loc_us-gaapLeasesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseCostTableTextBlock" xlink:label="loc_us-gaapLeaseCostTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLeasesAbstract" xlink:to="loc_us-gaapLeaseCostTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityMaturityTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLeasesAbstract" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/InventoryTables" xlink:title="00000021 - Disclosure - Inventory (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="loc_us-gaapInventoryDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:label="loc_us-gaapScheduleOfInventoryCurrentTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfInventoryCurrentTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/PropertyAndEquipmentTables" xlink:title="00000022 - Disclosure - Property and Equipment (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaapPropertyPlantAndEquipmentAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentAbstract" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/AccountsPayableAndAccruedLiabilitiesTables" xlink:title="00000023 - Disclosure - Accounts Payable and Accrued Liabilities (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="loc_us-gaapPayablesAndAccrualsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:label="loc_us-gaapScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/EquityIncentivePlanTables" xlink:title="00000024 - Disclosure - Equity Incentive Plan (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaapPlanNameAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapPlanNameAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_TwoThousandSeventeenEquityPlanMember" xlink:label="loc_SRNATwoThousandSeventeenEquityPlanMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_SRNATwoThousandSeventeenEquityPlanMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtTitleOfIndividualAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_EmployeesAndConsultantsMember" xlink:label="loc_SRNAEmployeesAndConsultantsMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_SRNAEmployeesAndConsultantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_DirectorMember" xlink:label="loc_srtDirectorMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_srtDirectorMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock" xlink:label="loc_us-gaapScheduleOfNonvestedShareActivityTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapScheduleOfNonvestedShareActivityTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/WarrantsTables" xlink:title="00000025 - Disclosure - Warrants (Tables)">
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_WarrantsAbstract" xlink:label="loc_SRNAWarrantsAbstract" />
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_ScheduleOfOutstandingWarrantsToPurchaseCommonStockTableTextBlock" xlink:label="loc_SRNAScheduleOfOutstandingWarrantsToPurchaseCommonStockTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_SRNAWarrantsAbstract" xlink:to="loc_SRNAScheduleOfOutstandingWarrantsToPurchaseCommonStockTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:label="loc_us-gaapScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_SRNAWarrantsAbstract" xlink:to="loc_us-gaapScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/GeneralDetailsNarrative" xlink:title="00000026 - Disclosure - General (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerContractsMember" xlink:label="loc_us-gaapCustomerContractsMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapCustomerContractsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardDateAxis" xlink:label="loc_us-gaapAwardDateAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapAwardDateAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardDateDomain" xlink:label="loc_us-gaapAwardDateDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardDateAxis" xlink:to="loc_us-gaapAwardDateDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_TwoThousandAndTwentyTwoMember" xlink:label="loc_SRNATwoThousandAndTwentyTwoMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardDateDomain" xlink:to="loc_SRNATwoThousandAndTwentyTwoMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaapPlanNameAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapPlanNameAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_TwoThousandTwentyOneAnnualEmployeeIncentiveCompensationPlanMember" xlink:label="loc_SRNATwoThousandTwentyOneAnnualEmployeeIncentiveCompensationPlanMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_SRNATwoThousandTwentyOneAnnualEmployeeIncentiveCompensationPlanMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="loc_us-gaapConcentrationRiskByTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapConcentrationRiskByTypeAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="loc_us-gaapConcentrationRiskTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskByTypeAxis" xlink:to="loc_us-gaapConcentrationRiskTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerConcentrationRiskMember" xlink:label="loc_us-gaapCustomerConcentrationRiskMember" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskTypeDomain" xlink:to="loc_us-gaapCustomerConcentrationRiskMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="loc_us-gaapConcentrationRiskByBenchmarkAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapConcentrationRiskByBenchmarkAxis" order="50" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaapConcentrationRiskBenchmarkDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskByBenchmarkAxis" xlink:to="loc_us-gaapConcentrationRiskBenchmarkDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesRevenueNetMember" xlink:label="loc_us-gaapSalesRevenueNetMember" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:to="loc_us-gaapSalesRevenueNetMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableMember" xlink:label="loc_us-gaapAccountsReceivableMember" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:to="loc_us-gaapAccountsReceivableMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MajorCustomersAxis" xlink:label="loc_srtMajorCustomersAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtMajorCustomersAxis" order="60" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_NameOfMajorCustomerDomain" xlink:label="loc_srtNameOfMajorCustomerDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtMajorCustomersAxis" xlink:to="loc_srtNameOfMajorCustomerDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_CustomerOneMember" xlink:label="loc_SRNACustomerOneMember" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_SRNACustomerOneMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_CustomerTwoMember" xlink:label="loc_SRNACustomerTwoMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_SRNACustomerTwoMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_CustomerThreeMember" xlink:label="loc_SRNACustomerThreeMember" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_SRNACustomerThreeMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_CustomerFourMember" xlink:label="loc_SRNACustomerFourMember" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_SRNACustomerFourMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_CashBalanceTransferredToBankAccount" xlink:label="loc_SRNACashBalanceTransferredToBankAccount" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SRNACashBalanceTransferredToBankAccount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCash" xlink:label="loc_us-gaapRestrictedCash" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRestrictedCash" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities" xlink:label="loc_us-gaapIncrementalCommonSharesAttributableToConversionOfDebtSecurities" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncrementalCommonSharesAttributableToConversionOfDebtSecurities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillImpairmentLoss" xlink:label="loc_us-gaapGoodwillImpairmentLoss" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapGoodwillImpairmentLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:label="loc_us-gaapContractWithCustomerLiabilityRevenueRecognized" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapContractWithCustomerLiabilityRevenueRecognized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligation" xlink:label="loc_us-gaapRevenueRemainingPerformanceObligation" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRevenueRemainingPerformanceObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationPercentage" xlink:label="loc_us-gaapRevenueRemainingPerformanceObligationPercentage" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRevenueRemainingPerformanceObligationPercentage" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="loc_us-gaapAllocatedShareBasedCompensationExpense" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAllocatedShareBasedCompensationExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="loc_us-gaapConcentrationRiskPercentage1" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapConcentrationRiskPercentage1" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/General-ScheduleOfRemainingPerformanceObligationsExpectedToBeRecognizedDetails" xlink:title="00000027 - Disclosure - General - Schedule of Remaining Performance Obligations Expected to be Recognized (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable" xlink:label="loc_us-gaapRevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapRevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems" xlink:label="loc_us-gaapRevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable" xlink:to="loc_us-gaapRevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardDateAxis" xlink:label="loc_us-gaapAwardDateAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable" xlink:to="loc_us-gaapAwardDateAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardDateDomain" xlink:label="loc_us-gaapAwardDateDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardDateAxis" xlink:to="loc_us-gaapAwardDateDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_TwoThousandAndTwentyOneMember" xlink:label="loc_SRNATwoThousandAndTwentyOneMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardDateDomain" xlink:to="loc_SRNATwoThousandAndTwentyOneMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_TwoThousandAndTwentyTwoMember" xlink:label="loc_SRNATwoThousandAndTwentyTwoMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardDateDomain" xlink:to="loc_SRNATwoThousandAndTwentyTwoMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_RemainingPerformanceObligationsRelatedToEngineeringOnlyPaidContracts" xlink:label="loc_SRNARemainingPerformanceObligationsRelatedToEngineeringOnlyPaidContracts" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems" xlink:to="loc_SRNARemainingPerformanceObligationsRelatedToEngineeringOnlyPaidContracts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_RemainingPerformanceObligationsRelatedToPartialEquipmentPaidContracts" xlink:label="loc_SRNARemainingPerformanceObligationsRelatedToPartialEquipmentPaidContracts" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems" xlink:to="loc_SRNARemainingPerformanceObligationsRelatedToPartialEquipmentPaidContracts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligation" xlink:label="loc_us-gaapRevenueRemainingPerformanceObligation" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems" xlink:to="loc_us-gaapRevenueRemainingPerformanceObligation" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/General-ScheduleOfRevenueBySourceDetails" xlink:title="00000028 - Disclosure - General - Schedule of Revenue by Source (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTable" xlink:label="loc_us-gaapDisaggregationOfRevenueTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapDisaggregationOfRevenueTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems" xlink:label="loc_us-gaapDisaggregationOfRevenueLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisaggregationOfRevenueTable" xlink:to="loc_us-gaapDisaggregationOfRevenueLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis" xlink:label="loc_srtProductOrServiceAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisaggregationOfRevenueTable" xlink:to="loc_srtProductOrServiceAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srtProductsAndServicesDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductOrServiceAxis" xlink:to="loc_srtProductsAndServicesDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquipmentMember" xlink:label="loc_us-gaapEquipmentMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_us-gaapEquipmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_EngineeringAndOtherServicesMember" xlink:label="loc_SRNAEngineeringAndOtherServicesMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_SRNAEngineeringAndOtherServicesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShippingAndHandlingMember" xlink:label="loc_us-gaapShippingAndHandlingMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProductsAndServicesDomain" xlink:to="loc_us-gaapShippingAndHandlingMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisaggregationOfRevenueLineItems" xlink:to="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/General-ScheduleOfShare-basedCompensationCostsDetails" xlink:title="00000029 - Disclosure - General - Schedule of Share-based Compensation Costs (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaapIncomeStatementLocationAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapIncomeStatementLocationAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaapIncomeStatementLocationDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementLocationAxis" xlink:to="loc_us-gaapIncomeStatementLocationDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfSalesMember" xlink:label="loc_us-gaapCostOfSalesMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementLocationDomain" xlink:to="loc_us-gaapCostOfSalesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdvertisingMember" xlink:label="loc_us-gaapAdvertisingMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementLocationDomain" xlink:to="loc_us-gaapAdvertisingMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" xlink:label="loc_us-gaapSoftwareAndSoftwareDevelopmentCostsMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementLocationDomain" xlink:to="loc_us-gaapSoftwareAndSoftwareDevelopmentCostsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:label="loc_us-gaapSellingGeneralAndAdministrativeExpensesMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementLocationDomain" xlink:to="loc_us-gaapSellingGeneralAndAdministrativeExpensesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="loc_us-gaapAllocatedShareBasedCompensationExpense" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAllocatedShareBasedCompensationExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/LeasesDetailsNarrative" xlink:title="00000030 - Disclosure - Leases (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract" xlink:label="loc_us-gaapLeasesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable" xlink:label="loc_us-gaapLesseeLeaseDescriptionTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLeasesAbstract" xlink:to="loc_us-gaapLesseeLeaseDescriptionTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems" xlink:label="loc_us-gaapLesseeLeaseDescriptionLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLesseeLeaseDescriptionTable" xlink:to="loc_us-gaapLesseeLeaseDescriptionLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLesseeLeaseDescriptionTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_FacilityLeaseMember" xlink:label="loc_SRNAFacilityLeaseMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_SRNAFacilityLeaseMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:label="loc_us-gaapAdjustmentsForNewAccountingPronouncementsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLesseeLeaseDescriptionTable" xlink:to="loc_us-gaapAdjustmentsForNewAccountingPronouncementsAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfAdoptionMember" xlink:label="loc_us-gaapTypeOfAdoptionMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsForNewAccountingPronouncementsAxis" xlink:to="loc_us-gaapTypeOfAdoptionMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingStandardsUpdate201602Member" xlink:label="loc_us-gaapAccountingStandardsUpdate201602Member" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTypeOfAdoptionMember" xlink:to="loc_us-gaapAccountingStandardsUpdate201602Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLesseeLeaseDescriptionTable" xlink:to="loc_srtRangeAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaapOperatingLeaseRightOfUseAsset" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLesseeLeaseDescriptionLineItems" xlink:to="loc_us-gaapOperatingLeaseRightOfUseAsset" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability" xlink:label="loc_us-gaapOperatingLeaseLiability" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLesseeLeaseDescriptionLineItems" xlink:to="loc_us-gaapOperatingLeaseLiability" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseDescription" xlink:label="loc_us-gaapLesseeOperatingLeaseDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLesseeLeaseDescriptionLineItems" xlink:to="loc_us-gaapLesseeOperatingLeaseDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:label="loc_us-gaapLesseeOperatingLeaseRenewalTerm" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLesseeLeaseDescriptionLineItems" xlink:to="loc_us-gaapLesseeOperatingLeaseRenewalTerm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_MonthlyRentDescription" xlink:label="loc_SRNAMonthlyRentDescription" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLesseeLeaseDescriptionLineItems" xlink:to="loc_SRNAMonthlyRentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TenantImprovements" xlink:label="loc_us-gaapTenantImprovements" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLesseeLeaseDescriptionLineItems" xlink:to="loc_us-gaapTenantImprovements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_UnamortizedAmountOfTenantImprovementAllowance" xlink:label="loc_SRNAUnamortizedAmountOfTenantImprovementAllowance" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLesseeLeaseDescriptionLineItems" xlink:to="loc_SRNAUnamortizedAmountOfTenantImprovementAllowance" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/Leases-ScheduleOfLeaseCostDetails" xlink:title="00000031 - Disclosure - Leases - Schedule of Lease Cost (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract" xlink:label="loc_us-gaapLeasesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseCost" xlink:label="loc_us-gaapOperatingLeaseCost" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLeasesAbstract" xlink:to="loc_us-gaapOperatingLeaseCost" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasePayments" xlink:label="loc_us-gaapOperatingLeasePayments" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLeasesAbstract" xlink:to="loc_us-gaapOperatingLeasePayments" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaapOperatingLeaseRightOfUseAsset" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLeasesAbstract" xlink:to="loc_us-gaapOperatingLeaseRightOfUseAsset" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityCurrent" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLeasesAbstract" xlink:to="loc_us-gaapOperatingLeaseLiabilityCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityNoncurrent" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLeasesAbstract" xlink:to="loc_us-gaapOperatingLeaseLiabilityNoncurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:label="loc_us-gaapOperatingLeaseWeightedAverageRemainingLeaseTerm1" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLeasesAbstract" xlink:to="loc_us-gaapOperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:label="loc_us-gaapOperatingLeaseWeightedAverageDiscountRatePercent" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLeasesAbstract" xlink:to="loc_us-gaapOperatingLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/Leases-ScheduleOfFutureAnnualMinimumLeasePaymentsDetails" xlink:title="00000032 - Disclosure - Leases - Schedule of Future Annual Minimum Lease Payments (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract" xlink:label="loc_us-gaapLeasesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLeasesAbstract" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLeasesAbstract" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDue" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLeasesAbstract" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityUndiscountedExcessAmount" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLeasesAbstract" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability" xlink:label="loc_us-gaapOperatingLeaseLiability" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLeasesAbstract" xlink:to="loc_us-gaapOperatingLeaseLiability" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/InventoryDetailsNarrative" xlink:title="00000033 - Disclosure - Inventory (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="loc_us-gaapInventoryDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSoldOverhead" xlink:label="loc_us-gaapCostOfGoodsAndServicesSoldOverhead" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_us-gaapCostOfGoodsAndServicesSoldOverhead" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_PrepaidInventoryExpenses" xlink:label="loc_SRNAPrepaidInventoryExpenses" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_SRNAPrepaidInventoryExpenses" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/Inventory-ScheduleOfInventoryDetails" xlink:title="00000034 - Disclosure - Inventory - Schedule of Inventory (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="loc_us-gaapInventoryDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryFinishedGoods" xlink:label="loc_us-gaapInventoryFinishedGoods" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_us-gaapInventoryFinishedGoods" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryWorkInProcess" xlink:label="loc_us-gaapInventoryWorkInProcess" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_us-gaapInventoryWorkInProcess" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryRawMaterials" xlink:label="loc_us-gaapInventoryRawMaterials" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_us-gaapInventoryRawMaterials" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryValuationReserves" xlink:label="loc_us-gaapInventoryValuationReserves" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_us-gaapInventoryValuationReserves" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaapInventoryNet" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_us-gaapInventoryNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/PropertyAndEquipmentDetailsNarrative" xlink:title="00000035 - Disclosure - Property and Equipment (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaapPropertyPlantAndEquipmentAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentMember" xlink:label="loc_us-gaapPropertyPlantAndEquipmentMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapPropertyPlantAndEquipmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaapIncomeStatementLocationAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapIncomeStatementLocationAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaapIncomeStatementLocationDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementLocationAxis" xlink:to="loc_us-gaapIncomeStatementLocationDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfSalesMember" xlink:label="loc_us-gaapCostOfSalesMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementLocationDomain" xlink:to="loc_us-gaapCostOfSalesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_InventoryMember" xlink:label="loc_SRNAInventoryMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementLocationDomain" xlink:to="loc_SRNAInventoryMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Depreciation" xlink:label="loc_us-gaapDepreciation" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDepreciation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="loc_us-gaapSellingGeneralAndAdministrativeExpense" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSellingGeneralAndAdministrativeExpense" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/PropertyAndEquipment-ScheduleOfPropertyAndEquipmentDetails" xlink:title="00000036 - Disclosure - Property and Equipment - Schedule of Property and Equipment (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="loc_us-gaapPropertyPlantAndEquipmentAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentAbstract" xlink:to="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="loc_us-gaapPropertyPlantAndEquipmentLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfPropertyPlantAndEquipmentTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="loc_us-gaapFurnitureAndFixturesMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapFurnitureAndFixturesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VehiclesMember" xlink:label="loc_us-gaapVehiclesMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapVehiclesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="loc_us-gaapLeaseholdImprovementsMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_us-gaapLeaseholdImprovementsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="loc_us-gaapPropertyPlantAndEquipmentGross" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentGross" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentLineItems" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/AccountsPayableAndAccruedLiabilities-ScheduleOfAccountsPayableAndAccruedLiabilitiesDetails" xlink:title="00000037 - Disclosure - Accounts Payable and Accrued Liabilities - Schedule of Accounts Payable and Accrued Liabilities (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="loc_us-gaapPayablesAndAccrualsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaapAccountsPayableCurrent" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapAccountsPayableCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedSalesCommissionCurrent" xlink:label="loc_us-gaapAccruedSalesCommissionCurrent" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapAccruedSalesCommissionCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="loc_us-gaapEmployeeRelatedLiabilitiesCurrent" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapEmployeeRelatedLiabilitiesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductWarrantyAccrualClassifiedCurrent" xlink:label="loc_us-gaapProductWarrantyAccrualClassifiedCurrent" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapProductWarrantyAccrualClassifiedCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="loc_us-gaapOtherAccruedLiabilitiesCurrent" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapOtherAccruedLiabilitiesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/NotePayableAndAccruedInterestDetailsNarrative" xlink:title="00000038 - Disclosure - Note Payable and Accrued Interest (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaapDebtInstrumentFaceAmount" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapDebtInstrumentFaceAmount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="loc_us-gaapDebtInstrumentInterestRateStatedPercentage" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapDebtInstrumentInterestRateStatedPercentage" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="loc_us-gaapDebtInstrumentMaturityDate" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapDebtInstrumentMaturityDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentIncreaseAccruedInterest" xlink:label="loc_us-gaapDebtInstrumentIncreaseAccruedInterest" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapDebtInstrumentIncreaseAccruedInterest" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:title="00000039 - Disclosure - Commitments and Contingencies (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapAwardTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="loc_us-gaapRestrictedStockUnitsRSUMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapRestrictedStockUnitsRSUMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtTitleOfIndividualAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_FormerEmployeeMember" xlink:label="loc_SRNAFormerEmployeeMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_SRNAFormerEmployeeMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_NumberOfUnitsVestedButNotSettled" xlink:label="loc_SRNANumberOfUnitsVestedButNotSettled" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SRNANumberOfUnitsVestedButNotSettled" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_NumberOfUnitsVestedAndSettled" xlink:label="loc_SRNANumberOfUnitsVestedAndSettled" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SRNANumberOfUnitsVestedAndSettled" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyDamagesAwardedValue" xlink:label="loc_us-gaapLossContingencyDamagesAwardedValue" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLossContingencyDamagesAwardedValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_RestrictedStockUnitsSharesIssuedInterestPercentage" xlink:label="loc_SRNARestrictedStockUnitsSharesIssuedInterestPercentage" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SRNARestrictedStockUnitsSharesIssuedInterestPercentage" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyDamagesPaidValue" xlink:label="loc_us-gaapLossContingencyDamagesPaidValue" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLossContingencyDamagesPaidValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_AggregateSharesIssuedUponExecutionOfSettlement" xlink:label="loc_SRNAAggregateSharesIssuedUponExecutionOfSettlement" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SRNAAggregateSharesIssuedUponExecutionOfSettlement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingExpense" xlink:label="loc_us-gaapOtherNonoperatingExpense" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOtherNonoperatingExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" xlink:label="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_StockIssuanceAmount" xlink:label="loc_SRNAStockIssuanceAmount" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SRNAStockIssuanceAmount" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/EquityIncentivePlanDetailsNarrative" xlink:title="00000040 - Disclosure - Equity Incentive Plan (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaapPlanNameAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapPlanNameAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_TwoThousandAndSeventeenEquityIncentivePlanMember" xlink:label="loc_SRNATwoThousandAndSeventeenEquityIncentivePlanMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_SRNATwoThousandAndSeventeenEquityIncentivePlanMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_TwoThousandAndTwentyOneEquityIncentivePlanMember" xlink:label="loc_SRNATwoThousandAndTwentyOneEquityIncentivePlanMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_SRNATwoThousandAndTwentyOneEquityIncentivePlanMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_TwoThousandAndSeventeenEquityPlanMember" xlink:label="loc_SRNATwoThousandAndSeventeenEquityPlanMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_SRNATwoThousandAndSeventeenEquityPlanMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapAwardTypeAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_IncentiveStockBonusAwardsMember" xlink:label="loc_SRNAIncentiveStockBonusAwardsMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_SRNAIncentiveStockBonusAwardsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_NonQualifiedStockOptionsMember" xlink:label="loc_SRNANonQualifiedStockOptionsMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_SRNANonQualifiedStockOptionsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="loc_us-gaapRestrictedStockUnitsRSUMember" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapRestrictedStockUnitsRSUMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_EmployeesMember" xlink:label="loc_SRNAEmployeesMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_SRNAEmployeesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_EmployeesAndConsultantsMember" xlink:label="loc_SRNAEmployeesAndConsultantsMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_SRNAEmployeesAndConsultantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_srtTitleOfIndividualAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_DirectorMember" xlink:label="loc_srtDirectorMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_srtDirectorMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_DirectorsMember" xlink:label="loc_SRNADirectorsMember" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_SRNADirectorsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_EmployeesDirectorsandConsultantsMember" xlink:label="loc_SRNAEmployeesDirectorsandConsultantsMember" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_SRNAEmployeesDirectorsandConsultantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaapSubsequentEventTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapSubsequentEventTypeAxis" order="50" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaapSubsequentEventMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTypeDomain" xlink:to="loc_us-gaapSubsequentEventMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:label="loc_us-gaapCommonStockCapitalSharesReservedForFutureIssuance" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapCommonStockCapitalSharesReservedForFutureIssuance" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaapShareBasedCompensation" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensation" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/EquityIncentivePlan-ScheduleOfStockOptionActivityDetails" xlink:title="00000041 - Disclosure - Equity Incentive Plan - Schedule of Stock Option Activity (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaapPlanNameAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapPlanNameAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_TwoThousandAndSeventeenEquityPlanMember" xlink:label="loc_SRNATwoThousandAndSeventeenEquityPlanMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_SRNATwoThousandAndSeventeenEquityPlanMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_EmployeesAndConsultantsMember" xlink:label="loc_SRNAEmployeesAndConsultantsMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_SRNAEmployeesAndConsultantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapAwardTypeAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_NonQualifiedStockOptionsMember" xlink:label="loc_SRNANonQualifiedStockOptionsMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_SRNANonQualifiedStockOptionsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_srtTitleOfIndividualAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_DirectorsMember" xlink:label="loc_SRNADirectorsMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_SRNADirectorsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermGranted" xlink:label="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermGranted" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermGranted" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm" xlink:label="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_2" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/EquityIncentivePlan-SummaryOfNon-vestedNon-qualifiedStockOptionActivityDetails" xlink:title="00000042 - Disclosure - Equity Incentive Plan - Summary of Non-vested Non-qualified Stock Option Activity (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaapPlanNameAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapPlanNameAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_TwoThousandAndSeventeenEquityPlanMember" xlink:label="loc_SRNATwoThousandAndSeventeenEquityPlanMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_SRNATwoThousandAndSeventeenEquityPlanMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_EmployeesAndConsultantsMember" xlink:label="loc_SRNAEmployeesAndConsultantsMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_SRNAEmployeesAndConsultantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_srtTitleOfIndividualAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_DirectorsMember" xlink:label="loc_SRNADirectorsMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_SRNADirectorsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsNumberOfOptionsExpired" xlink:label="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsNumberOfOptionsExpired" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsNumberOfOptionsExpired" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_2" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsExpired" xlink:label="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsExpired" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsExpired" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_2" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1" xlink:label="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1" xlink:label="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1_2" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested" xlink:label="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValuesGranted" xlink:label="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValuesGranted" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValuesGranted" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValueVested" xlink:label="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValueVested" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValueVested" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantDateFairValueForfeited" xlink:label="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantDateFairValueForfeited" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantDateFairValueForfeited" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfSharesGrantDateFairValueExpired" xlink:label="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfSharesGrantDateFairValueExpired" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfSharesGrantDateFairValueExpired" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested" xlink:label="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested_2" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/EquityIncentivePlan-ScheduleOfRestrictedStockUnitsActivityDetails" xlink:title="00000043 - Disclosure - Equity Incentive Plan - Schedule of Restricted Stock Units Activity (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaapPlanNameAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_us-gaapPlanNameAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_TwoThousandAndSeventeenEquityPlanMember" xlink:label="loc_SRNATwoThousandAndSeventeenEquityPlanMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_SRNATwoThousandAndSeventeenEquityPlanMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="loc_srtTitleOfIndividualAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_EmployeesDirectorsandConsultantsMember" xlink:label="loc_SRNAEmployeesDirectorsandConsultantsMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_SRNAEmployeesDirectorsandConsultantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_2" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_2" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_2" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/Warrants-ScheduleOfOutstandingWarrantsToPurchaseCommonStockDetails" xlink:title="00000044 - Disclosure - Warrants - Schedule of Outstanding Warrants to Purchase Common Stock (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xlink:label="loc_us-gaapWarrantsAndRightsNoteDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="loc_us-gaapClassOfWarrantOrRightOutstanding" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapWarrantsAndRightsNoteDisclosureAbstract" xlink:to="loc_us-gaapClassOfWarrantOrRightOutstanding" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_ClassOfWarrantOrRightIssued" xlink:label="loc_SRNAClassOfWarrantOrRightIssued" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapWarrantsAndRightsNoteDisclosureAbstract" xlink:to="loc_SRNAClassOfWarrantOrRightIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_ClassOfWarrantOrRightExercised" xlink:label="loc_SRNAClassOfWarrantOrRightExercised" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapWarrantsAndRightsNoteDisclosureAbstract" xlink:to="loc_SRNAClassOfWarrantOrRightExercised" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_ClassOfWarrantOrRightExpired" xlink:label="loc_SRNAClassOfWarrantOrRightExpired" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapWarrantsAndRightsNoteDisclosureAbstract" xlink:to="loc_SRNAClassOfWarrantOrRightExpired" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="loc_us-gaapClassOfWarrantOrRightOutstanding_2" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapWarrantsAndRightsNoteDisclosureAbstract" xlink:to="loc_us-gaapClassOfWarrantOrRightOutstanding_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapWarrantsAndRightsNoteDisclosureAbstract" xlink:to="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_ClassOfWarrantOrRightWeightedAverageExercisePriceIssued" xlink:label="loc_SRNAClassOfWarrantOrRightWeightedAverageExercisePriceIssued" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapWarrantsAndRightsNoteDisclosureAbstract" xlink:to="loc_SRNAClassOfWarrantOrRightWeightedAverageExercisePriceIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_ClassOfWarrantOrRightWeightedAverageExercisePriceExercised" xlink:label="loc_SRNAClassOfWarrantOrRightWeightedAverageExercisePriceExercised" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapWarrantsAndRightsNoteDisclosureAbstract" xlink:to="loc_SRNAClassOfWarrantOrRightWeightedAverageExercisePriceExercised" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_ClassOfWarrantOrRightWeightedAverageExercisePriceExpired" xlink:label="loc_SRNAClassOfWarrantOrRightWeightedAverageExercisePriceExpired" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapWarrantsAndRightsNoteDisclosureAbstract" xlink:to="loc_SRNAClassOfWarrantOrRightWeightedAverageExercisePriceExpired" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_2" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapWarrantsAndRightsNoteDisclosureAbstract" xlink:to="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerms" xlink:label="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerms" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapWarrantsAndRightsNoteDisclosureAbstract" xlink:to="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerms" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm" xlink:label="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapWarrantsAndRightsNoteDisclosureAbstract" xlink:to="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_ClassOfWarrantOrRightOutstandingAggregateIntrinsicValue" xlink:label="loc_SRNAClassOfWarrantOrRightOutstandingAggregateIntrinsicValue" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapWarrantsAndRightsNoteDisclosureAbstract" xlink:to="loc_SRNAClassOfWarrantOrRightOutstandingAggregateIntrinsicValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_ClassOfWarrantOrRightIssuedAggregateIntrinsicValue" xlink:label="loc_SRNAClassOfWarrantOrRightIssuedAggregateIntrinsicValue" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapWarrantsAndRightsNoteDisclosureAbstract" xlink:to="loc_SRNAClassOfWarrantOrRightIssuedAggregateIntrinsicValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_ClassOfWarrantOrRightExercisedAggregateIntrinsicValue" xlink:label="loc_SRNAClassOfWarrantOrRightExercisedAggregateIntrinsicValue" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapWarrantsAndRightsNoteDisclosureAbstract" xlink:to="loc_SRNAClassOfWarrantOrRightExercisedAggregateIntrinsicValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_ClassOfWarrantOrRightExpiredAggregateIntrinsicValue" xlink:label="loc_SRNAClassOfWarrantOrRightExpiredAggregateIntrinsicValue" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapWarrantsAndRightsNoteDisclosureAbstract" xlink:to="loc_SRNAClassOfWarrantOrRightExpiredAggregateIntrinsicValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_ClassOfWarrantOrRightOutstandingAggregateIntrinsicValue" xlink:label="loc_SRNAClassOfWarrantOrRightOutstandingAggregateIntrinsicValue_2" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapWarrantsAndRightsNoteDisclosureAbstract" xlink:to="loc_SRNAClassOfWarrantOrRightOutstandingAggregateIntrinsicValue_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/Warrants-ScheduleOfWarrantsOutstandingDetails" xlink:title="00000045 - Disclosure - Warrants - Schedule of Warrants Outstanding (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xlink:label="loc_us-gaapWarrantsAndRightsNoteDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapWarrantsAndRightsNoteDisclosureAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:to="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_WarrantsRangeMember" xlink:label="loc_SRNAWarrantsRangeMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_SRNAWarrantsRangeMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_WarrantsRangeOneMember" xlink:label="loc_SRNAWarrantsRangeOneMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="loc_SRNAWarrantsRangeOneMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="loc_us-gaapClassOfWarrantOrRightOutstanding" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm" xlink:label="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SRNASharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/IncomeTaxesDetailsNarrative" xlink:title="00000046 - Disclosure - Income Taxes (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="loc_us-gaapOperatingLossCarryforwards" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapOperatingLossCarryforwards" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_NetOperatingLossCarryForwardExpectedToExpireAmount" xlink:label="loc_SRNANetOperatingLossCarryForwardExpectedToExpireAmount" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_SRNANetOperatingLossCarryForwardExpectedToExpireAmount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_NetOperatingLossExpirationTerm" xlink:label="loc_SRNANetOperatingLossExpirationTerm" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_SRNANetOperatingLossExpirationTerm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_NolsUsageAgainstTaxableIncomePercentage" xlink:label="loc_SRNANolsUsageAgainstTaxableIncomePercentage" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_SRNANolsUsageAgainstTaxableIncomePercentage" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:label="loc_us-gaapBusinessAcquisitionPercentageOfVotingInterestsAcquired" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapBusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_NolsCarryforwardsTerm" xlink:label="loc_SRNANolsCarryforwardsTerm" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_SRNANolsCarryforwardsTerm" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://surna.com/role/SubsequentEventsDetailsNarrative" xlink:title="00000047 - Disclosure - Subsequent Events (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="loc_us-gaapSubsequentEventsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventsAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaapSubsequentEventTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapSubsequentEventTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaapSubsequentEventMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTypeDomain" xlink:to="loc_us-gaapSubsequentEventMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaapPlanNameAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapPlanNameAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_TwoThousandAndSeventeenEquityPlanMember" xlink:label="loc_SRNATwoThousandAndSeventeenEquityPlanMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_SRNATwoThousandAndSeventeenEquityPlanMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapAwardTypeAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_NonQualifiedStockOptionsMember" xlink:label="loc_SRNANonQualifiedStockOptionsMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_SRNANonQualifiedStockOptionsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtTitleOfIndividualAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_DirectorsMember" xlink:label="loc_SRNADirectorsMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_SRNADirectorsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_FormerEmployeeMember" xlink:label="loc_SRNAFormerEmployeeMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_SRNAFormerEmployeeMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" order="50" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentByTypeAxis" xlink:to="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_OfficeandManufacturingMember" xlink:label="loc_SRNAOfficeandManufacturingMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPropertyPlantAndEquipmentTypeDomain" xlink:to="loc_SRNAOfficeandManufacturingMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis" xlink:label="loc_srtStatementScenarioAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtStatementScenarioAxis" order="60" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srtScenarioUnspecifiedDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtStatementScenarioAxis" xlink:to="loc_srtScenarioUnspecifiedDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioForecastMember" xlink:label="loc_srtScenarioForecastMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtScenarioUnspecifiedDomain" xlink:to="loc_srtScenarioForecastMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="srna-20210331.xsd#SRNA_AggregateSharesIssuedUponExecutionOfSettlement" xlink:label="loc_SRNAAggregateSharesIssuedUponExecutionOfSettlement" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SRNAAggregateSharesIssuedUponExecutionOfSettlement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AreaOfLand" xlink:label="loc_us-gaapAreaOfLand" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAreaOfLand" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasesRentExpenseSubleaseRentals1" xlink:label="loc_us-gaapOperatingLeasesRentExpenseSubleaseRentals1" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOperatingLeasesRentExpenseSubleaseRentals1" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139855690564952">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Document and Entity Information - shares<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>May 11, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Surna Inc.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001482541<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Mar. 31,  2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Non-accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business Flag</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">237,526,638<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139855691503864">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Balance Sheets - USD ($)<br></strong></div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash</a></td>
<td class="nump">$ 3,271,128<span></span>
</td>
<td class="nump">$ 2,284,881<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable (net of allowance for doubtful accounts of $165,098 and $165,098, respectively)</a></td>
<td class="nump">26,732<span></span>
</td>
<td class="nump">33,480<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventory, net</a></td>
<td class="nump">519,159<span></span>
</td>
<td class="nump">327,109<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other</a></td>
<td class="nump">2,064,588<span></span>
</td>
<td class="nump">1,037,823<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total Current Assets</a></td>
<td class="nump">5,881,607<span></span>
</td>
<td class="nump">3,683,293<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsNoncurrentAbstract', window );"><strong>Noncurrent Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">141,825<span></span>
</td>
<td class="nump">147,732<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">631,064<span></span>
</td>
<td class="nump">631,064<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets, net</a></td>
<td class="nump">7,082<span></span>
</td>
<td class="nump">7,227<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepositsAssetsNoncurrent', window );">Deposits</a></td>
<td class="nump">8,061<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use asset</a></td>
<td class="nump">294,900<span></span>
</td>
<td class="nump">343,950<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsNoncurrent', window );">Total Noncurrent Assets</a></td>
<td class="nump">1,082,932<span></span>
</td>
<td class="nump">1,129,973<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">TOTAL ASSETS</a></td>
<td class="nump">6,964,539<span></span>
</td>
<td class="nump">4,813,266<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>CURRENT LIABILITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent', window );">Accounts payable and accrued liabilities</a></td>
<td class="nump">1,790,315<span></span>
</td>
<td class="nump">1,784,961<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Deferred revenue</a></td>
<td class="nump">6,087,093<span></span>
</td>
<td class="nump">3,724,189<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCompensationLiabilityCurrent', window );">Accrued equity compensation</a></td>
<td class="nump">52,794<span></span>
</td>
<td class="nump">128,434<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Other liabilities</a></td>
<td class="nump">37,078<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Current portion of operating lease liability</a></td>
<td class="nump">263,662<span></span>
</td>
<td class="nump">266,105<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total Current Liabilities</a></td>
<td class="nump">8,230,942<span></span>
</td>
<td class="nump">5,903,689<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrentAbstract', window );"><strong>NONCURRENT LIABILITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermNotesPayable', window );">Note payable and accrued interest</a></td>
<td class="nump">514,918<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other liabilities</a></td>
<td class="nump">37,078<span></span>
</td>
<td class="nump">74,156<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease liability, net of current portion</a></td>
<td class="nump">106,891<span></span>
</td>
<td class="nump">169,119<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrent', window );">Total Noncurrent Liabilities</a></td>
<td class="nump">658,887<span></span>
</td>
<td class="nump">243,275<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">TOTAL LIABILITIES</a></td>
<td class="nump">8,889,829<span></span>
</td>
<td class="nump">6,146,964<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and Contingencies (Note 7)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>SHAREHOLDERS' DEFICIT</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, $0.00001 par value; 150,000,000 shares authorized; 42,030,331 shares issued and outstanding</a></td>
<td class="nump">420<span></span>
</td>
<td class="nump">420<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, $0.00001 par value; 350,000,000 shares authorized; 236,526,638 and 236,526,638 shares issued and outstanding, respectively</a></td>
<td class="nump">2,366<span></span>
</td>
<td class="nump">2,366<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_CommonStockSharesToBeIssuedValue', window );">Common stock, $0.00001 par value; 1,000,000 shares to be issued</a></td>
<td class="nump">67,000<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid in capital</a></td>
<td class="nump">26,241,935<span></span>
</td>
<td class="nump">26,107,159<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(28,237,011)<span></span>
</td>
<td class="num">(27,443,643)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total Shareholders' Deficit</a></td>
<td class="num">(1,925,290)<span></span>
</td>
<td class="num">(1,333,698)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">TOTAL LIABILITIES AND SHAREHOLDERS' DEFICIT</a></td>
<td class="nump">$ 6,964,539<span></span>
</td>
<td class="nump">$ 4,813,266<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_CommonStockSharesToBeIssuedValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Common stock, $0.00001 par value; 1,000,000 shares to be issued.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_CommonStockSharesToBeIssuedValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6801-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 15: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 24: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130532-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCompensationLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate carrying value as of the balance sheet date of the liabilities for all deferred compensation arrangements payable within one year (or the operating cycle, if longer). Represents currently earned compensation under compensation arrangements that is not actually paid until a later date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 710<br> -SubTopic 10<br> -Section 25<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=6409733&amp;loc=d3e19512-108361<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 710<br> -SubTopic 10<br> -Section 30<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6409875&amp;loc=d3e20028-108363<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCompensationLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepositsAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value of amounts transferred to third parties for security purposes that are expected to be returned or applied towards payment after one year or beyond the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepositsAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(26))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of notes payable (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6904-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6911-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139855690551576">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Balance Sheets (Parenthetical) - USD ($)<br></strong></div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent', window );">Allowance for doubtful accounts, net</a></td>
<td class="nump">$ 165,098<span></span>
</td>
<td class="nump">$ 165,098<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value</a></td>
<td class="nump">$ 0.00001<span></span>
</td>
<td class="nump">$ 0.00001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized</a></td>
<td class="nump">150,000,000<span></span>
</td>
<td class="nump">150,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued</a></td>
<td class="nump">42,030,331<span></span>
</td>
<td class="nump">42,030,331<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding</a></td>
<td class="nump">42,030,331<span></span>
</td>
<td class="nump">42,030,331<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value</a></td>
<td class="nump">$ 0.00001<span></span>
</td>
<td class="nump">$ 0.00001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized</a></td>
<td class="nump">350,000,000<span></span>
</td>
<td class="nump">350,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="nump">236,526,638<span></span>
</td>
<td class="nump">236,526,638<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding</a></td>
<td class="nump">236,526,638<span></span>
</td>
<td class="nump">236,526,638<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_CommonStockSharesToBeIssuedParOrStatedValuePerShare', window );">Common stock, shares to be issued, par value</a></td>
<td class="nump">$ 0.00001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_CommonSharesToBeIssued', window );">Common stock, shares to be issued</a></td>
<td class="nump">$ 1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_CommonSharesToBeIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Common stock, shares to be issued.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_CommonSharesToBeIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_CommonStockSharesToBeIssuedParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Common stock, shares to be issued, par value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_CommonStockSharesToBeIssuedParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5074-111524<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124255206&amp;loc=SL82895884-210446<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139855694650088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Operations (Unaudited) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue, net</a></td>
<td class="nump">$ 2,366,529<span></span>
</td>
<td class="nump">$ 1,809,925<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfRevenue', window );">Cost of revenue</a></td>
<td class="nump">2,021,923<span></span>
</td>
<td class="nump">1,353,401<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="nump">344,606<span></span>
</td>
<td class="nump">456,524<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketingAndAdvertisingExpense', window );">Advertising and marketing expenses</a></td>
<td class="nump">177,145<span></span>
</td>
<td class="nump">148,921<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Product development costs</a></td>
<td class="nump">112,638<span></span>
</td>
<td class="nump">144,948<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, general and administrative expenses</a></td>
<td class="nump">740,473<span></span>
</td>
<td class="nump">1,108,993<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="nump">1,030,256<span></span>
</td>
<td class="nump">1,402,862<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating loss</a></td>
<td class="num">(685,650)<span></span>
</td>
<td class="num">(946,338)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpenseAbstract', window );"><strong>Other income (expense):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income (expense), net</a></td>
<td class="num">(107,000)<span></span>
</td>
<td class="nump">14,320<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="num">(718)<span></span>
</td>
<td class="num">(6,295)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Total other income (expense)</a></td>
<td class="num">(107,718)<span></span>
</td>
<td class="nump">8,025<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Loss before provision for income taxes</a></td>
<td class="num">(793,368)<span></span>
</td>
<td class="num">(938,313)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income taxes</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (793,368)<span></span>
</td>
<td class="num">$ (938,313)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDiluted', window );">Loss per common share - basic and dilutive</a></td>
<td class="nump">$ (0.00)<span></span>
</td>
<td class="nump">$ (0.00)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted', window );">Weighted average number of common shares outstanding, basic and dilutive</a></td>
<td class="nump">236,526,638<span></span>
</td>
<td class="nump">231,062,462<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate cost of goods produced and sold and services rendered during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements.  Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period.  Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 18: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123384075&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketingAndAdvertisingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total expense recognized in the period for promotion, public relations, and brand or product advertising.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketingAndAdvertisingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 730<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6472174&amp;loc=d3e58812-109433<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139855692438968">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Changes in Shareholders' Deficit (Unaudited) - USD ($)<br></strong></div></th>
<th class="th"><div>Preferred Stock [Member]</div></th>
<th class="th"><div>Common Stock [Member]</div></th>
<th class="th"><div>Additional Paid in Capital [Member]</div></th>
<th class="th"><div>Accumulated Deficit [Member]</div></th>
<th class="th"><div>Total</div></th>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2019</a></td>
<td class="nump">$ 420<span></span>
</td>
<td class="nump">$ 2,283<span></span>
</td>
<td class="nump">$ 25,326,593<span></span>
</td>
<td class="num">$ (25,684,927)<span></span>
</td>
<td class="num">$ (355,631)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, shares at Dec. 31, 2019</a></td>
<td class="nump">42,030,331<span></span>
</td>
<td class="nump">228,216,638<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_CommonStockSharesToBeIssuedBalance', window );">Balance, shares to be issued at Dec. 31, 2019</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">1,560,000<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonuses', window );">Common shares issued or to be issued on settlement of restricted stock units and award of stock bonuses</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 83<span></span>
</td>
<td class="num">$ (83)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesShares', window );">Common shares issued or to be issued on settlement of restricted stock units and award of stock bonuses, shares</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">8,310,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesSharesToBeIssued', window );">Common shares issued or to be issued on settlement of restricted stock units and award of stock bonuses, shares to be issued</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(1,560,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition', window );">Fair value of vested restricted stock units awarded to employees</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">18,872<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">18,872<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition', window );">Fair value of vested stock options granted to employees and directors</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">639,020<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">639,020<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_CommonSharesToBeIssuedInSettlementOfLegalDispute', window );">Common shares to be issued in settlement of legal dispute</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_FairValueOfVestedStockOptionsGrantedToEmployees', window );">Fair value of vested stock options granted to employees</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_FairValueOfVestedStockOptionsGrantedToDirectors', window );">Fair value of vested stock options granted to directors</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(938,313)<span></span>
</td>
<td class="num">(938,313)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Mar. 31, 2020</a></td>
<td class="nump">$ 420<span></span>
</td>
<td class="nump">$ 2,366<span></span>
</td>
<td class="nump">$ 25,984,402<span></span>
</td>
<td class="num">$ (26,623,240)<span></span>
</td>
<td class="num">$ (636,052)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, shares at Mar. 31, 2020</a></td>
<td class="nump">42,030,331<span></span>
</td>
<td class="nump">236,526,638<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_CommonStockSharesToBeIssuedBalance', window );">Balance, shares to be issued at Mar. 31, 2020</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2020</a></td>
<td class="nump">$ 420<span></span>
</td>
<td class="nump">$ 2,366<span></span>
</td>
<td class="nump">$ 26,107,159<span></span>
</td>
<td class="num">$ (27,443,643)<span></span>
</td>
<td class="num">$ (1,333,698)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, shares at Dec. 31, 2020</a></td>
<td class="nump">42,030,331<span></span>
</td>
<td class="nump">236,526,638<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_CommonStockSharesToBeIssuedBalance', window );">Balance, shares to be issued at Dec. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_CommonStockValueToBeIssuedBalance', window );">Balance, shares to be issued, value at Dec. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_CommonSharesToBeIssuedInSettlementOfLegalDispute', window );">Common shares to be issued in settlement of legal dispute</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 67,000<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 67,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_CommonSharesToBeIssuedInSettlementOfLegalDisputeSharesToBeIssued', window );">Common shares to be issued in settlement of legal dispute, shares to be issued</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_FairValueOfVestedStockOptionsGrantedToEmployees', window );">Fair value of vested stock options granted to employees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">128,434<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">128,434<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_FairValueOfVestedStockOptionsGrantedToDirectors', window );">Fair value of vested stock options granted to directors</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,342<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,342<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(793,368)<span></span>
</td>
<td class="num">(793,368)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Mar. 31, 2021</a></td>
<td class="nump">$ 420<span></span>
</td>
<td class="nump">$ 2,366<span></span>
</td>
<td class="nump">$ 26,241,935<span></span>
</td>
<td class="num">$ (28,237,011)<span></span>
</td>
<td class="num">$ (1,925,290)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, shares at Mar. 31, 2021</a></td>
<td class="nump">42,030,331<span></span>
</td>
<td class="nump">236,526,638<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_CommonStockSharesToBeIssuedBalance', window );">Balance, shares to be issued at Mar. 31, 2021</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_CommonStockValueToBeIssuedBalance', window );">Balance, shares to be issued, value at Mar. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 67,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonuses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Common shares issued or to be issued on settlement of restricted stock units and award of stock bonuses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonuses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Common shares issued or to be issued on settlement of restricted stock units and award of stock bonuses, shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesSharesToBeIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Common shares issued or to be issued on settlement of restricted stock units and award of stock bonuses, shares to be issued.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_CommonSharesIssuedOrToBeIssuedOnSettlementOfRestrictedStockUnitsAndAwardOfStockBonusesSharesToBeIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_CommonSharesToBeIssuedInSettlementOfLegalDispute">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Common shares to be issued in settlement of legal dispute.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_CommonSharesToBeIssuedInSettlementOfLegalDispute</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_CommonSharesToBeIssuedInSettlementOfLegalDisputeSharesToBeIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Common shares to be issued in settlement of legal dispute, shares to be issued.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_CommonSharesToBeIssuedInSettlementOfLegalDisputeSharesToBeIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_CommonStockSharesToBeIssuedBalance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Balance, shares to be issued.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_CommonStockSharesToBeIssuedBalance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_CommonStockValueToBeIssuedBalance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Balance, shares to be issued, value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_CommonStockValueToBeIssuedBalance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_FairValueOfVestedStockOptionsGrantedToDirectors">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of vested stock options granted to directors.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_FairValueOfVestedStockOptionsGrantedToDirectors</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_FairValueOfVestedStockOptionsGrantedToEmployees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of vested stock options granted to employees.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_FairValueOfVestedStockOptionsGrantedToEmployees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for restricted stock unit under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued which are neither cancelled nor held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139855689748008">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash Flows From Operating Activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (793,368)<span></span>
</td>
<td class="num">$ (938,313)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net loss to net cash provided by (used in) operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and intangible asset amortization expense</a></td>
<td class="nump">18,377<span></span>
</td>
<td class="nump">30,735<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share-based compensation</a></td>
<td class="nump">6,342<span></span>
</td>
<td class="nump">154,426<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_OtherSharebasedExpense', window );">Other share-based expense</a></td>
<td class="nump">67,000<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryWriteDown', window );">Provision for excess and obsolete inventory</a></td>
<td class="num">(4,371)<span></span>
</td>
<td class="num">(11,657)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnDispositionOfAssets', window );">Loss on disposal of assets</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">4,124<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense', window );">Amortization of ROU Asset</a></td>
<td class="nump">49,051<span></span>
</td>
<td class="nump">46,666<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsAndNotesReceivable', window );">Accounts receivable</a></td>
<td class="nump">6,748<span></span>
</td>
<td class="nump">688<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventory</a></td>
<td class="num">(187,679)<span></span>
</td>
<td class="num">(71,279)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidExpensesOther', window );">Prepaid expenses and other</a></td>
<td class="num">(1,026,765)<span></span>
</td>
<td class="nump">74,924<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities', window );">Accounts payable and accrued liabilities</a></td>
<td class="nump">5,354<span></span>
</td>
<td class="nump">289,289<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInContractWithCustomerLiability', window );">Deferred revenue</a></td>
<td class="nump">2,362,905<span></span>
</td>
<td class="num">(291,104)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInterestPayableNet', window );">Accrued interest</a></td>
<td class="nump">718<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_IncreaseDecreaseInLeaseDeposit', window );">Lease deposit</a></td>
<td class="num">(8,061)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingLeaseLiability', window );">Operating lease liability, net</a></td>
<td class="num">(64,672)<span></span>
</td>
<td class="num">(52,849)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDeferredCompensation', window );">Accrued equity compensation</a></td>
<td class="nump">52,794<span></span>
</td>
<td class="nump">36,463<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by operating activities</a></td>
<td class="nump">484,373<span></span>
</td>
<td class="num">(727,887)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash Flows From Investing Activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchases of property and equipment</a></td>
<td class="num">(12,326)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="num">(12,326)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash Flows From Financing Activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromNotesPayable', window );">Proceeds from issuance of note payable</a></td>
<td class="nump">514,200<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by financing activities</a></td>
<td class="nump">514,200<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net change in cash, cash equivalents and restricted cash</a></td>
<td class="nump">986,247<span></span>
</td>
<td class="num">(727,887)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations', window );">Cash, cash equivalents and restricted cash, beginning of period</a></td>
<td class="nump">2,284,881<span></span>
</td>
<td class="nump">922,177<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations', window );">Cash, cash equivalents and restricted cash, end of period</a></td>
<td class="nump">3,271,128<span></span>
</td>
<td class="nump">194,290<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental cash flow information:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Interest paid</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaidNet', window );">Income taxes paid</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_IncreaseDecreaseInLeaseDeposit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lease deposit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_IncreaseDecreaseInLeaseDeposit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_OtherSharebasedExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other share-based expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_OtherSharebasedExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnDispositionOfAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of property, plant and equipment assets, excluding oil and gas property and timber property.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351718&amp;loc=d3e2443-110228<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnDispositionOfAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4297-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsAndNotesReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period of the sum of amounts due within one year (or one business cycle) from customers for the credit sale of goods and services; and from note holders for outstanding loans.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsAndNotesReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 310<br> -Section 45<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123371682&amp;loc=d3e55415-109406<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDeferredCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the obligation created by employee agreements whereby earned compensation will be paid in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInDeferredCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInterestPayableNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in interest payable, which represents the amount owed to note holders, bond holders, and other parties for interest earned on loans or credit extended to the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInterestPayableNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in obligation for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidExpensesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) of consideration paid in advance for other costs that provide economic benefits in future periods.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidExpensesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3367-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWriteDown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from reductions in inventory due to subsequent measurement adjustments, including, but not limited to, physical deterioration, obsolescence, or changes in price levels.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4542-108314<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWriteDown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for right-of-use asset from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a borrowing supported by a written promise to pay an obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139855776311528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>General<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock', window );">General</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>Note 1 &#8211; General</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><b><i>Description of Business</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Surna Inc. (the &#8220;Company&#8221;)
was incorporated in Nevada on October 15, 2009 and operates under a trade name of Surna Cultivation Technologies. We design, engineer
and sell environmental control and other technologies for the Controlled Environment Agriculture (CEA) industry. The CEA industry is one
of the fastest-growing sectors of the United States&#8217; economy. From leafy greens (kale, Swiss chard, mustard, cress), microgreens
(leafy greens harvested at the first true leaf stage), ethnic vegetables and small fruits (such as strawberries, blackberries and raspberries)
to bell peppers, cucumbers, tomatoes, and cannabis, some producers grow crops indoors in response to market dynamics or as part of their
preferred farming practice. In service of the CEA industry, our principal technologies include: (i) liquid-based process cooling systems
and other climate control systems, (ii) air handling equipment and systems, (iii) a full-service engineering package for designing and
engineering commercial scale thermodynamic systems specific to cultivation facilities, and (iv) automation and control devices, systems
and technologies used for environmental, lighting and climate control. Our customers include commercial, state- and provincial-regulated
CEA growers in the U.S. and Canada as well as other international locations. Customers are those growers building new facilities and those
expanding or retrofitting existing facilities. Currently, our revenue stream is derived primarily from supplying our products, services
and technologies to commercial indoor facilities ranging from several thousand to more than 100,000 square feet. Headquartered in Boulder,
Colorado, we leverage our experience in this space to bring value-added climate control solutions to our customers that help improve their
overall crop quality and yield, optimize energy and water efficiency, and satisfy the evolving state and local codes, permitting and regulatory
requirements. Although our customers do, we neither produce nor sell cannabis or its related products.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><b><i>Impact of the COVID-19 Pandemic
on Our Business</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white">The impact
of the government and the business economic response to the COVID-19 pandemic has affected demand across the majority of our markets and
disrupted work on projects. The COVID-19 pandemic is expected to have continued adverse effects on our sales, project implementation,
operating margins, and working capital. As of the date of this filing, uncertainty continues to exist concerning the magnitude and duration
of the economic impact of the COVID-19 pandemic.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white">In response
to the COVID-19 pandemic and the government and business response, during 2020, the Company took measures to adjust its operations. These
actions included initial measures to cut costs and preserve cash, and encompassed downsizing workforce, compensation reductions, and reduced
hours worked that were later changed upwards and in some cases fully restored late in 2020, as the Company gained new contracts, bank
funding was available and the overall business climate improved. The Company continues to actively monitor its operations and sales efforts
in light of the continuing effects of the COVID-19 pandemic and will make adjustments to its operations as necessary.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white">Due to
the speed with which the COVID-19 pandemic developed and the resulting uncertainties, including the depth and duration of the disruptions
to customers and suppliers, its future effect on our business, on our results of operations, and on our financial condition, we cannot
predict the overall effect on our business over the longer term. Addressing this uncertainty, we have undertaken various plans to reduce
costs so as to mitigate the impact of the COVID-19 pandemic to the best of our ability, although they may not be sufficient in the long-run
for us to avoid reduced sales, increased losses and reduced operating cash flows.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white">Refer
to <i>Risk Factors</i>, included in Part II, Item 1A of this Quarterly Report on Form 10-Q below, for further discussion of the possible
impact of the COVID-19 pandemic on our business.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><b><i>Financial Statement Presentation</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The accompanying unaudited condensed
consolidated financial statements of the Company have been prepared in conformity with accounting principles generally accepted in the
United States of America (&#8220;GAAP&#8221;) for interim financial information and with the instructions to Form 10-Q and Rule 10-01
of Regulation S-X. Pursuant to these rules and regulations, certain information and note disclosures, normally included in financial statements
prepared in accordance with GAAP, have been condensed or omitted. In the opinion of management, all adjustments (consisting of normal
recurring items) considered necessary for a fair presentation have been included. Operating results for the three months ended March 31,
2021 are not necessarily indicative of the results that may be expected for the fiscal year ending December 31, 2021. The balance sheet
as of December 31, 2020 has been derived from the audited financial statements at that date but does not include all the information and
footnotes required by GAAP for complete financial statements. For further information, refer to the consolidated financial statements
and notes thereto contained in the Annual Report on Form 10-K for the year ended December 31, 2020. The notes to the unaudited condensed
consolidated financial statements are presented on a going concern basis.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><b><i>Basis of Consolidation and
Reclassifications</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The condensed consolidated financial
statements include the accounts of the Company and its controlled and wholly owned subsidiary, Hydro Innovations, LLC (&#8220;Hydro&#8221;).
Intercompany transactions, profit, and balances are eliminated in consolidation.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 30.25pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><b><i>Going Concern</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white">The accompanying
condensed consolidated financial statements have been prepared assuming that the Company will continue as a going concern, which contemplates
the realization of assets and the satisfaction of liabilities in the normal course of business. The Company has experienced recurring
losses since its inception. Since inception, the Company has financed its activities principally through debt and equity financing, customer
deposits and revenues from completed contracts. Management expects to incur additional losses and cash outflows in the foreseeable future
in connection with its operating activities. Management believes that the economic dislocations in the overall economy, in the near term,
will impact our revenues, losses and cash flows. There can be no assurance that the Company will be able to raise debt or equity financing
in sufficient amounts, when and if needed, on acceptable terms or at all. If results of operations for 2021 do not meet management&#8217;s
expectations, or additional capital is not available, management believes it has the ability to reduce certain expenditures. The precise
amount and timing of the funding needs cannot be determined accurately at this time, and will depend on a number of factors, including
the overall economy, market demand for the Company&#8217;s products and services, the quality of product development efforts, management
of working capital, and continuation of normal payment terms and conditions for purchase of the Company&#8217;s products. The Company
believes its cash balances and cash flow from operations will be insufficient to fund its operations for the next 12 months. If the Company
is unable to substantially increase revenues, reduce expenditures, or otherwise generate cash flows from operations, then the Company
will need to raise additional funding to continue as a going concern. The foregoing factors raise substantial doubt about the Company&#8217;s
ability to continue as a going concern for a period of one year from the date the financial statements are issued. These condensed consolidated
financial statements do not include any adjustment that might result from the outcome of this uncertainty.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><b><i>Use of Estimates</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Management makes estimates and
assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the
date of the financial statements and that affect the reported amounts of revenue and expenses during the reporting period. The Company
bases its estimates on historical experience and on various other assumptions that it believes to be reasonable under the circumstances,
the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent
from other sources. Actual results could differ from those estimates. Key estimates include: allocation of transaction prices to performance
obligations under contracts with customers, standalone selling prices, timing of expected revenue recognition on remaining performance
obligations under contracts with customers, valuation of intangible assets, valuation of equity-based compensation, valuation of deferred
tax assets and liabilities, warranty accruals, accounts receivable and inventory allowances, and legal contingencies.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><b><i>Cash, Cash Equivalents and
Restricted Cash</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">All highly liquid investments
with original maturities of three months or less at the date of purchase are considered to be cash equivalents. The Company may, from
time to time, have deposits in financial institutions that exceed the federally insured amount. The Company has not experienced any losses
to date on depository accounts.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">During the three months ended
March 31, 2021, the Company transferred a balance of $180,000 into a new bank account which was to be used for the sole purpose of paying
certain warranty claims. The balance on this restricted bank account as of March 31, 2021 was $86,697.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><b><i>Income (Loss) Per Common
Share</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Basic income (loss) per common
share is computed by dividing net income (loss) attributable to common stockholders by the weighted-average number of common shares outstanding
during the period without consideration of common stock equivalents. Diluted net income (loss) per common share is computed by dividing
net income (loss) by the weighted-average number of common shares outstanding and potentially dilutive common stock equivalents, including
stock options, warrants and restricted stock units and other equity-based awards, except in cases where the effect of the common stock
equivalents would be antidilutive. Potential common stock equivalents consist of common stock issuable upon exercise of stock options
and warrants and the vesting of restricted stock units using the treasury method.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white">During
the three months ended March 31, 2021 and 2020, there were warrants and options outstanding to purchase Company common stock and restricted
stock units that were convertible into shares of the Company&#8217;s common stock. During the three-month periods ended March 31, 2021
and 2020, the Company incurred a net loss and consequently the common share equivalents of these potentially dilutive equity instruments
have not been included in the calculations of loss per share because such inclusion would have been anti-dilutive. As of March 31, 2021,
and 2020, there were respectively, 30,249,300 and 45,748,400, potentially dilutive equity instruments outstanding in respect of warrants
and options outstanding to purchase Company common stock and restricted stock units that were convertible into shares of the Company&#8217;s
common stock.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><b><i>Goodwill</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 30.25pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Company recorded goodwill
in connection with its acquisition of Hydro Innovations, LLC in July 2014. Goodwill is reviewed for impairment annually or more frequently
when events or changes in circumstances indicate that fair value of the reporting unit has been reduced to less than its carrying value.
The Company performs a quantitative impairment test annually on December 31 by comparing the fair value of the reporting unit with its
carrying amount, including goodwill. If the fair value of the reporting unit exceeds its carrying amount, goodwill is considered not impaired.
An impairment charge would be recognized for the amount by which the carrying amount exceeds the reporting unit&#8217;s fair value. The
Company determined that it has one reporting unit.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">During the three months ended
March 31, 2021, the Company concluded that the projected impact of the COVID-19 pandemic on its sales, contract completion and revenues
in the near term, together with the volatility in its share price during the quarter represented potential indicators of impairment. Accordingly,
the Company performed an interim impairment analysis at March 31, 2021, and concluded that no impairment relating to goodwill existed
at March 31, 2021.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 30.25pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><b><i>Revenue Recognition</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">On January 1, 2018, the Company
adopted Accounting Standards Update (&#8220;ASU&#8221;) 2014-09 (Topic 606), <i>Revenue from Contracts with Customers</i> and all the
related amendments (&#8220;ASC 606&#8221; or the &#8220;revenue standard&#8221;) to all contracts and elected the modified retrospective
method.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Under the revenue standard, a
performance obligation is a promise in a contract with a customer to transfer a distinct good or service to the customer. Most of the
Company&#8217;s contracts contain multiple performance obligations that include engineering and technical services as well as the delivery
of a diverse range of climate control system equipment and components, which can span multiple phases of a customer&#8217;s project life-cycle
from facility design and construction to equipment delivery and system installation and start-up.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">A contract&#8217;s transaction
price is allocated to each distinct performance obligation and recognized as revenue when, or as, the performance obligation is satisfied.
When there are multiple performance obligations within a contract, the Company allocates the transaction price to each performance obligation
based on standalone selling price. When estimating the selling price, the Company uses various observable inputs. The best observable
input is the Company&#8217;s actual selling price for the same good or service, however, this input is generally not available for the
Company&#8217;s contracts containing multiple performance obligations. For engineering services, the Company estimates the standalone
selling price by reference to certain physical characteristics of the project, such as facility size and mechanical systems involved,
which are indicative of the scope and complexity of the mechanical engineering services to be provided. For equipment sales, the standalone
selling price is determined by forecasting the expected costs of the equipment and then adding an appropriate margin, based on a range
of acceptable margins established by management. Depending on the nature of the performance obligations, the Company may use a combination
of different methods and observable inputs if certain performance obligations have highly variable or uncertain standalone selling prices.
Once the selling prices are determined, the Company applies the relative values to the total contract consideration and estimates the
amount of the transaction price to be recognized as each performance obligation is fulfilled.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Company recognizes revenue
for the sale of goods when control transfers to the customer, which primarily occurs at the time of shipment. The Company&#8217;s historical
rates of return are insignificant as a percentage of sales and, as a result, the Company does not record a reserve for returns at the
time the Company recognizes revenue. The Company has elected to exclude from the measurement of the transaction price all taxes (e.g.,
sales, use, value added, and certain excise taxes) that are assessed by a governmental authority in connection with a specific revenue-producing
transaction and collected by the Company from the customer. Accordingly, the Company recognizes revenue net of sales taxes. The revenue
and cost for freight and shipping is recorded when control over the sale of goods passes to the Company&#8217;s customers.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Company also has performance
obligations to perform certain engineering services that are satisfied over a period of time. Revenue is recognized from this type of
performance obligation as services are rendered based on the percentage completion towards certain specified milestones.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Company offers assurance-type
warranties for its products and products manufactured by others to meet specifications defined by the contracts with customers and does
not have any material separate performance obligations related to these warranties. The Company maintains a warranty reserve based on
historical warranty costs.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Applying the practical expedient
in ASC 606-10-32-18, which the Company has elected, the Company does not adjust the promised amount of consideration for the effects of
a significant financing component since the Company expects, at contract inception, that the period between when the Company transfers
a promised good or service to a customer and when the customer pays for that good or service will be one year or less. Accordingly, the
remaining performance obligations related to customer contracts does not consider the effects of the time value of money.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Applying the practical expedient
in ASC 340-40-25-4, the Company recognizes the incremental costs of obtaining contracts as an expense when incurred since the amortization
period of the assets that the Company otherwise would have recognized is one year or less. These costs include certain sales commissions
and incentives, which are included in selling, general and administrative expenses, and are payable only when associated revenue has been
collected and earned by the Company.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Company does not have material
amounts of contract assets since revenue is recognized as control of goods is transferred or as services are performed. Contract liabilities
consist of advance payments and deferred revenue.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">For the three months ended March
31, 2021, the Company recognized revenue of $1,880,364 related to the deferred revenue at January 1, 2021. For the three months ended
March 31, 2020, the Company recognized revenue of $859,705 related to the deferred revenue at January 1, 2020.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Remaining performance obligations,
or backlog, represents the aggregate amount of the transaction price allocated to the remaining obligations that the Company has not performed
under its customer contracts. The Company has elected not to use the optional exemption in ASC 606-10-50-14, which exempts an entity from
such disclosures if a performance obligation is part of a contract with an original expected duration of one year or less. Accordingly,
the information disclosed about remaining performance obligations includes all customer contracts, including those with an expected duration
of one year or less.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Industry uncertainty, project
financing concerns, and the licensing and qualification of our prospective customers, which are out of the Company&#8217;s control, make
it difficult for the Company to predict when it will recognize revenue on its remaining performance obligations. There are risks that
the Company may not realize the full contract value on customer projects in a timely manner or at all, and completion of a customer&#8217;s
cultivation facility project is dependent upon the customer&#8217;s ability to secure funding and real estate, obtain a license and then
build their cultivation facility so they can take possession of the equipment. Accordingly, the time it takes for customers to complete
a project, which corresponds to when the Company is able to recognize revenue, is driven by numerous factors including: (i) the large
number of first-time participants interested in the indoor cannabis cultivation business; (ii) the complexities and uncertainties involved
in obtaining state and local licensure and permitting; (iii) local and state government delays in approving licenses and permits due to
lack of staff or the large number of pending applications, especially in states where there is no cap on the number of cultivators; (iv)
the customer&#8217;s need to obtain cultivation facility financing; (v) the time needed, and coordination required, for our customers
to acquire real estate and properly design and build the facility (to the stage when climate control systems can be installed); (vi) the
large price tag and technical complexities of the climate control and air sanitation system; (vii) the availability of power; and (viii)
delays that are typical in completing any construction project.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">As of March 31, 2021, the Company&#8217;s
remaining performance obligations, or backlog, was $11,578,000, of which $2,006,000, or 17%, was attributable to customer contracts for
which the Company has only received an initial advance payment to cover the allocated value of the Company&#8217;s engineering services
(&#8220;engineering only paid contracts&#8221;). There is the risk that the equipment portion of these engineering only paid contracts
will not be completed or will be delayed. These reasons include the customer being dissatisfied with the quality or timeliness of the
Company&#8217;s engineering services, delay or abandonment of the project because of the customer&#8217;s inability to obtain project
financing or licensing, or other reasons such as a challenging business climate including an overall post-Covid-19 economic downturn,
or change in business direction. After the customer has made an advance payment for a portion of the equipment to be delivered under the
contract (&#8220;partial equipment paid contracts&#8221;), the Company is typically better able to estimate the timing of revenue recognition
since the risks and delays associated with licensing, permitting and project funding are typically mitigated once the initial equipment
payment is received. There is significant uncertainty regarding the timing of the Company&#8217;s recognition of revenue on its remaining
performance obligations, and there is no certainty that these will result in actual revenues. The backlog at March 31, 2021, includes
booked sales orders of $449,000 from several customers that the Company does not expect to be realized until 2022, if at all. Given the
present economic uncertainty arising from the impact of the novel coronavirus COVID-19, the Company believes that several of its current
contracts may be delayed or cancelled in the short term.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The remaining performance obligations
expected to be recognized through 2022 are as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2021</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2022</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Total</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 55%"><font style="font-size: 10pt">Remaining performance obligations related to engineering only paid contracts</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 12%; text-align: right"><font style="font-size: 10pt">1,563,000</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 12%; text-align: right"><font style="font-size: 10pt">443,000</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 12%; text-align: right"><font style="font-size: 10pt">2,006,000</font></td>
    <td style="width: 1%">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Remaining performance obligations related to partial equipment paid contracts</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">9,566,000</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">6,000</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">9,572,000</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">Total remaining performance obligations</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">11,129,000</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">449,000</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">11,578,000</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The following table sets forth
the Company&#8217;s revenue by source:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>For the Three Months <br />
Ended March 31,</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2021</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2020</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 54%"><font style="font-size: 10pt">Equipment and systems sales</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 20%; text-align: right"><font style="font-size: 10pt">2,163,468</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 20%; text-align: right"><font style="font-size: 10pt">1,606,946</font></td>
    <td style="width: 1%">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Engineering and other services</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">181,083</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">131,591</font></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Shipping and handling</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">21,978</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">71,388</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">Total revenue</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">2,366,529</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">1,809,925</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><b><i>Accounting for Share-Based
Compensation</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 30.25pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Company recognizes the cost
resulting from all share-based compensation arrangements, including stock options, restricted stock awards and restricted stock units
that the Company grants under its equity incentive plan in its condensed consolidated financial statements based on their grant date fair
value. The expense is recognized over the requisite service period or performance period of the award. Awards with a graded vesting period
based on service are expensed on a straight-line basis for the entire award. Awards with performance-based vesting conditions, which require
the achievement of a specific company financial performance goal at the end of the performance period and required service period, are
recognized over the performance period. Each reporting period, the Company reassesses the probability of achieving the respective performance
goal. If the goals are not expected to be met, no compensation cost is recognized and any previously recognized amount recorded is reversed.
If the award contains market-based vesting conditions, the compensation cost is based on the grant date fair value and expected achievement
of market condition and is not subsequently reversed if it is later determined that the condition is not likely to be met or is expected
to be lower than initially expected.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white">The grant
date fair value of stock options is based on the Black-Scholes Option Pricing Model (the &#8220;Black-Scholes Model&#8221;). The Black-Scholes
Model requires judgmental assumptions including volatility and expected term, both based on historical experience. The risk-free interest
rate is based on U.S. Treasury interest rates whose term is consistent with the expected term of the option. The Company determines the
assumptions used in the valuation of option awards as of the date of grant. Differences in the expected stock price volatility, expected
term or risk-free interest rate may necessitate distinct valuation assumptions at those grant dates. As such, the Company may use different
assumptions for options granted throughout the year. During the three months ended March 31, 2021, the valuation assumptions used to determine
the fair value of each option award on the date of grant were: expected stock price volatility of 152.51%; expected term in years 10 and
risk-free interest rate of 1.2%.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The grant date fair value of restricted
stock and restricted stock units is based on the closing price of the underlying stock on the date of the grant.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Company has elected to reduce
share-based compensation expense for forfeitures as the forfeitures occur since the Company does not have historical data or other factors
to appropriately estimate the expected employee terminations and to evaluate whether particular groups of employees have significantly
different forfeiture expectations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.8pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">The following is a summary of share-based compensation
expenses included in the condensed consolidated statements of operations for the three months ended March 31, 2021 and 2020:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>For the Three Months <br />
Ended March 31,</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2021</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2020</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Share-based compensation expense included in:</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="width: 54%"><font style="font-size: 10pt">Cost of revenue</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 20%; text-align: right"><font style="font-size: 10pt">14,135</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 20%; text-align: right"><font style="font-size: 10pt">8,558</font></td>
    <td style="width: 1%">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Advertising and marketing expenses</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">6,474</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">2,912</font></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Product development costs</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">6,694</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">6,545</font></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Selling, general and administrative expenses</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">31,833</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">172,874</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">Total share-based compensation expense included in consolidated statement of operations</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">59,136</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">190,889</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Included in the $59,136 expense
for the three months ended March 31, 2021, is an accrual for $52,794 in respect of the 2021 Annual Employee Incentive Compensation Plan.
Included in the $190,889 expense for the three months ended March 31, 2020, is an accrual for $36,463 in respect of the 2020 Annual Employee
Incentive Compensation Plan.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><b><i>Concentrations</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Three customers accounted for
38%, 16%, and 11% of the Company&#8217;s revenue for the three months March 31, 2021. For the three months ended March 31, 2020, four
customers accounted for 17%, 16%, 10% and 10% of the Company&#8217;s revenue.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Two customers accounted for 60%,
and 31% of the Company&#8217;s accounts receivable for the three months ended March 31, 2021. For the three months ended March 31, 2020,
three customers accounted for 59%, 18%, and 15% of the Company&#8217;s accounts receivable.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><b><i>Recently Issued Accounting
Pronouncements</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">In August 2020, the FASB issued
ASU No. 2020-06, <i>Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging&#8212;Contracts in Entity&#8217;s
Own Equity (Subtopic 815-40)</i> which simplifies the accounting for convertible instruments. The guidance removes certain accounting
models which separate the embedded conversion features from the host contract for convertible instruments. Either a modified retrospective
method of transition or a fully retrospective method of transition is permissible for the adoption of this standard. Update No. 2020-06
is effective for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. Early adoption is
permitted no earlier than the fiscal year beginning after December 15, 2020. The Company does not expect this ASU to have a material impact
on its consolidated results of operations, cash flows and financial position.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">In March 2020, the FAS issued
ASU No. 2020-04 &#8220;<i>Reference Reform (Topic 848) Facilitation of the Effects of Reference Rate Reform on Financial Reporting&#8221;
(&#8220;ASU 2020-04&#8221;).</i> ASU 2020-04 provides optional guidance for a limited period of time to ease the potential burden in accounting
for (or recognizing the effects of) reference rate reform on financial reporting. The amendments are effective for the Company as of March
12, 2020 through December 31, 2022. The Company does not expect this ASU to have a material impact on its consolidated results of operations,
cash flows and financial position.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">In January 2020, the FASB issued
ASU No. 2020-01, <i>Investments&#8212;Equity Securities (Topic 321), Investments&#8212;Equity Method and Joint Ventures (Topic 323), and
Derivatives and Hedging (Topic 815)&#8212;Clarifying the Interactions between Topic 321, Topic 323, and Topic 815</i> (a consensus of
the Emerging Issues Task Force). This update clarifies whether an entity should consider observable transactions that require it to either
apply or discontinue the equity method of accounting for the purposes of applying the measurement alternative and how to account for certain
forward contracts and purchased options to purchase securities. For public entities, this guidance is effective for fiscal years beginning
after December 15, 2020. The Company does not expect this ASU to have a material impact on its consolidated results of operations, cash
flows and financial position. The adoption of this ASU has not had a material impact on the Company&#8217;s consolidated results of operations,
cash flows and financial position.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">In December 2019, the FASB issued
ASU 2019-12, <i>Income Taxes (Topic 740) &#8211; Simplifying the Accounting for Income Taxes, </i>which simplifies the accounting for
income taxes by removing certain exceptions to the general principles in Topic 740. The amendments also improve consistent application
of and simplify GAAP for other areas of Topic 740 by clarifying and amending existing guidance. ASU 2019-12 is effective for fiscal years
beginning after December 15, 2020. Early adoption is permitted. The adoption of this ASU has not had a material impact on the Company&#8217;s
consolidated results of operations, cash flows and financial position.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Other accounting standards that
have been issued or proposed by FASB that do not require adoption until a future date are not expected to have a material impact on the
financial statements upon adoption. The Company does not discuss recent pronouncements that are not anticipated to have an impact on
or are unrelated to its financial condition, results of operations, cash flows or disclosures.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the general note to the financial statements for the reporting entity which may include, descriptions of the basis of presentation, business description, significant accounting policies, consolidations, reclassifications, new pronouncements not yet adopted and changes in accounting principles.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -URI http://asc.fasb.org/topic&amp;trid=2197479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -URI http://asc.fasb.org/topic&amp;trid=2134479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -URI http://asc.fasb.org/topic&amp;trid=2122394<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139855694110520">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeasesTextBlock', window );">Leases</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Note 2 &#8211; Leases</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">In February 2016 the FASB issued
ASU 2016-02, <i>Leases (Topic 842)</i>(&#8220;ASC 842&#8221; or the &#8220;new lease standard&#8221;). The Company adopted ASC 842 as
of January 1, 2019, using the effective date method.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The new standard provides a number
of optional practical expedients in transition. The Company has elected to apply the &#8220;package of practical expedients&#8221; which
allow the Company to not reassess: (i) whether existing or expired arrangements contain a lease, (ii) the lease classification of existing
or expired leases, or (iii) whether previous initial direct costs would qualify for capitalization under the new lease standard. The Company
has also elected to apply the short-term lease exemption for all leases with an original term of less than 12 months, for purposes of
applying the recognition and measurements requirements in the new lease standard.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Upon adoption, the Company recognized
its lease for manufacturing and office space (the &#8220;Facility Lease&#8221;) on the balance sheet as an operating lease right-of-use
asset in the amount of $714,416 and as a lease liability of $822,374. The Facility Lease commenced September 29, 2017 and continues through
August 31, 2022. The Company has the option to renew the Facility Lease for an additional five years. However, the renewal option to extend
the Facility Lease is not included in the right-of-use asset or lease liability as the option is not reasonably certain of exercise. The
Company regularly evaluates the renewal option and when it is reasonably certain of exercise, the Company will include the renewal period
in its lease term.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Beginning September 1, 2018, and
each subsequent September 1 during the term, the monthly rent under the Facility Lease will increase by 3%. Total rent under the current
building lease is charged to expense over the term of the lease on a straight-line basis, resulting in the same monthly rent expense throughout
the lease. The difference between the rent expense amount and the actual rent paid is recorded to operating lease liability on the Company&#8217;s
condensed consolidated balance sheets.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Under the Facility Lease, the
landlord agreed to pay the Company or the Company&#8217;s contractors for tenant improvements made by the Company not to exceed $100,000,
which were used for normal tenant improvements. The Company determined that these improvements were not specialized and could be utilized
by a subsequent tenant and, as such, the improvements were considered assets of the lessor. As of January 1, 2019, the unamortized amount
of tenant improvement allowance of $81,481 was treated as a reduction in measuring the right-of-use asset.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Under the Facility Lease, the
Company pays the actual amounts for property taxes and insurance, excludes such payments from lease contract consideration, and records
such payments as incurred. The Company also pays the landlord for common area maintenance, which is considered a nonlease component. For
the Facility Lease, the Company has not elected the accounting policy to include both the lease and nonlease components as a single component
and account for it as the lease.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">In determining the right-of-use
asset and lease liability, the Company applied a discount rate to the minimum lease payments under the Facility Lease. ASC 842 requires
the Company to use the rate of interest that the Company would have to pay to borrow on a collateralized basis over a similar term an
amount equal to the lease payments in a similar economic environment. Since the discount rate is not implicit in the lease agreement,
we utilized an estimated incremental borrowing rate provided by the Company&#8217;s depository bank.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The lease cost, cash flows and
other information related to the Facility Lease were as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font-size: 10pt"><b>For the Three Months Ended March 31,</b></font></td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2021</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 77%"><font style="font-size: 10pt">Operating lease cost</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 20%; text-align: right"><font style="font-size: 10pt">54,222</font></td>
    <td style="width: 1%">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Operating cash outflow from operating lease</font></td>
    <td>&#160;</td>
    <td><font style="font-size: 10pt">$</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">69,844</font></td>
    <td>&#160;</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom; background-color: white">
    <td style="width: 77%; padding-bottom: 1.5pt; text-align: center">&#160;</td>
    <td style="width: 1%; padding-bottom: 1.5pt; text-align: center">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; width: 1%; text-align: center">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; width: 20%; text-align: center"><font style="font-size: 10pt"><b>As of March 31, 2021</b></font></td>
    <td style="width: 1%; padding-bottom: 1.5pt; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Operating lease right-of-use assset</font></td>
    <td>&#160;</td>
    <td><font style="font-size: 10pt">$</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">294,900</font></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Operating lease liability, current</font></td>
    <td>&#160;</td>
    <td><font style="font-size: 10pt">$</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">263,662</font></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Operating lease liability, long-term</font></td>
    <td>&#160;</td>
    <td><font style="font-size: 10pt">$</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">106,891</font></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Remaining lease term</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">1.4 years</font></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Discount rate</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">5.00</font></td>
    <td><font style="font-size: 10pt">%</font></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Future annual minimum lease payments
on the Facility Lease as of March 31, 2021 were as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1.5pt solid"><font style="font-size: 10pt"><b>Years ended December 31,</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 77%"><font style="font-size: 10pt">2021 (excluding the three months ended March 31, 2021)</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 20%; text-align: right"><font style="font-size: 10pt">212,020</font></td>
    <td style="width: 1%">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">2022</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">170,891</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-align: justify"><font style="font-size: 10pt">Total minimum lease payments</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">382,911</font></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="padding-bottom: 1.5pt; text-align: justify"><font style="font-size: 10pt">Less imputed interest</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(12,358</font></td>
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-bottom: 2.5pt; text-align: justify"><font style="font-size: 10pt">Present value of minimum lease payments</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">370,553</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -URI http://asc.fasb.org/subtopic&amp;trid=77888251<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139855694161304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Inventory<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureTextBlock', window );">Inventory</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Note 3 &#8211; Inventory</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Inventory consisted of the following:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="3" style="text-align: center"><font style="font-size: 10pt"><b>March 31,</b></font></td>
    <td>&#160;</td>
    <td colspan="3" style="text-align: center"><font style="font-size: 10pt"><b>December 31,</b></font></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2021</b></font></td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2020</b></font></td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 54%"><font style="font-size: 10pt">Finished goods</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 20%; text-align: right"><font style="font-size: 10pt">325,451</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 20%; text-align: right"><font style="font-size: 10pt">201,778</font></td>
    <td style="width: 1%">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Work in progress</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">10,083</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">4,231</font></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Raw materials</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">272,299</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">214,145</font></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Allowance for excess &#38; obsolete inventory</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(88,674</font></td>
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(93,045</font></td>
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">Inventory, net</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">519,159</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">327,109</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Overhead expenses of $17,443 and
$17,974 were included in the inventory balance as of March 31, 2021, and December 31, 2020, respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Advance payments on inventory
purchases are recorded in prepaid expenses until title for such inventory passes to the Company. Prepaid expenses included $1,960,000
and $916,000 in advance payments for inventory for the periods ended March 31, 2021, and December 31, 2020, respectively.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -URI http://asc.fasb.org/topic&amp;trid=2126998<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139855776229800">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock', window );">Property and Equipment</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Note 4 &#8211; Property and Equipment</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Property and equipment consisted
of the following:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font-size: 10pt"><b>March 31,</b></font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font-size: 10pt"><b>December 31,</b></font></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2021</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2020</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 54%; text-align: justify"><font style="font-size: 10pt">Furniture and equipment</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 20%; text-align: right"><font style="font-size: 10pt">410,748</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 20%; text-align: right"><font style="font-size: 10pt">398,422</font></td>
    <td style="width: 1%">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="text-align: justify"><font style="font-size: 10pt">Vehicles</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">15,000</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">15,000</font></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-bottom: 1.5pt; text-align: justify"><font style="font-size: 10pt">Leasehold improvements</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">215,193</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">215,193</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">640,941</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">628,615</font></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-bottom: 1.5pt; text-align: justify"><font style="font-size: 10pt">Accumulated depreciation</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(499,116</font></td>
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(480,883</font></td>
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="padding-bottom: 2.5pt; text-align: justify"><font style="font-size: 10pt">Property and equipment, net</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">141,825</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">147,732</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Depreciation expense was $18,233
for the three months ended March 31, 2021. For the three months ended March 31, 2021, $1,249 was allocated to cost of sales and $312
was allocated to inventory with the remainder recorded as selling, general and administrative expense.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99893-112916<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -URI http://asc.fasb.org/topic&amp;trid=2155823<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=SL120174063-112916<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99779-112916<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139855776188376">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accounts Payable and Accrued Liabilities<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock', window );">Accounts Payable and Accrued Liabilities</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Note 5 &#8211; Accounts Payable and Accrued Liabilities
</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Accounts payable and accrued liabilities
consisted of the following:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font-size: 10pt"><b>March 31,</b></font></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font-size: 10pt"><b>December 31,</b></font></td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2021</b></font></td>
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2020</b></font></td>
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 54%"><font style="font-size: 10pt">Accounts payable</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 20%; text-align: right"><font style="font-size: 10pt">860,087</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 20%; text-align: right"><font style="font-size: 10pt">918,639</font></td>
    <td style="width: 1%">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Sales commissions payable</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">13,649</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">48,263</font></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Accrued payroll liabilities</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">275,024</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">288,071</font></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Product warranty accrual</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">264,956</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">173,365</font></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Other accrued expenses</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">376,599</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">356,623</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="padding-bottom: 2.5pt; padding-left: 10pt"><font style="font-size: 10pt">Total</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">1,790,315</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">1,784,961</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a),20,24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139855776247496">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note Payable and Accrued Interest<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">Note Payable and Accrued Interest</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>Note 6 &#8211; Note Payable and Accrued Interest</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">On February 10, 2021, the Company
entered into a note payable with its current bank in the principal amount of $514,200, for working capital purposes.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The loan amount bears interest
at 1% and is due on February 5, 2026. The loan may be repaid in advance without penalty. The loan is also potentially forgivable in full
provided proceeds are used for payment of payroll expenses, rent, utilities and mortgage interest and certain other terms and conditions
are met. The loan has typical default provisions, including for change of ownership, general lender insecurity as to repayment, non-payment
of amounts due, defaults on other debt instruments, insolvency, dissolution or termination of the business as a going concern and bankruptcy.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">During the three ended March
31, 2021, interest of $718 was accrued in respect of this note payable.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI http://asc.fasb.org/topic&amp;trid=2208564<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139855694182520">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingencies</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Note 7 &#8211; Commitments and Contingencies</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><b><i>Litigation</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">As of December 31, 2019, there
were 6,750,000 restricted stock units that had not been settled due to a dispute with a former employee over the required withholding
taxes to be paid to the Company for remittance to the appropriate tax authorities. The Company commenced an arbitration action against
the former employee regarding the dispute. The former employee also made claims in the arbitration action against the Company for unpaid
wages. As stated in a pleading in the arbitration, on March 9, 2020, the Company issued the former employee 6,750,000 shares of the Company&#8217;s
common stock in settlement of these restricted stock units after taking measures to mitigate the Company&#8217;s exposure to penalties
and liability for the failure to properly withhold income taxes. The Arbitrator issued an interim award of approximately $10,000 in the
Company&#8217;s favor and a finding against the former employee. Effective June 9, 2020, the Arbitrator issued his final award in the
Company&#8217;s favor in the Colorado arbitration. The Arbitrator found against the former employee and awarded the Company costs of $33,985,
with interest at 8% per year. Effective July 22, 2020, the Colorado Court confirmed the Arbitration award and entered a final judgement
in favor of the Company and against the former employee. The Company pursued collection of this debt and has now collected the debt owed.
This former employee continued to pursue separate litigation against the Company for recovery of alleged consulting fees owed to him for
the 2015 calendar year prior to his appointment as an executive officer of the Company. Effective March 30, 2021, this separate litigation
has now been settled. While the Company disputed the merits of the claims, the Company has agreed and will be obliged to pay $40,000 over
eight months and to issue upon execution of the settlement agreement an aggregate of 1,000,000 shares of common stock of the Company.
As further discussed in <i>Note 11 Subsequent Events</i> below, these shares were issued on April 8, 2021 as &#8220;restricted securities,&#8221;
subject to a lock-up agreement of six months, without registration rights, and pursuant to a private placement exemption. The settlement
agreement also included mutual releases and no admission of liability. The cost to the Company of this settlement, $107,000, has been
recognized in full in other expenses during the three months ended March 31, 2021. As of March 31, 2021, $40,000 in respect of the cash
portion of the settlement has been included in accounts payables and accruals and $67,000 in respect of the stock issuance has included
in common stock to be issued.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">From time to time, in the normal
course of its operations, the Company is subject to litigation matters and claims. Litigation can be expensive and disruptive to normal
business operations. Moreover, the results of complex legal proceedings are difficult to predict, and the Company&#8217;s view of these
matters may change in the future as the litigation and events related thereto unfold. The Company expenses legal fees as incurred. The
Company records a liability for contingent losses when it is both probable that a liability has been incurred and the amount of the loss
is known. An unfavorable outcome to any legal matter, if material, could have an adverse effect on the Company&#8217;s operations or its
financial position, liquidity or results of operations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><b><i>Leases</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Company has a lease agreement
for its manufacturing and office space. Refer to <i>Note 2 Leases</i> above.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><b><i>Other Commitments</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 30.25pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">In the ordinary course of business,
the Company enters into commitments to purchase inventory and may also provide indemnifications of varying scope and terms to customers,
vendors, lessors, business partners, and other parties with respect to certain matters, including, but not limited to, losses arising
out of the Company&#8217;s breach of such agreements, services to be provided by the Company, or from intellectual property infringement
claims made by third parties. In addition, the Company has entered into indemnification agreements with its directors and certain of
its officers and employees that will require the Company to, among other things, indemnify them against certain liabilities that may
arise by reason of their status or service as directors, officers, or employees. The Company maintains director and officer insurance,
which may cover certain liabilities arising from its obligation to indemnify its directors and certain of its officers and employees,
and former officers, directors, and employees of acquired companies, in certain circumstances.&#160;</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI http://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI http://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 440<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6491277&amp;loc=d3e6429-115629<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139855694163896">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity Incentive Plan<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">Equity Incentive Plan</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Note 8 &#8211; Equity Incentive Plan </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>2017 Equity Incentive Plan</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white">Under
the Company&#8217;s 2017 Equity Incentive Plan, as may be modified and amended by the Company from time to time (the &#8220;2017 Equity
Plan&#8221;), the Board of Directors (the &#8220;Board&#8221;) (or the compensation committee of the Board, if one is established) may
award stock options, stock appreciation rights (&#8220;SARs&#8221;), restricted stock awards (&#8220;RSAs&#8221;), restricted stock unit
awards (&#8220;RSUs&#8221;), shares granted as a bonus or in lieu of another award, and other stock-based performance awards. The 2017
Equity Plan allocates 50,000,000 shares of the Company&#8217;s common stock (&#8220;Plan Shares&#8221;) for issuance of equity awards
under the 2017 Equity Plan. If any shares subject to an award are forfeited, expire, or otherwise terminate without issuance of such shares,
the shares will, to the extent of such forfeiture, expiration, or termination, again be available for awards under the 2017 Equity Plan.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white">During
the three months ended March 31, 2021, the Company issued no shares of its common stock under the 2017 Equity Plan.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white">As of
March 31, 2021, awards related to 22,686,800 shares remain outstanding.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white">There
was no unrecognized compensation expense for unvested non-qualified stock options and RSUs at March 31, 2021.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>2021 Equity Incentive Plan</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="background-color: white">On
March 22, 2021, the Board approved the 2021 Equity Incentive Plan (the &#8220;2021 Plan&#8221;), which permits the Board to grant awards
of up to 100,000,000 shares of common stock, subject to and effective upon stockholder approval. The 2021 Plan provides for the grant
of incentive stock options intended to qualify under Section 422 of the Internal Revenue Code of 1986, as amended (the &#8220;Code&#8221;),
non-qualified stock options, stock appreciation rights (&#8220;SARs&#8221;), restricted stock awards and restricted stock unit awards
and other equity linked awards.to our employees, consultants and directors. If an equity award (i) expires or otherwise terminates without
having been exercised in full or (ii) is settled in cash (<i>i.e.</i>, the holder of the award receives cash rather than stock), such
expiration, termination or settlement will not reduce (or otherwise offset) the number of shares of common stock that may be issued pursuant
to this Plan.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="background-color: white">Approval
of the 2021 Plan will be considered by stockholders at the Annual General Meeting of Stockholders to be held on May 28, 2021. If the 2021
Plan is not approved, it may be continued as an equity plan by the Board, but it will not be able to provide for tax qualified incentive
options or satisfy exchange requirements. If not approved by the stockholders, the current intention of the Board is to continue the 2021
Plan and issue awards as appropriate thereunder.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Non-Qualified Stock Options</u></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white">A summary
of the non-qualified stock options granted to employees and consultants under the 2017 Equity Plan during the three months ended March
31, 2021, are presented in the table below:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Number of Options</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Weighted Average Exercise Price</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Weighted Average Remaining Contractual Term</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Aggregate Intrinsic Value</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 44%"><font style="font-size: 10pt">Outstanding, December 31, 2020</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 11%; text-align: right"><font style="font-size: 10pt">14,251,000</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 11%; text-align: right"><font style="font-size: 10pt">0.083</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 11%; text-align: right"><font style="font-size: 10pt">8.3</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 11%; text-align: right"><font style="font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;-</font></td>
    <td style="width: 1%">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 10pt"><font style="font-size: 10pt">Granted</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">1,035,800</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><font style="font-size: 10pt">$</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">0.130</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">10.0</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><font style="font-size: 10pt">$</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 10pt"><font style="font-size: 10pt">Exercised</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 10pt"><font style="font-size: 10pt">Forfeited</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-bottom: 1.5pt; padding-left: 10pt"><font style="font-size: 10pt">Expired</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">-</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: right">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: right">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: right">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">Outstanding, March 31, 2021</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double">&#160;</td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">15,286,800</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">$</font></td>
    <td style="padding-bottom: 2.5pt; text-align: right"><font style="font-size: 10pt">0.084</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: right"><font style="font-size: 10pt">8.2</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">$</font></td>
    <td style="padding-bottom: 2.5pt; text-align: right"><font style="font-size: 10pt">-</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">Exercisable, March 31, 2021</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double">&#160;</td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">15,286,800</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">$</font></td>
    <td style="padding-bottom: 2.5pt; text-align: right"><font style="font-size: 10pt">0.084</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: right"><font style="font-size: 10pt">8.2</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">$</font></td>
    <td style="padding-bottom: 2.5pt; text-align: right"><font style="font-size: 10pt">-</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">A summary of non-vested non-qualified
stock options activity for employees and consultants under the 2017 Equity Plan for the three months ended March 31, 2021, are presented
in the table below:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Number of Options</b></font></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Weighted Average Grant-Date Fair Value</b></font></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Aggregate Intrinsic Value</b></font></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Grant-Date Fair Value</b></font></td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Nonvested, December 31, 2020</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><font style="font-size: 10pt">$</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><font style="font-size: 10pt">$</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><font style="font-size: 10pt">$</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="width: 44%; padding-left: 10pt"><font style="font-size: 10pt">Granted</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 11%; text-align: right"><font style="font-size: 10pt">1,035,800</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 11%; text-align: right"><font style="font-size: 10pt">0.124</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 11%; text-align: right"><font style="font-size: 10pt">-</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 11%; text-align: right"><font style="font-size: 10pt">128,543</font></td>
    <td style="width: 1%">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 10pt"><font style="font-size: 10pt">Vested</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">(1,035,800</font></td>
    <td><font style="font-size: 10pt">)</font></td>
    <td>&#160;</td>
    <td><font style="font-size: 10pt">$</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">0.124</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><font style="font-size: 10pt">$</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><font style="font-size: 10pt">$</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">128,543</font></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 10pt"><font style="font-size: 10pt">Forfeited</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><font style="font-size: 10pt">$</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-bottom: 1.5pt; padding-left: 10pt"><font style="font-size: 10pt">Expired</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">-</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: right">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: right">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">-</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">Nonvested, March 31, 2021</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double">&#160;</td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">-</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">$</font></td>
    <td style="padding-bottom: 2.5pt; text-align: right"><font style="font-size: 10pt">-</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">$</font></td>
    <td style="padding-bottom: 2.5pt; text-align: right"><font style="font-size: 10pt">-</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">-</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">For the three months ended March
31, 2021 and March 31, 2020, the Company recorded $0 and $106,288 as compensation expense related to vested options issued to employees
and consultants, net of forfeitures, respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">A summary of the non-qualified
stock options granted to directors under the 2017 Equity Plan during the three months ended March 31, 2021, are presented in the table
below:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Number of Options</b></font></td>
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Weighted Average Exercise Price</b></font></td>
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Weighted Average Remaining Contractual Term</b></font></td>
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Aggregate Intrinsic Value ($000)</b></font></td>
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 44%"><font style="font-size: 10pt">Outstanding, December 31, 2020</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 11%; text-align: right"><font style="font-size: 10pt">7,400,000</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 11%; text-align: right"><font style="font-size: 10pt">0.067</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 11%; text-align: right"><font style="font-size: 10pt">7.5</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 11%; text-align: right"><font style="font-size: 10pt">2,780</font></td>
    <td style="width: 1%">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 10pt"><font style="font-size: 10pt">Granted</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 10pt"><font style="font-size: 10pt">Exercised</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 10pt"><font style="font-size: 10pt">Forfeited/Cancelled</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-bottom: 1.5pt; padding-left: 10pt"><font style="font-size: 10pt">Expired</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">-</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: right">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: right">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: right">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">Outstanding, March 31, 2021</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double">&#160;</td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">7,400,000</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">$</font></td>
    <td style="padding-bottom: 2.5pt; text-align: right"><font style="font-size: 10pt">0.067</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: right"><font style="font-size: 10pt">7.2</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">$</font></td>
    <td style="padding-bottom: 2.5pt; text-align: right"><font style="font-size: 10pt">2,780</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">Exerciseable, March 31, 2021</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double">&#160;</td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">6,400,000</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">$</font></td>
    <td style="padding-bottom: 2.5pt; text-align: right"><font style="font-size: 10pt">0.073</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: right"><font style="font-size: 10pt">7.7</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">$</font></td>
    <td style="padding-bottom: 2.5pt; text-align: right"><font style="font-size: 10pt">-</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">A summary of non-vested non-qualified
stock options activity for directors under the 2017 Equity Plan for the three months ended March 31, 2021, are presented in the table
below:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Number of Options</b></font></td>
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Weighted Average Grant-Date Fair Value</b></font></td>
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Aggregate Intrinsic Value</b></font></td>
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Grant-Date Fair Value</b></font></td>
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 44%"><font style="font-size: 10pt">Nonvested, December 31, 2020</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 11%; text-align: right"><font style="font-size: 10pt">1,000,000</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 11%; text-align: right"><font style="font-size: 10pt">0.029</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 11%; text-align: right"><font style="font-size: 10pt">29,000</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 11%; text-align: right"><font style="font-size: 10pt">38,200</font></td>
    <td style="width: 1%">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 10pt"><font style="font-size: 10pt">Granted</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 10pt"><font style="font-size: 10pt">Vested</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 10pt"><font style="font-size: 10pt">Forfeited</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-bottom: 1.5pt; padding-left: 10pt"><font style="font-size: 10pt">Expired</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">-</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: right">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">Nonvested, March 31, 2021</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double">&#160;</td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">1,000,000</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: right"><font style="font-size: 10pt">0.029</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">29,000</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">38,200</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">During the three months ended
March 31, 2021 and 2020, the Company incurred $6,342 and $29,266, respectively, as compensation expense related to 500,000 and 500,000
vested options, respectively, issued to directors.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Effective June 24, 2020<i>, </i>the
Company issued 2 million non-qualified stock options under the 2017 Equity Plan to newly appointed directors. The options vested 50% upon
grant and 50% on April 1, 2021, if the Director remained on the Board up to that time. The options have a term of 5 years and have an
exercise price equal to the closing price of the Company&#8217;s common stock on The OTC Markets on the day immediately preceding the
grant date.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">As further discussed in <i>Note
11 Subsequent Events</i> below, 1,000,000 stock options issued to directors effective June 24, 2020 vested on April 1, 2021.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Restricted Stock Units</u></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 40.5pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">A summary of the RSUs awarded
to employees, directors and consultants under the 2017 Equity Plan during the three months ended March 31, 2021, are presented in the
table below:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Number of Units</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Weighted Average Grant-Date</b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Fair Value</b></p></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Aggregate Intrinsic</b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Value</b></p></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 61%"><font style="font-size: 10pt">Outstanding, December 31, 2020</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 10%; text-align: right"><font style="font-size: 10pt">&#160;&#160;&#160;&#160;-</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 10%; text-align: right">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 10%; text-align: right"><font style="font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-</font></td>
    <td style="width: 1%">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 10pt"><font style="font-size: 10pt">Granted</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 10pt"><font style="font-size: 10pt">Vested and settled with share issuance</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="padding-bottom: 1.5pt; padding-left: 10pt"><font style="font-size: 10pt">Forfeited/canceled</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">-</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: right">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">Outstanding, March 31, 2021</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double">&#160;</td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">-</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: right">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">$</font></td>
    <td style="padding-bottom: 2.5pt; text-align: right"><font style="font-size: 10pt">-</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">For the three months ended March
31, 2021 and 2020, the Company recorded $0 and $18,872, respectively, as compensation expense related to vested RSUs issued to employees,
directors and consultants.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Effective April 30, 2020, 800,000
RSUs vested. However, the holder elected to cancel the RSUs.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI http://asc.fasb.org/topic&amp;trid=2228938<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139855784978648">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Warrants<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_WarrantsAbstract', window );"><strong>Warrants</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_WarrantsDisclosureTextBlock', window );">Warrants</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><b>Note 9 &#8211; Warrants</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The following table summarizes
information with respect to outstanding warrants to purchase common stock during the three months ended March 31, 2021:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td colspan="2">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font-size: 10pt"><b>Weighted</b></font></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font-size: 10pt"><b>Weighted</b></font></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font-size: 10pt"><b>Average</b></font></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td colspan="2">&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font-size: 10pt"><b>Number</b></font></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td colspan="2">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Average</b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Exercise</b></p></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font-size: 10pt"><b>Remaining Life</b></font></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td colspan="2">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Aggregate</b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Intrincic</b></p></td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Outstanding</b></font></td>
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Price</b></font></td>
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>In Months</b></font></td>
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Value</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 44%"><font style="font-size: 10pt">Outstanding at December 31, 2020</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 11%; text-align: right"><font style="font-size: 10pt">7,562,500</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 11%; text-align: right"><font style="font-size: 10pt">0.25</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 11%; text-align: right"><font style="font-size: 10pt">&#160;&#160;&#160;&#160;6</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 11%; text-align: right"><font style="font-size: 10pt">&#160;&#160;&#160;&#160;&#160;0</font></td>
    <td style="width: 1%">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Issued</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Exercised</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Expired</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">0</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">0.00</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">-</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">0</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">Outstanding at March 31, 2021</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double">&#160;</td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">7,562,500</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">0.25</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double">&#160;</td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">6</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">0</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The following table summarizes information about warrants
outstanding at March 31, 2021:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font-size: 10pt">Weighted Average <br />
Life of</font></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font-size: 10pt">Warrants</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font-size: 10pt">Outstanding Warrants</font></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1.5pt solid"><font style="font-size: 10pt">Exercise price</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">Outstanding</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">In Months</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="width: 38%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 28%; text-align: right">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 28%; text-align: right">&#160;</td>
    <td style="width: 1%">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-align: right"><font style="font-size: 10pt">0.25</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">7,562,500</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;3</font></td>
    <td>&#160;</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_WarrantsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_WarrantsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_WarrantsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Warrants [Text block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_WarrantsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139855693897256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Note 10 &#8211; Income Taxes </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">As of March 31, 2021, the Company
has U.S. federal and state net operating losses (&#8220;NOLs&#8221;) of approximately $20,115,000, of which $11,196,261 will expire, if
not utilized, in the years 2034 through 2037, however, NOLs generated subsequent to December 31, 2017 do not expire but may only be used
against taxable income to 80%. In response to the novel coronavirus COVID-19, the Coronavirus Aid, Relief, and Economic Security Act temporarily
repealed the 80% limitation for NOLs arising in 2018, 2019 and 2020. Pursuant to Section 382 of the Internal Revenue Code of 1986, as
amended, use of the Company&#8217;s NOLs carryforwards may be limited in the event of cumulative changes in ownership of more than 50%
within a three-year period.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Company must assess the likelihood
that its net deferred tax assets will be recovered from future taxable income, and to the extent the Company believes that recovery is
not likely, the Company establishes a valuation allowance. Management&#8217;s judgment is required in determining the Company&#8217;s
provision for income taxes, deferred tax assets and liabilities, and any valuation allowance recorded against the net deferred tax assets.
The Company recorded a full valuation allowance as of March 31, 2021 and December 31, 2020. Based on the available evidence, the Company
believes it is more likely than not that it will not be able to utilize its net deferred tax assets in the foreseeable future. The Company
intends to maintain valuation allowances until sufficient evidence exists to support the reversal of such valuation allowances. The Company
makes estimates and judgments about its future taxable income that are based on assumptions that are consistent with the Company&#8217;s
plans. Should the actual amounts differ from the Company&#8217;s estimates, the carrying value of the Company&#8217;s deferred tax assets
could be materially impacted.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI http://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139855694137096">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Events<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">Subsequent Events</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Note 11 &#8211; Subsequent Events </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">In accordance with ASC 855, <i>Subsequent
Events</i>, the Company has evaluated all subsequent events through the date the financial statements were available to be issued. No
material subsequent events occurred after March 31, 2021, other than as set out below:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">As further discussed in <i>Note
8 Equity Incentive Plan </i>below, 1,000,000 stock options issued to directors effective June 24, 2020 vested on April 1, 2021.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">As further discussed in <i>Note
7 Commitments and Contingencies</i> above, on April 8, 2021, the Company issued 1,000,000 shares of its common stock in settlement of
litigation brought by a former employee.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">On April 30, 2021, the Company
entered into an agreement to sublease approximately 6,900 square feet of its office and manufacturing space. The sublease commenced on
April 30, 2021 and will continue on a month-to-month basis until either party gives 30-days&#8217; notice. Rent will initially be charged
at $5,989 per month, increasing to $11,978 per month effective July 1, 2021. The Sublessor will also be responsible for its prorated
share of utilities and other related costs.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -URI http://asc.fasb.org/topic&amp;trid=2122774<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6842918&amp;loc=SL6314017-165662<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139855691513928">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>General (Policies)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_DescriptionOfBusinessPolicyTextBlock', window );">Description of Business</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><b><i>Description of Business</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Surna Inc. (the &#8220;Company&#8221;)
was incorporated in Nevada on October 15, 2009 and operates under a trade name of Surna Cultivation Technologies. We design, engineer
and sell environmental control and other technologies for the Controlled Environment Agriculture (CEA) industry. The CEA industry is one
of the fastest-growing sectors of the United States&#8217; economy. From leafy greens (kale, Swiss chard, mustard, cress), microgreens
(leafy greens harvested at the first true leaf stage), ethnic vegetables and small fruits (such as strawberries, blackberries and raspberries)
to bell peppers, cucumbers, tomatoes, and cannabis, some producers grow crops indoors in response to market dynamics or as part of their
preferred farming practice. In service of the CEA industry, our principal technologies include: (i) liquid-based process cooling systems
and other climate control systems, (ii) air handling equipment and systems, (iii) a full-service engineering package for designing and
engineering commercial scale thermodynamic systems specific to cultivation facilities, and (iv) automation and control devices, systems
and technologies used for environmental, lighting and climate control. Our customers include commercial, state- and provincial-regulated
CEA growers in the U.S. and Canada as well as other international locations. Customers are those growers building new facilities and those
expanding or retrofitting existing facilities. Currently, our revenue stream is derived primarily from supplying our products, services
and technologies to commercial indoor facilities ranging from several thousand to more than 100,000 square feet. Headquartered in Boulder,
Colorado, we leverage our experience in this space to bring value-added climate control solutions to our customers that help improve their
overall crop quality and yield, optimize energy and water efficiency, and satisfy the evolving state and local codes, permitting and regulatory
requirements. Although our customers do, we neither produce nor sell cannabis or its related products.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_ImpactOfCovid19PandemicOnOurBusinessPolicyTextBlock', window );">Impact of the COVID-19 Pandemic on Our Business</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><b><i>Impact of the COVID-19 Pandemic
on Our Business</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white">The impact
of the government and the business economic response to the COVID-19 pandemic has affected demand across the majority of our markets and
disrupted work on projects. The COVID-19 pandemic is expected to have continued adverse effects on our sales, project implementation,
operating margins, and working capital. As of the date of this filing, uncertainty continues to exist concerning the magnitude and duration
of the economic impact of the COVID-19 pandemic.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white">In response
to the COVID-19 pandemic and the government and business response, during 2020, the Company took measures to adjust its operations. These
actions included initial measures to cut costs and preserve cash, and encompassed downsizing workforce, compensation reductions, and reduced
hours worked that were later changed upwards and in some cases fully restored late in 2020, as the Company gained new contracts, bank
funding was available and the overall business climate improved. The Company continues to actively monitor its operations and sales efforts
in light of the continuing effects of the COVID-19 pandemic and will make adjustments to its operations as necessary.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white">Due to
the speed with which the COVID-19 pandemic developed and the resulting uncertainties, including the depth and duration of the disruptions
to customers and suppliers, its future effect on our business, on our results of operations, and on our financial condition, we cannot
predict the overall effect on our business over the longer term. Addressing this uncertainty, we have undertaken various plans to reduce
costs so as to mitigate the impact of the COVID-19 pandemic to the best of our ability, although they may not be sufficient in the long-run
for us to avoid reduced sales, increased losses and reduced operating cash flows.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white">Refer
to <i>Risk Factors</i>, included in Part II, Item 1A of this Quarterly Report on Form 10-Q below, for further discussion of the possible
impact of the COVID-19 pandemic on our business.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Financial Statement Presentation</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><b><i>Financial Statement Presentation</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The accompanying unaudited condensed
consolidated financial statements of the Company have been prepared in conformity with accounting principles generally accepted in the
United States of America (&#8220;GAAP&#8221;) for interim financial information and with the instructions to Form 10-Q and Rule 10-01
of Regulation S-X. Pursuant to these rules and regulations, certain information and note disclosures, normally included in financial
statements prepared in accordance with GAAP, have been condensed or omitted. In the opinion of management, all adjustments (consisting
of normal recurring items) considered necessary for a fair presentation have been included. Operating results for the three months ended
March 31, 2021 are not necessarily indicative of the results that may be expected for the fiscal year ending December 31, 2021. The balance
sheet as of December 31, 2020 has been derived from the audited financial statements at that date but does not include all the information
and footnotes required by GAAP for complete financial statements. For further information, refer to the consolidated financial statements
and notes thereto contained in the Annual Report on Form 10-K for the year ended December 31, 2020. The notes to the unaudited condensed
consolidated financial statements are presented on a going concern basis.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Basis of Consolidation and Reclassifications</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><b><i>Basis of Consolidation and
Reclassifications</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The condensed consolidated financial
statements include the accounts of the Company and its controlled and wholly owned subsidiary, Hydro Innovations, LLC (&#8220;Hydro&#8221;).
Intercompany transactions, profit, and balances are eliminated in consolidation.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_GoingConcernPolicyTextBlock', window );">Going Concern</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><b><i>Going Concern</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white">The
accompanying condensed consolidated financial statements have been prepared assuming that the Company will continue as a going concern,
which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. The Company has experienced
recurring losses since its inception. Since inception, the Company has financed its activities principally through debt and equity financing,
customer deposits and revenues from completed contracts. Management expects to incur additional losses and cash outflows in the foreseeable
future in connection with its operating activities. Management believes that the economic dislocations in the overall economy, in the
near term, will impact our revenues, losses and cash flows. There can be no assurance that the Company will be able to raise debt or
equity financing in sufficient amounts, when and if needed, on acceptable terms or at all. If results of operations for 2021 do not meet
management&#8217;s expectations, or additional capital is not available, management believes it has the ability to reduce certain expenditures.
The precise amount and timing of the funding needs cannot be determined accurately at this time, and will depend on a number of factors,
including the overall economy, market demand for the Company&#8217;s products and services, the quality of product development efforts,
management of working capital, and continuation of normal payment terms and conditions for purchase of the Company&#8217;s products.
The Company believes its cash balances and cash flow from operations will be insufficient to fund its operations for the next 12 months.
If the Company is unable to substantially increase revenues, reduce expenditures, or otherwise generate cash flows from operations, then
the Company will need to raise additional funding to continue as a going concern. The foregoing factors raise substantial doubt about
the Company&#8217;s ability to continue as a going concern for a period of one year from the date the financial statements are issued.
These condensed consolidated financial statements do not include any adjustment that might result from the outcome of this uncertainty.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><b><i>Use of Estimates</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Management makes estimates and
assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the
date of the financial statements and that affect the reported amounts of revenue and expenses during the reporting period. The Company
bases its estimates on historical experience and on various other assumptions that it believes to be reasonable under the circumstances,
the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent
from other sources. Actual results could differ from those estimates. Key estimates include: allocation of transaction prices to performance
obligations under contracts with customers, standalone selling prices, timing of expected revenue recognition on remaining performance
obligations under contracts with customers, valuation of intangible assets, valuation of equity-based compensation, valuation of deferred
tax assets and liabilities, warranty accruals, accounts receivable and inventory allowances, and legal contingencies.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy', window );">Cash, Cash Equivalents and Restricted Cash</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><b><i>Cash, Cash Equivalents and
Restricted Cash</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">All highly liquid investments
with original maturities of three months or less at the date of purchase are considered to be cash equivalents. The Company may, from
time to time, have deposits in financial institutions that exceed the federally insured amount. The Company has not experienced any losses
to date on depository accounts.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">During the three months ended
March 31, 2021, the Company transferred a balance of $180,000 into a new bank account which was to be used for the sole purpose of paying
certain warranty claims. The balance on this restricted bank account as of March 31, 2021 was $86,697.&#160;</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Income (Loss) Per Common Share</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><b><i>Income (Loss) Per Common
Share</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Basic income (loss) per common
share is computed by dividing net income (loss) attributable to common stockholders by the weighted-average number of common shares outstanding
during the period without consideration of common stock equivalents. Diluted net income (loss) per common share is computed by dividing
net income (loss) by the weighted-average number of common shares outstanding and potentially dilutive common stock equivalents, including
stock options, warrants and restricted stock units and other equity-based awards, except in cases where the effect of the common stock
equivalents would be antidilutive. Potential common stock equivalents consist of common stock issuable upon exercise of stock options
and warrants and the vesting of restricted stock units using the treasury method.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white">During
the three months ended March 31, 2021 and 2020, there were warrants and options outstanding to purchase Company common stock and restricted
stock units that were convertible into shares of the Company&#8217;s common stock. During the three-month periods ended March 31, 2021
and 2020, the Company incurred a net loss and consequently the common share equivalents of these potentially dilutive equity instruments
have not been included in the calculations of loss per share because such inclusion would have been anti-dilutive. As of March 31, 2021,
and 2020, there were respectively, 30,249,300 and 45,748,400, potentially dilutive equity instruments outstanding in respect of warrants
and options outstanding to purchase Company common stock and restricted stock units that were convertible into shares of the Company&#8217;s
common stock.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock', window );">Goodwill</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><b><i>Goodwill</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 30.25pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Company recorded goodwill
in connection with its acquisition of Hydro Innovations, LLC in July 2014. Goodwill is reviewed for impairment annually or more frequently
when events or changes in circumstances indicate that fair value of the reporting unit has been reduced to less than its carrying value.
The Company performs a quantitative impairment test annually on December 31 by comparing the fair value of the reporting unit with its
carrying amount, including goodwill. If the fair value of the reporting unit exceeds its carrying amount, goodwill is considered not impaired.
An impairment charge would be recognized for the amount by which the carrying amount exceeds the reporting unit&#8217;s fair value. The
Company determined that it has one reporting unit.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">During the three months ended
March 31, 2021, the Company concluded that the projected impact of the COVID-19 pandemic on its sales, contract completion and revenues
in the near term, together with the volatility in its share price during the quarter represented potential indicators of impairment.
Accordingly, the Company performed an interim impairment analysis at March 31, 2021, and concluded that no impairment relating to goodwill
existed at March 31, 2021.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock', window );">Revenue Recognition</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><b><i>Revenue Recognition</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">On January 1, 2018, the Company
adopted Accounting Standards Update (&#8220;ASU&#8221;) 2014-09 (Topic 606), <i>Revenue from Contracts with Customers</i> and all the
related amendments (&#8220;ASC 606&#8221; or the &#8220;revenue standard&#8221;) to all contracts and elected the modified retrospective
method.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Under the revenue standard, a
performance obligation is a promise in a contract with a customer to transfer a distinct good or service to the customer. Most of the
Company&#8217;s contracts contain multiple performance obligations that include engineering and technical services as well as the delivery
of a diverse range of climate control system equipment and components, which can span multiple phases of a customer&#8217;s project life-cycle
from facility design and construction to equipment delivery and system installation and start-up.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">A contract&#8217;s transaction
price is allocated to each distinct performance obligation and recognized as revenue when, or as, the performance obligation is satisfied.
When there are multiple performance obligations within a contract, the Company allocates the transaction price to each performance obligation
based on standalone selling price. When estimating the selling price, the Company uses various observable inputs. The best observable
input is the Company&#8217;s actual selling price for the same good or service, however, this input is generally not available for the
Company&#8217;s contracts containing multiple performance obligations. For engineering services, the Company estimates the standalone
selling price by reference to certain physical characteristics of the project, such as facility size and mechanical systems involved,
which are indicative of the scope and complexity of the mechanical engineering services to be provided. For equipment sales, the standalone
selling price is determined by forecasting the expected costs of the equipment and then adding an appropriate margin, based on a range
of acceptable margins established by management. Depending on the nature of the performance obligations, the Company may use a combination
of different methods and observable inputs if certain performance obligations have highly variable or uncertain standalone selling prices.
Once the selling prices are determined, the Company applies the relative values to the total contract consideration and estimates the
amount of the transaction price to be recognized as each performance obligation is fulfilled.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Company recognizes revenue
for the sale of goods when control transfers to the customer, which primarily occurs at the time of shipment. The Company&#8217;s historical
rates of return are insignificant as a percentage of sales and, as a result, the Company does not record a reserve for returns at the
time the Company recognizes revenue. The Company has elected to exclude from the measurement of the transaction price all taxes (e.g.,
sales, use, value added, and certain excise taxes) that are assessed by a governmental authority in connection with a specific revenue-producing
transaction and collected by the Company from the customer. Accordingly, the Company recognizes revenue net of sales taxes. The revenue
and cost for freight and shipping is recorded when control over the sale of goods passes to the Company&#8217;s customers.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Company also has performance
obligations to perform certain engineering services that are satisfied over a period of time. Revenue is recognized from this type of
performance obligation as services are rendered based on the percentage completion towards certain specified milestones.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Company offers assurance-type
warranties for its products and products manufactured by others to meet specifications defined by the contracts with customers and does
not have any material separate performance obligations related to these warranties. The Company maintains a warranty reserve based on
historical warranty costs.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Applying the practical expedient
in ASC 606-10-32-18, which the Company has elected, the Company does not adjust the promised amount of consideration for the effects of
a significant financing component since the Company expects, at contract inception, that the period between when the Company transfers
a promised good or service to a customer and when the customer pays for that good or service will be one year or less. Accordingly, the
remaining performance obligations related to customer contracts does not consider the effects of the time value of money.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Applying the practical expedient
in ASC 340-40-25-4, the Company recognizes the incremental costs of obtaining contracts as an expense when incurred since the amortization
period of the assets that the Company otherwise would have recognized is one year or less. These costs include certain sales commissions
and incentives, which are included in selling, general and administrative expenses, and are payable only when associated revenue has been
collected and earned by the Company.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Company does not have material
amounts of contract assets since revenue is recognized as control of goods is transferred or as services are performed. Contract liabilities
consist of advance payments and deferred revenue.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">For the three months ended March
31, 2021, the Company recognized revenue of $1,880,364 related to the deferred revenue at January 1, 2021. For the three months ended
March 31, 2020, the Company recognized revenue of $859,705 related to the deferred revenue at January 1, 2020.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Remaining performance obligations,
or backlog, represents the aggregate amount of the transaction price allocated to the remaining obligations that the Company has not performed
under its customer contracts. The Company has elected not to use the optional exemption in ASC 606-10-50-14, which exempts an entity from
such disclosures if a performance obligation is part of a contract with an original expected duration of one year or less. Accordingly,
the information disclosed about remaining performance obligations includes all customer contracts, including those with an expected duration
of one year or less.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Industry uncertainty, project
financing concerns, and the licensing and qualification of our prospective customers, which are out of the Company&#8217;s control, make
it difficult for the Company to predict when it will recognize revenue on its remaining performance obligations. There are risks that
the Company may not realize the full contract value on customer projects in a timely manner or at all, and completion of a customer&#8217;s
cultivation facility project is dependent upon the customer&#8217;s ability to secure funding and real estate, obtain a license and then
build their cultivation facility so they can take possession of the equipment. Accordingly, the time it takes for customers to complete
a project, which corresponds to when the Company is able to recognize revenue, is driven by numerous factors including: (i) the large
number of first-time participants interested in the indoor cannabis cultivation business; (ii) the complexities and uncertainties involved
in obtaining state and local licensure and permitting; (iii) local and state government delays in approving licenses and permits due to
lack of staff or the large number of pending applications, especially in states where there is no cap on the number of cultivators; (iv)
the customer&#8217;s need to obtain cultivation facility financing; (v) the time needed, and coordination required, for our customers
to acquire real estate and properly design and build the facility (to the stage when climate control systems can be installed); (vi) the
large price tag and technical complexities of the climate control and air sanitation system; (vii) the availability of power; and (viii)
delays that are typical in completing any construction project.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">As of March 31, 2021, the Company&#8217;s
remaining performance obligations, or backlog, was $11,578,000, of which $2,006,000, or 17%, was attributable to customer contracts for
which the Company has only received an initial advance payment to cover the allocated value of the Company&#8217;s engineering services
(&#8220;engineering only paid contracts&#8221;). There is the risk that the equipment portion of these engineering only paid contracts
will not be completed or will be delayed. These reasons include the customer being dissatisfied with the quality or timeliness of the
Company&#8217;s engineering services, delay or abandonment of the project because of the customer&#8217;s inability to obtain project
financing or licensing, or other reasons such as a challenging business climate including an overall post-Covid-19 economic downturn,
or change in business direction. After the customer has made an advance payment for a portion of the equipment to be delivered under the
contract (&#8220;partial equipment paid contracts&#8221;), the Company is typically better able to estimate the timing of revenue recognition
since the risks and delays associated with licensing, permitting and project funding are typically mitigated once the initial equipment
payment is received. There is significant uncertainty regarding the timing of the Company&#8217;s recognition of revenue on its remaining
performance obligations, and there is no certainty that these will result in actual revenues. The backlog at March 31, 2021, includes
booked sales orders of $449,000 from several customers that the Company does not expect to be realized until 2022, if at all. Given the
present economic uncertainty arising from the impact of the novel coronavirus COVID-19, the Company believes that several of its current
contracts may be delayed or cancelled in the short term.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The remaining performance obligations
expected to be recognized through 2022 are as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2021</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2022</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Total</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 55%"><font style="font-size: 10pt">Remaining performance obligations related to engineering only paid contracts</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 12%; text-align: right"><font style="font-size: 10pt">1,563,000</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 12%; text-align: right"><font style="font-size: 10pt">443,000</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 12%; text-align: right"><font style="font-size: 10pt">2,006,000</font></td>
    <td style="width: 1%">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Remaining performance obligations related to partial equipment paid contracts</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">9,566,000</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">6,000</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">9,572,000</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">Total remaining performance obligations</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">11,129,000</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">449,000</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">11,578,000</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The following table sets forth
the Company&#8217;s revenue by source:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>For the Three Months <br />
Ended March 31,</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2021</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2020</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 54%"><font style="font-size: 10pt">Equipment and systems sales</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 20%; text-align: right"><font style="font-size: 10pt">2,163,468</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 20%; text-align: right"><font style="font-size: 10pt">1,606,946</font></td>
    <td style="width: 1%">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Engineering and other services</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">181,083</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">131,591</font></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Shipping and handling</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">21,978</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">71,388</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">Total revenue</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">2,366,529</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">1,809,925</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy', window );">Accounting for Share-Based Compensation</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><b><i>Accounting for Share-Based
Compensation</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 30.25pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Company recognizes the cost
resulting from all share-based compensation arrangements, including stock options, restricted stock awards and restricted stock units
that the Company grants under its equity incentive plan in its condensed consolidated financial statements based on their grant date fair
value. The expense is recognized over the requisite service period or performance period of the award. Awards with a graded vesting period
based on service are expensed on a straight-line basis for the entire award. Awards with performance-based vesting conditions, which require
the achievement of a specific company financial performance goal at the end of the performance period and required service period, are
recognized over the performance period. Each reporting period, the Company reassesses the probability of achieving the respective performance
goal. If the goals are not expected to be met, no compensation cost is recognized and any previously recognized amount recorded is reversed.
If the award contains market-based vesting conditions, the compensation cost is based on the grant date fair value and expected achievement
of market condition and is not subsequently reversed if it is later determined that the condition is not likely to be met or is expected
to be lower than initially expected.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white">The grant
date fair value of stock options is based on the Black-Scholes Option Pricing Model (the &#8220;Black-Scholes Model&#8221;). The Black-Scholes
Model requires judgmental assumptions including volatility and expected term, both based on historical experience. The risk-free interest
rate is based on U.S. Treasury interest rates whose term is consistent with the expected term of the option. The Company determines the
assumptions used in the valuation of option awards as of the date of grant. Differences in the expected stock price volatility, expected
term or risk-free interest rate may necessitate distinct valuation assumptions at those grant dates. As such, the Company may use different
assumptions for options granted throughout the year. During the three months ended March 31, 2021, the valuation assumptions used to determine
the fair value of each option award on the date of grant were: expected stock price volatility of 152.51%; expected term in years 10 and
risk-free interest rate of 1.2%.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The grant date fair value of restricted
stock and restricted stock units is based on the closing price of the underlying stock on the date of the grant.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Company has elected to reduce
share-based compensation expense for forfeitures as the forfeitures occur since the Company does not have historical data or other factors
to appropriately estimate the expected employee terminations and to evaluate whether particular groups of employees have significantly
different forfeiture expectations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.8pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">The following is a summary of share-based compensation
expenses included in the condensed consolidated statements of operations for the three months ended March 31, 2021 and 2020:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>For the Three Months <br />
Ended March 31,</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2021</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2020</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Share-based compensation expense included in:</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="width: 54%"><font style="font-size: 10pt">Cost of revenue</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 20%; text-align: right"><font style="font-size: 10pt">14,135</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 20%; text-align: right"><font style="font-size: 10pt">8,558</font></td>
    <td style="width: 1%">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Advertising and marketing expenses</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">6,474</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">2,912</font></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Product development costs</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">6,694</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">6,545</font></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Selling, general and administrative expenses</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">31,833</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">172,874</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">Total share-based compensation expense included in consolidated statement of operations</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">59,136</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">190,889</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Included in the $59,136 expense
for the three months ended March 31, 2021, is an accrual for $52,794 in respect of the 2021 Annual Employee Incentive Compensation Plan.
Included in the $190,889 expense for the three months ended March 31, 2020, is an accrual for $36,463 in respect of the 2020 Annual Employee
Incentive Compensation Plan.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskCreditRisk', window );">Concentrations</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><b><i>Concentrations</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Three customers accounted for
38%, 16%, and 11% of the Company&#8217;s revenue for the three months March 31, 2021. For the three months ended March 31, 2020, four
customers accounted for 17%, 16%, 10% and 10% of the Company&#8217;s revenue.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Two customers accounted for 60%,
and 31% of the Company&#8217;s accounts receivable for the three months ended March 31, 2021. For the three months ended March 31, 2020,
three customers accounted for 59%, 18%, and 15% of the Company&#8217;s accounts receivable.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recently Issued Accounting Pronouncements</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><b><i>Recently Issued Accounting
Pronouncements</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">In August 2020, the FASB issued
ASU No. 2020-06, <i>Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging&#8212;Contracts in Entity&#8217;s
Own Equity (Subtopic 815-40)</i> which simplifies the accounting for convertible instruments. The guidance removes certain accounting
models which separate the embedded conversion features from the host contract for convertible instruments. Either a modified retrospective
method of transition or a fully retrospective method of transition is permissible for the adoption of this standard. Update No. 2020-06
is effective for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. Early adoption is
permitted no earlier than the fiscal year beginning after December 15, 2020. The Company does not expect this ASU to have a material impact
on its consolidated results of operations, cash flows and financial position.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">In March 2020, the FAS issued
ASU No. 2020-04 &#8220;<i>Reference Reform (Topic 848) Facilitation of the Effects of Reference Rate Reform on Financial Reporting&#8221;
(&#8220;ASU 2020-04&#8221;).</i> ASU 2020-04 provides optional guidance for a limited period of time to ease the potential burden in accounting
for (or recognizing the effects of) reference rate reform on financial reporting. The amendments are effective for the Company as of March
12, 2020 through December 31, 2022. The Company does not expect this ASU to have a material impact on its consolidated results of operations,
cash flows and financial position.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">In January 2020, the FASB issued
ASU No. 2020-01, <i>Investments&#8212;Equity Securities (Topic 321), Investments&#8212;Equity Method and Joint Ventures (Topic 323), and
Derivatives and Hedging (Topic 815)&#8212;Clarifying the Interactions between Topic 321, Topic 323, and Topic 815</i> (a consensus of
the Emerging Issues Task Force). This update clarifies whether an entity should consider observable transactions that require it to either
apply or discontinue the equity method of accounting for the purposes of applying the measurement alternative and how to account for certain
forward contracts and purchased options to purchase securities. For public entities, this guidance is effective for fiscal years beginning
after December 15, 2020. The Company does not expect this ASU to have a material impact on its consolidated results of operations, cash
flows and financial position. The adoption of this ASU has not had a material impact on the Company&#8217;s consolidated results of operations,
cash flows and financial position.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">In December 2019, the FASB issued
ASU 2019-12, <i>Income Taxes (Topic 740) &#8211; Simplifying the Accounting for Income Taxes, </i>which simplifies the accounting for
income taxes by removing certain exceptions to the general principles in Topic 740. The amendments also improve consistent application
of and simplify GAAP for other areas of Topic 740 by clarifying and amending existing guidance. ASU 2019-12 is effective for fiscal years
beginning after December 15, 2020. Early adoption is permitted. The adoption of this ASU has not had a material impact on the Company&#8217;s
consolidated results of operations, cash flows and financial position.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Other accounting standards that
have been issued or proposed by FASB that do not require adoption until a future date are not expected to have a material impact on the
financial statements upon adoption. The Company does not discuss recent pronouncements that are not anticipated to have an impact on
or are unrelated to its financial condition, results of operations, cash flows or disclosures.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_DescriptionOfBusinessPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description of Business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_DescriptionOfBusinessPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_GoingConcernPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Going Concern.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_GoingConcernPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_ImpactOfCovid19PandemicOnOurBusinessPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Impact of the COVID-19 Pandemic on Our Business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_ImpactOfCovid19PandemicOnOurBusinessPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Entity's cash and cash equivalents accounting policy with respect to restricted balances.  Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4273-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskCreditRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for credit risk.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 825<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123345438&amp;loc=d3e61044-112788<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskCreditRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting.  The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18823-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=d3e5614-111684<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for goodwill and intangible assets. This accounting policy also may address how an entity assesses and measures impairment of goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue from contract with customer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130561-203045<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130566-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130563-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI http://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130566-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130563-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18823-107790<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130566-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130564-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130566-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b),(f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139855694104616">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>General (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock', window );">Schedule of Remaining Performance Obligations Expected to be Recognized</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The remaining performance obligations
expected to be recognized through 2022 are as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2021</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2022</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Total</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 55%"><font style="font-size: 10pt">Remaining performance obligations related to engineering only paid contracts</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 12%; text-align: right"><font style="font-size: 10pt">1,563,000</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 12%; text-align: right"><font style="font-size: 10pt">443,000</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 12%; text-align: right"><font style="font-size: 10pt">2,006,000</font></td>
    <td style="width: 1%">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Remaining performance obligations related to partial equipment paid contracts</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">9,566,000</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">6,000</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">9,572,000</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">Total remaining performance obligations</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">11,129,000</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">449,000</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">11,578,000</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueTableTextBlock', window );">Schedule of Revenue by Source</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The following table sets forth
the Company&#8217;s revenue by source:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>For the Three Months <br />
Ended March 31,</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2021</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2020</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 54%"><font style="font-size: 10pt">Equipment and systems sales</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 20%; text-align: right"><font style="font-size: 10pt">2,163,468</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 20%; text-align: right"><font style="font-size: 10pt">1,606,946</font></td>
    <td style="width: 1%">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Engineering and other services</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">181,083</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">131,591</font></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Shipping and handling</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">21,978</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">71,388</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">Total revenue</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">2,366,529</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">1,809,925</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock', window );">Schedule of Share-based Compensation Costs</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">The following is a summary of share-based compensation
expenses included in the condensed consolidated statements of operations for the three months ended March 31, 2021 and 2020:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>For the Three Months <br />
Ended March 31,</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2021</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2020</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Share-based compensation expense included in:</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="width: 54%"><font style="font-size: 10pt">Cost of revenue</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 20%; text-align: right"><font style="font-size: 10pt">14,135</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 20%; text-align: right"><font style="font-size: 10pt">8,558</font></td>
    <td style="width: 1%">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Advertising and marketing expenses</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">6,474</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">2,912</font></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Product development costs</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">6,694</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">6,545</font></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Selling, general and administrative expenses</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">31,833</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">172,874</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">Total share-based compensation expense included in consolidated statement of operations</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">59,136</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">190,889</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of expected timing for satisfying remaining performance obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130556-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of activity for award under share-based payment arrangement. Includes, but is not limited to, outstanding award at beginning and end of year, granted, exercised, forfeited, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139855776309848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseCostTableTextBlock', window );">Schedule of Lease Cost</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The lease cost, cash flows and
other information related to the Facility Lease were as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font-size: 10pt"><b>For the Three Months Ended March 31,</b></font></td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2021</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 77%"><font style="font-size: 10pt">Operating lease cost</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 20%; text-align: right"><font style="font-size: 10pt">54,222</font></td>
    <td style="width: 1%">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Operating cash outflow from operating lease</font></td>
    <td>&#160;</td>
    <td><font style="font-size: 10pt">$</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">69,844</font></td>
    <td>&#160;</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom; background-color: white">
    <td style="width: 77%; padding-bottom: 1.5pt; text-align: center">&#160;</td>
    <td style="width: 1%; padding-bottom: 1.5pt; text-align: center">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; width: 1%; text-align: center">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; width: 20%; text-align: center"><font style="font-size: 10pt"><b>As of March 31, 2021</b></font></td>
    <td style="width: 1%; padding-bottom: 1.5pt; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Operating lease right-of-use assset</font></td>
    <td>&#160;</td>
    <td><font style="font-size: 10pt">$</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">294,900</font></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Operating lease liability, current</font></td>
    <td>&#160;</td>
    <td><font style="font-size: 10pt">$</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">263,662</font></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Operating lease liability, long-term</font></td>
    <td>&#160;</td>
    <td><font style="font-size: 10pt">$</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">106,891</font></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Remaining lease term</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">1.4 years</font></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Discount rate</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">5.00</font></td>
    <td><font style="font-size: 10pt">%</font></td></tr>
  </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">Schedule of Future Annual Minimum Lease Payments</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Future annual minimum lease payments
on the Facility Lease as of March 31, 2021 were as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1.5pt solid"><font style="font-size: 10pt"><b>Years ended December 31,</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 77%"><font style="font-size: 10pt">2021 (excluding the three months ended March 31, 2021)</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 20%; text-align: right"><font style="font-size: 10pt">212,020</font></td>
    <td style="width: 1%">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">2022</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">170,891</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-align: justify"><font style="font-size: 10pt">Total minimum lease payments</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">382,911</font></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="padding-bottom: 1.5pt; text-align: justify"><font style="font-size: 10pt">Less imputed interest</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(12,358</font></td>
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-bottom: 2.5pt; text-align: justify"><font style="font-size: 10pt">Present value of minimum lease payments</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">370,553</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139855694091384">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Inventory (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock', window );">Schedule of Inventory</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Inventory consisted of the following:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="3" style="text-align: center"><font style="font-size: 10pt"><b>March 31,</b></font></td>
    <td>&#160;</td>
    <td colspan="3" style="text-align: center"><font style="font-size: 10pt"><b>December 31,</b></font></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2021</b></font></td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2020</b></font></td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 54%"><font style="font-size: 10pt">Finished goods</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 20%; text-align: right"><font style="font-size: 10pt">325,451</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 20%; text-align: right"><font style="font-size: 10pt">201,778</font></td>
    <td style="width: 1%">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Work in progress</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">10,083</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">4,231</font></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Raw materials</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">272,299</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">214,145</font></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Allowance for excess &#38; obsolete inventory</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(88,674</font></td>
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(93,045</font></td>
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">Inventory, net</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">519,159</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">327,109</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInventoryCurrentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139855694067864">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Schedule of Property and Equipment</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Property and equipment consisted
of the following:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font-size: 10pt"><b>March 31,</b></font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font-size: 10pt"><b>December 31,</b></font></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2021</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2020</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 54%; text-align: justify"><font style="font-size: 10pt">Furniture and equipment</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 20%; text-align: right"><font style="font-size: 10pt">410,748</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 20%; text-align: right"><font style="font-size: 10pt">398,422</font></td>
    <td style="width: 1%">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="text-align: justify"><font style="font-size: 10pt">Vehicles</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">15,000</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">15,000</font></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-bottom: 1.5pt; text-align: justify"><font style="font-size: 10pt">Leasehold improvements</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">215,193</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">215,193</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">640,941</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">628,615</font></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-bottom: 1.5pt; text-align: justify"><font style="font-size: 10pt">Accumulated depreciation</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(499,116</font></td>
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(480,883</font></td>
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="padding-bottom: 2.5pt; text-align: justify"><font style="font-size: 10pt">Property and equipment, net</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">141,825</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">147,732</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139855694091384">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accounts Payable and Accrued Liabilities (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock', window );">Schedule of Accounts Payable and Accrued Liabilities</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Accounts payable and accrued liabilities
consisted of the following:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font-size: 10pt"><b>March 31,</b></font></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font-size: 10pt"><b>December 31,</b></font></td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2021</b></font></td>
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2020</b></font></td>
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 54%"><font style="font-size: 10pt">Accounts payable</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 20%; text-align: right"><font style="font-size: 10pt">860,087</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 20%; text-align: right"><font style="font-size: 10pt">918,639</font></td>
    <td style="width: 1%">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Sales commissions payable</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">13,649</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">48,263</font></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Accrued payroll liabilities</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">275,024</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">288,071</font></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Product warranty accrual</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">264,956</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">173,365</font></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Other accrued expenses</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">376,599</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">356,623</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="padding-bottom: 2.5pt; padding-left: 10pt"><font style="font-size: 10pt">Total</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">1,790,315</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">1,784,961</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139855784180056">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity Incentive Plan (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock', window );">Schedule of Restricted Stock Units Activity</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Restricted Stock Units</u></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 40.5pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">A summary of the RSUs awarded
to employees, directors and consultants under the 2017 Equity Plan during the three months ended March 31, 2021, are presented in the
table below:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Number of Units</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Weighted Average Grant-Date</b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Fair Value</b></p></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Aggregate Intrinsic</b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Value</b></p></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 61%"><font style="font-size: 10pt">Outstanding, December 31, 2020</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 10%; text-align: right"><font style="font-size: 10pt">&#160;&#160;&#160;&#160;-</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 10%; text-align: right">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 10%; text-align: right"><font style="font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-</font></td>
    <td style="width: 1%">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 10pt"><font style="font-size: 10pt">Granted</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 10pt"><font style="font-size: 10pt">Vested and settled with share issuance</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="padding-bottom: 1.5pt; padding-left: 10pt"><font style="font-size: 10pt">Forfeited/canceled</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">-</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: right">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">Outstanding, March 31, 2021</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double">&#160;</td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">-</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: right">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">$</font></td>
    <td style="padding-bottom: 2.5pt; text-align: right"><font style="font-size: 10pt">-</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=SRNA_TwoThousandSeventeenEquityPlanMember', window );">2017 Equity Plan [Member] | Employees and Consultants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Schedule of Stock Option Activity</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white">A summary
of the non-qualified stock options granted to employees and consultants under the 2017 Equity Plan during the three months ended March
31, 2021, are presented in the table below:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Number of Options</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Weighted Average Exercise Price</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Weighted Average Remaining Contractual Term</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Aggregate Intrinsic Value</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 44%"><font style="font-size: 10pt">Outstanding, December 31, 2020</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 11%; text-align: right"><font style="font-size: 10pt">14,251,000</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 11%; text-align: right"><font style="font-size: 10pt">0.083</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 11%; text-align: right"><font style="font-size: 10pt">8.3</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 11%; text-align: right"><font style="font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;-</font></td>
    <td style="width: 1%">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 10pt"><font style="font-size: 10pt">Granted</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">1,035,800</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><font style="font-size: 10pt">$</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">0.130</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">10.0</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><font style="font-size: 10pt">$</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 10pt"><font style="font-size: 10pt">Exercised</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 10pt"><font style="font-size: 10pt">Forfeited</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-bottom: 1.5pt; padding-left: 10pt"><font style="font-size: 10pt">Expired</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">-</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: right">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: right">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: right">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">Outstanding, March 31, 2021</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double">&#160;</td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">15,286,800</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">$</font></td>
    <td style="padding-bottom: 2.5pt; text-align: right"><font style="font-size: 10pt">0.084</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: right"><font style="font-size: 10pt">8.2</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">$</font></td>
    <td style="padding-bottom: 2.5pt; text-align: right"><font style="font-size: 10pt">-</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">Exercisable, March 31, 2021</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double">&#160;</td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">15,286,800</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">$</font></td>
    <td style="padding-bottom: 2.5pt; text-align: right"><font style="font-size: 10pt">0.084</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: right"><font style="font-size: 10pt">8.2</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">$</font></td>
    <td style="padding-bottom: 2.5pt; text-align: right"><font style="font-size: 10pt">-</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock', window );">Summary of Non-vested Non-qualified Stock Option Activity</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">A summary of non-vested non-qualified
stock options activity for employees and consultants under the 2017 Equity Plan for the three months ended March 31, 2021, are presented
in the table below:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Number of Options</b></font></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Weighted Average Grant-Date Fair Value</b></font></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Aggregate Intrinsic Value</b></font></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Grant-Date Fair Value</b></font></td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Nonvested, December 31, 2020</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><font style="font-size: 10pt">$</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><font style="font-size: 10pt">$</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><font style="font-size: 10pt">$</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="width: 44%; padding-left: 10pt"><font style="font-size: 10pt">Granted</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 11%; text-align: right"><font style="font-size: 10pt">1,035,800</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 11%; text-align: right"><font style="font-size: 10pt">0.124</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 11%; text-align: right"><font style="font-size: 10pt">-</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 11%; text-align: right"><font style="font-size: 10pt">128,543</font></td>
    <td style="width: 1%">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 10pt"><font style="font-size: 10pt">Vested</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">(1,035,800</font></td>
    <td><font style="font-size: 10pt">)</font></td>
    <td>&#160;</td>
    <td><font style="font-size: 10pt">$</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">0.124</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><font style="font-size: 10pt">$</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><font style="font-size: 10pt">$</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">128,543</font></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 10pt"><font style="font-size: 10pt">Forfeited</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><font style="font-size: 10pt">$</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-bottom: 1.5pt; padding-left: 10pt"><font style="font-size: 10pt">Expired</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">-</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: right">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: right">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">-</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">Nonvested, March 31, 2021</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double">&#160;</td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">-</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">$</font></td>
    <td style="padding-bottom: 2.5pt; text-align: right"><font style="font-size: 10pt">-</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">$</font></td>
    <td style="padding-bottom: 2.5pt; text-align: right"><font style="font-size: 10pt">-</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">-</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=SRNA_TwoThousandSeventeenEquityPlanMember', window );">2017 Equity Plan [Member] | Directors [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Schedule of Stock Option Activity</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">A summary of the non-qualified
stock options granted to directors under the 2017 Equity Plan during the three months ended March 31, 2021, are presented in the table
below:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Number of Options</b></font></td>
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Weighted Average Exercise Price</b></font></td>
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Weighted Average Remaining Contractual Term</b></font></td>
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Aggregate Intrinsic Value ($000)</b></font></td>
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 44%"><font style="font-size: 10pt">Outstanding, December 31, 2020</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 11%; text-align: right"><font style="font-size: 10pt">7,400,000</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 11%; text-align: right"><font style="font-size: 10pt">0.067</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 11%; text-align: right"><font style="font-size: 10pt">7.5</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 11%; text-align: right"><font style="font-size: 10pt">2,780</font></td>
    <td style="width: 1%">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 10pt"><font style="font-size: 10pt">Granted</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 10pt"><font style="font-size: 10pt">Exercised</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 10pt"><font style="font-size: 10pt">Forfeited/Cancelled</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-bottom: 1.5pt; padding-left: 10pt"><font style="font-size: 10pt">Expired</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">-</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: right">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: right">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: right">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">Outstanding, March 31, 2021</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double">&#160;</td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">7,400,000</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">$</font></td>
    <td style="padding-bottom: 2.5pt; text-align: right"><font style="font-size: 10pt">0.067</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: right"><font style="font-size: 10pt">7.2</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">$</font></td>
    <td style="padding-bottom: 2.5pt; text-align: right"><font style="font-size: 10pt">2,780</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">Exerciseable, March 31, 2021</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double">&#160;</td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">6,400,000</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">$</font></td>
    <td style="padding-bottom: 2.5pt; text-align: right"><font style="font-size: 10pt">0.073</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: right"><font style="font-size: 10pt">7.7</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">$</font></td>
    <td style="padding-bottom: 2.5pt; text-align: right"><font style="font-size: 10pt">-</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock', window );">Summary of Non-vested Non-qualified Stock Option Activity</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">A summary of non-vested non-qualified
stock options activity for directors under the 2017 Equity Plan for the three months ended March 31, 2021, are presented in the table
below:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Number of Options</b></font></td>
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Weighted Average Grant-Date Fair Value</b></font></td>
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Aggregate Intrinsic Value</b></font></td>
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Grant-Date Fair Value</b></font></td>
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 44%"><font style="font-size: 10pt">Nonvested, December 31, 2020</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 11%; text-align: right"><font style="font-size: 10pt">1,000,000</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 11%; text-align: right"><font style="font-size: 10pt">0.029</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 11%; text-align: right"><font style="font-size: 10pt">29,000</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 11%; text-align: right"><font style="font-size: 10pt">38,200</font></td>
    <td style="width: 1%">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 10pt"><font style="font-size: 10pt">Granted</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 10pt"><font style="font-size: 10pt">Vested</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 10pt"><font style="font-size: 10pt">Forfeited</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-bottom: 1.5pt; padding-left: 10pt"><font style="font-size: 10pt">Expired</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">-</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: right">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">Nonvested, March 31, 2021</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double">&#160;</td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">1,000,000</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: right"><font style="font-size: 10pt">0.029</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">29,000</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">38,200</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the changes in outstanding nonvested shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=SRNA_TwoThousandSeventeenEquityPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=SRNA_TwoThousandSeventeenEquityPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=SRNA_EmployeesAndConsultantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=SRNA_EmployeesAndConsultantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=srt_DirectorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=srt_DirectorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139855777689928">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Warrants (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_WarrantsAbstract', window );"><strong>Warrants</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_ScheduleOfOutstandingWarrantsToPurchaseCommonStockTableTextBlock', window );">Schedule of Outstanding Warrants to Purchase Common Stock</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The following table summarizes
information with respect to outstanding warrants to purchase common stock during the three months ended March 31, 2021:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td colspan="2">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font-size: 10pt"><b>Weighted</b></font></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font-size: 10pt"><b>Weighted</b></font></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font-size: 10pt"><b>Average</b></font></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td colspan="2">&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font-size: 10pt"><b>Number</b></font></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td colspan="2">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Average</b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Exercise</b></p></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font-size: 10pt"><b>Remaining Life</b></font></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td colspan="2">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Aggregate</b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Intrincic</b></p></td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Outstanding</b></font></td>
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Price</b></font></td>
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>In Months</b></font></td>
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Value</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 44%"><font style="font-size: 10pt">Outstanding at December 31, 2020</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 11%; text-align: right"><font style="font-size: 10pt">7,562,500</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 11%; text-align: right"><font style="font-size: 10pt">0.25</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 11%; text-align: right"><font style="font-size: 10pt">&#160;&#160;&#160;&#160;6</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 11%; text-align: right"><font style="font-size: 10pt">&#160;&#160;&#160;&#160;&#160;0</font></td>
    <td style="width: 1%">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Issued</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Exercised</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Expired</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">0</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">0.00</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">-</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">0</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">Outstanding at March 31, 2021</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double">&#160;</td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">7,562,500</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">0.25</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double">&#160;</td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">6</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">0</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td></tr>
  </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock', window );">Schedule of Warrants Outstanding</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The following table summarizes information about warrants
outstanding at March 31, 2021:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font-size: 10pt">Weighted Average <br />
Life of</font></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font-size: 10pt">Warrants</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: center"><font style="font-size: 10pt">Outstanding Warrants</font></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1.5pt solid"><font style="font-size: 10pt">Exercise price</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">Outstanding</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">In Months</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="width: 38%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 28%; text-align: right">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 28%; text-align: right">&#160;</td>
    <td style="width: 1%">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-align: right"><font style="font-size: 10pt">0.25</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">7,562,500</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;3</font></td>
    <td>&#160;</td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_ScheduleOfOutstandingWarrantsToPurchaseCommonStockTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule of Outstanding Warrants to Purchase Common Stock [Table TextBlock]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_ScheduleOfOutstandingWarrantsToPurchaseCommonStockTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_WarrantsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_WarrantsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 50<br> -Section S99<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6784392&amp;loc=d3e188667-122775<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139855689459368">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>General (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_CashBalanceTransferredToBankAccount', window );">Cash balance transferred to bank account</a></td>
<td class="nump">$ 180,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCash', window );">Restricted cash</a></td>
<td class="nump">$ 86,697<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities', window );">Potentially dilutive equity instruments that are convertible into common stock</a></td>
<td class="nump">30,249,300<span></span>
</td>
<td class="nump">45,748,400<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Impairment of goodwill</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized', window );">Revenue recognized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 859,705<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Remaining performance obligations</a></td>
<td class="nump">$ 11,578,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationPercentage', window );">Remaining performance obligations, percentage</a></td>
<td class="nump">17.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected stock price volatility</a></td>
<td class="nump">152.51%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free interest rate</a></td>
<td class="nump">1.20%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share based compensation expense</a></td>
<td class="nump">$ 59,136<span></span>
</td>
<td class="nump">$ 190,889<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember', window );">Customer Concentration Risk [Member] | Sales Revenue, Net [Member] | Customer One [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk percentage</a></td>
<td class="nump">38.00%<span></span>
</td>
<td class="nump">17.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember', window );">Customer Concentration Risk [Member] | Sales Revenue, Net [Member] | Customer Two [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk percentage</a></td>
<td class="nump">16.00%<span></span>
</td>
<td class="nump">16.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember', window );">Customer Concentration Risk [Member] | Sales Revenue, Net [Member] | Customer Three [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk percentage</a></td>
<td class="nump">11.00%<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember', window );">Customer Concentration Risk [Member] | Sales Revenue, Net [Member] | Customer Four [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember', window );">Customer Concentration Risk [Member] | Accounts Receivable [Member] | Customer One [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk percentage</a></td>
<td class="nump">60.00%<span></span>
</td>
<td class="nump">59.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember', window );">Customer Concentration Risk [Member] | Accounts Receivable [Member] | Customer Two [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk percentage</a></td>
<td class="nump">31.00%<span></span>
</td>
<td class="nump">18.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember', window );">Customer Concentration Risk [Member] | Accounts Receivable [Member] | Customer Three [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=SRNA_TwoThousandTwentyOneAnnualEmployeeIncentiveCompensationPlanMember', window );">2021 Incentive Awards [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share based compensation expense</a></td>
<td class="nump">$ 52,794<span></span>
</td>
<td class="nump">$ 36,463<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardDateAxis=SRNA_TwoThousandAndTwentyTwoMember', window );">2022 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Remaining performance obligations</a></td>
<td class="nump">449,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerContractsMember', window );">Customer Contracts [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Remaining performance obligations</a></td>
<td class="nump">$ 2,006,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_CashBalanceTransferredToBankAccount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash balance transferred to bank account.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_CashBalanceTransferredToBankAccount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6351-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13531-108611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13537-108611<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6404-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityRevenueRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13777-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of convertible debt securities using the if-converted method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1930-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e2029-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of transaction price allocated to performance obligation that has not been recognized as revenue.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130556-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of remaining performance obligation to total remaining performance obligation not recognized as revenue.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130556-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=SRNA_CustomerOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=SRNA_CustomerOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=SRNA_CustomerTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=SRNA_CustomerTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=SRNA_CustomerThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=SRNA_CustomerThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=SRNA_CustomerFourMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=SRNA_CustomerFourMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=SRNA_TwoThousandTwentyOneAnnualEmployeeIncentiveCompensationPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=SRNA_TwoThousandTwentyOneAnnualEmployeeIncentiveCompensationPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardDateAxis=SRNA_TwoThousandAndTwentyTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardDateAxis=SRNA_TwoThousandAndTwentyTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerContractsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerContractsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139855694599672">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>General - Schedule of Remaining Performance Obligations Expected to be Recognized (Details)<br></strong></div></th>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems', window );"><strong>Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_RemainingPerformanceObligationsRelatedToEngineeringOnlyPaidContracts', window );">Remaining performance obligations related to engineering only paid contracts</a></td>
<td class="nump">$ 2,006,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_RemainingPerformanceObligationsRelatedToPartialEquipmentPaidContracts', window );">Remaining performance obligations related to partial equipment paid contracts</a></td>
<td class="nump">9,572,000<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Total remaining performance obligations</a></td>
<td class="nump">11,578,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardDateAxis=SRNA_TwoThousandAndTwentyOneMember', window );">2021 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems', window );"><strong>Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_RemainingPerformanceObligationsRelatedToEngineeringOnlyPaidContracts', window );">Remaining performance obligations related to engineering only paid contracts</a></td>
<td class="nump">1,563,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_RemainingPerformanceObligationsRelatedToPartialEquipmentPaidContracts', window );">Remaining performance obligations related to partial equipment paid contracts</a></td>
<td class="nump">9,566,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Total remaining performance obligations</a></td>
<td class="nump">11,129,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardDateAxis=SRNA_TwoThousandAndTwentyTwoMember', window );">2022 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems', window );"><strong>Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_RemainingPerformanceObligationsRelatedToEngineeringOnlyPaidContracts', window );">Remaining performance obligations related to engineering only paid contracts</a></td>
<td class="nump">443,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_RemainingPerformanceObligationsRelatedToPartialEquipmentPaidContracts', window );">Remaining performance obligations related to partial equipment paid contracts</a></td>
<td class="nump">6,000<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Total remaining performance obligations</a></td>
<td class="nump">$ 449,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_RemainingPerformanceObligationsRelatedToEngineeringOnlyPaidContracts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Remaining performance obligations related to engineering only paid contracts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_RemainingPerformanceObligationsRelatedToEngineeringOnlyPaidContracts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_RemainingPerformanceObligationsRelatedToPartialEquipmentPaidContracts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Remaining performance obligations related to partial equipment paid contracts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_RemainingPerformanceObligationsRelatedToPartialEquipmentPaidContracts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of transaction price allocated to performance obligation that has not been recognized as revenue.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130556-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardDateAxis=SRNA_TwoThousandAndTwentyOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardDateAxis=SRNA_TwoThousandAndTwentyOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardDateAxis=SRNA_TwoThousandAndTwentyTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardDateAxis=SRNA_TwoThousandAndTwentyTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139855692571304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>General - Schedule of Revenue by Source (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">$ 2,366,529<span></span>
</td>
<td class="nump">$ 1,809,925<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_EquipmentMember', window );">Equipment and Systems Sales [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">2,163,468<span></span>
</td>
<td class="nump">1,606,946<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=SRNA_EngineeringAndOtherServicesMember', window );">Engineering and Other Services [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">181,083<span></span>
</td>
<td class="nump">131,591<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ShippingAndHandlingMember', window );">Shipping and Handling [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">$ 21,978<span></span>
</td>
<td class="nump">$ 71,388<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_EquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_EquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=SRNA_EngineeringAndOtherServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=SRNA_EngineeringAndOtherServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ShippingAndHandlingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ShippingAndHandlingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139855694602536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>General - Schedule of Share-based Compensation Costs (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total share-based compensation expense included in consolidated statement of operations</a></td>
<td class="nump">$ 59,136<span></span>
</td>
<td class="nump">$ 190,889<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember', window );">Cost of Sales [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total share-based compensation expense included in consolidated statement of operations</a></td>
<td class="nump">14,135<span></span>
</td>
<td class="nump">8,558<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_AdvertisingMember', window );">Advertising and Marketing Expenses [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total share-based compensation expense included in consolidated statement of operations</a></td>
<td class="nump">6,474<span></span>
</td>
<td class="nump">2,912<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SoftwareAndSoftwareDevelopmentCostsMember', window );">Product Development Costs [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total share-based compensation expense included in consolidated statement of operations</a></td>
<td class="nump">6,694<span></span>
</td>
<td class="nump">6,545<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember', window );">Selling, General and Administrative Expenses [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total share-based compensation expense included in consolidated statement of operations</a></td>
<td class="nump">$ 31,833<span></span>
</td>
<td class="nump">$ 172,874<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_AdvertisingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_AdvertisingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SoftwareAndSoftwareDevelopmentCostsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_SoftwareAndSoftwareDevelopmentCostsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139855691427400">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Jan. 02, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use asset</a></td>
<td class="nump">$ 294,900<span></span>
</td>
<td class="nump">$ 343,950<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Lease liability</a></td>
<td class="nump">$ 370,553<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseDescription', window );">Operating lease term description</a></td>
<td class="text">The Facility Lease commenced September 29, 2017 and continues through August 31, 2022.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_MonthlyRentDescription', window );">Monthly rent description</a></td>
<td class="text">Beginning September 1, 2018, and each subsequent September 1 during the term, the monthly rent under the Facility Lease will increase by 3%.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201602Member', window );">ASU 2016-02 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use asset</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 714,416<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Lease liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">822,374<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_UnamortizedAmountOfTenantImprovementAllowance', window );">Unamortized amount of tenant improvement allowance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">81,481<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201602Member', window );">ASU 2016-02 [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TenantImprovements', window );">Tenant improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=SRNA_FacilityLeaseMember', window );">Facility Lease [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseRenewalTerm', window );">Operating lease renewal term</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_MonthlyRentDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Monthly rent description.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_MonthlyRentDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_UnamortizedAmountOfTenantImprovementAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Unamortized amount of tenant improvement allowance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_UnamortizedAmountOfTenantImprovementAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeaseDescriptionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeaseDescriptionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description of lessee's operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseRenewalTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseRenewalTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TenantImprovements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of improvements having a life longer than one year that were made for the benefit of one or more tenants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.1(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TenantImprovements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201602Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201602Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=SRNA_FacilityLeaseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=SRNA_FacilityLeaseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139855776439880">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases - Schedule of Lease Cost (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseCost', window );">Operating lease cost</a></td>
<td class="nump">$ 54,222<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasePayments', window );">Operating cash outflow from operating lease</a></td>
<td class="nump">69,844<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use asset</a></td>
<td class="nump">294,900<span></span>
</td>
<td class="nump">$ 343,950<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating lease liability, current</a></td>
<td class="nump">263,662<span></span>
</td>
<td class="nump">266,105<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease liability, long-term</a></td>
<td class="nump">$ 106,891<span></span>
</td>
<td class="nump">$ 169,119<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Remaining lease term</a></td>
<td class="text">1 year 4 months 24 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Discount rate</a></td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918643-209977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139855694913512">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases - Schedule of Future Annual Minimum Lease Payments (Details)<br></strong></div></th>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear', window );">2021 (excluding the three months ended March 31, 2021)</a></td>
<td class="nump">$ 212,020<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2022</a></td>
<td class="nump">170,891<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total minimum lease payments</a></td>
<td class="nump">382,911<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Less imputed interest</a></td>
<td class="num">(12,358)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Present value of minimum lease payments</a></td>
<td class="nump">$ 370,553<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease having initial or remaining lease term in excess of one year to be paid in remainder of current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139855694151368">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Inventory (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSoldOverhead', window );">Overhead expenses</a></td>
<td class="nump">$ 17,443<span></span>
</td>
<td class="nump">$ 17,974<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_PrepaidInventoryExpenses', window );">Prepaid inventory expenses</a></td>
<td class="nump">$ 1,960,000<span></span>
</td>
<td class="nump">$ 916,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_PrepaidInventoryExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Prepaid inventory expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_PrepaidInventoryExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSoldOverhead">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indirect cost incurred related to good produced and service rendered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSoldOverhead</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139855690563784">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Inventory - Schedule of Inventory (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoods', window );">Finished goods</a></td>
<td class="nump">$ 325,451<span></span>
</td>
<td class="nump">$ 201,778<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryWorkInProcess', window );">Work in progress</a></td>
<td class="nump">10,083<span></span>
</td>
<td class="nump">4,231<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryRawMaterials', window );">Raw materials</a></td>
<td class="nump">272,299<span></span>
</td>
<td class="nump">214,145<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryValuationReserves', window );">Allowance for excess &amp; obsolete inventory</a></td>
<td class="num">(88,674)<span></span>
</td>
<td class="num">(93,045)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventory, net</a></td>
<td class="nump">$ 519,159<span></span>
</td>
<td class="nump">$ 327,109<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoods">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation and LIFO reserves of completed merchandise or goods expected to be sold within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryFinishedGoods</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryRawMaterials">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation and LIFO reserves of raw materials expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryRawMaterials</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryValuationReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of valuation reserve for inventory.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryValuationReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWorkInProcess">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation and LIFO reserves of merchandise or goods in the production process expected to be completed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWorkInProcess</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139855692622360">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation expense</a></td>
<td class="nump">$ 18,233<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, general and administrative expenses</a></td>
<td class="nump">740,473<span></span>
</td>
<td class="nump">$ 1,108,993<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_PropertyPlantAndEquipmentMember', window );">Property and Equipment [Member] | Cost of Sales [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, general and administrative expenses</a></td>
<td class="nump">1,249<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_PropertyPlantAndEquipmentMember', window );">Property and Equipment [Member] | Inventory [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, general and administrative expenses</a></td>
<td class="nump">$ 312<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_PropertyPlantAndEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_PropertyPlantAndEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=SRNA_InventoryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=SRNA_InventoryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139855692463224">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Property and Equipment - Schedule of Property and Equipment (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">$ 640,941<span></span>
</td>
<td class="nump">$ 628,615<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Accumulated depreciation</a></td>
<td class="num">(499,116)<span></span>
</td>
<td class="num">(480,883)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">141,825<span></span>
</td>
<td class="nump">147,732<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Furniture and Equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">410,748<span></span>
</td>
<td class="nump">398,422<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_VehiclesMember', window );">Vehicles [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">15,000<span></span>
</td>
<td class="nump">15,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold Improvements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">$ 215,193<span></span>
</td>
<td class="nump">$ 215,193<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.14)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_VehiclesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_VehiclesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139855777706280">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Accounts Payable and Accrued Liabilities - Schedule of Accounts Payable and Accrued Liabilities (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">$ 860,087<span></span>
</td>
<td class="nump">$ 918,639<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedSalesCommissionCurrent', window );">Sales commissions payable</a></td>
<td class="nump">13,649<span></span>
</td>
<td class="nump">48,263<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Accrued payroll liabilities</a></td>
<td class="nump">275,024<span></span>
</td>
<td class="nump">288,071<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductWarrantyAccrualClassifiedCurrent', window );">Product warranty accrual</a></td>
<td class="nump">264,956<span></span>
</td>
<td class="nump">173,365<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Other accrued expenses</a></td>
<td class="nump">376,599<span></span>
</td>
<td class="nump">356,623<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent', window );">Total</a></td>
<td class="nump">$ 1,790,315<span></span>
</td>
<td class="nump">$ 1,784,961<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedSalesCommissionCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for sales commissions. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6911-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedSalesCommissionCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6911-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e7018-107765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProductWarrantyAccrualClassifiedCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for estimated claims under standard and extended warranty protection rights granted to customers. For classified balance sheets, represents the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=123368208&amp;loc=d3e12524-110249<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 25<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123377177&amp;loc=d3e11281-110244<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProductWarrantyAccrualClassifiedCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139855693941336">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Note Payable and Accrued Interest (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Feb. 10, 2021</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Loan principal amount</a></td>
<td class="nump">$ 514,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Loan interest rate</a></td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Loan due date</a></td>
<td class="text">Feb.  05,  2026<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentIncreaseAccruedInterest', window );">Accrued interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 718<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentIncreaseAccruedInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Increase for accrued, but unpaid interest on the debt instrument for the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentIncreaseAccruedInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentMaturityDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Date when the debt instrument is scheduled to be fully repaid, in YYYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentMaturityDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139855692408344">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 30, 2021</div></th>
<th class="th"><div>Jun. 09, 2020</div></th>
<th class="th"><div>Mar. 09, 2020</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyDamagesPaidValue', window );">Obligate to pay for dispute</a></td>
<td class="nump">$ 40,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_AggregateSharesIssuedUponExecutionOfSettlement', window );">Aggregate common shares issued upon execution of settlement</a></td>
<td class="nump">1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingExpense', window );">Other expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 107,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent', window );">Accounts payables and accruals</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_StockIssuanceAmount', window );">Stock issuance amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 67,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=SRNA_FormerEmployeeMember', window );">Former Employee [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyDamagesAwardedValue', window );">Interim awarded value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 33,985<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_RestrictedStockUnitsSharesIssuedInterestPercentage', window );">Restricted stock units shares issued interest percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units (RSUs) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_NumberOfUnitsVestedButNotSettled', window );">Number of units, vested but not settled</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,750,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_NumberOfUnitsVestedAndSettled', window );">Number of units, vested and settled</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,750,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyDamagesAwardedValue', window );">Interim awarded value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_AggregateSharesIssuedUponExecutionOfSettlement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate common shares issued upon execution of settlement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_AggregateSharesIssuedUponExecutionOfSettlement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_NumberOfUnitsVestedAndSettled">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of units, vested and settled.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_NumberOfUnitsVestedAndSettled</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_NumberOfUnitsVestedButNotSettled">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of Units, Vested but not settled .</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_NumberOfUnitsVestedButNotSettled</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_RestrictedStockUnitsSharesIssuedInterestPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Restricted stock units shares issued interest percentage.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_RestrictedStockUnitsSharesIssuedInterestPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_StockIssuanceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock issuance amount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_StockIssuanceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of obligations incurred through that date, including liabilities incurred and payable to vendors for goods and services received, taxes, interest, rent and utilities, compensation costs, payroll taxes and fringe benefits (other than pension and postretirement obligations), contractual rights and obligations, and statutory obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.15)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15(1),(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyDamagesAwardedValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of damages awarded to the plaintiff in the legal matter.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14557-108349<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyDamagesAwardedValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyDamagesPaidValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of damages paid to the plaintiff in the legal matter.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14557-108349<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyDamagesPaidValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=SRNA_FormerEmployeeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=SRNA_FormerEmployeeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139855688604216">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity Incentive Plan (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Apr. 01, 2021</div></th>
<th class="th"><div>Jun. 24, 2020</div></th>
<th class="th"><div>Apr. 30, 2020</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Mar. 22, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,342<span></span>
</td>
<td class="nump">$ 154,426<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=SRNA_IncentiveStockBonusAwardsMember', window );">Incentive Stock Bonus Awards [Member] | Employees [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Number of share awards granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,686,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units (RSUs) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares', window );">Number of options vested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units (RSUs) [Member] | Employees, Directors and Consultants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">18,872<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=SRNA_TwoThousandAndSeventeenEquityIncentivePlanMember', window );">2017 Equity Incentive Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Number of common stock shares issuance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=SRNA_TwoThousandAndTwentyOneEquityIncentivePlanMember', window );">2021 Equity Incentive Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Number of share awards granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=SRNA_TwoThousandAndSeventeenEquityPlanMember', window );">2017 Equity Incentive Plan [Member] | Directors [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,342<span></span>
</td>
<td class="nump">$ 29,266<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares', window );">Number of options vested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=SRNA_TwoThousandAndSeventeenEquityPlanMember', window );">2017 Equity Incentive Plan [Member] | Directors [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares', window );">Number of options vested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=SRNA_TwoThousandAndSeventeenEquityPlanMember', window );">2017 Equity Incentive Plan [Member] | Employees and Consultants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares', window );">Number of options vested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,035,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=SRNA_TwoThousandAndSeventeenEquityPlanMember', window );">2017 Equity Incentive Plan [Member] | Non-Qualified Stock Options [Member] | Directors [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod', window );">Number of options granted during the period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage', window );">Non-qualified stock options vested percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Non-qualified stock options term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">7 years 6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=SRNA_TwoThousandAndSeventeenEquityPlanMember', window );">2017 Equity Incentive Plan [Member] | Non-Qualified Stock Options [Member] | Directors [Member] | Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares', window );">Number of options vested</a></td>
<td class="nump">1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage', window );">Non-qualified stock options vested percentage</a></td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=SRNA_TwoThousandAndSeventeenEquityPlanMember', window );">2017 Equity Incentive Plan [Member] | Non-Qualified Stock Options [Member] | Employees and Consultants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 106,288<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Non-qualified stock options term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">8 years 3 months 19 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate number of common shares reserved for future issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockCapitalSharesReservedForFutureIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of vesting of award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options vested.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=SRNA_IncentiveStockBonusAwardsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=SRNA_IncentiveStockBonusAwardsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=SRNA_EmployeesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=SRNA_EmployeesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=SRNA_EmployeesDirectorsandConsultantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=SRNA_EmployeesDirectorsandConsultantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=SRNA_TwoThousandAndSeventeenEquityIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=SRNA_TwoThousandAndSeventeenEquityIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=SRNA_TwoThousandAndTwentyOneEquityIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=SRNA_TwoThousandAndTwentyOneEquityIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=SRNA_TwoThousandAndSeventeenEquityPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=SRNA_TwoThousandAndSeventeenEquityPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=srt_DirectorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=srt_DirectorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=SRNA_DirectorsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=SRNA_DirectorsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=SRNA_EmployeesAndConsultantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=SRNA_EmployeesAndConsultantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=SRNA_NonQualifiedStockOptionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=SRNA_NonQualifiedStockOptionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139855687949432">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity Incentive Plan - Schedule of Stock Option Activity (Details) - 2017 Equity Incentive Plan [Member] - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 24, 2020</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=SRNA_TwoThousandAndSeventeenEquityPlanMember', window );">Directors [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Number of Options, Granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=SRNA_TwoThousandAndSeventeenEquityPlanMember', window );">Non-Qualified Stock Options [Member] | Directors [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Number of Options, Outstanding Beginning</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,400,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Number of Options, Granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Number of Options, Exercised</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Number of Options, Forfeited/Cancelled</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod', window );">Number of Options, Expired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Number of Options, Outstanding Ending</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,400,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Number of Options, Exercisable Ending</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,400,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Outstanding Beginning</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.067<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Exercised</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Forfeited/Cancelled</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Expired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Outstanding Ending</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.067<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Exercisable Ending</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.073<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Weighted Average Remaining Contractual Term, Outstanding Beginning</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">7 years 6 months<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermGranted', window );">Weighted Average Remaining Contractual Term, Granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm', window );">Weighted Average Remaining Contractual Term, Outstanding Ending</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">7 years 2 months 12 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1', window );">Weighted Average Remaining Contractual Term, Exercisable Ending</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">7 years 8 months 12 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Aggregate Intrinsic Value, Outstanding Beginning</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,780<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Aggregate Intrinsic Value, Outstanding Ending</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,780<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1', window );">Aggregate Intrinsic Value, Exercisable Ending</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=SRNA_TwoThousandAndSeventeenEquityPlanMember', window );">Employees and Consultants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Number of Options, Granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,035,800<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=SRNA_TwoThousandAndSeventeenEquityPlanMember', window );">Employees and Consultants [Member] | Non-Qualified Stock Options [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Number of Options, Outstanding Beginning</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,251,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Number of Options, Granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,035,800<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Number of Options, Exercised</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Number of Options, Forfeited/Cancelled</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod', window );">Number of Options, Expired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Number of Options, Outstanding Ending</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,286,800<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Number of Options, Exercisable Ending</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,286,800<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Outstanding Beginning</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.083<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.130<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Exercised</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Forfeited/Cancelled</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Expired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Outstanding Ending</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.084<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Exercisable Ending</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.084<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Weighted Average Remaining Contractual Term, Outstanding Beginning</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">8 years 3 months 19 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermGranted', window );">Weighted Average Remaining Contractual Term, Granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm', window );">Weighted Average Remaining Contractual Term, Outstanding Ending</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">8 years 2 months 12 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1', window );">Weighted Average Remaining Contractual Term, Exercisable Ending</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">8 years 2 months 12 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Aggregate Intrinsic Value, Outstanding Beginning</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Aggregate Intrinsic Value, Outstanding Ending</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1', window );">Aggregate Intrinsic Value, Exercisable Ending</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted Average Remaining Contractual Term, Ending.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term, granted.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options of the plan that expired.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=SRNA_TwoThousandAndSeventeenEquityPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=SRNA_TwoThousandAndSeventeenEquityPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=SRNA_DirectorsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=SRNA_DirectorsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=SRNA_NonQualifiedStockOptionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=SRNA_NonQualifiedStockOptionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=SRNA_EmployeesAndConsultantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=SRNA_EmployeesAndConsultantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139855688483288">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity Incentive Plan - Summary of Non-vested Non-qualified Stock Option Activity (Details) - 2017 Equity Incentive Plan [Member]<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2021 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=SRNA_TwoThousandAndSeventeenEquityPlanMember', window );">Directors [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares', window );">Number of Options Nonvested, Beginning | shares</a></td>
<td class="nump">1,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Number of Options Nonvested, Granted | shares</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares', window );">Number of Options Nonvested, Vested | shares</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares', window );">Number of Options Nonvested, Forfeited | shares</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsNumberOfOptionsExpired', window );">Number of Options Nonvested, Expired | shares</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares', window );">Number of Options Nonvested, Ending | shares</a></td>
<td class="nump">1,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Weighted Average Grant-Date Fair Value, Beginning | $ / shares</a></td>
<td class="nump">$ 0.029<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted Average Grant-Date Fair Value, Granted | $ / shares</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue', window );">Weighted Average Grant-Date Fair Value, Vested | $ / shares</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue', window );">Weighted Average Grant-Date Fair Value, Forfeited | $ / shares</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsExpired', window );">Weighted Average Grant-Date Fair Value, Expired | $ / shares</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Weighted Average Grant-Date Fair Value, Ending | $ / shares</a></td>
<td class="nump">$ 0.029<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1', window );">Aggregated Intrinsic Value, Nonvested Beginning</a></td>
<td class="nump">$ 29,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1', window );">Aggregated Intrinsic Value, Nonvested Ending</a></td>
<td class="nump">29,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested', window );">Grant Date Fair Value Nonvested, Beginning</a></td>
<td class="nump">38,200<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValuesGranted', window );">Grant Date Fair Value Nonvested, Granted</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValueVested', window );">Grant Date Fair Value Nonvested, Vested</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantDateFairValueForfeited', window );">Grant Date Fair Value Nonvested, Forfeited</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfSharesGrantDateFairValueExpired', window );">Grant Date Fair Value Nonvested, Expired</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested', window );">Grant Date Fair Value Nonvested, Ending</a></td>
<td class="nump">$ 38,200<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=SRNA_TwoThousandAndSeventeenEquityPlanMember', window );">Employees and Consultants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares', window );">Number of Options Nonvested, Beginning | shares</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Number of Options Nonvested, Granted | shares</a></td>
<td class="nump">1,035,800<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares', window );">Number of Options Nonvested, Vested | shares</a></td>
<td class="num">(1,035,800)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares', window );">Number of Options Nonvested, Forfeited | shares</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsNumberOfOptionsExpired', window );">Number of Options Nonvested, Expired | shares</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares', window );">Number of Options Nonvested, Ending | shares</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Weighted Average Grant-Date Fair Value, Beginning | $ / shares</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted Average Grant-Date Fair Value, Granted | $ / shares</a></td>
<td class="nump">0.124<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue', window );">Weighted Average Grant-Date Fair Value, Vested | $ / shares</a></td>
<td class="nump">0.124<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue', window );">Weighted Average Grant-Date Fair Value, Forfeited | $ / shares</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsExpired', window );">Weighted Average Grant-Date Fair Value, Expired | $ / shares</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Weighted Average Grant-Date Fair Value, Ending | $ / shares</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1', window );">Aggregated Intrinsic Value, Nonvested Beginning</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1', window );">Aggregated Intrinsic Value, Nonvested Ending</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested', window );">Grant Date Fair Value Nonvested, Beginning</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValuesGranted', window );">Grant Date Fair Value Nonvested, Granted</a></td>
<td class="nump">128,543<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValueVested', window );">Grant Date Fair Value Nonvested, Vested</a></td>
<td class="nump">128,543<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantDateFairValueForfeited', window );">Grant Date Fair Value Nonvested, Forfeited</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfSharesGrantDateFairValueExpired', window );">Grant Date Fair Value Nonvested, Expired</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested', window );">Grant Date Fair Value Nonvested, Ending</a></td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantDateFairValueForfeited">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Forfeited.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantDateFairValueForfeited</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of options nonvested. Excludes equity instruments other than options, for example, but not limited to, share units, stock appreciation rights, restricted stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonVestedInPeriodFairValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvested</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValueVested">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Vested.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValueVested</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValuesGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested Granted.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedGrantDateFairValuesGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsExpired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted Average Grant Date Fair Value, Expired.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsExpired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfSharesGrantDateFairValueExpired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested Grant Date Fair Value, Expired</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfSharesGrantDateFairValueExpired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsNumberOfOptionsExpired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of Options, Expired.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsNumberOfOptionsExpired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of non-vested options outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of non-vested options forfeited.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average grant-date fair value of non-vested options forfeited.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average grant-date fair value of non-vested options outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options vested.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average grant-date fair value of options vested.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=SRNA_TwoThousandAndSeventeenEquityPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=SRNA_TwoThousandAndSeventeenEquityPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=SRNA_DirectorsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=SRNA_DirectorsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=SRNA_EmployeesAndConsultantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=SRNA_EmployeesAndConsultantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139855689715528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity Incentive Plan - Schedule of Restricted Stock Units Activity (Details) - 2017 Equity Incentive Plan [Member] - Employees, Directors and Consultants [Member]<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2021 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Number of Units, beginning | shares</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Number of Units, Granted | shares</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Number of Units, Vested and settled with share issuance | shares</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Number of Units, Forfeited/canceled | shares</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Number of Units, ending | shares</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Weighted Average Grant Date Fair Value, beginning | $ / shares</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted Average Grant Date Fair Value, Granted | $ / shares</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Weighted Average Grant Date Fair Value, Vested and settled with share issuance | $ / shares</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Weighted Average Grant Date Fair Value, Forfeited/canceled | $ / shares</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Weighted Average Grant Date Fair Value, ending | $ / shares</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding', window );">Aggregated Intrinsic Value, Outstanding beginning | $</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding', window );">Aggregated Intrinsic Value, Outstanding ending | $</a></td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Intrinsic value of outstanding award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=SRNA_TwoThousandAndSeventeenEquityPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=SRNA_TwoThousandAndSeventeenEquityPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=SRNA_EmployeesDirectorsandConsultantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=SRNA_EmployeesDirectorsandConsultantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139855692514088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Warrants - Schedule of Outstanding Warrants to Purchase Common Stock (Details)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2021 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsNoteDisclosureAbstract', window );"><strong>Warrants and Rights Note Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrants Outstanding, Beginning Balance | shares</a></td>
<td class="nump">7,562,500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_ClassOfWarrantOrRightIssued', window );">Warrants, Issued | shares</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_ClassOfWarrantOrRightExercised', window );">Warrants, Exercised | shares</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_ClassOfWarrantOrRightExpired', window );">Warrants, Expired | shares</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrants Outstanding, Ending Balance | shares</a></td>
<td class="nump">7,562,500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Weighted Average Exercise Price, Beginning Balance | $ / shares</a></td>
<td class="nump">$ 0.25<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_ClassOfWarrantOrRightWeightedAverageExercisePriceIssued', window );">Weighted Average Exercise Price, Issued | $ / shares</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_ClassOfWarrantOrRightWeightedAverageExercisePriceExercised', window );">Weighted Average Exercise Price, Exercised | $ / shares</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_ClassOfWarrantOrRightWeightedAverageExercisePriceExpired', window );">Weighted Average Exercise Price, Expired | $ / shares</a></td>
<td class="nump">0.00<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Weighted Average Exercise Price, Ending Balance | $ / shares</a></td>
<td class="nump">$ 0.25<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerms', window );">Weighted Average Life of Outstanding Warrants in Months, Beginning Balance</a></td>
<td class="text">6 months<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm', window );">Weighted Average Life of Outstanding Warrants in Months, Ending Balance</a></td>
<td class="text">6 months<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_ClassOfWarrantOrRightOutstandingAggregateIntrinsicValue', window );">Aggregate Intrinsic Value, Beginning Balance | $</a></td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_ClassOfWarrantOrRightIssuedAggregateIntrinsicValue', window );">Aggregate Intrinsic Value, Issued | $</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_ClassOfWarrantOrRightExercisedAggregateIntrinsicValue', window );">Aggregate Intrinsic Value, Exercised | $</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_ClassOfWarrantOrRightExpiredAggregateIntrinsicValue', window );">Aggregate Intrinsic Value, Expired | $</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_ClassOfWarrantOrRightOutstandingAggregateIntrinsicValue', window );">Aggregate Intrinsic Value, Ending Balance | $</a></td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_ClassOfWarrantOrRightExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Warrants exercised during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_ClassOfWarrantOrRightExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_ClassOfWarrantOrRightExercisedAggregateIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate intrinsic value of warrants exercised.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_ClassOfWarrantOrRightExercisedAggregateIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_ClassOfWarrantOrRightExpired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Warrants expired during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_ClassOfWarrantOrRightExpired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_ClassOfWarrantOrRightExpiredAggregateIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate intrinsic value of warrants expired.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_ClassOfWarrantOrRightExpiredAggregateIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_ClassOfWarrantOrRightIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Warrants issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_ClassOfWarrantOrRightIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_ClassOfWarrantOrRightIssuedAggregateIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate intrinsic value of warrants issued.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_ClassOfWarrantOrRightIssuedAggregateIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_ClassOfWarrantOrRightOutstandingAggregateIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate intrinsic value of outstanding warrants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_ClassOfWarrantOrRightOutstandingAggregateIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_ClassOfWarrantOrRightWeightedAverageExercisePriceExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average exercise price of warrants exercised.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_ClassOfWarrantOrRightWeightedAverageExercisePriceExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_ClassOfWarrantOrRightWeightedAverageExercisePriceExpired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average exercise price of warrants expired.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_ClassOfWarrantOrRightWeightedAverageExercisePriceExpired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_ClassOfWarrantOrRightWeightedAverageExercisePriceIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average exercise price of warrants issued.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_ClassOfWarrantOrRightWeightedAverageExercisePriceIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average life of outstanding warrants in months, ending balance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerms">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average life of outstanding warrants in months, beginning balance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerms</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsNoteDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsNoteDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139855691449320">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Warrants - Schedule of Warrants Outstanding (Details) - $ / shares<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price</a></td>
<td class="nump">$ 0.25<span></span>
</td>
<td class="nump">$ 0.25<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrants Outstanding</a></td>
<td class="nump">7,562,500<span></span>
</td>
<td class="nump">7,562,500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm', window );">Weighted Average Life of Outstanding Warrants in Months</a></td>
<td class="text">6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=SRNA_WarrantsRangeMember', window );">Warrants Range [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price</a></td>
<td class="nump">$ 0.25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrants Outstanding</a></td>
<td class="nump">7,562,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=SRNA_WarrantsRangeOneMember', window );">Warrants Range One [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm', window );">Weighted Average Life of Outstanding Warrants in Months</a></td>
<td class="text">6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average life of outstanding warrants in months, ending balance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=SRNA_WarrantsRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=SRNA_WarrantsRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=SRNA_WarrantsRangeOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=SRNA_WarrantsRangeOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139855695789208">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Details Narrative)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2021 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Net operating loss carry forward amount</a></td>
<td class="nump">$ 20,115,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_NetOperatingLossCarryForwardExpectedToExpireAmount', window );">Net operating loss carry forward expected to expire amount</a></td>
<td class="nump">$ 11,196,261<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_NetOperatingLossExpirationTerm', window );">Net operating loss expiration term</a></td>
<td class="text">2034 through 2037<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_NolsUsageAgainstTaxableIncomePercentage', window );">NOLs usage against taxable income, percentage</a></td>
<td class="nump">80.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Percentage of ownership change</a></td>
<td class="nump">50.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_NolsCarryforwardsTerm', window );">NOLs carryforwards term</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_NetOperatingLossCarryForwardExpectedToExpireAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net operating loss carry forward expected to expire amount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_NetOperatingLossCarryForwardExpectedToExpireAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_NetOperatingLossExpirationTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net operating loss expiration term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_NetOperatingLossExpirationTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_NolsCarryforwardsTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>NOLs carryforwards term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_NolsCarryforwardsTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_NolsUsageAgainstTaxableIncomePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>NOLs usage against taxable income percentage.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_NolsUsageAgainstTaxableIncomePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of voting equity interests acquired at the acquisition date in the business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32559-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139855687881640">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Events (Details Narrative)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Jul. 01, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Apr. 30, 2021 </div>
<div>USD ($) </div>
<div>ft&#178;</div>
</th>
<th class="th">
<div>Apr. 08, 2021 </div>
<div>shares</div>
</th>
<th class="th">
<div>Apr. 01, 2021 </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 30, 2021 </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 24, 2020 </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_AggregateSharesIssuedUponExecutionOfSettlement', window );">Aggregate common shares issued upon execution of settlement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementScenarioAxis=srt_ScenarioForecastMember', window );">Forecast [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesRentExpenseSubleaseRentals1', window );">Sublease rent charged | $</a></td>
<td class="nump">$ 11,978<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=SRNA_TwoThousandAndSeventeenEquityPlanMember', window );">2017 Equity Incentive Plan [Member] | Directors [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares', window );">Number of options vested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=SRNA_TwoThousandAndSeventeenEquityPlanMember', window );">2017 Equity Incentive Plan [Member] | Non-Qualified Stock Options [Member] | Directors [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod', window );">Number of options granted during the period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesRentExpenseSubleaseRentals1', window );">Sublease rent charged | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,989<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Office and Manufacturing [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AreaOfLand', window );">Area of land | ft&#178;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Former Employee [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SRNA_AggregateSharesIssuedUponExecutionOfSettlement', window );">Aggregate common shares issued upon execution of settlement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | 2017 Equity Incentive Plan [Member] | Non-Qualified Stock Options [Member] | Directors [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares', window );">Number of options vested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SRNA_AggregateSharesIssuedUponExecutionOfSettlement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate common shares issued upon execution of settlement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SRNA_AggregateSharesIssuedUponExecutionOfSettlement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SRNA_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AreaOfLand">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area of land held.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AreaOfLand</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:areaItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesRentExpenseSubleaseRentals1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total amount of sublease rental income recognized during the period that reduces the entity's rent expense incurred under operating leases.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123403562&amp;loc=d3e38371-112697<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesRentExpenseSubleaseRentals1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options vested.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=srt_ScenarioForecastMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=srt_ScenarioForecastMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=SRNA_TwoThousandAndSeventeenEquityPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=SRNA_TwoThousandAndSeventeenEquityPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=SRNA_DirectorsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=SRNA_DirectorsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=SRNA_NonQualifiedStockOptionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=SRNA_NonQualifiedStockOptionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=SRNA_OfficeandManufacturingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=SRNA_OfficeandManufacturingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=SRNA_FormerEmployeeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=SRNA_FormerEmployeeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>61
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M?!^2!F.,6_0T7X\48JVFL:W&VC$,>8!8\PRA9CC?AT6:&C/5BZPYC0IO0=5
MY3_;U UH]@TT')$%7C&9MC:CY$X*/-S^[PVPPL2.X>V+OP%02P,$%     @
M#4BK4M8C5268 P  _0P  !@   !X;"]W;W)K<VAE971S+W-H965T,2YX;6R-
MEUUOFS 4AJ^W7V%QO10,29I-2:26K5LU=>N:?6B:=N&"$U"-S6S3-/]^QX9
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M!M\G5)H!<'\MA-XWS /:+Y[E?U!+ P04    "  -2*M2705#S@L'   G'
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M-!Z!&74P(V?*W\@B>6_6QYW.^, Z 9&6ZK59'YWW&Z V-1I3L;D 'HFH/W"
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M\B0_W#,:,J$%U/TMY_+Y1'_'<?F4:/X?4$L#!!0    (  U(JU(Z;AT@; 8
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MG.("?%8BT'J>\%,%>]9>23)-*'Y$L+F-N3! Z(Y+,99G<Z>"7!JEOVNMA3E
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M@72J$UI3^5:*0&.B^=8^"7WE*1X>6,F$%NWF:W^2??\BVB:ZC2H_8T+1#/M
MOCZJ,PPLP$>IS,V&V6^TQS,[6\]2H_IDP)2%Q'0\ :5^M&_4X,P<O_@\%,Y0
M@>$I")+J+)KB(+;,!I*X5D.'_: _"S.">M(3:3C@I%P$LRC02@^MV5B'#W_P
MX&O& <4CN.5$EJ<KGTS0[5A6]B8K#-JM6DX!BTM%?+;E/$T7<APC5O;M\&-V
MYY$1S]X'IM1Y\F.J9U77,.F/%>)"J3"0:]*L.*IY3TO@C#L!P),AX-'SN4A;
MT T79+?%J8[%%!C]]=XWY\IJ"?&]N5#5[J0KBE'[1L9=O%85/J'7-F6%49?:
M[N&G6;'.\.U8)X#.:-+,S7 C=ATUY/A?"/H!#1>#MM=R!EW&#- CY?A4<5W8
ME3.IDNV<KG[*A <I P-EP+9##!5\$';4MAGWFAPS-VZLSK>EA_/L%_-*=KN@
MD7S-R2D=AV\3%?)#80J6GR3&S7:*1\2CSEKO+]"E@T3!S>T;1*(GB_G)V>D)
M0MUH..90.1W1B3J8I9X7 DY7*=26B<AZ.7,1IGX,Z8Q(0?ONN1",:;/ER(&4
M[L44*M?;R5'CI4NSB 0L;?^ Y-W#7IM/L$TF"\!/1+Y1N"P-O;J._W2;[5R'
M4W88.[LV*=^0H^7?0\5F)@OTQWC(;Q\8UI/%(7X/W\&R^D3?AL#:?3W'G)W/
M3^B_TXN3\Z.Z&!]SMY:_CD'=T6;I@HD ,LQN[;I;!+>^+A%H3RS5]MK\:R+-
M=N=:#Y*#?LW0!!85""+-)S<W[%'DDS8^=5'/M]=:;%.0(B^[SI>P &(-/\ZG
M#<3Q")4-]0]3%X8Q$V4%N8<E+E.0VH%V]XB!YG1<MA-WM*YVVC7:=4U>9G%_
MATM,FV!.V47,VOK LHY5C.<41HO3829J/O*BI0@68K235B3K@I5T=K'L1E5Z
MN99A9$)\/G#F\U]QSX>)*HQ9<<^BH"V0JHO=I0[>L?KID9$4,YVBC4[BSL>M
M!.G5U3P]NSS?T]P'&T,3C1*'2# >AV6<+IY_%2Q7%]?IR_G%'X=D#LO_B%9)
M38/KB?+/5;-.0[Y7&WW7Z];R9-YCL<8HQR0ACMOX(->W;V7 BIX?C+0A<:'A
M0,D==Y^Q!NV,J!'+2U6-E9B5+K9D;/8NYB>+<R>U\I H(]1HQ!,UG$6(1L$0
M5F9?")[<O2,'*=<Z= ;Y.#T>%_VR=3"B4\,HD8($V>,FN<<MAZHD3@5.H'4\
MU(K^%P?W ;AF$MQW[DJ<T4"HIF-,;-JY7U55'<Y5$?/4G<OV<A^U<\[<="<M
MXTJS<3M:4+C P='R.6NFE#M&3=ES!H%O^-EO\V:O6^=CQ1+U8KV]4 :9K/6F
MA$?0[D8,V&4NN\_"_J.RB!M1E?D6[= =JB@)H,:ZCCP.O;E LONPZ!6G8&K;
MAM&!-$I5^:F9@[RUF;C-91>N+^BTKQZ^&'=TQ)Y/R%6&'N4.XS*AI5_2R.!Z
M;H!-U0D@0(3L?BJ]-GPW"GXLVZDK9G88%NXQU(O$/(:+DRWWF771Q+7/=DV$
MC>SX$$E[[ASF:;MPWT?CIV;$&Y0DHAM%:N72@H(?/' DD5]W4R'[G)(R"C%;
M6,,@UP-MAPRQZP?W4B>W"+$\H"YJHA$&7-MTPM!#O928%I*A-%R5TH617'<I
MB[_/(\:B&W9Z)3<,2:2C64S7]#P:<_=)4?A^P77;OZ)$R B2<PCF;RIYI1<4
MR5-:M>A'UT(49,QVPL-;N99G[;BBBU9#SS,/\^.R*6DDRE:K1&67L17U;KG4
M(^?:<I=:Y,X+-T@@D$3=4M(^5C<8P_ YR] -IE@D<KWB^XW,I RX@0%E\$D.
M]FJ0%KI_'KC2C0*)P#+;NFLF9$@T97X=7>MB^#8&_CJ6,!<)$^ZJ4<W)BU<
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MKA16)$<'\'QA;>@OR,#P%?3ZOU!+ P04    "  -2*M2F^1(TD8#  #^!@
M&    'AL+W=O<FMS:&5E=',O<VAE970Y+GAM;)U536_;.!"]ZU<,5*-H 2'Z
M=&RGM@$GV:(]=!NDV.UAL0=:&MM$*5)+TG'R[W>&<F2WV&:!7FP.Q7GSWFCX
M-#\8^\WM$#T\MDJ[1;SSOKM*4U?OL!7NPG2HZ<G&V%9X"NTV=9U%T82D5J5%
MEEVFK9 Z7L[#WIU=SLW>*ZGQSH+;MZVP3]>HS&$1Y_'SQKW<[CQOI,MY)[;X
M!?T?W9VE*!U0&MFB=M)HL+A9Q*O\ZKKB\^' GQ(/[FP-K&1MS#<./C:+.&-"
MJ+#VC"#H[P%O4"D&(AK_'#'CH20GGJ^?T=\'[:1E+1S>&/55-GZWB*<Q-+@1
M>^7OS>$#'O6,&:\VRH5?./1GRR*&>N^\:8_)Q*"5NO\7C\<^G"5,LY\D%,>$
M(O#N"P66M\*+Y=R: U@^36B\"%)#-I&3FE_*%V_IJ:0\O_RH'U![8Y_FJ2<X
MWDSK8^IUGUK\)+6$3T;[G8/?=(/-]_DIT1BX%,]<KHL7 3\)>P%EGD"1%?D+
M>.6@K0QXY?]I@UOI:F7<WB+\M5H[;VD8_GZA0C54J$*%ZE>Z]W+J[\8CE/#Z
MU;3(\W=PXGI:U89FWWELP&S [Q V1M$EDGI[%5&OZEUHUBW6V*[1<A!QY[A]
M6?1>:DECT<#6F,;!",IBG%3CG%9%EB>3R33Z2O<%I(;.FJU%YR#/DFQ:0I44
M91[=BP,-FD<KA7)03(JDF,V@R*LDK\;1BID(73,I"_A8<_YKT7;OP*R=44CJ
MY*#DS72:7$XJ> MO9F6256-X&PTZ$]!D/B,8Y[,D'\\"U4F29S/X_(!V1TY#
M^&1"#ATW8I1/DJHJ0>@FXO6,< ]HN5RM]C2)+(F[=2J_%BI0%0'@U#KN5L)
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M?320_1T)VW$2 YP?\LU?4$L#!!0    (  U(JU+-6*ZU1 @  #T4   9
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M5N7F1NX^8I//Q/+%,M?N'W:U[7#D0UQI(XL&3!$47-1/]M3<0P]P%KX B!I
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M8+LM76/:J8@/<2.?KLHU@J70<S#>=NVN.;7-H:U[FEC2(,+!L\-M1Q5[>4*
MTHLWK\$<6AMF.6;=<-?-8/3HGE6Q7Z3;)&:FX&ZO7-O5[87UHKVG/1QO;[L0
M_@)-18;G,!T/#_?[Y-L;9/L279UN;3,7<0=,CR4NW>SE /;G#C>'[D4";*_Q
MY_\ 4$L#!!0    (  U(JU)2LYW?2 ,  .$&   9    >&PO=V]R:W-H965T
M<R]S:&5E=#$W+GAM;*55T6[;-A1]]U=<J,6>G,B2X\9N;0-.EJ$=T"V(M_:A
MV ,M75E$*5(AJ3K^^QU2CNNBJS&@+Q(IWG/N.9?DU7QG[&=7,WMZ:I1VBZ3V
MOGV=IJZHN1'NTK2LL5(9VPB/J=VFKK4LR@AJ5)J/1J_21DB=+.?QV[U=SDWG
ME=1\;\EU32/L_H:5V2V2+'G^\""WM0\?TN6\%5M>L_^[O;>8I4>64C:LG32:
M+%>+9)6]OKD*\3'@@^2=.QE3<+(QYG.8O"L7R2@(8L6%#PP"KR]\RTH%(LAX
M/' FQY0!>#I^9O\M>H>7C7!\:]1'6?IZD4P3*KD2G?(/9O>6#WXF@:\PRL4G
M[?K8?)90T3EOF@,8"AJI^[=X.M3A!# =_0"0'P!YU-TGBBI_%5XLY];LR(9H
ML(5!M!K1$"=UV)2UMUB5P/GENMLX?NQ8>[K[@J>;IQZT83$M#A0W/47^ XHQ
MO3?:UX[N=,GEM_@4<HZ:\F=--_E9PO?"7M(X&U(^RK,S?..CQW'D&_]?C_1I
MM7'>XD3\<X;^ZDA_%>FO?J:$YRG^,)XIR^B7%],\R][0]XK?A0-<&%L*73#.
MB*]IM;ZEZ60R/(D>'*)7CJK.^IHME=+A&#DN26H*>093NGOLI-^#LT T+@7=
M*Z'/@Z[IUC2-]$WD%[K$'%B]95U(=O0G\*V5BL:C?M^&!*8 :H7>#X!B&^F\
M 9K$UC('+L+<=1O%N%DDVM::)XF[QFI/KX:ST0C7M!.6J0H-RE0DD=U4E401
M@HA&Z*["/G864LBUHN!+^@N)CYP%9$,C<AL]^%9B9-A)I1 4O'1,H4]0$X[S
MA3<7<1 NO734(4(1RUB?5EC4;XO2.;!=E&+OXM9=OR%MO PB'H*Y2"ZU]%(H
M.-I 3BWLELN!\/1R,IQ-9]2"+R8:(K) 8W7!"LKR,LN&L^OIUP#BJN+8Q>CW
M#G2'&](;7@?#SAG;)Q7*F9#/LFL-6B@6"2T\U@]%MBAQ.7!U*"VJVL$;1'*_
MLR9ZM*Q"$&KCT/;_ZYZD)VVG8=@*S=4!@%KU'>CX]=B_5WW;^AK>-W]<^:W4
MCA17@(XNKR<)V;ZA]A-OVMC$-L:C)<9AC7\0VQ" ]<K@E!XF(<'QK[;\%U!+
M P04    "  -2*M2XLN<#?DG  #8>0  &0   'AL+W=O<FMS:&5E=',O<VAE
M970Q."YX;6RM?>N/VT:6[_?Z*PBOLW #[+;4+W?'28"VX\QX=K+V=3LS%[C8
M#R6R)'%,D1H^NJ/YZ^_YG5,O4I3:SBPPR+0ELNK4>3]+/SS6S9=V;4R7_+XI
MJ_;'9^NNVW[_\F6;K<U&MV?UUE3TS;)N-KJC?S:KE^VV,3KGES;ER_/9[/KE
M1A?5LY]^X,\^-C_]4/==653F8Y.T_6:CF]T;4]://SZ;/W,??"I6ZPX?O/SI
MAZU>F7O3_;;]V-"_7OI5\F)CJK:HJZ0QRQ^?W<V_?S._Q@O\Q-\*\]A&?R<X
MRJ*NO^ ?[_,?G\T D2E-UF$)3?_W8-Z:LL1*!,<_[:+/_)YX,?[;K?X+'YX.
ML]"M>5N7?R_R;OWCLYMG26Z6NB^[3_7CGXT]T!76R^JRY?\FC_+L)3V<]6U7
M;^S+!,&FJ.3_]>\6$=$+-[,#+YS;%\X9;MF(H?Q9=_JG'YKZ,6GP-*V&/_BH
M_#8!5U2@RGW7T+<%O=?]]"=3F4:7R8N/=5EDA6E/?GC9T;KX]F5FUW@C:YP?
M6.,B^;6NNG6;O*MRDP_??TGP>*#.'5!OSH\N^*MNSI*+>9J<S\[G1]:[\(>\
MX/4N#JQWEV5U7W5%M4K<,9/_=[=HNX:8XG^.;'#I-[CD#2X/;/"S:;.FV#*?
MU<OD3=_2 VT[A<H_M%!RWS>53MY7V5GRHEN;Y#__X^;\?/;Z;;W9ZFK'_YJ_
M/E&/NDV**JN;;=WHSN3TC^2_S8/.=4(+?LBZ>F&:9'X%S,YN$UWE"<DW'FV3
MGHC7)#HAI.0FJ?3&  +9^"WQ>/&@&:S/)EM7=5FO"(MGR=\-R4!;K*HT,=6*
M@#6-PK(D=R5]\E T=45"W!&+9<0D#3$X[TJ':)(N6BHA#9/@:&_EL9*@?Q?>
M3^Y639$1&'UCDA=OW]V=T-ERDH]F=Y9\QFOO[OPG2='2>8TB^+'B4K=TP.YT
M150%#[2D$>JF3>S7OU4%4'7? 0U Y?S5Z\00M/6&UOZEJ3=):?1REZP:0^HH
M>?%%ER9-[A\+(DRVUDV>)AO:E__(&B+7"7U09$TM+Z@7@]?IA0>"AG;4G8!7
M-"W]U?2&]TEHI96A)4RWKHHL>3 KT^E%22ABQ&XT87;9]$5'H+1]MDZ(Z&#E
M1Z)M0YA,DT6ILR_V7_Q2H]NM_?>)ZNID >ILS99H3X]G?=9O%OPGJ1O=U5@#
MKV6ZJO2BH'^U-;'#MJGS/J/G$F"2CEIOP6YY#6064-+MMJY:0ZN0BFJ^D$W)
M=\1(14:X;@#F5C>=17O1*#(C2P**,+'4S0:4V4(@B\R<$:L3F9H'^MN1*29P
MFM1]0T\3KQ=;8JT!(]&'99^;[Y,7Q4E2%O_LB_P4BCO' 3)(4U:3%@ C[(@.
MFU8%CLS*@A!@/*_:)U):BQ;314/DJW)^V=#"6V9-)DOT()Y,EGU9GKHC.-'@
M,Q)MB,#,[R(Z^)364/%36;W9F"8KZ'!M1OP&%#2;VN+3;9>T6Y,52_J 4)Y%
M0KK465$67>$H^:)X(*!Z)B\;0U#7GC$W@!%$CM QP&@/Y '>@4"GA%PR>1;Z
M,>K.D@]$(K%@IO%4B0Z6@M,[<\IO$VD>0$U=GC9FU9?07@HD!ZO)^R*L9_=G
M_,);74&M$5,]@IGI_X6"1=494EDX)>&NK#/^DS356P^*;H#.FAC5+;[HBS+'
M02IR(P+N>"-^4IG?2='R(X2&QM )ET7'9S>_%RW_$=[#9L3755=:3FW,@ZE(
MOHEWC=Y /9&N)6\$YR:L-46Y(Y$F1=/VVVVYXVV8P2%P'4@CC#1!&Q ^\(I(
M8WR$1H.K5G9Y@@/6GL[4M[P426K-Z-!5,I_-TMEL1IY1#Q0MR:<X2_Y,KA[^
M35@5>_*F[DN"/E7D")&5R>N4*$":"RL36P-N0A8=SU3$^4RV HRJ,U8,"V;O
M!UWVYE3GY"_LRUQ=]DPS/%X/F(C [)*U*;=)L0''&*M):CY6R2HI(6CI[#LF
MWJXP)6GEFBSJIO@7!-$T*_GJD?8D4)=+^ -5MA-!:8E=6E+6X#7S4)</K"?
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M,]$SUC9!O9'2) &/5\AZ8*457B#J&.AB(J=NUT(!4A[8O861S.M'"EC_!>!
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M# .C3:[AU//!@) THH8G*?S5&HXQS,%[$9AZ2Z95U!MY7A0G8'V(7#G0S2_
M#1). 1<"*!TSHW *I"P0GYXD_%3. 8E7W$P3"KL1HV]C+@P0NN-2:.I%SZE%
MEWWJUHTQ,%'(9QKD,]6ONB'5[]*1'#U",;B="T8DJ48-^^:XU:W+AARZA/2(
M=PG=9LL"L7VR,QJA-9N%GVE5Y&+\?F)1%[H$YI5DZC5SZ/C1&?NX?%(777+0
MAYV<W$T*&.>AZ#_L+R[(W<EK8C"<T07MH),PLN<MCD27==V!O^";<<1#WMJ.
M.8//"-$O36<FMSV#&)#Q:FS8[E=.$\X+.5W]I()0CLO9R:'8O&9/07P<J[#O
MJHJB0A*N;=VPO7(B^%^>&(X*]-(>9H4(=@\!ZX_I,C"/Y4[#AE>3MROY'O:[
M46$HCD9VK[R^?W54.[_!0F"3MQXHIQ$^F:PD=Q5Y(U$>4[K_CZZN]E9GW 7M
M,(VD6.LXKNNL_>@GK  [P%WKD@:E=;X>US44&WGA,,+]@M1$H9$O_/,N;VK2
M1E7]X!3F7__ZUFMW_MJI]S/U'KH]<S%%0_Z'=B[[EC,_XCA9J12R&G*%Z32=
MMT<!+\?H>>/I>7,4XW]B-GDK;#)%L&]X'111 \O\%'EB'IXPP$3O?B..G4UJ
M.SJQ#^[B "BN$<.G2CQK/&)(6V@KQJ0#=%G\RSO%"*^ZUCO8DJ81HN#KLA W
M3O*__(@U'AG"*E;+SCT=QBC0F2%?E:M@;*S+1B\ACR5\:=@G/TONY4/W03KR
M4%J+.2-,RJ&/ .=SUB5R3 W[F[E92*0+'4H.C,4Z1>O*.?X(%>JVZ)S=YW1B
M*_K=:=D\!'-GR:_>REJS(X%/E<'CS<6[Y_RH=TO9":W[COU0AT12CJ2L#()
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MV\$&Q4C'!;:G+3HWCU1;[W)P/8&LX\W.WH7>3&N,URYM$ZF_-<N#)527M%7
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M_WTJ[R-S &$*P)5BI(PSF9WD-BJWT8&V7/3W]:TH-U0,ALIA<)TB)@C0$C0
MJ J H 2+9_LJ*DKPC^),_9C-@=_ B6Z+Q6\RAH;(29W[,OJQ7=+Q*_Y)8;[$
ML>KD=W?]IXG[V>([^;'>\+C\YO&O=MRP-$MZ=7;VBOR 1GY&6/Y!&H=_NG=1
M=V10^,^UT12%X0'Z'K^_X/Z!#?R/.?_T_P%02P,$%     @ #4BK4C]R_G->
M!   J H  !D   !X;"]W;W)K<VAE971S+W-H965T,3DN>&ULE5;?;Z-&$'[G
MKUC14]5*- 8,&%S;4I+FVCZ<&L5I^U#U80UCLPJPW.X2)_WK.[-@XHMBY^X%
M]M?,?#O?S.PL]E(]Z!+ L*>Z:O32+8UIYY.)SDNHN;Z0+32XLY6JY@:G:C?1
MK0)>6*&ZFH2^GTQJ+AIWM;!KMVJUD)VI1 .WBNFNKKEZOH)*[I=NX!X6[L2N
M-+0P62U:OH,UF#_;6X6SR:BE$#4T6LB&*=@NW<M@?I70>7O@+P%[?31F=).-
ME \T^;U8NCX!@@IR0QHX_A[A&JJ*%"&,SX-.=S1)@L?C@_:/]NYXEPW7<"VK
MOT5ARJ6;NJR +>\J<R?WO\%PGYCTY;+2]LOV_=E9Z+*\TT;6@S BJ$73__G3
MX(<C@=0_(1 . J'%W1NR*'_AAJ\62NZ9HM.HC0;VJE8:P8F&2%D;A;L"Y<SJ
M5VA \8K]<,\W%>@?%Q.#6FEOD@\:KGH-X0D-4_9)-J;4[*8IH/A2?H)H1DCA
M =)5>%;A)ZXNV#3P6.B'P1E]T_&*4ZMO>D+?99[+KC&BV;%;68E<@&;_7&ZT
M41@2_YXQ$(T&(FL@.F%@C9E2=!4PN65W0)E@;8&R.=/DP/[85&+'*0S134\M
M1B04S$BV 13(Y:X1_[UV7>^ILX8I8>>ZY3DL7<Q(#>H1W-5]"9@M!Q3M$0KY
M@L*!+U&H$04SI9+=KB3OAXPK8%RSK:PP>_7<(4KZG7MI>.7<O6<(-5=\L /-
M#B\ BH[+IGIF+1<%RS%ZB G-/K# BY.IY_L^CJ/H, KQG]#XV\RU7!F!H0V?
M.]%B'3&O[65HS>IER6 )5V:AM62O][X?"7/@!6$V@CZ,<#F>I79R)L3B,<3B
M;PBQ1V@Z8)MGMI:=RN&MP#FK[G3@]$33A0W5 Z;!$/O*E([![6M9M[QY_OZ[
M- QF/Y.W1RC:0ID[6"L9';TO%<!0&L:P\9V;D0S>%$P_:P.U9IIC[;%,!\A_
ME*0V%A)D/8L2Y^8H;DA*HGY\5Q"UR%$L2 //3Z<LP)H19X&S+D7;'LZ6^*EH
M$@9>-DO9+/"F:3K2V\,GPU,,A3C,K.'4S[PLC,\1EXS$)5]-W+K$=/J)WI#"
M>A*?-AM%.-%&O\7B6=U?PZ+0C!\>7(*@CR#D1Q!L/6@T>E,T>=5A(<>!Y1'3
MI: =FS@:ZV=A\TL;_!&/FM1BCZ"&A-@._!O+?]T_#4!/ \/"GI=C9;?T4$R\
M&S/K$Z#9 /H8\]PA9Q*F%W*#R NF,0Y2+XY3Y[)X!*P,^A BZ)L'L,_#Z(3$
MBV81!D46A,ZMDD67&WSJ'[&%Z6,W)\+P5))%^(VCV%EC7X$J/+8;'E32S M\
ML04]--1ZO*A'%Z13#%BL->DL&H+Q%#5OW?($%Z^H^,#B#&^>D LRWTO3[,V(
MGAQU#S6HG>V1-+./9M](C*MC&W;9=Q\OQ_L>#AG&5-6L@BV*^A<S+$.J[XOZ
MB9&M[44VTF!G8X<EMI*@Z #N;Z4TAPD9&)O3U?]02P,$%     @ #4BK4H[Y
MZ>9J P  W0<  !D   !X;"]W;W)K<VAE971S+W-H965T,C N>&ULC55M;^,V
M#/[N7T$8'= ":?R6Y)(B"9"V*V[ %0O:W@W#L ^*3<?&298GR4W[[T?)CB_=
M)<&^))9$/GQ(/J+F.ZF^ZP+1P)O@E5[XA3'U31#HM$#!]%#66-%)+I5@AI9J
M&^A:(<N<D^!!'(:30+"R\I=SM[=6R[EL#"\K7"O0C1!,O=\BE[N%'_G[C:=R
M6QB[$2SG-=OB,YJO]5K1*NA1LE)@I4M9@<)\X:^BF]NQM7<&WTK<Z8-OL)EL
MI/QN%[]E"S^TA)!C:BP"H[]7O$/.+1#1^*?#]/N0UO'P>X_^X'*G7#9,XYWD
M?Y29*1;^U(<,<]9P\R1WG['+QQ%,)=?N%W:M[6CF0]IH(T7G3 Q$6;7_[*VK
MPX'#-#SA$'<.L>/=!G(L[YEAR[F2.U#6FM#LATO5>1.YLK)->3:*3DOR,\LO
M2"EIN'QA&X[Z:AX8 K5'0=H!W+8 \0F !!YE90H-OU899A_] R+3,XKWC&[C
MLX"/3 TAB080AW%T!B_I,TP<7G(^P[]6&VT4B>#O,YBC'G/D,$<G,)_I;F0-
M1Y Y.'RXD]H<*]YYG)<"@3O_E/P'D#)=0$X710.K,D^: A6457OWVFO F<$,
MC 0Z@P>6EKPT[QV)'2H$IB&7W&+<>"1<9_=2*,0/C0(J<UK8.GNVSM[O-2H*
M46T/^, %C$>#.(X/3AU#NMR6).1*"I#_\;R R6PP'8V\E;;EZ>/ T3C*WIIK
MF5\WVE+7&FW8>#8:S,+P)VM>LHU+F$K5*(65,YXD@\DD/F?,9;6]-J@$F4?A
M9#"=1=X3VIGUP]P=1\,1O"-3VKLO=2H;"D"8".-A&,(O9Y0S[I4S_M_*>6A,
M0PU;557#.#P2&=&(KI5K]DZCS^ACFCH;P4[Q&UVS%!<^C6F-ZA7]91>*M:%$
M%ZI-O.Y">:2O(Z)B1]KXL]+^M$4#=-*ZQQ3%AI2[5Q=<XEO*F\P6VT8P3HZB
ME2-^E*/#OX(XB@=A'%KW&*)/H6O9BS0GV4,RC0>S*/*^H-90BKJQ]Z2LJ*U(
M4KXDO&0\A2MO;8M"?7UEO'%M.(%W 0F%'8\3.-;VX&#D"E1;][!H<))IIV^_
MV[]=JW9D_S!O'SY*?5M6FN+GY!H./U%_5?N8M LC:S? -]+0<^ ^"WI_45D#
M.L^E-/N%#="_Z,M_ 5!+ P04    "  -2*M2.EVA%:@"  !G!0  &0   'AL
M+W=O<FMS:&5E=',O<VAE970R,2YX;6R%5$U/&S$0O>=7C%:H FG%?I./)I$"
M%)4#$H*V'*H>G-U)UL)K;VV'P+_OV)ML4PG22]9CSWOS9N+GZ5;I9U,C6GAM
MA#2SH+:VG421*6MLF#E7+4HZ62G=,$NA7D>FU<@J#VI$E,;Q1=0P+H/YU._=
MZ_E4;:S@$N\UF$W3,/UVB4)M9T$2[#<>^+JV;B.:3UNVQD>TW]M[35'4LU2\
M06FXDJ!Q-0L6R>0R=_D^X0?'K3E8@^MDJ=2S"VZK61 [02BPM(Z!T><%KU (
M1T0R?N\X@[ZD QZN]^PWOG?J9<D,7BGQQ"M;SX)1 !6NV$;8![7]BKM^"L=7
M*F'\+VR[W"P-H-P8JYH=F!0T7'9?]KJ;PP%@%'\ 2'> U.ON"GF5U\RR^52K
M+6B736QNX5OU:!+'I?M3'JVF4TXX.[^5+RBMTF]P^HTM!9JS:62)UYU&Y8[C
MLN-(/^#(X$Y)6QOX(BNL_L5'I*<7E>Y%7:9'">^8/H<L"2&-T^0(7]8WF7F^
M[+]-7G-3"F4V&N'G8FFLIEOQZTB%O*^0^PKY!Q4>R2S51B"H%?35WIOD41KG
MP(EI68FS@"QF4+]@<*"^5&0&8[%R96R-L%*"7,7E>C*@F96U']HUEM@L4;M@
MX";HQA@/;KCD=$\J6"M5&3B!+"W"O$AHE<9).!R.!D]D(. 26JW65-Y $H?Q
M*(,\3+-D\,"V=/,L:LZ$@728ANEX#&F2ATE>#!9."9.E$Z4!7TN'_\2:]C.H
MI5$"+1)U?]E&H_!BF,,9G(ZS,,X+.!OT?88@Z34Z@2(9ATDQ]E*'81*/X;U_
M*CJX_ WJM;>XH5EMI.U\T._VK\BB,\_?].X)HAFNN30@<$70^'Q8!* [6W>!
M5:VWTE)9,J9?UO02HG8)=+Y2RNX#5Z!_6^=_ %!+ P04    "  -2*M2>*3E
M/Z\"  "L!0  &0   'AL+W=O<FMS:&5E=',O<VAE970R,BYX;6R%5$UOVS ,
MO?M7",8.+6#4GTF<( F0M!TV8 6"=NL.PPZ*S<1"9<F5Y*;]]Z/DQ$N'-+M8
MI$0^\E%^FNZD>M(5@"&O-1=ZYE?&-),PU$4%-=57L@&!)QNI:FK05=M0-PIH
MZ9)J'B91- QKRH0_G[J]E9I/96LX$[!21+=U3=7;$KC<S?S8/VS<LVUE[$8X
MGS9T"P]@?C0KA5[8HY2L!J&9%$3!9N8OXLDRL_$NX)'!3A_9Q#)92_EDG:_E
MS(]L0\"A,!:!XO("U\"Y!<(VGO>8?E_2)A[;!_3/CCMR65,-UY+_9*6I9G[N
MDQ(VM.7F7NZ^P)[/P.(5DFOW);LN-L.*1:N-K/?)Z-=,="M]W<_A*"&//DA(
M]@F)Z[LKY+J\H8;.ITKNB++1B&8-1]5E8W-,V$MY, I/&>:9^4KA_2KS1J@H
MR>USRQJ<N"$7W^F:@[Z<A@:+V-"PV ,N.\#D \"4W$EA*DUN10GE^_P0F^L[
M3 X=+I.S@'=479$T#D@2)?$9O+1GG#J\]#^, [+B%*F^)_YKL=9&X;_R^TRI
MK"^5N5+9!Z4>4$)ERX'(#3D]Z%/S/8MI13K1#2U@YJ,*-:@7\-_?(O1D"HGB
MT09*#QLP%9"-Y*A")K83#\=:5&ZN-U! O09E'<\.V4XZ\CZW2C#3*O@']!/)
MXB@893E:Z3@/LB3Q'J%B!?XO)!X$413M%^\;H%XJR4O"ZD;)%[  FB1X'(_3
MP^H-LR@89S$9)GDPC ?>HBC:NN44&T>!(<N"42?ABVP\#N)X2"[1S*,@SU-R
MZ9TF'Q !MMDXBX,\&3AK%(S2A)RZV/!(036HK7LG- ZP%:834[_;/T6+3H%_
MP[MW# >[94(3#AM,C:Y& Y^H[FWH'",;I\>U-*AN9U;XG(*R 7B^D=(<'%N@
M?Z#G?P!02P,$%     @ #4BK4A:QTQ_) @  Z 4  !D   !X;"]W;W)K<VAE
M971S+W-H965T,C,N>&ULC51-C]HP$+WG5UC1'EHIVGR'@  )=ENU4E=%R[8]
M5#V89"#6.G%J.PO[[SM.0J#J@GHAGO',>S//S$SW0CZK D"30\DK-;,+K>N)
MZZJL@)*J6U%#A3=;(4NJT90[5]42:-XFE=P-/"]Q2\HJ>SYM?2LYGXI&<U;!
M2A+5E"65KTO@8C^S??OH>&2[0AN'.Y_6= =KT-_JE43+'5!R5D*EF*B(A.W,
M7OB3963BVX#O#/;J[$Q,)QLAGHWQ.9_9GBD(.&3:(%#\O, =<&Z L(S?/:8]
M4)K$\_,1_6/;._:RH0KN!/_!<EW,[-0F.6QIP_6CV'^"OI_8X&6"J_:7[+O8
M.+1)UB@MRCX9*RA9U7WIH=?A+"'U+B0$?4+0UMT1M57>4TWG4RGV1)IH1#.'
MMM4V&XMCE7F4M99XRS!/SQ=9)II**[*BKW3#@= J)^B4#>3D"Z,;QIEFH,B[
M)W.MWD]=C;0FV<UZBF5'$5R@",F#J'2AR(<JA_SO?!?+'6H.CC4O@ZN #U3>
MDM!W2. %_A6\<- @;/'""WA]Z^K4.^6*_%QLE);XK_EUA2(:***6(KI L<9A
MRAN45VS)_TK^EM)76<P 3U1-,YC9.*$*Y O8IQ>NS^AH3\=/=%8F<-241B\6
MJ0L@6\%Q9EFUFU@H>5:TFM]#!N4&I#$L\P#F%3SK'Y8;DB:>XZ4C/(W]U$G"
ML;6F1N5,E"539JI/T7[H)-&81*D3)*%U% -O)=9P7B4)1K'C!1$)TM3Q1KZU
MDB)O,DWV5$I:Z=>N-<I)D$3..$Z(/PJ=,(FMK]B2'!J' ZXUA7CA*''B\9B$
M<>(D06@]"8W)-\1W1F//"?VX.Z<(EOCDK;^">S9])<A=NV-,FZA'-XB#=UAC
MBVYZ3^'=#D29=PQEX;#%5.]V%-M$=GNE,[2HVUG>"(V;H3T6N(I!F@"\WPJA
MCX8A&);[_ ]02P,$%     @ #4BK4EYRY=*P!   <Q$  !D   !X;"]W;W)K
M<VAE971S+W-H965T,C0N>&ULQ5A;;^(X%'[/KSA"?6@E2D*XM@*DWF:G#[VH
MG78>5OM@D@-$36S&=DHK[8_?8R<$4$GHH)G9AQ;'/G=_YXN=P4+(%S5#U/"6
MQ%P-:S.MYZ>NJX(9)DPUQ!PYK4R$3)BF1SEUU5PB"ZU2$KN^YW7=A$6\-AK8
MN7LY&HA4QQ''>PDJ31(FW\\Q%HMAK5E;3CQ$TYDV$^YH,&=3?$3]-+^7].06
M5L(H0:XBP4'B9%@[:YZ>GQAY*_ <X4*MC<%D,A;BQ3Q<A\.:9P+"& -M+##Z
M><4+C&-CB,+XD=NL%2Z-XOIX:?V+S9UR&3.%%R+^'H5Z-JSU:Q#BA*6Q?A"+
MKYCGTS'V A$K^Q\6F6RW58,@55HDN3)%D$0\^V5O>1W6%/I>B8*?*_@V[LR1
MC?*2:38:2+$ ::3)FAG85*TV!1=QLRF/6M)J1'IZ=/4CC?0[7/, N:D/W,>,
MP^$W-HY1'0U<33Z,I!OD]LXS>WZ)O1;<"*YG"JYXB.&FODNQ%0'ZRP#/_4J#
M-TPVH-6L@^_YS0I[K2+AEK77+K'W2+ .TQA!3. !E991H#&$1RV"%WCBD59P
M9I!"5=F6?:5QTT&G:LX"'-:H113*5ZR-RKPL&\%$HF<(#X]/"MB"22J<HP5@
M,H_%.Z*J0QA)0K&0M,Y#" 17!#K&R4I*9996W?>:/<BWTVYBF,J(3^V:GDE$
M2+*=0;,S0'4-9D5AZ\ D@HV9FT C;O0<;6  8].ZI\YMFHS)%T5K$W"^6\23
M\-DK2FI@^$M22,<$0X0O+)+PS.(4G;/I5.+43%YSJ@.U<Y"OW*5:418A15F'
M2PS0VL]#\N 8#N#8L4;)R;'S3'6D@:F 0JUC&B\B/0,U,[%'2J6,4$R"U*X3
MC$C6#<Q,;+4WG&TFGWF""G"U"W"U*\'U80_^OK%)_0/_PM5R.VT&%VM[N!2J
M"*!3!-#Y-+HSL-W-+?M58;K2Y'9,%^!U<O!RP8]_I"R.)A&56UG7PKI6,,VW
M<!W3OQC(3C60H03(=WF$'Z!\]88RB!31(74N?EQ_0//",U'11FI)[Q;*';ZA
M3&!OO#?;=;_3K'N>1W#T&EZ_!?U&:Z,):+75J?=SB6:+E$C0BBPC#M<;P,[/
MB3QV=4"S4_?[W<*RUV^3;W_=L"G@3ZA5=5.W '.W&LPK?KPE>+UF_7^[@;1/
M@[S2U0Z0FPCX*H(-K#N;6&=Y"$#GI?W0;A3WX6QG3ZAO9>UR%)>P/.U*5IU2
M)E_^E8'9;^<23;]?[[1;2[X_7,D=E4BNX3V';(YY^[06VE;>/]C-_[T"L;V]
M^?^R>(=_@N_[A</^K^?[2I.?:(4/?.^4\OWJX/);#RH9Z)W_E]_A\("X^V@7
MS??J;<];L7RW![U&A\9^O=?WUHX[6PG=O; GFO@GJ'V;/[_PM_2RE=Z[FZJ]
M%JGV=O7*20'=DS_'[I6N?A.[?PK;^[+YOL#^ VQNCR@6%80)_\1 Z20'2:M?
M]SWOXYF][$A23LT[G6R%H+MV$4Y03NUU7]&;-^4ZNQ,7L\47A;/L(KT2SSY'
M4#Q3*A3$."%5K]&C4[+,KOC9@Q9S>ZT>"TV7=#N<(2,@& %:GPBAEP_&0?&=
M9?0?4$L#!!0    (  U(JU*A39RW @,  (,'   9    >&PO=V]R:W-H965T
M<R]S:&5E=#(U+GAM;)U5;4_;,!#^GE]QBO9ADZ )*054M95:8!K2V"K*X+.;
M7!.+Q,YLA[+]^IV=UH2M[::I4N.7N^>>.S]GC]92/>D"T<!+50H]#@MCZF$4
MZ;3 BNF>K%'0SDJJBAF:JCS2M4*6.:>JC)(X/HLJQD4X&;FUN9J,9&-*+G"N
M0#=5Q=2/&99R/0Y/PNW"'<\+8Q>BR:AF.2[0?*OGBF:11\EXA4)S*4#A:AQ.
M3X:S@;5W!@\<U[HS!IO)4LHG.[G)QF%L"6&)J;$(C#[/>(EE:8&(QO<-9NA#
M6L?N>(O^T>5.N2R9QDM9/O+,%./P(H0,5ZPIS9U<?\)-/HY@*DOM_F'=V@[(
M.&VTD=7&F1A47+1?]K*I0\?A(M[CD&P<$L>[#>187C'#)B,EUZ"L-:'9@4O5
M>1,Y+NRA+(RB74Y^9O+(E&+":'A_SY8EZ@^CR!"LW8S2#<2LA4CV0/3A5@I3
M:+@6&69O_2.BXSDE6TZSY"#@+5,]Z)\<01(G)P?P^C['OL/K_R7' U"G'NK4
M09WN@5I04V1-B2!7\+4QVC"1<9&#+Z.1,&]46I!0X%)6%0EO863ZM*NL!T/9
M;ASJFJ4X#JG=-*IG#"?W!<)*EM1*-JJQ1[;I)_X3=<!%VZ96[VMN"FH;79/^
M+2W9H;ONT*VW=-.6KK9T(6N4BT#Q3*$0H6K/&.T9 YU06O@C&@:/3OR8^0%,
MGU%14P=?FFJ)*MA,X?H%5<HIV!W:&\.&^,Q7&$SS7&'.#,*-,!0YY6G0K>]<
M\=3N;:7VP,H&WU@P U>8HHVV)1;#^='@+#D:Q#&\@[B7#.#,#H(;K1OB>-S^
M@BVI[DK-%<U;/W(_=GZ_Q7M;A3W!X(#J!EYU@W]6G5=:A\PN<1U$_!]Q05=<
M;$ER\C(*Y*'"#/]4Q:XD?&;^/*!VI]ZU\0H(7(5?2][?6>>H<S%6J')W_6M2
M>B-,>T?Z5?_"3-N+]=6\?9XHIYP+#26NR#7NG5.!57OEMQ,C:W?-+J6A2]L-
M"WHE45D#VE]):;83&\"_NY-?4$L#!!0    (  U(JU(,%42V) 4  $D7   9
M    >&PO=V]R:W-H965T<R]S:&5E=#(V+GAM;*U876_;-A3]*X2P 2V06B(E
M^2.P#21.N^8A79"LV\.P!T:ZMHE(HDO2=C+LQX^4%,F.94I)G8=8'[R'AX>\
M]U <;[EXE$L A9[2)),39ZG4ZMQU9;2$E,H>7T&FW\RY2*G2MV+ARI4 &N=!
M:>(2S^N[*669,QWGSV[%=,S7*F$9W HDUVE*Q?,E)'P[<;#S\N".+9;*/'"G
MXQ5=P#VH[ZM;H>_<"B5F*622\0P)F$^<"WP^\WT3D+?XD\%6[EPC,Y0'SA_-
MS74\<3S#"!*(E(&@^F<#,T@2@Z1Y_"A!G:I/$[A[_8+^)1^\'LP#E3#CR5\L
M5LN),W10#'.Z3M0=WWZ%<D"AP8MX(O/_:%NV]1P4K:7B:1FL&:0L*W[I4RG$
M3H#&:0X@90!Y'1 <"?#+@%PYMV"6#^N**CH="[Y%PK36:.8BUR:/UJ-AF9G&
M>R7T6Z;CU/0WR$#0!'VX D59(M$W*@0UTGY$G]#W^ROTX9>/8U?IKDR &Y6P
MEP4L.0+KHQN>J:5$G[,8XOUX5U.L>)(7GI?$"GA#10_Y^ P1C^ &/K/NX9Z%
MCE_)YN=XP1&\&95+O7P2FD6 E*"9G(,0$"/%]>/L42_/B*\SU:1<@=S/D4V6
M;:9XZ.F_L;MI8!14C (KHSN02K!(:0Z1)M?4<7#0\;#?'PV:^PVK?D-KO[=<
M0:8839)G%+-D;98.@A]KIIX1RS2GM4YZ)9%:4H6H !3Q; -"L8<$= .M5\33
M5">T7NK18Q/MHO]PA[;OD6#D[RA6+('#AD$X"(;!,6G[U1#[UB%>IRO*A!D&
MXG.TX#S>LB1IHFK%,17Y7*YH!!-'EUP)8@/.%%E6XZ B.&B9^PUD:]!E->*+
MC/W[.N,*>0:'TQ^.!E[8+,ZPZGO8TK<Q"Y8MT I$;BLF)?A#PA;4%&K9I-/P
M, 5P.!@>38)116;T<V3.S(M(SZ2VJ"9B=G@\Z'G>KY8)PUY==CTKU.>G%>3)
MFB][M-*I"VC#$TTST:G36''MB#@DO1!;V>V8 N[&3H%(&[G8X[&'GH$*:2-#
M:C+$/JE,/GZ:"\C+!>C$44@[5./TM2#A'K%/7UW^L;W^WR]-*3/[A]C4+[VI
MDOD"0_!DKIO)'1;^<(3]_JLJUM ,C[SA<-2<&K@V"&QWB%F^FP"!9CPS*2 *
MQD9>]/<-I \@_D'_H7N:@$1E23E#W_16<N=M!?)[!M5SFZ2UCV"[D>RS$H:5
M/5=;\/SA8;*6"ML#V[.\-@YL=X[32O['EG>2O+8-;/>-MTMNQ\/]HY*_/7!_
M3+4=8;L?G5CRI:D[742O+0K;3>3MHK>8$CXJ>DN@UR(ZJ=V,V+WGM*)_X6O1
M17-2^QFQ^]%;-9^UX+5+5[L;L7M21^DNBN\)HUX$;$/-[ODGRC*IG8ZT?.F\
M=;FVX/4;I"LUMP>&HS;-:R<D)W'"KIIWK,NDMD)R8BMLP?./EHB60-S@H?MC
MJJV0G,0*.VO>M3"3V@W):=UPUH*'PS;Q:E,C=E,SAQ[H.J=G/J\OME3$LM/H
M:ULB=C=XSXZVA-S;T9+!*'BUHVUHYO>#OM^\H?5KU_'MKJ-5(5U$\&N?\.UU
M_5T?LR7FWKE#,#KZ+>O7UN!WMP:]+"/5:<K]G3,L>T5]WV@//T_,D?'A<-V=
M0TD]B$5^5BM1GM[%N5_UM#H/OLA/05\]O\3GL^)4MX8I#IEOJ%BP3*($YAK2
MZPWT'(CBW+:X47R5'WT^<*65S"^70&,0IH%^/^=<O=R8#JK3\^G_4$L#!!0
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MJ+P9S"=&9JX!FTJ#[9P;+K"!!F4/X/Y,2K.9V)ZN;,F'?P%02P,$%     @
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M#I)N&+=[_K9._]@K[ 9IVJW<WM!L531;)VG:BG E0SEH\NL!\AFHWR?T2ZK
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MI/3.![@YLBGD34>+I:V%<Z&QLMIFB6\?2+, YQ="Z&W'!.A>T_0O4$L#!!0
M   (  U(JU+)UW: ]@(  &4*   9    >&PO=V]R:W-H965T<R]S:&5E=#,V
M+GAM;+U6VVZC,!#]%0OM0RNU!7-)2)5$:I.MME(K18W:?5CM@P.3@&HPM4W2
M_OW:0,B-TNRJW1>P8<[,F3-FF/Z*\6<1 4CTFM!4#(Q(RNS2-$4004+$!<L@
M56_FC"=$JBU?F"+C0,("E%#3MJR.F9 X-8;]XMF$#_LLES1.8<*1R).$\+=K
MH&PU,+"Q?O 0+R*I'YC#?D86, 7YF$VXVIFUES!.(!4Q2Q&'^<"XPI<C[&I
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MS6R[Y=:\OBBM@SE?"S.1K6$'O'O/TW]02P,$%     @ #4BK4OA)D>]M P
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MP8,&^+J'>@?\8Q_S8:OYFV[X&I)G>#C[%^YCSNK$#>O$#1W?N(7O^Y:S/35
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M'?@@,R)05E<'S*#QV\#"#/K\IIT$-I8E_,D5PBV5<<YE*1#^GC]()73<_>,
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MI3&@[QLA]'YB K2/[_P74$L#!!0    (  U(JU)L)W6[M0,  -4-   9
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MG$C7TN#YMKC=XG<7*-L!WT=2FJ>&/>367W*S?P%02P,$%     @ #4BK4BM
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M@ <,B:+Z'-P[C\+U.15N?F<:_P)02P,$%     @ #4BK4I>*NQS     $P(
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M;%!+ 0(4 Q0    (  U(JU)AR%$)[0   "L"   1              "  :\
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M2P$"% ,4    "  -2*M2U,ZM21X#  !0"P  &               @($;$P
M>&PO=V]R:W-H965T<R]S:&5E=#,N>&UL4$L! A0#%     @ #4BK4I@1.=VA
M!   41   !@              ("!;Q8  'AL+W=O<FMS:&5E=',O<VAE970T
M+GAM;%!+ 0(4 Q0    (  U(JU)>5(K++P8  %8D   8              "
M@48;  !X;"]W;W)K<VAE971S+W-H965T-2YX;6Q02P$"% ,4    "  -2*M2
M.FX=(&P&  !R&@  &               @(&K(0  >&PO=V]R:W-H965T<R]S
M:&5E=#8N>&UL4$L! A0#%     @ #4BK4J.R@P,*)P  ^G(  !@
M     ("!32@  'AL+W=O<FMS:&5E=',O<VAE970W+GAM;%!+ 0(4 Q0    (
M  U(JU)KC7=XNP@  !$5   8              " @8U/  !X;"]W;W)K<VAE
M971S+W-H965T."YX;6Q02P$"% ,4    "  -2*M2F^1(TD8#  #^!@  &
M            @(%^6   >&PO=V]R:W-H965T<R]S:&5E=#DN>&UL4$L! A0#
M%     @ #4BK4HU.WA,: P  M 8  !D              ("!^EL  'AL+W=O
M<FMS:&5E=',O<VAE970Q,"YX;6Q02P$"% ,4    "  -2*M2Q0C?%,0"   +
M!@  &0              @(%+7P  >&PO=V]R:W-H965T<R]S:&5E=#$Q+GAM
M;%!+ 0(4 Q0    (  U(JU)[T,/ILP,  -0'   9              " @49B
M  !X;"]W;W)K<VAE971S+W-H965T,3(N>&UL4$L! A0#%     @ #4BK4LU8
MKK5$"   /10  !D              ("!,&8  'AL+W=O<FMS:&5E=',O<VAE
M970Q,RYX;6Q02P$"% ,4    "  -2*M2-$T92K\(   ]&P  &0
M    @(&K;@  >&PO=V]R:W-H965T<R]S:&5E=#$T+GAM;%!+ 0(4 Q0    (
M  U(JU*!-T%^X0(  +<&   9              " @:%W  !X;"]W;W)K<VAE
M971S+W-H965T,34N>&UL4$L! A0#%     @ #4BK4K#R3"!E!0  T@L  !D
M             ("!N7H  'AL+W=O<FMS:&5E=',O<VAE970Q-BYX;6Q02P$"
M% ,4    "  -2*M24K.=WT@#  #A!@  &0              @(%5@   >&PO
M=V]R:W-H965T<R]S:&5E=#$W+GAM;%!+ 0(4 Q0    (  U(JU+BRYP-^2<
M -AY   9              " @=2#  !X;"]W;W)K<VAE971S+W-H965T,3@N
M>&UL4$L! A0#%     @ #4BK4C]R_G->!   J H  !D              ("!
M!*P  'AL+W=O<FMS:&5E=',O<VAE970Q.2YX;6Q02P$"% ,4    "  -2*M2
MCOGIYFH#  #=!P  &0              @(&9L   >&PO=V]R:W-H965T<R]S
M:&5E=#(P+GAM;%!+ 0(4 Q0    (  U(JU(Z7:$5J (  &<%   9
M      " @3JT  !X;"]W;W)K<VAE971S+W-H965T,C$N>&UL4$L! A0#%
M  @ #4BK4GBDY3^O @  K 4  !D              ("!&;<  'AL+W=O<FMS
M:&5E=',O<VAE970R,BYX;6Q02P$"% ,4    "  -2*M2%K'3'\D"  #H!0
M&0              @('_N0  >&PO=V]R:W-H965T<R]S:&5E=#(S+GAM;%!+
M 0(4 Q0    (  U(JU)><N72L 0  ',1   9              " @?^\  !X
M;"]W;W)K<VAE971S+W-H965T,C0N>&UL4$L! A0#%     @ #4BK4J%-G+<"
M P  @P<  !D              ("!YL$  'AL+W=O<FMS:&5E=',O<VAE970R
M-2YX;6Q02P$"% ,4    "  -2*M2#!5$MB0%  !)%P  &0
M@($?Q0  >&PO=V]R:W-H965T<R]S:&5E=#(V+GAM;%!+ 0(4 Q0    (  U(
MJU+1"[D^[P(  )X+   9              " @7K*  !X;"]W;W)K<VAE971S
M+W-H965T,C<N>&UL4$L! A0#%     @ #4BK4CW;HH'X @  :0D  !D
M         ("!H,T  'AL+W=O<FMS:&5E=',O<VAE970R."YX;6Q02P$"% ,4
M    "  -2*M2-(XB^Q8#   _"@  &0              @('/T   >&PO=V]R
M:W-H965T<R]S:&5E=#(Y+GAM;%!+ 0(4 Q0    (  U(JU+\F &VY ,   T-
M   9              " @1S4  !X;"]W;W)K<VAE971S+W-H965T,S N>&UL
M4$L! A0#%     @ #4BK4KW/_6CS @  EP@  !D              ("!-]@
M 'AL+W=O<FMS:&5E=',O<VAE970S,2YX;6Q02P$"% ,4    "  -2*M2+)#B
M:W0"  #_!0  &0              @(%AVP  >&PO=V]R:W-H965T<R]S:&5E
M=#,R+GAM;%!+ 0(4 Q0    (  U(JU(+Y4)X4 (  ,\%   9
M  " @0S>  !X;"]W;W)K<VAE971S+W-H965T,S,N>&UL4$L! A0#%     @
M#4BK4L+^XYBC @  _ 8  !D              ("!D^   'AL+W=O<FMS:&5E
M=',O<VAE970S-"YX;6Q02P$"% ,4    "  -2*M2ED%.G9P"  !9!P  &0
M            @(%MXP  >&PO=V]R:W-H965T<R]S:&5E=#,U+GAM;%!+ 0(4
M Q0    (  U(JU+)UW: ]@(  &4*   9              " @4#F  !X;"]W
M;W)K<VAE971S+W-H965T,S8N>&UL4$L! A0#%     @ #4BK4E5.59W) @
MX <  !D              ("!;>D  'AL+W=O<FMS:&5E=',O<VAE970S-RYX
M;6Q02P$"% ,4    "  -2*M2*\;,458"  #;!0  &0              @(%M
M[   >&PO=V]R:W-H965T<R]S:&5E=#,X+GAM;%!+ 0(4 Q0    (  U(JU+X
M29'O;0,  /T*   9              " @?KN  !X;"]W;W)K<VAE971S+W-H
M965T,SDN>&UL4$L! A0#%     @ #4BK4M/!GS@U!0  OAP  !D
M     ("!GO(  'AL+W=O<FMS:&5E=',O<VAE970T,"YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    (  U(JU+V\M7QH (  %D(   9              "
M@6@+ 0!X;"]W;W)K<VAE971S+W-H965T-#4N>&UL4$L! A0#%     @ #4BK
M4E>>#O/# @  B <  !D              ("!/PX! 'AL+W=O<FMS:&5E=',O
M<VAE970T-BYX;6Q02P$"% ,4    "  -2*M2;"=UN[4#  #5#0  &0
M        @($Y$0$ >&PO=V]R:W-H965T<R]S:&5E=#0W+GAM;%!+ 0(4 Q0
M   (  U(JU(K0+=R(P,  '02   -              "  245 0!X;"]S='EL
M97,N>&UL4$L! A0#%     @ #4BK4I>*NQS     $P(   L
M ( !<Q@! %]R96QS+RYR96QS4$L! A0#%     @ #4BK4E#<..+K P  1Q\
M  \              ( !7!D! 'AL+W=O<FMB;V]K+GAM;%!+ 0(4 Q0    (
M  U(JU*Y(]HWL@$  %0<   :              "  70= 0!X;"]?<F5L<R]W
M;W)K8F]O:RYX;6PN<F5L<U!+ 0(4 Q0    (  U(JU)EX9FUMP$  &4<   3
M              "  5X? 0!;0V]N=&5N=%]4>7!E<UTN>&UL4$L%!@     W
- #< ^ X  $8A 0    $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.21.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>114</ContextCount>
  <ElementCount>353</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>49</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>5</UnitCount>
  <MyReports>
    <Report instance="srna-20210331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/DocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="srna-20210331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>00000002 - Statement - Condensed Consolidated Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/BalanceSheets</Role>
      <ShortName>Condensed Consolidated Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="srna-20210331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>00000003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/BalanceSheetsParenthetical</Role>
      <ShortName>Condensed Consolidated Balance Sheets (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="srna-20210331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>00000004 - Statement - Condensed Consolidated Statements of Operations (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/StatementsOfOperations</Role>
      <ShortName>Condensed Consolidated Statements of Operations (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="srna-20210331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>00000005 - Statement - Condensed Consolidated Statements of Changes in Shareholders' Deficit (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/StatementsOfChangesInShareholdersDeficit</Role>
      <ShortName>Condensed Consolidated Statements of Changes in Shareholders' Deficit (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="srna-20210331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>00000006 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/StatementsOfCashFlows</Role>
      <ShortName>Condensed Consolidated Statements of Cash Flows (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="srna-20210331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>00000007 - Disclosure - General</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/General</Role>
      <ShortName>General</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="srna-20210331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>00000008 - Disclosure - Leases</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/Leases</Role>
      <ShortName>Leases</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="srna-20210331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>00000009 - Disclosure - Inventory</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/Inventory</Role>
      <ShortName>Inventory</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="srna-20210331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>00000010 - Disclosure - Property and Equipment</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/PropertyAndEquipment</Role>
      <ShortName>Property and Equipment</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="srna-20210331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>00000011 - Disclosure - Accounts Payable and Accrued Liabilities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/AccountsPayableAndAccruedLiabilities</Role>
      <ShortName>Accounts Payable and Accrued Liabilities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="srna-20210331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>00000012 - Disclosure - Note Payable and Accrued Interest</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/NotePayableAndAccruedInterest</Role>
      <ShortName>Note Payable and Accrued Interest</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="srna-20210331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>00000013 - Disclosure - Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/CommitmentsAndContingencies</Role>
      <ShortName>Commitments and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="srna-20210331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>00000014 - Disclosure - Equity Incentive Plan</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/EquityIncentivePlan</Role>
      <ShortName>Equity Incentive Plan</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="srna-20210331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>00000015 - Disclosure - Warrants</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/Warrants</Role>
      <ShortName>Warrants</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="srna-20210331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>00000016 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/IncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="srna-20210331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>00000017 - Disclosure - Subsequent Events</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/SubsequentEvents</Role>
      <ShortName>Subsequent Events</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="srna-20210331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>00000018 - Disclosure - General (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/GeneralPolicies</Role>
      <ShortName>General (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="srna-20210331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>00000019 - Disclosure - General (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/GeneralTables</Role>
      <ShortName>General (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://surna.com/role/General</ParentRole>
      <Position>19</Position>
    </Report>
    <Report instance="srna-20210331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>00000020 - Disclosure - Leases (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/LeasesTables</Role>
      <ShortName>Leases (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://surna.com/role/Leases</ParentRole>
      <Position>20</Position>
    </Report>
    <Report instance="srna-20210331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>00000021 - Disclosure - Inventory (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/InventoryTables</Role>
      <ShortName>Inventory (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://surna.com/role/Inventory</ParentRole>
      <Position>21</Position>
    </Report>
    <Report instance="srna-20210331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>00000022 - Disclosure - Property and Equipment (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/PropertyAndEquipmentTables</Role>
      <ShortName>Property and Equipment (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://surna.com/role/PropertyAndEquipment</ParentRole>
      <Position>22</Position>
    </Report>
    <Report instance="srna-20210331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>00000023 - Disclosure - Accounts Payable and Accrued Liabilities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/AccountsPayableAndAccruedLiabilitiesTables</Role>
      <ShortName>Accounts Payable and Accrued Liabilities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://surna.com/role/AccountsPayableAndAccruedLiabilities</ParentRole>
      <Position>23</Position>
    </Report>
    <Report instance="srna-20210331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>00000024 - Disclosure - Equity Incentive Plan (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/EquityIncentivePlanTables</Role>
      <ShortName>Equity Incentive Plan (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://surna.com/role/EquityIncentivePlan</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="srna-20210331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>00000025 - Disclosure - Warrants (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/WarrantsTables</Role>
      <ShortName>Warrants (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://surna.com/role/Warrants</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="srna-20210331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>00000026 - Disclosure - General (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/GeneralDetailsNarrative</Role>
      <ShortName>General (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://surna.com/role/GeneralTables</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="srna-20210331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>00000027 - Disclosure - General - Schedule of Remaining Performance Obligations Expected to be Recognized (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/General-ScheduleOfRemainingPerformanceObligationsExpectedToBeRecognizedDetails</Role>
      <ShortName>General - Schedule of Remaining Performance Obligations Expected to be Recognized (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>27</Position>
    </Report>
    <Report instance="srna-20210331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>00000028 - Disclosure - General - Schedule of Revenue by Source (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/General-ScheduleOfRevenueBySourceDetails</Role>
      <ShortName>General - Schedule of Revenue by Source (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>28</Position>
    </Report>
    <Report instance="srna-20210331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>00000029 - Disclosure - General - Schedule of Share-based Compensation Costs (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/General-ScheduleOfShare-basedCompensationCostsDetails</Role>
      <ShortName>General - Schedule of Share-based Compensation Costs (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>29</Position>
    </Report>
    <Report instance="srna-20210331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>00000030 - Disclosure - Leases (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/LeasesDetailsNarrative</Role>
      <ShortName>Leases (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://surna.com/role/LeasesTables</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="srna-20210331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>00000031 - Disclosure - Leases - Schedule of Lease Cost (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/Leases-ScheduleOfLeaseCostDetails</Role>
      <ShortName>Leases - Schedule of Lease Cost (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>31</Position>
    </Report>
    <Report instance="srna-20210331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>00000032 - Disclosure - Leases - Schedule of Future Annual Minimum Lease Payments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/Leases-ScheduleOfFutureAnnualMinimumLeasePaymentsDetails</Role>
      <ShortName>Leases - Schedule of Future Annual Minimum Lease Payments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>32</Position>
    </Report>
    <Report instance="srna-20210331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>00000033 - Disclosure - Inventory (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/InventoryDetailsNarrative</Role>
      <ShortName>Inventory (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://surna.com/role/InventoryTables</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="srna-20210331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>00000034 - Disclosure - Inventory - Schedule of Inventory (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/Inventory-ScheduleOfInventoryDetails</Role>
      <ShortName>Inventory - Schedule of Inventory (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>34</Position>
    </Report>
    <Report instance="srna-20210331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>00000035 - Disclosure - Property and Equipment (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/PropertyAndEquipmentDetailsNarrative</Role>
      <ShortName>Property and Equipment (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://surna.com/role/PropertyAndEquipmentTables</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="srna-20210331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>00000036 - Disclosure - Property and Equipment - Schedule of Property and Equipment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/PropertyAndEquipment-ScheduleOfPropertyAndEquipmentDetails</Role>
      <ShortName>Property and Equipment - Schedule of Property and Equipment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>36</Position>
    </Report>
    <Report instance="srna-20210331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>00000037 - Disclosure - Accounts Payable and Accrued Liabilities - Schedule of Accounts Payable and Accrued Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/AccountsPayableAndAccruedLiabilities-ScheduleOfAccountsPayableAndAccruedLiabilitiesDetails</Role>
      <ShortName>Accounts Payable and Accrued Liabilities - Schedule of Accounts Payable and Accrued Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>37</Position>
    </Report>
    <Report instance="srna-20210331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>00000038 - Disclosure - Note Payable and Accrued Interest (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/NotePayableAndAccruedInterestDetailsNarrative</Role>
      <ShortName>Note Payable and Accrued Interest (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://surna.com/role/NotePayableAndAccruedInterest</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="srna-20210331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>00000039 - Disclosure - Commitments and Contingencies (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/CommitmentsAndContingenciesDetailsNarrative</Role>
      <ShortName>Commitments and Contingencies (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://surna.com/role/CommitmentsAndContingencies</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="srna-20210331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>00000040 - Disclosure - Equity Incentive Plan (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/EquityIncentivePlanDetailsNarrative</Role>
      <ShortName>Equity Incentive Plan (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://surna.com/role/EquityIncentivePlanTables</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="srna-20210331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>00000041 - Disclosure - Equity Incentive Plan - Schedule of Stock Option Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/EquityIncentivePlan-ScheduleOfStockOptionActivityDetails</Role>
      <ShortName>Equity Incentive Plan - Schedule of Stock Option Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>41</Position>
    </Report>
    <Report instance="srna-20210331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>00000042 - Disclosure - Equity Incentive Plan - Summary of Non-vested Non-qualified Stock Option Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/EquityIncentivePlan-SummaryOfNon-vestedNon-qualifiedStockOptionActivityDetails</Role>
      <ShortName>Equity Incentive Plan - Summary of Non-vested Non-qualified Stock Option Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>42</Position>
    </Report>
    <Report instance="srna-20210331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>00000043 - Disclosure - Equity Incentive Plan - Schedule of Restricted Stock Units Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/EquityIncentivePlan-ScheduleOfRestrictedStockUnitsActivityDetails</Role>
      <ShortName>Equity Incentive Plan - Schedule of Restricted Stock Units Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="srna-20210331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>00000044 - Disclosure - Warrants - Schedule of Outstanding Warrants to Purchase Common Stock (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/Warrants-ScheduleOfOutstandingWarrantsToPurchaseCommonStockDetails</Role>
      <ShortName>Warrants - Schedule of Outstanding Warrants to Purchase Common Stock (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="srna-20210331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>00000045 - Disclosure - Warrants - Schedule of Warrants Outstanding (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/Warrants-ScheduleOfWarrantsOutstandingDetails</Role>
      <ShortName>Warrants - Schedule of Warrants Outstanding (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="srna-20210331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>00000046 - Disclosure - Income Taxes (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/IncomeTaxesDetailsNarrative</Role>
      <ShortName>Income Taxes (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://surna.com/role/IncomeTaxes</ParentRole>
      <Position>46</Position>
    </Report>
    <Report instance="srna-20210331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>00000047 - Disclosure - Subsequent Events (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://surna.com/role/SubsequentEventsDetailsNarrative</Role>
      <ShortName>Subsequent Events (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://surna.com/role/SubsequentEvents</ParentRole>
      <Position>47</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>srna-20210331.xml</File>
    <File>srna-20210331.xsd</File>
    <File>srna-20210331_cal.xml</File>
    <File>srna-20210331_def.xml</File>
    <File>srna-20210331_lab.xml</File>
    <File>srna-20210331_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://fasb.org/us-gaap/2021-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://fasb.org/srt/2021-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2021</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>66
<FILENAME>0001493152-21-010965-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001493152-21-010965-xbrl.zip
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M!,Q.U?$1N>(!:W &!*X3N?'7J0O3PK,]TSYNZDFU[W^#J"7#_3R,/K/'=-5
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MB]BO$C-'B/JJG#5SR.YW\BC]Z'&]PW.],C+OVH->I6ZBYX#ZYT/F""6_!/I
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M-04V,XN:87O0MMH'00T\%?)1\1D<3A!K)7MNF?V^I>WYTMFV JLLO@>FW=T
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M*ZB/N: JPJ-<(&Z,;+O='12$>=G<^5ZCW\+0C2F.A=MP-Z'O7@(#W3-GL_B
M!3+I=!;\6*LFK0;,K/YOV>O!'.HZ7'$PZ>"[BMC4\=R+ &.!PN@IU_LOMKL(
M-$,X?%$M6#GXQA 4VK9ASRP.0GKU)QXXAW,COF<N87!3+* QT\]<;.:-OCD,
MA:2%W>UTK8UA^&<8?;L(KJ(0V7!3/'3L=AX$F;$WAZ#815C&:5,2A&OG\1.<
MP9$'PVU,"U8G<V>2._C&$!0ZN?NV/1QN"@$6S*.0"[R+BAZV$ UM,Q</"Q-L
M!TH1C P&/5UF%@=%6!TQG*X8C?A^%D5+=,-BPG+0:VL;DS_ZYC 40@5(RT%_
M QBB&7-O')_%[\/)Q(MCP-J6Z.@,[%X[ \GR.;8&J)#P:/<ZPPT!DA',U\P'
M%G.ECN/!J]MAR1X,S+XF5==.5 EDQ>1,U]2O'4M#!N+8G8V2?SH8&9P\$;X=
M_[WO *(QVGA+S%G]=KNG2:""TU4(92$L LWID1L;0DG7&X)BJR.^=K?7TR]W
M5\^R/4S%_(>]KGZ\E8/I [M-+H(XB69H+ET(WYQXO<KPSTRD6Z%9%^V)R20,
M*.3^O3/U$L>GB-]8'%;N>1B=SY)9Q"[B>+;$CU8J)0#@@C^]!Y;F!JP/">^:
MYIQKL#3<N9D5[];G#[R;SQ_(!)_'9P^.Y^.A!A-2@;P"^%$H(/#?A<$LII&7
MY:L4Q9)M]P:]@8ZE72WRX,BT[7QB^_(((S]=!FP+8K/,!6K;*QXW26JA?[!^
MEQ?<7:/?+TZ]ADL$#2!Q* 5-!X1.>KVKKB@^/JB;SYUF9LTE!17U?7;G=ZAJ
MS!UL>\P3LW=BM^5]+7SN-!N0\7"'<?P>M)>G<1B1Z-Q8,S(MJYL-CUXZ1\;%
M])DEBT^>\R?1(30"[?1+R&O";.GMM*QAS^[):Z7R$Z^$FQZDO5JXKEYUVVF;
M[8ZZ3(<_^DN@RPZ?A23TXZ\Q[/+9G>.!WO+%^8ZRD4<U+^&/S2Y)!M)S5W#*
M>;)[-XN] #W'(^"RV,/5I ]?CO\($RT7A#\5S>5H;0:XSF"; ;& \0Q%E]KR
MJ_:?&AH7QEFPGD']O!S_+L,O%A'1.6F;Q0Z=R_'8&S$8Z9,3S,:8D1GEQ1S=
M_#5.%I#8&^K,G0*U^NXNODY#HF\P;9Q'7(":&2]+D.V<V(/T/%VWM-77M,/!
M,$\@K8.L\C7U-!VACSH"WN?? ,TYD1>"S&$C)RX4&I6-_2J_(B([LD\OQ\)J
MO8SHM$#]?INDVF4)@,MG%)G#^YYTNB!3MDD>EA)QU63KH9J[8Y:8N8J 73?=
MF&RB:GE,K8)IBZW;+5@;;N[*I%Z>T[L51)EE;:SA@0XJM$XM5[M@TGWA6)-?
MKWJ?Q&H/ ^AZ$M &5;V85"LFZB&TJ0MMY3ZOGW97H!?1;G<..I=#1:#>/D>]
MP*%Q>$"(LZL%H_B.KIY^P3OIQ/?X7[1N'QR?1__$\ 8:.?@#F,#9+[0G-[X,
ML0>=P4!/]]D&BITOJ=B]?=^R[$'%2^*[G#IBN9/K2_A.G/U73G09W21X3T.[
M*\M)%%[%ZK/--*5)O $,<@TN\]Y\#!(O>;IF=QXL&$CULS,IS B_WLRBP#'
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M7YCH/5]83<)6]U,C3IY\]LNK,;STQK#,:6)\\29@%GYFC\9U.'&"%O^B9=S
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MF,L_+CZ<6$/C"C:,@8#EU!.0_-J_1GL+QP2()-#83D;(4&^,QWO07>J$UM5
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M;QMEQ.36"U+6QE@PBK^CV$_2Q,1]Q3Q38D:&HJ$EHHC<Y"+R!KF;7L>Z*3(
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M#B//O[Q3M].R[:*E<PY2WVGK8CHI'=#)&LX2/%RYP33G92J(AZ+$L*NMWZ)
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M@C=D'S0E1/7!PH8[/UB#EMUN$TCRXGEMB1+JE5+LT19>AMN=(4V&;7]&LED
M%L'&6(C8\45KF1_:EDV +#R;7HY3NTO>T0O+G&&C#76UC]V-F.\#@;14AW=J
MG>)B$C/V':-^LV+YN;?C96Z\YV_+1;/F^,IY0@+C[9NC&7-_%P4)/18?P\5Y
M-W-Q+E=EB&411L7"#&UEBJA?>@=GA;"IAC!'(,R?0U@-\FM?\JWZNGOA#6WF
MFG3/V'.+C*/!2R5%T@[3/:3"C=E!'?5G% M028'W9X;BBF,&:E@??C&.H(S+
M+W/LE\30\[_9'F!$[*!_*+P\0XP.P7;KM<NF ]0C5J#H&F_(.L3NGEX<@_%:
MEK^*[OTV:DU)ST>[U>L\_Z35SJ!E][;/#=^'U"\AXLF( PJ,P C)&'/'2HUV
MO]LR[>W[,-5^G8-!R^S7*(M_:\EX%878'MMX=*+_O[TO;6X;R1+\OA'['Q"]
M=H0= :E(2J*HKIF)4/FH=D]5V6/97;L?DT120AL$V#@DLW_]OB,SD0!!";P!
M&3$]W3())EZ^?/GN(Q8A1A.0/$707E(<GKM7%W4C?^TEQ?[EF7LV? 8Q\MH[
M_DA#8[4/3-=+[<*&>-Y!U[/+H7M1N\%%ER:U+;HOANYPT/XTJ2="U_KC0$[3
MDJ7_%(:H]_26^.D"H45IX%Y>]=RSVCE3793ZL(<S J5DN&WO^9VUYMTPQE@.
M5;Z5XZ/6\%9$'8>%J"-]5!5Q_&"W1=];I+%Q0<6/H?->CD&]CQ?P&AU:M\K1
M"29RH7+O^,@13HA(U%%("IS[::)''8) ";_I/@7SV \G_ASCY3,:386-#B[Z
MY^Z@!R_#O("'*/[&@XOG/LX?F&?Q/ (EKFM+4(#E"R SB$2H\3BFV3RFES\"
M)%*G_Y)HVD\<#YNL6V=[04<[/'7,0C.Q@%4<U6O ZAZ !QIEJ0/*M C2A?43
M'[,GDLB9P_F'J2^"@)H*W/KW1 FPQC0+ @(&BQ9\S)V /R92>MPL(4O@$SQU
MU:$ R4$[/;3VCJT&,&DM2Q7;H2W-HCB]%;?2;)D^G8!.(^"U$=D!.)".GP9V
MX_F8DL+!<'SU3*;63NY$XJ2+.>I#CB>G(@M2AT F5Z"K.BX@72*TDSL1WE+3
M^N@AE'%RY\_S1)! 4K*(#[###<!I6():.B!B%RK_+@I/U#\('EB(CY'.R=40
M4*\)WHH'?!273..,*C\0(E!#[V4X6<#S?@+_R"CG)N)]^R&GX*AH_SA+_!"[
MFV'"BW,;T0V+X'3CD!"$=S3.YNGD@.T_BKRY=+D.F]NQ.IT)3K P3\E*/2)P
M\O0C0XC(TB[[(TY$4M($:%(US. 3@9MC,\W*%*$5LK,L8M^@RSHEJ@ I_08P
M A #7;0D">BR((ZMS1!=%K9S!,)H'-_/[PO\X>,?OP%CN\V3_GV#GX9<H29A
MC\>2E[K9]*](P8DEIP1B>Z6A>WE!;77PUJ:Q/\'$J23%^Y.%J-ND=R!=[X2'
MMQBDI@R=1*9I@%48(&A)*0*FC -V6!\2*#=F\$HYFP?1 AA)="]CE5_XK\Q'
M90H?Q!(_H'>")!7?N1G0&/F$[Y7Z I$DBB5<EY3$M/I6S$%N@9HEX-6P@B,R
MD-XQ"4Z6=_KG&.J">X7IC" #XK%/:8L@,L2$_^=6H,!A4"AAK+B!6-Z*V$R;
M4[OE5Y0?)25A)CSI3 +ASQ*M#:Y^Z])&LQ!1H)(V;W$O<)9)*GB"$>!W'DA!
MT"RO[:(<Y1RE*]V^R%X?I"?RZ*I-YH20W('6D&AYJI5AS;HN?]9I=K,9O(Q)
MQ==4H54;^"7.>*\F*3%-D2($:;\S*9!MT_'/^(++52]&38F8/#[,2IK.^D,6
M:J94FWY/4^$'^G%*0PT6AOA0TXEF1#J:8*X5)K%W%&,*53^4=O[,$0] !+@W
MHKOO/C;[A>5>]'NZ"16\D6"I@GPJ[F%5REMTIG!=<>LV!92.X]1Y-YURTRGG
M[UDHB\>Y#">*65@6K0T"LQ8TBG[>H.]+>)%-2$OXF**;[#&(>6_X<D5@^>U+
M4F[S=G;F7HTN7"9MLIV,1ILZHY?8G8LF$Q<W#S@>#(K$K.!]$V4QM5*:^@"*
M5T -W3!"!56$*"M.*"3],_-NI5%*47LGA!1)GG?TV!G93 :L-SH)S*64DUPC
M18L$55I<#'7O,'K0SRB0Z>OH07JG!,T7.LL2<B>D'62<NLVO@ALW%SCOV F,
M7%S)5#"A&]CP@N@77GY+D(8)Z-ZDZDN\\ ^\_!T0._S&L$.0&Q=@I**V+_B
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M%Q<NH<S'AW)L$H2,48*=OBX*&U29)5]Q9*Y!8*N:D@]#JZCX.P^5:6)2?@A
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M_24&YU?N&2A_^/3YA7MY/G+/L<MFS6T7R$D5&RO65ICLL2,*='9%?2KYPZ+
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M?^*<7_9.!KW7],Q; /R>7#><-?4WZ>$@&7,+!C_KNC#*CGU',S?M.T+ ?7R
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M0Q,ML:$XS\9@/S&B?$F%HX!3PW-KJC^,G_VH&FMP+E(S&#6/<2[FU655$('
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M-DS!POV/G[Z/X\#_*_XW_//_ U!+ P04    "  -2*M2]0EM$V0/   GJ
M$0   '-R;F$M,C R,3 S,S$N>'-D[5U;<]LV%G[>G=G_@-7,SG9G1Y9D)VGB
MQNW(MU2SMJ3:<M+VI0.1D(0)!2@ :5O]]8L+2?$*DK)<,:'SX$C$.0?G?!\
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M-)J9)49@>]TDL($-O0 *K#0/Y;YE48_(R?8:3ATD(!57F(?L*PRGV!$U!P-
M*4DS"[TD"X%-X!M5;/AF0<1N\W@94A>ED!X0%XD _6Y@%C$S<9AD0AK+9"$P
MV#P*SNARB5TUHQ+XBKF6B\6DEUAACS )F.$_2L(?,:70CQEK'O1R0);9+4M$
M@^_16*S:->19!6:H7R6AUB9 : -((\V#^!-D#)(@UQ5^,X/Y.@EFH-<\_$3[
MH4LT@8_!:!"]8$;Q37J6)U6!TFT>DK?>E*,OGHCE0DYV@Y5R\JH9T]2B;:,/
MM('F >NO6\?4P9N;5O*B&=;4@LY7!]\%!IJ;4YC(N5(<5?^2&=/4(B_$5*LW
M$%&=)H@"&KMBQ/,PM;;3N@V&,\P:1!%-7C2#FEJJA>H-QC4K\1"%V%!N1CNU
M',M.3S08^C+9AR@5%>3-U*26:F5S%@TF*V.5%N4FO]A,1;FE7(-Q#U9C4; 3
MU\P(YZ[O&@RJ/SL[1R[$#A]*0&1;B\W[4H5FF%,+P' &Z!L"H:7F MZ6^P-M
MST&CV0U:0E$EF8\14WN41(<?31T\U[L&+AY7R'*1/:&GZ 99=$[PG\CVH8SQ
MM"N;9GKS'B#*5:E?OWQ$&WH (BZ B \@< *X%$P1V/@1-I27YJ&H%%-3#YVN
M]0[<0N(SI<V4YJZ#DY0JVV"Z]G<#OQ 5A5[M%6G+O;FVW+F-"%<>GU'N\@+6
MRJB:*<Q==L<IC%0$HC4!5563^=3+ZNS[8$Z9D9&CW(7[RUTP0#O2 ]0%V0AC
M/:58S,Q!:IWO<Q#O%.JBZ@$O'2""]:7G"M#ZA'C0N195+[VEDA$K0_4HS\Q4
M66TS@:G402:!NBZ@*P-^;3ZM07U-IC;,;F4/;_G%9G)2R8-(%NUED(O 'ND6
M2:P3#)@DS62DT@<;,N*=)4U2 ZG)RF5F=XY2DF9J4GF'O/SG2Z?)9B;2*PQT
MY/-54M_,8BJMD<-BO+<54-U @LODKB.$E1&/-8!GM&]N(*G$2.E<>KS)E$_!
M-[<1&7<'9@_DU53,5*<2)H4;#%\&]X)-A]FD55$P4Y9*D!@W);[0E?.D*YNF
M,H)&>EZELB4Y3[]>:,FD)9I+=*GU>;22U?<M42Y$8_?'K;7-!*92+=D$)M*1
MLC:@JP-!?4V^KV62XRV7D*U'LR$E[7MQ+T&V_!2^V[\5X=O;-#>#5,(FMQEH
M#V0KV/@ 8DZ\-(]J/?]&8,BP?*2F@+L3GO MAH R9LR-()48*C,6;*KU>5<5
MO] >V?D0(6GDN?)<%WG@4+@'@HX]9BU4@GRYI$2A&.-]!W;,Q*>24.$.BSC7
MD5HW(BX%0<5 U^PWA!?FHXP%ER(8%I%L4#'SF;]C)LYG>#E*;(-IB[PMD9=R
MSQ<P4V)\O>)E?ISURD4V!8529AZ*7\GXMLF0?^0^@ALT ^K\LF-Y<M5)BV-Y
M:%W+O[9@:":N"7K:P?%2?XC0#AZ73B B31O.+U.,)M'P*PY,0&:EK*3.5Q-&
M5"I6K.X[@?.! 1>[4GT<J0;(>L20VME%R Z<5@U9J"#G&6.]DO9W&J1H?56#
M3#389PKU;%/+3@,67:=JP/'>]DSQGH>51,/U#W#K;$YP\[\G3WE[+P*GS 4D
M=5:<Z71!?2[B%;64*8.*_-8.]-KR4KMWV#[J'3QR>^-I%2<V,%1S(M#;PHF<
M,PZSZN=YXO*#:DQE*S6>E6BL.E.S@QR7!U?:&UO;N),^M? )_BAC6SA4?/YB
MGE-%FNH[WZIQJ&<Y;%VE@415@B^5&DK<FL<8(E8U#Z(ZX;?M&FORT,UR#2/0
MTHU"GL/YA ::?8SGMHX4-$__'$X]Q[P9]O\8>LLI8J.9RF=\5'FN4\\=4O<6
MN6*\%KK2]9-6"3GL./()TTG+99X<]>79K\?B;H"I/5$W+=O39\VU@+Z):0DN
M=WWR@8N64DI$+J:JXE[A2<D/C'JK0! +D8JA](E='$=,:-]!9.6W;K5QSB//
M!,>(R705G*,@LJTT*X<;'BPKI:2='<2LO$SM+^[+5?M<B9ZN-R+^EKG^ V2V
M3KY&,P>?$)XO)*?WB(D(PWW^\OD9@Y;K06>"V#+ ;"\U;]G$@JO[!'Q(R?XP
M?V+E^X>]X+V7&^1 ]=K+!9EC@H1G9#XBSGH,L1V$PS>]?2>V"D'1<V$W*)KJ
M4UQ/6A9#MCP.,PK5DA+D0K;^"Z$:0['8@$ZX=^E)6!49JRM8?_TH]D$F5#<W
MU7TZL/]N_=3HQ;BF'S &W_TIBO_UXG&%V>ZP+EW;OF="NP[TF7%\ G"Q.96J
MM![PZ>GQ@(R5[Y<0,_5K%;T=0FBHXEL=;<.&L_.6V 30U, O?[TE;"M\QS>C
M<E55Z.3?#-(?GZ?9&BKZ9E%.QWQ)V0SA'>)KKN*;139Y7PZ##B8Z.B>21N>9
MYP=;^%%;CORM-RH >4J#3C %R.66UO7F%-E)E/1:,9((S"17UQ!'[L*?6JKV
M*D^W(#P,++=T^Q9HH^ES,@;YPO]!F8GH0'R&&%,'AD#RV7]#)22ME.C6O#UO
MG/WYG*&Y&!VBB=R[%247C\A2YL0XHG+7^HAV'7)EK;TO]627DFY*3/O+*'W9
M177M9M>4N MG?:/>V^,6PRN-FHXEMW1;_%V9UMN!VW?"/\I<>;R-AG@TFR B
M\!LL5XS>*^F^X] '_31=1U-5J:Z<C1E:06R';Q[[HU^8/324UW34&"+7_UTG
M,K^BG)]!QM9B_B%G)YO#E?0\(][;MM+\2E!07JM>%'T:42BU[[XYI Z_XW".
M^G,H@9S 1^F/WEB9?@I87KP\;<_WY$]ZJ]K83+<Q'J,FIW#_&=\S!W(>[EP>
ML1N9LTY,@HTB^[[A9GHG9@?,PKP@AJA43<.(K>,*9&H90N(A2 #YF&$KN=;:
M6KT>6>K*_I=KI&4M?+4@%#?Q<OKU & O6P+""=[>:J_IC2P23+B2'! YG^'8
MBB=$ME:OZ9S1<-?>!HHBS=JF5XPW_FV0**'\E8&A1M#MH"A0K2T0^>G/,60C
MIGX%56="Q_Z]H43FU*#ZI!7*SF[.^:[[:<4206XDJ\:TZ^EF)#>O71NQC9LC
MLDD+YKQJ36S]D$.?Q7!*B1=)E3R;]9IWB1T'K.T]+ZAA'7M? #UC>.9G4\]:
M6YU@W3@VB 5X)>X_SCGF*\]-#F)5]&K[F#)\I#J:Z1T%D8-#@JT<$WJQ7#ET
MC38=KKK:5X[ N9B/6"YE%1&(JM46@:KMN=I#[4IV:C(D2"H5N64F,KF"=7V:
M,R"B K%0/T?Z_P&YTE]7E./P.4>A5%TG',%9%IN7^R?HT3UU!%5!;&:1)R1\
MW,#,#N*(//\<S4X]C@GB7/VNX3H54$G9FD0V6*Z@)0:#,WJ/[=Z[,20V6F)K
M1$8>*PAT.]6:Q/V!ZB27A1C)B<\L4I,XJI\^I'Z>*17L#NS4!)'(*T1B^JOW
M"B%VCRW$KY'<RQ:$7$;P"3'95*92=W$C]+A+EXB-"(H'D%50)X<G#S3;X6A!
MK1Q>,)2#<;RH#DZ'.SSB#J<OU\%9P?AD03TNQA71UR8/HG"=:AY%0G4-)-4Q
MBX1J%LBM_"TJ%R&BCQ:4YPGFQF.2K4E80_0P$%.1%1)_B!LN^U(A%<G5))Q(
M2ZI"5(%X'8(;4O)+QB&I":8*I>H02DXKJV>C"G-!^AAP[CERZ9N<'14(U2J0
M$&=8)J(BZ3J$=DF9F'4$+L<#R2FK@]O!BN%&;D9(W1=S2VOGNL'O6CD=&?##
M:8;^Z:Z@>83G!$=WBQCO'%L;J@,@P7S]DGHL>R8?*ZF#RY?0DK]"LE8YO41/
MSRRJ@]/&F4;L-.P*,Y1LO3J$>Q=_.RX>4UYA'1R/XSW$!$FX;U?(\H\.*9Y&
M%BO5(="P[6R>=*I'GPFNBL7J$$PX5<F9P=3*V=%LABTDVLHU)-Y,[AF4*;6X
MYP4R=0@C9]%><40KI5>'<(,Y35_HRXV>R;G.YCKT/P7N_H7OF+SOZ(,%Q<?_
M U!+ P04    "  -2*M2RWS2BK81  ",V0  %0   '-R;F$M,C R,3 S,S%?
M8V%L+GAM;.U=66\C-Q)^7V#_ ]?!+I('C25[)IEQ,KOP.3#@L1S;D^SN2]#N
MIBQB6J2F#]O*KU^2?:@/7BUUBS2P1N*16ZSB5U5D5?'L7_[UL@C!$XQB1/#'
MO<F;\1Z V"<!PH\?][[<C8[O3B\O]T"<>#CP0H+AQSU,]O[US[_^!="?7_XV
M&H$+!,/@")P1?W2)9^1G<.TMX!'X!#&,O(1$/X/?O#!E3\@%"F$$3LEB&<($
MTB^RBH_ NS?O/3 :&;#]#>* 1%]N+TNV\R19'NWO/S\_O\'DR7LFT=?XC4\6
M9OSN2!KYL&1V=WM]#/Y^< 8.Q@>3\>'A!$S&OX)?)^#LXOK-RXP*<^8EM!S[
MFA8;OZ._)N/[@X.C\>'1V\E_#2M-O"2-RTK'+^_'X^,Q_<G(?PD1_GK$?CUX
M,0341#@^>HG1Q[V*K,^';TCTN'\P'D_V__WYZLZ?PX4W0IB9RH=[!17C(J*;
M?/CP89]_6Q1ME7QYB,*BCL/] D[)F7Z+%.4K2&)T%'-X5\3W$M[2M-4 :0GV
MUZ@H-F*/1I.#T>'DS4L<[!7*YQJ,2 AOX0RP?VF+*6N-TPA[K(GLLV_VJ772
M!<3),0[.<8*2%3-5M.!(*7K.:A[!V<>]F-*-BI;!ZOO.A#99+6FWB1%K]7M@
M?Q.()U[(='DWAS")=9B$A?L&<>-%5.PY3)#OA9T0"2E[@,<Z%62VB*>SZ9+Y
M'FH#K;+45#W#.IU[^!'&E_AN3I4P)V% '> 9G"$?)5V FO#I&[H7SR]"\MQ)
MH2VB'D!E<47;Y!K%>JCX"E)_HQ6_7JJ':B_Q$U4FB5:ZFEL%>ZC\)B*T3R0K
MYMZ^I6C)[*K#H:+I =*Q[Y,4,S>R\AY"2&NA3Z(4!E?(>T A2I#>2%UX] #Y
MFB2P5=4E3F $8ZTZC8A[ $FSL@5*>,>E]9P2&LVHC\&^@3H-2'L R!H3BZ\^
MK0<]P1L:4G3 %"0] /K=BR(/Z^-QLUPO3H%^A/?>B]XX@J)]A(;T(8;?4JK7
M<^9U]%%!4KZ_@'!#0F326"7%^P-RS[JJ*8QZX=ZBE!D&4=D^(Y89"DGQ@:*7
M&28]Y8XBF1G<[IR&\<=F:+6$/?IF,T3BTOVYA#.8>"B,KUDU3&1#YR CZP_8
MB$T;!&D(I[-;.CY'F ;N&QCQ(2RUS_0A1(_9B.C\90G]! ;WY(3R]\DC1G_"
M($=H*$_/M0VD!NJ-4GBRRB:&MA!0Q6<0Z'PP.&*S(@&;8H,XYLH\)7$2;RQ'
M!Z:]1:^NW45-U1NLBE;X Z8#0[T:,Q@"[$6:I!$-"CCUPL^TTRW2!2]#HP7/
MV3>5H2/?/C.+KBU$2]@GN(J*FO4:XS3@,5""U%6U77@,!+FB+ 6:303IQGE'
M.6$%E$EQ0_&'KWGHF92N+7<C9L/.M'0580-6PV3^78%W8#$,X&J*DQ#_ZW3)
MTIICGWY/BQKVF6WY#B5:NEAXT6HZNR9X]$0;,PS8IV\T3J,9@D'/ F]=V^ 6
MOJ6H(L0&%!S,%XQH?^G3U!TJZ'%P6P$P31.^1D^[?SF8)3=TY#'G>>9B03!'
M9BAM?S4,(V[QJ )J<\GTS/J=L>V>O&I)!YC1[8K2E%X%U?="/PWY /.*_EVC
M@"\)Q $,"CX,]#8K^O0Q8S#.?B9@! JJZD?:'$#& M1X#(-;O')? WI T95+
MK/0SC?D!'93#@'V*28@"^ET <DX@9Y6C+?"&Q*]A#-F^#!+53<P@QA0CWWTQ
M\^('O@4CC4>/GK?<9[;?AV$2%T]X:QB-)_E.C._RQW\<QS%%<)I&464=,/0>
M8,CK_2,OURBV;Q-QGMK>0A^B)Y8>7L-$+X"2JBE/I<4<1SX@40"CCWN3@KT7
M^;5VTMX%DY>@+6B1M<D1HFVBH)]%9*%2;ZY*TD&"JO9IY7O@&:+'><)!V[16
M.3RF8.76J9<RL\:!56N(Y')/^S<17'HH8/.UU E1?SM-YC R[/-&Q&:V.K1J
MJPY:<,^$;),.^Y]EN$]>"+D'*-)9]@65I_Z@4E)NW"W9FIG]K56S]Z(Y]QI$
M)CH=P_EF0;M:TJXORF;HV-@LJ4[3*2.#FLJ-N-VV1<L!Z45WKZ%](B1X1F$H
M-\ZZA!LA6VN(IDCN*?T,+DG,IB>,>[F<PHW8K#6*3F3WC)3O1,:/?$'MEF&:
MSK[0U())(+>4ALR-F*HUEY'P[MGL$B<>?D1L-2&3$R;G+WZ8LODDO:<SHS:S
MX#O;%NRB"O<,F6'693VNY :RP?SF@P\[H54IQVOPV96%3^W(5U36A2DOU6JN
M\0R8$1/;G4<NF&16K(-JW&N;;&4X\OSD=Y3,3],X(0L8%?A76L.:4=MV(\86
M[:(,]TQ9SX[,C:BCLYW+&YO/3 'N&>X,SB"%6-M&:6X^,VK;&;ZQ$;LHPSU3
M\NG=+J%12F [H3?O=6J1W;-1!:O))(>DN(.>WD0: U*'$K".,P(*3;C7#)O]
MQLAZ"AJ'LBR]V;2RNV>O*X(?[V&T8)M#BYQ?X36$I1U*I;0V4LGKH'7:Y[.5
MKMPI-R>SP)9!U:('T$OT&KH\W[:87Z*1;?.4MRU16;L#^W+C);],2#6(;Y:T
MW37D>F\-V,5"NM>4CH, ,<&]\,9#P24^]98H\133_E("V[W<V#@:D=VST4V4
MCSU->HVPL.WX;FP;A:CNV>66;1C&,#CW(G8P.#[V_73!U,H._M:N-FJ;R836
M]MR(L=7,%=&C$04;NF^OCZOQA9\$CMF)[,LX3F$@ZSF,3D]F>^)#;PTS.5SM
M394<[!@'75(</:7MQ,%4-GE:^FHR["[R*0HJQ?QEORGE%?U[^ ,.XHL :Z<=
M#C<Y[0"^KW'^8:C3&IJK VN"O#439,T2D!E8,P7??\%>2A,M&/Q@\S#'IXC$
M\4U$9JI@7"MD=W 4)^5-'*J14:V8;>\FT'%K/"202]#'1]8S.H[P@DHH6G,M
MMP2Q/1[TO^#>>U&E>!LPL^W)];;<0D?N)1WE/'U^$D(Q22<H:A/Y9R_Z"AD<
MMK\C>()1@N(U.+D8.CK;SD1JD48S-)/?O19W"V-(\;"3%F>T)X6$[WK7FDU#
M9MMMF%K-2'KWC'8'PY#M!,TNF^(M;H$PBI/LI+#6>J;TMN=I3,W831_NV;.4
M,SNI?D5CGH'CKQ9VQDVV)6@>\!!$="<'D>8BR9NI>RGE-<&D+IC66RA(K&\,
MV$ <'9WMKJ052;1)0$_DG-,K+HK2&JQ5T+9GZ&HAB:0.>H>UJRO&4PBG5,KU
M1,H)G)$(5FY4.7^A49:J'&$O6EU2M?$E:S82(SPH-V]:%]EWP$IM]^8=:%06
MC01QR\E NWL5O4)O>0T3D^2P4<QVZQ>B;GG'X<WOG#E+8?*&=T*'+LHY82F!
M[=YK;F*IM)I N,/EE<[O"*JM4;S;9(TBKP8@#*H5_<-;DOAGD-=76[[8P6I,
M^[U#-4%_W$A0RA-PIJXLQK#;F2@H.AA]0E1))ZLO,;N_M R@^06$RKV277C\
M/WYLX%PZ6J@9Z87>R;EP< :7$?01UPC]'$*N81P<+TB4H#^]ZKU[POLE#*@=
M"!3;V;*+DMPS,7?N)\W7 "CF:"7E;<_);FU&M2+<,QSU'Q$[-7,&LW\O<7&B
MF;8]ONM_?=^?,G_KP,7V5KNMC;R)TMR<#VF(4=PJJ$P*-&2VM^X-8%V!6EZ%
M.>L7#\9\+K6+7<7T9@;^\3496*6H5V'I+J^L[.*^U?S,6L)/KZDE='_WI]O1
M7'F;19<6H6%DUA3>OZ:F8*0Z]]K )P]A-AZ<XC,4\YOMJ/*F,]VU51HR,_M^
M<->^1FIY%;Y>=#E&EYXLIC><#!F[:^%NFG*OXRHO-JQ. ^@W 73F9&A]A^?"
M-M6>>^U -/[(5GSRI$1SE;T)M:&]'9XOZZ(E%VV<7]__>T35=$:>E1Z\7=;0
M?@Y/E,DU,/RQ13Z^XS-U_,VE<G_*2LL*&YK Q6DLE5CN]IAF?Y=<^]/%-4I9
M&!KW5<UB:?0U?+=K0[K*_N3IN*3[Z8@,+>7B=)2)>*YV1XG4S*O'6ZXN"WE8
MO1(B?V/Q/3GVOZ4H@M+W*<AE[<+#T75IA6V;%TMT5IB# V^)%BX0]K"_70L7
M\K#\;A0?PH#O43.[VDQ.X6CK5=BM_;84I3+<<\9;O6GH!D:(!.TXE)\L/7_Q
M^1ZN6R^!Y[,9]%4W0>\8A^VF9D?O[4U 7?,/)S=*NZQ,5>C;0IG##<]=5J;*
M$[MR$TE^V++$5=L@^A-[!2R*_9!0*DC_*$L/LW>5CP@DFU7?-[$4A8>!4L[:
MB-%\:**IE!\&4)%9"I/**K;)N(FM(,W>XMM.O_L%VFEAN09\T@1>L (Y+RY
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MZ6>+&>N:RSG&C+&Y;KHE&&/&M%F!;%F<!/G[M,4%=!FK7?5SMPDHZP;WX>T
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M(MLF0?WX/-M?WQ"SV\]PGO<\9<;Y>M/DUE[C3VD<=OE"R%D4)<NL0,:7EQ7
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M[S\<__C^^]=\^4U3^:P&LS3&=WB%F)D_%V\;@MX\HN#[IO[L.<,KL3)QEOU
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M-=6=O&AC=W90C$;W83_@!X)*&U<'P,L9.SC_OLTFOK<_H0$ZRM<;[ TU&JR
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MHQ<H,YQ?<?3T3.PY>2$#_!.^*=>/.%NLF,F=BQ!FV!PKS"5D=S.XB^1QDL
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M0@I,1JQ:%! 0?0RBA,:;BX2>*DAS=OYKL:*/ZA6R[!@:'J>/DYFHWWNN3,4
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M;OI+4X_==E*/-5?YK\&E'CO'CX7QM%I&[/8I(97"_<>#1)1@8*=4CT_[]5B
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M7G$NOF>2*"B+9XS.%I^OSH_?_X0:B8@ ELB<#+$3#;#UE<Z!=W]3@]J6V>7
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M'\,J+:W-CHN]&+?OOXTSLO\*G)T,,$ =J3@_^E/PQF_H*L_I=>7N,8J>4"#
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M0-$HQK_W2J<944T*:R=V>S>1Q0ZG08Z79^F:>F1V$Z#S]'-^^K:EJ;-9LB4
ML^NG.\OW<S]UHFH17V#=4;CWCC"715P/JN73L)-Q'S]2=M0MH_M*>8X>WWJ$
M=4&(E03LSJRVRF0U=JVY4SN%8*>=;K**Z/6VG:7"Z693F<+U+X,^I>E2U^#N
M_9ZQ:2P;?,^"350$<34]KA/K+"_3[+(LR@PW@[BDUD?(<9M"=*29_8RBED+
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M+3B)%W3KR9*C/L;AM(DHO],?<V/5LQ^]'$A+K1/8(3W:Q9_L G J85<@:Z1
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M%TXD7B*)3UPW7::^2(^NO:78! O2%XJ;Q6 40]S@$B$"89-#$_L-#I$U/\8
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M2(5!/O@'^TG]-)6<2JV H9*5TM4J+XKE^*6XKX)Y&"USQ/5YV- !H(IEO]
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M7??0**ZIG_"(K&.-\D&G;P_\H^IE3=F)QFP#K7)*/BH6.2F !(6Z%5#9B09
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M)M/HGD7/GBMSVO"F[2WW#Q8I*W8<,B8HB!=;"I)B5>J>HCE^ZIY*HYH8M/%
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M-U]Q^+SA@'.\'/\_F:.(F>@SYCZ<-OO+C,@Z#6+D/&4W?(UX>&'^,\N<NMJ
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M8V"'EH,1,Q>,47QS\1?Q#[$K\]_\%U!+ 0(4 Q0    (  U(JU))U3$%*<D
M "6U"  1              "  0    !S<FYA+3(P,C$P,S,Q+GAM;%!+ 0(4
M Q0    (  U(JU+U"6T39 \  ">H   1              "  5C)  !S<FYA
M+3(P,C$P,S,Q+GAS9%!+ 0(4 Q0    (  U(JU++?-**MA$  (S9   5
M          "  >O8  !S<FYA+3(P,C$P,S,Q7V-A;"YX;6Q02P$"% ,4
M"  -2*M2WK_*@W$E  "1MP( %0              @ '4Z@  <W)N82TR,#(Q
M,#,S,5]D968N>&UL4$L! A0#%     @ #4BK4J;J_O [6   5W(% !4
M         ( !>! ! '-R;F$M,C R,3 S,S%?;&%B+GAM;%!+ 0(4 Q0    (
M  U(JU*M+)5Y.CH  ,XR!  5              "  >9H 0!S<FYA+3(P,C$P
A,S,Q7W!R92YX;6Q02P4&      8 !@"* 0  4Z,!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
